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ABSTRACT:  A  mixture  of  (5S,9S)-5,9-dimethyl  heptadecane  ( l a ) ,  the  
main  sex-pheromone  component  of  Leucopcera  sc i te11 a,  and  its  
(5R,9S)-isomer  ( 2 a )  was synthesized  conveniently  from  (R)-citronellal  
(4, obtained  from racemic citronellal by enantiomer  selective  baker's  
yeast reduction)  in four  steps.  
(5SR,9S)-5,9-Dimethyl-pentadecane  (mixture  of  l b  and  2 b ) ,  a  possible  
sex-attractant  of Peri1eucopcera  coffeella  was prepared  analogously.  
5,9—Dimethylheptadecane  and 5,9-dimethylpentadecane  were  isolated  and  
identified  as the major  sex pheromone  components  of mountain-ash  bentwing  
(Leucopcera  scicella,  Zeller)  and  Peri1eucopcera  coffeella  (Guer.-Menev),  
respectively1,2.  Although  the  ( 5 S , 9 S )  isomer  ( l a )  carries  the  biological  
la: R= Ec 
lb: R- H 
2a: R- Et 
2b: R-H 
activity,  its  1:1  mixtures  with  all  the  other  stereoisomers  also  showed  
essentially the same activity  in field  trials3.  
Two  recent  publications  reported  the  synthesis  of  these  compounds  as  
diastereomeric  mixtures2,4.  Leikauf  prepared  all  of  the  stereoisomers  of  
5,9-dimethylheptadecane  in optically active  form3.  
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In  course  of  our  studies  on  stereocontrolled  synthesis  of  insect  
pheromones  we  elaborated  a  short  and  convenient  route  to  (9S)  isomers  of  
both pheromone components  (1 and  2).  
Racemic citronellal  (3) was  incubated with fermenting  Baker's yeast to 
afford  a  mixture  of  (R)-( + )-citronellal  ( 4 ,  21%,  [a]D=  +12.7°)  and  
(S)-(-)-citronellol  (5, 33%), which was separated  by  chromatography.  
Br" Ph3  P  
6a:  R=  Et  
6b: R=  H  
7a: R-  Et  
7b: R=  H  
8a:  R=  Et  
8b: R=  H  
9a: R-  Et  
9b: R-  H  
10a: R=  Et  
10b: R=  H  
1  +  2  
Scheme  I:  i) NaOEt,  toluene, azeotropic  removal of ethanol,  then  
addition  of  4 at -50"C, 2 h, r.t.; ii) Se02,  EtOH, reflux, 3 h; 
Hi)  n-Pr(Ph) P*Br~, NaOEt,  toluene, azeotropic removal  of ethanol, 
then addition  of 8a or 8b  at  -50"C, 3 h, r.t.; iv) PDC,  CH2C12,  
2 h, r.t.; v) 10% Pd/C, Hz,  MeOH-EtOAc.  
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The syntheses of la+2a and lb+2b were accomplished  as shown in Scheme 
I.  Thus  4  was  coupled  with  the  ylide  generated6  from  6a  (77%) .  The  
resulting  diene  7a7  (3:2 mixture  of  E-  and  Z-isomers) was  treated  with  
selenium(IV) oxide in refluxing ethanol8 to give a mixture of aldehyde 8a7 
(32%)  and  alcohol  9a7  (19%) .  The  latter  was  easily  oxidized  to  8a  
(piridinium  dichromate,  CH2C12/  70%).  Coupling  reaction  of  8a  with  the  
ylide  generated6  from  propyltriphenylphosphonium  bromide  yielded  triene  
10a7  (50%,  unseparated  mixture  of  geometrical  isomers),  which  on  
hydrogénation  (Pd/C  in methanol-ethyl  acetate,  83%)  gave  a  mixture7  of  
natural pheromone component  (la) and its (5R,98)-isomer  (2a)7.  
(R)-(+)-citronellal  (4)  also  served  as  a  key  intermediate  in  the  
synthesis  of  pheromone  component  lb.  Here,  in  the  coupling  reaction  we  
used the ylide generated from 6a, and prepared a mixture7  of  (58,98)-  and  
(5R,98)-isomers7  (lb and  2b, respectively)  by the same reaction  sequence  
as described above, via the intermediates 7b, 8b, 9b, and 10b  (22% overall 
yield from 4). 
The mixture of la and 2a proved as active as  (8,8) isomer  (la) alone 
in field tests. The detailed results will be published elsewhere10. 
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Abstract:  Enantiomer selective  hydrolysis of  racemic  1,2-diol  diacetates  (rac-2a-h) was  investigated by 
using  the  inexpensive  commercial  porcine  pancreatic  lipase.  The  hydrolysis  proceeds  with  
variable  regioselectivity  but  with  moderate  to  good  enantioselectivity  yielding  a  mixture  of  
isomeric monoacetates (3a-h  and 4a-h)  and unchanged diacetate  enantiomers (2a-h).  Evidence  
was  found  that  both  monoacetates  (3a-h  and  4a-h)  are  formed  with  the  same  sense  of  
enantiomer selectivity. 
1,2-Diols  are  important  structural  unit  or  synthetic  building  block  for a  large  number  of  biologically  
active  natural  or  synthetic  compounds.  The two  enantiomers  of  such  compounds  possess  different biological 
activity,  e.g.  while  the  active  enantiomer  of  pheromone  brevicomin  contains  1,2-dioxy-butane  subunit  with R 
configuration the  other isomer  shows  inhibitory properties1.  Prostacyclin  analogs  showing  platelet-aggregation  
inhibitory properties were synthesized from (5)-l,2-heptanediol2.  These examples indicate that there is a need for 
rational method of enantioseparation of racemic 1,2-dioIs. 
The utility of hydrolases,  especially  lipases for enantiomer  and regioselective  transformation of alcohols 
and related  compounds is well  known3.  Recently,  lipase  catalyzed transformations of  1,2-diol  derivatives were 
studied  by  several  groups.  Although  hydrolysis4  or  alcoholysis5  of  1,2-diol  diacetates  were  also  investigated,  
enzymic  acylation  (transesterification)  was  chosen  as a tool  for kinetic  resolution of  racemic  1,2-diols  in the 
majority of these  studies6"11.  Transesterification methods  applying lipase from Candida cyilindracea  (CcL) in 
aqueous  biphasic  system  consisting  tributyrin  as  ester  component6,  porcine  pancreatic  lipase  (PPL)  in  ethyl  
acetate  or  butyrate7  or  methyl  propionate8  matrix,  or  lipase  from  Pseudomonas  sp.  (Amano  PS)  in  
tetrahydrofiirane containing vinyl acetate  and triethylamine9>10  have been reported. Acylation of diols by acetic-
or butyric anhydride catalyzed by PPL in ether or tetrahydrofiirane has also been investigated11.  Generally, high 
or  exclusive  regioselectivity  preferring  the  primary  hydroxyl  groups  has  been  observed  by  these  enzymic  
acylations  parallel with variable degree of  enantiomer selectivity.  Contrariiy,  hydrolysis4  or alcoholysis5  of  1,2-
diol  diacetates  by  using  lipases from Pseudomonas  sp.  (P. aeruginosa  lipase,  and  Amano  PS,  respectively)  
proceeded with moderate regio-  and variable enantiomer selectivity. 
In  the  present  study  our  aim was  to  investigate  the  hydrolysis  of  1,2-diol  diacetates  catalyzed  by the 
inexpensive PPL (Scheme 1., Table) with respect mainly to the degree of enantiomer selectivity and applicability. 
Enantiomer  selectivity  of  hydrolysis  could  be  compared to  that  observed  by  enzymic  acylation  of  the  parent  
diols8  with methyl propionate using the same lipase (PPL) in the case of  diols  rarc-la,b,c,e.  
2 2 1 1 
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Scheme  1.  PPL-catalyzed  encmtiomer selective hydrolysis of  1,2-diol  diacetales  
Reagents: i..) Ac20,  cat. H2S04,  reflux,  15 min; ii.)  PPL, H20,  pH 7,  r.t.; iii.)  cat.  NaOMe,  MeOH, r.t 
Although  enhanced  enantiomer  selectivity  is often observed  by  acylation  of racemic  alcohols  in  organic  
media  in  comparison  with  the  hydrolysis  of  the  ester  of the  same  alcohol  by  the  same  enzyme3,  in  the  case  of  
1,2-diols the  situation  is opposite.  Enantiomer  selectivities  of hydrolyses of diacetates  rac-2a,b,c,e  have proved 
to be superior to those  observed  by acylation of the corresponding  diols  rac-2a,b,c,e  with  methyl propionate8  in  
each case.  Furthermore,  our  preliminary experiments  have shown that the  hydrolysis  of  1,2-diol  diacetate  rac-2d 
catalyzed by PPL proceeds  at  least  one magnitude faster than  the corresponding  transesterification  of the  parent  
diol  rac-Id  in ethyl acetate or methyl  propionate with the same enzyme. 
The ratio  of monoacetate  regioisomers  (3  and  4)  obtained  by hydrolysis12  much  depends  on  the  constitution  of  
the diacetate  rac-2  (Table),  contrarily to the exclusive acylation of the  primary hydroxyl group  in the  acylation8.  
The  monoacetate  regioisomers  have  proven  to  be  separable  by  simple  vacuum-chromatography24  from  the  
3+4c,d,e,h  mixtures.  Analysis of each  diol products ent-lc  obtained from the separated  monoacetates  3c  and  4c  
(Scheme  2.)  showed  that  the  enantiomer-preferences  are  the  same  in  the  PPL  hydrolysis  for  primary  and  
secondary acetoxy groups.  
OAc 
OAc 
rac-2c 
OAc OAc OH 
OAc  +  ,OH  +  
2c 
OH 
OH 
lc 
4c 
OAc 
3c 
1' 
OH 
ent-lc 
[afo= -14.7  ,  86%e.e.  [ab=  -14.2  ,  81%e.e.  
OH 
.OH 
ent-lc 
OH 
Scheme 2.  Regioselectivity  - enantiomer preference  correlation in PPL  hydrolysis  
Reagents: i..)  PPL, H20,  pH 7, r.t.,  30% conversion; ii.) cat.  NaOMe, MeOH, r.t. 
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Table: PPL-catalyzed enantiomer selective hydrolysis of  1,2-diol diacetates ° 
Substrate 
rac-1 
Conv. % 2,  Yield"  % 
[alDof 
1 
e.e. of 
lc ,  %  
Config. 
of 1 
3:4 
ratio1' 
3+4, 
Yield",  %  
WDof 
ent-1 
e.e.of 
ent-lc, % 
a 50 75 •4.85  f  28 ft 0.62 64 +4.19  f  24 
30 0.45 61 +5.33  f  30 
70« 49 -9.09  f  52 ft 
b 50 58 +8.9  «  72 ft 1.1 67 -8.8  s  69 
30 1.0 86 -10.5  *  82 
70« 48 +11.6  «  91 ft 
c 50 77 +14.1  *  81 ft 2.2 80 -13.2  *  76 
30 2.5 86 -14.5  *  85 
70« 48 +17.4  *  >96 ft 
d 50 78 +10.9  '  72 ft 0.57 72 -9.4  '  56 
30 0.64 80 -11.4  '  68 
70« 68 +13.4  '  80 ft 
e 50 73 +9.4  J  77 ft 0.75 71 -7.4  i  62 
30 0.81 77 -9.3  i  78 
70« 70 +11.0  i  92 ft 
f 50 81 +4.2  *  58 ft 4.4 75 -4.0  *  55 
30 4.0 68 -4.9  4  68 
70« 57 +6.3  *  87 ft 
S 50 75 +3.2  '  54 ft 4.3 54 -2.9  '  49 
30 4.4 SO -4.4  '  75 
70« 54 +5.4 I 92 ft 
h 50 81 -2.8  "  51 ft 1.7 73 +3.0  m  55 
30 1.7 75 +3.1  m  57 
70« 63 -3.3  m  61 ft 
a.- reaction conditions:  5-20 mg PPL/mmol substrate, water, pH 7.5, RT, 0.2-3  h. For details see the Experimental  section;  4.-
isolated  yield  after separation  in  respect  to the  given  conversion;  c.- determined  by  NMR using  Eu-shift  reagents13  and/or  
comparing the measured  optical rotatory power with the corresponding  literature data  given for each diol below,  d: Isomeric 
ratio was estimated from the integration of the CO-CH3, -CH2-O, and CH-O signals in the 'H-NMR spectra of  3+4 mixtures;  
«.- The diacetate fraction separated after hydrolysis to 30% conversion was further hydrolyzed to a degree which corresponds to 
70% conversion of the original  substrate;/-  (neat). Maximum value found14 for (ft), [a]D +17.48° (neat); g:  (c  2.5,  ethanol).  
The highest values  found"  for the pure enantiomeis: (ft), [a]20D  -12.87  (c 2.5, ethanol), (ft), [ a p D  +12.4  (c 2.5, ethanol);  
*.- (c  12, ethanol).  Maximum values found for (ft), [ajD +16.2  (c  14, ethanol)!6  and  for (5),  [a]23D  -16.1  (c 3,  ethanol)17.  
Since our preparation had higher (+17.4°) rotation value as found in the literature optical purity calculations are based on our 
own value; u (c  12, ethanol). Literature values found for (ft), [a]2®  +16.8  (c  12, ethanol)18-19  and for (ft), [a]220  -16.6  (c  
11.9, ethanol),  100% e.e.19;  /  (c  1, ethanol). Literature value found20 for (ft), [a]22D -11.9° (c  1, ethanol), >94% e.e.;  (c 5, 
water). Literature values found21 for (ft), [a]22,,  +7.1  (c 5, water), >94%e.e. and for (ft), [a]22,,  -6.4  (c 5, water),  88% e.e.; 
/.- (c 2, ethanol). The highest values found22 for (ft), [a]21„  +5.9  (c  1.7, ethanol) and for (ft), [a]21D  -5.4  (c 2, ethanol);  m: (c 
10, benzene). Maximum value found23 for (ft), [a]20D +5.45  (c  10, benzene). 
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It  is  noteworthy,  that  quite  consistent  structure-regioselectivity  and  structure-enantiomer  selectivity  
equations  could  be  obtained  for the  PPL  hydrolysis  of  diacetates  rac-2a-h  by  minimizing  multilinear  equation  
systems  using  NMR  signals  (acetate  methyl,  O-methyne,  O-methylene  chemical  shifts),  calculated  (MM2)  
distances,  mass of side  substituent  R,  and TLC Rf value of the diacetates  as unconditional  parameters.  
In  case  of  hydrolyses  with  moderate  enantiomer  selectivity  a  cascade  procedure  can  be  applied  to  
enhance the enantiomeric  purity.  This possibility  is illustrated  by the tandem hydrolysis of rac-2f  (Scheme 3.).  
I  (40%)  iii  
2f 
3 f+4 f 
O A c 
rac-2f 
2f 
i  (50%)  
3f+  4f  
ent-lt 
2f 
3 f+4f 
/ (60%)  iii  
If 
Scheme  3.  Cascade  hydrolysis  of  1,2-diacetoxy-3-chioropropane  (rac-H).  [Under formula  of  diol  
enantiomers  If and ent-U  an illustrative part  of 400 MHz PMR spectra  in the presence  of Eufhfc) 3  as  
chiral shift reagent13  are shown] 
Reagents :  i..)  PPL,  H2O,  pH  7, r.t.  (degree  of conversion  is given  in  parentheses);  ii.)  A c j O ,  cat.  H2SO4,  ref lux,  15  min . ;  
iii.)  cat.  N a O M e ,  MeOH,  r.t.  
Comparing  the  90%  enantiomeric  purity of  diol  ent-If  prepared from rac-21 by the  sequence of  PPL  hydrolysis  
(to  50% conversion)  -  reacetylation of the monoacetate fraction 3f+4f - PPL hydrolysis (to  60% conversion )  to  
which  obtained  by  the  one-step  hydrolysis  (55%e.e.  and  68%e.e.  at  50%  and  30%  conversion,  respectively)  
shows  that  significant  improvement  of  enantiomeric  purity  can  be  achieved  using  consecutive  hydrolyses,  
naturally,  in charge of chemical yield. 
From  the  viewpoint  of  practical  applicability  it  is  worth  to  mention  that  in  case  of  rac-2a,b,c,f,g  the  
diacetate (2)  and monoacetate  (3+4) fractions obtained  after PPL hydrolysis  are conveniently  separable  by using 
only extractive  methods.  
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Conclusions 
Analysis of  data on  lipase  catalyzed  hydrolysis of  1,2-diol  diacetates  compared to  the lipase  catalyzed  
acylation of  1,2-diols  shows  that  contrarily to  the  acylation -  hydrolysis  of  simple  racemic  alcohols  and their 
esters  where  a  common  or  very  similar  transition  state  for  the  hydrolysis  or  acylation  is  assumable3  the  
hydrolytic process is  mechanistically  quite different from the acylation of the  parent diol.  The consequences of 
this  difference are the  very  high  regioselectivity  parallel  with  moderate  enantiomer  selectivity  and the  poorer  
acceptance of the  1,2-diols as substrates in case of acylations and moderate and variable regioselectivity parallel 
with a higher enantiomer selectivity  and a higher rate of transformation in case of  hydrolyses.  It  means,- that in 
synthetic  procedures  requiring  high  regioselectivity  in  transformation  of  1,2-diols  the  acylation,  while  in  
syntheses needing higher enantiomer selectivity the hydrolysis of the diacetates are the method of choice. 
EXPERIMENTAL 
The  3H-NMR spectra were measured  on JEOL FX-100 (100 MHz) or Bnicker AW-80 (80 MHz) spectrometers in  CDCI3  solutions 
containing TMS as internal  standard. Enantiomer purity determinations13  using Eu(hfc)3 as chiral shift reagent  were made in dry 
dj-acetonitrile  on  a  Varian  VXR-400  (400  MHz)  spectrometer.  Optical  rotations  were  determined  on  a  Perkin  Elmer  241  
polarimeter.  Thin-layer  chromatography  (TLC)  was  made  using  Merck  Kieselgel  60  F254  aluminum  sheets.  TLC  plates  were  
developed using the following solvent systems:  hexane-acetone =  5:2,  A; diisopropyl  ether-acetone = 2:1, B.  Spots were visualized 
by  treatment  with  3%  ethanoUc  phosphomolybdic  acid  solution  and  heating  of  the  dried  plates.  Preparative  vacuum-
chromatography24  was  performed  using  Merck  Kieselgel  60  F254.  Acetic  anhydride  and  racemic  diols  (rac-lajbfif)  were  
purchased from Merck.  The other diols (rac-ld,e,gji) were synthesized by known procedures. Porcine pancreatic lipase (PPL, Type 
II) was obtained from Sigma. All solvents used were freshly distilled. 
Acetvlation of racemic diols (roc-la-hl:  general procedure 
Acetic anhydride (12.4 g,  0.12  mol) was added dropwise to the stirred diol (rac-la-h,  0.10  mol) containing one drop of 
conc.  H2SO4  at  a  rate  providing  gentle  reflux.  After introducing  acetic anhydride  the  mixture  was  stirred  for  15 min  and  then  
neutralized  by adding sodium acetate. Product was isolated by vacuum distillation in 70-88% yield showing the appropriate IR and 
ta-NMR  spectra.  
rac-ls:  yield:  70%, b.p.:  81-82°C (22  mbar/17  torr),  TLC: Rf(A)= 0.59; rac-2b: yield:  73%, b.p.:  85°C  (15 mbar/11 ton), TLC: 
Rf(A)= 0.58;  rac-tc:  yield: 78%  b.p.:  92-94°C  (11  mbar/8  ton),  TLC: Rf(A)=  0.59;  roc-2d:  yield:  81%  b.p.:  128-132°C  (20  
mbar/15 ton),  TLC: Rf(A)= 0.60; roc-2e: yield: 81% b.p.:  132-139°C (4 mbar/3 ton),  TLC: Rf(A)= 0.62; rac-lt:  yield: 77% b.p.:  
118-122°C (21 mbar/16 ton),  TLC: Rf(A)= 0.48; rac-2g: yield: 88% b.p.:  114-116°C (21 mbar/16 ton), TLC: Rf(A)= 0.45; rac-2h: 
yield: 72% b.p.:  138-139°C (4 mbar/3 ton),  TLC: Rf(A)=0.59. 
Hydrolysis of  racemic diol diacetates (rac-2a-hl: general procedure fon 50 mmol scale) 
To a stirred emulsion of  1,2-diol diacetate  (rac-2a-h,  50 mmol) and 80 ml of water PPL enzyme (I  g) was added and the 
pH value of the mixture was kept constant 7.4 by dropping  1M NaOH solution from an autoburette. After consumpting the desired 
amount of base (0.4 - 4 h) the mixture was extracted with ethyl acetate (4 x 60 ml). The combined ethyl acetate layers were washed 
with brine (40 ml) and dried (MgSO^.  After evaporating the solvent  in vacuo the remaining oil  was separated either by vacuum-
chromatography23  (a) or extraction  (A) yielding diacetate (2a-b) and monoacetate (3+4a-h) fractions in 48-85% and 55-85% yield 
(based on conversion),  respectively.  
a)  The  remaining  oil  was  applied  onto  a  column  filled  with  silica  gel  (100  g)  and  eluted  first  with  hexane-acetone  =  10:1  
(approximately  1000 ml) then  with hexane-acetone  =  5:1 eluant  mixtures.  After analyzing  the  collected fractions the  appropriate  
parts were combined and evaporated yielding diacetate (2a-h) and monoacetates (3+4 a-h). 
b) The  remaining  oil  was  dissolved  in  hexane  (ISO  ml)  and  then  extracted  with  water  (3-4  x  150  ml).  After  reextracting  the  
combined  aqueous  layers with  hexane  (100  ml)  the  unified hexane  layers  were  dried  (MgS04)  and  evaporated  in  vacuo  giving  
diacetate  (2a,b«cXg).  The aqueous layer was then extracted with ethyl acetate (3-4  x  80 ml).  Evaporation  of  the solvent from the 
combined and dried (MgS04) ethyl acetate layers in vacuo gave monoacetates (3+4a,b4^f,g). 
For  calculated  yields  of  fractions  2a-h  and  3+4a-h  and  isomeric  ratio  of  monoacetates  (3  to  4)  see  Table.  Physical  
properties (IR,  ta-NMR  spectra, TLC)  of optically active diacetates (2a-h) were similar to the racemic compounds (rac-2a-h). 
Hydrolysis of  1,2-diacetoxypropane {rac-2a) 
a) Hydrolysis of roe-2a: (10 g) at  50% conversion yielded after extractive separation 2a (3.75 g) and 3+4a  (2.36 g). 3+4a:  TLC:  Rf  
(A) = 0.39,  1H-NMR,  &  1.19 (d, J= 6Hz,  1.3H, 4a  -CH3),  1.22 (d, J= 6Hz,  1.7H,  3a -CH3),  2.07  (s,  1.3H, CH3),  2.09  (s,  1.7H,  
CH3), 3.61 (d, J= 5Hz,  1.15H, 3a -OCH2-), 3.8-4.3 (m,  1.3H, 4a -OCH2- and OCH), 4.7-5.2 (m, 0.31H, 3a OCH). 
b) Hydrolysis of roc-2a: (25 g) at 30% conversion yielded diacetate (11.16 g) and 3+4a (3.37 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2a (3.68 g) and monoacetates (2.41 g). 
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Hydrolysis of 1,2-diacetoxybutane (rac-2b)  
a) Hydrolysis of rac-2b:  (10 g) at 50% conversion  gave after extractive separation  2b  (2.90 g) and 3+4b  (2.54  
(A) = 0.40,  1 H-NMR,  & 0.96  (m,  3H, CH3),  1.25-2.0 (tn,  2H, CH2),  2 0 8  0>r s-  3H,  CO-CH3),  3.55-3.77  (m,  
3.78-4.35 (m,  1.4H, 4b OCH2 and OCH), 4.6-5.05 (m, 0.55H, 3a OCH). 
b) Hydrolysis of rac-2b: (15 g) at 30% conversion yielded diacetate (6.82 g) and 3+4b (2.93 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2b (2.14 g) and monoacetates (2.35 g). 
Hydrolysis of 1,2-diacetoxypentane (rac-2e) 
a) Hydrolysis of rac-2c: (10 g) at 50% conversion gave after extractive separation 2c (3.85 g) and 3+4c (3.1 g). 
b) Hydrolysis of rac-2e: (15 g) at  30% conversion yielded diacetate (6.82 g), 3c and 4c (total monoacetates: 3.02 g). Analytical data 
for the rcgioisomers separated by vacuum-chromatography  on silica gel: 3c:  TLC: Rf (A) = 0.39,  1 H-NMR,  & 0.93  (m, 3H, CH3),  
1.48 (mc, 4H, 2 CH2),  2.09 (s, 3H, CO-CH3), 3.67 (mc, 2H,  OCH2), 4.7-5.2 (m,  1H,  OCH); 4c:  TLC: Rf (A) -  0.41,  1 H-NMR.  & 
0.93 (m, 3H, CH3),  1.45 (mc, 4H, 2 CH2), 2.06 (s, 3H, CO-CH3),  3.7-4.3 (m, 3H,  OCH2 and OCH). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2c (2.14 g) and monoacetates (2.35 g). 
Hydrolysis of 1,2-diacetoxyheptane (rac-2A) 
a)  Hydrolysis of rac-2d:  (10 g) at  50% conversion gave after separation by vacuum-chromatography  2d  (3.9 g) and 3+4d  (2.9  g).  
Analytical data for the regioisomers: 3d:  TLC:  Rf (A) = 0.39,  1 H-NMR, & 0.89 (m, 3H, CH3),  1.38 (mc, 8H, 4 CH2),  2.08 (s, 3 H, 
CO-CH3),  3.67 (mc, 2H,  OCH2), 4.7-5.2 (tn,  1H,  OCH); 4d: TLC:  Rf (A) -  0.42, 'H-NMR.  & 0.89 (tn, 3H, CH3),  1.41 (mc, 8H, 4 
CH2), 2.06 (s, 3H, CO-CH3), 3.7-4.3 (tn, 3H,  OCH2 and OCH). 
b) Hydrolysis of rac-2d: (20 g) at 30% conversion yielded diacetate (11.3 g) and 3+4d (3.87 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2d (4.05 g) and monoacetates (2.94 g). 
Hydrolysis of 1,2-diacetoxydecane (rac-2e)  
a) Hydrolysis of rac-ht:  (10 g) at  50% conversion yielded after separation by vacuum-chromatography  2e (3.85 g) and 3+4e (2.87 
g). 3e:  TLC: Rf (A) = 0.41,  4e:  TLC:  Rf  (A) = 0.43, 3+4e:  1 H-NMR,  & 0.89  (tn, 3H, CH3),  1.35 (mc,  14H, 7 CH2),  2.06 (s,  ca.  
1.3H, CO-CH3),  2.08 (s, ca.  1.7H, CO-CH3),  3.64  (mc,  1.2H,  3e OCH2),  3.75-4.3 (tn,  1.45H, 4e OCH2  and OCH), 4.7-5.2  (m,  
0.6H, 3e OCH). 
b) Hydrolysis of rac-2e: (10 g) at 30% conversion gave diacetate (5.2 g) and 3+4e (1.94 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2e (2.10 g) and monoacetates (1.87 g). 
Hydrolysis of3-chloro-l,2-diacetoxypropane  (rac-2f)  
a) Hydrolysis of rac-2f:  (10 g) at  50% conversion yielded after extractive separation  2f (4.05 g) and 3+4f  (2.94 g). 3+4f:  TLC: Rf 
(A) = 0.32,1 H-NMR,  &  2.10 (br s,  3H, CO-CH3),  3.4-3.95 (m, 2.35H, C1-CH2 and 3f OCH2),  3.95-4.5 (m, 2.45H, 4f OCH2  and  
OCH), 4.8-5.3 (m, 0.2H, 3f OCH). 
b) Hydrolysis of rac-2f: (20 g) at 30% conversion yielded diacetate (10.9 g) and 3+4f (3.20 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2f (3.43 g) and monoacetates (3.71 g). 
Hydrolysis ofl,2-diacetoxy-3-methoxypropane  (rac-2g)  
a) Hydrolysis of  rac-2g:  (10 g) at  50% conversion gave after extractive separation  2g (3.76 g) and 3+4g (2.10 g). 3+4g:  TLC: Rf 
(A) = 0.30,1 H-NMR.  &  2.08 (s, 2.45H, 4g CO-CH3), 2.10 (s, 0.55H, 3g CO-CH3), 3.37(s, 3H, OCH3),  3.42 (d, J -  5Hz,  1.65H, 4g 
CH2-OMe), 3.56 (d, J= 5Hz, 0.35H, 3g CH2-OMe),  3. 65-4.25 (tn, 2.45H, 4g OCH2 and OCH), 4.8-5.2 (m, 0.2H, 3g OCH). 
b) Hydrolysis of rac-2g:  (30 g) at 30% conversion yielded diacetate (14.7 g) and 3+4g (3.51 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2g (4.83 g) and monoacetates (4.82 g). 
Hydrolysis of  3-benzyloxy-1,2-diacetoxypropane (roc-2h) 
a)  Hydrolysis of rac-2h:  (3 g) at  50% conversion yielded after separation  by vacuum-chromatography  2b  (1.22 g) and 3+4h  (0.92  
g). 3h:  TLC: Rf (A) = 0.37, 4h:  TLC: 91(A)  = 0.41,3+4h:1 H-NMR,  &  2.04 (s, ca.  1.9H, 4h  CO-CH3),  2.07 (s, ca.  1.1H, 3h  CO-
CH3),  3.4-4.3 (tn, ca. 4.6H, BnO-CH2, OCH2, and 4h OCH), 4.51 (s, 2H, OCH2Ph), 4.8-5.3 (m, ca. 0.4H, 3h OCH), 7.30 (tn, SH, 
ArH). 
b) Hydrolysis of rac- 2h: (3.1 g) at 30% conversion gave diacetate (1.87 g) and 3+4h (0.57 g). 
c) Hydrolysis of diacetate fraction from b) at 57% conversion gave 2h (0.59 g) and monoacetates (0.62 g). 
Desacetvlation of diacetates  (2a-h) or monoacetates (3.4a-h) to optically active diols (la-h)  or  CewMa-hV general procedure 
Acetylated  1,2-diol  (2a-h  or 3,4a-h;  20 mmol) was dissolved in 0.2% methanolic NaOMe solution  (15 ml) and  stirred  at  
r.t.  for  4  h.  After  neutralizing  the  mixture  by  1M  HC1  methanol  was  evaporated  off  and  the  rest  was  purified  by  vacuum-
chromatography using hexane-acetone* 2:1 as eluant to give diol (la-h or enMa-h) in 70-85% yield. 
la  or em-la:  TLC: Rf(A)= 0.15; lb  or e/iMb:  TLC:  Rf(A)= 0.20; lc  or en/-lc:  TLC:  Rf(A)= 0.22; Id  or enl-li:  TLC: Rf(A)= 0.27; 
le or ent-le:  TLC: Rf(A)= 0.29;  If  or enr-lf:  TLC:  Rf(A)= 0.20, Rf(B)= 0.68; lg  or enf-lg:  TLC:  Rf(A)= 0.11, Rf(B)= 0.37, lh  or  
enl-lh:  TLC: Rf(A)= 0.29. For  optical  rotation  value,  enantiomeric  purity and  configuration  data  of the  diols (la-h  or  enr-la-h)  
prepared from the corresponding diacetates (2a-h) or monoacetates (3+4a-h) obtained by PPL hydrolyses of racemic diacetates (rac-
2a-h) see Table. 
g).  3-Mb: TLC:  Rf  
1.05H, 3b  OCH2),  
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Abstract:  Reaction  of  the protected  glycidol  derivatives  (1A-C)  with  a  
wide  variety  of  Grignard  reagents  (2a-h)  in the presence  of  catalytic  amount  of  
CuCN  provided  the  corresponding  monoprotected  diol  derivatives  (3)  in  a  
highly  regioselective  manner.  
1,2-Diols either in racemic or in enantiomerically  pure form are  important  
structural  units  or  synthetic  building  blocks  for  numerous  biologically  active  
natural  or  synthetic  compounds,  and  for  this  reason,  they  are  subject  of  many  
recent  interests.  In  the  course  of  our  investigations  on  biocatalytic  enantiomer-
separation  of  diverse  1,2-diol  derivatives,  e.g.  1,2-diol  diacetates1,  a  need  for  a  
general  synthetic  procedure  for  the  production  of  such  compounds  was  
recognised. 
The utility of Grignard reagents for oxirane ring-opening reactions is well 
known2.  Ring-opening reaction of oxirane with Grignard  reagents  in absence3  or  
in  presence  of  Cul  catalyst4  was  used  for two  carbon  chain  elongation.  Similar  
ring-opening  reaction  of  methyloxirane3  in  the  presence  of  CuCN  proceeded  
regioselectively,  the  oxirane  ring  was  attacked  predominantly  from  the  
* To  whom correspondence should be addressed. 
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unsubstituted  side.  Grignard  reagents,  mostly  in  the  presence  of  Cu(I)  salt  
catalysts,  opened  the  oxirane  ring  of  alkyloxiranes",  vinyloxiranes7,  P-epoxi-
8  •  9  
sulphones,  -sulphoxides  or  esters  or  dianhydro  sugars  also  in  a  regioselective  
manner.  Although,  scattered  examples  for  reaction  of  Grignard  reagents  with  
enantiomers  of  benzyl  glycidyl  ether  (1A)  exist10,  usefulness  and  generality  of  
ring opening  reaction  of protected  glycidol  derivatives  with  Grignard  reagents  for  
preparation  of  1,2-diol  derivatives has not  been  systematically  studied.  
It  was  our  aim,  therefore,  to  investigate  the  applicability  of  the  ring  
opening reaction  of various protected  glycidol  derivatives  (1A-C)  with  a  selection  
of Grignard  reagents  (2a-h) yielding the corresponding  monoprotected  diols  (3).  
+  R2-MgX  
H) 
1A-C  2 a " h  
R1 
A CHjPh 
B SiMe3 
C SiMe2But 
R2 
a Et 
b Bu 
c n_C1oM21 
d i-Pr 
e t-Bu 
f (CH^OTHP 
g Ch^Ph 
h Ph 
Conditions: i..) cat.  CuCN. ether type solvent; ii.)  saturated NH4C1 
(for details  see Table and  Experimental)  
Benzyl-,  trimethylsilyl-,  and  fc/V-butyldimethylsilyl  derivatives  of  glycidol  
(1A-C,  respectively);  and  Grignard  reagents  prepared  from  primary  alkyl  halides  
of  different  lengths,  secondary  and  tertiary  alkyl  halides,  phenyl  and  benzyl  
halides,  or  co-functionalized  alkyl  halide  (2a-h,  respectively)  were  chosen  as  
reaction  partners  in the present  study.  
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First,  the  reaction  between  (/er/-butyldimethylsilyloxy)methyl  oxirane  (IC)  and  
butylmagnesium  bromide  (2b)  (Table,  Entries  18-23)  was  chosen  as  a  typical  
probe  on  which  effects  of  solvent,  temperature,  and  amount  of  CuCN  catalyst  
were examined.  It  was found that the  reaction can be conveniently  carried  out  in  
ether  type solvents  in the  presence of  catalytic  amount  of CuCN at  -15°C within  
15 min. 
Diethyl  ether,  tetrahydrofuran  and  2-methyItetrahydrofuran  were  investigated  as  
solvents  (Entries  18,  19 and  23,  respectively).  The  desired  diol  derivative  (3Cb)  
was  obtained  in  all  three  solvents  in  satisfactory  yield.  The  reaction  in  
diethylether  (Entry  18),  however,  gave  a  slightly  lower  yield  and  more  diol  
byproduct  (4C).  Considering  yield,  cost,  safety, and  extractability  from water  2-
methyl-tetrahydrofuran  was  chosen  as  solvent.  Next,  the  effect  of  amount  of  
CuCN  catalyst  was  studied  in  tetrahydrofuran  at  -15°C  (Entries  19-21).  It  was  
concluded that CuCN should be applied  in catalytic  (ca. 2 mole%) amount  (Entry  
19);  reactions  either  in  the  presence  of  higher  amount  of  CuCN  (Entry  21,  25  
mole%)  or  in  the  absence  of  CuCN  (Entry  20)  gave  disappointing  results:  i.e.  
much  slower  reaction  and  appearance  of  diverse  unidentified  byproducts  were  
observed  in both cases. Finally, the reaction was carried out at higher  temperature  
(0°C to RT for 2 h, Entry  22) but under  this condition  a reasonable proportion  of  
ring cleavage  product  diol  (4C) was  produced  parallel  with  a significant  drop  in  
yield  of  the  desired  diol  derivative  (3Cb).  Consequently,  reaction  in  2-
methyltetrahydrofiiran in the presence of 2 mole% CuCN at -15°C for  15 min was 
chosen  as  general  method  for  further  study  with  protected  glycidol  derivatives  
(1A-C) and Grignard reagents (2a-h). 
Each reaction  in the present study performed between glycidol  derivatives  
(1A-C)  and  several  Grignard  reagents  (2a-h)  (see  Table)  proved  to  be  highly  
regioselective,  a  regioisomeric  product  arising  from attack  at  the  carbon  of  the  
oxirane  ring  bearing  substituent  was  never  isolated  or  detected.  A  concomitant  
formation of the corresponding diol byproduct  (4A-C), however,  was observed  in  
the majority of the cases, even  if the  reaction  was conducted under strictly water-
free conditions.  Our  preliminary  investigations  showed  that  the  relative  amount  
of the diols can be reduced by lowering the temperature from RT or 0°C to -15°C, 
hence, most of the reactions were investigated at this temperature.  Results of  ring  
cleavage  reactions  of  the  glycidol  derivatives  (1A-C)  with  Grignard  reagents  
(2a-h)  indicate  (see  Table)  that  the  process  is  more  influenced  by the  nature  of  
the  Grignard  reagent  and  much  less  sensitive  to  the  kind  of  protecting  group  in  
the glycidol  derivative.  These  reactions  seem to  be  widely  applicable,  since  ring  
opening with short, medium or long primary alkylmagnesium  bromides (2a, b, c; 
Entries  1-3,  9-11,  17-24;  respectively)  as  well  as  with  secondary  or  tertiary  
alkylmagnesium halides (2d, e; Entries 4,5;  12,13; 25,26; respectively)  proceeded  
with  satisfactory  to  good  yields.  In  the  case  of  the  reactions  with  
isopropylmagnesium  bromide  (2d,  Entries  4,  12  and  25),  however,  higher  
temperature  and  prolonged  time  (0°C  to  RT,  2  h)  was  needed  to  obtain  
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Table: Reaction of protected glycidol  derivatives (1) with Grignard reagents (2) 
Entry 1 2 (X) Conditions" 3(4)b 
(solventc; CuCN 
[equiv.]; 
temp., time.) Yield (%) 
1 A a Br Me-THF 0.02 -15°C,  15 min 89 
2 A b Br Me-THF 0.02 -15°C,  15 min 87(5) 
3 A c Br Me-THF 0.02 -15°C,  15 min 80(9) 
4 A d Br Me-THF 0.02 -15°C-RT,  120 min 44(46) 
5 A e CI Me-THF 0.02 -15°C,  15 min 61(20) 
6 A f Br Me-THF 0.02 -15°C-RT,  120 min 65(6) d 
7 A g CI Me-THF 0.02 -15°C,  15 min 88(3) 
8 A h Br Me-THF 0.02 -15°C,  15 min 85(4) 
9 B a Br Me-THF 0.02 -15°C,  15 min 83 
10 B b Br Me-THF 0.02 -15°C,  15 min 82(7) 
11 B c Br Me-THF 0.02 -15°C,  15 min 71(9) 
12 B d Br Me-THF 0.02 -15°C-RT,  120 min 57(24) 
13 B e CI Me-THF 0.02 -15°C,  15 min 58(19) 
14 B f Br Me-THF 0.02 -15°C to RT, 60 min 59(13) d 
15 B g CI Me-THF 0.02 -15°C,  15 min 87 
16 B h Br Me-THF 0.02 -15°C,  15.min  88 
17 C a Br Me-THF 0.02 -15°C,  15 min 93 
18 C b Br Et20 0.02 -15°C,  15 min 75(12) 
19 C b Br THF 0.02 -15°C,  15 min 88 
20 C b Br THF 0 -15°C,  15 min e 
21 C b Br THF 0.25 -15°C,  15 min e 
22 C b Br THF 0.02 0°C-RT,  120 min 54(38) 
23 C b Br Me-THF 0.02 -15°C,  15 min 92 
24 C c Br Me-THF 0.02 -15°C,  15 min 79(12) 
25 C d Br Me-THF 0.02 -15°C-RT,  120 min 62(29) 
26 C e CI Me-THF 0.02 -15°C,  15 min 65(18) 
27 C f Br Me-THF 0.02 -15°C-RT,  120 min 63(9)f 
28 C g CI Me-THF 0.02 -15°C,  15 min 89 
29 C h Br Me-THF 0.02 -15°C,  15 min 91 
"  For  details  on  preparation  of  Grignard  reagents  and  reaction  conditions  see  Experimental.  
b  Isolated  yields of product(s)  separated  by chromatography  on  silica gel.  Yield of  diol  4  is given 
between  brackets.  Single  number  indicates  that  no  diol  (4)  was  isolated.  c  Me-THF:  2-
methyltetrahydrofuran.  d  Beside a  minor  amount  of  diol  (4)  further unidentified  byproducts  were  
observed.e  TLC investigation  of the  raw product  revealed  rather low  conversion  and  presence  of  
unidentified byproducts. 
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satisfactory yields.  Similarly good results were achieved  in reactions with  phenyl-
or  benzylmagnesium  halides  (2g,  h;  Entries  7,8;  15,16  and  28,29;  respectively).  
The  reactions  of  glycidol  derivatives  (1A-C)  with  a  Grignard  reagent  prepared  
from  l-bromo-6-(2-tetrahydropyranyl)oxy-hexane  (2f)  (Entries  6,  14,  27)  
affording  skeletons  functionalized  at  both  ends  further  illustrate  the  synthetic  
usefulness of this  process.  In  reactions  with  Grignard  compound  2f  a  prolonged  
reaction  time  and  higher  temperature  (-15°C to  RT,  2  h)  were  also  required  for  
acceptable  yield.  
In  summary,  the  highly  regioselective  ring  opening  reaction  between  
Grignard  reagents  (2a-h)  and  protected  glycidol  derivatives  (1A-C)  proved  to  be  
generally  applicable  yielding  1,2-diol  derivatives  protected  at  the  primary  
hydroxyl  group  (3Aa-Ch).  These  products  may  conveniently  be  manipulated  
further at  the  free secondary  hydroxyl  moiety  or  may  provide  the  corresponding  
1,2-diols after deprotection. 
EXPERIMENTAL 
NMR  spectra  were  measured  on  Brucker  AW-80  or  Varian  VXR  400  
spectrometers  operating  at  80  and  400  MHz  for  *H and  101  MHz  for  I3C  in  CDCI3  
containing TMS as internal  standard.  IR spectra (v,  film) were recorded  on a Spekord IR 
20M  spectrometer.  GLC  chromatography  was  performed  on  a  HP  5890  Series  II  gas  
chromatograph  equipped  with  a  HP-1  25  m  x  0.20  mm,  0.20  pm  column  and  FID  
(vhydrogen=  1.6  ml/min,  tj=  140°C,  t«,=  230°C,  100°C:  1  min,  100-200°C:  5°C/min).  
Preparative vacuum-chromatography"  was carried out using Merck Kieselgel 60 (60-200 
(im).  All isolated products were homogenous by TLC on Merck  Kieselgel 60  F254  plates 
and  gave  satisfactory  elemental  analysis  (C,H)  data.  Halogen  compounds  for  Grignard  
reagents  2a-e,g,h  were  commercial  products  from  Fluka  or  Aldrich.  Magnesium  and  
1,2-dibromoethane  were  supplied  by  Merck.  The  protected  glycidol  derivatives  (1A-C)  
and  bromide  for Grignard  reagent  2f  were  prepared  by  known  procedures.  Dry  diethyl  
ether was obtained from Fluka, tetrahydrofuran and 2-methyltetrahydrofuran were  freshly  
distilled from LiAIR» and stabilized with 2,6-di-terf-butyl-p-cresol. 
General procedure for  ring cleavage ofglycidol  derivatives by Grignard reagents 
A)  Preparation of  Grignard reagents: A  four  necked  flask  containing  Mg  (0.6  g,  25  
mmol)  and  small  pieces  of  I2  was  flamed  out  by  a  burner,  connected  to  a  dry reflux 
condenser and cooled down under a slight positive pressure of nitrogen. After cooling, the 
flask was  equipped  with  a dropping  funnel filled with  a  solution  of  halogen  compound  
(25  mmol)  in  15 ml  of  solvent  indicated  in  Table  and  with  a  second  dropping funnel  
containing 25 ml of pure solvent. A small portion (2-3 ml) of solvent followed by 0.1 ml 
of 
1,2-dibromoethane were introduced into the flask, and after the gas evolution was ceased, 
pure  solvent  and  solution  of  the  halide  were  dropped  simultaneously.  The  Grignard  
reactions  were  performed  at  the  boiling  point  of  die  lowest  boiling  component  or  at  
50-55°C for 45 min. 
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B)  Ring cleavage of glyadol  derivatives  (1A-C)  by Grignard reagents (2a-h):  To  the  
resulting solution of the Grignard reagent (2), CuCN catalyst (amount indicated in Table) 
was  added  at  0°C  followed  by  addition  of  a  solution  of  the  corresponding  glycidol  
derivative (1, 20 mmol) in  15 ml of solvent (for temperature and reaction time see Table). 
The reaction mixture was  worked up by pouring into 40 ml of saturated  NH4CI solution 
IR: 3300-3750, 3030, 3000, 2935,  1470,  1245,  1090, 845, 805, 710 cm"1, 'H-NMR: 0.11 
(s, 9H, SiCH3), 0.87 (t, 3H, CH3),  1.23-1.50 (br m, 8H, 4CH2), 3.34 and 3.58 (mc, 2xlH, 
OCH2), 3.62 (m,  1H, O-CH). 
l-TrimethvlsilvIoxytridecan'2-ol (3Bc) 
IR: 3300-3750, 3030, 3000, 2935,  1470,  1245,  1090, 845, 805, 705 cm"1, 'H-NMR: 0.10 
(s, 9H, SiCHj), 0.87 (t, 3H, CH3),  1.28 (mc,  18H, 9 CH2),  1.43 (m, 2H, CH2), 3.35 and 
3.60 (mc, 2xlH, OCH2),  3.62 (m,  1H, OCH). 
]-Trimethvisilvloxy-4-methvlpentan-2-ol (3Bd) 
IR: 3350-3750, 3030, 3000, 2925,  1470,  1370,  1250,  1100, 810 cm"1, 'H-NMR: 0.09 (s, 
9H, SiCHs), 0.94 (d, 6H, 2 CH3),  1.14 and  1.41 (mc, 2xlH, CH2-Pr!),  1.73 (mc,  1H, CH), 
3.35 and 3.61 (mc, 2xlH, CH2-0), 3.71 (mc,  1H, CH-O). 
J-Trimethvlsilvloxy-4,4-dimethylpentan-2-ol (3Be) 
IR: 3350-3750, 3030, 3000, 2905,  1465,  1370,  1250,  1100, 805 cm"1,  'H-NMR: 0.06 (s, 
6H, SiCH,), 0.89 (s, 9H, SiCCI^), 0.95 (s, 9H, CCH3),  1.17 and  1.32 (mc, 2xlH, CH2-
Bu'), 3.30 and 3.50 (mc, 2xlH, SiOCH2), 3.75 (mc,  1H, CH-OH). 
J-TrimethvlsUv/oxv-9-ftetrahvdro-2H-pvran-2-vhxv)nonan-2-ol (3Bf) 
IR: 3750-3350, 3010, 2990, 2920,  1470,  1360,  1100,  1060,  1005, 805, 750 cm"1, 'H-
NMR: 0.13 (s, 9H, SiQk),  1.30-1.65 (m,  16H, 8CH2),  1.70 and  1.83 (mc, 2xlH, CH2), 
3.37 and 3.49 (mc, 2xlH, CH20), 3.35 and 3.58 (mc, 2xlH, CH20), 3.63 (mc,  1H, CH-
OI, 3.73 and 3.87 (mc, 2xlH, CH20), 4.57 (mc,  1H, OCHO). 
]-Trimethvlsih'loxv-4-phenvlbutan-2-ol (3Bg) 
IR: 3300-3750, 3175, 3155, 3105, 3025, 2990, 2920,  1510,  1490,  1455,  1385,  1355,  
1240,  1095, 805 cm"1, 'H-NMR: 0.11 (s, 9H, 2 SiCH3),  1.71 (mc, 2H, CH2Ph), 2.68 and 
2.81 (mc, 2xlH  CH2-CH2Ph), 3.40 and 3.59 (mc, 2xlH, CH2-0), 3.64 (mc,  1H, CH-O), 
7.15-7.35 (m, 5H, ArH). 
]-Trimethvlsi/vioxv-3-phenylpropan-2-ol (3Bh) 
IR: 3300-3750, 3195, 3160, 3115, 3040, 3005, 2930,  1470,  1250,  1100, 810 cm"1, 'H-
NMR: 0.06 (br s, 6H, 2SiCH3), 0.89 (s, 9H, SiC(CH,)), 2.77 (dd, 2H, CH2Ph), 3.46 and 
3.60 (mc, 2xlH, OCH2), 3.85 (mc,  1H, CH-OH), 7.15-7.35 (m, 5H ArH). 
l-ftert-Butyl-dimethylsilyloxv)pentan-2-ol (3Ca) 
GLC: tR=  1.28 min; IR: 3300-3750, 3035, 3000, 2940,  1470,  1370,  1250,  1090, 845, 805 
cm"1, 'H-NMR: 0.05 (s, 6H, SiCH3), 0.88 (s, 9H, SiCCH3), 0.91 (t, 3H, CH3),  1.28-1.53  
(m, 4H, 2CH2), 3.36 and 3.59 (mc, 2xlH, OCH2), 3.63 (m,  1H, OCH);  13C-NMR: -5.34 
(SiCH3), -5.40 (SiCH3),  14.16 (CH3),  18.30 (SiC(CH3)3),  18.81 (CH2), 25.89 
(SiC(CH3)3), 34.93 (CH2), 67.32 (OCH2), 71.56 (OCH). 
l-(tert-Butvl-dimethvlsilyloxy)heptan-2-ol (3Cb) 
GLC: tR= 2.43 min; IR: 3300-3750, 3035, 3000, 2935,  1475,  1250,  1090, 810, 750 cm"1, 
'H-NMR: 0.06 (s, 6H, SiCH3), 0.87 (t, 3H, CH3), 0.88 (s, 9H, SiCCH,),  1.28 (mc 6H, 
3CH2),  1.40 (m, 2H, CH2), 3.37 and 3.60 (mc, 2xlH, OCH2), 3.62 (m,  1H, OCH);  13C-
NMR: -5.32 (SiCH,), -5.38 (SiCHj),  14.06 (CH3),  18.31 (SiC(CH3)3), 22.62 (CH2), 25.29 
(CH2), 25.90 (SiC(CH3), 31.97 (CH2), 32.79 (CH2), 67.31 (OCH2j, 71.87 (OCH). 
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l-ftert-Butvl-diniethvlsilvloxv)tridecan-2-ol (3Cc) 
GLC: tR=  11.05 min; IR: 3300-3750, 3035, 3000, 2940,  1470,  1250,  1090, 815 cm"1, *H-
NMR: 0.07 (s, 6H, SiCH3), 0.88 (t, 3H, CH3), 0.90 (s, 9H, SiCCH3),  1.27 (mc.  18H, 9 
CH2),  1.43 (m, 2H, CH2), 3.38 and 3.61 (mc, 2xlH,  OCH2), 3.62 (m,  1H, OCH);  13C-
NMR: -5.33 (SiCH3), -5.39 (SiCH3),  14.13 (CH3),  18.30 (SiC(CH3)3), 22.71 and 25.61 
(2CH2), 25.89 (SiC(CH3), 25.90, 29.37, 29.60, 29.62, 29.65, 29.68 and 29.77 (8 CH2), 
67.31 (OCH2), 71.86 (OCH). 
J-ftert-Butvl-dimethvlsilvloxv)-4-methylpentan-2-ol  (3Cd)  
GLC: tR=  1.50 min; IR: 3300-3750, 3035, 3000, 2940,  1470,  1375,  1250,  1090, 815 cm" 
\  'H-NMR: 0.08 (s, 6H, SiCH3), 0.89 (s, 9H, SiCCH3), 0.93 (d, 6H, 2CH3),  1.14 and 
1.38 (mc, 2xlH,  CH2),  1.79 (m,  1H, CH), 3.36 and 3.60 (mc, 2xlH, OCH2), 3.72 (m,  1H,  
OCH);  13C-NMR: -5.32 (SiCH3), -5.39 (SiCH3),  18.31 (SiC(CH3)3), 22.21 (CH3), 23.45 
(CH3), 24.56 (CH), 25.90 (SiC(CH3)3), 41.78 (CH2-PO, 67.71 (CH20), 69.97 (CH-O). 
l-(tert-Butyl-dimethylsilvloxy)-4. -f-dimethylpentan-2-ol  (3Ce)  
GLC: tR= 1.70 min; IR: 3350-3750, 3030, 3000, 2925,  1470,  1370,  1250,  1100, 805, 750 
cm"1, 'H-NMR: 0.06 (s, 6H, SiCHj), 0.89 (s, 9H, SiCCHj), 0.95 (s, 9H, CCUj),  1.17 and 
1.32 (mc, 2xlH,  CHa-Bu'), 3.30 and 3.50 (mc, 2xlH,  SiOCH2), 3.75 (mc,  1H. CH-OH); 
13C-NMR: -5.30 (SiCH3), -5.37 (SiCH3),  18.30 (SiC(CH3)3),  25.91 (SiC(CH3)3), 30.04 
(CH2C(CH3)3),  30.07 (C(CH3)3), 46.20 (CH2-Bu'), 68.38 (CH20), 69.39 (CH-O). 
l-fiert-Butvl-dimethvlsUvloxv)-9-Ctetrahvdro-2H-pvran-2-yloxv)nonan-2-ol (3Cf) 
GLC: tR=  15.84 min; IR: 3750-3350, 3025, 3010, 2940,  1470,  1450,  1375,  1360,  1260,  
1110,  1065,  1015, 805, 750 cm"1, 1 H-NMR: 0.08 (s, 6H, SiCHj), 0.90 (s, 9H, SiCCH,), 
1.35-1.65 (m,  16H, 8CH2),  1.70 and  1.83 (mc, 2xlH, CH2), 3.37 and 3.50 (mc, 2xlH, 
CH20), 3.38 and 3.62 (mc, 2xlH, CH20),  3.63 (mc,  1H, CH-O), 3.73 and 3.87 (mc, 
2xlH, CH20), 4.57 (mc,  1H, OCHO); l3C-NMR: -5.32 (SiCH3), -5.38 (SiCH3),  18.30  
(SiC(CH3)3),  19.70, 25.51, 25.54 (3CH2), 25.90 (SiC(CH3)3),  26.19, 29.41, 29.67, 29.74, 
30.79, 32.79 (6CH2), 62.32, 67.30, 67.64 (3CH2-0),  71.82 (CH-O), 98.83 (OCHO). 
l-(tert-Butvl-dimethvlsilvloxv)-4-phenylbutan-2-ol (3Cg) 
GLC: tR= 7.04 min; IR: 3300-3750, 3175, 3155, 3105, 3025, 2990, 2920,  1610,  1490,  
1455,  1385,  1355,  1240,  1095, 805, 740 cm"1, 'H-NMR: 0.06 (br s, 6H, 2 SiCH3), 0.89 
(s, 9H, CCHj),  1.71 (mc, 2H, CH2Ph), 2.67 and 2.81 (mc, 2xlH CHj-CHzPh), 3.42 and 
3.61 (mc, 2xlH, CH2-0), 3.64 (mc,  1H, CH-O), 7.15-7.32 (m, 5H, ArH); 13C-NMR: -
5.33 (SiCH3), -5.39 (SiCH3),  18.30 (SiC(CH3)3), 25.90 (SiC(CH3)3), 31.87 (CH2), 34.52 
(CH2), 67.19 (CH20), 71.07  (CH-O),  125.80 (ArC),  128.36 (AiC),  128.45 (AiC),  142.07  
(ArC-CH2). 
l-{tert-Butvl-dimethvlsUy/oxv)-3-phenvlpropcm-2-ol  (3Ch)  
GLC: tR= 5.28 min; IR: 3300-3750, 3195, 3160, 3115, 3030, 3005, 2930,  1500,  1480,  
1465,  1250,  1100, 810, 750 cm"1,  'H-NMR: 0.06 (br s, 6H, 2SiCH,), 0.89 (s, 9H, 
SiC(CHj)), 2.77 (dd, 2H, CH2Phj, 3.47 and 3.60 (mc, 2xlH, OCH2), 3.88 (mc,  1H, CH-
OH), 7.18-7.34 (m, 5H ArH);  IJC-NMR: -5.35 (SiCH3), -5.37 (SiCH3),  18.28  
(SiC(CH3)3), 25.88 (SiC(CH3)3),  39.57  (CH2),  66.19 (CH20),  72.78  (CH-O),  126.33  
(ArC),  128.42 (ArC),  129.29 (ArC),  138.26 (AIC-CH2). 
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followed by separation of the layers, extraction with 40 ml of solvent, drying the resulting 
organic layer over MgS04. After evaporation off the solvent, the residue was subjected to 
vacuum-chromatography  to yield  pure product  (for yields  see Table).  All products  were 
characterized by IR and NMR spectra. 
l-BenzvloxvDentan-2-ol (3Aa) 
IR: 3300-3800, 3160, 3120, 3035, 3000, 2930,  1500,  1470,  1450,  1370,  1090, 710 cm'1, 
'H-NMR: 0.89 (t, 3H, CH3),  1.28-1.53 (m, 4H, 2CH2), 3.33 and 3.54 (mc, 2xlH,  OCH2),  
3.83 (m,  1H, OCH), 4.55 (s, 2H, 0-CH2-Ph), 7.32 (mc, 5H, ArH). 
I-Benzvloxvheptan-2-ol  (3Ab) 
IR: 3300-3750, 3160, 3120, 3035, 3000, 2930,  1500,  1470,  1450,  1370,  1085, 705 cm'1, 
'H-NMR: 0.88 (t, 3H, CH3),  1.29 (mc, 6H, 3CH2),  1.43 (mc, 2H,  1CH2), 3.32 and 3.50 
(mc, 2xlH, 0-CH2), 3.80 (m,  1H, OCH), 4.54 (s, 2H, 0-CH2-Ph),  7.33 (mc, 5H, ArH). 
l-Benzvloxvtridecan-2-ol  (3 Ac) 
IR: 3300-3750, 3160, 3120, 3030, 3005, 2940,  1500,  1470,  1450,  1375,  1090, 705 cm"1, 
'H-NMR: 0.88 (s, 9H, SiCCH3),  1.28 (mc,  18H, 9 CH2),  1.43 (m, 2H, CH2), 3.31 and 
3.51 (mc, 2xlH,  OCH2), 3.78 (m,  1H, OCH), 4.52 (s, 2H, 0-CH2-Ph), 7.33 (mc, 5H, 
ArH). 
l-Benzvloxv-4-methvlpentan-2-ol  (3Ad)  
IR: 3300-3800, 3190, 3155, 3110, 3020, 2940,  1500,  1465,  1450,  1385,  1365,  1090, 700 
cm"1, 'H-NMR: 0.88 (d, 6H, 2CH3),  1.00-1.28 (m, 2H, CH2),  1.76 (m,  1H, CH), 3.0-3.4 
(m, 2H, OCH2), 3.68 (m,  1H, OCH), 4.55 (s, 2H, 0-CH2-Ph),  7.32 (mc,  5H, ArH). 
l-Benzvloxv-4.4-dimethvlpentan-2-ol  (3Ae) 
IR: 3300-3750, 3165, 3110, 3020, 3000, 2940,  1500,  1470,  1450,  1380,  1365,  1090, 710 
cm"1, 'H-NMR: 0.95 (s, 9H,  CCH3),  1.1-1.35 (m, 2H, CHs-Bu1), 3.0-3.4 (m, 2H, 
SiOCH2), 3.70 (mc,  1H, CH-OH), 4.54 (s, 2H, 0-CH2-Ph),  7.31 (mc, 5H, ArH). 
l-Benzvloxv-9-{'tetrahvdro-2H-pvran-2-vbxv)noncm-2-ol (3Af) 
IR: 3350-3750, 3180, 3160, 3110, 3010, 2990, 2920,  1500,  1470,  1370,  1100,  1060,  
1005, 805, 750, 710 cm"1, 'H-NMR:  1.3-1.5 (m,  14H, 7CH2),  1.5-1.9 (m, 4H, 2 CH2), 
3.3-3.8 (m, 7H,  3 CH20 and O-CH), 4.55 (m+s, 3H, OCHO and 0-CH2-Ph),  7.3 (mc, 
5H, ArH). 
l-Benzvloxv-4-phenvlbutan-2-ol  (3Ag)  
IR: 3300-3750, 3180, 3155, 3115, 3005, 2940,  1500,  1460,  1370,  1095, 710 cm"1, *H-
NMR:  1.6 (mc, 2H, CH2Ph), 2.5-2.8 (m, 2H CH2-CH2Ph), 3.1-3.5 (m, 2H, CH2-0),  3.63  
(mc,  1H, CH-O), 4.43 (s, 2H, 0-CH2-Ph), 6.95-7.35 (m,  10H, ArH). 
1 -Benzvloxv-3-phenvlpropan-2-ol (3Ah) 
IR: 3300-3800, 3175, 3150, 3110, 3005, 2930,  1610,  1500,  1460,  1370,  1090, 705 cm"1, 
'H-NMR: 2.72 (d,  1H, one H of CH2Ph), 3.05-3.5 (m, 3H, one H of CH2Ph and OCH2), 
3.8 (mc,  1H, CH-OH), 4.40 (br s, 2H, 0-CH2-Ph),  7.0-7.35 (m,  10H, ArH). 
l-Trimethvlsilyloxvpentan-2-ol  C3Ba) 
IR: 3300-3750, 3035, 3000, 2930,  1470,  1240,  1090, 840, 805, 710 cm"1, 'H-NMR: 0.10 
(s, 9H, SiCH3), 0.90 (t, 3H, CH3),  1.28-1.53 (m, 4H, 2CH2), 3.35 and 3.60 (mc, 2xlH, 
OCH2), 3.63 (m,  1H, OCH). 
l-Trimethvlsilvloxvheptan-2-ol  (3Bb) 
IV. meliekiet 
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Abstract: Enantiomer selectivity of lipase catalyzed acylation of 2-acylated  1,2-diols was 
studied. First, acylation of 2-acetoxyheptan-l-ol  rac-3b with vinyl  acetate was investigated by 
varying  the  enzyme  and the  solvent,  showing  the  highest  enantiomer  selectivity  by  using  
lipase  from Pseudomonas  fluorescens  (PfL) in  hexane-vinyl  acetate  (VA).  We have found 
varying  or even  reversed  enantiomer selectivity  for different secondary  acyl  moieties  in 2-
acyloxyheptan-l-ols  rac-3bA-F.  Next,  all  six  possible  types  of  enantiomer  selective  
biotransformations (hydrolysis of  diacetate  and the two kinds of monoacetetes;  acylation of 
diol  and the two kinds of monoacetates) were compared on two model diols rac-4b,d. Among 
the transformations investigated,  acetylation of secondary monoacetates  rac-3b,d showed the 
highest enantiomer selectivity. Finally, PfL catalyzed acetylations of several  2-acetylated  1,2-
diols rac-3a-g were investigated under our optimum conditions. 
Copyright ©  1996 Elsevier  Science  Ltd  
Optically active  1,2-diols are widely used as synthetic building blocks for numerous natural products, 
pharamaceuticals  and tine chemicals.  Manufacture of these diols in enantiomerically  highly enriched form  has  
primary  importance,  since  the  two  enantiomers  of  these  compounds  may  possess  markedly  different  
biological  activities,  e.g.  while  the active  enantiomer of  pheromone  brevicomin  contains  1,2-dioxy-butane  
subunit with the R configuration, the other enantiomer shows inhibitory properties'.  Consequently, enantiomer 
selective biotransformations of  1,2-diol derivatives have been the subject of many recent interests. 
The usefulness of hydrolases,  especially  lipases, for enantiomer and regioselective  transformation of 
diols and related compounds is well known24.  Enzymatic biotransformations of  1,2-diol derivatives have been 
extensively studied: lipase-catalyzed acylation (transesterification) of racemic  1,2-diols4"'3 or primary  acetates 
of  1,2-diols3,13  were chosen as a tool  for kinetic resolution in most studies. Hydrolysis14,13  or alcoholysis16 of 
1,2-diol  diacetates,  however, have also been investigated.  Generally, very high regioselectivity  preferring the 
primary hydroxyl  group along with a variable  but a usually low degree of  enantiomer selectivity  has been 
observed  by the lipase-catalyzed  acylations of  1,2-diols3. The further enzymatic  acetylation of  the primary 
acetate products proved to be a slower but a more enantiomer selective process3,13.  In contrast, hydrolysis of 
1,2-diol  diacetates proceeded with moderate regioselectivity  but the enantiomer selectivity  was significantly 
higher  than  for  acylation  of  the  corresponding  1,2-diol  with  the  same  enzyme13.  This  observation,  that  
acylation of  the  1,2-diols  proved to be  less  enantiomer selective  than the hydrolysis  of  the corresponding 
diacetate,  suggested  us  that  the size  and/or characteristics  of  the  substituent  at  C2  plays a  crucial  role in 
enantiomer  selectivity.  Based  on  this  hypothesis,  we  expected  a  higher  enantiomer  selectivity  in  
biotransformations of 2-acetates than those of the corresponding enzymatic reactions of derivatives with free 
2-hydroxy group. 
These  remarkable differences  in selectivities  between different enzymatic  reactions of  1,2-diols and 
their acetate derivatives prompted us to test our above hypothesis and compare the enantiomer selectivities of 
all  the possible lipase-catalyzed  kinetic  resolutions  (acetylations Al-3  and hydrolyses Hl-3)  of  these diol 
derivatives (Scheme 1). 
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Scheme  1. Lipase-catalyzed  enantiomer selective biotransformations of  1,2-diol  derivatives (rac-1-4) 
Preparation  of  the rac-l ,2-diols rac-4a-gand their  acetate  derivatives  (Scheme 2)  were  based  on the 
corresponding  l-benzyloxy-2-alkanols  rac-la-g  which  were  prepared  from  racemic  benzyl  glycidyl  ether 6 
and  the  corresponding  Grignard  reagents'7.  The  secondary  monoacetates  rac-3a-g  were  obtained  via  
acetylation  of the secondary  alcohols rac-7a-g followed  by hydrogenolysis.  2-Acylated heptane-l,2-diols rac-
3bA-F were also synthesized  in an analogous manner.  
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Scheme 2.  Preparation of the rac- 1,2-diol  derivatives utilized in the present study 
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First,  the  selectivity  of  several  lipases  in acetylation  of  2-acetyloxy-heptan-l-ol  rac-3b  with  vinyl  
acetate was investigated  (Method A-3 in Scheme  1, Table  1).  
Table  1.  Acetylation of  racemic 2-acetoxy-heptan-l-ol  rac-3b  with different enzymes 
Enzyme1 
(mg) 
Timeb 
(h) 
c (%) (/?)-3b 
Y(%) 
Diol  from 
[«k 
(R)-3b 
ee(%) 
1 (S)- lb 
|  Y(%)  
Diol  from 
[«k 
(S)-lb 
ee(%) 
Espc 
PfL  (5)  1.1 46 52 +8 8 43 1  40  -8.8 43 3.8 
PPL (30) 4.6 55 33 +5.7 28 40 -5.4 26 2.2 
MjL (30) 120 19 78 + 1.4 7 18 -6.1 30 2.0 
CcL (30) 5.3 54 39 +3.3 16 46 -4.4 22 1.8 
PLE (50) 20 48 31 +2.9 14 29 -3.0 15 1.5 
AnL (30) 20 46 49 -0.2 ld 41 +0.3 2d 1.0 
RaL (30) '  1  - - - "  1  - - -
" PPL:  lipase  from porcine  pancreas,  CcL:  lipase  from  Candida  rugosa  (cylindracea),  PfL: lipase  from  Pseudomonasfluorescens,  
PLE:  esterase  from pig liver  (acetone  powder),  AnL:  lipase  from Aspergilus  niger,  MjL:  lipase from Mucor  javonicus,  RaL:  lipase  
from Rhisopus  arrhisus,b  rac-3b  (200  mg)  and  the  given amount  of enzyme  were  stirred  in vinyl  acetate  (2  ml)  at  RT.  c  E  values  
(Ea>) were  calculated  from an equation"  containing  the enantiomeric  excesses  of  substrate  (S)  and  product  (P).  Determination  of  
enantiomeric  excess values:  /.)  transformation  of  S and  P  into  the  corresponding  1,2-diols,  /'/.) H-NMR  investigation  of  di-MTPA-
esters  prepared  from  the  1,2-diols  and  (R)-MTPA-Cl  in  pyridine/CCL.  Configuration  is  opposite  to  the  products  obtained  with  
other enzymes. e  The  reaction  proved  to be extremely  slow  in comparison  with other  enzymes  
Lipase  from Pseudomonas fluorescens  (PfL)  was  choosen  for the  further  study,  since  this  enzyme  showed  
both  the highest  enantiomer selectivity  and efficacy among the lipases tested. 
Next,  the solvent effect on enantiomer selectivity  of acetylation  of  racemic 2-acetoxy-heptan-l-ol  rac-
3b  with  PfL  was  investigated.  Interestingly,  no  correlation  between  the  solvent  polarity  (IogP)  and  
enantiomer selectivity was found.  In this solvent effect study,  the inhibitory behaviour of chloroform was also 
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quite surprising.  The best selectivities were obtained in neat vinyl  acetate  or with hexane as solvent, therefore, 
this hexane-vinyl  acetate  1:1 system was applied in further acylations. 
Table 2.  Effect of solvent on acetvlation of  racemic 2-acetoxy-heptan-l-ol  rac-3b with PfL 
Solvent Time" < I  (R)-3b  Diol 
from (R)-3b 
I  (S)-lb  Diol 
from (S)-lb 
1  P  b  
(h) (%) Y(%) [«In ee(%) 1  Y(%)  [«L ee(%) 
chloroform C - . - - -
/er/-butanol 6.75 71 27 +3.2 16 68 -2.3 11 1.4 
carbon tetrachloride 4.75 66 34 +3.4 17 67 -2.6 13 1.5 
diethyl ether 4.75 64 32 +4.7 23 58 -5.0 25 2.0 
2-methyltetrahydrofuran 4 46 44 +5.2 26 38 -6.3 31 2.4 
ethyl acetate 120 34 60 +4.7 23 38 -7.7 38 2.7 
tetrahydrofuran 8.25 40 46 +3.0 15 31 -8.4 41 2.8 
hexaned 3.55 42 52 +5.1 25 37 -8.1 40 2.9 
hexane 6.75 54 41 +5.4 26 49 -8.3 41 3.0 
hexane-vinyl  acetate 1:1 1.3 55 38 +9.9 49 48 -8.1 40 3.7 
vinyl  acetate  1.1 46 47 +8.8 43 40 -8.8 43 3.8 
' rac-3b  (200  mg), vinyl  acetate  (5  mmol)  and  PfL  (5 mg) were  stirred  at RT  in  the  solvent  given  in Table.  E  value  calculated  from  
he  enantiomeric  excesses  of  substrate  (S)  and  product  ( P ) "  (see  also  Table  1) . c  The  reaction  proved  to  be  extremely  slow  in  
ompanson  with other solvents.d  Saturated  with  water  
We thought it also worthwhile  to investigate  the influence of  structural  features of  the 2-acyl  moiety  
on the  enantiomer  selectivity  of the PfL-catalyzed  acylation  process.  Our study  with a series  of  racemic 2-
acyloxy-heptan-l-ols rac-3bA-F; synthesis:  (Scheme  2)  showed a strong  correlation  between the size of the 
acyl  moiety  in  the 2-position  and the degree  of  enantiomer  selectivity:  a decrease  in selectivity  (ESp)  along 
with the increasing bulkiness  was observed.  In the case of  acylation of the very bulky pivaloyl  derivative rac-
3bF,  even a reversal  in enantiomer preference was found, deduced  from the observed (R) configuration of the 
diol 3b  obtained after hydrolysing the product 5*F. 
Table 3.  Effect of 2-acyl  moiety (Y) on acetylation of  racemic 2-acyloxy-heptan-l-ols rac-3bA-F by PfL 
Y Time8 c 3b* Diol from 5*A-F config. Diol from Espb 
A-F 3b* A-F 5* A-F 
(h) (%) Y(%) [a]n ee(%) Y(%) [a]n ee(%) 
A acetyl 1.3 55 39 +9.9 49 48 S -8.1 40 3.6 
B propionyl 4 31 55 +4.0 20 25 S -8.7 43 3.0 
C trifluoroacetyl 120 32 57 +3.8 19 26 s -8.4 41 2.9 
D phenylacetyl 2.1 34 61 +1.3 6 31 s -2.5 6 1.4 
E benzoyl 3.5 49 45 0 0 43 0 0 1.0 
F pivaloyl 4 45 53 -1.2 6 42 R +0.7 4 1.1 
Vac-3bA-F  (1 mmol)  and  PfL  (5  mg)  were  stirred  in  a solution  of vinyl  acetate  (1  ml) and  hexane  (1  ml)  at  RT,  E value  calculated  
rom the enantiomeric  excesses of  substrate  (S) and product  (P)1 8  (see  also Table  1).  
For  testing  our  starting  hypothesis  on  the  crucial  role  of  the  2-acetyl  moiety  in  enantiomer  selectivity,  
derivatives  of  two  different  diols  -  the  straight-chain  heptan-l,2-diol  rac-Ab and  the  branched-chain  4-
methylpentan-l,2-diol  rac-4d - were chosen as models.  All  six possible types of biotransformations - the three 
possible  kinds  of  enzymatic  transesterifications,  such  as  acetylation  of  diols  rac-4b,d;  method  A-l,  
acetylation  of  primaiy  monoacetates  rac-2b,d;  method  A-2,  and  acetylation  of  secondary  monoacetates  
rac-3b,d;  method A-3 ,  and the three possible  kinds of enzymatic  hydroiyses,  namely hydrolysis of  diacetates  
rac-lb,d;  method H-l,  hydrolysis  of  primary  monoacetates rac-2b,d;  method H-2,  hydrolysis  of  secondary  
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monoacetates  rac-3b,d;  method H-3  - were  compared  in  this  study  (Scheme  1, Table  4).  Acetylations  were  
carried out under our standard conditions using vinyl  acetate (VA) as  an "irreversible" transesterifying reagent 
and lipase  from  Pseudomonas  fluorescens  (PfL) and hydrolyses were  performed  in water  at a constant  pH of 
7.2. 
Table 4. Lipase  catalyzed  enantiomer selective  hydrolyses  (Methods H-1,2,3) and acetylations  (Methods  
A-1,2,3) of  1,2-diol  derivatives  (rac-l-4a,b)  
Substrate Method a Time c S b diol  from  S P c diol from P 1  Espd  
00 (%) Y(%) [a]D ee(%) Y(%) [a]D ee(%) 
rac- lb H-l 0.66 51 40 +3.1 15 36 -2.7 13 1.5 
rac-lb H-2 3.15 53 45 -2.7 13 46 +2.8 14 1.5 
rac-3 b H-3 5.3 63 15 -4.5 22 49 +1.1 5 1.3 
rac-4b A-l 0.75 24 67 -0.5 3 21 +1.9 9 1.2 
rac-lb A-2 432 44 52 +5.7 28 41 -7.0 34 2.6 
rac-3b A-3 1.33 55 39 +9.9 49 48 -8.1 40 3.6 
rac- Id H-l 3.3 39 45 +9.1 30 42 -9.7 32 2.5 
rac-2d H-2 13 20 64 -0.1 0 14 + 1.1 4 1.1 
rac-3d H-3 25 24 60 -0.3 1 21 +1.4 5 1.1 
rac-4d A-l 3 51 44 -9.9 32 46 +9.5 31 2.6 
rac-2d A-2 192 29 59 +6.6 22 24 -14.1 46 3.3 
rac-3d A-3 1.75 41 53 + 17.3 57 37 -30.2 99 >100 
"  Me thods  H-1,2,3  (cf.  Scheme  1): Racemic  substrate  (1  mmol) and  PfL  (5 mg)  were  stirred  in water at R T  and  the pH  was  kept  at  
7.2  by  addition  of  0.05  M  NaOH  solution  from an  autoburette  Methods  A-1,2,3  (cf.  Scheme  1): Racemic  substrate  (1  mmol)  and  
PfL  (5  mg)  were  stirred  in  a  solution  of  vinyl  acetate  (1  ml)  and  hexane  (1  ml)  at  RT.  Products  of  the  reactions  were  isolated  by  
separation  on  silica  gel  with  a  hexane-acetone  eluent.  S.  remaining  fraction  of  racemic  substrate,  c  P:  product(s)  of  enzymatic  
t ransformatioa  d  E values  (Es>) were calculated  from an equation18  containing  the enantiomeric  excesses  of  substrate  (S) and  product  
(P)  (c.f. Table  1).  
Results  of the  test  reactions  (Table  4)  indicate  that,  according  to  our  expectations,  the  highest  
enantiomer  selectivity  can  be  obtained  in  enzymatic  acetylation  of  the  secondary  monoacetates  rac-3b,d  
(Method  A-3).  Interestingly,  this  process  proved  to  be  not  only  the  most  selective  but  one  of  the  fastest  as  
well.  In accordance with  the previous observations,  acetylation of  the diols rac-4b,d  (Method A-l)  proved to 
be  a fast,  highly  regioselective  but less  enantiomer  selective  reaction.  Considering  this  high  regioselectivity  
toward  the  primary  hydroxylic  group  in  lipase-catalyzed  acetylation,  sluggishness  of  the  acetylation  of  
primary monoacetates rac-2b,d  (Method A-2)  is not surprising.  Among the hydrolytic processes,  hydrolysis  of  
the  diacetates  rac-lb,d  (Method  H-l)  proved  to  be  the  fastest  and  most  selective.  In  accordance  with  our  
previous  findings  in  hydrolysis  of  1,2-diol  diacetates15,  no acyl  migration  was  found either  in  hydrolyses  or  
acylations19. 
Interestingly,  not only  the measure  but the sense of the enantiomer selectivity  of these  lipase-catalyzed  
biotransformations  were  substrate-dependent.  Reversal  in enantiomer preference was observed  in  both  series;  
within  hydrolyses  the  moderate  ¿-enantiomer  preference  of  diacetate  hydrolysis  (Method H-l)  turned  to a 
slight /^-preference  in hydrolyses of monoacetates  (Methods H-2,3),  while  in transesterifications  the moderate 
/?-enantiomer  preference  of  diol  acetylation  (Method  A-l)  changed  to  a  higher  degree  of  ¿"-enantiomer  
selectivity  in acetylations  of  monoacetates  (Methods  A-2,3)  It is  noteworthy,  that similar  process-dependent  
change  in  stereoselectivity,  was  observed  in  Pseudomonas  cepacia  lipase-catalyzed  hydrolyses  and  
acetylations of  1-0-  and 3-O-P-D-glucosyl-  and galactosyl-vn-glycerols20.  
Finally,  dependence  of  the  enantiomer  selectivity  of  PfL-catalyzed  acylations  of  secondary  
monoacetates  rac-3a-g  on  the  structural  features  of  the  1,2-diol  skeleton  was  investigated.  For  this  study,  
typical  representives  of  secondary  monoacetates  having  straight-chain  alkyl  rac-3a-c,  branched-chain  alkyl  
rac-3d,e,  and  arylalkyl  rac-3f,g  side-chains  were  prepared.  The  racemic  substrates  were  then  subjected  to  
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PfL-catalyzed  reaction  under  our  standard  conditions.  Results  of  these  reactions  (Table  5)  indicate  that for 
high  enantiomer  selectivity  a bulky  side  chain (entries  d-f) is  required.  The non-branched  substrates (entries  
a-c,g)  gave  only  moderate  selectivities  indicating  that  branching  in  (3-position  to  the  acetoxy  moiety  is  
essential  for good  enantiomer  differentiation.  This finding,  that bulkiness of the side  chain of  1,2-dioIs  plays  
a crucial  role  in enantiomer selectivity,  is  in agreement with the previous  results  on acetylation  of  1,2-diois  or  
primary  monoacetates3'2"'3.  
Table 5.  Effect of side-chain  (R) on acetylation  of  racemic 2-acetvlated  1,2-diols Qac-3a-g)  with PfL 
R [«Jodie, Time
b c (R>3 diol from (R>3 1  CS>i  diol  from (syi Espc 
(100%ee)a (h) (%) Y(%) [off ee(%) Y(%) [ok ee(%) 
a ethyl 21.7 2.25 42 32 +10.5 48 23 -13.2 60 7.0 
b «-butyl 20.4 1.3 55 39 +9.9 49 48 -8.1 40 4.4 
c rt-decyl 13.4 8 40 41 +5.6 42 27 -7.2 54 4.5 
d /-propyl 30.6 1.75 41 53 +17.3 57 37 -30.2 >98 >100 
e /-butyl 27.9 3.3 43 ' 52 +22.7 81 39 -27.9 >98 >100 
f phenyl 29.6 3 38 57 + 18.9 67 34 -290 >98 >100 
? benzyl 30.8 9 51 43 +12.9 42 46 -13.6 44 3.8 
'  Extrapolated  values  calculated  f rom specific rotation of dtols  and  f rom the corresponding  enantiomeric  excess values  obtained  f rom  
' H - N M R  spectra  of  di-MTPA-esters  of  the  1,2-diols.  Absolute  configurat ion  of  the  1,2-diols  ( 4 a - d / „ g )  was  determined  by  
comparison  with  literature  rotation  values  {[a]  (c,  solvent)}  of  compounds  having  known  absolute  configuration:  (S)-4a:  -23.2  (1,  
elhanol)21,  -19.2  (2,  ethanol)22,  (R)-4a:  +17.4  (2,  ethanol)2;  (S)-4b:  -20.6  (1,  ethanol)21,  (S)-4c:  -10.1  (1.2,  methanol;3 ,  (R)-4c:  +10.1  
(1.18,  methanol)23,  (S )4d :  -31.5 (1. ethanol)2 ' ,  (R)-Id:  +13.82  (neat)24;  (Z)-4f:  -36  (1,  ethanol)25,  (R)-i(:  +23  (1.03,  CHCfe)2 ';  (S)-4g:  
-34.1  (1,  e thanol ) 2 I .  (S)<onfiguration  for  (-)- te  is assumed  by  analogy  with the  other  members  of  1,2-diol  series.  b  rac-3  (1  mmol)  
and  PfL  (5  mg)  were  stirred  in  a solution  of  vinyl  acetate  (1  ml)  and  hexane  (1  ml)  at  RT.  e  E  values  (Esp)  were  calculated  f rom  an  
equation'  containing  the enantiomeric  excesses  of  substrate  (S) and  product  (P)  (c.f.  Table  1).  
In  summary,  it  can  be  concluded  that  acetylation  of  the  easily  accessible  2-acetates  of  1,2-diols  
proved  to  be  the  best  alternative  among  the  six  possible  types  of  lipase-catalyzed  kinetic  resolutions  of  
racemic  1,2-diol  derivatives  both  with  respect  to  enantiomer  selectivity  and  productivity.  Lipase-catalyzed  
acetylation  seems  to be  an  ideal  choice  for obtaining  homochiral  products  from racemic  2-acylated  1,2-diol  
derivatives  having bulkiness  in P-position to the acetoxy  moiety.  
EXPERIMENTAL. 
The  'H-NMR  spectra  were  taken  on  JEOL  FX-100  (100  MHz)  or  Brucker  AW-80  (80  MHz)  
spectrometers  in  CDC13 solution containing TMS as internal  standard  Enantiomeric  purity  determinations (cf. 
Table  1, note c)  using  di-(5)-MTPA  esters of the corresponding diols  were carried out in  CDC13 solution  on a 
Varian  VXR-400  (400  MHz) NMR-equipment.  IR  spectra were  recorded  on  a  Specord  2000  spectrometer  
Optical  rotations were  determined on a Perkin  Elmer 241  poiarimeter.  Thin-layer  chromatography  (TLC) was 
made  using  Merck  Kieselgel  60 F254  alumina  sheets.  Spots  were visualized  by  treatment  with  3% ethanolic 
phosphomolybdic  acid  solution  and  heating  of  the  dried  plates  Preparative  vacuum-chromatography27  was  
performed  using  Merck  Kieselgel  60  F254.  The  l-benzyloxy-alkan-2-ols  rac-la-g  were  prepared  by  a  
published  procedure'7  Porcine  pancreatic  lipase  (PPL,  Type  II)  was  obtained  from  Sigma.  Lipases  from  
Candida  rugosa  (cylindracea)  (CcL),  Pseudomonas  fluorescent  (PfL),  Aspergilus  niger  (AnL),  Mucor  
javonicus  (MjL),  Rhisopus arrhisus  (RaL),  esterase  from  pig  liver  (PLE,  acetone  powder),  acetic  anhydride,  
and  vinyl  acetate  were products of FLUKA.  All  solvents used were freshly  distilled  
PREPARATION  OF 2-ACYLATED  1-BENZYLATED  1,2-DIOLS rac-8a-g  AND  rac-8bB-F  
General procedure  1-Benzylated- 1,2-diol  rac-la-g,  10  mmol,  pyridine  (30  mmol,  2.4  ml),  and  catalytic  
amount of dimethylaminopyridine  were dissolved  in hexane  and dichloromethane (10  ml,  each) followed  by a 
dropwise  addition  of  the  corresponding  acyl  chloride  or  anhydride  (15  mmol)  at  room  temperature.  The  
mixture was  kept  at 45°C until  TLC investigation  showed  no remaining  starting  material  (20-90  minutes).  The  
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resulting mixture was then diluted with diethyl  ether (10 ml) and washed with  5% hydrochloric  acid (2x10 
ml),  saturated NaHCOj solution (10 ml),  and brine (10  ml).  The organic phase was  dried over Na2S04  and 
solvents were evaporated off in vacuo. 
rac-2-Acetoxy-I-benzyIoxypentan rac-Sa 
(AcjO) Yield:  91%, 'HNMR (CDC13,8 ppm): 0.90 (m, 3H, CH3),  1.51 (mc, 4H, 2CH2), 2.03 (s, 3H, CO-CH3), 
3.48 (mc, 2H, OCHj), 4.53 (s,  2H, 0-CH2-Ph), 4.9-5.2  (m,  1H, OCH), 7.20-7.34 (m, 5H,  CfiHj); IR (film, v 
cm'1): 3030 (w), 2960, 2872,  1738,  1496 (w),  1454,  1372,  1241,  1106,  1055,  1026, 944, 908,  736;  Calcd. for 
C14H20O3: C 71.16, H 8.53; found: C  70.80, H 8.56. 
rac-2-Acetoxy-I-benzyloxyheptan rac-S b 
(AcjO) Yield:  98%, 'HNMR  (CDC13,5 ppm): 0.93 (m, 3H, CH3),  1.24 (mc, 4H, 2CH2), 2.02 (s, 3H, CO-CH3), 
3.44 (mc,  2H,  OCH2), 4.57 (s,  2H, 0-CH2-Ph), 4.9-5.2  (m,  1H, OCH), 7.20-7.37 (m,  5H,  CfiHj); IR  (film, v 
cm"1): 3030 (w),  2956,  2931,  2860,  1738,  1496,  1454,  1372,  1242,  1112,  1027,  943,  906,  735;  Calcd. for 
C U S H 2 4 0 3 :  C  72.69, H  9.15;  found:  C  72.98, H 9.08. 
rac-2-Acetoxy-l-benzyioxytridecan rac-Sc 
(AcjO)  Yield:  95%, 'H NMR  (CDC13,8  ppm): 0.87 (m,  3H, CH3),  1.23 (mc, 20H,  10CH2), 2.03 (s,  3H, CO-
CH3), 3.44 (d, 2H, OCH2), 4.48 (s, 2H, 0-CH2-Ph), 4.9-5.2 (m,  1H, OCH), 7.21-7.34 (m, 5H, CfiH,); IR (film, 
v  cm'1):  3030  (w),  2925,  2860,  1740,  1496  (w),  1454,  1371,  1240,  1118,  1096,  1027,  902;  Calcd.  for  
C^HMOS: C 75.82, H 10.41; found: C  76.35, H 10.50. 
rac-2-Acetoxy-l-benzyloxy-4-meihylpentane rac-Sd 
(ACiO) Yield:  94%, 'HNMR  (CDC13, 8 ppm): 0.92-0.98  (d, 6H, 2CH3),  1.50 (mc,  3H, CH2, CH), 2.04 (s, 3H, 
CO-CH3), 3.45 (d,  2H, OCH2), 4.52 (s, 2H, 0-CH2-Ph),  5.0-5.3 (m,  1H, OCH), 7.19-7.35  (m,  5H, C6H3); IR 
(film, V cm'1): 3060 (w),  3030 (w),  2957, 2869,  1737,  1496,  1469,  1454,  1371,  1240,  1115,  1026,  947, 908, 
736; Calcd. for C,sH2203: C  71.97, H 8.86; found: C 71.61, H  8.92. 
rac-2-Acetoxy-l-benzyloxy-4,4-dimethylpentane rac-8e 
(Ac20) Yield:  96%, 'HNMR (CDC13, 8ppm): 0.87 (m, 9H, 3CH3),  1.49 (mc, 2H, CH2), 2.00 (s, 3H, CO-CH3), 
3.41  (d,  2H, OCH2), 4.44 (s, 2H, 0-CH2-Ph),  5.05-5.38  (m,  1H, OCH), 7.21-7.35  (m,  5H, CfiHj);IR  (film, v 
cm'1):  3030 (w),  2955,  2906,  2867,  1737,  1496 (w),  1476,  1453,  1371,  1240,  1204 (w),  1125,  1095,  1052,  
1024, 944, 736; Calcd. for C,6H2403.  C  72.69, H 9.15; found. C 72.11, H 9.10. 
rac-2-Acetoxy-l-benzyloxy-4-phenylpropane rac-&f 
(AczO)  Yield:  81%, 'H NMR  (CDCI3, 8 ppm): 2.04 (s,  3H,  CO-CH3),  2.89  (m,  2H,  Ar-CH2) , 3.44 (d, 2H, 
OCH2) ,4.53 (s,  2H, 0-CH2-Ph), 5.02-5.20 (m,  1H, OCH), 7.0-7.5 (m,  10H, 2QHj); IR (film, V  cm'1): 3063 
(w),  3029,  2933,  2863,  1826,  1737,  1604,  1496,  1454,  1372,  1239,  1124,  1097,  1050,  1029, 958,  896,  747;  
Calcd. for CigH20O3: C  76.03, H 7.09;  found: C 75.88, H 7.14. 
rac-2-Acetoxy-l-henzyloxy-4-phenylbutane rac-Sg 
(AcjO) Yield:  96%, 'HNMR (CDC13,8ppm): 2.01 (s,  3H, CO-CH3), 2.44-2.78  (m, 4H, 2CH2), 3.51 (d, 2H, 
OCH2), 4.46 (s, 2H, 0-CH2-Ph), 4.9-5.2 (m,  1H, OCH), 7.0-7. 2 (m,  10H, 2QHj); IR (film, v cm'1): 3062 (w), 
3027, 2933, 2862,  1737,  1603 (w),  1496,  1454,  1372,  1240,  1126,  1099,  1044,  1028,  907 (w), 737; Calcd. for 
C,9H2203: C  76.48, H 7.43; found: C  76.10, H 7.42. 
rac-l-Benzyloxy-2-propionyloxyheptane rac-ibB 
(C2H3C0C1)  Yield:  85%, 'HNMR  (CDC13, 8ppm): 0.86 (m, 3H, CH3), 0.96-1.48  (m,  11H, 4CH2,  CH3), 2.33 
(q, 2H, OOC-CH2), 3.42 (d, 2H, 0-CH2), 4.55 (s, 2H, 0-CHrPh), 4.87-5.20 (m,  1H, OCH), 7.18-7.32 (m,  5H,  
CfiHj); IR (film, v cm'1): 2956, 2932,2860,  1737,  1496,  1454,  1367,  1274,1189,  1112,  1082,905,  734;  Calcd.  
for CI7H2603: C 73.35, H 9.41; found: C 73.94, H 9.34. 
rac-l-Benzyloxy-2-(trifluoroacetyl)oxyheptane rac-ibC 
[(CF3C0)20]  Yield:  85%, 'HNMR{CDC13,  8ppm): 0.89  (m, 3H, CH3),  1.06-1.62 (m, 8H, 4H2), 3.58 (d, 2H, 
0-CH2),  4.49 (s,  2H, 0-CH2-Ph),  5.0-5.2  (m,  1H, O-CH), 7.18-7.38  (m,  5H,  CfiHj); IR  (film, v  cm'1): 2959, 
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2933, 2863,  1785,  1455,  1386,  1342,  1222,  1167,  1110,  1028 (w),  867,  732; Caled, for C16H2!F303: C 60.37, 
H 6.65, F 17.90; found: C 60.61, H 6.70, F 17.88. 
rac-l-Benzyloxy-2-(phenylacetyl)oxyheptane  rac-8bD  
( C S H J C H J C O C I )  Yield.  8 4 % ,  'HNMR (CDC1 3 ,  8 ppm): 0 . 8 2  (m, 3 H ,  C H 3 ) ,  1 .01-1 .61  (m, 8H,  4 C H 2 ) ,  3 .6  (m,  
4 H ,  0 - C H 2 ,  0 ( 0 ) C - C H 2 - P h ) ,  4 . 21  (s,  2 H ,  0 - C H 2 - P h ) ,  4 . 8 5 - 5 . 2 0  (m,  1H,  O - C H ) ,  7 .1 -7 .4  (m,  10H, 2 Q H , ) ;  IR  
(film, v  cm"1): 2 9 5 5 ,  2 9 3 0 ,  2 8 5 9 ,  1734,  1496,  1454,  1364,  1257 ,  1159 ,  1111,  1029,  9 0 8 ;  Caled, for C 2 2 H 2 8 0 3 : 
C 7 7 . 6 1 ,  H  8 .29 ;  found:  C  77 .92 ,  H  8 .35 .  
rac-2-Benzoyloxy-l-benzyloxyheptcme rac-SbE 
(CeHjCOCl)  Yield:  95%, 'HNMR(CDC13, 8 ppm): 0.86 (m, 3H, CH3),  1.08-1.67 (m, 8H, 4CH2), 3.62 (d, 2H, 
0-CH2),  4.52 (s,  2H, 0-CH2-Ph),  5.17-5.41  (m,  1H, O-CH), 7.12-7.54  (m,  10H, 2C6H5); IR (film, v  cm1):  
2955, 2930, 2859,  1790,  1716,  1601,  1495,  1452,  1364,  1314,  1274,  1212,  1175,  1106,  1070,  1026, 997, 936; 
Caled, for C2,H2603: C 77.27, H 8.03; found: C  77.81, H 7.99. 
rac-l-Benzyloxy-2-pivaloyIoxyheptane rac-SbF 
[(CH3C)3CC0C1] Yield-.  82%, 'HNMR (CDCI3, 8 ppm): 0.86 (m, 3H, CH3),  1.17 (s, 9H, 3CH3),  1.27-1.41 (m, 
8H, 4H2),  3.48 (d, 2H, 0-CH2), 4.52 (s, 2H, 0-CH2-Ph), 4.85-5.17  (m,  1H, O-CH), 7.20-7.38  (m, 5H, C«HS); 
IR (film, v cm'1): 2957, 2932, 2861,  1810,  1728,  1496 (w),  1480,  1455,  1366,  1283,  1164,  1111,  1042,  1006,  
940, 735; Caled, for Ci9H30O3: C 74.47, H 9.87; found: C 74.77, H 9.80. 
PREPARATION OF 2-ACYLATED  1 ,2-DIOLS rac-3a-g AND rac-3bB-F 
General procedure: To a suspension of  10 %  Pd-C catalyst (100 mg) in isopropyl  alcohol  (20-30 ml), 7-10 
mmol of  the corresponding  l-benzylated-2-acylated-l,2-diol  (rac-8a-g or rac-8bB-F)  was  added  and  the  
suspension was vigorously  stirred under hydrogen atmosphere at 40°C for 1-3.5 hours.  The catalyst was then 
filtered  off and the solvent was evaporated in vacuo.  The oily residue was purified by column chromatography 
with hexane:acetone. 
rac-2-AceioxypenUm-l-ol rac-Zu 
Yield:  72%, 'H NMR (CDC13,8  ppm): 0.95 (m, 3H, CH3),  1.42 (me, 4H, 2CH2), 2.06 (s,  3H, CO-CH3), 3.63 
(me, 2H,  OCH2),  4.8-5.1  (m,  1H, OCH); IR (film, v  cm'1): 3446 (be), 2960, 2930, 2875,  1738,  1713,  1470,  
1435,  1375,  1242,  1126,  1050,  1029, 955; Caled, for C7H1403: C 57.51, H 9.65; found: C 57.22, H 9.59. 
rac-2-Acetoxyheptan-l-ól rac- 3b 
Yield:  15%, 'HNMR (CDCI3,8  ppm): 0.92 (m, 3H, CH3),  1.38 (me, 4H, 2CH2), 2.06  (s,  3H, CO-CH3), 3.72 
(me,  2H, OCH2),  4.8-5.1  (m,  1H, OCH); IR (film, V  cm'1): 3442  (be), 2955,  2932, 2861,  1739,  1461,  1375,  
1242,  1047, 956; Caled, for C9H1A: C 62.04, H 10.41; found: C 62.47, H 10.34. 
rac-2-Acetoxytridecan-l-ol rac-3c 
Yield:  70%, 'HNMR (CDC13, 8 ppm):  0.83 (m, 3H, CH3),  1.20 (me, 20H,  10CH2), 2.04 (s, 3H, CO-CH3), 3.63 
(me, 2H, OCH2), 4.78-5.0 (m,  1H, OCH); IR (film, v  cm'1): 3452 (be), 2924, 2854,  1965,  1740,  1719,  1466,  
1374,  1241,  1055, 941, 891; Caled. forC,jH2803: C  69.72, H 11.70; found: C 70.14, H 11.72. 
rac-2-Acetoxy-4-methylpentan-I-olrac-Zd 
Yield:  74%, 'HNMR(CDC\3, 8 ppm): 0.92-0.98 (d, 6H, 2CH3),  1.50 (me, 3H, CH2, CH), 2.07 (s, 3H, CO-
CH3), 3.62 (me, 2H, OCH2), 4.8-5.1 (m,  1H, OCH); IR (film, v cm'1): 3446 (be), 2958, 2872,1739,  1713,  
1470,  1432,  1372,  1241,  1171,  1145,  1067,1025,  952, 879, 820; Caled. forCgHI603: C 59.98, H 10.07;  found:  
C 59.80, H 9.99. 
rac-2-A cetoxy-4,4-dimethylpentan-l-ol rac-3e 
Yield:  81%, 'HNMR  (CDC13) 8 ppm): 0.87 (m, 9H, 3CH3),  1.41 (me, 2H,  CH2), 2.01  (s,  3H, CO-CH3), 3.55 
(me, 2H, OCH2), 4.84-5.16  (m,  1H, OCH); IR (film, v  cm'1): 3446 (be), 2955, 2896, 2871,  1736,  1476,  1430  
(w),  1368,  1242,  1198,  1083,  1046,  1023, 944, 910; Caled, for C9H1803: C 62.04, H 10.41; found: C 61.92, H 
10.43. 
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rac-2-Acetoxy-3-phenylpropan-l-ol rac-Zi 
Yield:  65%, 'H NMR  (CDC13, 8  ppm): 2.00  (s,  3H,  CO-CH3),  3.61  (mc, 2H,  OCH2), 4.04 (m,  2H, Ph-CH2), 
4.92-5.20 (m,  1H, OCH), 7.05-7.32 (m, 5H, CsH,); IR (film, v  cm"1):  3445 (be), 3062, 3028,2937,  1736,  1604,  
1496,  1454,  1431,  1374,  1241,  1086,  1033, 943, 749; Calcd. for CnH,^:  C 68.02, H 7.27; found: C  68.22, H 
7.23. 
rac-2-Acetoxy-4-phenylbutan-l-ol rac-Zg 
Yield:  79%, 'HNMR (CDClj, 8  ppm): 2.00 (s, 3H, C O - C H J ) ,  2.47-2.82 (m, 2H, CH2), 3.71 (mc,  2H, OCH2), 
4.02 (m, 2H, Ph-CH2), 4.86-5.02 (m,  1H, OCH), 7.00-7.32  (m, 5H, C6H3); IR (film, v  cm"1): 3443 (be), 3026, 
2948,  1737,  1608 (w),  1496,  1454,  1371,  1244,  1096,  1043, 950, 915; Calcd. forC,2H1603.  C 69.21, H 7.74; 
found: C 68.93, H 7.71. 
rac-2-Propionyloxyheptan-l-ol rac-3bB 
Yield: 79%,  'H NMR  (CDC13, 8  ppm): 0.87  (m,  3H,  CH3),  1.06-L57  (m,  11H,  4CH2,  CH3),  2.3  (q, 2H, 
0(0)C-CH2),  3.81  (d, 2H, 0-CH2), 4.90-5.06 (m,  1H, OCH); IR (film, v cm1):  3446 (be), 2956,  2932, 2860, 
1737  1463,  1423,  1378,  1342,  1276,  1190,  1125 (w),  1083,  1021, 920, 889, 806; Calcd. for CioH2003: C 63.80, 
H  10.71; found: C  64.25, H 10.75. 
rac-2-(Trifluoroacetyl)oxyheptan-l-olrac-ZbC 
Yield:  81%, 'HNMR  (CDCI3, 8 ppm): 0.84  (m, 3H,  CH3),  1.02-1.51  (m,  8H, 4H2),  3.64 (d,  2H, 0-CH2),  5.1 
(mc,  1H, O-CH); IR (film, v  cm"1): 3355 (be), 2960,  2935,  2863,  1788,  1460,  1382,  1345,  1260,  1223,  1170,  
1074, 867, 812, 776, 730; Calcd. for CsH^FjOj: C  47.37, H 6.62, F 24.97; found: C 46.95, H 6.59, F 25.19. 
rac-2-(Phenylacetyl)oxyheptan-I-ol rac-ZbD 
Yield:  88%,  'H NMR  (CDC13, 8 ppm): 0.91  (m, 3H,  CH3),  1.04-1.47  (m,  8H, 4CH2),  3.58  (s,  2H, Ph-CH2),  
3.67  (d, 2H, 0-CH2), 4.71-4.98  (m,  1H, O-CH), 7.03-7.40 (m,  5H,  C«HS); IR (film, v cm1):  3442 (be), 2955, 
2930, 2860,  1733,  1496,  1454,  1259,  1161,  1075, 964,  910; Calcd. for C1SH2203: C 71.97, H 8.86; found:  C  
71.68, H 8.85. 
rac-2-Benzoyloxyheptan-l-ol rac-Z bE 
Yield:  83%,  'HNMR  (CDC13, 8  ppm): 0.92 (m, 3H,  CH3),  1.05-1.74  (m,  8H, 4CH2),  3.79 (d,  2H, 0-CH2), 
4.96-5.22  (m,  1H,  O-CH), 7.05-7.44  (m,  5H,  C«H5); IR (film, v  cm"1): 3462  (be),  2955,  2931,  2860,  1717,  
1602,  1451,  1359,  1276,  1177,  1115,  1096,  1070,  1026, 936; Calcd. forCi4H20O3: C 71.16, H 8.53; found:  C  
71.44, H 8.54. 
rac-2-Pivaloyloxyheptan-l-oi rac-ZbY 
Yield:  74%,  AM?(CDC13,  Sppm): 0.88 (m, 3H, CH3),  1.18 (s, 9H, 3CH3),  1.22-1.43  (m, 8H, 4H2), 3.62 (d, 
2H, 0-CH2),  4.77-4.98 (m,  1H, O-CH); IR (film, v cm1): 3447 (be), 2958, 2933, 2872, 2072 (b),  1729,  1708,  
1538  (w),  1481,  1461,  1398,  1367,  1285,  1164,  1093,  1061,  1034,  938,  893,  770;  Calcd.  for C12H2403: C 
66.63, H  11.18; found: C 66.36, H 11.15. 
PREPARATION OF 1 ,2-DIOLS  rac-4b,d 
General procedure:  To a suspension  of  10 %  Pd-C catalyst (100 mg) in isopropyl  alcohol  (20-30 ml), 7-10 
mmol  of the corresponding  1-benzylated -1,2-diol  (rac-7b,d) was added and  the suspension was vigorously 
stirred under hydrogen atmosphere  at 40°C for 2-3  hours. The catalyst was then filtered off  and the solvent 
was  evaporated  in  vacuo.  The  oily  residue  was  purified  by  column  chromatography  on  silica  gel  with  
hexane:acetone=l:l. 
rac-Heptan-1,2-diol rac-4b 
Yield. 89%, 'HNMR  (CDClj, 8 ppm): 0.94 (m,  3H, CH3),  1.41  (mc, 4H, 2CH2),  3.4-3.8  (m,  3H,  O-CH, O-
CH2); IR (film, v  cm1):  3356 (be),  2955,  2931,  2860,  1466,  1378,  1133,  1072,  1032,  938,  871;  Calcd. for 
C7H1602: C 63.60, H 12.20; found: C 64.11, H 12.22. 
rac-4-Methylpentan- 1,2-diol rac-4d 
Yield. 85%, 'HNMR  (CDC13, 8 ppm): 0.87  (d, 6H, 2CH3),  1.21 (q, 2H, CH2),  1.77 (mc,  1H, O-CH), 3.4-3.9 
(m, 3H, O-CH, 0-CH2); IR (film, v cm1):  3355 (bc), 2956, 2930, 2871,  1469,  1386,  1368,  1220,  1171,  1145,  
1071,  1028, 948, 920, 882, 842, 734; Calcd. for C6HI402: C 60.98, H 11.94; found: C  60.61, H 11.86. 
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PREPARATION OF 1-ACETYLATED 1,2-DIOLS rac-2b,d 
General procedure:  The  corresponding  1,2-diol rac-4b,d,  (10  xnmol),  pyridine  (25  mmol,  2.4  ml),  and  
catalytic amount of dimethylaminopyridine were dissolved in hexane (10 ml) followed by a  dropwise addition 
of  acetic  anhydride  (10  mmol,  0.95  ml)  at  room  temperature.  The  mixture  was  then  stirred  at  room  
temperature  until  TLC investigation  showed  no remaining  starting  material  (20-90  minutes).  The resulting 
mixture  was  then  diluted  with  diethyl  ether  (10  ml)  and washed  with  5% hydrochloric  acid  (2x10  ml),  
saturated NaHC03  solution (10 ml), and brine (10 ml). The organic phase was dried over Na2S04  and solvents 
were evaporated off in vacuo.  The residue was purified by column chromatography on silica gel  with hexane-
acetone. 
rac-l-Acetoxyheptan-2-ol rac-2b 
Yield:  69%, 'HNMR (CDCI3> S ppm): 0.92 (t,  3H, CH3),  1.2-1.6 (m,  8H, 4H2), 2.08 (s,  3H, CO-CH3), 3.8-4.1 
(m, 3H, O-CHj, O-CH); IR (film, V  cm"1): 3447 (be), 2956, 2933, 2860,  1742,  1458,  1371,  1241,  1137,  1041,  
944,916; Calcd. for C9H,803: C 62.04, H 10.41; found: C  62.35, H 10.47. 
rac-l-Acetoxy-4-methylpentan-2-ol rac-ld 
Yield:  77%, 'HNMR(CDC13,  8ppm): 0.97 (d, 6H, 2CH3),  1.19-1.41 (m, 3H, CH2-CH), 2.06 (s; 3H, CO-CH3), 
3.97 (mc,  3H,  O-CH, 0-CH2); IR (film, V cm1):  3454 (be), 2957,  2871  (w),  1741,  1469,  1369,  1241,  1171,  
1149,  1038, 981,950, 921; Calcd. for C8H1603: C  59.98, H 10.07; found: C 60.22, H 10.08. 
PREPARATION OF  1,2-DIOL DIACETATES  rac-lb,d 
General procedure:  The  corresponding  1,2-diol  rac-4b,d, (10  mmol),  pyridine  (50  mmol,  4.0  ml),  and  
catalytic amount of dimethylaminopyridine were dissolved in hexane (10 ml) followed by a dopwise addition 
of acetic anhydride (25 mmol, 2.4 ml) at room temperature.  The mixture was kept at 40°C for 20 minutes and 
the resulting mixture was then diluted with diethyl  ether (10 ml) and washed with  5%  hydrochloric acid (2x10 
ml),  saturated NaHCOj solution (10 ml),  and brine (10 ml).  The organic phase was  dried over Na2S04  and  
solvents were evaporated off in vacuo.  The remaining oil  was purified by column chromatography  on silica 
gel with hexane-acetone. 
rac-l,2-Diacetoxyheptane rac-lb 
Yield:  72%, 'H NMR (CDC13,8 ppm): 0.84 (t,  3H, CH3),  1.16-1.38  (m,  8H, 4H2),  2.01  (s,  3H, CO-CH3), 4.1 
(mc,  2H, 0-CH2), 4.85-5.10  (m,  1H, O-CH); IR (film, v  cm1):  2957,  2933,  2862,  1744,  1461,  1371,  1243,  
1227,1126 (w),  1096,  1048, 958, 873; Calcd. for CMH20O3: C 61.09, H 9.32; found: C  60.60, H 9.30. 
rac-l,2-Diacetoxy-4-methylpentane rac-ld 
Yield:  75%, 'H NMR (CDC13, 8 ppm): 0.96 (d, 6H, 2CH3),  1.2-1.6 (m, 3H, CH2-CH), 2.02 (s; 6H, 2CO-CH3), 
3.8-4.3  (m, 2H, 0-CH2), 4.95-5.15  (m,  1H, O-CH); IR (film, v  cm"1): 2959,  2873 (w),  1745,  1558 (w),  1506  
(w),  1471,  1431,  1372,  1227,  1097,  1045,  1026,  952,  890; Calcd.  for C,0H,gO3: C 59.39, H 8.97; found: C 
58.97, H 9.00. 
ACETYLATION OF  RACEMIC 2-ACETOXY-HEPTAN- 1 -OL rac-3b WITH DIFFERENT ENZYMES 
General procedure:  Racemic 2-acetoxyheptan-l-ol  rac-3b (200 mg) and enzyme were stirred in vinyl acetate 
(2 ml)  at room temperature.  After reaching a reasonable conversion  (for conversions  and reaction times see 
Table  1)  enzyme  was filtered off  and  solvent  was  evaporated.  The  residue  was  subjected  to  column  
chromatography  on  silica  gel  with  hexane-acetone  resulting  pure  diacetate  (lb)  and  monoacetate  (3b)  
fractions.  Spectral  data for optically  active compounds have not differed significantly  from that obtained for 
the  corresponding racemic  compounds.  Data for type of enzyme (amount of  enzyme),  lb:  %  yield,  3b: % 
yield,  are  given  below.  (For  determination  of  absolute  configuration  and  enantiomeric  purity  via  the  
corresponding  1,2-diol, see Table 1  and Experimental, Section on enantiomeric purity determination.) 
PfL (5), (/?)-3b: 52, (S)-lb: 40; PPL (30), (ft)Jb:  55, (S)-lb: 40; MjL (30), (R)-3b: 78, (S)-lb:  18; CcL (30), 
(7?)-3b: 54, (5>lb: 46; PLE (50), (R)-3b:  48, (5>lb: 29; AnL (30), 3b: 46, lb: 41. 
ACETYLATION  OF  RACEMIC 2-ACETOXY-HEPTAN- 1 -OL rac-3b IN DIFFERENT SOLVENTS 
General procedure:  Racemic 2-acetoxyheptan-l-ol  rac-3b (200 mg), vinyl  acetate (5  mmol) and PfL (5 mg) 
were  stirred in  the given  solvent  (2 ml)  at room temperature.  After reaching a reasonable  conversion  (for  
conversions  and reaction times, see Table 2) PfL enzyme was filtered off  and solvent  was evaporated.  The  
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further work  up  and analysis  of  products  were  carried  out  as  described  in  the  previous  section.  Data for 
solvent, (R)-3b: % yield, (S)-lb: % yield,  are given below. 
Chloroform, no reasonable conversion; /er/-butanol, (R)-3b: 27, (5)-lb.  68;  carbon tetrachloride,  (7?)-3b: 34, 
(Syib:  67; diethyl ether, (7?>3b: 32, (5)-lb:  58; 2-methyltetrahydrofuran, (7?)-3b: 46, (S)-lb:  38; ethyl acetate, 
(R)-3b: 60, (S)-lb:  38;  tetrahydrofuran,  (7?)-3b: 46, (5)-lb:  31;  hexane (satd. with water),  (R)-3b:  52, (5)-lb: 
37;  hexane, (R>3b: 41, (S)-lb: 49; hexane-vinyl  acetate  1:1, (R)-3b:  38, (£)-lb: 48. 
ACETYLATION OF RACEMIC 2-ACYLOXY-HEPTAN- 1 -OLS rac-3bA-F BY PfL 
General procedure : Racemic 2-acyloxyheptan-l-ol  rac-3bA-F  (1  mmol)  and  PfL (5  mg)  were  stirred  in  
hexane-vinyl  acetate  1:1 (2 ml) at room temperature. After reaching a reasonable conversion (for conversions 
and reaction times see Table 3) PfL was removed by filtration and solvents were evaporated. The further work 
up and analysis of products were carried out as described in the previous sections.  Data for remaining fraction 
of substrate 3bA-F: % yield, and the acetylated products 5*A-F: % yield,  are given below. 
(R)-3bAs  (R)-3b,  (S)-S*As  (S)-lb;  (R)-3bB:  55,  (S)-5*B:  25; (R)-3bC:  57,  (S)-5*C: 26;  (R)-3bD: 61, (S)-
5*D: 31; 3bE: 45, 5*E: 43; (5>3bF:  53, (R)-5*F: 42. 
HYDROLYSIS OF RACEMIC  1,2-DIOL DIACETATES  rac-lb,d  (Method H-l), PRIMARY  rac-2b,d  (Method H-2),OR 
SECONDARY MONOACETATES (rac-3b,d; Method H-3)BYPfL 
General procedure:  Racemic  1,2-diol  diacetate  rac-lb,d,  primary  rac-2b,A,  or  secondary  rac-3b,d  
monoacetate (3  mmol) and PfL (15 mg) were  stirred in water (25 ml)  at RT and pH value was kept at 7.2 by 
addition of 0.05M NaOH solution  from an autoburette.  When reasonable conversion (preferably  around 0.5) 
was achieved, the mixture was extracted with ethyl  acetate (3x30 ml).  The combined organic phase was dried 
over Na2S04,  and  the  solvent  was  evaporated  off  in  vacuo.  The  oily  residue  was  purified  by  column  
chromatography on silica gel with hexane:acetone.  Yields for remaining fraction of substrates and products are 
listed below. For configuration and enantiomeric purity analysis of products, see Table 4. 
Method H-l.  (7?)-lb: 40, (S>2b+(5)-3b:  36; (R)-ld:  45, (¿)-2d+(^-3d:  42; Method H-2: (S)-2b: 45,  (R)-4b: 
46; (S)-2d: 64, (R)-4d:  14; Method H-3: (S)-3b:  15, (7?Mb: 49; (S)-3d: 24, (R)-4d:  21.  
ACETYLATTONS OF RACEMIC  1,2-DIOLS  rac-lb,d  (Method A-l),  PRIMARY rac-2b,d (Method A-2),  OR 
SECONDARY MONOACETATES (rac-3a-g (Method A-3) BY PfL 
General procedure: Racemic diol rac-4b,d, (1.5  mmol; Method A-l)),  or primary rac-2b,d (Method A-2), or 
secondary monoacetates  rac-3a-g  (Method A-3),  vinyl  acetate (5 mmol) and PfL (5 mg) were stirred in the 
hexane-vinyl  acetate  1:1 (2 ml) at room temperature. After reaching a reasonable conversion (for conversions 
and reaction times,  see Tables 4  and 5) PfL enzyme was filtered off and solvent was evaporated. The further 
work  up  and  analysis  of  products  were  carried  out  as  described  at  the  previous  acylations.  Yields  for  
remaining fraction of substrates and products are listed below. 
Method A-l:  (S)-4b: 24, (R)-2b. 21; (S)-4d:  51, (R)-2A:  46; Method A-2: (R)-2b:  44, (S)-lb:  41; (R)-2d: 59, 
(5)-ld: 24; Method A-3: (R)-3a:  32, (S)-la: 23; (R)-3b: 39, (S)-lb: 48; (R)-3c:  40, (S)-lc: 27;  (R)-3d: 41, (5> 
ld: 37; (R)-3e:  43, (5)-le: 39; (R)-3f:  38, (5)-lf: 34; (R)-3g: 51, (S)-lg: 46. 
DETERMINATION OF THE ENANTIOMERIC COMPOSITION  1 ,2-DIOL DERIVATIVES 
General procedure: Step I: Hydrolysis of the acylated derivative l-3a-g, 3bA-F, 5«A-F to the corresponding 
1,2-diols (R)- or (5)-4a-g: A  10%(v/v) methanolic  solution of the appropriate acylated derivative,  containing 
catalytic  amount of  sodium methylate, was  stirred  at room temperature overnight.  After evaporating off the 
methanol  from  the  mixture,  residue  was  purifiad  by  chromatography  on  a  small  silica  gel  column  with  
hexane-acetone  yielding (yield  was usually  over 90  %) pure  1,2-diol  [(/?)-  or (S)-4a-g.  For optical  rotation  
values of the optically active 1,2-diols (R)- or (5)-4a-g, see Tables 1-5. 
Step  II:  Preparation  of  bis-(S)-MTPA  esters  of  1,2-diols  4a-g: (R)-MTPA-Cl  (125  pmol),  pyridine  (150  
|imol),  and the corresponding  1,2-diol  (R)- or (£)-4a-g,  (50 pmol) were mixed in  CC14 (1ml)  in an ampoule. 
The  ampoule  was  sealed  and kept  at 45°C for  1 hours.  After cooling to RT,  the  mixture was  diluted with 
diethyl  ether (5  ml)  and washed with  5% hydrochloric  acid  (1  ml),  saturated NaHC03  solution  (1  ml),  and 
brine (1 ml).  After drying (Na2S04)  and removing the solvents, the remaining oil was analyzed by  'H-NMR.  
The  characteristic  signals  of  the  0-CH2-  moieties  of  the  bis-MTPA  esters  (given  below)  were  used for 
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determination of diastereomeric-composition  (reflecting to the enantiomeric composition of the parent diol). 
For absolute configuration determination of  1,2-dioIs 4a-g, see notea in Table  5.  
Characteristic  'H-NMR signals (CDC13,8,  ppm): (*)-4a,  bis-MTPA ester. 4.54 (dd,  1H), 4.57 (dd,  1H); (S)-
4a, bis-MTPA ester: 4.61  (dd,  1H), 4.64 (dd,  1H); (R>4b, bis-MTPA ester: 4.54 (dd,  1H), 4.57 (dd,  1H); (S)-
4b, bis-MTPA ester: 4.61  (dd,  1H), 4.64 (dd,  1H); (R)-4c,  bis-MTPA ester. 4.54 (dd,  1H), 4.57 (dd,  1H); (S)-
4c,  bis-MTPA ester: 4.61  (dd,  1H), 4.64 (dd,  1H); («Md,  bis-MTPA ester: 4.54 (dd,  1H), 4.57 (dd,  1H); (5)-
4d, bis-MTPA ester: 4.61  (dd,  1H), 4.64 (dd,  1H); (R)-4e, bis-MTPA ester: 4.51  (dd,  1H), 4.54 (dd,  1H); (S)-
4e, bis-MTPA ester: 4.55  (dd,  1H), 4.58 (dd,  1H); (R)-4f,  bis-MTPA ester: 4.55 (dd,  1H), 4.58 (dd,  1H); (S)-
4f, bis-MTPA  ester:  4.63  (dd,  1H), 4.66 (dd,  1H); (R)-4g,  bis-MTPA  ester: 4.56 (dd,  1H), 4.59 (dd,  1H); (S)-
4g, bis-MTPA ester: 4.63 (dd,  1H), 4.66 (dd, 1H). 
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Abstract:  (+)-Faranal  j^a,  the  trail  pheromone  of  Pharaoh's  ant,  
and  its  congener,  (+)-13-norfaranal  J_b  were  synthetized  from  
chiral  building  block  ji employing  diastereose1ective  carbon-
carbon  bond  formation.  The  application  of  crude  pig  liver  
esterase  enzyme  for  the  preparation  of  4_ is  also  discussed.  
(+)-Faranal  is  the  most  attractive  component  of  the  trail  pheromone  produced  
by  Pharaoh's  ant  (Monomorium  pharaonis,  L.),  which  is  a serious  houshold  pest  in  
most  of  the  world.  This  compound  has  a  very  high  behavioural  efficiency  and  the  
detection  threshold  is  about  1 pg cm - 1  of  a  trail.  The  structure  of  (+)-faranal  
2-4 
was  assigned  to  be  (3S , 4jT, 6E  ^lOjU-3 , 4 , 7 ,11-te tr amethy 1 -6 , 10-1 r idecad iena 1  l_a  
R 
All  four  optical  isomers  of  faranal  have  some  biological  activity.  However,  
racemic  faranal  has  only  one  tenth  of  the  trail  pheromone  activity  of  the  natural  
product.  Surprisingly,  the  3-epimer  (3£,4R^-faranal)  was  also  weakly  active  and  
does  not  interfere  with  the  activity  of  natural  product,  since  ants  follow  a  
trail  made  of  a  1:1  mixture  of  stereoisomeric  compounds.  Furthermore,  structure  
modification  study  showed  that  among  structurally  related  compounds  a  40  : 60 
mixture  of  (3S,4R)~  and  ( 3^, 4R) -13-norf arana 1  (_lb and  its  3-epimer)  had  also  the  
4  5  
ability  to  release  trail-following  activity  '  
(+)-Faranal  has  been  an  attractive  synthetic  target  of  considerable  current  
interest  because  of  its  challenging  structural  features  and  extremely  high  level  
of  biological  activity.  Four  different  synthetic  apprcches  to  faranal  have  been  
reported.  In cooperation  with  Japanese  group,  Ritter  et  a 1.  elaborated  the  first  
synthesis  of  faranal  .  Actually,  this  small  scale  bicorganic  synthesis  leading  
to  a  40  : 60  mixture  of  (+)-faranal  and  its  (3R^)-epimer,  established  its  absolute  
stereochemistry; 
Mori  and  Ueda  have  confirmed  the  structural  assignments  of  (+)-faranal  by  
synthetising  both  enantiomers.  Their  attractive  linear  approach  is  rather  lenghty  
and  required  the  chemical  resolution  of  an  intermediate  
Recently,  two  convergent  approaches  for  the  synthesis  of  racemic  faranal  
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were  reported.  Knight  and  Ojhara  assembled  the  sesquiterpenoid  skeleton  of  
faranal  by  Wittig  condensation,  which  yielded  an  approximately  1  : 1  mixture  of  
(E)-  and  (Z)-isomers.  Racemic  faranal  and  its- (6Z)-isomer  were  then  separated  by  
•  q  
preparative  scale  g.l.c.  ' .  In  an  alternative  synthesis  of  racemic  faranal,  
Baker's  group  employed  the  addition  of  an  alkylcopper  complex  to  terminal  acetylene  
for  the  stereoselective  construction  of  the  6E  double  bond  
Recent  interest  in  the  use  of  trail  pheromone  to  increase  the  rate  of  toxic  
bait  pick-up  has  led  us  to develop  new  synthetic  method  for  the  preparation  of  
enantiomerically  pure  (+)-faranal  and  ( + )-13-norfaranal  (pa  and  l_b,  respectively).  
Our  approach  is  strategically  quite  different  from  the  existing  ones  in  the  
construction  of  the  skeleton  of  faranal  (Scheme  1.).  Namely,  we  formed  the  
1a => 
Scheme  1.  (rethrosynthetic)  
=> 
V 
à 
V 
rS 6 
MeOOC  COOMe  
4,5-bond  of  the  molecule  stereoselectively  by  electrophilic  enolate  alkylation  of  
an  appropriately  functionalized  chiral  building  block  (4)  with  U)-homogerany 1 
bromide  (2).These  key  intermediates  can  be  easily  prepared  from  geraniol  and  
glutaconic  ester  (6),  respectively.  
(3!5)-Methyl  valerolactone  (4),  our  chiral  key  intermediate,  was  prepared  
from  dimethyl  3- methylglutarate  O )  obtained  by  catalytic  hydrogénation  of  
12 
glutaconic  ester  (6)  (Scheme  2.).  
Scheme  2 : rb PLE A 
MeOOC  COOMe  
7 
HOOC  COOMe  
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Recently,  this  compound  was  enantiotopically-selectively  hydrolysed  with  pig  
liver  esterase  (PLE)  enzyme  system  The  enzyme  attacked  preferentially  at  
the  pro-(jj)-methoxycarbonyl  group  and  (jp-monoester  (jp  was  isolated  in  above  
80  X  yield  and  in  80  - 90  % optical  purity.  However,  the commercially  available  
pure  pig  liver  esterase  is rather  expensive.  Therefore,  we  tried  to perform  the  
selective  hydrolysis  of  diester  (.]_)  with  crude  enzyme.  Thus,  molar  amount  of  
diester  (7)  was  suspended  in  0.1  M phosphate  buffer  (pH  7) extract  of  pig  liver  
acetone  powder  1^.  The  pH  value of  the resulting  mixture  was  kept  within  6.9  -  7.1  
range  by  continuous  addition  of  10  X sodium  hyroxide  solution.  After  consumption  
of  one  equivalent  of  base  (approximately  5 h),  the mixture  was  worked  up  to  yield  
the  (F! )-enantiomer  of monoester  (p)  in  72  X yield  and  in  85  X optical  purity.  
Since  the  optical purity  was  not  satisfactory,  the  crystalline  1,-cinchonidine  salt  
of monoester  (19) was  formed  and  recrystallized  from  water-acetone.  Acidification  
of  this  salt  yielded  optically  pure  (R)-monoester  (_B, e.e.>96  %),  which  was  
selectively  reduced  with  sodium  in NH 7-Et0H  1 8  or  LiBH,.  in  THF  1 3  to  give  (3S)-
methyl  valerolactone  (2)'  
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(I)-Homogerany1  bromide  (_3) , another  key  intermediate,  was  prepared  fr om  the  
readily  available  geraniol  (¿)  by  the  combination  of  known  methods  with  some  
modification  (Scheme  3.).  
OBz 
0 
OBz 
OH  10  OH  11  
OBz 
HO 
OBz 
OH  12  13q 
1 3 b 
Scheme  3.  
R =  ORz  
R =  H  
R=  Br  
Thus,  reaction of  geraniol with  sodium  hydride  and  benzyl  bromide  gave  geranyl  
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benzyl  ether  , which  was  generally  not  purified,  but  directly  treated  with  
3-chloroperoxybenzoic  acid  to  produce  epoxy  compound  (90•  A number  of  reagents  
20  21  2 2 (e.g.  sodium  glass  , lithium  perchlorate  , lithium  diethylamide  , aluminium 
2 3 
isopropoxide  )  were  then  examined  for  the  conversion  of  epoxide  (9)  to  allylic  
alcohol  ( H p .  In  our  hands,  aluminium  isopropoxide  proved  to  be  superior  to  the  
other  reagents.  The  reaction  was  performed  in  refluxing  toluene  and  afforded  the  
desired  product  (_10)  in  good  yield.  Catalytic  epoxidation  of  alcohol  (JUD)  with  
t-butyl  hydroperoxide  in  the  presence  of  catalytic  amount  of  VOCacac)-  in  
benzene afforded epoxy  alcohol  (LI),  which  was  then  converted  into  (Z)-homogerany1  
benzyl  ether  (13a)  by  the  sequence  involving  oxirane  reaction  with  lithium  
dimethyl  cuprate  and  elimination  of  the  hydroxy  groups  of  the  resulting  diol  (12)  
by  treatment  with  dimethylformamide  dimethyl  acetale  and  acetic  anhydride  
HPLC  analysis  showed  that  the  product  (13a) was  contaminated  by  less  than  8  %  of  
(£)-isomer  ,  which  was  removed  after  deprotection  by  treatment  with  lithium  in  
liquid  ammonia  by  column  chromatography.  The  resultant  (Z^)-homogeraniol  (13b) was 
then  converted  to  diastereomerically  pure  (_Z)-homogeranyl  bromide  (3)  by  treatment  
with  phosphorous  tribromide,  in  24  % overall  yield  (based  on  geraniol).  
Next  task  was  to connect  the  two  building  blocks  (3  and  . For  this,  wo plan 
a  diastereoselective  carbon-carbon  bond  formation  by  an  electrnphilic  enolate  
alkylation  (Scheme  4.).  
Enolate  (4ja)  generated from the  lactone  ( O  seemed  particularly  attractive  for  
this  purpose  by  virtue  of  its  rigidity  and  conformationally  enforced  proximity  of  
its  reacting  center  (C2)-  Furthermore,  in  the  transition  state  of  alkylation  only  
one  of  the  possible  conformers  (4£,  methyl  group  in  perpendicular  position  )  is  
stabilized  by  hyperconjugative  interaction.  Here,  the  incoming  electrophile  
preferentially  attacks  on  the  opposite  side  of  the  plan  and  renders  the  (Re-
configuration  at  the  newly  created  chiral  center  (Scheme  4.).  
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Scheme  4.  
Coupling  reaction  between  enolate  (4_a)  generated  from  the  lactone  (4.)  
with  lithium  diethylamide,  and  (ZJ-homogeranyl  bromide  (_3) proceeded  as expected  to  
give  predominantly  the  desired  anti-isomer  (2£,3Sj)-.2>  together  with  a  small  
amount  (less  than  6 %)  of  syn-isomer  (22j,3^).  This  high  onti  stereofacial  selec-
tivity  was  evidenced  by  the  trans  relationship  found between  the  substituents of 
lactone  moiety  in  the  product  (2),  as deduced  from  the  coupling  constant  value  
J^  3  in NMR  spectra,  that  requires  trans-arrangement  for  this  substituent.  
Trivial  reactions  were  then  used  to  convert  lactone  (_2)  into  (+)-faranal  
(la_)-  Thus,  transesterification  of  2 with  MeOH  and  Et^N  led  to  a hydroxy  ester  
(14a) which  was  converted  to protected  ester  (14b)  by  treatment  with  dihydropyran  
in  the  presence  of  pyridinium  p-toluenesulfonate.  Reduction  of  14b  with  excess  
lithium  aluminium  hidride  gave  the  alcohol  (15a)  which  was converted  to  the  
corresponding  mesylate  (15b)  by mesyl  chloride  in  the  presence  of  triethylamine.  
The  mesylate  (15b)  was  reduced  with  lithium  aluminium  hidride  in  refluxing  THE  
and  then  the  protecting  group  of  the  resulting  ether  (16a)  was  removed  by  acid  
catalyzed  hydrolysis.  Finally,  oxidation  of  the  resulting  alcohol  (16b)  with  
pyridinium  dichromate  afforded  (+)-faranal  (JjD  in  1.9  % and  3.5  % overall  yield  
(based  on  and  respectively).  
Chiral  lactone ( O  also  served  as  the  key  intermediate  in  the  first  stereo-
controlled  synthesis  of  (+)-13-norfaranal  (_lb)(Scheme  4.).  Here,  in  the  electro-
philic  ester  enolate  alkylation  we  used  geranyl  bromide  (3_a)  and  isolated  the  
desired  anti-isomer  2b,  together  with  a  small  amount  of  syn-isomer  (6 %).  This  
was  converted  to  stereoisomerically  94  %  pure  (+)-13-norfaranal  (IJo)  by  the  
method  described  above  for  (+)-faranal,  via  intermediates  14c,  14d,  15c,  15d,  
16c  an  16d  in  19.4  %  overall  yield  from  lactone  4^ .  
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IN  spectra  were  obtained with  a Specord  IR-75  (Carl  Zeiss,  Jena) spectrophotometer. lH-  and  
1 3C-NMR  spectra  were  recorded  on  a OEOL  FX-100  FT-NMR  instrument  at  100  and  25 MHz,  respectively,  
and  are  reported  in ppm  downfield  from  internal  IMS.  Mass  spectra  were  taken on  a  JE0L-20K  and  a  
JMS-Ol'SG-2  combined  GC-MS  system  at  75  eV  ionizing  energy.  HPLC measurements  were  carried  nut  on  a  
Ou Pont  830  instrument.  For  the capillary  GLC  analyses  a Packard  628  instrument  equipped  with  FIU  
was  used.  Thin  layer  chromatography  was  carried  out  using  Xieselgel  60  F 2 J 4  on  alumina  plates  (E.  
Merck  £o,FRG)  and hexane-acetone=5:0.2(A),  hexane-acetone=10:1(8),  hexane-acetone=5:2'C)  or  hexane-
ethyl  acetate=2:1(0)  eluant  systems.  Spots  were  visualised  by  immersing  the  plates  into  5 X 
ethanoiic  solution  of  phosphomolibdenic  acid  and  then  heating.All  solvents  used  were  freshly  
distilled  and  anhydrous,  and operations  with  alkyl  lithiums,  cuprates,  LiBH4  and  LiAlH4  were  carried  
out  under  dry  argon  atmosphere.  
Oimethvl  3-methylqlutarate  (7)  
Dimethyl  glutaconate  (£,435  g,  2.5  moles)  was  catalytically  hydrogenated  by  10  X palladium  on  
active  carbon  under  4 atm hydrogene  pressure  at  65°C.  After  consumption  of  the calculated  61  1  
(2.5 moles)  hydrogene  the  catalyst  was  filtered  off  and  the product  was  distilled  in vacuo  to  yield  
7  (349  g,  91  X)  as  a colorless  oil  Bp.:  115°C(0.5  torr);  TLC(B):Rf = 0.29;  IR(film), v„  : 2900,  1725,  
~~  *  «  HIM * 
1440,  1370,  1260,  1190,  1150,  1080,  1010 cm" 1;  1H-HMR(CC1 4, <T):  1.01  (d,J = 5Hz,  3H.-CH,),  2.26  (m,5H,  
2-CH 2-  and  1-CH=),  3.55  (s,6H,  2 COOCHj);  MS  m/e:  174(2)lM+],  143(1011),  142(51 ),  115(51),  114(92),  
101(94),  83(20),  82(28),  73(60),  69(91),  59(75),  55(60),  43(61),  42(38),  41(65),  39(40).  
(3R)-Hydroqen-methyl  3-methylqlutarate  (8)  
Pig  liver  acetone  powder*  (100  g) was  homogenized  with  0.1  M phosphate  buffer  (pH-8,1200  mL)  
and  then centrifuged  at  3000  g  at  room  temperature  for  five  minutes.To  this  obtained  supernatant  
(pH value  changed  to about  7.0 during  the  extraction  process)  having  31  U/mL  enzyme  activity(measured  
on ethyl  butyrate as a subsrate at  2S°C,  pH=8)  compound  T_ (314  g,  1.8 moles)  was  added  and  the  pH  
value  of  the  resulted  well  stirred  emulsion  was  kept  within  6.9-7.1  range  by  continous  addition  of  
10  X  (Z.78  M)  sodium  hydroxide  solution.  After  consumption  of  1 equivalent  of  base  (645 mL)  the  
mixture  was  acidified  to pH=2  by  the  addition  of  concentrated  hydrochloric  acid.  To  the  emulsion  
sodium  chloride  (150 g) was  added  and  the  resulting  mixture  was  centrifuged  at  3000  g  for  five  
minutes.  The  precipitated  part was  washed  with  ethyl  acetate  (400 mL)  and  the  supernatant  was  
extracted  three  times with  ethyl  acetate  (800 mL,  each).  The  combined  ethyl  acetate  solutions  were  
washed  with  brine  (200 mL)  and dried  over  MgSO^.  Evaporation  of  the solvent  in  vacuo  gave  crude  8,  
which was  further  purified  by  vacuum-distillation  to  yield  pure £(213  g,  76  X)  as  a colorless  oil.  
Bp.:  1Q6-107°C  (0.05  torr);L°Og2=0•49°(neat).  Lit. 2 8 : C«]22=*0. 58°(nea t,  100  X  ee).  
Recrystallzation  of  this  product  (8,12  g,  75 mmol) with  1-cinchonidine  (22.2  g,  75 mmol)  from  water  
(210 mL)  containing  acetone  (60 mL)  resulted  chrystalline  salt  of  8 as white  needles.  Chrystals  
were  then solved  in  1M hydrochloric  acid  (60 mL) and  extracted  three  times  with  ether  (30 mL,  each).  
The  combined  ethereal  solutions  were then washed with  brine  (15 mL)  and dried  over  MgSO^.  After  
evaporation  of  the  solvent  in vacuo  optically  pure  £  (7.7  g,  64  X) was  obtained  as  a pale  yellow  
oil.[®Gn 2=  0.57°(neat);  TLC  (C):  Rf=  0.35;  IR(film),  V m  : 3200,  2900,  1725,  1700,  1440,  1380,  
u  i  i  max  
1290,  1200,  1160,  1080,  1010  cm"  ; H-NMR  (CC14,<T):  1.08  (d,J=5,5Hz,  3H,-CH}),  2.31  (m,  5H,2-CH2-
and  1-CW=),  3.62  (s, 3H,COOCHj),  11.3  (br  s,  1H.COOH);  MS m/e:  160(1)[M+],  143(11),  142(25),  129(65),  
128(27),  114(66),  101(66),  100(50),  87(18),  83(16),  82(21),  74(67),  72(21),  69(78),  60(13),  59(100),  
56(12),  55(42),  45(13),  44(77),  43(33),  42(46),  39(27).  
(-)-(3S)-Methylvalerolactone  (4)  
a)  To  a  stirred  and boiling  solution  of  distilled  ammonia  (700 mL) containing  dry  ethanol  (60  mL)  
and £  (32  g,  700  mmol)  sodium pieces were  added  portionwise.  After  complete  sodium  addition  the  
mixture  was  boiled  and  stirred  for  1 h and then- solid  ammonium  chloride  was  added  until  the  
disappearance  of  the deep  blue  color  of  the mixture.  Ammonia  was  evaporated  and  the  residue  was  
dissolved  in water  (400 mL).  The  aqueous  solution  was  acidified  to pH  2 at  0°C  with  50  X H 2S0 4  and  
then  extracted  three  times  with ethyl  acetate  (400  mL,  each).  Ethyl  acetate  solutions  were  combined  
and washed  with  brine  (80 mL),  dried  over  MgSO..  After  evaporation  of  the  solvent  in  vacuo  the  
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residue  was  vacuum-chromatographed  (VLC)  (on  200  g  of  63-100  jam Kieselgel  60 with  hexane-acetone=  
10:1  eluant)  to  yield  4  (12.8  g,  56  X).  
Product  can  only  be  stored  without  decomposition  at  4°C  in diluted  aprotic  (e.g.ethe real) solution 
for  a  longer  period.  
b)  To an  ice  cooled  and stirred solution  of  £  (101  g,  0.63  mol)  in methanol  (500 mL)  LiOH  H.O  
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(26.3  g, 0.63  mol) was  added partionwise  maintaining  the  inner  temperature  under  15°C.  After  complete  
dissolution  of  the  LiOH  HjO methanol  and water  was  evaporated  from  the  resulted  salty  product  in  
vacuo  to yield  dry  lithium  salt  of  6  (100.4  g,  95  X).  80  g  (0.4B  mol)  of  this  salt  was suspended  in  
dry  THF  (800 mL)  under  dry  argon  atmosphere  and  then  LiBH 4(16.5  g,  0.76 mol)  was  added  to  the  
vigorously  stirred  suspension.  The  resulted  mixture  was  refluxed  for  1 h  and  after  coaling  to  room  '  
temperature  poured  into  ice-water  (500 mL), which  was  then acidified  to  pH=2  by  dropwise  addition  
of  concentrated  hydrochloric  acid.  The acidified  aqueous  mixture  was extracted  four  times  with  ethyl  
acetate  (400 mL,  each)  and  then  the combined  organic  layers  were  washed  with  brine  (ISO mL)  and  
dried  over  MgSO^.  After  evaporation  of  the  solvent  in  vacuo  and  VLC  purification  (as above)  pure  £  
(29.9  g,  55  X) was  obtained.  
[«]Q3=-23.5°  (c=5.21,  CHClj,  from  unrecrystallized  8)  and C«]^3=-26.9°(c=4.98,  CHClj,  from  
recrytallized  B), Lit. 2 8: 0<]g2= + 27.6°  (c=5.72,  CHClj,  3R-enantiomer,  100  X ee);  TLC(C):Rf=0.39;  
1R  (film),- v m a x :  2900,  1720,  1460,  1440,  1400,  1370,  1310,  1280,  1240,  1220,  1160,  1080,  1060,  1000,  
920 cm" 1;  1H-MMR  (CDCl,,f):  1.09  (d,  3=6.5Hz,-CHj),  1.4-2.3  (br  m,  5H,  2-CH 2-  and  1-CH=),  4.0-4.5  
(m,2H,-CH2-0);  MS  m/e : 115( 4) [M-. 1 ] + ,  114 (21)[M*],85(1),84(2) ,71(3),70(23),  55(100), 42(83 ), 41 (54), 39( 40) . 
(2EJ-1- 8enzyloxy-6.7-epoxy-3.7-dimethyl-2-octene  (9)  
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To an ice-cooled and stirred  solution  of  geranyl  benzyl  ether  (30  g,  0.122  mol)  in dry  dichloro-
methane  (300 mL)  3-chloro-peroxybenzoic  acid  (31.5  g,  0.128  mmol,  75  X content  ) was  added  portionwise  
maintaining  the  inner  temperature  under  5°C.  After  complete  addition  the  resulted  mixture  was  stirred  
at  0°C  fnr 1 h  and  then  the  precipitated  white  solid  was  filtered  off.  Filtrate  was washed  two  times  
with  10  X sodium  hydroxide  solution  (80 mL,  each)  and  then brine  (50 mL).  After  evaporation  of  the  
solvent  VLC  of  the  residue  (on  300  g  of  silica  gel  with  hexane-acetone=5:0.1  eluant)  resulted  2  
(21.9,  69" X)  as  an oil.  TLC  (B):Rf=0.36;  IR(film), \> m a x:  2900,  2840,  1660,  1445,  1370,  1240,  1190,  
1100,  1080,  1060,  1020,  725,  690 cm" 1;  1H-NMR  CCC1 4,  <f): 1.18  (m,  6H,  2-CHj),  1.4-1.8  (m,  5H,-CH 2-
and  -CHj), 2.12  (mc,  2H,-CH2-),  2.49  (t,  3=6Hz,  1H,C6  -CH=),  3.90  (d,  3=7Hz,  2H, -CH 2-0Bz),  4.38  
(s,  2H,  O-CHj-Ph),  5.33  (t,  3=7Hz,  1H,-CH=C),  7.19  (m,5H,Ar-H);MS  m/e:  210(1)[M+],  174(6),  154(4),  
123(7),107(7),  91(100),  85(13),  71(19),  59(20),  43(7).  
(2E)-l-8enzyloxy-6-hydroxv-3,7-dimethyl-2.7-octadiene  (10)  
A solution  of 2  (15.6  g,  60 mmol)  and  aluminium  isopropoxide  (12.3  g,  60 mmol)  in dry  toluene  
(100 mL)  was  refluxed  and  stirred  for  8 h.  After  cooling  to  room temperature  hexane  (100 mL)  was  
added  to  the  resulting  mixture  arid then  the  organic  solution  was  washed  with  2M hydrochloric  acid  
(100 mL),  saturated  NaHCOj  solution  (40 mL)  and  brine  (40  mL).  The  organic  layer  was  then  dried  over  
MgS0 4  and  the  solvent  was  removed  in vacuo  to give  10  (14.6  g,  93  X)  as  a pale  yellow  oil.  TLC(C):  
Rf = 0.47;  IR  (film)  V m a x :  3400,  2900,  2B50,  1670,  1500,  1460,  1380,  1075,  1040,  900,  740,  700  cm" 1;  
1H-NMR  (COClj.f):  1.66  (s,  3H,-CHj),  1.71  (s,  3H,-CHj),  1.95  (mc,  4H,  2-CH 2-),  3.57  (m,  lH,=CH-0),  
3.99  (d,  J = 6.5  Hz,  2H,-CH 2 -OBZ),  4.47  (s,  2H,  0 -CH 2-Ph),  4.80  and  4.92  ( m . m ^ H ,  C = C H 2 ) ,  5.38  (t,  
3=6,5Hz,lH,-CH=C),  7.27  (br  S,  511, Ar-H);  MS m/e:  260(1)[M*],  242(1 ), 174(3),  169(4),  151(13), 125(7), 
123(10),  109(8),  107(18),  97(6),  95(B),  93(10),  92(17),  91(100),  82(12),  81(19),  71(16),  69(15),  
68(11),  67(15),  55(12),  44(22),  42(19).  
(2E)-l-Benzyloxy-7,8-epoxy-6-hydroxy-3.7-dimethyl-2-octene  (11)  
To  a solution  of  10  (10.4  g,  40 mmol)  in dry  benzene  (100  mL)  20 mg  of  V0(acac)2  catalyst  was  
added  and  then  t-BuOOH  (8.0  g,  90  X content,  80 mmol)  was  dropped  to  the  resulting mixture  over  a  
period  of  15 min.  After  stirring  at  room  temperature  for  2 h,  additional  V0(acac)2  catalyst  (20  mg)  
was  added  to  the  reaction mixture  and  stirring  was  continued  for  another  2h.  The  obtained  mixture  
was  then diluted  with  hexane  (.100 mL)  and washed  with  10  X  Na 2C0j  solution  (30 mL)  and brine(30  mL).  
After  drying  (MgSO^)  and evaporation  in vacuo  the  resulting  residue  was  purified  by VLC(on  200  g  of  
63-200  /wm silica  gel  with hexane-acetone=10.-l  eluant)  to yield  pure  1_1  (8.6  g,  78  X)  as  an  oil.  
TLC(C):Rf = 0.38;  IR  (film), V m a x .  3350,  2900,  2830,  1660,  1500,  1450,  1380,  1360,  1190,  1060,  1020,  
940,  900,  740,  700 cm" 1;  1H-NMR'(CClft, S):  1.30  (s,3H,-CHj),  1.50  (m,2H,-CH^) , 1.66(s,3H,-CHj),  2.22  
(m,2H,-CH2-),  2.61  (mc,2H,  Cg-CHj-) , 3.48  (m,lH,0H),  3.96  (d,3=6.5Hz,2H,-CHj-OBz),  4.36(s,2H,0-CHj-Ph),  
5.39  (t, 3=6. 5Hz,  1H,-CH=C),  7.29  (br  s,5H,Ar-H);  MS m/e: 2 7 6 U  l)tM +3,  174(2),  170(2),  169(3),  167(3),  
153(3),  141(3),  123(4),  121(4),  111(9),  97(9),  91(100),  87(10),  81(26),  43(31),  41(25).  
(2E,6.7-anti)-l-Benzyloxy-6.7-dihydroxy-3,7-dimethyl-2-octene  (12)  
To  a suspension  of copper(l)  iodide  (9.4  g,  48.4  mmol)  in dry  ether  (100 mL)  1.38  M  ethereal  
methyl  lithium  solution  (70 mL,  97 mmol) was  added  below  -20°C under  dry  argon  atmosphere.  After  
stirring  at -20°C  for  10 minutes  the  mixture  became  homogenous  and  then  1_1 (6.67  g, 24.2  mmol)  in  
dry  ether  (30 mL)  was  added  to  this  solution  at  -20°C.  The  resulting  mixture  was  stirred  at  0°C  for  
4  h and  then  was  quenched  by  addition  of  10  X NH^Cl  solution  (30 mL).  'The ethereal layer was washed with 
two  additional  portion  of  10  X NH^Cl  solution  (30 mL,each)  and  brine  (30  mL)  and  dried  over  MgSO^.  
The  VLC  (100  g  of  63-200 y m  silica  gel  , hexane-acetone=10:l  eluant)  of  the  residue  of  the  evaporation  
in  vacuo  gave  12  (A.45  g,  63  X).  TLC(C):Rf=0.34;  IR  (film), V m a x :  3350,  2900,  2840,  1660,  1450,  1380,  
Synthetic  route  to (+)-faranal  and  ( +  )-13-norl'aranal  1483 
1060,  1000,  730,  695 cm" 1;  1H-NMR  (COClj, i):  0.91  (t,  3=6,5Hz,  SH.-CHj),  1.12  (s,  SH.-CHJ),  1.45  
(mc, 4H,2 - C H 2 - ) ,  1.65  (s,  S H . - C H J ) ,  2.12  (t,  3=6Hz,  2H , - C H 2 - ) ,  2.36  (br  s,  2H,2  OH),  3.35  (m,  1H,=CH  
-0),  4.01  (d,  J=7Hz,  2H,-CH2-0BZ),  4.47  (s,  2H,  O-CHj-Ph),  5.42  (t,  J=7Hz,  1H , -CH=C),  7.28  (br  s,  
5H,  Ar-H);  MS m/e:  292(< 1)CM+],  274(3),  219(5),  183(4),  166(3),  163(3),  155(5),  137(5),  112(8),  
111(14),  91(100),  81(20),  73(58),  68(30),  57(22),  43(22),  41(15).  
(2E.6Z)-l-Benzvloxv-3.7-dimethyl-2,6-nonadiene  (13a;  Z-hnmnqeranyl  benzyl  ether)  
A solution  of  1_2 (9.8  g,  29.8  mmol)  in N.N-dimethylformamide  dimethyl  acetate  (30 mL)  was  
stirred  overnight  at  room  temperature  and  then evaporated  in vacuo.  To  the  residue  acetic  anhydride  
(30 ml)  was  added  and  the  solution  was  boiled  and  stirred  for  8  h.  After  coaling  to  room  temperature  
the mixture  was  diluted  with  hexane  (250 mL) and washed with  water  (50 mL),  two  times with  10  X  
sodium  hydroxide  solution  and brine  (50 mL).  After  drying  over  MgS0 4  the  solvent  was  removed  in  
vacuo  and  the  residue  was  purified  by  VLC  (100  g silica  gel,  hexane-acetone=5:0.1  eluant)  to  yield  
13a  (5.05  g,  65 X)  as an  oil.  TLC  (A):Rf=0.62;  IR  (film),  :  2970,  2930,  2850,  1660,  1450,  1370,  
1230,  1100,  1060,  1020,  725,  690  cm" 1;  1H-NMR  (CCl4,<f): 0.95  (t,  3=6.5Hz,  SH.-CHj),  1.65  (s,  3H.-CH,),  
1.72  (s,  3H,-CHj),  2.10  (m,  4H,  2-CHj-),  3.94  (d,  3=6.5Hz,  2H,-CH20Bz),  4.46  (s,  2H,  O-CHj-Ph),5.05  
(m,  1H,-CH=C),  5.33  (t,  3=6.5Hz,  1H,-CH=C),  7.29  (br  s,5H,Ar-H);  MS m/e:  258(11 )CM*],  229(25,176(6),  
167(7),  150(25),  137(26),  121(17),  91(100),  83(66),  55(66),  41(29);  HPLC:  tR =  147  s (main  component,  
95  X,  (2E,6E)-isomer:tR=  138  s,  5  X;  250x4.5 mm  LiChrosorb  RP-8  10 ^m,l  ml/min  acetonitrile  eluant,  
A  =  254  nm).  
(2E.6Z)-3,7-nimethyl-2.6-nonadien-l-ol  (13b:  Z-homooeraniol)  
To  a stirred  Ooiling  solution  of  LiNHjCprepared  from  lithium  (1.4 g, 167 mmol)]  in dry  ammonia  
(300 mL)  was  added  a solution  of  13a  (4.3  g,  16.7 mmol)  in  dry  .n-hexane  (30 mL).  After  stirring  for  
30 min,  an  excess  of  ammonium  chloride  was  added,  and  the mixture  was  diluted  with  n-hexane  (800  mL).  
The  ammonia  was  evaporated,  and water  (150 mL) was  added.  The separated  aqueous  layer  was  extracted  
with  hexane  (200 mL) and  the  hexane  layer  was  washed  with  saturated  MH^Cl  solution  (100  mL),  and  
dried  over  MgSO^.  After  removing  the solvent  the  residue  was  purified  by  low  presure  liquid  
chromatography  (LPLC)  (on  10-40  ¡Am Kieselgel  HR  using  hexane-acetone=10:1  as  eluant)  to afford  13b  
(2.37  g,  B4  X ) .  TLC(C): Rf = 0.50;  IR  (film),  4>max:  3350,  2980,  2940,  2880,  1660,  1450,  1380,  1000  cm" 1;  
1H-flMR  (CClt,<r):  0.96  (t,  3=6.5Hz,  3H,-CHj),  1.64  (br  s, 6H,2-CH 3),  2 . 0 1  (m,  4H,2-CH2-),  2.03  (q,  
3=6.5Hz,  2H,-CH2-),  3.76  (m,lH,0H),  4.03  (d, 3=6.5Hz,2H,-CHj-0),  5.07  (m,  1H,-CH=C),  5.37  (t,3 = 6.5Hz, 
1H,-CH=C);  MS m/e:  168( 1)[M +],  151(1),  150  (1),  137(3),  121(3),  111(2),  107(2),  93(7),  83(32'),  
67(17),  55(100),  53(18),  43(12),  41(81),  39(38).  
f2E ,6Z)-T-Brnmo-3.7-dlmethyl-2,6-nonadiene  (3;  Z-homnqeranyl  bromide)  
To  a stirred  solution  of  13b  (1.68  g,  10 mmol)  in  dry  ether  (50 mL)  there was  added  a  solution  
of phosphorous  tribromide  (1.25  g,  4.5 mmol)  in dry  ether  (5 mL)  under  dry  argon  atmosphere  at  -5°C  
in darkness.  The  resulting  mixture  was  stirred  at  0°C  for  45 min,  and  then  brine  (20 mL)  was  added.  
After  extraction  of  the  aqueous  layer  with  ether  (20 mL),  the combined  ethereal  solutions  were  
washed  with  ice-cooled  and  saturated  NaHCOj solution  (10 mL)  and brine  (10 mL)  and dried  over  
MgSO^.  Evaporation  of  the  solvent  in vacuo  at 0-5°C gave  2  (2.19  g,  95  X)as  a pale  yellow  oil.  The  
product  is sensitive  for  light, heat,  wet  and was  used  up  immediately  for  the  next  step.  TLC(hexane):  
R f=0.80;  IR  (CC1 4),  VM A X :  3030,  2980,  2945,  2880,  2870,  1650,  1450,  1380,  1200,  1105,  1060  cm" 1;  
1H-IIMR  (CCl4,i):  0.90  (t,  3 = 6.5Hz,  3H,-CHj),  1.60  (s,  3H,-CH}),  1.66  (s,3H,-CH3),  1.93  (q,  3 = 6.5Hz, 
2H,-CH2-),  2.0  (m,  4H,  2-CH 2-),  3.86  (d,  3=8.5Hz,  2H,-CH2Br),  4.96  (m,  1H,-CH = C),  5.44  (t,  3 = 8.5Hz, 
IH,-CH=Ci;  MS  m/e:  232(3),  230(2),[M+],  175(2),  171(2),  151(18),  123(2),  109(2),  95(11),  83(100),  
81(17),  68(12),  67(11),  55(72),  41(23).  
f 2R . 3S . 2'E . 6 ' Z)-2-(3". 7-0imethyl-2 . 6-nonadienyl )-3-methyl-5-pentanolide  ( 2) 
To  a solution  of  lithium  diethyl  amide [prepared  from  diethyl  amine  (0.60  g,  8.2 mmol)  and  
n-buthyl  lithium  (8.2 mmol,  1.1  M  hexane  solution)] in  dry  THF  (20 mL)  there  was  added  a  solution  
of  4  (0.94  g,  8.2 mmol,  > 9 5  X ee)  in dry  THF  (5 mL)  below  -70°C, and  the  resulting  mixture  was  
stirred  at  -78°C for  1 h.  Then  3 (1.89  g,  8.2 mmol) dissolved  in dry  THF  (5 mL)  and dry  HMPA  (0.8  mL)  
was  added  below  -70°C.  The  resulting  mixture  was  stirred  at -78°C for  1 h  and then stayed  at -30°C 
overnight.  The  reaction  was  diluted  with  ether  (50 mL)  and  quenched by  10  X hydrochloric acid (20 mL) and 
the  acidic  layer  was extracted  two  times with ether  (20 mL;  each).  The  combined  organic  solutions  
were washed  with  saturated  NaHC03  solution  (10 mL)  and  brine  (20 mL)  and dried  over  MgS0 4.  After  
evaporation  of  the  solvent  in vacuo,  the  residual  oil  was  chromatographed  at  low  pressure  (on  
40-60  jim LiChroprep  Si  60  with hexane-acetone=10:0.5  as eluant)  to afford  2 (1.07  g,  48  X)  as  an  oil.  
t o < 1546 =  -8.8°,  L"*]Q5= -6.8°  (c=2.89,  CHClj);  TLC( C) : Rf = 0. 58;  IR  (film), V m a x :  2970,  2940,  2890,  
1730,  1660,  1450,  1380,  1270,  1200,  1145,  1100,  1060  cm" 1;  ^ - N M R  (COClj.J"):  0.95  (t,  3 = 7.5Hz, 
3H,-CHj),  1.08  (d,  3=6Hz,  3H,-CH3),  1.65  (br  s, 6H,2-CHj),  1.7-2.B  (br  m,  10H,4-CH2-  and  2-CH=),  
4.0-4.5  (m,  2H,-CH2-0),  5.09  (m,  2H,2-CH=C);  1 JC-NMR  (COClj):  12.81 ( - C H J ) ,  16.26(-CHJ),20.68(-CHJ),  
22.85( -CHJ),  24.81(-CH2-),  26. ISi - C H J - ),  27.79( -CHJ-),  29.89(-CHC;)  30.98( -CHJ-),  40.16( - C H J - ) ,  
4 8 . 3 2 ( - D <  ), ¿7.48(0-^2-),  120.69(-CH=) , 123. 79(-CH=) , 137.16(=C=),  137.72(=C=),  173.69(0 = 0); 
1484 L.  POPPE  et  al.  
MS m/e:  265(7)CM*1] +,  264(27)(M*],  207(15),  194(7),  183(27), 181(23),  150(18),  127(17),  123(17),  
115/16),  114(100),  99(34),  95(21),  93(16),  83(26),  82(19),  81(23),  69(16),  55(75),  43(17),  41(62);  
GLC:  t R =  13,84  min  (94  X,  (2R,3S)-isomer;  t R = 13.67  min,  6  X,  (2S,  3S)-isomer;  30  m  x 0,25  mm  
SP-2100  glass  capillary  column, tR = 160-260°C,  3°C/min,  N 2).  
(2R,3S, 2 'E i-2-(3 .7-0imethyl-2.6-octadienyl)-3-methyl-5-pentanolide  (2a)  
Enolate  generated  from  4(31  g,  0.272  mol,  95  X ee ) by LiNEtj  (0.272  mol)  and  geranyl  bromide 2 5  
(59.1  p.  0-272  mol) was coupled  as describe  for  the  preparation  of  2  to give  2a  (34.6  g,  51  X)  as  
a  hale  yellow  oil  TLC  (C):Hf  = 0.57  ;  = -8.6°, [<*3Q3 = -6.8°  (c = 3.35,  CHClj);  IR(film),  
V m a x :  2 9 7 0 ,  2 9 3 0 '  2 B B D '  1 7 3 D -  1 6 6 0 '  1 4 5 0 '  1 3 B 0 '  1 2 6 5 '  U 4 0 '  1 1 0 ° *  1 0 7 0  c m _ 1 ;  1H-NMR(C0C1 3, <f); 
1.09  (d,  J=6Hz,  3H,-CHj),  1.4-1.9  (br m,3H,-CH 2-  and  -CH=), 1.60  (s,  3H,-CHj),  1.65  (s,  3H,-CH3),  
2.03  (mc,  6H,  3-CH 2-),  2.4  (m,  1H,  CH-C00),  4.25  (roc, 2H,-CH2-0),  5.09  (m,  2H,2-CH=C); 1 3C-NMR(CDC1 3):  
16.23  (C 3,-CH 3),  17.67  (C7,-CHj),  20.65  (Cg-CHj),  25.71  (Cg,),  26.50  (Cj,),  27.67  (Cj),  29.84  ,  
30.95  (Cj,),  39.89  (C^,),  48.26  (C3),  67.54  (Cg),  120.63  (C2,),  124.17  (Cg,),  131.31  (C 7,),  137.66  
( C 3 J ,  173.75  (C 2),  (main component,  ~  94  X); MS  m/e:  250(37) CM*},  207(18),  194(3),  181 (30) ,137(23), 
136(23),  127(19),  114(100),  109(26),  99(39),  69(74),  55(25),  41(84);  GC:  t R=  11.83  min,(2R,3S)-isomer,  
94  X  (tR =  11,64  min,(2S,3S)-isomer,  6  X,  30  m  x 0.25  mm  SP-2100  column,  t R = 160-260°C,  3°C/min,N2).  
Methyl(2R.1'S.4E.8Z)-5,9-dimethyl-2-(1 -methyl-3-hydroxy-propyl)-4,8-undecadienoate  (14a)  
A  solution  of  2  (1.05  g,  3.98 mmol)  in dry  methanol  (6 mL)  and  triethylamine  (3 mL)  was  stirred  
at  room  temperature  overnight,  and  then  methanol  and  triethylamine  was  removed  by  vacuum  evaporation.  
LPLC  of  the  residue  on  40-60 /um-LiChroprep  Si  60  using  hexane-acetone=10:1  as eiuant  gave  14a(0.88  g,  
75  X)  as  an oil.  TLC(C):Rf=0.44;  IR  (film), 5> m a x:  3350,  2950,  2900,  1730,  1660,  1450,  1380,  1185,  
1150,  1100,  1050 cm" 1;  1H-NMR  (COClj, <T): 0.95  (m,  (d  and  t),  6H,  2-CHj),  1.4-1.9  (br m,  3H,-CH 2-
and - C H O ,  1.61  (s,  3H,-CHj), 1.66  (s,  SH.-CHj),  1.9-2.4  (br m,  9H,4-CH 2-  and CH-C00),  3.63  (s,  3H,  
COO-CHj),  3.75  (t,  3=6. 5Hz,  2H,-CH2-0),  5.07  (m,  2H,2-CH=C);  MS  ro/e:  296(10)LM'*],  239(7),  207(10),  
195(9),  181(16),  153(8),  135(16),  123(14),  107(14),  97(14),  93(16),  83(44),  82(21),  81(23),  79(16),  
69(13),  68(10),  67(22),  55(100),  43(19),  41(65).  
Methyl(2R.rS.4E.BZ)-5.9-dimethyl-2-(l-methyl-3-tetrahvdropyranyloxy-propvl)-4,8-undecadienoate  (14b)  
To  a solution  of  14a  (830 mg,  2.8  mmol)  and  2H-dihydropyran  (300 mg,  3.6 mmol)  in dry  dichloro-
methane  (15 mL)  was  added piridinium  tosylate  catalyst  (30 mg)  and  the mixture  was  stirred  at  room  
temperature  for  6 h.  The  resulted  solution  was washed  with water  (3 mL)  and brine  (3 mL)  and  dried  
over  MgSOg.  Evaporation  of  tne solvent  in  vacuo  and  LPLC  of  the  residue  (on LiChroprep  Si  60  by  
hexane-acetone=S:0.1  as eiuant) gave  14b  (1020 mg,  95  X)  as  an  oil  TLC(B):Rf=0.52;  IR  (film),y  
max 
2940,  2BB0,  1735,  1450,  1440,  1390,  1360,  1330,  1260,  1200,  1170,  1150,  1125,  1080,  1030,  990,  980,  
905,  870,  810 cm" 1;  XH-HMR  (COCl^i):  0.93  (d,  3=6Hz,  3H,-CHj),  0.96  (t,  3=7Hz,  SH.-CHj),  1.4-1.8  
(m,  15H,  2-CHj and  4-CHj-  and -CH=),  1.8-2.4  (m,  9H,  4-CH 2-  and  =CH-C00),  3.1-4.0  (m,  4H,  2-CH 20),  
3.64  is,  3H,COO-CHj),  4.57  (m, 1H,  O-'CH-O),  5.05  (m,  2H,  2-CH=C).  
Methyl (2R , 1' 5.4E)-5 .9-d line thy 1 -2-(1 -me thy 1-3-hyroxy-propyl )-4 . B-decadi enoate  (14c)  
2a  (32.5  g,  0.13 mol)  was converted  to  14c  (29.2  g, 80  X)  as described  for  the  preparation  of  
14a.  TLC(C):Rf=0.46;  IR  (film), V m a x :  3400,  2940,  2900,  1730,  1660,  1440,  1380,  1185,  1150,  1100,  
1050  cm" 1;  1H-IIMR(C0C13,4):  0.95  Cd,  J = 6Hz,  3H,-CHj),  1.4-1.95  (br m,  3H,-CH 2-  and  -CH=),  1.60  
(br  s,  6H,  2-CHj),  1.66  (s,  3H,-CHj),  1.9-2.4  (br m,  7H,3-CH2-  and  -CH-C00),  3.64  (s,  3H,  0-CHj),  
3.65 (t,  J=6Hz,  2H,  0-CH 2-),  5.06  (m,  2H,  2-CH=C); MS m/e:  2B2( 10 )LM+], 250(6),  239(10),  207(16),  
195(11),  181(24),  145(13),  134(20),  113(22),  108(31),  96(19),  93(20),  81(29),  79(16),  69(100),  
55(22),  43(12),  41(63),  39(8).  
Methyl(2R,1'S,4E)-5,9-rtimethyl-2-(l-methvl-3-tetrahydropvranyloxy-propyl)  -4.B-decadienoate  (14d)  
14c  (26.0  g,  92 mmol) was converted  to  14d  (32.8  g,97 X) as  described  for  the  preparation  of  
14b.  TLCCB):Rf>0.51;  IR(film),  V  : 2940,  2875,  1730,  1665,  1450,  1440,  1385,  1360,  1320,  1260,  
ILIA X  I  I  
1200,  1160,  1140,  1120,  1075,  1030,  995,  980,  905,  875,  810 cm" 1;  H-NMR  (COClj.i):  0.93  (d,J=6Hz,  
3H,-CHj),  1.4-1.8  (br m,  18H, 3-CHj and  4-CH 2-  and - C H O ,  1.8-2.4  (br m,  7H,3-CH 2-  and  CH-C00),  
3.1-4.0  (m,  4H,  2-CH 2-0),  3.63  (s,  3H,COO-CHj),  4.55  (m,lH,  0-CH-0),  5.05  (m,  2H,  2-CH=C);  
(3S.4R.6E ,10Z)-4-Hvdroxymethyl-l  - tetrahydropyranyloxy-3.7.ll-trimethyl-6 .10-tridecadiene  (15a)  
To  a stirred  suspension  of  lithium  aluminium  hydride  (0.21  g,  5.4  mmol)  in dry  ether  (8  mL)  
was  added  a solution  of  14b  (1000  mg,  2.7  mmol)  in dry  ether  (3 mL) and  the  resulting  mixture  was  
stirred  at  room  temperature  for  1 h.  The  reaction  was  quenched  by  careful  dropwise  addition  of  
water  (3 mL)  and  then  15  X hydrochloric  acid  (5 mL)  was added  to  the mixture  to dissolve  the  
precipitates.  After  fast  separation  the  acidic  layer  was  extracted  with  ether  (10  mL  ) and  the  
combined  ethereal  solutions  were washed  with saturated  NaHC0 3  solution  (5 mL)  and  brine  (5  mL).  
After  drying  over  MgS04  the  solvent  was  evaporated  in  vacuo  to  afford  15a  (803 mg,  87  X)  as  an  oil.  
TLC(C):Rf=0.64;  IR  (film), 3>max:  3370,  2940,  2910,  2860,  1655,  1440,  1425,  1370,  1340,  1250,  1190,  
1170,  1120,  1060,  1020,  970,  895,  860,  800 cm" 1;  XH-NMR(CDC1 3,J):  0.89  (d,J=6Hz,  SH.-CHj),  0.95  
(t,  J = 7Hz,  3H,-CHj),  1.3-1.9  (br m,  16H,2-CHj  and  4-CHj-  and 2 - C H O ,  1.9-2.4  (m,  8H,  4-CH 2-),  
3.1-4.1  (br  m,  6H,  3-CH2-0),  4.54  (m,  1H,  0-CH-0),  5.07  (m,  2H,  2-CH=C).  
Synthetic route  to (+)-faranal  and  ( + )-13-norl'aranal 1485 
(3S,4R,6E .10Z)-4-Mesvloxyniethyl-l-tetrahydropyranvloxv-3.7,ll-trimethyl-6.10-tridecadiane  113b)  
To  a  stirred  solution  of  15a  (780  mg,  2.21  mmol)  and  triethylamine  O i O mg,  3.09 mmol}  in  Cry  
ether  (6 ml)  was  added  a solution  of  mesyl  chloride  (290  mg,  2.54  mmol)  in  dry  ether  (3 mL)  at  G°C,  
and  the  resulting  mixture  was  stirred  at  room  temperature  for  1 h.  The mixture  was  then  diluted  with  
ether  (6 mL)  and  10  X hydrochloric  acid  (6 mL)  was  added.  After  separation  and  extraction  of  the  
acidic  layer  with  ether  (6 mL)  the  combined  ethereal  solutions  were  washed  with  saturated  NaHCQj  
solution  (3 mL) and  brine  (3 mL)  and were  dried  over  MgS04-  Evaporation  of  the  solvent  in  vacuo  
yielded  15b  (836 mg,  88  X).  TLC  (D):Rf=0.61;  IR  (film), V m a x :  2960,  2940,  2870,  2860,  1670,  1440,  
1430,  1350,  1250,  1200,  1180,  1130,  1110,  1070,  1030,  970,  950,  860,  830,  810 cm" 1;  *H-HMR  (CDClj.f):  
0.93  (mc(d  and  t),  6H,  2-CHj),  1.4-1.9  (br m,  16H,  2-CHj  and  4-CH 2  and 2 - C H O ,  2.0  (mc,  8H,  4-CH,),  
2.88  (s,  3H,  S02-CHJ),  3.1.-4.0  (br m,  4H,  2 - C H J O ) ,  4.06  (d,  J=6Hz,  2H, -CH2-0Ms),  4.55  (m,  1H,  
0-CH-0),  5.05  (m,  2H,  2-CH=C).  
(3S,4R,6E)-4-Hvdroxymethvl-l-tetrahydropyranvloxv-3.7,ll-trimethyl-6.10-dodecadiene  (15cJ  
Lithium  aluminium  hydride  reduction  of  14d  (32.8  g,  89 mmol)  according  to  the method  desribed  
at  l_5a afforded  1_5 (27.3  g,  90  X)  as  an  oil.  TLC  (C):Rf=0.63;  IR  (film), V m a x :  3400,  2940, -2920, 
2865,  1645,  1440,  1430,  1370,  1340,  1310,  1250,  1190,  1170,  1150,  1120,  1105,  1060,  1015,  970,  895,  
860,  800  cm" 1;  ^ - N M R  (COClj.i):  0.92  (d,  J=6Hz,  3H,-CHj),  1.3-1.95  (br  m,  19H,  3-CHj and  4-CHj-  and  
2 - C H O ,  2.03  (mc,  6H,  3-CHj-),  3.2-4.2  (br m,  4H,  2-CH 2-0),  3.58  (d,  J=6Hz,  2H,  O-CHj-),  4.56  (m,  1H,  
0-CH-0),  5.11  (m,  2H,  2-CH=C).  
( 35.4R,6E)-4-Mesvloxymethvl-l-tetrahydropvranvloxy-3.7,ll-trimethyl-6  ,10-dodecadiene  11 5rt J 
Mesylation  of  15c  (26.3  g,  78 mmol)  by  the  process  desribed  at  15b  gave  15d  (29.0  g,  89  X as  an  
oil.  TLC  (D):Rf = 0.61;  IR  (film),  \>max:  2960,  2930,  2870,  1670,  1445,  1350,  1250,  1200,  1180,  1130,  
1115,  1070,  1060,  1025,  970,  950,  910,  860,  840,  810 cm" 1;  ^ - N M R  (COClj.i-):  0.93  (d,  J=6.5Hz,  3H,  
- C H J ) ,  1.4-1.9  (br m,  19H,  3 -CHJ  and  4 - C H J -  and  2 - C H O ,  2.01  (mc,  6H,  3 - C H J - ) ,  2.94  (s,  3H,  SOJCHJ),  
3.2-4.1  (br  m,  4H,  2 -CH 2-0),  4.11  (d,  J=6Hz,  2H,  -CHJ-OMs),  4.56  (M,  1H,  0-CH-0),  5.08  (m, 2H,2 -CH*C ) . 
f3S,4R,6E,10Z)-l-Tetrahydropvranvloxy-3.4.7,ll-tetramethyl-6.10-tridecadiene  (16a)  
To  a stirred  suspension  of  lithium  aluminium  hydryde  (0.30  g,  7.9 mmol)  in  dry  THF  (8 mL)  was  
added  a  solution  of  15b (805 mg.  1.98 mmol)  in dry  THF  (8 mL)  and  the  resulting  mixture  was  refluxed  
for  lh.  After  cooling  the  reaction  was  quenched  by  careful  dropwise  addition  of  water  (4 mL).  Then  
15  X hydrochloric  acid  (5 mL)  was  added  to  solubilize  the  precipitate  and  the mixture  was  extracted  
three  times  with  ether  (12 mL,  each).  The  combined  organic  solutions  were  washed with  saturated  
HaHCOj  solutions  (4 mL)  and brine  (4 mL)  and  dried  over  MgS0 4.  After  removal  of  the  solvent  in  vacuo  
16a  (586  mg,  90  X) was  yielded  as  an oil.  TLC  (A): Rf = 0.61;  IR(  film),  v m a j <:  2950,  2930,  2870,  1665,  
1445,  1430,  1375,  1350,  1315,  1260,  1200,  1160,  1120,  1110,  1080,  1070,  1030,  990,  980,  900,  870,  
810  cm" 1;  1H-NMR  ( C D C 1 } I S ) :  0.83,  0.89,  0.95  (d, d,  t,  9H,  3-CHj),  1.4-1.9  (br m,  16H,  2-CH ?  and  
4-CH 2-  and 2 - C H O ,  2.0  (mc,  8H,  4-CHj-),  3.2-4.1  (br m,  4H,  2-CH 2-0),  4.55  (m,  1H, 0-CH-0),  5.10  
(m,  2H,  2-CH=C).  
(3S,4R,6E.10Z)-3,4,7,11-Tetramethy1-6.10-tridecadien-l-ol  (16b)  
A solution  of  16a  (531  mg,  1.58 mmol)  and  p-toluene  sulfonic  acid  (5 mg)  in methanol  (10  mL)  
was  stirred  at  room  temperatura  overnight.  After  addition  of  10 yL  of  triethylamine  the  solution  
was  concentrated  in  vacuo  and  the  residue  was  purified  by  LPLC  (on LiChroprep  Si  60 with  hexane-
- a c e t o n e O O : 1 as eluant)  to  give  16b  (373 mg,  94  X)  as  an  oil.  TLC  (C):Rf=0.48; C o tl| 2 6 = -5.7°, 
[<x]22 = _ 4  5O ( c = 4 > 8 7 i  CHClj);  IR  (film), V m a x :  3350,  2970,  2930,  2880,  1660,  1450,  1380,  1110,  1055,  
1015,  1000  cm" 1;  ^-IIMR  (CClj.f):  0.83,  0.88,  0.97  (d,  d,  t, 9H,  3-CHj),  1.4-1.9  (m,  4H,-CH 2-  and  
2 - C H O ,  1.59  (s,  3H, -CHj),  1.66  (s,  3H,-CHj)  2.0  (m,  BH, 4 - C H z O ,  3.46  (s,  1H,  OH),  3.55  (t,  J = 6Hz, 
2H,-CH 2-0),  5.06  (m,  2H,  2-CH=C);  MS m/e:  252(13)[M*]  , 223(3),  195(12),  179(5),  177(5),  151(7),  
137(35),  123(17),  113(13),  109(19),  99(29),  95(49),  83(100),  69(37),  55(79),  41(32).  
( 3S . 4R . 6E )-l-Tetrahydropyranyloxy-3 ,4,7 . 11-tet ramethy]-:6 .10-dodecadiene  (16c)  
Lithium  aluminium  hydride  reduction  of  the mesylate  I5d  (29.6  g,  72 mmol)  according  to  the  
method  described  at  16a  yielded  16c  (22.0  g,95  X)  as  an oil.  TLC  (A):Rf=0.62;  IR  (film),  V m a x:2960,  
2940,  2870,  1665,  1450,  1440,  1380,  1350,  1320,  1260,  1200,  1160,  1130,  1110,  1070,  1060,  1030,  990,  
900,  870,  810  cm" 1;  1H-NMR  (COClj.O:  0.83  (d,  J=6Hz,  3H.-CH,).  0.88  (d,  J = 6Hz,  3H,-CHj),  1.4-1.9  
(br  m,  19H,3-CHj  and  4-CHj-  and  2-CH=),  2.02  (m,  6H,  3-CH 2-),  3.2-4.1  (br m,  4H,  2-CH 2-0),  4.57  
lm, 1H, 0-CH-0),  5.12  (m,  2H,  2-CH=C).  
(3S,4R,6E)-3.4.7.ll-Tetramethyl-6-lO-dodecadlen-l-ol  (I6rt)  
Oeprotection  of  16c  (21.7  g,  67 mmol)  by  the process  described  at  16b  but  purified  by  VLC  the  
crude  product  (on  200  g  of  63-200 pm  silica  gel  with hexane-acetoneOO: 1 as eluant)  gave  16dl 15 .2 g, 
96  X)  as  an  oil.  TLC  (C) :Rf = 0.49; L~l| 3 6 = -5. 9° , | > ^ 3 = -4.6° (c=4.21,  CHClj);  IR  (film), V ^ :  3350,  
2980,  2945,  2890,  1660,  1455,  1380,  1205,  1105,  1055,  1010 cm" 1;  1H-HMR  (COClj.cT):  0.82  (d,J=6.5Hz,  
JH.-CHj),  0.87  (d., J=6. 5Hz,  3H,-CHj),  1.4-1.9  (br m,  4H,-CH 2-  and 2 - C H O ,  1.60  (br  s,  6H,  2-CHj',  
1.68  (s,  3H.-CH,),  2.03  (mc,  6H,  3-CH 2-),  3.62  (t,  J=6Hz,  2H,-CH 2-0),  5.10  (m,  2H,-CH = C);  13C-IIMR  
(CDClj):  16.09  (C 4 -CHJ and C ?-CH 3  ),  16.76  (Cj-CHj),  17.67  (CJJ-CHJ),  25.71  (C 1 2),  26.71  (C,),  
486 L.  POPPE  et  al.  
31.53  (C5),  33.73  (Cj) 35.95  (C2> 38.78  , 39.90  (Cg), 61.63  (Cj),  123.91  (Cfi),  124.44  (C1(J),  
131.22  ( C n ) ,  135.32  ( C 7 ) ,  (main component, -  94  X);  MS  m/e:  238(ll)[M +j,  195(12),  177(4),  165(4),  
137(7),  123(39),  109(25),  99(24),  95(49),  83(42),  81(37),  69(100),  55(41),  41(48).  
(•Q-(3S,4R,6E.10Z)-3,4.7,ll-Tetramethyl-6.10-tridecadienal  (la;  ( + )-Faranal) 
To  a solution  of  16b  (332 mg,  1.32 mmol)  in  dry  dichloromethane  (15 ml)  was  added  piridinium  
dichromate  (505  mg,  1.35 mmol) portionwise  at  room  temperature.  After  stirring  for  3 h  the  resulting  
mixture  was  filtered  through  a small  column containing  15  g  of  Kieselgel  60 and  the column  was  eluted  
with  ether  (50  mL).  The  resulted  solution  was  then  evaporated  in  vacuo  and purified  by  LPLC  (on  
LiChroprep  Si  60  with  hexane-acetone=5:0.1  as eluant)  to yield ^a  (214  mg,  65  X)  as  an oil  that  
froze  keeping  at  -30°C. Mp.:-25°C,  TLC  (A):Rf=0.51; C * ] " ^  +19.4°,  .17,4°  (c=  4.12,  CHClj,  
>  95  X ee),  Lit. 7: ! > ] " =  +16.2°  <c=  0,5,  hexane,  90  X ee);  IR  (film),  » m a x :  2970,  2940,  2880,  
2720,  1730,  1655,  1450,  1380,  1120,  1080,  1020  cm" 1;  ^ - N M R  (CDClj.f):  0.84  (d,  3=6.5Hz,  3H,-CHj),  
0.93  (d,  3=6.5Hz,  3H,-CHj),  0.97  (t,  3=7Hz,  3H,-CHj),  1.60  (s,  3H,-CH 3),  1.67  (s,  JH.-CHj),  1.8-2.6  
(br m,  12H,-5-CH 2-  and  2-CH=), 5.09  (m,  2H,  2-CH=C),  9.74  (t,  3=2Hz,-CH0);  1 JC-NMR  (CDClj.if):  12.81  
(C 1 3),  16.00  (CJ-CHj),  16.12  (C 7-CH 3),  17.55  (CJ-CHJ),22.B7(C U-CH 3),  24.81  (C 1 2> , 26.27  (C,),  
30.97  (C 5),  32.02  ( C j ) ,  38.49  (C,),  40.11  ( C g ) ,  47.43  (C2),  123.12  (Cfi),  123.91  (C 1 Q),  135.96  C ?),  
137.18  (C X 1),  203.21  (Cj),  (main c o m p o n e n t 9 4  X);  MS m/e:  250(6)[M +] , 232(2),  221(2),  206(2),  
203(3),  193(26),  177(3),  175(8),  137(21),  123(20),  107(11),  95(18),  83(100),  69(22),  55(78),43(17),  
41(33);  HPLC:  t R=  4.12  min  (250  x  4.6 mm  column, 10 ^im LiChrosorb  RP-18, 2.0 ml/min  MeOH-water=9:1  
eluant, X=215  mm/;  GLC:  t R=  21.11  min,  (3S,4R)-isomer,  94  X  (tR = 20.B7  min,  (3S,4S)-isomer,  6  X;  
40  m  x 0.128  mm  0V-1  capillary  column,  t R=  180°C,  Nj).  
(+)-(3S,4R,6£)-3.47.11-Tetramethyl-6.10-dodecadienal  (lb;  (+)-13-Norfaranal)  
Oxidation  of  16d  (10.0  g,  42 mmol)  by  the method  described  above  afforded  It) (6.63  g  67 X)  as  
an  oil.  TLC  (A) : Rf = 0. 52 ; M " 6 =  +-19.6°, C«]£2 = -17.5°  (c=4.46,  CHClj);  IR  (film),  V m a x:  2980,  2945,  
2880,  2720,  1730,  1660,  1450,  1380,  1115,  1080,  1020 cm" 1;  1H-NMR  (CDClj.J"):  0.84  (d,  J=6.5Hz,  
3H,-CHj),  0.94  (d,  3=6.5Hz,  IH.-CHj),  1.59  (s,  6H,  2-CHj),  1.68  (s,  3H,  -CHj),  1.8-2.6  (m,  10H,  
4-CH 2-  and  2-CH=),  5.10  (m,2H,2-CH=C),  9.75  (t,  J=2Hz,  1H.CH0);  1 JC-NMR  (CDC13):  15.97  (C 4-CH 3),  
16.09  (C 7 -CHJ),  17.55  (Cj-CHj), 17.67  (CJJ-CHJ),  25.71  (C 1 2),  26.62  (C,),  31.91  (Cj),  32.00  (C 3),  
38.49  (C 4),  39.84  (CR),  47.42  (C 2),  123.09  (Cfi),  124.29  ( C J G ) ,  131.31  (Cjj), 135.90  (C,). 203.21  ICj);  
(main  component,  94  X);  MS  m/e:  236(4)[M*],  193(22),  175(5),  149(5),  137(5),  123(33),  109(17),  
SI(23),  69(100),  41(40),  GLC: t R=  17.46 min,  (3S,4R)-isomer , 94  X  (tR=  17.22  min,  (3S,4S)-isomer,  
6  X;  40  m  X 0.128  mm  0V-1  capillary  column,  t R=  180°C,  N 2).  
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The  title  compounds  2 and  their  corresponding  (6S)  epimers  
18 are prepared  in several  steps  by starting with  chiral  formyl  
ester  5, and  oc-tetralones  10: (1) coupling reaction with the  ylide  
generated  from  11 to  yield  unsaturated  ester  13,  (2)  reduction  
to  the  corresponding  alcohol  14,  (3) addition  of  the  Grignard  
reagent  derived  from 14 to formyl ester  5 to afford the  hydroxy  
esters  16 and  17, and  (4) lactonization.  This  procedure  is  also  
used  to  synthesize  the  P-naphthyl  analogs  29  and  30.  Some  
results  obtained  from HMG-CoA  reductase  inhibitor  screen-
ing  are  also  reported.  
O n e  of  the  mos t  a t t r a c t i v e  a n d  efficient way  to  cure  a n d  p reven t  
c a r d i o v a s c u l a r  d iseases  is  the  lower ing  of  choles te ro l  s e r u m  lev-
e l s ' 1 - 3 ' .  T h e  recent ly  i n t r o d u c e d  d r u g s  mevinol in  (1), synv ino l in  a n d  
e p t a s t a t i n  r educe  d ras t i ca l ly  the  choles te ro l  level  by  inh ib i t ing  the  
H M G - C o A  reduc ta se  in  the  ra te - l imi t ing  step  of choles te ro l  b iosyn-
t h e s i s ' 4 - 9 ' .  T h e s e  f u n g a l  m e t a b o l i t e s  have  been  a n  a t t r ac t ive  syn-
the t ic  t a rge t  of  c o n s i d e r a b l e  c u r r e n t  interest  because  of  the i r  cha l -
lenging  s t r u c t u r a l  f ea tu re s  a n d  biological  act ivi ty.  A l t h o u g h ,  m a n y  
excel lent  syn the t i c  a p p r o a c h e s  to  mevino l in  a n d  its  s emisyn the t i c  
de r iva t ive  h a v e  been  repor ted ' 1 0 ' ,  these  c o m p o u n d s  a re  p r o d u c e d  
b y  mic rob io log ica l  p r o c e d u r e s .  
Va r ious  s t ruc tu ra l ly  s implif ied  ana logs  of  mev ino l in  h a v e  been  
syn thes ized  a n d  e v a l u a t e d  for  H M G - C o A  reduc ta se  inh ib i to ry  ac-
tivities.  R e p o r t s  on  the  s t ruc tu re -ac t iv i ty  re la t ionsh ips  s h o w e d  t h a t  
t he  (3 R ) -3 -hydroxy-S-va le ro lac tone  moie ty  is  essential  fo r  b io log-
ical  act ivi ty,  whereas  t he  highly  subs t i tu ted  h e x a h y d r o n a p h t h a l e n e  
ring  of  mev ino l in  m a y  be  replaced  by  simplified  l ipophi l ic  g r o u p s .  
F u r t h e r m o r e ,  the  i nh ib i t o ry  potencies  depend  o n  the  size a n d  s h a p e  
of  the  l a t t e r  g r o u p s " 1 - 1 3 ' .  
During  the  course  of  our  program  in  this  area,  we  have  
decided  to  perform  the  synthesis  and  biological  evaluation  
of  new  structural  analogs  of  mevinolin  (Scheme  1).  In  this  
paper  we  describe  the  preparation  of  naphthalene  analogs  
of  the  general  structure  2  and  3,  which  afford some  mod-
erately  effective inhibitors  of  HMG-CoA  reductase.  
The  basic  strategy  of  our  synthesis  is  summarized  in  
Scheme  2.  This  illustrates  the  easy  generation  of  the  chiral  
center  of  the  lactone  moiety  which  involves  the addition  of  
Grignard  reagent  4  to  the  chiral  formyl  ester  5  prepared  
S c h e m e 
X? 
A^C 
2 A - 8 - C R1 R.2 3 A - B - C - D 
• CH=C—CHJ(£) H H a CH=C-CH 2 -CH 2 
b CH2~CH—CH2 H H b CH=C-CH=CH 
c CH2-C=CH H H 
d CH2—CH—CH2 OMe H 
e CH 2 -CH-CH 2 H OMe 
f CH2—CH—CH2 H Ph 
from the prochiral  hydroxy ester  6. The stereochemical fea-
tures  of  this  addition  have  not  been  elucidated  previously.  
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We  have  expected  that  the  formation  of  the  (4R,6R)  
diastereomer having the same stereochemistry of the lactone 
moiety  as  mevinolin  would  predominate.  
S c h e m e  2  
tBuMe2SiO. 
C02Me  i  \  Me02C„  „C02Me 
Results  and  Discussion  
The key  formyl  ester intermediate 5 is synthesized  in the 
following  manner  (Scheme  3).  Protection  of  the  hydroxy  
group  of dimethyl-3-hydroxyglutarate (6)  by  silyl  ether for-
mation  using  tert-butyldimethylsilyl  chloride  followed  by  
pig  liver  esterase-(PLE-)mediated  hydrolysis  gives  monoes-
ter  8 a  in good  yield.  The  optical  purity  of  the  product  has  
been  determined  by  HPLC  and  'H-NMR  analysis  of  the  
diastereomeric (R)-a-methylamide'141.  Although the enzyme-
catalyzed  hydrolysis  affords the desired (R ) ester  as the ma-
jor product  the enantiomeric  purity is rather low (e.e. 52%). 
Therefore,  we  have  investigated  the  enzyme-catalyzed  hy-
drolysis  of  the  other  protected  3-hydroxyglutarates  7 b —d. 
In  accord  with  Santaniello's  result'151,  the  highest  enantio-
selectivity  has  been  achieved  with  the  PLE-catalyzed  hy-
drolysis  of  acetoxy  ester  7b.  In  this  case  the  (R)  half  ester  
8b has been obtained in 90% e.e. and in 45% chemical yield. 
Base-catalyzed  hydrolysis  of 8b affords the  (R (-hydroxy es-
ter 8  (R  =  H), which  is  treated  with  tert-butyldimethylsilyl  
chloride to  yield  the silyl-protected  monoester 8 a.  Selective  
reduction  of the carboxy function in the latter with diborane 
affords hydroxy ester 9, which is converted into formyl ester 
a  3:2  mixture  of (£)  and (Z)  isomers  of  naphthylideneace-
tates  13 a  and  13 b respectively,  which  are separated  by col-
umn chromatography.  Reduction of the (£) isomer  13 a with 
an excess of lithium aluminum hydride gives the alcohol  14 a 
which is converted into the corresponding  bromide  15 a, the 
precursor of the desired Grignard reagent,  by utilizing phos-
phorus  tribromide.  
S c h e m e  4  
13 14 
Me3Si-- C H 2 - 0 0 2 E t 
11 
or 
0 
>1 
( E t 0 ) 2 P - C H 2 - C 0 2 R 
12 R 
a Et 
b Me 
(1) 15  +  Mg  ( - . 4 )  
(2) +  5  
15 
C02Et  CH2OH  CH2Br  
tBuMejSiO..  .  tBuMe,SiOK  
i  T  CO?Me  2  V ^  CO  
16 17 18 
S c h e m e  3  
OR 
Me02cs^AC02Me 
0SiMe2 tBu 
„C0 2Me  5  
13 14,  15,  18  A - B - C R1 R2 16,  17  
a a CH=C-CH 2 (£ ) H H a 
b - CH=C-CH 2 (Z) H H -
OR 
H 0 2 C ^ A ^ C 0 2 M E  >  
c 
d 
b 
c 
CH2—CH — CH2 
CH 2 -C=CH 
H 
H 
H 
H 
b 
c 
8 • - C H = C - C H 2 ( 0 OMe H -
7,  8  R 
f 
g 
d 
CH=C-CH 2 (Z ) 
CHo—CH-CH0 
OMe 
OMe 
H 
H d 
a SiMe2tBu h -
z  z  
CH=C—CH2(£) H OMe — 
b COMe i - CH=C-CH 2 (Z) H OMe -
c H i e CH2 —CH—CH2 H OMe -
d CH2OMe k - CH=C-CH 2 (£ ) H Ph -
• COCHjPh I 
m f 
CH=C-CH 2 (Z ) 
CH2—CH—CH2 
H 
H 
Ph 
Ph — 
The other  building  blocks 4  are prepared  from known a-
tetralone  derivatives  (Scheme  4).  Condensation  of  a-tetra-
lone  (10a)  with  the  carbanion  generated  from  ethyl  trime-
thylsilylacetate  (11) with  lithium  diisopropylamide  provides  
The above condensation reaction is also used for the prep-
aration of the naphthylideneacetates  13e,f,  13h,i,  and  13 k, 1 
from  the  appropriate  a-tetralone  derivatives  10 b —d. Cata-
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lytic  reduction  of  the  (E)  isomers  of  these  esters  13a,e.h,  
and  f  over  Pd  catalyst  yields  the  corresponding  naphthyl-
acetates  13 c, g,j, and m which are converted into the desired 
bromides  15 a, b,d,e,  and  f  according  to  the  same  sequence  
of  reactions  (reduction  with  lithium  aluminum  hydride and 
treatment  with  phosphorus  tribromide).  
From the Wittig-Horner reaction of a-tetralone (10a) with 
the  less  reactive  anion  of  phosphonate  ester  12 only  traces  
of (£)-naphthylideneacetate  13 a  are  isolated.  Here,  the  ini-
tially  formed  ct,3-unsaturated  esters  13a  and  13 b  undergo  
base-catalyzed  rearrangement  to  the  thermodynamically  
more stable  (3,y-unsaturated ester  13 d as  the major product. 
The  application  of  the  same  two-step  procedure  (reduction  
and  halogenation)  to  the  latter  furnishes  the  corresponding  
bromide  15 c. 
For  the coupling  of the two  building blocks  the Grignard 
reagent  4,  obtained  from  the  bromides  15a—d  with  mag-
nesium  in tetrahydrofuran,  is  treated  with  the  chiral  formyl  
ester  5.  The  reaction  proceeds  smoothly  and  yields  2:1  
mixtures  of  the expected  stereoisomers  16 a  —d and  17 a —d, 
which  are  separated  by column  chromatography.  Desilyla-
tion  of  the separated  diastereomers  16a—d  and  17a  —d on 
treatment  with 48% hydrogen fluoride in acetonitrile results 
in  spontaneous  lactonization  to  the  target  compounds  
2a —d and  18a —d. 
The  configurations  of  these  compounds  2 a —d  and  
18 a  —d have been assigned mainly  on the basis of the chem-
ical  shifts  observed  for  C-4  and  C-6  in  their  BC-NMR  
spectra[IS>.  For  instance,  in  the  chair  conformation  of  the  
major  isomer  (4R,6R)-2c,  bearing  the  bulky  substituent  in  
equatorial  position,  the  hydroxy  group  occupies  an  axial  
position  and exerts  a stronger  y-gauche effect on the  chem-
ical  shift  in  the  6-position  (5  =  75.78)  than  in  the  major  
isomer  (4R,6S)-18c  (8  =  76.95).  Furthermore,  the  relative  
Rf values  of these diastereomers  parallel  those  of the known 
similar compounds, which have strengthened our confidence 
in  the  assignments  of  configurations'17,181.  
In t w o  cases ,  t h e  r e a c t i o n  of  t h e  b r o m i d e s  15 e,  f w i th  m a g n e s i u m  
h a s  fa i led  even  b y  i n c r e a s i n g  t h e  d u r a t i o n  a n d  t e m p e r a t u r e  of  t h e  
r e a c t i o n ,  t h e  so le  o b s e r v e d  r e su l t  b e i n g  the f o r m a t i o n  of  b y p r o d u c t s  
b y  s e l f - coup l ing  of  t h e  b r o m i d e  w i t h  the  G r i g n a r d  r eagen t .  
Therefore,  an  alternate  route  to  target  compounds  2e, f 
has  been  elaborated  (Scheme  5).  Reaction  of  the  bromides  
15e,f  with  triphenylphosphane  affords  the  phosphonium  
salts  19 a, b, and then the phosphoranes generated from these 
salts  by reaction  with  butyllithium  were treated with formyl 
ester 5. Base-catalyzed hydrolysis of the products 20 a, b [(Z) 
isomer  > 98%] affords the corresponding acids 20c, d which 
are subjected  to iodolactonization  with  iodine  in wet meth-
ylene  chloride.  The  2:1  mixture  of  the  diastereomeric  io-
dolactones  21a, b and 22a, b formed is separated  by column 
chromatography  and  then  separately  reduced  with  tribu-
tyltin  hydride  to  give  the  protected  lactones  21c,d  and  
22c,d.  Finally,  desilylation  of  the  latter  with  hydrogen flu-
oride  in  acetonitrile  affords the  target compounds 2e,f  and  
18e,f. 
The first procedure  is also  used  to  prepare  lactones  with  
a 2-naphthyl  moiety  29 a, b (Scheme 6). Here, p-tetralone (23) 
S c h e m e  5  
PhjP 
15e,  f  >  
tBuMe2SiO„ 
+ PPh 3  Br"  
"CO/ 
20 
-0 
21 
I 
22 
I 4 
2e,  f  
4 
18e,  f  
19 R 20 R1 R2 21, 22 R X 
a OMe a Me OMe a OMe I 
b Ph b Me Ph b Ph I 
c H OMe c OMe H 
d H Ph d Ph H 
is treated  with the  phosphonate  ester  anion  to  give  the  P,y-
unsaturated  ester  24 a.  Reduction  of  this  ester  with  lithium  
aluminum  hydride  affords  the  alcohol  25 a  which  is  con-
verted into  the corresponding  bromide 26 a by reaction with 
phosphorus  tribromide.  Treatment  of  26 a  with  magnesium  
S c h e m e  6  
OCfc +  12  
23 
r r V 
(1)  26  +  
V (2)  +  5  
24 25 26 
R C02Me CH2 OH  CH2Br  
tBuMe 2 SiON^v.  .  tBuMe+SiO  ^ ^  ^2  Y  CO,Ue  2  C02Me  k^ OH 
7 
a-8-C 
I -D 
OH V 
c 
I 
D 
A - 8 - C 
27 28 29 
24 A - B - C - D 25  -  29  
a CH=C—CH2—CH2 a 
b CH2—CH—CH2—CH2 -
c CH=C-CH=CH b 
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furnishes the Grignard compound which is treated with for-
myl ester 5. The obtained product is a 2:1 mixture of epimers 
27 a and 28 a, which  are separated  by chromatography.  De-
silylation  of  these  compounds  with  hydrogen fluoride and 
spontaneous  lactonization  furnish  the desired  products  3 a 
and 29a,  respectively.  
The unsaturated  ester 24 a has also been used as starting 
material  in  the  preparation  of  29 b.  In  this  case  catalytic  
reduction of ester 24 a over Pd catalyst yields a 2:1  mixture  
of  tetrahydronaphthylacetate  and naphthylacetate 24 b and 
24 c, respectively, by partial disproportionation. As expected, 
the  treatment  of  24 a  only  with  Pd  catalyst  affords a  1:1  
mixture of 24b and 24c. The separated 24c is then converted 
into  3 b according  to  the  method  described  above  for  the  
synthesis  of 3 a via the intermediates  25 b, 26 b, and 27 b. 
The  naphthalene  analogs  2,  3,  18,  and  29  of  mevinolin  
synthesized  here  are evaluated  as  inhibitors  of  HMG-CoA 
reductase  by  using  mevinolin  as  a  reference  compound"91.  
All  compounds  show moderate  inhibitory  activity.  For ex-
ample,  the IC»  value  of 2f is 6-10 -6  M. Compounds pos-
sessing  an  unnatural  configuration  on  the  lactone  moiety  
(18 and 29)  reveal no  remarkable activity'201.  
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Experimental 
IR spectra  were obtained  with a Specord  IR-75 (Carl Zeiss, Jena) 
spectrophotometer.  — 'H-  and  13C-NMR  spectra  were  recorded  
with  a JEOL  FX-100  FT-NMR  instrument  at  100 and  25  MHz;  
internal  standard  TMS.  The following abbreviations  are  used:  sin-
glet  (s), doublet  (d), triplet  (t), quartet  (q), heptet  (h), multiplet  (m),  
and  broad  (br.).  — MS measurements  were carried out  with  a  Kra-
tos  MS-25 RFA  combined  GC/MS  system (ionizing  energy  70 eV,  
voltage 4  kV).  — HPLC chromatographic analyses were performed 
with  a  Du  Pont  830  instrument  equipped  with  a  UV  detector  or  
with  a  Waters  600  instrument  equipped  with  a  photodiode  array  
detector  990. Stationary  phase: straight-phase  (S. P.)  Perkin-Elmer  
Silica  5 pm  (25  cm  x  4.6  mm)  or  reverse-phase  (R.  P.)  Finepack  
C-18  10 pm.  — The  silica  gel  used  was  obtained  from  Merck  and  
that  used for thin-layer chromatography  was Kieselgel PF-j,,  whilst  
that  employed for column chromatography was Kieselgel  60.  —  All  
solvents  were  dried  by  means  of  standard  methods,  and  most  re-
actions  were carried  out  under  argon.  
Dimethyl  3-f(tert-Butyldimethylsilyl)oxyJglutarate  (7a):  To  a  
stirred  solution  of 61211 (17.65  g, 0.1 mol) and imidazole  (10.2  g, 0.15 
mol)  in dry  DMF  (100  ml) was added  ferr-butyldimethylsilyl  chlo-
ride (22.6 g, 0.15 mol), and  the resulting mixture was stirred at  room  
temp, for 2 h. Crushed  ice (300  g) was  then added, and  the  mixture  
was extracted  several  times  with  hexane  (500  ml). The  organic  ex-
tracts  were  combined,  dried  (MgSO«),  the  solvent  was  evaporated  
under  reduced  pressure, and  the residue  was purified  by  distillation  
to  give 7a  (25.5  g,  58.5%),  colorless  oil'22!  -  B.p.  114—116:C/0.8  
Torr.  -  ng  =  1.433.  -  IR  (film):  v  =  1720 cm"1  (CO).  -  'H  
NMR:  8  =  0.05  (s,  6H,  2CH3),  0.75  (s, 9H,  3CH3),  2.46  (d,  J  =  
6  Hz, 4H,  2 CH2),  3.58  (s, 6H, 20CH3),  4.45 (t. J  =  6  Hz,  CH).  
t-Methyl  Hydrogen  (R)-3-[(tert-ButyldimethylsilyljoxyJglutar-
ate  (8a).  — Method  A:  Pig  liver  acetone  powder  (7.5  g)  was  ho-
mogenized  with  0.15  M  phosphate  buffer (pH  =  8, 75 ml) and  then  
centrifugated  at  3000  g at  room  temp,  for  1 min.  To  the  obtained  
supernatant  layer (pH  value changed to  7.2 g during the  extraction  
process)  having  40  U/ml  enzyme  activity  (measured  on  ethyl  bu-
tyrate  as  a  substrate  at  25 "C, pH  =  8) 7a  (4.45 g,  15.3 mmol)  was  
added  and  the  pH  value  of the  resulting  well-stirred  emulsion  was  
kept  within  the  range  6.9—7.1  by  continuous  addition  of  a  1 M 
sodium  hydroxide  solution.  After consumption  of  1 equivalent  of  
the  base  (15  ml) the  mixture  was  acidified  to  pH  =  3 with  concd.  
hydrochloric  acid  and  then  centrifugated at  3000 g for  1 min.  The  
supernatant  was washed three times with  ethyl acetate (50 ml each), 
and  the precipitate was washed once with ethyl acetate (50 ml). The 
combined  ethyl  acetate  solutions  were  washed  with  brine  (30  ml)  
and  dried  (MgS04).  Evaporation  of  the  solvent  in  vacuo afforded 
a  crude  product  which  was  purified  by  chromatography  with  hex-
ane/acetone  (5:2)  as  eluent  to  give  pure  8a  (3.6 g,  85%)  as  light  
yellow  oil1231.  -  [a]g  =  +1.5  (c  =  4,  CHClj),  [a ]&  =  +2.0  
(c  =  4,  CHC13).  -  TLC  (CHCl3/EtOAc,  3:1):  Rr  =  0.47.  -  IR  
(film):  v  =  3600-2500  cm"'  (COOH),  1740,  1710  (CO).  -  'H  
NMR  (CC14): 8  =  0.08 (s, 6H,  2CH3),  0.86 (s, 9H,  3CH3),  2.52  (d,  
J  =  6 Hz,  2H,  CH2),  2.57  (d,  J  =  6 Hz,  2H,  CHj),  3.62  (s,  3H,  
OCHj), 4.47 (m, 1H,  OCH).  
Methyl  (3R.I'R)-3-[(tert-Butyldimethylsilyl)oxy]-4-[N-(  1'-
phenylethyl)carbamoylJbutyrate:  To  a stirred mixture  of 8a  (0.56  g,  
2  mmol),  triethylamine  (0.44 g,  4.4  mmol),  and  (R)-l-phenylethyl-
amine (0.27  g, 2.2 mmol) in dry dichloromethane  (5 ml) was  added  
thionyl  chloride  (0.27 g, 2.3 mmol),  and  the  resultant  solution  was  
stirred  at  room  temp,  for  2 h.  The  reaction  mixture  was  diluted  
with  dichloromethane  (50  ml) and  then  successively  washed  with  
10%  hydrochloric acid  (5 ml), saturated  aqueous  sodium  hydrogen  
carbonate  solution  (5  ml), and  brine  (5  ml).  After drying  (MgS04)  
the solvent was evaporated  in vacuo to yield 0.61  g (81%) of a  light  
yellow  oil"41.  -  TLC  (diisopropyl  ether/EtOAc,  10:1):  Rt  =  0.32  
and  0.44 [(3R) and  (3S) isomers, respectively].  — HPLC  [solvent:  
hexane/dioxane, 21:4; flow rate: 1 ml min - 1 ; detector: UV (254 nm); 
column:  Partisil  5 p  (250  x  4.5  mm)]:  R,  =  21.7  min  (76%)  and  
23.4  min  (24%)  [(3R)  and  (3S) isomers,  respectively],  -  IR  (film):  
v  =  3300 cm - 1  (NH),  1725,1630 (CO).  -  •H NMR  (CDC13): 8  =  
0.02  (s,  1.5H,  3S  SiCH3),  0.07  (s, 4.5H,  3ft,  SiCH3),  0.8  [s,  6.75H,  
3ft C(CH3)3], 0.85 [s, 2.25 H, 3S C(CH3)3],  1.44 (d, 7  =  6 Hz, 0.75 H, 
3S  CH3),  1.47  (d,  J  =  6 Hz,  2.25 H,  3ft  CH3),  2.42  and  2.44  (dd,  
J  =  6  Hz, 2H,  CH2),  2.57 (d,  J  =  6 Hz, 2H,  CHj),  3.63 (s, 0.75 H, 
35 OCH3),  3.67 (s, 2.25H, 3ft  OCH3),  4.49  (m, 1H,  OCH),  5.09 (m,  
1H,  NCH),  6.5 (m, 1H,  NH),  7.28 (m, 5H,  aromatic  H).  
Method  B: To  a  stirred  mixture  of  8 c  (1.5 g,  9.2  mmol) and  im-
idazole  (2.92  g, 43  mmol)  in  dry DMF  was  added  ferf-butyldime-
thylsilyl  chloride  (3.2 g,  21  mmol),  and  the  resulting  mixture  was  
stirred  at  room  temp,  for  2 h.  The  reaction  mixture  was  diluted  
with ether (40 ml) and then poured into ice/water (40 g). The organic 
layer was separated, and the aqueous layer was extracted  with ether 
(60 ml). The combined  organic layers were washed  with a  saturated  
NH4C1 solution, dried (MgS04), and  the solvent  was evaporated  in  
vacuo  to  yield  crude  methyl  tert-butyldimethylsilyl  3-[(tert-butyl-
dimethylsilylJoxyjglutarate  (3.5 g,  97%). 
The  above  described  methylsilyl  ester  was  dissolved  in  a  3:1:1  
mixture  of methanol, tetrahydrofuran and  water (100 ml), and after 
the  addition  of  potassium  carbonate  the  mixture  was  stirred  at  
room temp, for 1 h. The organic solvents were evaporated  in vacuo, 
the residue  was extracted  with  ether  (30 ml), and  then  the  aqueous  
layer  was  acidified  with  10%  hydrochloric  acid  (pH  =  2.5).  The  
solution  was  extracted  three  times  with  ether  (20  ml  each),  the  
combined  ethereal  extracts  were  dried,  and  the  solvent  was  evap-
orated  in vacuo to give 8a.  -  [a]£  =  + 2.9 (c  =  2.6, CHC13) (90% 
e.e.). 
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Dimethyl  3-Acetoxyglutarate  (7 b): To a stirred mixture of 6 (4.0  g,  
23  mmol) and  triethylamine  (3.44 g,  34 mmol)  in  dry  ether  (40 ml) 
was  added  acetyl  chloride  (3.56 g,  3.25  ml,  45  mmol),  and  the  re-
sulting  solution  was  stirred  at  room  temp,  for  18 h.  The  reaction  
mixture was diluted  with ether (60 ml) and successively washed  with  
10%  sodium  hydroxide  solution,  saturated  sodium  hydrogen  car-
bonate  solution,  and  brine,  and  then  dried  (MgSOJ.  Evaporation  
of  the  solvent  gave  an  oily  residue  which  was  purified  by  column  
chromatography  with  hexane/acetone  (10:1)  as  eluent  to  yield  7b  
(4.5 g,  91%)  as  a  colorless  oil124'.  -  TLC  (hexane/acetone.  5:2):  
R,  =  0.42.  -  IR (film): v  =  1735 cm"'  (CO).  -  'H NMR (CDClj:  
5  =  2.0  (s,  3H,  CHJ,  2.7  (d,  J  =  6  Hz, 4H,  2 CHJ,  3.67  (s,  6H,  
2 OCHJ,  5.48 (m,  1H,  OCH).  
Methyl  Hydrogen  (R)-3-Acetoxyglutarate  (8b): Pig  liver  acetone  
powder  (10 g)  was  homogenized  with  0.15  M phosphate  buffer  
(pH  =  8,100  ml) and  then  centrifugated at  3000 g at  room  temp,  
for  1 min.  To  the  obtained  supernatant  (pH  value  changed  to  
7.1—7.3  during  the  extraction  process)  having  40  U/ml  enzyme  
activity  (measured  on  ethyl  butyrate  as  a  substrate  at  25'C,  
pH  =  8)  7 b  (4.4  g,  20  mmol)  was  added  and  the pH  value  of  the  
resultant  vigorously  stirred  emulsion  was kept  within  the range  of  
6.9—7.1  by continuous addition  of  1 M sodium hydroxide  solution.  
After consumption  of  1 equivalent  of  the  base (20 ml),  the  mixture  
was  acidified  to  pH  =  3  with  concd.  hydrochloric  acid  and  then  
centrifugated  at  3000 g  for  1 min.  The  supernatant  layer  was  
washed  three  times  with  ethyl  acetate  (50 ml each), and  the  precip-
itate  was  washed  with  ethyl  acetate  (50  ml).  The  combined  ethyl  
acetate solutions were washed with brine (40 ml) and dried (MgSOJ. 
Evaporation  of  the  solvent  in  vacuo  gave  a  crude  product  which  
was  purified  by  chromatography  with  hexane/acetone  (10:1)  as  
eluent  to  yield 8b  (1.85 g, 45%) as  a  pale yellow  oil.  — TLC  (hex-
ane/acetone,  5:2):  R,  =  0.2.  -  [o]g  =  +5.4  (c  =  5.5,  CHC1J  
(90%  e.e.)  {ref.P" [a ]g  =  +6.1  (CHC1J  (100%  e.e.)}.  -  IR (film): 
v  =  3700- 2500  cm"1  (COOH),  1730,  1700  (CO).  -  'H  NMR  
(CDClj:  5  =  203  (s, 3H, CHJ,  2.71  (d, J  =  6 Hz, 2H,  CH3),  2.74 
(d,  7  =  6 Hz, 2H, CHJ,  3.68  (s, 3H,  OCH3),  5.46 (m,  1H,  OCH).  
Methyl  (3R,1'R)-3-Acetoxy-4-[N-(I'-phenylethyl)carbamoyl]bu-
tyrate:  To  a  stirred  mixture  of  8 b  (0.41 g,  2 mmol),  triethylamine  
(0.44 g,  4.4  mmol)  and  (R)-1 -phenylethylamine  (0.27 g,  2.2  mmol)  
in  dry  dichloromethane  (5 ml)  was  added  thionyl  chloride  (0.27  g,  
0.17  ml,  2.3  mmol),  and  the  resulting  mixture  was stirred  at  room  
temp,  for  2  h. The  reaction  mixture  was  diluted  with  dichlorome-
thane  (50 ml) and then  successively  washed  with  10%  hydrochloric  
acid,  saturated  aqueous  sodium  hydrogen  carbonate  solution  and  
brine.  After drying  (MgSO«),  the  solvent  was  removed  in  vacuo  to  
afford 0.53 g (86%) of a light  yellow oil.  -  TLC (diisopropyl  ether/  
EtOAc, 3:1): R,  =  0.48.- -  HPLC [Partisil 5 pm (25 cm  x  4.5 mm); 
eluent: diisopropyl ether/CH2CI2,1:4]:  R,  =  58.3 min.  -  IR (film): 
v  =  3300 cm- '  (NH),  1730,1635 (CO).  -  'H  NMR  (CDClj): 8  =  
1.47 (d,  J  =  7 Hz, 3H,  CH3),  1.97 (s, 3H, CHj),  2.56 (d, J  =  6  Hz,  
2 H, CHJ, 2.7 and 2.72 (dd, J  =  6 Hz,2H, CHJ, 3.67 (s, 3 H, OCH J, 
5.1 (m,  1H, NCH),  5.45 (m,  1H,  OCH),  5.97 (m,  1H, NH),  7.29 (m, 
5 H, aromatic  H).  
Methyl  Hydrogen  (R)-3-Hydroxyglutarate  (8c): To  a  stirred  so-
lution  of  sodium  methoxide  (5.4 g,  0.1  mol)  in  dry  methanol  (150  
ml)  was  added  a  solution  of 8b  (3.1  g,  15 mmol)  in  dry  methanol  
(60  ml),  and  the  resultant  mixture  was  stirred  at  room  temp,  for  
8  h. The reaction mixture was acidified with  10% hydrochloric acid 
(pH  =  2), and  the  solvent  was  evaporated  in  vacuo.  The  residue  
was  poured  into  ice/water  arid  then  extracted  with  ether  (150 ml).  
The ethereal  solution  was dried (MgS04) and  the solvent  was evap-
orated  in  vacuo  to  afford  8c  (1.5 g,  62%)  as  an  oil'23'.  — TLC 
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(EtOAc/hexane, 4:1):  Rf  =  0.2.  -  IR  (film):  =  3480 cm - 1  (OH),  
1720,1700 (CO).  -  'H  NMR (CDClj:  5  =  2.54 (d, J  =  6  Hz, 2H, 
CHJ,  2.6 (d, J  =  6  Hz, 2H, CHJ,  3.68 (s, 3H,  OCH J ,  4.45 (quint,  
J  =  6  Hz,  1H,  OCH).  
Methyl  ( R)-3-f  (tert-Butyldimethylsilyl)oxy  ]-5-hydroxypentan-
oate  (9): To  a stirred suspension  of sodium tetrahydroborate  (0.12 g, 
3.6 mmol)  in dry  bis(2-methoxyethyi) ether (15 ml) was added  drop-
wise  a  solution  of  Et20—BF3  (6  ml)  in  dry  bis(2-methoxyethyl)  
ether  (10  ml) during  3 h, and  the diborane generated  was swept  by 
a  slow stream  of argon  into  a flask containing  a  cooled  solution  of  
8a  (4.1  g,  15  mmol)  in  dry  tetrahydrofuran  (20  ml).  After  cooling  
to 0eC, the  reaction  was quenched  by the addition  of ice/water  (30 
ml),  the  mixture  was  basified  (pH  =  7.8 — 8)  with  potassium  car-
bonate  solution  and  then  extracted  four  times  with  ether  (20  ml  
each). The combined  ethereal  extracts  were  washed  with  brine and 
dried  (MgS04),  and  the  solvent  was  removed  in  vacuo  to  afford 9 
(3.5 g,  90%)  as  a  light  yellow  oil.  -  TLC  (hexane/EtOAc,  7:3):  
Rr  =  0.5.  -  IR  (film):  v  =  3440  cm"1  (OH),  1730  (CO).  -  'H  
NMR  (CC14):  5  =  0.05  (s,  3H,  CHJ,  0.1  (s, 3H,  CHJ,  0.85  (s,  9H, 
3 CHJ,  1.65  (q,  J  =  6  Hz,  2H,  CHJ,  2.4  (d,  J  =  6 Hz,  CHJ,  3.0  
(br.  s, 1H, exchangeable  with DjO, OH),  3.55 (s, 3H, OCH J,  3.6 (t, 
7  =  6  Hz, OCHJ, 4.22 (quint, J  =  6  Hz, OCH).  -  MS: mi-  (%)  =  
262  (3) [ M + ] ,  245  (4) [ M +  -  OH],  231  (6) [ M +  -  OCHJ,  205  
(40) [M +  -  C 4HJ,  173 (33),  131  (100),  75 (100),  73 (47).  
C|2H2i04Si  (262.4)  Calcd.  C  54.92  H  9.99  
Found  C  54.70  H  9.82  
Methyl  (R)-3-[(tert-Butyldimethylsilyl)oxy]-4-formylbutyrate  
(5): To  a  stirred  solution  of 9  (2.5  g,  9.5 mmol)  in dry  dichlorome-
thane  (80 ml) was added  pyridinium  chlorochromate  (15 g) in por-
tions, and  the  resultant  mixture was stirred  at  room  temp,  for  1 h. 
The  solution  was concentrated  in  vacuo to  a  volume  of  25  ml and 
filtered through a short silica gei column. Evaporation  of the solvent 
in vacuo afforded pure  5 (1.54 g, 62%)  as a colorless oil. This com-
pound  was  not  stable for a  long period  of time at  room  temp, and 
was stored  at  0°C.  -  TLC (hexane/EtOAc,  7:3):  R,  =  0.65.  -  IR  
(film): v  =  1720 cm"1  (CO).  -  'H  NMR (CDClj: 5  =  0.05 (s, 6H, 
2 CHJ,  0.85  (s, 9H,  3 CHJ,  2.54 (d,  J  =  6 Hz,  2H,  CHJ,  2.64 (m, 
2H,  CHJ,  3.66  (s, 3H,  OCHJ,  4.62  (quint,  J  =  6 Hz,  1H,  OCH),  
9.78  (t,  7  =  2  Hz,  1H,  CHO).  -  ,3C  NMR  (CDClj:  5  =  4.92  
(SiCHJ,  17.81  [SiC(CHJJ,  25.56  [S iQCHJJ ,  42.35  (C-2),  50.83  
(C-4),  51.35 (OCHJ,  64.96  (C-3),  170.97 (C-l),  200.45 (C-5). 
C,2H2404Si  (260.4)  Calcd.  C  55.35  H  9.29  
Found  C  55.22  H  9.11  
Dimethyl  3-(Methoxymethoxy)glutarate  (7d):  By  analogy  with  
the procedure used for the preparation  of acetoxyglutarate 7 b, com-
pound  6  was  protected  with  chloromethyl  methyl  ether  in  46%  
yield.  -  TLC  (hexane/acetone,  5:2):  R{  =  0.44.  -  IR  (film): v  =  
1740 cm"1  (CO).  -  'H  NMR  (CC14): 8  =  2.54  (d,  J  =  6  Hz,  4H, 
2 CHJ,  3.27 (s, 3 H, OCHJ,  3.63 (s, 6 H, 2 OCHJ, 4.27 (m, 1H. OCH), 
4.56 (s, 2H,  OCHjO).  -  MS: m/z (%)  =  220 (<1) [M + ] ,  189 (13) 
[ M +  — O C H J ,  175 (3),  159 (3), 127 (27),  100 (14), 59 (14), 45 (100). 
Methyl  Hydrogen  3-(Methoxymethoxy)glutarate  (8d):  The  en-
zymatic  hydrolysis  of  7d  was  carried  out  as  described  for  7 b  to  
yield racemic 8d  in 65%  yield.  — TLC (hexane/acetone.  5:2): R(  =  
0.19.  -  IR  (film):  v  =  3600- 2500  cm"'  (COOH),  1725.  1690  
(CO).  -  'H  NMR  (CDClj:  8  =  166 ( d , 7 = 6  Hz, 4H.  2CHJ,  
3.33  (s,  3H,  OCHJ,  3.67  (s, 3H,  OCHJ,  4.37  (m.  1H,  OCH),  4.65  
(s,  2H,  OCHjO).  -  MS:  m/z  (%)  =  206  (<1)  [M + ] ,  175  (11)  
[M T  -  OCHJ ,  145 (8),  127 (14),  113 (12),  100 (15), 45 (100).  
Methyl  (3RS.l'R)-3-(Methoxymethoxy)-4-[N-(i'-phenylethyl)-
carbamoyl]butyrate:  This  compound  was  prepared  from  8d  and  
150 C. Szäntay et  al.  
(R)-l-phenylethylamine  in 78%  yield as described for the  synthesis  
of  8 b.  — TLC  (diisopropyl  ether/acetone,  3:1):  Rf  =  0.42.  -  IR  
(film): v  =  3300 cm"'  (NH), 1730,1640(CO).  -  'H NMR  (CDC13):  
8  =  1.46  (d,  J  =  7  Hz,  3H,  CH3),  2.51  (d,  J  =  6 Hz, 2H,  CHj),  
2.58  and  2.64  (d,  J  =  6  Hz  and  d,  J  =  6 Hz,  2H,  CHJ,  3.26  (s,  
1.5H,  OCHJ,  3.31  (s,  1.5H,  OCHj),  3.67  (s,  3H,  OCH3),  4.34  (m,  
1H,  OCH),  4.58  (s,  1H,  OCHjO),  4.66  (s,  1H,  0CH : 0) ,  5.09  (m,  
1H,  NCH),  6.27  (m,  1H,  NH),  7.28  (m,  5H,  aromatic  H).  -  MS:  
m/z  (%)  =  309  (7) [M + ] ,  278  (11) [M +  -  OCHJ,  264  (18),  127  
(19),  120 (100),  106  (25),  105 (62),  103  (7), 91  (7),  79  (8), 77  (12), 46 
(71). 
Dimethyl  3-(Phenylacetyloxy)glutarate  (7e):  According  to  the  
procedure  described  for  the  preparation  of  7 b,  compound  6  was  
acetylated  with  phenylacetyl  chloride  in  56%  yield.  — TLC  (hex-
ane/acetone,  5:2): Rt  =  0.44.  -  IR  (film): v  =  1730 cm"'  (CO).  -
'H  NMR  (CDClj): 5  =  2.69 (d, 7  =  6 Hz, 4H, 2CHJ,  3.58 (s, 2H, 
CHj),  3.61  (s, 6H,  2 OCHJ,  5.50 (m,  1H, OCH),  7.26 (m, 5H,  aro-
matic H).  -  MS: m/z(%)  =  294(8) [M+],263  (7) [M +  -  OCH3],  
176 (12),  127 (41),  118  (83),  99 (9), 91  (100).  
An  attempted  enzymatic  hydrolysis  of 7e resulted  only  in  the for-
mation  of  6.  
Preparation of Ethyl  (Naphthyiidene)  acetates 13. —  General Pro-
cedure: To  a stirred solution  of lithium diisopropylamide,  prepared  
from  2.74 g  (3.8  ml,  27.2  mmol)  of  diisopropylamine  in  50  ml  of  
freshly  distilled  tetrahydrofuran  and  17.6  ml  of  n-butyllithium  
(1.4 M  in  hexane;  1.73 g, 27 mmol) at  — 78 °C, was added  dropwise  
a  solution  of  31 mmol  of ethyl  (trimethylsilyl)acetate  (11) in  10 ml 
of tetrahydrofuran over a period  of  15 min. After additional  10 min 
at  — 78 °C,  a  solution  of  12 mmol  of the appropriate  tetralone  10  
in  10 ml tetrahydrofuran  was added, and the resulting mixture was 
stirred  at  - 7 8 ° C  for  2 h, warmed  to  -20°C,  stirred  for  2 h,  and  
then  warmed  to room  temp,  in the course  of 2 h. The reaction  was  
quenched  by  the addition  of ice/water  (100 ml). The  organic  layer  
was separated, the aqueous layer was extracted  with ether (100 ml), 
and  the combined  organic solutions  were successively washed  with  
water,  5%  sulfuric acid, saturated  sodium  hydrogen  carbonate  so-
lution, and  water  and  then  dried (MgSOJ. Evaporation  of the  sol-
vent  gave a mixture  of (£) and (Z) isomers which was separated  or  
purified  by  column  chromatography  with  hexane/EtOAc  (7:3)  as  
eluent. 
Ethyl  (Ej-(  1.23.4-Tetrahyiro-l-naphthytidene  ¡acetate  (13a):  Yield  0.97  g  
(37%)  light  yellow oil.  -  TLC (hexane/EtOAc,  9:1): Rt  =  0.63. -  HPLC  
(S.P.;  hexane/CHjClJdioxane,  60:40:5):  R, =  27.5  min.  -  IR  (film): v  =  
1700 cm"1  (CO). -  'H  NMR (CC1J: 5  -  1.31  (t, J  =  7 Hz, 3H, CHJ  1.89  
(q, J  -  6 Hz, 2H, CHJ, 2.79 (t, /  =  6 Hz, 2H, CHJ, 3.20 (td, 7  =  6  Hz and 
1.5  Hz, 2H, CHJ,  4.20 (q, J  -  7 Hz, 2H,  OCHJ,  6.33  (t, /  -  2 Hz,  1H,  
C=CH),  7.05-7.7  (m, 4H,  aromatic  H). -  "C  NMR (CDClj): 8 -  14.42  
(CHJ,  22.76 (C-3'J, 28.08 (C-4'),  30.22 (C-2'X  59.64 (O-CHJ  112.53 (C-2), 
124.79 (C-5'),  126.34 (C-8'),  129.14 (C-T), 129.52 (C-6'),  134.23 (C-8a), 141.26 
(C-4a),  152.62 (C-l'),  166.94 (C-l).  -  MS: m/z  (%) =  216  (74) [M+],  188  
(23),  171 (78) [M-  -  OC2HJ,  143 (82),  128 (100),  115 (64), 91 (25), 57  (24).  
Ethyl (Z)-(1.2.3.4-Tetrahydro-l-naphthylidene)acetate  (13b):  Yield  0.91  g  
(35%) yellow oil.  -  TLC (hexane/EtOAc, 9:1): R, =  0.55. -  HPLC (S.P.; 
hexane/CHjClJdioxane,  60:40:5):  R,  =  22.5  min. -  IR  (film): v =  1705  
cm"1  (CO).  -  'H  NMR  (CC1,): 8 =  1.24 (t, /  -  7 Hz, 3H, CHJ  1.96 (q, 
/  -  6 Hz, 2H, CHJ,  2.51 (m,  2H, CHJ,  2.86 (t,  J  =  6  Hz, 2H, CHJ, 4.16 
(q, /  =  7 Hz, 2H, OCH2), 5.79 (t, /  =  1.5  Hz, 1H, C-CH), 7.0-7.7 (m, 4H, 
aromatic H). -  l3C NMR (CDClj: 8 -  14.13 (CHJ  23.17 (C-3'), 29.19  (C-
4'), 34.98 (C-2'), 59.97 (OCHJ, 114.52 (C-2),  124.70 (C-5'), 128.30 (C-8'),  129.32  
(C-7'),  129.41  (C-6'),  133.21  (C-8a),  138.97  (C-4a),  155.66 (C-l'),  166.91 (C-
1). -  MS: m/z (%) =  216 (100) [M+],  187 (19),  171 (82), [M*  -  OC2HJ,  
143  (68),  128  (91),  115  (60),  103  (14),  91  (18),  73  (17),  55  (26).  
Ethyl  (E)-(l,23.4-TetrahydroJi-methoxy-l-naphthylidene)acetate  (13b):  
Yield  1.82 g (40%) yellow  oiL -  TLC (hexane/EtOAc,  7:3):  R, =  0.74.  -
IR (film): v  =  1695 cm"1  (CO). -  'H NMR (CDClj: 8 -  1.3  (t, J  -  7 Hz, 
3H, CHJ  1.77 (t, /  -  6  Hz, 2H, CHJ  2.64 (t, /  -  6 Hz, 2H, CHJ  3.83 (s,  
3H, OCHJ, 4.15 (q, /  -  7 Hz, 2H, OCHJ  6.74-7.17  (m, 4H, C-CH  and  
aromatic H).  -  MS: m/z (%) =  246 (25) [M*],  215 (100), [M+  -  OCHJ,  
201 (30) [M*  -  OCHjCHJ],  187  (92),  158 (44),  128 (54),  115  (60).  
C|5H„03  (246.3)  Calcd.  C 73.15  H  7.37  Found  C 73.02  H 7.19 
Ethyl  (Z)-(133.4-Tetrahydro-8-methoxy-l-naphthylidene)acetate  (131):  
Yield  0.95 g  (32%)  yellow  crystals. -  M.p.  60- 62°C.  -  TLC  (hexane/  
EtOAc,  7:3):  R, -  0.7. -  IR  (KBr):  v =  1700 cm"1  (CO). -  'H  NMR  
(CDClj: 8  -  1.16 (t, /  -  7 Hz, 3H, CHJ  1.87 (t, J  =  6 Hz, 2H, CHJ  2.48  
(t, J  -  6 Hz, 2H, CHJ  2.73 (t, /  -  6 Hz, 2H, CHJ  3.72 (s, 3H, OCHJ 4.2 
(q,/  —  7 Hz, 2 H, OCHJ  5.87 (t,/  —  1.5 Hz, 1H, C=CH), 6.7—7.2(m, 3H, 
aromatic H).  -  MS: m/z (%) -  246 (47) [M+],  215 (100) [M-  -  OCHJ,  
201  (28),  187  (61),  172 (14),  158  (25),  129  (19), 115  (19).  
C,JH„OJ  (246.3)  Calcd.  C 73.15 H  7.37  Found  C 73.10  H 7.21 
Ethyl  (1,23.4-Tetrahydro-7-methoxy-l-naphthylidene)acetate  (3:1  Mixture  
of (£) and (Z) Isomers 13e and  131):  Yield 2.25 g (76%) yellow oil.  -  TLC  
(hexane/EtOAc, 7:3): R, =  0.67 and 0.7.  -  HPLC (hexane/C^CIJdioxane, 
60:40:1): R,  =  7.22 and  8.74 min. -  IR (film): v  =  1720 cm"1  (CO).  -  'H  
NMR (CDClj 8 =  1.3 (t, J  -  7 Hz, 1.8H, CHJ  1.38 (t, /  =  7 Hz,  1.2H,  
CHJ,  1.9 (m, 2H, CHJ  1.5-3.3 (m, 4H, 2CHJ, 3.75 (s, 3H, OCH3), 4.12 (q, 
7  =  7 Hz,  1.2H, OCHJ  4.18 (q, J  -=  7 Hz,  0.8H, OCHJ  5.7  (m,  0.6H,  
C=CH),  6.2 (m, 0.4H, C=CHX 6.6-7.4  (m, 3H, aromatic  H). -  MS: m/z 
(%) -  246  (50) [M+],  201  (60) [M+  -  OCH2CHJ,  200  (100)  [M+  -
HOCHjCHJ,  186 (22), 172  (48) [M+  -  HC02CH2CHJ,  158  (30),  128  (30),  
115  (33).  
C,5H„OJ  (246.3)  Calcd.  C  73.15  H  7.37  Found  C  73.32  H  7.28  
Ethyl  (123.4-Tetrahydro-7-phenyl-l-naphthylidene)acetate(3:1  Mixture of 
(£)  and  (Z) Isomers  13k  and  131): Yield  281 g  (80%)  yellow  oil.  -  TLC  
(hexane/EtOAc,  7:3): R, =  0.85. -  HPLC (R.P.; Me0H/H20,  9:1): R,  -
6.0 and  6.15 min.  -  IR  (film): v -  1705 cm-1  (CO),  1615 (C-Q.  -  'H  
NMR (CCL): 8  -  1.18 [t, J  =  7 Hz,  1.2H, CH3, (Z) isomer],  1.25 [t, /  =  
7 Hz, 1.8H, CHj, (£) isomer],  1.85  (m, 2H, CHJ 24  (m, 2H, CHJ  2.6-3.1  
(m, 2H,  CHJ,  4.05  (q, /  =  7 Hz,  1.2H, OCHJ  4.08 (q, J  =  7 Hz,  0.8 H, 
OCHJ  5.81  [m,  0.6H, C-CH,  (Z)  isomer],  6.42 [m,  0.4H, C=CH,  (£)  
isomer], 7.0-7.9 (m, 8H, aromatic H). -  "C NMR (CDClj 8  -  14.10 [(Z) 
isomer, CH3],  14.36 [(£)  isomer, CHJ,  2273  [(Z), C-3'],  23.34 [(£), C-3'], 
28.05 and 28.93 (C-4'), 29.84 [(£), C-2*],  35.13 [(Z), C-21 59.70 [(£), OCHJ, 
60.05  [(Z).  OCHJ,  112.65  [(£),  C-2'],  114.78  [(Z),  C-2],  123.38,  126.95,  
127.27,  127.95,  128.33,  128.68,128.73,  129.58,  133.30, 134.47,137.57,  137.98,  
139.24,  139.38,  140.70,  140.93,  152.46 [(Z), C-l*],  154.65 [(£), C-11 166.91 
(C-l).  -  MS: m/z (%) =  292 (100) [M+],  263 (20) [M+  -  CH2CH3], 247 
(61) [M+  -  OCHjCHJ, 246 (100) [M+  -  HOCH2CHJ,  218  (52), 203  (42),  
189 (32), 178  (24), 165 (26), 152 (18), 101  (18),  91  (10),  77  (9).  
QOHBOJ  (292.4)  Calcd.  C 8216  H  6.90  Found  C 8228  H 7.14 
Preparation  of  Ethyl (dihydronaphthyl)acetates  13  and  24. — 
General  Procedure:  To  a  stirred  mixture  of  ethyl  or  methyl  di-
ethoxyphosphorylacetate  (12a or  12b) (0.1  mol) and  tetralone  10 or 
23, respectively, (0.1 mol) in dry benzene (80 ml) was added  dropwise  
a  solution  of  sodium  methoxide  (6.0  g, 0.11  mol)  in  dry  methanol  
(50  ml),  and  the  resulting  mixture  was  stirred  at  room  temp,  for  
4 d.  The reaction  mixture  was poured  into  ice/water  (200  ml),  the  
organic  layer  was separated,  and  the  aqueous  layer  extracted  with  
ether (300 ml). The combined organic layers were washed with water 
and dried (MgSOJ. Removal  of the solvent  under reduced  pressure  
gave  an  oil  which  was  purified  by  column  chromatography  with  
hexane/EtOAc  (9:1) as  eluent.  
Ethyl (3.4-Dihydro-l-naphthyl)acetate  (13d):  Yield  12.11 g (56%)  yellow  
oil1"1.  -  TLC  (hexane/EtOAc,  9:1):  R,  =  0.7.  -  HPLC  (S.P.;  hexane/  
CH^l^dioxane,  60:40:1): R,  =  6.0 min.  -  IR  (film): v  =  1720 cm"1 (CO), 
1615 (C=C).  -  'H  NMR (CCIJ. 8 =  1.18 (t, /  =  7 Hz, 3H, CHJ, 23 (m, 
2H, CHJ  2.7 (m, 2H, CHJ  3.28 (t, J  =  1.5  Hz, 2H, CHJ  4.03 (q, /  =  7  Hz,  
2H, OCHJ,  5.84 (t, J  =  3.5 Hz, 1H, C = CH),  7.0 (m, 4H, aromatic  H).  -
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MS: m/z  (%)  =  216 (34) [M+],  171 (20) [M+  -  C2H5OH],  142  (54),  141  
(95), 129 (50),  128 (100),  115 (71), 91 (15). 
Methyl  (3.4-Dihydro-2-naphthyl)acetate  (24a):  Yield  10.52 g  (52°/.)  light  
yellow oil12".  -  TLC (hexane/EtOAc,  7:3): R,  =  0.67.  -  HPLC (S.R; hex-
ane/CH2Cl2/dioxane,  60:40:1):  R,  -  4.5  min.  -  IR  (film): V =  1730  c m - '  
(COX  1640 (C=C) .  -  'H  NMR  (CO«):  5  =  2.3  (M, 2H,  CHJ,  2.7  (M,  2H,  
CHJ ,  3.03 (s, 2H, CHJ,  3.6 (s, 3H,  OCHJX  7.0 (m, 4H,  aromatic  H).  -  MS:  
M/Z (%)  -  202  (20) [ M * ] ,  141  (72) [ M +  -  C02CHJ],  128  (100) [M+  -
CH 2 C0 2 CH 2  +  H],  115  (83X 63  (21X 59  (20).  
Preparation  of  Alkyl  (1,2J,4-  Tetrahydronaphthyl)  acetates.  — Gen-
eral Procedure:  A solution  of the appropriate  naphthylideneacetate  
13 (50 mmol) in dry ethanol  (100 mi) was shaken  in an  atmosphere  
of  hydrogen  with  palladium/charcoal  catalyst  (0.4 g)  for  4  h.  The  
catalyst was removed by filtration, and the filtrate was concentrated 
in vacuo. The  oily residue was purified by column  chromatography  
with  hexane/EtOAc  (10:1)  as  eluent.  
Ethyl (12J,4-Tetrahydro-l-naphthyl)acetate (13c): Yield 8.95 g (82%) light 
yellow oil.  -  TLC (hexane/acetone, 5:2): R, =  0.62. -  IR  (film): v  -  1725  
cm"1  (CO).  -  •H NMR  (CC14): 5  =  1.2 (t, J  =  7 Hz, 3H, CHj), 1.8 (m, 4H, 
2CHj), 13-2.9  (m, 4H,  2 CHJ,  3.2 (m,  1H,  CHX 4.05 (q, J  =  7 Hz, 2H, 
OCHj), 6.95 (m, 4H,  aromatic  H).  -  MS: m/z  (%)  =  218  (40) [M+],  144  
(97X  131  (100) [M+  -  C ^ O J ,  130 (89),  129 (65),  128 (33),  115  (17), 91  (16).  
C,4H,t02  (218.3)  Calcd.  C 77.03  H 8.31  Found  C 76.86  H 8.17 
Ethyl  (l/2J.4-Tetrahydro-8-methoxy-l-naphthyl)acetate (13g):  Yield  
11.30 g (91%) fight yellow oil.  -  TLC  (hexane/EtOAc, 7:3): R,  =  0.75.  -
IR (film): v  -  1730 cm"1  (CO). -  'H NMR (CDClj): 8  =  1.25 (t, J  -  7 Hz, 
3H,CHj),1.7-2.9(m,9H,4CH2,CHX3.8(s,3H,OCHjX4.15(q,y  =  7 Hz, 
2H, OCHJ, 6.8-7.3 (m, 3H, aromatic H). 
CisHfflOj (248.3)  Calcd.  C 72.55  H  8.12  Found  C 72.32  H 7.92 
Ethyl  (1,23,4-  Tetrahydro-  7-methoxy-l-naphthyl)  acetate  (13j):  Yield  
10.55 g (85%) pale yellow oil'301.  -  TLC (hexane/EtOAc, 7:3): Rr  =  0.73.  -
IR  (film): v  =  1730 cm" 1  (COX  -  'H  NMR  (CC14): 8  =  1.25 (t, /  -  7  Hz,  
3H,  CHJX  1.75 (m, 4H, 2 C H J ,  2.55 (m, 5H, 2CH,, CH),  3.68 (s, 3H,  OCHJ),  
4.05 (q, J  =  7  Hz, OCHJ, 6 .4-6 .9  (m, 3H, aromafic H).  -  MS: m/z  (%)  -
248  (95)  [ M + ] ,  175  (40)  [M+  -  CO,CH2CHJ],  174  (100)  [ M *  -
H C 0 2 C H 2 C H J ,  161 (98) [M+  -  CH2C02CH2CHJ],  160  (92),  146  (30X  134  
(30X 115  (30X 103  (18X 91  (28X 77  (18).  
CIJHJOOJ  (248.3)  Calcd.  C 72.55  H  8.12  Found  C 72.68  H 8.03 
Ethyl  (13J,4-Tetrahydro-7-phenyl-l-naphthyi)acetate (13m):  Yield  12.8 g 
(87%) pale yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  »  0.85.  -  IR (film): 
V =  1735 c m - 1  (CO).  -  , H N M R ( C D a 2 X S  =  1.22(t,J  =  7  HZ.3H.CHJX  
1.85 (m, 4H,  2 CHJ ,  2.7 (m, 5H, 2CH2I  CHX 4.13 (q, J  =  7  Hz, 2H,  OCHJ,  
7 .0 -7 .6  (M, 8H,  aromatic  H).  -  MS:  m/z  (%)  -  294  (30) [M+],  220  (43)  
[M+  -  C0 2CH 2CHJ  +  H],  207  (30X  193 (18),  140 (100), 91  (16).  
C20H22O2  (294.4)  Calcd.  C 81.60  H  7.53  Found  C 81.36  H 7.42 
Methyl  (1.2J.4-Tetrahydro-2-naphthyl)acetate  (24b):  Yield  7.15 g  (70%)  
pale  yellow oil.  -  TLC (hexane/EtOAc,  7:3): R,  =  0.79.  -  IR  (film):  V = 
1735 cm" 1  (CO).  -  ! H NMR  (CC14): 8  -  1.5-3.0(m, 9H, 4CH2)  CH),  3.55  
(s, 3H,  OCHJX 6.95 (m, 4H, aromatic  H).  -  MS: m/z  (%)  =  204 (17)  [ M + ] ,  
130  (100) [ M -  -  CH2C02CH3  +  H],  129  (48X  128  (36),  116  (23),  115  (43),  
91  (23).  
C,3H,602  (204.3)  Calcd.  C 76.44  H 7.90  Found  C 76.18  H 7.68 
Methyl  (2-Naphthyl)acetate  (24c):  Yield  2.6 g (26%) yellow  oil.  -  TLC  
(hexane/EtOAc,  7:3):  Rr  =  0.67.  -  IR  (film):  v  =  1730 cm"1  (CO).  -  !H  
NMR  (CC14): 8  -  3.6  (s,  m,  5H,  CH2,  OCHj), 7.0-7.7  (m. 7H,  aromatic  
H). -  MS:  m/z  (%)  -  201  (9) [M* +  1],  200 (66) [M+],  142 (12),  141  (100)  
[M-  -  COjCHJ],  139 (16),  115 (27), 63 (6), 59  (9).  
C,JHI202  (200.2)  Calcd.  C 77.98  H 6.04  Found  C  78.12  H 6.25 
Preparation  of  2-(l-Naphthyl)ethanols  14  and  25.  —  General  
Procedure:  To  a  stirred  suspension  of  lithium  tetrahydridoalumi-
nate  (2.9  g,  0.075  mol)  in  dry  ether  (50  ml)  was  added  dropwise  a  
solution  of the appropriate  acetate  13 or  24 (0.04 mol) at  0°C. The 
resulting suspension  was stirred at 0CC for 2 h and then  hydrolyzed  
by  sequential  dropwise  addition  of  wet  ether  (40  ml)  and  5 ml  of  
2 N aqueous  sodium  hydroxide  solution. The  mixture  was  filtered,  
the solids were washed  with ether (60 ml), and the combined  filtrates  
and  washings  were  washed  with  brine  (20  ml)  and  then  dried  
(MgS04). The solvent was evaporated  in vacuo and  the residue  was  
purified  by column  chromatography.  
(E)-2-(lJJ.4-Tetrahydro-l-naphthylidene)ethanol  (14a):  Yield  4.32 g 
(62%) yellow oil.  -  TLC (hexane/acetone,  7:3): R,  -  0.4.  -  IR  (film):  v  =  
3350 cm"1  (OH).  -  •H NMR  (CDClj): 8  -  1.9 (m, 2H, CHJ,  2.4 (m, 2H, 
CHJ,  2.8 (t, J  =  6 Hz, 2H, CHJ,  4.3 (d, J  =  6 Hz, 2H, HOCHJ,  6.15 (m, 
1H, C=CH),  7.15 (m, 4H, aromatic  H).  -  MS: m/z  (%)  =  174 (26) [M+], 
157  (21) [M-  -  OH],  147  (70X  130 (100) [M+  -  C2H40],  128  (58X 115 
(54X  77 (18),  63  (17X 51  (16).  
C,2H,40  (174.2)  Calcd.  C  82.72  H 8.10  Found  C 82.47  H 8.02 
The  corresponding  (Z)  isomer  Yield  4.74 g  (68%),  oil.  -  TLC  (hexane/  
EtOAc,  7:3):  R,  -  0.54.  -  IR  (film): v =  3350 cm"1  (OH).  -  'H  NMR  
(CCL): 6  =  1.88 (m, 3H. CHj, OH), 2.45 (t, /  =  6 Hz, 2H, CHJ, 2.8 (t, J  =  
6 Hz,  2H,  CHJ,  4.25  (d,  /  =  6 Hz,  2H,  OCHJ,  5.52  (t,  J  =  6 Hz,  1H,  
C=CHX  7.05 (br. s, 4H, aromatic  H). -  "C  NMR (CDClj): 8  =  24.13 (C-
3'),  29.66  (C-4'X  34.17 (C-2'X  60.37  (C-1X 124.84 (C-5'X  125.20 (C-2),  127.56  
(C-8-X 128.38 (C-7'X 128.56 (C-6% 135.02 (C-1'X 138.77 (C-4a'X 139.06 (C-8a'). 
2-(l,2.3.4-Tetrahydro-l-naphthyl)ethanol  (14b):  Yield  6.49 g  (92%)  light  
yellow  crystals1*1.  -  M.p.  36-38°C.  -  TLC  (hexane/EtOAc,  7:3): R,  =  
0.45. -  HPLC (S.P.; hexane/CHjClj/dioxane, 60:40:1): R,  =  17 min. -  IR  
(filmX v  =  3350 cm"1  (OH).  -  !H  NMR  (CC14): 8  =  1.4-2.15  (m,  6H,  
3CHJ, 15-3.1  (m,  3H, CH2)  CH),  3.2 (br. s,  1H, exchangeable  with  D20,  
OHX 3.6 (t, J  =  6 Hz, 2H, OCHJ,  6.85 (m, 4H, aromatic  H). -  13C NMR 
(CDClj: 8  -  19.63 (C-3'X 27.64 (C-2'), 29.49 (C-4'X 34.08 (C-1'X 39.61  (C-2),  
60.73  (C-1X 125.46 (C-7' and C-6'), 128.47 (C-5'X 129.03  (C-8'X  136.93 (C-4a'X 
140.64 (C-8a').  -  MS: m/z  (%)  =  176 (19) [M-  +  1],  175 (16) [M+],  157  
(23X  131  (100X  130  (43X 129  (36X  115  (42),  91  (34).  
C,JH, 6 0  (176.3)  Calcd.  C  81.77  H  9.14  Found  C  81.58  H  8.91  
2-(3,4-Dihydro-l-naphthyl)ethanol  (14c):  Yield  4.81 g (69%)  light  yellow  
oil.  -  TLC (hexane/acetone,  5:2X Rr  -  0.48.  -  IR  (film): v  =  3320 cm -1 
(OHX -  'H  NMR (CDClj): 8  =  2.1 (m, 2H, CHJ, 2.72 (m, 4H, 2CHJ, 3.73 
(t, J  -  6 Hz,  2H, OCHJ,  5.88  (t, /  =  4.5 Hz,  1H, C-CHX  7.1  (m, 4H, 
aromatic H).  -  MS: m/z (%)  =  174 (75) [M-],  156 (22) [M*  -  H20],  141 
(63X 129 (100) [M-  -  CjHjO],  115  (48X 91 (27), 77  (15).  
C12H,40  (174.2)  Calcd.  C 82.72  H 8.10  Found  C 82.77  H 7.86 
2-(1.2,3,4-Tetrahydro-8-methoxy-l-naphthyl)ethanol  (14d):  Yield  5.36 g 
(65%) pale yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  =  0.47.  -  IR (film): 
v  -  3300 cm" 1  (OH).  -  'H  NMR  (CDClj): 8  =  1.75 (m, 7H,  3CH2,  CHX  
2.75 (m, 2H, CHJ, 3.15 (br. s, 1H, exchangeable with D20,  OHX 3.76 (q, J  =  
6  Hz, 2H, O C H J ,  3.78 (s, 3H,  OCHJX 6.6-7.1  (m, 3H, aromatic  H).  -  MS:  
m/z  (%)  -  206  (12) [ M + ] ,  188 (5) [ M +  -  OHJ,  175 (4)  [M*  -  OCHJ],  
161  (100) [ M +  -  OCHJCHJ],  115 (27), 91 (27).  
C , J H „ 0 2  (206.3)  Calcd.  C  75.96  H  8.79  Found  C  75.78  H  8.61  
2-(l3J.4-Tetrahydro-7-methoxy-i-aaphthyl)ethaaol  (14e):  Yield  7.59 g 
(92%) fight yellow  oil131».  -  TLC (hexane/EtOAc, 7:3): R,  =  0.43.  -  HPLC  
(S.P.;  hexane/CHjClj/dioxane, 60:40:1):  R, =  26.7  min.  -  IR  (film) v  -
3380 cm"1  (OH).  -  !H NMR  (CCD: 8  -  1.7 (m, 6H, 3 CHJ, 27  (m, 4H, 
CHj, CH,  OH),  3.7  (t,  J  -  6 Hz,  2H,  OCHJ,  6.3-6.9  (m,  3H,  aromatic  
H).  -  MS: m/z  (%)  -  206 (40) [M*],  175  (18) [M+  -  CH2OH],  162 (80),  
161 (100) [M-  -  CH2CH,OH],  146 (20), 134 (33), 121  (20X 115  (25), 91  (30),  
77  (15).  
CUH, |0 2  (206.3)  Calcd.  C  75.69  H  8.79  Found  C  75.50  H  8.66  
2-(í,23,4-Tetrahydro-7-phenyl-í-naphthyljethanol(l4tf.  Yield 8.17 g(81%) 
light  yellow  oil.  -  TLC  (hexane/EtOAc,  7:3):  Rr =  0.4.  -  IR  (film): v  =  
3380 cm"1  (OH).  -  •H NMR (CDClj): 8  =  1.6-2.2 (m, 6H, 3CHJ,  1.9 (br. 
s,  1H, exchangeable  with D :0,  OHX  2-76 (m. 2H. CHJ,  297 (m. 1H, CH), 
3.74 (t, J  -  7 Hz, 2H,  OCHJ,  7.1 -7.6  (m. 8H, aromatic  H).  -  13C NMR 
(CDClj): 8  -  19.62 (C-3'X 27.67 (C-2'X 29.27 (C-4'X 34.28 (C-1'X 39.75  (C-2X  
60.92 (C-1),  124.46 (C-8'X  126.91 (C-5'X  126.97 (C-2* and  C-6*X 127.32 (C-4*),  
128.64 (C-3* and  C-5*),  129.61  (C-6'X  136.22  (C-4a'X  138.59  (C-8a'X  141.07  
(C-1*), 141.34 (C-7'). 
CnHjoO  (252.3)  Calcd.  C 85.67  H 7.99  Found  C 85.40  H 7.75 
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2-f 3.4-Dihydro-2-mphthyl jethanol (25a):  Yield  6.13 g  (88%)  light  yellow  
oil131.  -  TLC  (hexane/EtOAc,  7:3):  R,  =  0.4.  -  HPLC  (S.P.;  hexane/  
CH-Cli'dioxane,  60:40:1):  R,  -  18.5  min.  -  IR  (film)  v  -  3340  cm -1  
(OH).  -  'H NMR (CDClj): 8  =  2.25 (m, 4H, 2CHJ. 2.6 (m, 3H. CH2, OH), 
3.35 (t. J  =  6 Hz, 2H,  OCH,),  6.08  (s,  1H. C=CH)  6.9 (m. 4H,  aromatic  
H).  -  MS: m/z  (%)  =  174  (56) [M"],  156 (12) [M"  -  H ;0],  143 (100) 
[M-  -  CH:OH],  141 (46).  128 (85),  115 (37).  91 (28). 77 (15). 63  (9).  
C,:H,40  (174.2)  Calcd.  C  82.72  H  8.10  Found  C 82.51  H 8.32 
2-f 2-/\'aphrhylJerhanol  (25b):  Yield  6.75 g  (98%)  colorless  semisolid.  -
TLC  (hexane/EtOAc,  7:3):  R,  =  0.23.  -  HPLC  (S.P.;  hexane/CH.Clj/di-
oxane, 60:40:1): R,  -  18.8 min.  -  IR  (KBr): v  -  3300 cm"1  (OH).  -  'H  
NMR (CDClj: 5  =  1.6 (br. s, 1H, exchangeable with D20. OH), 3.0 (t, J  =  
6 Hz, 2H, CHJ,  3.9 (t, J  -  6 Hz, 2H, OCHJ,  7.0-7.85  (m, 7H, aromatic 
H).  -  MS: m/z (%)  =  172 (29) [M*],  141 (100) [M"  -  CH:OH],  130 (38),  
129  (36),  115  (47).  
C,,H120  (172.2)  Calcd.  C  83.68  H  7.03  Found  C 83.77  H 7.24 
Preparation  of  (2-Bromoethyl)  naphthalenes  15 and 26.  —  General  
Procedure:  To  a  stirred  mixture  of  2-(naphthyl)ethanol  14  or  25  
(0.03  mol)  and  pyridine  (0.3 ml)  in  dry  benzene  (5 ml)  at  0°C  was  
added  dropwise  phosphorus  tribromide  (2.8  g,  1.88 ml,  0.01  mol),  
and  the  resulting  mixture  was  stirred  at  room  temp,  for  6 h.  The  
reaction  mixture  was  poured  into  ice/water,  the  organic  layer  was  
separated,  and  the  aqueous  layer  was extracted  with  ether (30 ml).  
The  combined  organic  layers  were  washed  with  saturated  sodium  
hydrogen  carbonate  solution  and  water  and  then  dried  (MgS04).  
The  solvent  was evaporated  in  vacuo  and  the residue was purified 
by  column  chromatography.  
(E)-l-  (2-Bromoethylidene)  -1,23.4-tetrahydronaphthalene  (15a):  Yield  
4.13 g  (58%)  yellow  oil.  -  TLC  (hexane/acetone,  5:1):  R, =  0.78. -  'H  
NMR  (CDClj): 8  -  2.1 (m, 2H, CHJ,  2.5 (m, 2H, CHJ,  2.8 (td, J  =  6 Hz 
and  1.5 Hz, 2H, CHJ,  3.38 (d, J  =  6 Hz, 2H, CH,),  5.78  (m, 1H, C - C H ) 
7.0 (m, 4H, aromatic  H).  
C|,HuBr  (237.1)  Calcd.  Br  33.70  Found  Br 33.52 
1-f 2-Bromoethyl)-l ,23.4-tetrahydronaphthalene  (15b):  Yield  4.81 g  (67%) 
light  yellow  oil™.  -  TLC  (hexane/EtOAc,  7:3):  R,  =  0.95.  -  'H  NMR  
(CCL): 8  =  1.35-2.15  (m, 6H,  3CH2), 2.3-3.0  (m, 3H,  CH,,  CH),  3.17 (t, 
J  =  7 Hz, 2H, BtCHJ, 6.75 (m, 4H, aromatic H).  -  l3C NMR (CDClj): 8  =  
19.65 (C-3)  27.18  (C-2)  29.48  (C-4),  32.05 (C-l'),  36.06  (C-l),  39.83 (C-2') 
125.72 (C-7), 125.89 (C-6)  128.49 (C-5) 129.26 (C-8), 136.98 IC-4a), 139.58 (C-
8a).  -  MS: m/z (%)  -  240  (8), 238  (9) [M+],  132 (10),  131 (100) [M+  -
C2H4Br],  129 (9),  128 (8),  115 (9). 91 (8). 
C|,H|jBr  (239.2)  Calcd.  Br 33.42  Found  Br 33.08 
l-(2-Bromoethyl)-3,4-dihydronaphthalene (15c): Yield 6.05 g (85%) yellow 
oil.  -  TLC (hexane/acetone,  5:2): R,  =  0.95. -  'H  NMR  (CCI4): 5  =  2.2  
(m, 2H, CHj), 2.5-3.0  (m, 4H, 2CHj), 3.26 (t, J  =  6 Hz, 2H,  BrCHj), 5.78 
(t, J  =  3 Hz, 1H, C - C H )  7.0 (m, 4H, aromatic  H).  -  l3C NMR (CDClj): 
8  =  23.05 (C-3),  28.11  (C-4),  31.19 (C-2'),  36.51 (C-l'),  122.04 (C-2),  126.42  
(C-7),  126.95 (C-6),  127.35  (C-8),  127.77  (C-5),  133.62  (C-8a),  133.80 (C-4a),  
136.60 (C-l).. 
C,,H,jBr  (237.1)  Calcd.  Br  33.70  Found  Br 33.51 
l-(2-Bromoethyl)-l.23,4-tetrahydro-S-methoxynaphthalene  (15d):  Yield  
6.00 g (79%) pale yellow oil.  -  TLC (hexane/EtOAc,  5:1): Rr  =  0.9. -  'H  
NMR  (CC14): 8  =  1.7 (m. 6H, 3 CHJ,  2.1 (m, 1H, CH). 2.7 (m, 2H, CHj), 3.4 
(t,  J  =  6 Hz, 2H,  BrCHJ,  3.72 (s. 3H,  OCHj), 6.5-7.1  (m, 3H,  aromatic  
H).  -  MS: m/z (%)  -  270 (9), 268 (10) [M+],  161 (100),  115 (9), 91 (8), 77 
(4)'  C,jH„BrO  (269.2)  Calcd.  Br 29.69  Found  Br 29.28 
t-( 2-Bromoethyl )-l,23,4-tetrahydro-7-methoxynaphthalene  (15e):  Yield  
6.76 g (89%) yellow oil.  -  TLC (hexane/EtOAc. 7:3): Rr  =  0.85.  -  HPLC  
(S.P.; hexane/CHjClj/dioxane, 60:40:1):  R,  =  4.2 min.  -  'H  NMR  (CCI4):  
8  =  1.75 (m, 4H,  2 CHJ,  2.1  (m, 2H, CHJ,  2.65 (m. 3H. CH2, CH),  3.4 (t, 
J  -  6 Hz. BrCHJ,  3.7 (s, 3H, OCHj). 6.4-7.0 (m, 3H. aromatic  H).  -  MS:  
m/z (%)  =  270 (13),  268  (14) [M+],  188 (8) [M+  -  HBr],  175  (9),  161  (100)  
[M+  -  CH,CH,Br],  115 (18), 91  (12), 77  (8).  
C,jH„BrO  (269.2)  Calcd.  Br  29.69  Found  Br 29.62 
1-f 2-Bromoethyl)-1,23.4-tetrahydro-7-phenylnaphthalene  (151):  Yield  
7.56 g (80%) yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  =  0.94.  -  'H NMR 
(CDClj): 8  -  1.8 (m. 4H, 2CHJ, 13  (m, 2H, CHJ. 18  (in, 3H, CH,,  CH),  
3.55 (t, J  -  7 Hz, 2H,  BrCH,), 7.0-7.7  (m, 8H, aromatic H). 
C„H„Br  (315.2)  Calcd.  Br 25.3S  Found  Br 25.21 
2-(2-Bromoethyl)-3.4-dihydronaphthalene  (26a):  Yield  6.55 g  (92%)  light  
yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  -  0.95. -  'H NMR (CCD: 8  =  
2.18 (t, J  -  8 Hz. 2H, CHJ, 169 (t, J  =  8 Hz, 2H, CHJ, 178 (t, J  =  7  Hz,  
2H, CHJ,  3.45 (t, J  =  7 Hz. 2H.  BrCH,),  6.23 (t, /  =  1  Hz,  1H, C-CH), 
6.9 (m, 4H, aromatic H).  -  13C NMR (CDClj): 8 =  26.71 (C-3), 27.91  (C-4),  
30.54 (C-2'), 40.45 (C-l'),  124.70,125.66,126.39,126.57,127.13.134.11134.26,  
137.86.  -  MS: m/z (%)  -  238 (5), 236 (6) [M+],  157 (17) [M+  -  Br],  143 
(36), 141 (25), 129 (100),  128 (78),  115 (44). 
C|2H|jBr  (237.1)  Calcd.  Br 33.70  Found  Br 33.43 
2-( 2-Bromoethyl ¡naphthalene (26 b): Yield  5.83 g (83%) pale yellow oil.  -
TLC (hexane/EtOAc,  7:3): R, =  0.95.  -  'H  NMR  (CCD: 8 =  3.3 (t, J  =  
6 Hz, 2H,  CHJ,  3.4 (t, J  =  6 Hz, 2H,  BtCHJ,  7.1 -7.7  (m, 7H,  aromatic  
H). -  MS:  m/z (%)  =  236 (22), 234 (22) [M-],  155 (43) [M-  -  Br],  154  
(21), 153 (21),  141 (100) [M*  -  CH2Br],  128 (28),  127 (21),  115  (33).  
C|2HuBr  (235.1)  Calcd.  Br 33.99  Found  Br 33.65 
Preparation  of Alkyl  3-[(tert-Butyldimethylsilyl)oxy]-5-hydroxy-
naphthylheptanoates  16,  17, 27  and  28.  — General  Procedure: To  a  
stirred  mixture  of  magnesium  turnings  (0.24 g,  10  mmol)  in  dry  
tetrahydrofuran  was  added  dropwise  the  appropriate  hialide  15  or  
26 and  the  resulting  mixture was refluxed for  1 h. The solution  was  
cooled  to  room  temp,  and  added  dropwise  to  a  stirred  solution  of  
5 (7.5 mmol) in tetrahydrofuran (10 ml). The  resultant  mixture  was  
stirred  at  room  temp,  for  1 h.  The  reaction  was  quenched  by  the  
addition  of ice/water  (30 ml), the  organic  layer  was separated,  and  
the aqueous layer was extracted  three times with ether (30 ml each).  
The combined  organic  solutions  were washed  with  brine and  dried  
(MgSOJ.  Evaporation  of  the  solvent  gave  an  oily  residue  which  
was shown  by HPLC  analysis to be  a 2:1 mixture  of the  diastereo-
mers  16  and  17  or  27  and  28.  These  isomers  were  separated  by  
column  chromatography.  
Methyl  (3R,5R)-(E)-3-[ftert-Butyldimethylsilyl)oxy¡-5-hydroxy-7-
f 1,23.4-terrahydro-l-naphthylidene)heptanoate (16a): Yield 0.75 g (24%) yel-
low oil.  -  TLC (hexane/EtOAc, 7:3): R,  =  0.51.  -  IR(fiIm):v  =  3380 cm"1 
(OH).  -  'H  NMR  (CDClj): 8  -  0.03 (m, 6H, 2CH3), 0.83 (s, 9H, tBu)  2.5  
(m, 12H, 6CHJ,  3.64 (s, 3H, OCHj), 4.26 (m, 1H, OCH), 4.6 (m, 1H, OCH), 
5.87 (t, J  =  4.5 Hz,  1H, C-CH),  7.15 (m, 4H,  aromatic  H). -  ,3C  NMR  
(CDClj): 8  -  5.09 (SiCHj),  17.84 and  25.68  (tBu),  23.10 (C-3'),  27.96 (C-6),  
28.37 (C-4'),  34.51 (C-21,  36.7 (C-4),  39.37 (C-2), 51.33 (OCHj)  65.08 (C-3), 
73.35 (C-5),  122.53 (C-7),  125.42 (C-8'),  126.36 (C-T),  126.68 (C-6'), 127.59 (C-
5'),  134.37 (C-8a')  135.49 (C-4a'),  136.68 (C-l'),  171.06 (C-l). 
Methyl  (3R.5S)-fE)-3-f(tert-Butyldimethylsilyl)oxy]-5-hydroxy-7-
(l,23,4-tetrahydro-l-naphthylidene)heptanoate(n*):  Yield 0.47 g(15%) pale 
yellow oil.  -  TLC (hexane/EtOAc,  7:3):  R(  -  0.58.  -  IR  (film):  v  =  3380  
cm"1  (OH),  1730 (CO)  -  'H  NMR (CDClj): 8  -  0.03 (m, 6H. 2CHJ,  0.8  
(m, 9H,  tBu), 25 (m, 12H, 6 CHJ,  3.63 (s, 3H, OCHj) 4.15 (m, 1H, OCH) 
4.51 (m,  1H, OCH)  5.85 (m,  1H, C - C H )  7.1 (m, 4H,  aromatic  H).  -  13C  
NMR (CDClj): 8  -  4.86 (SiCHj)  17.15 and  25.56 (tBu)  22.96 (C-3')  27.87  
(C-6)  28.22 (C-4')  34.36 (C-2')  38.43 (C-4) 40.04 (C-2)  51.30 (OCHj) 66.19 
(C-3),  76.31  (C-5)  122.41  (C-7)  125.45  (C-8'),  126.27  (C-T),  126.59  (C-6'),  
127.50 (C-5'j,  134.17 (C-8a')  135.16 (C-4a'),  136.54 (C-l')  171.11 (C-l). 
Methyl  (3R.5R,J'RS)-3-fftert-Butyldimethylsilyl)oxy]-5-hydroxy-7-
(1.23.4-tetrahydro-l-naphthyl)heptanoate  (16b):  Yield  0.63 g (20%)  yellow  
oil.  -  TLC (hexane/EtOAc,  7:3): R,  =  0.65.  -  IR  (film): v =  3380 cm"1  
(OH)  1720 (CO).  -  'H  NMR (CDClj): 8  =  0.09 (s, 6H. 2CH3) 0.90 (s, 9H, 
tBu)  1.79 (m, 10H, 5CHJ,  2.6 (m, 2H, CHJ,  2.76 (m, 2H, CHJ, 28  (m, 1H, 
CH)  3.5 (s, 3H, OCHj)  3.95 (m, 1H, OCH)  4.3 (m, 1H, OCH)  6.9 (m, 4H, 
aromatic  H).  -  MS: m/z (%)  =  420 (1) [M+],  331 (5) [M+  -  CHjOH  -
C4H9], 256 (6), 144 (40), 131 (97), 129 (41)  115 (28),  101 (33), 91  (30), 75  (100).  
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Methyl  (3R5R,l'RS)-3-[(tert-Butyldimethylsilyl)oxy]-5-hydroxy-7-
(1.2J,4-tetrahydro-l-naphthyl)heptanoate  (17b):  Yield  0.38 g  (12%)  yellow  
oil.  -  TLC  (hexane/EtOAc,  7:3):  R,  -  0.7.  -  IR  (film):  v  -  3360  cm" 1  
(OH),  1720  (CO).  -  'H  NMR  (CCI,):  6  -  0.02  (s, 6H,  2CHJ ,  0.8  (s,  9H,  
tBu),  1.3-2.1  (m,  10H,  5CHJ,  2 .1-3 .1  (m,  5H.  2CH : ,  CH),  3.48  (s,  3H,  
OCHJ),  3 .9 -4 .3  (m,  2H,  20CH),  6.7-7.05  (m,  4H,  aromatic  H).  -  MS:  
M/Z (%)  -  420 (<1)  [M*] ,  331  (6) [ M -  -  CHJOH  -  C«H,],  256  (6),  144  
(44),  131  (93),  129 (38),  115  (27),  101  (35),  91 (28),  75 (100).  
Methyl  (3RJR  )-3-[  (tert-Butyldimethylsilyl)oxy]-S-hydroxy-7-(3,4-dihy-
dro-l-naphthyl)hcpianoate (16c): Yield 0.79 g (25%) light  yellow oil.  -  TLC  
(hexane/EtOAc,  7:3):  R,  -  0.6.  -  IR  (film): v  -  3400 cm"1  (OH),  1715  
(CO).  -  'H  NMR (CDClj): 8  =  0.07 (s, 6H, 2CHJ, 0.9 (s, 9H, tBu), 2.5 (m, 
10 H, 5 CHJ,  3.65 (s, 3H,  OCHj), 4.15 (m,  1H,  OCH), 4.26 (m, 1H,  OCH),  
5.9  (t,  J  -  4 Hz,  1H,  C-CH),  7.15  (m,  4H,  aromatic  HX -  "C  NMR  
(CDClj: 8  =  4.83 (SiCHj),  17.93 and  25.71 (tBu),  23.14 (C-3'X 28.02 (C-6X 
28.40 (C-4'X 34.52 (C-7), 36.51 (C-4), 41.98 (C-2X 51.48 (OCHJ, 65.05 (C-3), 
74.44 (C-5X 122.59 (C-2'), 125.58 (C-8'X 126.39 (C-7'), 126.72 (C-6'), 127.65 (C-
5'),  134.44  (C-8a0,  135.49  (C-4a'),  136.78 (C-l],  171.21  (C-l).  -  MS: m/z 
(%)  -  418 (<1) [M-],  386 (3) [M+  -  CHjOH], 254 (11), 169 (15), 143  (23),  
142 (100),  141 (22),  128 (16),  101 (20),  75 (29), 73 (17). 
Methyl  (3RJS)-3-f  (tert-Butyldimethylsilyl  joxy  j-5-hydroxy-  7-  (3.4-dihy-
dro-l-naphthyl)heptanoate (17c):  Yield 0.72 g (23%) yellow oil.  -  TLC (hex-
ane/EtOAc, 7:3): R,  -  0.66.  -  IR (film): v  =  3380 cm"1 (OH), 1720 (CO).  -
'H  NMR (CDClj: 8  =  0.07 (s, 6H, 2CHJ, 0.88 (s, 9H,  tBu), 2.55 (m, 10H, 
5 CHJ,  3.66 (s, 3H, OCHJ,  4.15 (m,  1H,  OCH), 4.3 (m,  1H, OCH),  5.89 (t, 
J  =  4 Hz,  1H, C-CH),  7.15 (m, 4H, aromatic  H).  -  l3C  NMR  (CDC13):  
8  -  4.92 (SiCHJ,  17.87 and  25.68 (tBu),  23.10 (C-3'),  28.02 (C-6), 28.37 (C-
4'),  34.57  (C-7),  38.63  (C-4),  42.41  (C-2X  51.45  (OCHJ,  66.34  (C-3X  76.46  
(C-5),  122.56 (C-2'),  125.66 (C-8'),  126.42 (C-7'),  126.74 (C-6'X  127.64 (C-5'X 
134.34 (C-8a0,135.34 (C-4a')_  136.71 (C-1'X  171.29 (C-l).  -  MS: m/z (%)  =  
418 (<1) [M~],  386  (4X 254 (12),  169  (18).  143  (26),  142  (100X 141  (25), 128 
(16),  101  (22), 75  (30),  73  (19).  
Methyl  (3RJS)-3-f(tert-Butyldimethylsilyl)oxy]-S-hydroxy-7-(123.4-te-
trahydro-8-methoxy-i-naphthyl)heptanoate  (16d):  Yield  0.41 g (12%)  yellow 
oil.  -  TLC  (hexane/EtOAc,  7:3):  R,  =  0.8. -  IR  (film): v  -  3380 cm"1  
(OH),  1735 (CO). -  'H  NMR (CDClj: 8 =  0.05 (s, 6H, 2CHJ,  0.9 (s, 9H, 
tBuX 1.2-2.1  (m. 12H, 6 CHJ, 27  (m, 3H, CH2,  CHX 3.75 (s, 3H,  OCHJ,  
3.9 (s, 3H, OCHJ,  4.1 (m, 2H, OCH), 6.6-7.2 (m, 3H, aromatic H). 
Methyl  (3RJS)-3-[(tert-Butyldimelhylsilyl)oxyJ-5-hydroxy-7-{  12,3,4-te-
trahydro-8-methoxy-l-naphthyl)heptanoate  (17d):  Yield  0.27 g  (8%)  yellow  
oil.  -  TLC  (hexane/EtOAc,  7:3):  R,  -  0.84.  -  IR  (film)  v  -  3380  cm" 1  
(OHX  1730 (CO).  -  'H NMR  (CDCIJ:  8  -  0.05 (s, 6H, 2CHJ ,  0.85  (s, 9H, 
tBuX 1.2-2.1  (m, 12H, 6CHJ ,  2.7 (m, 3H, CHJ, CH),  3.7 (s, 3H, OCH3X  3.9  
(s, 3H,  OCHJX 4.0 (m, 2H, 20CH) , 6 .6-7.2  (m, 3H. aromatic  H).  
Methyl  (3R5R)-3-[(tert-Butyldimethylsilyl)oxy]-S-hydroxy-7-(3.4-di-
hydro-2-naphthyl)heptanoate  (27a):  Yield  1.00 g  (32%)  yellow  oil.  -  TLC  
(hexane/EtOAc,  7:3)  R,  -  0.53.  -  IR  (film): v  -  3380 cm" 1  (OHX  1720  
(CO).  -  'H  NMR  (CC1J:  8  -  0.05  (s, 6H,  2CH3X  0.8  (s, 9H,  tBuX  1.75 (m, 
2H, CHJ, 2 .0-2 .8  (M, 10H, 5CHJ,  3.65 (s, 3H,  OCHJX 4.2 (M, 2H,  20CH) ,  
6.15 (m,  1H,  C—CHX  6-9 (m, 4H,  aromatic  HX  
Methyl  (3RJS)-3-[(tert-Butyldimethylsilyt)oxy]-5-hydroxy-7-(3,4-dihy-
dro-2-naphthyl)heptanoate  (28a): Yield 0.91 g (29%) pale yellow oil.  -  TLC  
(hexane/EtOAc,  7:3):  Rt  -  0.7.  -  IR  (film): v  -  3400 cm"'  (OH),  1725  
(CO).  -  'H NMR (CC1J: 8  -  0.05 (s, 6H, 2CHJ, 0.85 (s, 9H,  tBuX 1.5-2.8 
(m,  12H,  6CHJ,  3.55  (s,  3H,  OCHJ,  4.05  (m,  2H,  20CH),  6.1  (m,  1H,  
C-CH),  6.85 (m, 4H. aromatic  HX  
Methyl  (3R.5R)-3-f(tert-Butyldimethylsilyl)oxy]-5-hydroxy-7-(2-naph-
thyllheptanoate  (27b): Yield  1.16 g (37%) light  yellow  oU. -  TLC (hexane/ 
EtOAc. 7:3): R,  -  0.5.  -  IR (film): v  -  3380 cm"1  (OHX 1720 (CO).  -  'H  
NMR  (CCL): 8  -  0.05 (s, 6H, 2CHJ,  0.85 (s, 9H,  tBuX 1.8 (m, 4H,  2CHJ,  
2.2-2.8  (m, 4H,  2CHJ,  3.65 (s, 3H,  OCHJ,  4.1 (m, 2H, 20CH),  7.0-7.7  
(m,  7H,  aromatic  H). -  MS: m/z  (%)  -  384 (9) [M*],  327  (27) [M-  -
C4HJ,  193  (11X 167 (34X 141 (100),  101 (33X 75 (38), 59  (11).  
Methyl  (3RJS)-3-f(tert-Butyldimethylsilyl)oxy/-5-hydroxy-7-(2-naph-
thyl)heptanoate  (28b). Yield 0.97 g (31%) light  yellow oil.  -  TLC (hexane/ 
EtOAc.  7:3): R,  =  0.55.  -  IR  (film): v  =  3360 cm"1  (OH),  1730 (CO).  -
'H NMR (CC1J: 8 —  0.05 (s,6H.2CHJ, 0.85 (s,9H, tBu), 1.8 (m,4H,2CHJ, 
2.2 — 2.8 (m, 4H, 2CHJ,  3.55 (s, 3H, OCHJ,  3.95 (m, 2H, 20CH),  7.0-7.7  
(m,  7H,  aromatic  H).  -  MS: m/z  (%)  =  384  (5) [M*],  327  (28) [M*  -
C,H,],  193 (11X  167 (30X 141 (100),  127 (22),  101 (48),  75 (61), 59  (10).  
Preparation of  4-Hydroxy-6-(2-naphthylethyl)-3.45,6-tetrahyd.ro-
2H-pyran-2-ones  2 a - d ,  18a—d,  3,  and  29.  -  General  Procedure:  
To  a  stirred  solution  of  the  appropriate  ester  16,  17,  27,  or  28  
(3 mmol)  in  dry  acetonitrile  (200 ml)  was added  48%  hydrofluoric  
acid  (10 ml), and  the  resultant  solution  was  stirred  at  room  temp,  
for 2 h. The reaction mixture was diluted with ether (200 ml), cooled 
to 0°C and  mixed  with a  saturated  solution  of potassium  hydrogen  
carbonate  (70  ml). The  organic  layer  was  separated,  washed  with  
brine, and  then  dried  (MgS04X The solvent  was evaporated  under  
reduced  pressure,  and  the  residue  was  purified  by  column  chro-
matography  with  hexane/EtOAc (3:2)  as  eiuent.  
(4R,6R)-(E)-4-Hydroxy-6-[2-(  1.2J3.4-tetrahydro-l-naphthylidene)ethyl]-
3.4.5,6-tetrahydro-2H-pyran-2-one (2a): Yield 0.42 g (52%) yellow oil.  -  TLC  
(hexane/EtOAc,  3:2):  R, =  0.18.  -  IR  (film): v  =  3420 cm"1  (OH),  1725  
(CO).  -  'H  NMR (CDClj: 8  -  1.9 (m, 4H, 2CHJ,  2.2 (m, 2H, CHJ,  2.6  
(m, 6H, 3CHJ,  4.0 (br. s,  1H,  OHX 4.3 (m, 1H, OCH), 4.7 (m, 1H, OCH), 
5.88 (t,  J  -  4 Hz,  1H, C-CH),  7.15  (m, 4H,  aromatic  H). -  ,3C  NMR  
(CDClj:  8  -  23.14  (C-3*),  28.05  (C-1'X  28.40  (C-4*X  34.58  (C-2"X  36.01  
(C-5X 38.67 (C-3), 62.63  (C-4X 75.79 (C-6X 122.56 (C-2'X 125.61 (C-8*), 126.42 
(C-7*), 126.75 (C-6"),  127.68 (C-5"X 134.47 (C-8a'X 135.46 (C-4a*),  136.81 (C-
1"),  170.92 (C-2).  
C17HJO03  (272.3)  Calcd.  C  74.97  H  7.40  Found  C  75.12  H  7.21  
(4R,6S)-(E)-4-Hydroxy-6-(2-(  1.2J.4-tetrahydro-l-naphthylidene)ethylJ-
3.4.5.6-tetrahydro-2H-pyran-2-one  (18a):  Yield  0.58 g  (71%)  yellow  oil.  -
TLC  (hexane/EtOAc,  3:2):  R,  -  0.16.  -  IR  (film): v  -  3440 cm"1  (OHX  
1725 (CO).  -  'H  NMR (CDClj: 8  -  1.9 (m, 4H, 2CHJ,  2.2 (m, 2H, CHJ, 
2.7  (m, 6H, 3CHJ,  4.25 (m, 2H, 20CH),  5.89 (t, J  -  4  Hz,  1H, C-CHX 
7.15 (m, 4H, aromatic  H).  -  ,3C NMR (CDClj: 8  =  23.05 (C-3*X 27.99 (C-
13, 28.32 (C-4*), 34.28 (C-2*), 37.68 (C-5),  39.43 (C-3),  63.59 (C-4),  76.40 (C-
6X  122.50  (C-2'X  125.75  (C-8*X  126.39  (C-7*),  126.78  (C-6*X  127.68  (C-5*X  
134.26 (C-8a*X 135.11 (C-4a*), 136.72 (C-1'X  171.41 (C-2). 
CUHJOOJ  (272.3)  Calcd.  C 74.97  H 7.40  Found  C  74.82  H 7.14 
(4R.6R,l'RS  )-4-Hydroxy-6-[  2-(  1,2,3,4-tetrahydro-l-naphthyl)ethyl]-
3.4JjS-tetrahydro-2H-pyran-2-one (2 b):  Yield 0.56 g (68%) light yellow oil.  -
TLC (hexane/EtOAc, 1:4): R, -  0.5. -  IR (film): v  -  3450 cm"1  (OHX 1725 
(CO).  -  'H  NMR (CDClj: 8  -  1.74 (m,  10H, 5CHJ,  2.58 (m, 2H, CHJ, 
2.72 (m, 2 H, CHJ, 2.8 (m, 1H, CH), 3.77 (br. s,  1H,  OHX 4.27 (m, 1H,  OCH), 
4.68 (m,  1H, OCH),  7.06 (m, 4H,  aromatic  H).  -  ,3C  NMR (CDClj: 8  -
19.77  (C-3*), 27.43 (C-2*),  29.51  (C-4*X 31.56 and  31.64  (C-1'X 33.02  (C-2"X  
35.50 (C-5X 37.11 and  37.20 (C-1*X 38.43 (C-3X 62.15  (C-4X 76.28 and 76.57  
(C-6X  125.45  (C-6* and  C-7*),  128.32  (C-5*X  128.99  (C-8"X  136.95  (C-4a*X  
140.40  (C-8a*),  171.46  (C-2).  -  MS:  m/z  (%)  -  274  (3)  [M+],  256  (12)  
[M+  -  HJO],  196  (30), 170  (11X 144  (80),  131  (100X  130  (27X 129  (40X  115  
(20X91(5). 
C,7Ha03  (274.4)  Calcd.  C  74.42  H 8.08  Found  C  74.71  H 8.25 
(4R.6S,l'RS)-4-Hydroxy-6-[2-(1.2,3.4-tetrahydro-l-naphlhyl)ethyl]-
3,4JjS-tetrahydro-2H-pyran-2-one  (18 b):  Yield  0.49 g  (60%)  light  yellow  
oil.  -  TLC (hexane/EtOAc,  1:4):  R, =  0.45.  -  IR  (film): v -  3400 cm-1 
(OHX  1725 (CO).  -  'H  NMR (CDClj: 8  -  1.76 (m,  10H, SCHJ,  2.5 (m, 
2H, CHJ,  2.75 (m, 2H, CHJ,  2.8 (m, 1H, CH),  3.19 (br. s, 1H,  OHX 4.21  (m,  
2H,  2 OCH),  7.08 (m, 4H,  aromatic  H). -  ,3C  NMR  (CDClj: 8  -  19.86  
(C-3"), 27.55 (C-2*X 29.60 (C-4*X 31.74 (C-1'X 33.17 (C-2'X 37.24 (C-1"X  37.76  
(C-5X 39.49 (C-3), 63.71 (C-4), 77.49 and  77.75 (C-6X 125.61 (C-6* and C-7*X 
128.41  (C-5*X  129.14  (C-8*X  137.07 (C-4a*),  140.38 (C-8a*),  171.12 (C-2).  -  .  
MS: m/z (%)  -  274 (6) [M*],  256 (12) [M+  -  HjO],  196 (30), 170 (12),  144  
(80),  131  (100X  130 (28).  129  (35),  91  (35).  
C,7H r03  (274.4)  Calcd.  C 74.42  H 8.08  Found  C  74.54  H 8.17 
(4R,6R)-4-Hydroxy-6-f2-(3.4-dihydro-l-naphthyl)ethyl]-3,4J,6-tetrahy-
dro-2H-pyran-2-one (2 c): Yield 0.42 g (52%) light yellow oil.  -  TLC (hexane/ 
EtOAc. 3:2): R,  -  0.25. -  IR  (film): v  =  3450 cm"1  (OH),  1720 (CO).  -
'H  NMR (CDClj: 8  =  1.95 (m, 4H, 2CHJ,  2.2 (m, 2H, CHJ,  2.8 (m, 6H, 
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3 CHJ, 4.42 (m,  1H, OCH),  4.79 (m, 1H,  OCH), 5.94 (t, J  -  4 Hz, C=-CH), 
7.2  (m,  4H,  aromatic  H).  -  13C  NMR  (CDCIJ:  8  =  23.13  (C-3"),  28.02  
(C-1'X 28.37 (C-4"X 34.57 (C-2'X 36.03 (C-5X 38.69 (C-3), 6153 (C-4), 75.78 (C-
6),  122.53  (C-2*X  125.51  (C-8"X  126.39  (C-7*),  126.71  (C-6"),  127.65  (C-5"X  
134.46 (C-8a"), 135.46 (C-4a"), 170.97 (C-2).  -  MS: m/z (%)  =  272 (6) [M+], 
167 (5),  142 (100),  141 (21),  129 (10),  128 (12),  115 (5). 
QJHJOOJ  (2723)  Caled.  C  74.97  H  7.40  Found  C  74.81  H 7.59  
(4R.6S)-4-Hydroxy-6-/2-(3.4-dihydro-l-naphthyl)ethyl]-3,4J,6-tetrahy-
dro-2H-pyran-2-one  (18c):  Yield  0.63 g (77%) light  yellow  oil.  -  TLC (hex-
ane/EtOAc,3:2):Rr  =  0.17.  -  IR(filmXv  =  3440cm"1 (OH), 1725(CO).  -
'H  NMR  (CDCIj): 8  =  1.9 (m, 4H, 2CHJ  22  (m, 2H, CHJ  2.7  (m, 6H, 
3 CHJ  4.26  (m, 2H,  2OCH),  5.92 (t, J  -  4 Hz,  1H, C-CHX  7.2  (m, 4H, 
aromatic  H).  -  ,3C  NMR  (CDCIJ  8  -  23.04  (C-3"),  37.96  (C-10,  28.31  
(C-4"),  34.41 (C-2"),  37.64 (C-5),  39.42 (C-3),  63.50 (C-4),  76.95 (C-6),  12247  
(C-2"),  125.72  (C-8"),  126.39  (C-7"),  126.74 (C-6"),  127.68  (C-5"),  134.26  (C-
8a"),  135.13 (C-4a"),  136.68  (C-1"X 171.52  (C-2).  -  MS: m/z  (%)  =  272  (6)  
[M+],  167 (6),  142 (100),  141 (20),  129 (10),  128 (14),  115 (5).  
C.JHJOOJ  (272.3)  Caled.  C 74.97  H  7.40  Found  C 75.16  H 7.32  
(4R.6R)-4-Hydroxy-6-[2-(1.2.3.4-tetrahydro-8-methoxy-i-naphthyl)-
ethylJ-3.4J.6-tetrahydro-2H-pyran-2-one (2d): Yield 0.78 g (90%) pale yellow 
oil.  -  TLC  (EtOAc/hexane,  4:1):  R,  -  0.6. -  IR  (film): v  -  3440  cm' 1  
(OH),  1730 (CO).  -  'H NMR (CC1J 8  -  1.1-1.8 (m, 8H, 4 CHJ  21 - 2 4 
(m, 4H, 2 CHJ, 28 (m, 3 H, CH* CHX 3.6 (s, 3H, OCHJ  4.1 (m, 1H, OCH), 
4.5 (m, 1H, OCH), 6.5-7.1  (m, 3H, aromatic H). 
CIIHM04  (304.4)  Caled.  C 71.03  H  7.95  Found  C 71.28  H  8.16  
(4R,6S)-4-Hydroxy-6-[2-(i,2.3.4-tetrahydro-8-methoxy-i-naphthyl)-
ethylJ-3.4J,6-tetrahydro-2H-pyran-2-one(18d): Yield 0.43 g (50%) pale yellow 
oiL  -  TLC  (EtOAc/hexane,  4:1):  R,  =  0.44.  -  IR  (film): v  -  3450 cm-' 
(OH),  1725 (CO).  -  "H NMR (CC1J  8  -  1.2-1.8  (m, 8H, 4 CHJ  23  (m,  
4H, 2 CHJ, 2.9 (m, 3H, CH2,  CH), 3.65 (s, 3H, OCHJ, 4.0 (m, 2H, 2OCH), 
6.5—7.1 (m, 3H, aromatic  H).  
C„H M 0 4  (304.4)  Caled.  C  71.03  H  7.95  Found  C  71.11  H  8.16  
(4R,6R)-4-Hydroxy-6-f2-(3.4-dihydro-2-naphthyl)ethyl]-3,4JjS-tetrahy-
dro-2H-pyran-2-one (3 a): Yield 0.48 g (46%) yellow oil.  -  TLC (EtOAc/hex-
ane,  4:1):  R,  =  0.5.  -  IR  (film): v  =  3440 cm"'  (OH),  1725  (COX  -  'H  
NMR (CDC13X 8  -  1.4—2.0 (m, 4H, 2 CHJ  20—2.5 (m, 4H, 2 CHJ, 2.6—2.9 
(m, 4H, 2CH2), 2.8 (br. s, 1H,  OHX 4.33 (m, 1H, OCHX 4.73 (m, 1H, OCHX 
6.24 (br. s, 1H, C=CHX 6.9-7.2 (m, 4H, aromatic H).  -  l3C NMR (CDCIj): 
8  =  27.34 (C-3"),  28.05  (C-4"), 3253 (C-l],  33.43  (C-2'X  35.77  (C-5),  38.58  
(C-3), 62.45 (C-4X 75.64 (C-6),  12277,  125.43,  126.28,  126.42,  127.16,  134.32  
134.59,  140.49,  171.06  (C-2).  -  MS:  m/z  (%)  =  272  (37)  [M+],  254  (8)  
[M+  -  H20],  194 (23),  168 (83),  167 (35),  143 (48X 142 (100),  141 (76),  128  
(59),  115  (26X  
CÍJHMOJ  (272.3)  Caled.  C  74.97  H  7.40  Found  C 75.05  H 7.49  
(4R.6S)-4-Hydroxy-6-/2-(3,4-dihydro-2-naphthyl)ethyl]-3.4J,6-tetrahy-
dro-2H-pyran-2-one  (29a):  Yield  0.52 g  (64%)  light  yellow  oil.  -  TLC  
(EtOAc/hexane,  4:1):  Rr  -  0.37.  -  IR  (film): v  -  3450 cm"'  (OH),  1720  
(CO).  -  'H  NMR  (CDCIj): 8  =  1.4-2.0  (m, 4H, 2CHJ  20-2.6  (m, 4H, 
2 CHJ 2.7-3.0  (m, 4H, 2 CHJ  3.31 (br. s, 1H,  OHX 4.22 (m, 2H, 20-CHX 
6.23  (s,  1H, C=CH),  6.9-7.2  (m, 4H,  aromatic  H).  -  ,3C  NMR  (CDCIj):  
8  =  27.26  (C-3"X 28.02  (C-4"X 3250 (C-l'),  33.29  (C-2'X  37.62  (C-5X 39.43 
(C-3), 63.50 (C-4X 76.81  (C-6X  122.97,  125.46,  125.37,  126.45,  127.18,  134.29,  
134.47,  140.20,  171.44  (C-2).  -  MS:  m/z  (%)  =  272  (35)  [M*],  254  (6)  
[M+  -  H20],  194 (20X 168 (80),  167 (36),  143 (50X  142 (100), 141  (85X 128 
(71X  115  (36).  
C„HJO03  (272.3)  Caled.  C 74.97  H  7.40  Found  C 75.13  H 7.62  
(4R.6R)-4-Hydroxy-6-/2-(2-naphthyl)ethyl/-3,4J.6-tetrahydro-2H-pyran-
2-one (3b): Yield 0.45 g (55%) yellow oil.  -  TLC (EtOAc/hexane, 4:1): Rr  -
0.42.  -  IR  (film): v  -  3430 cm"1  (OH),  1720 (CO).  -  'H  NMR  (CDCIj):  
8  =  1.4-2.1  (m, 4H, 2CHJ  2.6 (m, 2H, CHJ  2.7-3.2  (m, 3H, CH2, OH). 
4.24 (m,  1H,  OCH),  4.69 (m,  1H,  OCHX 7.3-7.9  (m, 7H, aromatic  H).  -
,3C  NMR  (CDCIJ:  8  =  31.15 (C-l J  35.72  (C-5X  37.06  (C-2'X  38.52  (C-3),  
62.33 (C-4), 75.29 (C-6X  125.28,125.99,126.49,127.13,127.39,127.56,128.06,  
132.01,  133.56,  138.50,  171.08 (C-2).  -  MS: m/z  (%)  -  270 (44) [M+],  252  
(4) [M-  -  H20],  192 (10), 179  (8X 167 (11),  155 (7X 142 (100),  141 (60),  128 
(10X 115  (18).  
C„H„Oj  (270.3)  Calcd.  C 75.53  H 6.71  Found  C 75.34  H 6.92 
(4R.6S)-4-Hydroxy-6-/2-(2-naphthyl)ethyl]-3,4J.6-tetrahydro-2H-pyran-
2-one (29b): Yield 0.70 g (86%) yellow oil.  -  TLC (EtOAc/hexane, 4:1): R,  -
0.38.  -  IR  (film): v  =  3460 cm"'  (OHX  1715  (COX -  'H  NMR  (CDCIJ:  
8  -  1.4-26  (m, 4H, 2CHJ  27-3.0  (m,  5H,  2CH2,  OH),  4.15  (m,  2H,  
2OCH), 7.2-7.5  (m, 3H, aromatic  H), 7.6-7.9  (m, 4H, aromatic H).  -  ,3C  
NMR (CDCIJ: 8  =  31.09 (C-1% 36.92 (C-2'X 37.70 (C-5X 39.43 (C-3X 63.50 
(C-4),  76.23  (C-6'),  125.37,  126.07,  126.60,  127.07,  127.42  127.59,  128.15,  
13207,  133.56,  138.24,  171.24 (C-2).  -  MS: m/z  (%)  -  270 (28) [M*],  252  
(5) [M+  -  HaO],  192 (12X 179  (9X 167 (13), 155 (7), 142 (100),  141 (68), 128 
(10X  115  (20).  
C,7H„OJ  (270.3)  Calcd.  C 75.53  H 6.71  Found  C 75.65  H 6.92  
Preparation  of  Alkyltriphenylphosphonium  Bromides  19.  —  Gen-
eral  Procedure:  A  mixture  of triphenylphosphane  (2.62 g,  10 mmol) 
and  the  appropriate  alkyl  halide  15a  or  15b  (9.8  mmol)  in  dry  
acetonitrile  (10  ml) was  stirred  at  reflux for  40 h.  The  solvent  was  
evaporated  and  the  residue  was treated  with  ether, and  then  dried  
in  a  vacuum  desiccator.  
f2-(12J.4-Tetrahydro-7-methoxy-i-naphthyl)ethyl]-triphenylphosphomum 
Bromide (19a):  Yield  5.1 g  (98%)  colorless  crystals.  -  M.p.  85°C.  -  'H  
NMR (CDCIJ: 8  -  1.8 (m, 6H, 3CHJ, 265 (m, 3H, CH2, CH), 3.45 (m, 2H, 
PCHJ,  3.68  (s,  3H,  OCHJ,  6.6-7.1  (m, 3H,  aromatic  H),  7.65  (m,  15H,  
aromatic H). 
[2-(i23,4-Tetrahydro-7-phcnyl-l-naphthyl)ethyl]-triphenylphosphonium 
Bromide  (19b): Yield  5.49 g (97%) colorless semisolid.  -  'H NMR  (CDCIJ:  
8  -  1.95 (m, 6H, 3CHJ  27  (m, 3H, CH*  CHX 3.4 (m, 2H, CHJ  7.1 -7 .4 
(m, 3H, aromatic  HX 7.65 (m, 15H, aromatic H). 
Preparation  of  Alkyl  Heptenoates  20 a, b.  —  General  Procedure:  
To  a stirred  and  cooled  (—70 ° Q  suspension  of phosphonium  bro-
mide  19  (4.2  mmol)  in  125 ml  of  dry  tetrahydrofuran  was  added  
dropwise  3.4  ml  of  n-butyllithium  (1.4 M  in  hexane,  0.31  g,  4.6  
mmol) and  the  resulting  yellow  solution  was stirred  at  — 20°C  for  
1  h. After cooling to  - 7 0 ° C ,  a solution  of  5  (1.25  g, 4.82 mmol)  in  
40 ml  of dry  tetrahydrofuran was added  dropwise, and  the  mixture  
was  stirred  at  0°C  for  2  h. The  reaction  was quenched  by  the  ad-
dition  of acetic acid (2 ml), and the solvent was evaporated  in vacuo. 
The  residue  was  taken  up  in  ether  (200  ml)  and  filtered,  and  the  
filtrate  was concentrated. The resulting  oil  was purified by  column  
chromatography  with hexane/EtOAc (7:3)  as  eluent.  
Methyl  (3R.l'RS)-(Z)-3-[(tert-Butyldimethylsilyl)oxy]-7-(l,2.3,4-telra-
hydro-7-mcthoxy-l-naphthyl)-5-heptenoate(20o):  Yield 1.42 g(78%) light yel-
low oil.  -  TLC (hexane/EtOAc, 7:3): Rr  -  0.83.  -  IR(film):v  -  1740 cm- ' 
(CO),  1620 (C=Q.  -  'H  NMR (CDCIJ: 8  -  0.05 (s, 6H, 2CHJ  0.9 (s, 9H, 
tBuX 1.8 (m, 4H, 2CHJ  245 (m, 6H, 3CHJ,  2.7 (m, 3H, CH2,  CHX 3.66 (s, 
3H, OCHJ  3.8 (s, 3H, OCHj), 4.2 (m, 1H, OCH),  5.55 (m, 2H,  CH=CHX  
6.6-7.2  (m, 3H,  aromatic  H).  -  MS: m/z  (%)  -  432  (3) [M+],  417  (50)  
[M*  -  CHJ,  401  (10) [M*  -  OCHJ,  375 (30) [M*  -  C4HJ,  227  (20X 
201  (22X 187 (23),  161 (100), 115 (21), 89 (55X 73 (65). 
Methyl  (3RJ'RS)-(Z)-3-f(tert-Butyldimethylsilyl)oxyJ-7-(iJJ.4-tetra-
hydro-7-phenyl-l-naphthyl)-5-heptenoate  (20b): Yield  1.43 g  (71%) light  yel-
low  oil.  -  TLC (hexane/EtOAc,  7:3): R,  -  0.67.  -  HPLC  (R.P.;  MeOH/  
H20,7:3): R,  =  5.1 min.  -  IR (film): v  =  1740 cm"1  (COX 1620 (C=Q.  -
'H  NMR  (CDCIJ:  8  =  0.05  (s, 6H, 2CHJ,  0.95  (s, 9H,  tBu),  1.1-1.8  (m,  
4H,  2 CHJ  2.4 (m, 6H, 3 CHJ, 285  (m, 3H, CH2,  CHX 3.66 (s, 3H, OCHJ, 
4.2 (m,  1H, OCH),  5.6 (m, 2H, CH-CHX  7.1 -7 .6  (m, 8H, aromatic  H).  -
MS: m/z(%)  -  478 (1) [M+],463 (6) [M+  -  CHJ,421 (98) [M+  -  C4HJ,  
273 (35), 207 (100),  179 (30).  165 (25X  159 (42), 89  (65X 75 (42), 73 (75). 
Preparation  of  Heptenoic  Acids  20c, d.  — General  Procedure:  To  
a  stirred  solution  of  the  appropriate  alkyl  heptenoate  20a, b  (3.4  
mmol)  in  ethanol  (60  ml)  was  added  a  6.7%  solution  of  sodium  
hydroxide  (60  ml),  and  the  resultant  mixture  was  heated  under  
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reflux for  4 h.  The  ethanol  was  distilled  ofT in  vacuo,  the  residue  
acidified with concd. H Q  (10 ml) and then extracted with ether (4  x  
50  ml).  The  combined  ethereal  extracts  were  washed  with  brine,  
dried  (MgS04),  the ether  was evaporated,  and  the  oily  residue  was  
purified  by  column  chromatography  with  hexane/EtOAc  (7:3)  as  
eluent. 
(3R.l'RS)-(Z)-3-[(tert-Butyldimethylsilyl)oxy/-7-(lJJ,4-tetrahydro-7-
methoxy-l-naphthyl)-5-heprenoic acid (20c):  Yield  1.21 g (85%) yellow oil.  —  
TLC (hexane/EtOAc. 7:3): R,  =  0.5.  -  IR (film): V  =  1715 cm"1 (CO), 1620 
( C = Q .  -  'H  NMR  (CDClj):  8  =  0.05  (s, 6H, 2CHJ,  0.85 (s, 9H,  tBu),  1.7  
(m,  4H,  2CHJ ,  2.45  (m,  6H,  3CHJ ,  2.68  (m,  3H,  CH,,  CH),  3.72  (s,  3H,  
OCHJX 4.05 (m, 1H, OCH), 5.5 (m, 2H, CH =  CHX 6.5-7.1  (m, 3H,  aromatic  
H).  -  MS: m/z  (%)  =  418 (20) [ M - ] ,  361 (40) [M +  -  C4H,], 287 (10), 269 
(35X 227 (35), 201  (25),  187  (45X  161 (100),  75 (60). 
(3R.l'RS)-(Z)-3-[(tert-Butyldimethylsilyl)oxyJ-7-(UJ.4-tetrahydro-7-
phenyl-l-naphthyl)-5-heptenoic  acid (20dX  Yield  1.12 g (71%) yellow oil.  —  
TLC  (hexane/EtOAc,  7:3):  R,  =  0.67.  -  HPLC (S.P;  hexane/CHjClj/di-
oxane,  60:40:1):  R,  =  7.22  min.  [(Z)  isomer,  95%)]  and  8.00  min  [(E)  
isomer, 5%)].  -  IR (film):  v  =  1715 cm"1  (COX 1615 (C=Q.  -  'H  NMR  
(CDClj): 8  -  0.08 (s, 6H, 2CHJ,  1.8 (m, 4H, 2CHJ, 245 (m, 6H, 3CH2), 28 
(m, 3H, CH2,  CHX 4.12 (m, 1H, OCH), 5.55 (m, 2H, CH =  CHX 7.05-7.7 (m, 
8H, aromatic H).  -  MS: m/z (%)  =  464 (20) [M*], 407 (40) [M*  —  C4H9],  
333 (30),  315 (25), 273 (50), 207 (100),  179 (30),  165 (28),  145 (22X 75 (80). 
Preparation  of  Iodo  Lactones  21 a, b  and  22 a, b.  — General  Pro-
cedure:  Iodine  (9.0 g,  71  mmol)  was  added  to  a  stirred  mixture  of  
potassium iodide (0.61  g, 3.6 mmol), the appropriate  heptenoic acid 
derivative 20c, d (2.4 mmoi), and sodium hydrogen carbonate (1.6  g,  
19  mmol)  in  40  ml  of  tetrahydrofuran  and  20  ml  of  water.  The  
resulting mixture  was stirred  at room  temp, for 3 h. A satd. sodium 
thiosulfate solution  (ISO ml)  was added,  and  then  the mixture  was  
extracted  with  ether  (200  ml).  The  ethereal  solution  was  washed  
with  brine  and  dried  (Na2S04).  Removal  of  the  solvent  under  re-
duced  pressure  gave  a  mixture  of  the  isomers  21 a, b  and  22 a, b 
which  were separated  or  purified by column chromatography  with  
hexane/EtOAc (9:1) as  eluent.  
/ 4R,6S,l'RS,l"RS)-4-[(  tert-Butyldimethylsilyl)oxy]-6-/2-(  1,2,3,4-tetrahy-
dro-7-methoxy-2-naphthyl)-l-iodoethyl]-3.4JSfi-tetrahydro-2H-pyran-2-one 
(21a) and Its  (6R)  Isomer  22a:  Yield  1.10 g (84%) pale  yellow  oil.  -  TLC  
(hexane/acetone,  8:2): R,  =  0.28.  -  IR  (film): v  =  1725 cm-1  (CO).  -  'H  
NMR (CDClj): 8  =  0.15 (s, 6H, 2CHj), 1.9 (m, 8H, 4CHJ, 27 (m, 5H, 2CH,, 
CH),  3.15 (m, 1H,  ICH),  3.8 (s, 3H, OCHs), 4.2 (m, 1H,  OCH), 4.4 (m, 1H, 
OCH), 6.6—7.2 (m, 3H, aromatic H).  —  These isomers were not separated. 
(4R.6SXRSJ'RS)-4-[(tert-ButyldimethylsiIyl)oxy]-6-f2-(1.2  J,4-tetrahy-
dr 0-7-phenyl-1-naphthyl).  l-iodoethyl]-3.4.¡,6-tetrahydro-2H-pyran-2-one  
(21 b): Yield 0.58 g (41 %) fight yellow oU. -  TLC (hexane/acetone, 9:1): Rt  =  
0.29.  -  IR  (film): v  =  3460 cm"1  (OHX  1720 (CO).  -  'H  NMR (CDClj):  
8  =  0.1 (s, 6H. 2CHj), 0.9 (s, 9H, tBu),  1.85 (m, 6H, 3CH2), 21 -2.9 (m, 7H, 
3CH2,  CHX 3.15 (m, 1H,  ICH), 4.2 (m,  1H, OCH), 4.35 (m,  1H, OCH), 7.4 
(m, 8H, aromatic  H).  -  MS: m/z  (%)  =  590 (<1) [M+],  533 (1) [M+  -
C4H,], 463 (3) [M+  -  I],  331 (20), 207 (100),  179 (15),  165 (13),  101 (60), 75 
(60). 
(4RJSR,l'RS,J'RS)-4-f  (tert-Butyldimethylsilyl)oxy]-6-[2-(  i  .2J.4-tetra-
hydro-7-phenyl-t-naphthyl)-l-iodoethylJ-3.4J,6•tetrahydro-2H-pyran-2-one 
(22b): Yield 0.24 g (17%) light  yellow oil.  -  IR (film): 5  =  3450 cm"1  (OH), 
1720 (COX -  lH NMR (CDClj): 8  =  0.1 (s. 6H, 2CH3X 0.9 (s. 9H, tBu),  1.9 
(m. 6H, 3CHJ, 2.2-2.9  (m, 7H, 3CH2,  CH), 3.2 (m, 1H, ICH), 4.15 (m, 1H, 
OCHX 4.3 (m,  1H, OCH),  7.5 (m, 8 H, aromatic  H.  -  MS: m/z (%)  =  590  
(<1)  [M+],  533 (1) [M*  -  C«H,], 463 (5) [M*  -  I],  331  (20X 207 (100). 
179  (17),  165  (14),  101  (63X 75  (62).  
Deiodination  of  Iodo  Lactones  21 a, b and  22a, b.  — General  Pro-
cedure: To a stirred solution  of the iodo lactones 21 or 22 (0.9 mmol) 
in  dry  benzene  (20  ml)  were  added  consecutively  azobis(isobuty-
ronitrile)  (0.01 g,  0.06  mmol)  and  tributyltin  hydride  (0.75 g,  2.6  
mmol)  under  argon, and  the  resultant  mixture  was  heated at  60 3C 
for  2  h.  Benzene  was  removed  in  a  rotary  evaporator  and  the  oily  
residue  was  transferred to  a  short  silica  gel column. After  standing 
for  2  h, the  product  was eluted  with  hexane/EtOAc  (7:3).  
(4R£R,i'RS)-4-[(tert-Butyldimethylsilyl)oxy/-6-{2-(i.2.3.4-tetrahydro-7-
methoxy-l-naphthyl)ethyl/-3,4J.6-tetrahydro-2H-pyran-2-one  (21c)  and  Its  
(6S)  Isomer 22c: Starting with a  mixture  of  21 a  and  21 b, the  deiodination  
afforded a 2:1  mixture  of the diastereomers 21c  and  22c, which  were sepa-
rated  by column  chromatography.  
21c  Yield  0.23 g (61%) pale yellow oil.  -  TLC (hexane/EtOAc,  7:3): R,  =  
0.7.  -  IR  (film): v  =  1730 cm"1  (CO).  -  'H  NMR  (CDClj): 8  =  0.05 (s,  
6H, 2CHj), 0.85 (s, 9H, tBu),  1.75 (m, 10H, 5CHj), 2.6 (m, 5H, 2CHj, CH), 
3.75 (s, 3H, OCHj), 4.15 (m. 1H, OCH), 4.3 (m, 1H, OCH), 6.5-7.1 (m, 3H, 
aromatic H). 
C24Hj(04Si  (418.6)  Calcd.  C 68.85  H 9.15  Found  C 68.56  H 8.92 
22c: Yield 0.09 g (25%) yellow oil.  -  TLC (hexane/EtOAc, 7:3): ff, =  0.6.  -
IR (film): v  =  1725 cm"1 (CO).  -  'H NMR (CDClj): 8  -  0.05 (s,6H,2CHj), 
0.87 (s, 9H, tBu),  1.75 (m, 10H, 5CHJ,  2.55 (m, 5H, 2CH2l  CH), 3.65 (s, 3H, 
OCHj), 4.1 (m, 1H,  OCH), 4.2 (m,  1H, OCH). 
C24Hu04Si  (418.6)  Calcd.  C  68.85  H 9.15  Found  C 68.58  H 8.91 
/ 4R,6RJ'RS)-4-f(  tert-Butyldimethylsilyl)oxy/-6-f2-(  I,2J,4-tctrahydro-7-
phenyl-i-naphthyl)ethyl  J-3.4J,6-tetrahydro-2H-pyran-2-one  (21 d):  Yield  
0.34 g (81%) pale yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  =  0.75.  -  IR  
(film): v  =  1730 cm"1  (CO).  -  'H NMR (CDClj): 8  =  0.05 (s, 6H, 2CHj), 
0.85 (s, 9H,  tBu),  1.8 (m, 8H, 4CH2X  2.55 (m, 2H, CHJ,  2.8 (m, 5H, 2CH* 
CH),  4.2 (m, 1H,  OCH), 4.65 (m, 1H,  OCH),  7.35 (m, 8H,  aromatic  H).  -
MS: m/z (%)  =  464 (3) [M*],  407 (10) [M+  -  C4H9], 389 (12X 332 (8), 315 
(10), 297  (18X 273 (22),  247  (80X 233  (20),  220 (40),  207  (100),  192 (20),  179  
(25),  165 (30),  101  (65X  75  (60).  
CjjHwOjSi  (464.7)  Calcd.  C 74.95  H 8.68  Found  C 75.15  H 8.47 
(4R.6S,l'RS)-4-f(tert-Butyldimethylsilyl)oxy/-6-[2-(lJ3.4-tetrahydro-7-
phenyl-l-naphthyi)ethylJ-3.4J.6-tetrahydro-2H-pyran-2-one  (22d):  Yield  
0.38 g (90%) pale yellow oil.  -  TLC (hexane/EtOAc, 7:3): R,  -  0.62. -  IR  
(film): v  -  1730 cm"1  (CO).  -  ! H NMR  (CDCI,):  8  =  0.05  (s, 6H,  2CHJ),  
0.85  (s, 9H,  tBu),  1.8 (m, 8H, 4CH2),  2.4 (m, 2H,  CHJX 2.75 (m, 5H,  2CHJ,  
CHX 4.1 (m, 1H, OCH), 4.2 (m, 1H, OCH), 7.3  (m, 8 H, aromatic H).  -  MS:  
m/z  (%)  =  464 (3) [M+],  407 (10) [ M *  -  C4H9],  389 (UX  332  (8X 315 (5X 
297 (12), 273 (20X 247  (40X 233  (18X 220 (75), 207  (100X  192 (18),  179 (30),  165  
(30),  101  (71X 75  (80).  
CjoHuOjSi  (464.7)  Calcd.  C 74.95  H 8.68  Found  C 75.18  H 8.92 
Removal  of  the  Silyl  Protecting  Group  from  the  Lactones  21 and 
22.  — General  Procedure: To  a  stirred  solution  of  the  lactone 21 d 
or  22 d  (0.6 mmol)  in  dry  acetonitrile (45 ml)  was  added  dropwise  
48%  hydrofluoric acid (2  ml), and  the resulting mixture was stirred 
at  room  temp, for  2 h. After cooling  to  0°C,  the mixture  was  neu-
tralized  with  a  satd.  sodium  carbonate  solution,  the  organic  layer  
was separated, and  the aqueous layer was extracted  with ether (100 
ml).  The  combined  organic  layers  were  washed  with  brine,  dried  
(MgS04), concentrated  under reduced pressure, and the residue was 
purified  by  column  chromatography  with  EtOAc/hexane (4:1)  as  
eluent. 
(4R.6R.l'RS)-4-Hydroxy-[2-(1.2J.4-tetrahydro-7-methoxy-i-naphthyi)-
ethyl/-3.4J.6-tetrahydro-2H-pyran-2-one (2e) Yield 0.17 g (92%) light yellow 
oil.  -  TLC  (EtOAc/hexane,  4:1):  Rt  =  0.6. -  IR  (film): v  =  3430 cm"1  
(OHX  1725 (CO).  -  'H  NMR (CDClj): 8  =  1.73 (m,  10 H, 5CHJ.  2.68 (m, 
6H. 2CHj, CH, OH), 3.78 (s, 3H, OCHj), 4.36 (m, 1H, OCH), 4.70 (m, 1H, 
OCH), 6.66 (m. 1H, aromatic  H). 6.71  (s, 1H, aromatic  HX 6.97 (d. J  = 8 Hz, 
1H. aromatic  H).  -  "C NMR (CDClj): 8  =  20.33 (C-3'X 27.70 (C-2*X  28.90 
(C-4*),  31.71 and  31.77  (C-1'X  33.17  (C-2'X  36.13  (C-5),  37.70  (C-1"X 38.76 
(C-3),  55.40 (O-CHJX  62.77 (C-4),  76.23 (C-6),  111.77 (C-6"),  113.70 (C-8"X 
129.44 (C-4a"),  129.93  (C-5"X  141.69  (C-8a"X  157.72  (C-7"),  170.42 (C-2).  -
MS: m/z  (%)  =  304 (30) [M-],  286 (12) [M*  -  H20], 200  (8X 174 (68),  161  
(100),  159 (75),  128 (15),  115 (18), 91  (20).  
C,IHJ,04  (304.4)  Calcd.  C  71.03  H  7.95  Found  C  71.28  H  8.16  
( 4R.6R,t'  RS ¡-4-Hydroxy-(2-(  1.2.3,4-tetrahydro-7-methoxy-l-naphthyl  1-
etliyl/-3,4,5,6-tetrahydro-2H-pyran-2-one  (18e):  Yield  0.17 g (91%) fight yel-
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low oil.  -  TLC (EtOAc.'hexane. 4:1): R,  -  0.5.  -  IR (film): v  -  3450 cm"1 
(OH)  1725 (CO).  -  'H NMR (CDClj) 8  -  1.7 (m, 10H.5CHJ,  2.7 (m. 6H, 
2CHj,  CH. OH)  3.79  (s. 3H.  OCHj)  4.30  (m. 2H,  20CH),  6.65  (m,  1H.  
aromatic H)  6.72  (s.  1H.  aromatic  H)  6.98  (m.  1H.  aromatic  H)  — MS: 
mtz (%)  =  304 (25) [M*].  286 (8) [M*  -  H :0],  200 (5)  174 (56)  161  (100)  
159 (62)  128  (17)  115  (18)  91  (23).  
C„H;404  (304.4)  Calcd.  C  71.03  H  7.95  Found  C 70.85  H  7.68  
( 4R.6R.1' RSj-4-Hydroxy-[2-(  13J.4-teirahydro-7-phenyI-t-naphthyl)-
ethylJ-3.4J.6-tetrahydro-2H-pyran-2-one (2f):  Yield 0.15 g (71%) light  yellow 
oil.  — TLC  (EtOAc.'hexane.  4:1):  R,  =  0.5.  -  IR  (film) v  =  3460  cm"1  
(OH)  1715 (CO).  -  'H  NMR (CDClj) 8  =  1.75 (m, 10H, 5CHJ,  2.56 (m, 
2H. CH :)  2.77 (m. 2H, CH,)  2.8 (m, 1H, CH)  3.10 (br.  s, 1H, OH)  4.25  (m,  
1H. OCH), 4.67 (m. 1H, OCH)  7.12 (d, /  =  8 Hz,  1H, aromatic H)  7.4 (m, 
7H, aromatic  H).  -  ,3C NMR (CDC13): 6  =  19.74 (C-3*), 27.38 (C-2") 29.34 
(C-4")  31.80 (C-1')  33.17 (C-2')  35.63 (C-5)  37.47 (C-l")  38.49 (C-3), 62.33 
(C-4),  76.40 (C-6)  124.49 (C-8")  126.95 (C-5")  127.10 (C-4")  128.68  (C-3"  
and C-5")  129.58 (C-6")  136.25 (C-4a")  138.53 (C-8a")  140.93 (C-l")  141.25  
(C-7")  171.15  (C-2).  -  MS:  m. r  (%)  -  350 (50) [M-],  332  (30)  [M*  -
H,0],  315 (10)  272 (7)  247 (25)  220 (70)  207 (100)  205 (58)  192 (30)  191  
(30)  179  (35), 165  (38).  
CJJHMOJ  (350.4)  Calcd.  C  78.82  H  7.48  Found  C 78.95  H  7.28  
(4R.6RJ'RS)-4-Hydroxy-[2-t  l,2J,4-tetrahydro-7rphenyl-l-naphthyl)-
ethylJ-3.4Jj6-tetrahydro-2H-pyran-2-one (181): Yield 0.20 g (93%) light yellow 
oil.  -  TLC  (EtOAc/hexane.  4:1):  R,  =  0.48.  -  IR  (film): v  -  3460 cm"'  
(OH),  1725 (CO).  -  'H  NMR (CDClj): 8  =  1.79 (m, 10H, 5CHJ,  2.65 (m, 
2H, CH,)  2.77 (m, 2H, CHJ,  2.8 (br. s, 1H, OH)  2.87 (m, 1H, CH)  4.15  (m,  
2H, 2OCH)  7.12 (d, J  =  8 Hz, 1H, aromatic H) 7.2-7.6 (m, 7H, aromatic 
H).  -  l3C NMR (CDClj) 8  -  19.92 (C-3"), 27.58 (C-2") 29.34 (C-4"), 31.85 
(C-l')  33.29 (C-2")  37.56 (C-l")  37.82 (C-5)  39.52 (C-3)  63.74  (C-4),  77.63  
(C-6),  124.58  (C-8"),  127.01  (C-4")  128.71  (C-3"  and  C-5"),  129.61  (C-6")  
136.34 (C-4a")  138.68 (C-8a"),  140.84 (C-l"),  141.37 (C-7")  170.86 (C-2).  -
MS: m/2 (%)  -  350 (25) [M~].  332 (21) [M*  -  HjO],  315 (5)  272 (5) 247 
(6)  220 (90) 207 (100), 205 (78)  192 (28)  191 (30)  179 (38)  165 (40). 
CJJHBOJ  (350.4)  Calcd.  C  78.82  H  7.48  Found  C 78.57  H 7.31 
Isolation  and  Assay  of  HMG-CoA  Reductase:  Microsomes  were  
prepared  from livers  of rats that  had  been maintained  on rat  chow-
containing  cholestyramine  for  7 d.  HMG-CoA  reductase  was  sol-
ubilized  from  the  microsomes  according  to  the  method  of  Heller  
and  Schrewsberg'31' and  purified by means  of the method  of  Klein-
sek  et  al'32).  The  enzyme  assay  was  accomplished  according  to  the  
method  of Alberts et al"9', which was slightly modified. Before assay, 
the compounds were converted  into their ring-opened sodium  dihy-
droxycarboxylate  salts and  then  were  incubated  with  4.7 pg  of  en-
zyme (specific activity  18 nmol • min~'  • mg~'),  50 pM of  14C-HMG-
CoA  (specific activity  2.71 mCi/mmol), 2  pM  of NADPH  in  160 mM 
of  potassium  phosphate  puffer  at  37  "~C for  20  min.  After  the  iso-
lation and determination  of radioactive  mevalonate, the IC»  values  
of  the  compounds  were  calculated  on  the  basis  of  their  percent  
inhibitions.  Mevinolin  was  used  as  reference  compound,  its  I C »  
value  was  9.1 • 10"9 M. 
CAS  Registry  Numbers  
2a :  137847-53-1  /  2b  (isomer  1):  137847-67-7  /  2b  (isomer  2):  
137847-93-9  /  2c:  137847-95-1  /  "2d  (isomer  1):  137847-97-3  /  2d  
(isomer  2):  137848-25-0  2e  (isomer  1):  137848-08-9  /  2e  (isomer  
2):  137848-18-1  '2f(isomer  1): 137848-10-3/2f  (isomer 2):  137848-
20-5 / 3 a :  137847-54-2 / 3 b :  137847-99-2 / 5:121980-45-8 /  6:  7250-
55-7  /  7a:  112904-68-4  7b:  90613-44-8  /  7d:  112904-67-3  /  7e:  
137847-71-3  8a:  109744-49-2  /  8b:  26432-16-6 /  8c:  87118-53-4  /  
8d:  112904-71-9  /  9:  119136-74-2  /  10a:  529-34-0  /  10b:  13185-
18-7 /  10c: 6836-19-7 /  lOd: 41526-73-2 /11:4071-88-9  /  12a:  867-
13-0  /  12b:  1067-74-9  /  13a:  94834-50-1  ./ 13b:  94834-49-8  /  13c:  
137847-77-9  .  13d:  54125-45-0  /  13e:  137895-06-8  /  13f:  137847-
74-6  /  13g:  137847-78-0  13h:  137847-72-4  /  13 i:  137847-73-5  /  
13j:  137847-79-1  /  13k:  137847-75-7  /  131:  137847-76-8  /  13m:  
137847-80-4  (£)-14a:  137847-55-3  /  (Z)-14a:  137847-81-5  /  14b:  
137847-82-6  /  14c:  4725-34-2  /  14d:  137847-83-7  /  14e:  137847-
84-8  /  14f:  137847-85-9  /  15a:  137847-56-4  /  15b:  137868-48-5  /  
15c:  137847-86-0  /  15d:  137868-49-6  /  15e:  137868-50-9  /  15f:  
137847-87-1 /  16a:  137847-57-5 /  16b (isomer  1): 137940-78-4 /  16b  
(isomer 2): 137847-88-2 / 16c: 137847-89-3 /  16d (isomer  1): 137940-
82-0 /  16d (isomer  2): 137939-86-7 /  17a:  137847-58-6 /  17b (isomer 
1):  137940-81-9  /  17b (isomer  2):  137939-72-1  /  17c:  137847-90-6  /  
17d  (isomer  1):  137847-91-7  /  17d  (isomer  2):  137940-84-2  /  18a:  
137847-59-7 /  18b  (isomer  1):  137847-94-0 /  18b  (isomer  2):  137848-
11-4 /  18c:  137847-96-2 /  18d (isomer  1): 137847-98-4 /  18d (isomer 
2):  137848-26-1  /  18e  (isomer  1):  137848-09-0  /  18e  (isomer  2):  
137848-19-2 / 1 8 f  (isomer  1):  137848-21-6 /  18f (isomer  2):  137848-
22-7 /  19a: 137847-60-0 /19b :  137848-01-2 / 20a (isomer  1): 137847-
61-1 /  20a  (isomer  2):  137868-51-0  /  20b  (isomer  1): 137848-02-3  /  
20b  (isomer  2):  137848-12-5  /  20c  (isomer  1):  137848-03-4  /  20c  
(isomer 2):  137848-13-6 / 20d (isomer  1): 137848-04-5 /  20d  (isomer  
2):  137848-14-7  /  21a  (isomer  1):  137847-62-2  /  21a  (isomer  2):  
137939-74-3 / 21a (isomer  3): 137939-75-4 /  21a (isomer 4):  137939-
76-5 /  21b (isomer  1):  137940-83-1  /  21b  (isomer  2):  137939-80-1  /  
21b  (isomer  3):  137939-81-2  /  21b  (isomer  4):  137939-82-3  /  21c  
(isomer  1): 137868-35-0 / 21c (isomer 2):  137848-15-8 /  21 d  (isomer  
1):  137848-07-8  /  21d  (isomer  2):  137848-16-9  /  22a  (isomer  1):  
137939-76-9 / 22a (isomer 2): 137939-77-6 /  22a (isomer  3): 137939-
78-7 /  22a  (isomer  4):  137939-79-8  /  22b  (isomer  1):  137848-05-6  /  
22b  (isomer  2):  137939-83-4  /  22b  (isomer  3):  137939-84-5  /  22b  
(isomer 4):  137939-85-6 / 22c (isomer  1): 137848-06-7 /  22c  (isomer  
2):  137895-05-7  /  22d  (isomer  1):  137939-73-2  /  22d  (isomer  2):  
137848-17-0  /  23:  530-93-8  /  24a:  41791-31-5  /  24b:  137939-71-0  /  
24c:  2876-71-3  /  25a:  63626-01-7  /  25b:  1485-07-0 /  26a:  137847-
63-3 /  26b: 2086-62-6 / 27a:  137847-64-4 / 27b:  137915-27-6 /  28a:  
137847-65-5 /  28b:  137847-92-8  /  29a:  137847-66-6  /  29b:  137848-
00-1 /  HGM-CoA  reductase:  9028-35-7 /  methyl  (3R,lR>3-[(tert-bu-
tyldimethylsilyl)oxy]-4-[N-( 1 '-phenylethyl)carbamoyl]butyrate: 
137847-68-8  /  (R)-l-phcnylethylamine:  9131-70-1  /  methyl  tert-bu-
tyldimethylsilyl  3-[(tert-butyldimethylsilyl)oxy]glutarate:  91424-
35-0  /  methyl  (3R,1 'R)-3-acetoxy-4-[N-(l '-phenylethyl)carbamoyl]-
butyrate:  137847-69-9 / methyl (3R,1 'R)-3-(methoxymethoxy)-4-[N-
(l'-phenylethyl)carbamoyl]butyrate:  137847-70-2 /  methyl  (3S,1'R)-
3-[(teri-butyldimethylsilyl)oxy]-4-[N-(r-phenylethyl)carbamoyl]bu-
tyrate:  137848-23-8  /  methyl  (3S,l'R)-3-(methoxymethyl)-4-[N-(l'-
phenylethyl)carbamoyl]butyrate:  137848-24-9  
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Synthesis and lipase-catalyzed asymmetric acetylation of 3-hydroxy-
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Abstract:  Prochiral  dialkylacetal  derivatives  of  3-hydroxy-2-hydroxymethylpropanal  
6a-e  were  synthesized  from  the  corresponding  2-substituted  diethyl  malonates  5a-e  
and  subjected  to  asymmetric  enzymatic  acetylation.  The  diethyl  malonates  5a-f  were  
prepared  from  diethyl  chloromethylenemalonate  3  by  using  either  a  one-  or  a  two-step  
process. Asymmetric  acetylation of 3-hydroxy-2-hydroxymethylpropanal  diethyl acetal 6b 
with several  enzymes  was  studied  first, showing  the highest  enantiotopic  selectivity  with  
lipase  from Pseudomonas ftuorescens (PfL). Solvent effect was also  investigated:  the best 
selectivity  was  obtained  in  a  mixture  of  hexane  and  diethyl  ether.  Furthermore,  several  
other  acetals  6a-e  were  also  tested  under  the  optimal  acetylation  conditions.  ©  1997  
Elsevier  Science  Ltd.  All rights reserved. 
Optically  active  C3  building  blocks  are  of  continuously  raising  interest  both  in  the  manufacture  of  
commercial  products and  in the research  of  biochemical  processes.  Products arising from  asymmetric  
functionalization  of  3-hydroxy-2-hydroxymethylpropanal  dialkylacetals  6a - e  can  be  favorably  used  
as  multifunctional building  blocks  due  to  their  three  sites  of  different  reactivity.  
Diethyl  ethoxymethylenemalonate  1  is  a  commercially  available  compound  and  can  be  converted  
to the desired  acetals 6 a - e  conveniently  in  reaction  sequences  which  manifest  sometimes  unexpected  
behaviour  (Scheme  1).  Since  charge  distribution  on  the  <x-  and  /¡-carbon  centers  adjacent  to  the  
ether  oxygen  atom  in  the  vinyl  ether  type  compound  diethyl  ethoxymethylenemalonate  1 is  opposite  
to  the  normal  vinyl  ethers,  preparation  of  diethyl  formylmalonate  by  the  generally  applied  acid-
catalyzed  methods  failed.  The  desired  reaction,  however,  could  be  carried  out  in  aqueous  NaOH  
solution1  smoothly. Diethyl formylmalonate exists,  in accordance with  previous results, exclusively  in  
its enolic  form (i.e. diethyl  hydroxymethylenemalonate,  2. The  close  similarity  of charge  distribution  
on  C]  and  C2  of  this  enolic  compound  2  to  those  of  its  parent  vinyl  ether  1  may  also  rationalize  
why  traditional  acid-catalyzed  acetal  formation cannot  be applied for further transformations.  Diethyl  
ethoxymethylenemalonate 1, however, can be directly converted into diethyl  (diethoxy)methylmalonate  
5b  under  basic conditions, e.g.  by  using sodium  ethylate2,3  or sodium4  in  ethanol.  Similarly,  diethyl  
ethoxymethylenemalonate  1 was  transformed into  the corresponding dimethylacetal  dimethylester  by  
base-catalyzed  reaction  in  methanol.5  Since  general  methods  for  the  preparation  of  further  acetals  
were  needed,  we have chosen  the known  diethyl  chloromethylenemalonate  36 ,  obtained  from  diethyl  
hydroxymethylenemalonate  2 by a significantly improved method using thionyl chloride, as a  common  
precursor.  A  report  on  transformation  of  this  chloromethylene  derivative  3  with  an  alcohol  in  the  
presence of pyridine to the corresponding diethyl alkoxymethylenemalonate7  prompted us to prepare  a  
series of  such alkoxymethylene compounds 4 a - h  from  which  a mild base-catalyzed  alkoxide  addition  
yielded the desired acetals 5a - e smoothly. Bulkiness of the alcohol seems to play  a crucial role in  these 
*  Corresponding  author.  Email:  poppe@ch.bme.hu  
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addition  reactions:  rio-propoxide-,  terr-butoxide-  and  phenoxide-addition  cannot  be  accomplished.  
Attempted  preparation  of  methyl-phenyl  or  methyl-isopropyl  acetals  was  also  unsuccessful  either  
from diethyl  methoxymethylenemalonate  4a  or f rom diethyl  (/ 'jo-propyloxy)methylenemalonate  4g  or  
diethyl phenoxymethylenemalonate4h  with  the corresponding  alcohol. Alternatively,  acetals 5 a - e  can  
be  obtained  directly  from  diethyl  chloromethylenemalonate  3  in  a  one-pot  reaction  by  using  a  slight  
excess  (1.1-1.3  equiv.)  of  sodium  hydride  in  the  corresponding  alcohol.  Cyclic  acetal  5c,  however,  
could  only  be prepared  by  the one-pot  method.  Reduction  of diester  acetals 5a - e  by  lithium  aluminum  
hydride  yielded  the  acetal  derivatives  of  3-hydroxy-2-hydroxymethylpropanal  6a-e .  Unfortunately,  
the  diallyl  acetal  5f  decomposed  during  this  reduction.  
E t O O C ^ COOEt 
OH 
L) EtOOi 
EtOOO^COOEt 
X 
a.) 
UL) 
OR 
4a-h 
COOEt 
a 
iv.) 
E t O C X / . COOEt 
RO  OR  
5a-f 
v.; HO  Y  OH  
RO  OR  
6a-e 
4-6 R 
a -CH3 
b -CH2CH3 
c -CH2OH2" 
d -CH2C6H5 
e -CH2CH2CH(CH3)2 
f -CH2CH=CH2 
g -CH(CH3)2 
h -C5H5 
Reagents:  L)  SOCL,.  DMF;  ii). ROH.  pyridine:  uLJ  ROH. cat.  Na;  iv.) ROH,  1.3 equiv.  NaH;  v.)  LiAlH,.  
R Reaction  iit)  Reaction  iv.)  Reaction  v.)  Reaction  vL)  
4,  Yield % 5,  Yield % 5.  Yield  %  6,  Yield  % 
|  a,  methyl- 95 87 92 86 
fa, ethyl 96 90 93 92 
c,  1,2- - - 94 37 
ethenyl-
d,  benzyl- 95 80 80 82 
e,  i-amyl- 95 86 89 74 
f,  allyl- 94 85 77 decomposition  |  
g,  i-propyl- 95 no  reaction  no  reaction  -
h,  phenyl- 91 no  reaction  no  reaction  -
Scheme  1.  Preparation  of  3-hydroxy-2-hydroxymethylpropanal  acetals  6a-e.  
After having the desired  prochiral  diols 6 a - e  in our  hands,  first we  tested  the asymmetric  acetylation  
of  3-hydroxy-2-hydroxymethylpropanal  diethylacetal  6b  with  vinyl  acetate  in  hexane  using  various  
enzymes  (Table  1).  
Since  the  highest  selectivity  was  achieved  with  PfL,  this  enzyme  was  chosen  for  further  studies.  
Next,  the  solvent  effect on  enantiotopic  selectivity  of  this  PfL-catalyzed  acetylation  was  investigated  
(Table  2).  
Interestingly,  no  correlation  between  the  polarity  of  the  solvent  and  the  enantiotopic  selectivity  of  
the  enzyme  was  found. Trace  water  content  of  the  solvent  also  seems  to  have  no  significant  influence  
on  the  selectivity,  and  in  the  protic  rerr-butanol  no  reaction  occurred.  Since  the  best  enantiotopic  
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Table  1.  Acetylation  of  3-hydroxy-2-hydroxymethylpropanal  diethylacetal  6b  with  various  enzymes  
HO'  " Y ^ ^ O H  enzyme  H O ^ V ^ O A c  
EtO  OEt  CH^CHOAc  
6b 
Enzyme' Time6 Yield eec 
(mg) (h) (%) (%) 
PfL (10) 8 71.7 66 
PPL (30)  120 78.2 17 
CcL  (30)  120 74.9 57 
PLE  (50)  120 75.5 52 
MjL (10) 170 - -
RaL  (10)  170 - -
Lipase-PS  (10)  8 66 60 
Lipase-AK  (10)  8 57 57 
'  PfL: lipase  from  Pseudomonas  fluorescens.  PPL: l ipase  from porcine  pancreas ,  CcL:  l ipase  
f rom  Candida  cylindracea.  PLE:  pig  Uver  acetone  powder.  MjL:  lipase  from  Mucor  
Javonicus,  RaL:  l ipase  from  Rhisopus  arrhisus;  * 200  mg  of  acetal 6b  was  st irred  with  the  
enzyme  in  vinyl  aceta te  (2  ml)  at  RT;  c  Enant iomeric  excess  va lues  were  determined  by  
us ing  'H-NMR spec t ra  of (S)-MTPA-ester  of 7b. 
Table  2.  Acetylation  of  3-hydroxy-2-hydroxymethylpropanal  diethylacetal  6b  by  PfL  in  various  solvents  
Solvent Time' Yield ee 
(h) (%) (%) 
hexane 10 95 68 
hexane  : Et^O (1  :  1)  10 85 71 
hexane  : (i-Pr)20  ( 1 : 1 )  10 93 69 
CC14 10 90 48 
toluene 20 94 68 
tetrahydrofuran 20 69 62 
acetonitrile 20 84 69 
t-butanol 10 - -
hexane  : (¿-Pr20)  : H20 20 83 69 
1 (1  :  1  : 0.002) 
' 6b  (200  mg) a n d  PfL (10  mg) were  stirred  In the  given  solvent  (2  ml) a n d  vinyl acetate  (0.25  ml)  
selectivity  was  achieved  in  the  mixture  of  hexane  and  diethyl  ether,  this  solvent  mixture  was  applied  
in  the  further  studies.  
After studying  the factors influencing the enantiotopic  selectivity  of acetylation  of the prochiral  diol  
6b,  absolute  configuration  of  the  monoacetate  product  7b  was  determined  by  chemical  correlation  
(Scheme  2).  The  reaction  sequence  leading  to  the  known  (/?)-(-)-3-benzyloxy-2-methylpropanal  
(/?)-ll8 '9 ,  via  mesylation,  reduction  of  the  mesylate,  benzylation  and  hydrolysis,  starting  from  the  
monoacetate  7b  proved  its  (^-configuration.  
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7b 
i.) a.)  |  iiL>  
EtO  OEt  
(R)-9 
OBn 
EtO'  "OEt  
(fl)-lO 
iv.) OBn 
Scheme  2.  Determination  of  the  absolute  configuration  of  the  optically  active  monoacetate  7b.  Reagents:  i.)  MsCl,  Et3N;  
ii.)  LiAlH4;  iii.)  BnCl,  NaH;  iv.)  cat.  HC1,  A c 0 H - H 2 0 .  
Table  3.  Acetylation  of  prochiral  diols  having  various  acetal-type  substitueras  6a-d  
HO  OH  
RO  OR  
6a-d 
PfL 
Cb/CHOAc 
R Time
 a  Yield [a]Db [alo100*  b c 
ee 
(h) (%) (%) 
a,  methyl- 12 46 +4.1 +9.4 44" 
b,  ethyl- 10 85 +4.9 +7.0 71 
c,  1,2-ethenyl- 7 38 +0.3 - - 0 
d,  benzyl- 21 92 +7.4 + 10.5 70  d  
e,  i-amyl- 24 70 +3.7 +5.5 68  d  
" 200  mg  of  6a-e,  PfL  (10  mg),  and  vinyl  acetate  (0,25  ml)  in  hexane:diethyl  e ther  1:1  (2  ml)  was  
stirred  at  KT;  " c=l ,  acetone;c  extrapolated  values  calculated  from specific rotation  of 6a-e and  from  
the  corresponding  enantiomeric  excess values  obtained  from  'H-NMR spectra  of MTPA-esters  of  the  
monoacetates;  '  absolute  configuration  is assumed  to be  (R) by analogy with  that  of  7b.  
Finally,  several  prochiral  diols  with acetal-type  2-substituents 6a-e  were  acetylated  using PfL  under  
the  optimum  conditions  (Table  3).  Within  this  series,  (^-configuration  was  assigned  to  all  optically  
active products  7a,b,d,e,  based  on the analogous manner  of the enzymatic acetylations  and  on the  same  
signs  of  the  specific  rotations  of  the  products. The  lipase-catalyzed  reaction  yielding  monoacetate  7b  
with  e.e.  of  71% from the diethyl  acetal  6b  proceeded  with  the highest  enantiotopic  selectivity.  While  
di-i-amyl  and  dibenzyl  acetals 6d,e  gave similarly  good  results  (68  and  70% e.e.,  respectively),  only  a  
modest  enantiotopic  selectivity  was found  in acetylation  of  the dimethyl  acetal  6a,  and almost  racemic  
product  7c  was  obtained  from  the  cyclic  acetal  6c.  The  bulkiness  of  the  acetal-type  2-substituent  
seems  to  be  decisive  for  the enantiotopic  selectivity:  the  small  substituents  gave  poor results,  the  best  
selectivity  was  manifested  with  the  medium-size  diethyl  acetal.  Further  increase  of  the  bulkiness  of  
the  acetal  moiety,  however,  did  not  increase  the  selectivity.  
In  summary,  it  may  be  concluded  that  the  enzymatic  acetylation  of  the  prochiral  3-hydroxy-2-
hydroxymethylpropanal  acetals  6a-e  is  a  convenient  method  for  the  preparation  of  optically  active  
acetals  of  3-acetoxy-2-hydroxymethyl-propanal  7a-e,  which  may  serve  as  multifunctional  chiral  
building blocks. The highest enantiotopic selectivities  were  obtained  with  diethyl  and dibenzyl  acetals,  
6b and  6e respectively, using lipase from Pseudomonasfluorescens  (PfL) and vinyl acetate  in  a mixture 
of  hexane  and  diethyl  ether.  Among  the  optically  active  acetals  7a-e,  the  dibenzyl  acetal  7e,  whose  
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acetal  moiety  can  be  manipulated  both  by  acid-catalysis  and  catalytic  hydrogénation,  may  have  the  
highest  synthetic  value.  
Experimental 
The  'H-NMR  spectra  were  recorded  on  a  Bruker  WM-250  spectrometer  operating  at  250  MHz.  
Enantiomeric  excess  values  were  determined  by  'H-NMR  spectroscopy  at  500  MHz  on  a  Bruker  
DRX-500 spectrometer. All NMR spectra were measured  in CDCI3  solution and chemical shift values 
are  expressed  in  ppm  values from TMS  as  internal  standard  on  the  Ô scale.  IR  spectra  of  thin  film  
samples  were  taken  on  a  Specord  2000  spectrometer.  Optical  rotations  were  determined  on  a  Perkin  
Elmer  241  polarimeter.  Thin  layer  chromatography  was  carried  out  using  Merck  Kieselgel  60  F254  
alumina  sheets  applying hexane:acetone  10:4 mixture  for elution.  Spots  were  visualized  by  treatment  
with 5% ethanolic phosphomolybdic acid solution and heating of the dried plates. Preparative  vacuum-
chromatography10  was  performed  using  Merck  Kieselgel  60  F254.  Porcine  pancreatic  lipase  (PPL,  
Type II) was obtained  from Sigma. Lipases from Candida  rugosa  (cylindracea)  (CcL),  Pseudomonas  
fiuorescens (PfL), Aspergillus niger (AnL), Mucor javonicus  (MjL), Rhisopus arrhisus (RaL), esterase 
from  pig  liver (PLE,  acetone powder), diethyl  ethoxymethylenemalonate,  acetic  anhydride,  and  vinyl  
acetate  were  products  of  Fluka. Lipase  PS  and Lipase  AK  were  gifts from Amano.  All  solvents  used  
were freshly  distilled.  
Diethyl chloromethylenemalonate 3 
To  a  solution  of  diethyl  hydroxymethylenemalonate  (2,  29.4  g,  157  mmol)  and  N,N-
dimethylformamide  (0.5  ml)  in  toluene  (200  ml)  thionyl  chloride  (12.6  ml,  173  mmol)  was  added  
dropwise.  The  reaction  mixture  was  heated  under  reflux  until  gas  evolution  ceased.  After  removal  
of  the  solvent  by  rotary  evaporation,  the  residue  was  distilled  in  vacuo  yielding  24.7  g  (77%)  of  
a  colorless  oil  with  characteristic  odor.  Bp:  64°C  (0.2  Torr);  1 H-NMR:  1.29  (t,  3H,  CH3),  1.34  (t,  
3H, CH3),  4.26  (q,  2H,  OCH2),  4.37  (q,  2H,  OCH2),  7.47  (s,  1H,  =CH-C1);  IR:  3080,  2980,  1740,  
1610,  1460,  1450,  1370,  1330,  1250,  1210,  1100,  1070,  1020,  910,  870,  840,  750 cm" 1 ;  Calcd.  for  
C8HH04C1:  C 46.50,  H 5.37; found C 46.69,  H  5.38.  
Preparation of diethyl alkoxymethylenemalonates  4a-h 
General procedure 
Diethyl  chloromethylenemalonate  (3,  2.07  g,  10.0  mmol)  and  pyridine  (1  ml)  was  added  to  the  
corresponding  alcohol  (20  ml)  and  the  resulting  solution  was  stirred  at  RT  for  15  minutes.  After,  
removal  of  the  excess  alcohol  by  rotary  evaporation,  the residue  was  acidified  with  5%  HC1 (10 ml)  
and  extracted  with  dichloromethane (3x10  ml). The  combined  dichloromethane  extracts  were  dried  
over Na2S04  and  concentrated  in  vacuum  leaving  a  colorless  oil  which  was  purified  by  preparative  
vacuum-chromatography  using hexane:acetone  10:1  as  eluent.  
Diethyl methoxymethylenemalonate 4a 
Yield: 95%. 1H-NMR : 1.31 (t, 3H, CH3),  1.36 (t, 3H, CH3),  4.01 (s, 3H, OCH3), 4.15-4.23 (m, 4H, 
2  OCH2),  7.55  (s,  1H, =CH-0) ;  IR:  2980,  1730,  1640,  1450,  1400,  1380,  1280,  1210,  1140,  1090,  
1020,970,  860,770 c m - 1 ;  Calcd.  for C9H14O5:  C  53.46,  H 6.98;  found  C 53.26,  H  6.96.  
Diethyl ethoxymethylenemalonate 4b 
Yield: 96%. 1 H-NMR  and  IR  spectra were  in  accordance  with  the  literature1 '.  
Diethyl benzyloxymethylenemalonate 4d 
Yield:  95%.  1 H-NMR:  1.28  (t,  3H,  CH3),  1.33  (t,  3H,  CH3),  4.08^1.45  (m,  4H,  2  OCH2),  4.69  
(s,  2H,  OCH2Ph),  7.25-7.50 (m,  5H, ArH),  7.62  (s,  1H, =CH-0) ;  IR:  3500 (br), 2980,  1730,  1630,  
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1500,1460,1370,1290,1150,1090,1020,910,860,740,  700 cm" 1 ;  Calcd. for.CisHigOs:  C  64.74,  
H  6.52; found  C 64.63,  H  6.54.  
Diethyl (i-amyloxy)methylenemalonate 4e 
Yield:  95%.  1H-NMR:  0.94  (d,  6H,  2  CH3),  1.30  (t,  3H,  CH3),  1.34  (t,  3H,  CH3),  1.30-1.79  (m,  
3H, CH  and CH2),  4.10-4.43  (m,  6H,  3 OCH2),  7.60 (s,  1H, = C H - 0 ) ;  IR:  2960,  1730,  1630,  1470,  
1380,1290,1180,1090,1030,960,860,  800 c m - 1 ;  Calcd. for C i 3 H 2 2 0 5 :  C 60.45,  H  8.58; found  C  
60.20,  H  8.55.  
Diethyl allyloxymethylenemalonate 4f 
Yield: 94%. 1 H-NMR:  1.30 (t, 3H, CH3),  1.33 (t, 3H, CH3), 4.18-4.40  (m, 4H, 2 OCH2),  4.62  (mc,  
2H,  OCH2),  5.37  (mc,  2H,  =CH2) ,  5.93  (mc,  1H, =CH-) ,  7.60  (s,  1H, = C H - 0 ) ;  IR:  2980,  1730,  
1640,  1590,  1490,  1380,  1250,  1200,  1170,  1080,  1020,  760,  690  cm" 1 ;  Calcd.  for C n H i 6 0 5 :  C  
57.89,  H 7.07;  found C  58.10,  H  7.09.  
Diethyl (i-prvpyloxy)methylenemalonate 4g 
Yield: 95%.  1 H-NMR:  1.20-1.44  (m,  12H,  4 CH3),  4.1-4.3  (m,  5H,  2  OCH2,  OCH),  7.66  (s,  1H,  
= C H - 0 ) ;  IR:  2980,  1730,  1630,  1470,  1450,  1380,  1290,  1250,  1190,  1140,  1100,  1030,  920,  850,  
790 c m - 1 ;  Calcd. for CnHigOs:  C  57.38,  H  7.88; found C  57.62,  H  7.90.  
Diethyl phenyloxymethylenemalonate 4h 
Yield: 91%. 1 H-NMR:  1.31 (t, 3H, CH3),  1.37 (t, 3H, CH3), 4.20-4.43 (ms, 4H, 2 OCH2),  7.10-7.48  
(m,  5H,  ArH),  7.89  (s,  1H, =CH-0 ) ;  IR:  2980,  1730,  1630,  1470,  1450,  1370,  1280,  1240,  1180,  
1090,1030,970,940,860,  770 cm" 1 ;  Calcd. f o r C i 4 H i 6 0 5 :  C 63.63, H 6.10; found C 63.37, H  6.12.  
Diethyl dialkoxymethylmalonates 5a-f from diethyl alkoxymethylenemalonates 4a—f 
General procedure 
To  a  solution  of  diethyl  alkoxymethylenemalonate  (4a-f,  10 mmol)  in  the  corresponding  alcohol  
(ca. 5 mmol) catalytic amount  (ca.  15 mg) of sodium was added and the resulting solution  was  stirred  
at 50°C for 30 minutes. After removal of the excess alcohol by rotary evaporator, 5% hydrochloric acid 
(5 ml)  was  added  and  the  resulting  mixture  was  extracted  with  chloroform (3x5  ml).  The  combined  
chloroform  extracts  were  dried  over Na 2 S0 4  and  the  solvent  was  evaporated  in  vacuo.  The  residue  
was  purified by  preparative  vacuum-chromatography  using  hexane:acetone  10:1  as eluent  resulting  a  
colorless  oil.  
Diethyl dimethoxymethylmalonate 5a 
Yield:  87%.  1 H-NMR:  1.29  (t,  6H,  2 CH3),  3.43  (s,  6H,  2  OCH3),  3.74  (d,  CH),  4.22  (q,  4H,  2  
OCH2),  5.00  (d,  1H, O-CH-O);  IR:  2980,  2840,  1740,  1610,  1450,  1370,  1310,  1230,  1180,  1090,  
1040, 950,  910,  860 cm" 1 ;  Calcd.  for CioHigOe:  C  51.27,  H  7.75;  found C 51.14,  H  7.77.  
Diethyl diethoxymethylmalonate 5b 
Yield: 90%. 1 H-NMR  and  IR  spectra were  in  accordance  with  the  literature.  
Diethyl dibenzyloxymethylmalonate 5d 
Yield: 80%. 1 H-NMR:  1.23 (t,  6H,  2 OCH3),  3.91  (d,  1H, CH),  4.18  (q,  4H,  2 OCH2),  4.66  (dd,  
4H,  2  OCH2Ph),  5.40  (d,  1H, O-CH-O),  7.2-7.4  (m,  10H,  Ar);  IR:  3030,  2980,  2940,  1750,  1740,  
1500,  1450,  1370,  1310,  1100,  1060,  1030, 910,  860,  740 cm" 1 ;  Calcd.  for C 2 2 H 2 6 06:  C  68.38,  H  
6.78; found  C 68.09,  H  6.76.  
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Diethyl (di-i-amyloxy)methylmalonate 5e 
Yield:  86%.  1H-NMR:  0.86  (d,  12H,  4  CH3) ,  1.15-1.72  (m,  12H,  2  CH,  2  CH3  and  2  CH2),  
3.45-3.78  (m, 5H, CH and  2 OCH2),  4.18  (q, 4H,  2 OCH2) ,  5.09  (d,  1H, O-CH-O);  IR:  2960,  2870,  
1740,  1640,  1470,  1370,  1310,  1180,  1140,  1100,  1070,  1030,  860 c m - 1 ;  Calcd.  for C i 8 H 3 40 6 :  C  
62.40,  H  9.89; found C 62.28,  H  6.43.  
Diethyl diallyloxymethylmalonate 5f 
Yield: 85%.1 H-NMR:  1.32 (t, 6H, 2CH3), 3.80 (m,  1H, CH), 4.07-4.35 (m, 8H, 4 OCH2),  5.15-5.43  
(m,  5H,  2  =CH 2  and  O-CH-O),  5.90  (in,  2H,  2  = C H - ) ;  Calcd.  for C i 4 H 2 2 0 6 :  C  58.73,  H  7.74;  
found  C  58.84,  H  7.71.  
Diethyl dialkoxymethylmalonates 5a-f from diethyl chloromethylenemalonate 3 
General procedure 
To a solution of diethyl chloromethylenemalonate (3, 3.1 g,  15.0 mmol) in the corresponding  alcohol  
(15 ml) sodium hydride (0.48 g, 20.0 mmol) was added at 0°C and the resulting mixture was stirred for 
30 minutes.  After removal  of  the excess  alcohol  by  rotary  evaporator,  the  residue  was  neutralized  by  
addition  of  5%  hydrochloric  acid,  diluted  by  water  (10  ml)  and  extracted  with chloroform (3x5  ml).  
The  combined  chloroform  extracts  were  dried  over N a 2 S 0 4  and  concentrated.  Usually,  the  product  
was  used  in the  next reduction  step as such. Analytical  samples  were purified by preparative  vacuum-
chromatography  with  hexane:acetone  10:1  as  eluent.  
Diethyl dialkoxymethylmalonates 5a,b,d-f 
For  yields:  see  table  in  Scheme  1; for analytical  data:  see  the  preceding  section.  
Diethyl (1,3-dioxolan-2-yl)malonate 5c 
Yield:  94%.  1 H-NMR:  Ml  (t,  6H,  2  CH3),  3.68-3.83  (ms,  5H,  CH  and 0 C H 2 - C H 2 0 ) ,  4.21  (q,  
4H,  2  OCH2),  5.08  (d,  1H, O-CH-O);  IR:  3650,  2970,  2840,  1740,  1730,  1620,  1450,  1440,  1370,  
1300,  1230,  1180,  1170,  1080,  1040,  940,  920,  860,  750 c m " 1 ;  Calcd.  for C I O H I 6 0 6 :  C  51.72,  H  
6.94; found C 51.93,  H  6.93.  
Reduction of the diethyl dialkoxymethylmalonates 5a-e 
General procedure 
To  a  suspension  of  lithium  aluminum  hydride  (0.95  g,  25  mmol)  in  dry  tetrahydrofurane (30  ml)  
a  solution  of  the  diethyl  dialkoxymethylmalonate  (5a-e,  10.0  mmol)  in  dry  tetrahydrofurane  (10.0  
ml)  was  added  dropwise  and  the  reaction  mixture  was  heated  under  reflux for  1 hour. After  cooling,  
the  reaction  mixture  was  quenched  by careful addition  of  water  (5  ml)  and  the  resulting  suspension  
was  diluted  with  ethyl  acetate  (25 ml). The precipitate  was  filtered off and  the  filtrate was  dried  over  
N a 2 S 0 4  and  concentrated  by  rotary  evaporation.  The  residue  was  purified  by  preparative  vacuum-
chromatography  with  hexane:acetone  10:3 as  eluent.  
3-Hydroxy-2-hydroxymethylpropanal dimethyl acetal 6a 
Yield:  86%.  1 H-NMR:  2.03  (m,  1H, CH),  3.42  (s,  6H,  2  OCH3),  3.77  (m,  4H,  2  OCH2),  4.48  (d,  
1H,  O-CH-O);  IR:  3400  (br),  2940,  2840,  1650,  1460,  1390,  1270,  1190,  1130 c m " 1 ;  Calcd.  for  
C 6 H I 4 0 4 :  C 47.99,  H  9.40; found C 48.16,  H  9.43.  
3-Hydroxy-2-hydroxymethylpropanal diethyl acetal 6b 
Yield: 92%. 1 H-NMR:  1.15 (t,  6H,  2 CH3),  1.93 (m,  1H, CH),  3.46 and  3.67 (2 m,  4H,  2  OCH2),  
3.70 (m,  4H,  2 OCH2),  4.54  (d,  1H, O-CH-O) ;  IR:  3390  (br),  2940,  2850,  1650,  1450,  1380,1270,  
1190,  1130,  1060, 970 cm" 1 ;  Calcd. for C 8 H i 8 0 4 :  C  53.91,  H  10.18; found C 53.80,  H  10.15.  
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3-Hydroxy-2-hydroxymethylpropanal 1,2-ethenyl acetal 6c 
Yield:  37%.  'H-NMR:  2.05 (m,  1H, CH), 3.75-4.03 (m,  8H, 4 OCH2),  4.95 (d,  1H, O-CH-O);  IR:  
3380 (br), 2950, 2890,1470,1400,1240,  1150,1030,950,920 c m - 1 ;  Caled, for C 6 H i 2 0 4 :  C  48.64,  
H  8.16; found  C  48.75,  H  8.18.  
3-Hydroxy-2-hydroxymethylpropanal dibenzyl acetal 6d 
Yield:  82%.  'H-NMR:  2.10  (m,  1H,  CH),  3.77  (m(d),  4H,  2  OCH2),  4.60  (dd,  4H,  2  OCH2Ph),  
4.81  (d,  1H, O-CH-O),  7.28  (m,  10H, ArH);  IR:  3370,  3030,  2930,  2870,  1950,  1500,  1450,  1400,  
1290,  1240,1210,  1140,  1040, 930, 740, 700 cm" 1 ;  Caled, for C i 8 H 2 2 0 4 :  C 71.50,  H  7.33; found  C  
71.78,  H  7.33.  
3-Hydroxy-2-h.ydroxymethylpropa.nal di-i-amyl acetal 6e 
Yield: 74%. 'H-NMR: 0.91 (d,  12H, 4CH3),  1.10-1.78 (m, 6H, 2 CH and 2 CH2), 2.09 (m,  1H, CH), 
3.39-3.80  (m,  8H,  4  OCH2),  4.61  (d,  1H, O-CH-O);  IR:  3370  (br),  2960,  2930,  2870,  1740,  1470,  
1370,1240,1110,1070,  800 cm" 1 ;  Caled, for C14H30O4:  C 64.09, H  11.52; found C 64.00, H  11.48.  
Acetylation of 3-hydroxy-2-hydroxymethylpropanal diethyl acetal 6b with various enzymes 
General procedure 
To  a  solution  of  3-hydroxy-2-hydroxymethylpropanal  diethyl  acetal  (6b,  200 mg)  in  vinyl  acetate  
(2 ml) enzyme  (for amount,  see Table  1) was  added and  the resulting suspension  was  stirred  at  room  
temperature  (for reaction  time,  see Table  1). After reaching  a reasonable  conversion  the enzyme  was  
filtered  off and the  filtrate  was concentrated by rotary evaporator. The residue was subjected to column 
chromatography using hexane:acetone 5:1 as eluant yielding pure  3-acetoxy-2-hydroxymethylpropanal  
diethyl  acetal  7b.  For yields and enantiomeric  composition,  see Table  1.  
Acetylation of 3-hydroxy-2-hydroxymethylpropanal diethyl acetal 6b in various solvents 
General  procedure:  3-Hydroxy-2-hydroxymethylpropanal  diethyl acetal (6b, 200 mg), vinyl  acetate  
(0.25  ml)  and  lipase  from  Pseudomonas  fluorescens  (10  mg)  were  added  to  the  solvent  (2  ml;  for  
solvents,  see  Table  2)  and  the  resulting  suspension  was  stirred  at  room  temperature.  Work  up  of  
the  products  was  carried  out  as  described  in  the  previous  section.  For  reaction  times,  yields,  and  
enantiomeric  composition,  see  Table  2.  
Acetylation of 3-hydroxy-2-hydroxymethylpropanal dialkyl acetals  6a-e  
General  procedure:  3-Hydroxy-2-hydroxymethylpropanal  dialkyl  acetal  (6a-e,  200  mg),  vinyl  
acetate (0.25 ml) and lipase from  Pseudomonas  fluorescens  (10 mg) were added to a mixture of  hexane 
and diethyl  ether (1 ml, each) and  the resulting  suspension  was stirred  at room  temperature. Work  up  
of the  product  was  carried  out  as described  in  the  previous  sections.  
3-Acetoxy-2-hydroxymethylpropanal dimethyl acetal 7a 
Yield: 46%. [a]D=+4.1,  (c=l,  acetone), e.e.%=44; ' H-NMR:  2.10 (s, 3H,  CH3), 2.16 (m,  1H, CH), 
3.43  (s,  3H,  .OCH3),  3.47  (s,  3H,  .OCH3),  3.72  (m(d),  2H,  OCH2),  4.04-4.27  (m,  2H,  AcOCH2),  
4.44  (d,  1H, O-CH-O);  IR:  3465  (br),  2940, 2830,  1740,  1470,  1370,  1240,  1190,  1130,  1040,  980  
cm" 1 ;  Caled,  for C 8 H i 6 0 5 :  C 49.99,  H  8.39; found  C 50.24,  H  8.27.  
3-Acetoxy-2-hydroxymethylpropanal diethyl acetal 7b 
Yield:  85%. [a]D=+4.9,  (c=l,  acetone),  e.e.%=71;  'H-NMR:  1.22 (t, 3H, CH3),  1.23 (t, 3H,  CH3),  
2.14  (s,  3H, CH3),  2.16  (m,  1H, CH),  3.51-3.57  (m,  2H,  OCH2),  3.67-3.80 (m,  4H,  2  OCH2),  4.14  
and 4.24 (2xdd, 2H, AcOCH2),  4.58 (d,  1H, O-CH-O);  IR: 3464 (br), 2980,2930,2900,  1740,1450,  
1370,  1240,  1110,  1060, 900 c m - 1 ;  Caled,  for C I 0 H 2 0 O 5 :  C 54.53,  H 9.15;  found C  54.22,  H  9.31.  
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3-Acetoxy-2-hydroxymethylpropanal 1,2-ethenyl acetal 7c 
Yield:  38%. [afo=+0.3, (c=l,  acetone);  1 H-NMR:  2.08  (m,  1H, CH),  2.12  (s,  3H, CH3),  3.73-4.15  
(m, 6H,  3  OCH2),  4.02^1.28  (m, 2H, AcOCH2),  4.91  (d,  1H, O-CH-O);  IR:  3450  (br), 2950,  2880,  
1730,  1470,  1390,  1240,  1150,  1040 cm" 1 ;  Calcd.  for C 8 H I 4 0 5 :  C  50.52,  H 7.42; found C  50.71,  H  
7.69. 
3-Acetoxy-2-hydroxymethylpropanal dibenzyl acetal 7d 
Yield: 92%. [a]D=+7.4,  (c=l,  acetone), e .e .%=70;1H-NMR : 1.92 (s, 3H, CH3),  2.40 (m,  1H, CH),  
3.74 (m, 2H, 0 -CH 2 ) , 4.00-4.29 (m, 2H, AcOCH2), 4.57 (dd, 4H, 2 OCH2Ph), 4.71 (d,  1H, O-CH-O), 
7.28 (m,  10H, ArH);  IR:  3470 (br), 2960, 2930,  1740,  1460,  1370,  1230,  1040, 740 cm" 1 ;  Calcd. for 
C 2 0 H 2 4 O 5 :  C  69.75, H  7.02;  found C 70.01,  H  7.19.  
3-Acetoxy-2-hydroxymethylpropanal di-i-amyl acetal 7e 
Yield: 7 0 % .  [ A ] D = + 3 . 7 ,  (c=l,  acetone), e . e . % = 6 8 ; 1 H-NMR: 0 . 9 0  (d,  1 2 H ,  4  C H 3 ) ,  1 . 1 0 - 1 . 7 8  (m,  
6 H ,  2  C H  a n d  2 C H 2 ) ,  2 . 0 4  ( s ,  3 H ,  C H 3 ) ,  2 . 1 1  ( m ,  1 H ,  C H ) ,  3 . 4 1 - 3 . 8 3  ( m ,  6 H ,  3  O C H 2 ) ,  4 . 0 3 - 4 . 3 0  
( m ,  2 H ,  A C O C H 2 ) ,  4 . 6 1  ( d ,  1 H , O - C H - O ) ;  IR:  3 4 7 0  ( b r ) ,  2 9 6 0 ,  2 9 3 0 , 2 8 7 0 ,  1 7 4 0 , 1 4 7 0 ,  1 3 7 0 ,  1 2 4 0 ,  
1 1 1 0 ,  1 0 7 0 ,  8 3 0  c m - 1 ;  Calcd.  for C I 6 H 3 2 0 5 :  C  6 3 . 1 3 ,  H  1 0 . 5 9 ;  found C  6 3 . 4 9 ,  H  1 0 . 3 3 .  
Determination of enantiomeric excess of 3-acetoxy-2-hydroxymethylpropanal dialkyl acetals 7a-e 
General procedure 
To a solution  of (/?)-(-)-MTPA-Cl  (38 mg, 0.15 mmol) in carbon tetrachloride (0.35 ml) 3-acetoxy-
2-hydroxymethylpropanal  dialkyl  acetal  (7a-e,  0.10  mmol;  the corresponding  racemic  samples  were  
obtained  from 6a-e by chemical  acetylation  using acetic anhydride and pyridine), pyridine (16 mg, 0.2 
mmol),  and N,N-dimethylaminopyridine  (ca.  1 mg)  were  added  and  the resulting  mixture  was  heated  
in a sealed  ampoule  at 50°C for 3 hours. The reaction  mixture was washed  with 5% hydrochloric  acid  
(3x0.3  ml),  the  organic  phase  was  dried  over  Na 2 S0 4  and  concentrated  by  rotary  evaporator.  The  
residue  was  analyzed  by  1 H-NMR spectroscopy  as  such.  
Characteristic 1 H-NMR signals of7a-e  MTPA-esters (diastereomeric mixtures from  racemic monoa-
cetates) 
(R)-7a  MTPA ester:  3.997 (dd, 0.5  H);  (S)-7a MTPA ester: 4.035  (dd, 0.5  H);  
(R)-7b MTPA ester: 4.026  (dd, 0.5 H);  (S)-7b MTPA ester:  4.059  (dd,  0.5  H);  
(±)-7c  MTPA ester: 2.015  (s,  1.5 H), 2.018 (s,  1.5  H);  
(/?)-7d MTPA  ester: 4.062 (dd, 0.5 H);  (S)-7d MTPA ester: 4.097  (dd, 0.5  H);  
(/?)-7e MTPA ester: 4.210 (dd,  0.5 H);  (S)-7e MTPA ester:  4.213  (dd, 0.5  H);  
Determination of the configuration of 3-acetoxy-2-hydroxymethylpropanal diethyl acetal 7b 
(S)-(+)-3-Acetoxy-2-methanesulfonyloxymethylpropanal diethyl acetal 8 
To  a  solution  of  3-acetoxy-2-hydroxymethylpropanal  diethyl  acetal  (7b,  5.12  g,  23.3  mmol;  
[C<]D=+5.0, C=1, acetone),  triethylamine  (4.0 ml, 29 mmol) and 4-dimethylaminopyridine  (50 mg) in 
dichloromethane (25 ml) a solution of methanesulfonyl chloride (2.2 ml, 28 mmol) in dichloromethane 
(20 ml)  was  added dropwise  below 25°C  and  the resulting mixture  was  stirred  at  RT for 30  minutes.  
The  reaction  mixture  was  then  washed  with  water  (2x10  ml)  and  the  organic  layer  was  dried  over  
N a 2 S 0 4  and  concentrated  by  rotary evaporator  yielding  6.7  g (23.4 mmol,  96%)  of  a colorless  oil.  
[«]D=+0.9,  (C=1, acetone);  1 H-NMR:  1.24  (t,  6H,  2CH3),  2.10  (s,  3H,  CH3),  2.40  (m,  1H,  CH),  
3.02  (s,  3H,  S0 2CH 3) ,  3.45-3.78  (m,  4H,  2  OCH2),  4.10-4.45  (m,  4H,  2  AcOCH2),  4.55  (d,  1H,  
O-CH-O);  IR:  2980,  2930,  1740,  1460,  1370,  1250,  1180,  1120,  1060,  960,  840,  750 cm" 1 ;  Calcd.  
for C H H 2 2 0 7 S :  C 44.28,  H  7.43,  S  10.75;  found C 44.15,  H  7.41,  S  10.78.  
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(R)-(+)-3-Hydroxy-2-methylpropanal diethyl acetal 9 
To  a  suspension  of  lithium  aluminum  hydride  (5.0 g,  131 mmol)  in  dry  tetrahydrofuran (250  ml)  
a  solution  of  (S)-(+)-3-acetoxy-2-methanesulfonyloxymethylpropanal  diethyl  acetal  (8,  6.5  g,  21.8  
mmol)  in  tetrahydrofuran  (25  ml)  was  added  dropwise  under  reflux  and  the  resulting  mixture  was  
stirred  under  reflux  for  5  min.  The  reaction  was  then  quenched  by  careful  addition  of  water  (30  
ml)  and  the  resulting  precipitate  was  removed  by  filtration.  The  filtrate  was  concentrated  by  rotary  
evaporator  and  the  remaining  aqueous  emulsion  was  extracted  with  ethyl  acetate  (3x30  ml).  The  
combined  organic  extracts  were  dried  over  Na2S04  and  concentrated.  The  residue  was  purified  by  
vacuum-chromatography  using  hexane:acetone  10:1 as eluent to give 2.6  g  (74%)  of  a colorless  oil.  
[<x]D=+6.2, (c=l,  acetone);  lH-NMR:  0.91 (d, 3H, CH3),  1.24 (t, 4H, CH3),  1.26 (t, 3H, CH3),  2.01  
(m,  1H, CH),  3.40-3.88  (m, 6H,  3 OCH2),  4.37 (d,  1H, O-CH-O);  IR:  3420 (br),  2980, 2930,  2880,  
1460,1370,1350,1120,1060 cm" 1 .  Caled, for C 8 H i 8 0 3 :  C 59.23,  H  11.18; found C 59.46, H  11.19.  
(R)-(+)-3-Benzyloxy-2-methylpropanal diethyl acetál 10 
To  a  solution  of  (/?)-(+)-3-hydroxy-2-methylpropanal  diethyl  acetal  (9,  0.81  g,  5.0  mmol)  in  dry  
tetrahydrofuran  (10  ml)  sodium  hydride  (0.4  g,  10  mmol,  60%  in  mineral  oil)  was  added  and  
the  resulting  mixture  was  heated  under  reflux  for  1  hour.  Potassium  iodide  (1.25  g,  7.5  mmol),  
tetrabutylammonium  chloride (70 mg, 0.25 mmol) and  benzyl chloride.(0.7 ml, 6.0 mmol) were  then  
added  and  heating  was  continued  for  1 hour.  After cooling,  the  reaction  mixture  was  concentrated  
by  rotary  evaporator  and  water  (3  ml)  was  added.  The  resulting  emulsion  was  extracted  with  
dichloromethane  (3x5  ml),  the  combined  organic  extracts  were  dried  over Na 2 S0 4  and  the  solvent  
was removed  to  leave  1.15  g (92%)  of  a colorless  oil.  
[a]D=+4.2, (c=l,  acetone);  lH-NMR:  1.03 (d, 3H, CH3),  1.20 (t, 4H, CH3),  1.21 (t, 3H, CH3),  2.09  
(m,  1H, CH),  3.30-3.82  (m, 6H,  3 OCH2),  4.43  (d,  1H, O-CH-O) ,  4.50  (s,  2H, OCH2Ph),  7.31  (m,  
5H, ArH);  IR:  2970, 2880,  1450,1370,1110,  1060,  1030, 740 c m " 1 ;  Caled. f o r C i 5 H 2 4 0 3 :  C  71.39,  
H 9.59; found C  71.18,  H  9.61.  
(R)-(—)-3-Benzyloxy-2-methylpropanal 11 
To  a  solution  of  water  (2  ml),  acetic  acid  (2  ml)  and  5%  hydrochloric  acid  (0.1  ml)  (/?)-(+)-3-
benzyloxy-2-methylpropanal  diethyl acetal (10,0.4  g,  1.6 mmol) was added and the resulting  mixture  
was  stirred  at  RT for  2  hours.  The  reaction  mixture  was  then  extracted  with  ethyl  acetate (2x3  ml)  
and  the  combined  organic  extracts  were  washed  with  saturated  sodium  hydrogen  carbonate  solution  
(4 ml) and brine (4 ml). After drying over Na 2 S0 4  the solvent was removed  by rotary evaporator.  The 
oily  residue  was purified by  vacuum-chromatography  to yield  0.21  g (74%)  of  a colorless  oil.  
[a]D=-17.4,  (c=l,  chloroform),  [ ( f t ) - ( - ) - l l ,  literature:  [a]D=-28.14,  (c=1.4,  chloroform);  
[ a ] D = - 2 8 ,  (c=l, chloroform)];1H-NMR:  1.17 (d, 3H, CH3),  2.68 (m,  1H, CH), 3.67 (m, 2H,  OCH2),  
4.53 (s, 2H, OCH2Ph),  7.32 (m, 5H, Ar), 9.72  (d,  1H, CHO);  Caled, for C n H i 4 0 2 :  C  74.13, H  7.92;  
found C  74.21,  H  7.90.  
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Abstract:  Preparation  and  porcine  pancreatic  lipase  (PPL)-cata-
lyzed  enantiotope  selective  acetylation  of  the  prochiral  2-benzo-
yloxy-l,3-propanediol  (la)  is described. The reaction  with PPL and 
vinyl  acetate gave monoacetate  (2a) of  96 % e.e. 
Key  words:  2-0-benzoylglycerol,  enantiotope  selective,  acetyla-
tion,  lipase  
Chiral  glycerol  derivatives  are considered  to be useful C3 
building  blocks for the preparation  of homochiral  biolog-
ically  active  molecules  such  as phospholipids1,  phospho-
lipase  A2  inhibitors2,  PAF  (platelet-activating  factor)3,  
and many  others4.  
Biocatalytical  preparation  of  these  chiral  C3  units  were  
carried  out  either  by  enantiomer  selective  or  enantiotope  
selective  manner.  The  kinetic  resolution  of  racemic  glyc-
erol  derivatives  such  as  glycerol  acetonide5,6  ,  glycerol-
2,3-carbonate  7  provided  moderate  selectivity  and  50%  
theoretical  limit  of  the  desired  enantiomer.  On  the  other  
hand,  enantiotope  selective  transformation  of  prochiral  
1,3-propanediols  (1) or their diacyl derivatives  (3) provide 
theoretically  100%  of  a single enantiomer  (2 or  ent-2).  
OH 
R,  R2  
A c y W s x X S / ,  O-Acyl  
Acyl-X 
enzyme 
HzO 
enzyme 
R 1  R 2  
R,  Ra  
ent-2 
Enzyme-catalyzed  acylation  of  several  2-0-alkylglycerol  
derivatives  (1,  RI,R2=  O-alkyl, H),  such  as the  2-0-meth-
yl-,8,9  2-O-ethyl-,8,9  or 2-O-benzylglycerol8 gave  optical-
ly  active  monoacetates  (2).  Hydrolyses  of  the  
corresponding diacyl compound  (3, R,, R2= OBn, H) with 
different enzymes under various conditions  were also per-
formed.11"15  In  the  case  of  the  2-O-alkyl  substituents,  the  
lipase-catalyzed  process  proved  to  be  pro-S  selective.  
Consequently,  acylation  of the 2-0-benzylglycerol  (1, R,, 
R2=  OBn,  H)  provided  (5)-l-0-acetyl-2-C-benzylglycer-
ol  (2, R j =  H,  R2=  OBn)  11  and  hydrolyses  of  the  corre-
sponding  diacyl "derivative  (3, R,= H, R2= OBn)  gave  the  
(R)-enantiomer  (ent-2,  R,= OBn, R2= H).11,12 The slow ra-
A 
HO  OH  
CHO 
1a 
(a) cat. cc. H2S04, RT, 4 h, 28%; (b) BzCl (1.1 eq.), Et3N (1.2 eq.), cat. 
DMAP,  CH2C12,  RT, 2 h, 96  %; (c) H2, cat.  10 %Pd/C, EtOAc,  RT, 8 
h, 73  %.  
Scheme  1  
1a 
Entry Enzyme  (mg)  Time 2a 
<h) Y % e.e.  % 
1 Novozym 435  (250)  0.5 5 ' 1 
2 Lipase  G  (100)  72 5* 3 
3 Lipase  AK (100) 1 32 7 
4 PsL (100)  2.5 36 19 
5 Lipase  N (100) 72 13 20 
6 CcL (50) 72 10 33 
7 PPL  (300)  1 63 96 
* According  to TLC data,  most of the diol la  was converted  to  
diacetate. 
(a) l a  (300 mg), enzyme,  vinyl  acetate  (1 ml), THF (3 ml),  hexane 
(3 ml),  RT 
Scheme  2  
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cemisation  (ca.  2  %/h) found when optically  active (S)-l-
O-acetyl-2-O-benzylglycerol  (2,  R,=  H,  R2=  OBn)  was  
incubated in phosphate butter pH 7 without enzyme is the 
drawback of  the hydrolytic  method.11  
Although the enantiotope selective  biotransformations of  
2-O-alkylglycerol  derivatives (1 or 3, R,,R2= O-alkyl, H) 
are well documented, no example of enzymic  enantiotope  
selective acylation of 2-O-acylglycerol derivatives (1, R|, 
R2= O-acyl, H) was found. 
It is worthwile noting  that two compounds of  this family 
(2, R„ R2= O-acyl, H), namely  l-0-acetyl-2-0-(16-meth-
yl)heptadecanoyl-  and  l-0-acetyl-2-0-(18-methyl)nona-
decanoylglycerol,  were  isolated  from  Nicotina  
benthamiana.16 
As a part of  our interest  in exploring new  stereoselective  
biocatalytic methods, we decided to investigate the lipase-
catalyzed  acetylation of  the 2-O-acylglycerol  derivatives  
(1,  RHR2=  O-acyl,  H).  Hence,  2-O-benzoyloxyglycerol  
(la,  R1=OBz,  R2=H)  was  selected  as  a representative  of  
this class. 
Preparation  of  the  desired  diol  (la)  was  straightforward  
(Scheme  1). Condensation  reaction  17 of  glycerol  (4)  and  
benzaldehyde  (5)  provided  cii-5-hydroxy-2-phenyl-1,3-
dioxane (6).18  Consequent benzoylation  and deprotection 
of the benzylidene protected intermediate (8)19 by catalyt-
ic  hydrogenation  yielded  the  desired  diol  (la)20  in  pure  
crystalline form. 
With  the  desired  prochiral  diol  (la)  in  hand,  the  enan-
tiotope selectivity of  acetylation by several  commercially  
available lipases was tested (Scheme 2).  
Among  the  enzymes  investigated,  lipase  from  porcine  
pancreas (PPL) proved to be the most selective  providing 
almost enantiomerically  pure product (2a)21 in good yield 
(Entry 7). The enantiomeric purity of the product (2a) was 
determined from the 'H-NMR signals of its MTPA ester.22 
The composition of  the solvent  in this reaction  catalyzed  
by PPL played an important role. Since the crystalline diol 
(la)  is poorly soluble in apolar solvents,  the reaction  was  
slow  in hexane.  Enzymatic  acetylations  using  vinyl  ace-
tate as acylating  agent in more polar solvents like chloro-
form,  ethyl  acetate  or  vinyl  acetate  gave  decreased  
enantiotope  selectivity  compared  to  that  obtained  in  the  
best solvent system (THF:hexane  1:1).  
Prediction of the sense of enantiotopic selectivity  seemed  
to  be  not  obvious  for  lipase-catalyzed  acylation  of  this  
new class  of  prochiral  1,3-propanediols.  The  lipase-cata-
lyzed acylation of 2-0-alkyl-1,3-propanediols  (1, R,, R2= 
O-alkyl,  H) proved to be pro-S  selective.  In the case of 2-
alkyl- 1,3-propanediols  (1, R,,  R2= alkyl, H) bearing apo-
lar substituent  at position 2,  enantiotope preference is  in-
verted  in  a geometrical  sense,  although  as  a result of  the  
sequence rules, the affected group is still labelled  pro-S.23  
Acetylation  of  the  diol  bearing  2-lV-benzyloxycarbonyl  
group by PPL was found to bepro-R." 
The absolute configuration of our product (2a) was deter-
mined by chemical  correlation (Scheme 3.).  
y 
2a  -  9  u  
(a) BzCI (1.1  eq.), Et3N (1.2 eq.), THF, 0-20°C, 2 h, 88 %. 
Scheme 3 
The  optical  rotation  of  our  dibenzoyl  compound  
(9)24  ([a]D=-2.78;  c = 0.78,  methanol)  comparing  to  
the literature data for (S)-(9)  ([<x]D= -0.8; c = 0.13,  metha-
nol) "proved its (S)-configuration,  and therefore (/^-con-
figuration of our enzymic product (2a).  
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5.08 (m,  1H, CH-O), 7.36 (t, 2H, 7= 7.5 Hz, 2 /n-Ar-H), 7.50 
(t, 1H, 7= 7.5 Hz, p-Ar-H), 7.89  (d, 2H, 7= 7.5 Hz, 2 o-Ar-H). 
(21)  The prochiral diol (la, 300 mg,  1.53 mmol) was dissoved in 
dry THF (3 ml). To this solution vinyl acetate (1 ml), hexane 
(3 ml) and lipase from porcine pancreas (PPL, 300 mg) were 
added and the resulting suspension was stirred at RT for I  h.  
The lipase (which after washing by acetone and drying proved 
to be active in a subsequent reaction) was removed by 
filtration.  The oily residue remaining after evaporation of the 
filtrate was purified by low pressure chromatography on silica 
gel using hexane - acetone 4 : 1  eluant mixture. 
Data for (R)-3-acetoxy-2-benzoyloxy-l-propanol  (2a, 230 
mg, 63 %): [a]D= -27.4 (c  1, ethanol), 96 %e.e.; vmu  (KBr)/  
cm"1 3400, 2960, 2910,2850,1730,1720,  1590,1470,1450,  
1350,1270,1110,1020,960,705;  SH (500 MHz, CDClj): 2.04 
(s, 3H, 0=C-CH3), 3.32 (br s,  1H, OH), 3.85 (m, 2H,  CH2-
OH), 4.40 (m, 2H, CH2-OAc), 5.33 (m,  1H, CH-O), 7.43 (t, 
2H, 7= 7.5 Hz, 2 m-Ar-H), 7.56 (t,  1H, 7= 7.5 Hz, 1 p-Ar-H), 
8.04 (d, 2H, 7= 7.5 Hz, 2 o-Ar-H). 
(22)  Reaction of 2a with (R)-MTPA-Cl (1.2 eqv., CC14, pyridine) • 
gave diastereomeric MTPA esters. Useful signals (5H, 500 
MHz, CDCI3):  3.517 [s, OCHj, (7?)-2a MTPA ester], 3.544 [s, 
OCH3,  (S)-2a MTPA ester]. 
(23)  Poppe, L.; Nóvák, L. Selective Biocatalysis: A Synthetic 
Approach;  VCH: Weinheim-New York,  1992.  
(24)  Data for (5)-l-acetoxy-2,3-benzoyloxypropane  (9):  
[a]„= -2.78 (c 0.78,  methanol); vm„ (KBr)/cm-'  3050,2950,  
1740,1720,1600,1580,1485,1450,1360,1315,1250,1175, 
1100,1070,1045,1025,935,  850,710, 680; 5„ (500 MHz, 
CDClj): 2.09 (3H,s), 4.47 (2H, mc, CH2OAc), 4.62 (2H, mc, 
CHjOBz), 5.68 (1H, m, CH-OBz), 7.26 (4H, mc, 4 m-ArH), 
7.44 (2H, mc, 2 p-Ar-H), 8.04 (4H, mc, 4 o-Ar-H). Spectra are 
in agreement with literature data.23 
(25)  Uzawa, H.; Nishida, Y.; Ohrui, H.; Meguro, H. 7. Org.  Chem.  
1990,55,116. 
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ABSTRACT 
Preparation and  lipase-catalyzed  enantiotope  selective  acetylation o f the prochiral  2-acyloxy-
propane-l ,3-diols  ( l a - h )  is described.  A  strong  influence of the  acyl moiety  in these  diols  on  
the enantiotope  selectivity of the porcine pancreatic  lipase (PPL)-catalyzed  reaction wi th  vinyl  
acetate was observed.  The best  result was achieved with  2-(4-methylbenzoyl)oxypropane-l ,3-
diol resulting monoacetate (2g) of  >98  %  e.e.  
Keywords: 
Enzymes and enzyme reactions; acylation; enantioselection;  substituent effects. 
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INTRODUCTION 
In  the  preparation  of  homochiral  biologically  active  molecules,  such  as  P A F  (platelet-
activating factor)  [1], phospholipids  [2], phospholipase  A 2  inhibitors  [3], and many others  [4],  
chiral glycerol derivatives o f high enantiomeric purity might he useful C 3 building  blocks.  
Enantiomer  selective  biocatalytical  methods,  e.g.  kinetic  resolution  o f  racemic  glycerol  
derivatives  such  as  glycerol  acetonide  [5,6],  glycerol-2,3-carbonate  [7],  provided  moderate  
selectivity  and  50  %  theoretical  limit  o f  the  desired  enantiomer.  On  the  other  hand,  
enantiotope  selective  transformation  o f  prochiral  1,3-propanediols  (1)  or  their  diacyl  
derivatives (3) provide theoretically  100  %  o f  a single enantiomer  (2 or  ent-2)  (Fig.  1).  
Among  the  2-O-alkylglycerol  derivatives  (1  or  3,  RI ,R 2=  O-alkyl,  H),  the  enantiotope  
selective  biotransformations  of  2-benzyloxy  substituted  compounds  are  the  most  studied.  
Hydrolyses  o f  the  corresponding  diacyl  compound  (3,  RI,R2=  OBn,  H)  with  different  
enzymes  under  various  conditions  were  performed. [ 8 - 1 1 ,  1 3 ]  The  slow  racemization  (ca.  2  
%/h)  found  when  optically  active  (S)-1 -O-acetyl-2-O-benzylglycerol  (2,  R i =  H ,  R 2 =  OBn)  
was  incubated  in  phosphate  buffer p H  7  without  enzyme  is  the  drawback  o f  the  hydrolytic  
method  [ 1 3 ] .  Enzyme-catalyzed  acylation o f 2-O-benzylglycerol  [ 1 2 - 1 5 ]  ( 1 ,  R I , R 2 =  OBn,  H)  
and  other  2-O-alkyl-  ( 1 ,  R I , R 2 =  O-alkyl,  H)  such  as  the  2-O-methyl-  [ 1 4 , 1 5 ] ,  2 - 0 -
ethylglycerols  [ 1 4 , 1 5 ]  yielding optically active monoacetates  ( 2 ,  R I , R 2 = O-alkyl, H) were  also  
studied.  The  lipase-catalyzed processes proved to be pro-S  selective for the  2-O-alkylglycerol  
derivatives.  Consequently,  acetylalion  of the  2-O-benzylglycerol  (1, RI ,R2=  OBn, H )  yielded  
(<S)-1 -O-acetyl-2-O-benzylglycerol  (2,  RI=  H,  R 2 =  OBn)  [13]  and  hydrolyses  of  the  
corresponding  diacyl derivative  (3, RI= H, R 2 = OBn) afforded the  (R)-enantiomer  (ent-2,  RI=  
OBn, R 2 = H )  [ 8 , 1 3 ] .  
Although the enantiotope  selective biotransformations of 2-O-alkylglycerol derivatives  (1  
or 3, RI ,R 2= O-alkyl, H)  are well documented,  no example o f enzymatic  enantiotope  selective  
acylation  o f  2-O-acylglycerol  derivatives  (1,  RI ,R2=  O-acyl,  H )  was  found.  It  is  worthwhile  
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noting  that two  compounds o f this family (2, Ri ,R 2 =  0-acyl ,  H),  namely  1 -0-acetyl-2-(9-( 16-
methyl)heptadecanoyl-  and  1 - 0 - a c e t y l - 2 - O ( l 8-methyl)nonadecanoylglycerol,  were  isolated  
from Nicotina  benthamiana  [16].  
A s  a  part  o f  our  interest  in  exploring  n e w  stereoselective  biocatalytic  methods,  w e  
decided to  investigate the lipase-catalyzed acetylation o f the 2-Oacylg lycero l  derivatives  ( l a -
i, R i ,R 2 =  O-acyl, H). In our preliminary work, the 2-benzoyloxypropane-l ,3-diol  (1,  RI=OBz,  
R 2 =H)  was  selected  as  the  first  representative  of  this  class  [17].  This  diol  was  tested  with  
several hydrolases  for the enantiotope selective acetylation.  The best result  was achieved  wi th  
porcine  pancreatic  lipase  (PPL)  and  vinyl  acetate  in  hexane-THF  yielding  monoacetate  (2,  
R i=OBz,  R 2 =H) of 96  %  ee  [17]. In this  study our  aim was to  investigate the  influence of  the  
2-acyloxy  moiety  on  the  enantiotope  selectivity  of  enzymatic  acetylation  of  these  prochiral  
1,3-diols.  Hence,  several  prochiral  carboxylic  and  sulfonic ester  derivatives  o f  glycerol  were  
prepared  and tested for enzymatic  acetylation.  
EXPERIMENTAL 
Materials  and  methods  
The  J H-NMR  spectra were recorded on  a Bruker AW-250  spectrometer  operating  at  250  
MHz.  For  enantiomeric  excess  determinations,  a  Bruker  DRX-500  spectrometer  operating  at  
500 M H z  was  used.  All  spectra  were  taken  in  CDCI3  solution  and  chemical  shift values  are  
expressed  in p p m  values  from  T M S  as  internal  standard  o n  5  scale.  IR  spectra  of  thin  film  
samples were  taken on  a  Specord 2000  spectrometer.  Optical  rotations were  determined  o n  a  
Perkin  Elmer  241  polarimeter  at  20  °C.  Thin  layer  chromatography  was  carried  out  using  
Merck  Kieselgel  60  F2s4  alumina  sheets  (using  hexane:acetone  10:4,  if otherwise  not  stated).  
Spots  were  visualized  by  treatment  with  5  %  ethanolic  phosphomolybdic  acid  solution  and  
heating  o f  the  dried  plates.  Preparative  chromatographic  separations  were  performed  using  
vacuum-chromatography  [18]  on  Merck  Kieselgel  60  (0.063-0.200  mm).  Chemicals  were  
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products  of  Fluka  or  Aldrich.  All  solvents  used  were  freshly  distilled.  CcL  (lipase  from  
Candida  rugosa,  formerly  Candida  cylindracea),  PPL  (lipase  from  porcine  pancreas)  and  
papain were  obtained  from  Sigma. PfL  (lipase  from  Pseudomonas  fluorescens)  was  a  product  
of  Fluka.  Novozym  435  (immobilized  lipase  of  Candida  antarctica)  and  Lipozym  I M  
(immobilized  lipase of  Mucor  miehei)  were  gifts  from  Novo  Nordisk.  Lipase  A  (lipase  from  
Aspergillus  niger),  Lipase A K  (lipase  from  Pseudomonas  fluorescens);  Lipase  G  (lipase  from  
Penicillinum  camambertii),  Lipase  M  (lipase  from  Mucor  javonicus),  Lipase  N  (lipase  from  
Rhisopus  niveus)  and Lipase PS (lipase  from  Pseudomonas  sp.) were gifts  from  Amano.  
cis-5-Hydroxy-2-phenyl-l,  3-dioxane  (6)  
The  reaction between  glycerol  (4,  50 g, 0.54 mol)  and  benzaldehyde  (5,  50  g,  0.47  mol)  
according to the known method  [19] gave crystalline product ( 6 , 3 0 g, 35  %).  
1H-NMR:  3.15 (1H, d, J=  10.0 Hz, OH), 3.58 (1 H,  br d, J=  10.0 Hz),  4.09 (2H, dd, J=  12.0  
and  1.5 Hz), 4.17 (2H, dd, J =  12.0 and  1.5 Hz),  5.54  (1H, s ) ,  7.36 (3H, m),  7.49  (2H, m);  IR  
(KBr,  cm'1):  3285, 3190 ,2985 ,2920 ,2855 ,  1450,1390,  1340,  1280,  1240,  1230,  1155,1090,  
1015, 995, 975,950,  930,830,  810, 740. (Spectra are in agreement  with literature data  [19])  
Preparation  of cis-5-(aryl-  or alkylsulfonyl)oxy-2-phenyl-l,3-dioxanes  (7a-c)  
General  procedure:  To  a  solution of m-5-hydroxy-2-phenyl-l,3-dioxane  (6,  3.73  g,  20  
mmol)  and  triethylbenzylammonium  chloride  (50  mg)  in  diethyl  ether  (25  ml)  finely  
powdered  K O H  (3.36  g,  60  mmol)  was  added  and  the  mixture  was  cooled  to - 5  °C.  At  this  
temperature  aryl-  or  alkylsulfonyl  chloride  (22  mmol)  was  added  portionwise.  The  resulting  
mixture was  vigorously  stirred  at  -5  °C  for 40 min  and  at  room temperature  for  15  min.  The  
white suspension was  diluted  with  ethyl  acetate  (25 ml)  and washed with water  (15 ml).  The  
aqueous phase  was  re-extracted  with  ethyl  acetate  (2  x  25  ml).  The  combined  organic  layers  
were  dried  over  Na 2SQt.  Evaporation  of  the  solvent  in  vacuo  afforded the  desired  acylated  
products  (7a-c).  
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cis-2-Phenyl-5-(p-toluenesulfonyl)oxy-l,  3-dioxane  (7a)  
According to the general procedure,  6.15 g (92 %) of white crystalline solid was prepared. 
M.p.:  120-123  °C (ethyl ace ta te) ; 1 H-NMR : 2.40  (s, 3H, CH3),  4.01 and 4.23  (m(A2B2), 4H,  2  
CH2), 4.43 (s,  1H, CH-O),  5.45 (s,  1H, O-CH-O),  7.26-7.65 (m, 7H, ArH),  7.82 (d, 2H,  ArH);  
IR  (KBr,  cm"1): 3445,2860,1650,1465,1395,  1355,  1190,  1175,1145,  1080,  1015,  985,930,  
745; Calcd. for CnHi 8 0 5 S:  C 61.06,  H 5.43,  S 9.59; found C 60.89, H  5.42,  S 9.61. 
cis-5-Benzenesulfonyloxy-2-phenyl-l,  3-dioxane  (7b)  
According to the general procedure,  4.8  g  (75 %) of white  crystalline solid was  prepared.  
M.p.:  127-130  °C (diethyl ether);1 H-NMR:  4.09 and  4.27  (m(A2B2), 4H,  2  CH2),  4.52  (s,  1H,  
CH-O),  5.49  (s,  1H, O-CH-O),  7.26-7.68  (m,  7H,  ArH),  7.97  (d,  2H,  ArH);  IR  (KBr,  cm"1):  
3445,  2855,  1685,  1640,  1445,  1350,  1185,  1145,  1075,  1015,  910,  870,  850,  755;  Calcd.  for  
Ci6H ,605S:  C  59.99, H  5.03,  S  10.01;  found  C 60.07,  H  5.02,  S  10.03.  
cis-5-Methanesulfonyloxy-2-phenyl-I,  3-dioxane  (7c)  
The  general  procedure  followed  preparative  vacuum  column  chromatography  (silica  gel,  
hexane:acetone  10:1) yielded 2.22  g (43 %) of white  crystals.  
M.p.:  128-130°C  (ethyl  acetate);1 H-NMR:  3.14  (s,  3H,  CH3),  4.18  and  4.44  (m(A2B2),  4H,  
2CH2),  4.68 (s,  1H, CH-O),  5.56 (s,  1H, O-CH-O),  7.37 (mc,  3H,  ArH),  7.50 (mc,  2H,  ArH);  
IR  (KBr,  cm"1): 3425,  3025,  1450,  1385,  1330,  1170,  1135,  1080,  1015, 980,  955,  940,  910,  
870, 740; Calcd. for Ci iH, 40 5S:  C 51.15,  H  5.46,  S  12.41; found C 51.24, H  5.47,  S  12.43.  
Preparation  of cis-5-acyloxy-2-phenyl-I,3-dioxanes  (7d-i)  
General procedure:  To  a  solution of  cis-5-hydroxy-2-phenyl-1,3-dioxane  (6,  3.73  g,  20  
mmol),  pyridine  (1.95  ml,  24  mmol)  and  4-(dimethylamino)pyridine  (50  mg)  in  
dichloromethane  (30  ml),  acyl  chloride  (22  mmol)  was  added  at  room  temperature  and  the  
mixture was stirred for  1-12 h. The resulting mixture was washed with  5  %  HCl solution (2  x  
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10  ml),  10  %  N a 2 C 0 3  solution  (10  ml)  and  brine  (10  ml).  After  drying  over  Na 2 S0 4  and  
evaporation of the solvent, the  solid residue was recrystallized to give white crystals  (7d-i).  
cis-5-Acetyloxy-2-phenyl-l,3-dioxane  (7d)  
Yield:  84 %;  M.p.:  98-101  °C  (hexane:ethyl  acetate  1:1);  lH-NMR:  2.16  (s,  3H,  CH3),  4.10-
4.28 (2 x  dd, 4H, 2CH2), 4.70 (d,  1H, CH-O), 5.55 (s,  1H, O-CH-O),  7.35 (m, 3H, Ar-H),  7.49  
(m, 2H, Ar-H);  JR  (KBr, c m 1 ) :  3440,  1730,  1460,  1390,  1375,  1245,  1140,  1085,  1020,  985,  
950, 920,  745; Calcd. for C, 2H,40 4 :  C 64.85, H  6.35; found C 64.79,  H  6.36.  
cis-5-Diphenylacetyloxy-2-phenyl-l,3-dioxane  (7e)  
Yield:  86 %;  M.p.  : 116-119 °C (hexane:ethyl  acetate  1:1); *H-NMR:  4.12-4.33  (m(A2B2),  4H,  
2CH2),  4.76 (br  s,  1H, CH-O),  5.19  (s,  1H, Ph-CH-Ph),  5.55  (s,  1H, O-CH-O),  7.16-7.56  (m,  
15H,  Ar-H);  IR  (KBr,  cm 1 ) :  3435,  1725,  1495,  1450,  1390,  1330,  1310,  1270,  1195,  1160,  
1140,  1085,1020,  745. Calcd. for C24H2 204 :  C 76.99, H 5.92; found C 76.81,  H  5.93.  
cis-2-Phenyl-5-pivaloyloxy-l,  3-dioxane  (7f)  
Yield:  83 %;  M.p.:  106-111 °C (hexane:ethyl  acetate  1:1 );'H-NMR:  1.29 (s,  9H, 3CH3),  4.11-
4.27 (m(A2B2), 4H, 2CH2), 4.65 (br s,  1H, CH-O),  5.53 (s,  1H, O-CH-O), 7.37 (m, 3H,  Ar-H),  
7.49 (m, 2H,  Ar-H);  IR  (KBr,  cm 1 ) :  3400,  2985,  1705,  1455,  1395,  1284,  1165,  1140,  1085,  
1015, 990,955,  745; Calcd.  for C,5H2o04:  C  68.16,  H  7.63; found C 68.15,  H  7.64.  
cis-5-(4-Methylbenzoyl)oxy-2-phenyl-l,  3-dioxane  (7g)  
Yield:  80 %;  M.p.:  119-122 °C  (hexane:ethyl  acetate  1:1);  ]H-NMR:  2.41  (s,  3H, CH3),  4.21-
4.46 (m(A2B2),  4H, 2CH2), 4.94 (br  s,  1H, CH-O),  5.61  (s,  1H, O-CH-O), 7.24 (d, 2H,  Ar-H),  
7.38  (m,  3H,  Ar-H),  7.51  (m,  2H,  Ar-H),  8.06  (d,  2H,  Ar-H),;  IR  (KBr,  cm"1):  3445,  1775,  
1710,  1610,1455,1390,1275,  1210,  1145,  1115,  1085,  1020, 980,  950,  900,  755, 745;  Calcd.  
for CI 8 H, 8 0 4 :  C  72.47,  H  6.08; found C 72.34,  H  6.07.  
cis-5-Cyclohexanecarbonyloxy-2-phenyl-l,  3-dioxane  (7h)  
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Yield:  96  %;  Up.:  73-75  °C (hexane); 'H-NMR::  1.20-1.36 (m,  3H),  1.44-1.56 (m,  2H),  1.65  
(mc,  1H),  1.72-1.80  (m,  2H),  1.94-2.0  (m,  2H),  2.45  (mc,  1H,  CH-CO),  4.15  and  4.25  
(m(A2B2),  4H,  2  CH 2-0) ,  4.69 (br  s,  1H,  CH-Ph),  5.54  (s,  1H,  O-CH-O),  7.32-1  AO  (m,  3H,  
Ar-H),  7.48-7.52  (m, 2H,  Ar-H);  IR  (KBr,  cm'1):  2936,  2880,  1712,  1456,  1392,  1365,  1312,  
1248,  1176,  1140,  1084,  1000,  744,  696;  Calcd.  for  Cj7  H22 0 4 :  C  70.32,  H  7.64;  found  C  
70.18, H  7.72.  
cis-5-Lauryloxy-2-phenyl-l,  3-dioxane  (7i)  
Yield:  60  %  (purified  by  chromatography  on  silica  gel  using  hexane-acetone  10:1);  waxy  
solid;  'H-NMR:  0.87  (t,  3H,  CH3),  1.20-1.38  (m,  16H,  8  CH2),  1.67  (mc,  2H,  CH2),  2.44  (t,  
2H,  CH2-CO), 4.16 and 4.27 (m(A2B2),  4.72  (br  s,  1H,  CH-Ph),  5.56  (s,  1H, O-CH-O),  7.33-
7.40 (m, 3H, Ar-H),  7.49-7.53  (m, 2H, Ar-H);  IR  (KBr, cm 1 ) :  2920,  2880,  1736,  1456,1432,  
1392,  1360,  1276,  1240,  1200,  1176,  1144,  1088,  1016,  744,  696;  Calcd.  for C 2 2 H 3 4 0 4 :  C  
72.89, H 9.45; found C 73.01,  H  9.52.  
Preparation  of2-(aryl-  or alkylsulfonyl)oxypropane-l,3-diols  (la-c)  
General  procedure:  To  a  20  %  methanolic  solution  of  the  c/s-5-(aryl-  or  
alkylsulfonyl)oxy-2-phenyl-l,3-dioxane  (7a-c,  9-18  mmol),  equimolar  amount  of  
concentrated  hydrochloric  acid  was  added  and  the  mixture  was  refluxed  for  1  min.  After  
cooling  to room temperature,  most  of the  methanol  was removed  in  vacuo,  the  solution  was  
neutralized  with  saturated  Na 2 C0 3  solution,  and  further  diluted  with  water  (up  to  a  final  
volume  of 20-30  ml.  After complete  evaporation  of  the  methanol,  the  residue  was  extracted  
with  hexane  (2  x  15 ml,  removal  of  benzaldehyde),  and  with  ethyl  acetate  (3  x 20  ml).  The  
combined  ethyl  acetate  layers  were  dried  over  Na 2S0 4 .  Evaporation  in  vacuo  resulted  the  
corresponding product  (la-c).  
2-(p-Toluenesulfonyl)oxypropane-l,  3-diol  ( la)  
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OiL Yield:  76 %;  1 H-NMR:  2.42  (s, 3H, CH3), 3.74  (m,  4H, 2CH 2 -0) ,  4.53 (m(t),  1H,  CH-O),  
7.33  (d,  2H,  Ar),  7.81  (d,  2H, Ar);  IR  (film, c m 1 ) :  3395  (br),  2950,  1700,  1600,  1455,  1360,  
1175,  1095,  1055,  925,  815;  Calcd. for  CIOH,405S:  C 48.77,  H  5.73,  S  13.02; found  C  48.70,  
H  5.74,  S  13.00.  
2-Benzenesulfonyloxypropane-1,3-diol  ( lb)  
OiL Yield:  74 % ; 1 H - N M R : 3.76 (m, 4H,  2CH 2 -0 ) ,  4.59  (m(t),  1H, CH-O),  7.56  (t, 2H,  Ar),  
7.69  (t,  1H, Ar),  7.94  (d,  2H,  Ar);  IR  (film,  cm'1):  3385  (br),  3945,  1450,  1360,  1185,  1095,  
1055,  1010,  925,  790,  755; Calcd.  for  C 9 H, 2 0 5 S:  C  46.54,  H  5.21,  S  13.80;  found  C 46.52,  H  
5.20,  S  13.79.  
2-Methanesulfonyloxypropane-l,  3-diol  (lc)  
Yield:  69  %;  Mp.:  65-68  °C  (hexane-ethyl  acetate  1:1);  1 H-NMR  (MeOH-df):  3.07  (s,  3H,  
CH3),  3.68  (m,  4H,  2CH 2 -0) ,  4.53  (m,  1H,  CH-O);  IR  (film,  cm'1):  3385  (br),  1340,  1170,  
1085,  1040,  1010,  985,  930,  795;  Calcd.  for  C4H,o05S:  C  28.23,  H  5.92,  S  18.84;  found  C  
28.28,  H  5.93,  S  18.83.  
Preparation  of2-acyloxypropane-l,3-diols  (ld-h)  
General  procedure:  To  a 20  %  isopiopanolic  solution of the  c/r-5-acyloxy-2-phenyl-l,3-
dioxane  (7d-h,  16-18  mmol),  Pd-C  (5 %)  was  added  and  the  mixture  was  vigorously  stirred  
under  hydrogen  at  room  temperature.  After  uptaking  the  calculated  amount  of  hydrogen  (2  
equivalents),  the  catalyst  was  filtered  o f f  Evaporation  of  the  solvent  in  vacuo  yielded  the  
corresponding  product  ( ld-h) .  
2-Acetoxypropane-l,  3-diol  (Id)  
Oil. Yield: 67 % ; 1 H - N M R : 2.13  (s, 3H,  CH3),  3.81  (m(d),  4H,  2CH 2 -0) ,  4.89  (mc,  1H,  CH-
O);  IR  (film,  c m 1 ) :  3380  (br),  2940,  1735,  1245,  1045,  960,  830;  Calcd.  for  C 5 H I 0 O 4 :  C  
44.77,  H  7.51; found C 44.70,  H  7.52.  
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2-Diphenylacetoxypropane-l,3-diol  (le)  
OiL  Yield:  7 5  %; 1 H-NMR: : 3 . 7 4  (me, 4 H ,  2 C H 2 - 0 ) ,  4 . 8 7  (me,  1 H ,  C H - O ) ,  5 . 0 6  (s,  1 H ,  Ph-
C H - P h ) ,  7 . 1 0 - 7 . 2 8  (m,  1 0 H ,  A R - H ) ;  IR  (film, cm"1): 3 4 0 5  (br),  1 7 3 5 ,  1 4 9 5 ,  1 4 5 5 ,  1 3 0 5 ,  1 1 9 0 ,  
1 1 5 0 ,  1 0 5 0 ,  1 0 1 0 , 7 4 5 , 7 0 0 ;  Calcd. for C I 7 H I 8 0 4 :  C 7 1 . 3 1 ,  H  6 . 3 4 ;  found  C 7 1 . 4 3 ,  H  6 . 3 3 .  
2-Pivaloyloxypropane-l,3-diol  (If)  
OiL Yield: 7 7 % ; 1 H-NMR:  1 . 2 2  (s, 9 H ,  C H 3 ) ,  3 . 7 7  (m(d), 4 H ,  2 C H 2 - 0 ) ,  4 . 8 6  (m(t),  1 H ,  C H -
O); IR  (film, c m 1 ) :  3 4 1 5  (br), 2 9 7 0 ,  2 8 4 5 ,  1 7 1 0 ,  1 4 8 0 ,  1 4 6 0 ,  1 4 0 0 ,  1 3 7 0 ,  1 2 8 5 ,  1 1 7 0 ,  1 0 4 0 ,  
9 8 0 ,  7 7 0 ;  Calcd.  for C S H I 6 0 4 :  C  5 4 . 5 3 ,  H  9 . 1 5 ;  found  C  5 4 . 6 4 ,  H  9 . 1 7 .  
2-(4-Methylbenzoyl)oxypropane-l,  3-diol  (lg) 
Yield:  76  %;  M.p.:  84-90  °C  (hexane:ethyl  acetate  1:1);  1 H-NMR:  2.38  (s,  3H,  CH3),  3.90  
(m(d), 4H, 2CH 2 -0) , 5.11 (m(t),  1H, CH-O),  7.20 (d, 2H, Ar-H),  7.91  (d, 2H, Ar-H); IR  (film,  
cm 1 ) :  3410  (br),  1685,  1610,  1460,  1420,  1355,  1305,  1185,  1130,  1085,  1055,  1040,  835,  
760,  700; Calcd.  for C H H 1 4 0 4 :  C 62.85, H  6.71; found C 62.79, H  6.72.  
2-Cyclohexanecarbonyloxypropane-l,  3-diol  (lh)  
Semisolid.  Yield: 96 % ; 1 H-NMR:  1.19-1.35  (m, 3H),  1.38-1.50 (m, 2H),  1.65 (me,  1H),  1.71-
1.81  (m,  2H),  1.87-1.96  (m,  2H),  2.34  (me,  1H,  CH-CO)  3.75-3.84  (m(dd),  4H,  2CH2-0) ,  
4.89  (m(t),  1H, CH-O);  IR  (film, cm 1 ) :  3400  (br), 2936, 2856,  1710,  1452,  1428,  1384,1312,  
1248,  1172,1136,  1040; Calcd. for C , 0 H, 8 0 4 :  C 59.39,  H  8.97; found C  59.29,  H  9.02.  
Preparation  of racemic 3-acetyloxy-2-acyloxypropan-l-ols  (rac-2a-g)  
General  procedure:  To  a  solution  of  the  2-acyloxypropane-l,3-diol  ( la -g ,  5  mmol)  in  
ethyl  acetate  (10  ml),  pyridine  (0.45 ml),  4-(dimethylamino)pyridine  (25  mg)  and  acetic  acid  
anhydride (0.47 ml) were added. The mixture was stirred at room temperature  for  1 h and  then  
washed  with  5  %  HC1 solution ( 2 x 5  ml),  10  %  Na 2 C0 3  solution  (5  ml)  and  brine  (5  ml).  
After drying  over Na 2 S0 4  the  solvent was removed  in  vacuo  and the residue was purified  by  
preparative  vacuum  column  chromatography  (silica  gel,  hexane-acetone)  affording  the  
product (rac-2a-g)  as an  oil.  
3-Acetoxy-2-(p-toluenesulfonyl)oxypropan-l-ol  (rac-2a)  
Yield:  51 %;  JH-NMR:  1.92  (s, 3H,  CH3-CO),  2.45  (s, 3H,  Ar-CH3),  3.75  (mc,  2H,  CH 2 -0) ,  
4.14-4.26  (m,  2H,  CH2-OAc),  4.70  (mc,  1H,  CH-O),  7.34  (d,  2H,  Ar),  7.82  (d,  2H,  Ar);  IR  
(film, cm'1): 3415 (br), 2955,1745,  1600,  1360,1240,1190,  1175,  1100,  1050,930,  915,775;  
Calcd. for CI 2HI 60 6S:  C 49.99,  H  5.59,  S  11.12; found  C 49.98,  H  5.61,  S  11.11.  
3-Acetoxy-2-benzenesulfonyloxypropan-l-ol  (rac- 2b) 
Yield: 47 %;  ]H-NMR:  1.92 (s, 3H, CH3-CO), 3.78 (mc, 2H, CH 2 -0) ,  4.15-4.28 (m, 2H,  CH2-
OAc),  4.72  (mc,  1H,  CH-O),  7.57  (t, 2H, Ar-H),  7.69  (t,  1H, Ar-H),  7.94  (d,  2H,  Ar-H);  IR  
(film, cm 1 ) :  3415 (hr), 2955 ,1745,1450,  1365,  1215,1190,  1125,1100,  1050, 930,  790,  755;  
Calcd. for C n H i 4 0 6 S :  C 48.17,  H  5.14,  S  11.69;  found  C 48.24,  H  5.14,  S  11.72.  
3-Acetoxy-2-methanesulfonyloxypropan-l-ol  (rac-2e)  
Yield:  45  %;  *H-NMR:  2.12  (s,  3H,  CH3-CO),  3.13  (s,  3H,  CH3-S),  3.85  (mc,  2H,  CH 2 -0) ,  
4.22-4.41  (m,  2H,  CH2-OAc),  4.88  (mc,  1H,  CH-O);  IR  (film, cm 1 ) :  3520  (br),  3030,  2940,  
1745,  1350,  1235,  1175,  1050,  975,  930,  805,  740;  Calcd.  for C 6 Hi 2 0 6 S:  C  33.96,  H  5.70,  S  
15.11; found C 33.96,  H  5.71,  S  15.15.  
2,3-Diacetoxypropan-l-ol  (rac-2d)  
Yield:  54 %;  ]H-NMR:  2.11  (s, 3H,  CH3-CO),  2.16 (s, 3H, CH3-CO),  3.71-3.77  (m, 2H,  CH2-
O),  4.12-4.38  (m,  2H,  CH2-OAc),  5.08  (mc,  1H,  CH-O);  IR  (film,  cm'1):  3465  (hr),  2960,  
1745,  1440,1375,  1230,  1050, 960,845; Calcd. for C 7 Hi 2 0 5 :  C  47.73,  H  6.87; found  C  47.81,  
H  6.85.  
3-Acetoxy-2-diphenylacetoxypropan-l-ol  (rac-2e)  
Yield:  51  %;  ]H-NMR:  1.96  (s,  3H,  CH3-CO),  3.70  (mc,  4H,  2CH 2 -0) ,  4.L6-4.31  (m,  2H,  
CH2-OAc),  5.05  (mc,  1H,  CH-O),  5.07  (s,  1H,  Ph-CH-Ph),  7.30  (mc,  10H,  Ar-H);  IR  (film,  
cm-1):  3460  (br),  3030,  2955,  1740,  1585,  1495,  1450,  1370,  1235,  1190,  1150,  1045,  1015,  
745,700;  Calcd. for C,9H2o05:  C 69.50, H 6.14; found C 69.67,  H  6.15.  
3-Acetoxy-2-pivaloyloxypropan-l-ol  (rac-2f)  
Yield:  48 % ; ' H - N M R : 1.22  (s,  9H,  3CH3),  2.07  (s,  3H,  CH3-CO),  3.74  (mc,  2H,  CH 2 -0) ,  
4.19-4.37  (m,  2H,  CH2-OAc),  5.07  (mc,  1H,  CH-O);  IR  (film,  cm"1):  3475  (br),  2970,  1730,  
1480,  1460,  1400,  1370,  1285,  1235,  1160,  1050;  Calcd.  for  C I 0 H I 8 O 5 :  C  55.03,  H  8.31;  
found C 55.12, H  8.30.  
3-Acetoxy-2-(4-methylbenzoyl)oxypropan-l-ol  (rac-2g)  
Yield:  50 % ; 1 H - N M R : 2.08  (s, 3H, CH3-CO), 2.42 (s, 3H,  Ar-CH3),  3.87  (m(t),  2H,  CH 2 -0) ,  
4.41  (m(d),  2H,  CH2-OAc),  5.31  (m(t),  1H,  CH-O),  7.26  (d,  2H,  Ar-H),  7.93  (d,  2H,  Ar-H);  
IR  (KBr,  cm"1):  3455  (br),  2955,  1715,  1610,  1510,  1445,  1410,  1370,  1275,  1180,  1110,  
1045,1020,  920, 840,750; Calcd.  for C 1 3Hi 60 5 :  C 61.90, H 6.39; found C 62.04,  H  6.41.  
Enzymatic  acetylation  of2-acyloxypropane-l,3-diols  (la-h)  
General  procedure:  For  solvents,  enzymes, reaction times and yields,  see Tables 2-4.  To  
a  solution  of  the  prochiral  diol  ( l a -h ,  250  mg)  in  the  solvent  indicated,  vinyl  acetate  and  
enzyme  were  added.  After  stirring  the  mixture  at  room  temperature  for  the  given  time,  the  
enzyme was  filtered  of£  the  solvent  was  removed  from  the  filtrate  in  vacuo  and  the  residue  
was  purified  by  preparative  vacuum  column  chromatography  (silica  gel,  hexane:acetone  
10:1.5). For yields,  optical rotation and  enantiomeric  composition of the products  (2a-h),  see  
Tables  2-4.  Spectral  ( 'H-NMR  and  IR)  data  for the  products  (2a-g)  were  indistinguishable  
from  that of the racemic 3-acetoxy-2-acyloxypropan-1 -ols  (wc-2a-g).  
3-Acetoxy-2-cyclohexanecarbonyloxypropan-l  -ol  (2h) 
'H-NMR:  1.19-1.34 (m, 3H),  1.39-1.52  (m, 2H),  1.65 (mc,  1H),  1.72-1.80  (m,  2H),  1.87-1.96  
(m, 2H), 2.07 (s, 3H,  CH3-CO), 2.36 (mc,  1H, CH-CO),  3.73 (mc, 2H, CH2-0) ,  4.21-4.35  (m,  
2H,  CH2-OAc),  5.08  (me,  1H,  CH-O);  IR  (KBr,  cm 1 ) :  3464  (br),  2936,  2856,  1736,  1452,  
1416,1372,  1244,  1168,1048;  Calcd.  for  C12H20O5:  C 59.00, H  8.25;  found  C 59.08,  H  8.33.  
Preparation  of  MTPA  esters  Jrom  the  racemic  and  optically  active  3-acetyloxy-2-
acyloxypropan-l-ols  (2a-g)  
The  racemic  or  optically  active  3-acetyloxy-2-acyloxypropan-1 -ois  (2a-g,  9-12  mg),  
pyridine  (25  [il)  and  (4-dimethylamino)pyridine  (2  mg)  were  added to  a solution of  5  %  (/?)-
MTPA-CI  in carbon tetrachloride  (350  pi) and the mixture  was heated  in  a  sealed ampoule  at  
50  °C for  3 h. The resulting  mixture was  successively  washed  with  5  %  HC1 solution  (1  ml),  
saturated  Na2C03  solution (1 ml) and  brine (1 ml).  The organic phase was dried over  N a 2 S 0 4  
and  the  solvent  was  evaporated.  The  diastereomeric  ratio  of the  forming MTPA  esters  were  
determined  from  their  1H-NMR  spectra  (500  MHz,  CDCI3,  TMS).  Several  signals  used  for  
enantiomeric purity determination are listed  in Table  1.  
Determination  of the absolute  configuration  of the monoacetates  (2a-h)  
Enzymatic  acetylation  of 3-benzyloxypropane-l,2-diol  (ft)72  
To  a  solution of 3-benzyloxypropane-l,2-diol  (9,  9.5  g) in  hexane  (50  ml), THF  (50  ml)  
and  vinyl  acetate  (25  ml)  Lipase-AK  (1  g)  was  added  and  the  mixture  was  stirred  at  room  
temperature  for  27  h.  The  enzyme  was  filtered  off,  the  solvent  was  evaporated  from  the  
filtrate  and  the  residue  was  subjected  to  preparative  vacuum  column  chromatography  (silica  
gel,  hexane:acetone  10:0.5 to  10:2) to  give  (R)-1 -acetoxy-3-benzyloxypropan-2-ol  [10,  yield:  
5.2  g,  [<X]D= -3.3  (c  1,  chloroform);  lit.22:  [a]O=  +4.1  (c  1.04,  chloroform),  enantiomericaliy  
pure  (S)-10] and  (S)-l,2-diacetoxy-3-benzyloxypropane  [11, yield:  5.2 g,  [<X]D= +12.4  (c  0.5,  
chloroform); lit.22: [a ] D = +14.0 (c 0.5, chloroform), enantiomericaliy  pure<S)-l l] .  
Catalytic  hydrogénation  of (R)-l-acetoxy-3-benzyloxypropan-2-ol  (10)  
A  solution of (i?)-l-acetoxy-3-benzyloxypropan-2-ol  [10, 2.0  g,  8.9  mmol,  [ a ]o =  -3.3  (c  
1, chloroform)] in isopropanol (20 ml) was hydrogenated on  10 % Pd-C (300 mg) at 40  °C for 
45 min. The catalyst  was  filtered  off and solvent was  evaporated  in  vacuo.  Yield:  1.18  g  (100  
%) of (i?)-3-acetoxypropane-1,2-diol  (13)8  {[a]D= -9.9 (c 2,  pyridine)}.  
Bis-sulfonylation  of (R)-3-acetoxypropane-l,2-diol  (13)  
General  procedure:  To  a  solution  of  (i?)-3-acetoxypropane-l,2-diol  [13,  0.40  g,  3.0  
mmol,  [<X]D=  -9.9  (c  2,  pyridine)],  triethylamine  (1.0  ml,  7.2  mmol)  and  4-
(dimethylamino)pyridine  (10 mg)  in dichloromethane  (3 ml) p-toluenesulfonyl  chloride  (1.26  
g, 6.6 mmol,  for en/-8a) or benzenesulfonyl chloride (1.17 g, 6.6 mmol, for ent-8b)  was  added  
and  file  resulting  mixture  was  stirred  at  room  temperature  for  3  h.  The  mixture  was  then  
washed  with  5  %  HCl  solution ( 2 x 1  ml),  10  %  Na 2 C0 3  solution  (1  ml)  and  saturated  
N a H C 0 3 (1 ml). The organic phase was dried over Na 2 S0 4  and the  solvent was evaporated  in  
vacuo  to leave the product  (ent-8a  or e«/-8b) as an oil.  
(S)-l-Acetoxy-2,3-di(p-toluenesulfonyl)oxypropane  (ent-8a)  
Yield:  89 %;  [a]D=  -15.2  (c  1, methanol) ; 1 H-NMR :  1.91  (s,  3H,  CH3-CO),  2.45  (s,  3H,  Ar-
CH3),  2.46 (s,  3H,  Ar-CH3),  4.02-4.23  (m, 4H,  CH2-OAc  and  CH2-OTs),  4.76  (mc,  1H,  CH-
0 ) ,  7.32-7.37  (2  x  d,  4H,  Ar-H),  7.68-7.78  (2x  d,  4H,  Ar-H);  IR  (film,  cm"1):  2960,  1745,  
1600,  1455,  1365,  1230,  1190,  1095,  1045,  1000,  935,  815,  765;  Calcd.  for  Ci9H22OgS2:  C  
51.57,  H  5.01,  S  14.49; found C 51.57,  H  5.02,  S  14.47.  
(S)-l-Acetoxy-2,3-di(benzenesulfonyl)oxypropane  (e/tf-8b)  
Yield: 9 0  %;  [<x]D= - 1 6 . 0  (c  1 ,  methanol);1 H-NMR:  1 . 8 9  (s, 3 H ,  C H 3 - C O ) ,  4 . 0 7 - 4 . 2 3  (m,  4 H ,  
C H 2 - O A C  and CH 2-0S0 2Ph),  4 . 7 9  (mc,  1 H ,  C H - O ) ,  7 . 4 8 - 7 . 8 9  (m,  1 0 H ,  A r - H ) ;  IR  (film,  cm"  
1):  2960,  1745,  1710,  1450,  1370,  1225,  1190,  1035,  1005,  935,  755;  Calcd.  for  C I 9 H I 8 0 8 S 2 :  
C 49.27,  H  4.38,  S  15.47;  found  C 49.34,  H 4.37,  S  15.46.  
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Arylsulfonylation  of  monoacetates  (2a,b) from  enzymatic  acetylation  of  the prochiral  diols  
( l a ,b ) 
General  procedure:  3-Acetyloxy-2-(p-toluenesulfonyl)oxypropan-1 -ol  [2a,  0.33  mmol,  
[<x]D= +9.2 (c  1, methanol)]or  3-acetyloxy-2-benzenesulfonyloxypropan-1 -ol [2b, 0.33  mmol,  
[a] D =  +6.2  (c  1, methanol)],  4-(dimethylamino)pyridine  (1  mg)  and  triethylamine  (0.05  ml)  
were  dissolved  in  dichloromethane  (0.7  ml)  and p-toluenesulfonyl  chloride  (0.35  mmol,  for  
2a)  or  benzenesulfonyl  chloride  (0.35  mmol,  for 2b)  was  added.  The  resulting  mixture  was  
stirred  at room temperature  for  3 h,  and  it was washed  with  5  %  HC1 solution,  10  %  N a 2 C 0 3  
solution and  saturated N a H C 0 3 .  The  organic  phase  was  dried  over N a 2 S 0 4  and  solvent  was  
evaporated  in  vacuo  to  leave the product  (8a or 8b) as an oil.  Spectral ( 'H-NMR  and  IR)  data  
were indistinguishable  from  those of the above products  {ent-8a  or  ent- 8b). 
{R)-l-Acetoxy-2,3-di(p-toluenesulfonyl)oxypropane  (8a):  [CC]D= +8.8 (c  1,  methanol).  
(Ryi-Acetoxy-2,3-di(benzenesuIfonyl)oxypropane  (8b): [a]D= +4.8 (c  1, methanol). 
Preparation  of  l-acetoxy-2-acyloxy-3-benzyloxypropanes  (12d-h)  
General procedure:  To a solution of (R)-l-acetoxy-3-benzyloxypropan-2-ol  [10, 314 mg, 
1.4  mmol,  [<X]D=  -3.3  (c  1,  chloroform)],  triethylamine  (0.23  ml)  and  4-(dimethylamino)-
pyridine (5 mg)  in dichloromethane  (1.5 ml) the corresponding  acyl chloride  (1.54 mmol)  was  
added  and  the  resulting  mixture  was  stirred  at  room temperature  for  1-6 h.  The  mixture  was  
then washed with  5  %  HC1 solution (2  x 0.5 ml),  10 % N a 2 C 0 3  solution (0.5 ml) and  saturated  
N a H C 0 3  (0.5  ml).  The  organic phase was  dried  over N a 2 S 0 4  and the  solvent  was  evaporated  
in  vacuo.  The residue was purified by preparative  vacuum  column chromatography  (silica  gel,  
hexane:acetone 5:1) to give the product  (12d-h) as an o i l  
(R)-l, 2-Diacetoxy-3-benzyloxypropane  (12d)  
Yield:  77 %; [a ] D =  -15.8 (c  1, methanol) ; 1H-NMR: 2.02  (s, 3H, CH3-CO),  2.07  (s, 3H,  CH3-
CO), 3.58 (m(d), 2H, CH2-OBn),  4.14-4.36 (m, 2H, CH2-OAc), 4.53 (m, 2H, 0-CH2-Ph),  5.21  
(me,  1H,  CH-O),  7.31  (me,  5H,  Ar-JH); IR  (film, cm'1):  2865,  1745,  1455,  1370,  1225,  1100,  
1050,1020,  96Q, 740, 700; Caled,  for C,4H,805 :  C 63.15, H  6.81; found C 63.30, H  6.82.  
(R)-l -Ac$toxy-3-benzyloxy-2-(diphenylacetoxy)propane  (12e)  
Yield:  81  %;  [ct]D= -12.9  (c  1, methanol);1 H-NMR:  1.89  (s,  3H,  CH3-CO),  3.57  (m(d),  2H,  
CH2-OBn),  4.17-4.32  (m, 2H, CH2-OAc),  4.44 (me, 2H,  0-CH 2-Ph),  5.05  (s,  1H,  Ph-CH-Ph),  
5.33  (mc,  1H,  CH-O),  7.21-7.50  (m,  15H,  Ar-H);  IR  (film,  cm'1):  2865,  1745,  1600,  1495,  
1455,  1365,  1230,  1190,  1150,  1115,  1045,  975,  740;  Caled,  for  C26H2605:  C  74.62,  H  6.26;  
found C 74.75, H  6.26.  
(R)-l -Acetoxy-3-benzyloxy-2-pivaloyloxypropane  (12f)  
Yield:  81  %;  [ a ] D =  -14.6  (c  1,  methanol);  JH-NMR:  1.20  (s,  9H,  3CH3),  2.03  (s,  3H,  CH3-
CO),  3.6J  (m(d),  2H,  CH2-OBn),  4.17-4.33  (m,  2H,  CH2-OAc),  4.54  (s, 2H,  0-CH2Ph),  5.22  
(mc,  1H,  CH-O),  7.24-7.38  (m,  5H,  Ar-H);  IR  (film,  cm'1):  2975,  2870,  1810,  1735,  1480,  
1455,1370,  1285,  1235,  1155,1115,1045,  740;  Caled, for Ci 7H 2 40s:  C  66.21,  H  7.84; found 
C  66.37, H  7.85.  
(R)-l -Acetoxy-3-benzyloxy-2-(4-methylbenzoyl)oxypropane  (12g)  
Yield:  78  %;  [<x]D= -9.2  (c  1,  methanol);  1 H-NMR:  2.01  (s,  3H,  CH3-CO),  2.35  (s,  3H,  Ar-
CH3),  3.69  (mc,  2H,  CH2-OBn),  4.26-4.49  (m,  2H,  CH2-OAc),  4.56  (m(d),  2H,  0-CH2-Ph),  
5.45  (mc,  1H, CH-O),  7.22 (d, 2H, Ar-H),  7.30  (mc,  5H, Ar-H),  7.92 (d, 2H, Ar-H);  IR  (film,  
cm'1):  2865,  1745,  1720,  1610,  1495,  1455,  1365,  1275,  1230,  1180,  1105,  1045,  910,  840,  
750; Caled, for C20H22O5:  C 70.16, H  6.48; found C 70.01,  H  6.46.  
(R)-l-Acetoxy-3-benzyloxy-2-cyclohexanecarbonyloxypropane  (12h)  
Yield:  97  %;  [<x]D=  -12.5  (c  1,  methanol);  lH-NMR:  1.18-1.34  (m,  3H),  1.38-1.51  (m,  2H),  
1.64  (mc,  1H),  1.69-1.79  (m,  2H),  1.83-1.93  (m,  2H),  2.02  (s,  3H,  CH3-CO),  2.32  (mc,  1H,  
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CH-CO),  3:58  (me,  2H,  CH2-OBn),  4.18-4.37  (m, 2H,  CH2-OAc),  4.53  (me,  2H,  0 -CH 2 -Ph) ,  
5.22  (me,  1H,  CH-O),  7.26-7.37  (m,  5H,  Ar-H);  IR  (film,  cm'1):  2936,  2856,  1740,  1736,  
1 4 8 8 , 1 4 5 2 , 1 3 6 8 , 1 3 1 2 , 1 2 9 2 , 1 2 3 6 , 1 2 3 0 , 1 1 6 8 , 1 1 3 2 ,  1048,  740,  696;  Calcd. for  C i 9 H 2 6 0 5 :  
C  68.24,  H  7.84; found  C  68.09,  H  7.93.  
Catalytic  hydrogénation  of  l-acetoxy-2-açyloxy-3-benzyloxypropanes  (12d-h)  
General  procedure:  The  1 -acetoxy-2-acyloxy-3-benzyloxypropane  (12d-h)  from  the  
previous reaction w a s  dissolved  in  isopropanol  (3 ml).  Catalyst  (10  %  Pd-C,  10 % w / w of  the  
substrate)  was  added  .and  hydrogénation  was  carried  out  at  room  temperature  for  0.5  to  2  
hours.  The  catalyst  was  then  filtered  o f f and  the  solvent  was  evaporated  from  the  filtrate  to  
leave  the  (R)-monoacetates  [(R)-2d-h]  in  yields  between  66  and  82  %.  ' H - N M R  and  I R  
spectra  were  identical  to  those  o f  the  racemates  (rac-2d-g)  or  monoacetates  from  the  
enzymatic reaction  (2d-h) .  
2,3-Diacetoxypropan-l-ol  [(Z2)-2d]:  [a]D= -4-6 (c  1,  methanol);  
3-Acetoxy-2-(diphenylacetoxy)propan-l-ol  [(I?)-2e] :  [<X]D= -28.7 (c  1,  methanol);  
3-Acetoxy-2-pivaloyloxypropan-l-ol  [(fl)-2f]:  [ a ]o=  -8.2 (c  1,  methanol);  
3-Acetoxy-2-(4-methylbenzoyl)oxypropan-l-ol  [(J?)-2g]:  [<X]D= -20.6 (c  1,  methanol);  
3-Acetoxy-2-cyclohexanecarbonyloxypropan-l-ol  [(/?)-2h]:  [ a ]o=  -6.7 (c  1,  methanol).  
RESULTS AND DISCUSSION 
Preparation  o f  the  desired  prochiral  2-acyloxypropane-l ,3-diols  ( l a - h )  was  
straightforward (Scheme  1).  Condensation reaction  [19] of  glycerol  (4)  and  benzaldehyde  (5)  
provided  cw-5-hydroxy-2-phenyl-1,3-dioxane  (6).  The  benzylidene  protected  secondary  
alcohol  (6)  was  transformed  into  sulfonic  (7a-c)  or  carboxylic  esters  (7d-i)  in  slightly  
different ways.  The  sulfonic esters  (7a-c)  were  obtained  by reaction o f the  secondary  alcohol  
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(6)  with alkyl-  or arylsulfonyl chloride and powdered  potassium hydroxide  in diethyl  ether  at  
- 5  °C, whereas the  carboxylic esters (7d-i) were obtained  by  acylation of the  alcohol (6)  with  
the  corresponding  acyl  chloride  using  pyridine  and  catalytic  amounts  of  
4-(dimethylamino)pyridine  (DMAP)  in  dichloromethane  at  room  temperature.  Benzylidene  
deprotection  of  the  two  types  of  esters  (7a-c  and  7d-i)  was  also  different.  Benzylidene  
removal  from  the sulfonic  ester  intermediates  (7a-c)  was performed  by  acid  hydrolysis  with  
concentrated  hydrochloric  acid  in  refluxing  methanol,  whereas  carboxylic  esters  (7d-i)  were  
deprotected  by catalytic  hydrogenation over  10  % Pd(C)  in isopropanol  at room  temperature,  
providing the desired prochiral diols ( la -g)  smoothly.  In the case of the  lauryl  derivative  (71),  
however,  deprotection  proceeded  with  immediate  acyl  migration  leading  almost  exclusively  
to  1 - O-laurylglyceroL  Although  substantial  degree  of  acyl  migration  was  observed  by  the  
2-0-diphenylacetyl  ( l e )  and 2-0-cyclohexanecarbonyl  ( l h )  products  within  days  standing  in  
standard  glass  flasks at  room temperature,  these prochiral  diols ( l e  and  l h )  were  suitable  for  
enzymatic transformation immediately after the  deprotection.  
In  our  preliminary  study  the  enantiotope  selective  acetylation  of  2-benzoyloxypropane-
l,2-diol ( l , Ri=OBz, R2=H), which was considered as the  first  representant of the prochiral  2-
acyloxy-l,3-propanediol  family,  was  investigated  [17].  The  lipase  from  porcine  pancreas  
(PPL)  proved  to  be  the  most  selective  among  the  enzymes  studied  providing  the  acylated  
product  (2,  Ri=OBz,  R2=H)  with  96  %  enantiomeric  purity  in  good  yield.  Because  of  that  
promising result, the  same inexpensive commercial  lipase was chosen for the present  study  of  
the further 2-acyloxypropanediols ( l a -h ) ,  too.  
Composition  of the  solvent  in the  PPL-catalyzed  acetylation  reaction of  carboxylic  ester  
type  2-benzoyloxypropane-1,2-diol  (1,  Rj=OBz,  R2=H)  played  ah  important  role  [17],  i.e.  
enzymatic  acetylations  in polar  solvents  like  chloroform,  ethyl  acetate  or  vinyl  acetate  gave  
significantly  decreased  enantiotope  selectivity  compared  to  that  obtained  in  the  best  solvent  
system  (hexane:THF  1:1).  Therefore,  we  investigated  the  solvent  dependence  of  the  PPL-
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catalyzed  acetylation  process  for  the  prochiral  sulfonic  ester  compounds  ( l a -c )  as  well.  
Trends  o f  solvent  dependence  of  the  enantiotope  selectivity  in  the  acetylation  o f  the  p-
toluenesulfonic  ester  ( l a )  representing  the  prochiral  2-sulfonyloxy  diols  were  found  similar  
(Table  2.) to the previous  results with  the  2-benzoyloxypropane-l,3-diol  (1,  Ri=OBz,  R2=H)  
[17]. The  degree of  selectivity,  however,  remained  significantly  lower  (31  %  ee)  even  in  the  
best hexane:THF  1:1 solvent  system.  
After  finding  common  conditions  for  the  lipase-calalyzed  enantiotope  selective  
acetylation (PPL, hexane:THF  1:1), the diols ( l a -h ) were  subjected to this  enzymatic  reaction  
(Table 3., Figure  2.).  
Prediction  o f  die  sense  o f  enantiotopic  selectivity  seemed  to  be  not  obvious  for  lipase-
catalyzed  acylation  o f  this  new  class  of  prochiral  1,3-propanediols.  The  lipase-catalyzed  
acylation  of  2-O-aIkyl-1,3-propanediols  (1,  R i , R 2 =  O-alkyl, H)  proved  to  be pro-S  selective.  
In  the  case  of  2-alkyl- 1,3-propanediols  (1,  Ri,R2=  aikyl,  H)  bearing  apolar  substituent  at  
position  2,  enantiotope  preference  is  inverted  in  a  geometrical  sense,  although  as  a  result  of  
the  sequence  rules,  the  affected  group  is  still  labeled  pro-S  [20].  Acetylation  of  the  diol  
bearing  2-N-benzyloxycarbonyl  [13]  or 2 - 0  benzoyloxy  [17]  group by PPL  was  found to  be  
pro-R  selective.  
Because  of the above  discussed  uncertainty  and  since  all the  products  (2b-h)  except  (2a)  
[21]  were  new  compounds,  absolute  configuration  determination  of  the  acetates  (2a-h)  was  
necessary  (Figure  2.).  The  configurations  were  determined  by  chemical  correlation  starting  
from  (R)-1 -acetoxy-3-benzyloxypropan-2-ol  (10).  The  monoacetate  (10)  with  known  R  
configuration  was  obtained  from  Lipase-AK  catalyzed  enantiomer  selective  acetylation  of  
racemic  3-benzyloxypropane-l,2-diol  (9)  [22].  This secondary alcohol  (10) was  acylated  into  
the  benzyl  protected  compounds  (12d-h)  from  which  debenzylation  gave  the  authentic  (/?)-
mono acetates  (i?)-(2d-h).  Comparing  the  optical, rotation  of  these  (J?)-(2d-h)  products  with  
those  o f  obtained  from  the  PPL-catalyzed  process  proved  the  R  configuration  o f  bulkier  
carboxylic  ester  products  (2e-h),  while  the  smaller  2-acetoxy  compound  (2d)  was  found  to  
have  S  configuration. The authentic (S)-bis-sulfonic esters  (enf-8a,b) were  also prepared  from  
(j?)-(10)  via  debenzylation  and  subsequent  bis-sulfonylation of the  chiral diol (13).  The  same  
bis-sulfonic  esters  having  opposite  sign  of  optical  rotation  (8a,b)  were  obtained  by  
sulfonylation of the enzymatic products (2a,b) proving their  S  configuration.  
The results listed  in Table  3.  indicated that the  degree  and even the  sense of  enantiotope  
selectivity  of  the  PPL-catalyzed  enantiotope  acetylation  of  the  prochiral  2-acyloxypropane-
1,3-diols ( l a -h )  was  strongly  dependent  on the  moiety  at  position  2.  Data obtained  with  the  
carboxylic  ester  series  ( ld -h)  showed  that  there  is  a  size  optima  at  the  size  of  the  4-
benzoyloxy [ lg - > 2g (>98 % ee)] moiety  for the  substituent at position 2. High but  somewhat  
lower  pro-R  selectivity  was  obtained  for  the  compounds  bearing  benzoyloxy  {(1,  R t=OBz,  
R2=H) ->  (2, R l=OBz,  R2=H)  (96 % ee)  [17]} or  cyclohexanecarbonyloxy  [ lh  - > 2h  (>95  %  
ee)]  moieties having  similar  bulkiness,  whereas the  more  bulky pivaloyloxy J l f  ->  2f  (67  %  
ee)] or diphenylacetoxy  [ le  —> 2e (16 % ee)] derivatives were transformed with decreased  but  
still pro-R  selectivity.  The  small acetoxy  [ l c  2c  (40  %  ee)] moiety  resulted  in  a  moderate  
pro-S  selectivity. Results for the sulfonic esters ( la-c)  showed that increasing the bulkiness  in  
the  closer  vicinity  of  the  prochiral  center  (Le.  change  of  the  O-CO-  to  the  sterically  more  
demanding  0 - S 0 2 -  structural  unit)  alters  the  sense  of  the  enantiotopic  preference,  too.  The  
prochiral  diol with  methanesulfonyloxy J l c  - »  2c  (~0  %  ee)]  moiety  was  acetylated  with  no  
selectivity,  while the  G?-toluenesulfonyl)oxy [ l a  - » 2a  (31  %  ee)] or benzenesulfonyloxy  [ l b  
-> 2b  (31 % ee)] compounds were acetylated with a moderate pro-S  selectivity.  
The carboxylic ester.type 2-(4-methylbenzoyl)oxy  product  (2g) allows the introduction  of  
a  leaving group at  a primary hydroxy lie function of an  almost  enantiomerically  pure  glycerol  
unit.  From  synthetic  point  of  view,  homochiral  form  of  the  sulfonic  ester  products  (2a-c)  
bearing  a  leaving group  at position  2  would  represent  a  different valuable  class of the  chiral  
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C3  units. Unfortunately, the  results for the PPL-catalyzed  acetylation o f the prochiral  sulfonic  
esters  ( l a - c )  providing  racemic  product  for  the  mesylate  (2c)  or  products  with  low  
enantiomeric  purity  for the  arylsulfonates  (2a,b),  were  disappointing.  As  a  representative  o f  
the  prochiral  sulfonic  esters,  2-(p-toluenesulfonyl)oxypropane-1,2-diol  ( l a )  was  therefore  
investigated with further enzymes (Table  4.).  
This study o f the acetylation of the prochiral tosylate ( l a )  with further enzymes was  only  
partially  successful. Although  lipases  from  Mucor  sp.  [Lipase  M  (f rom Mucor  javarticus)  and  
Lipozyme  EM  ( f rom  Mucor  miehei)]  catalyzed  the  acetylation  with  better  enantiotope  
selectivities than that  observed  with PPL,  enantiomeric  purities  of the product  (2a,  34  and  42  
%  ee, respectively) were  still too  low  for  synthetic  purposes.  
CONCLUSIONS 
In  conclusion,  a  strong dependence  o f the degree  and even the  sense of  selectivity  on  the  
2-acyloxy  moiety  in  the  PPL-catalyzed  acetylation  of  the  prochiral  2-acyloxypropane-l ,3-
diols ( l a - h )  was  found. The  slight  increase o f  size  of the  2-acyloxy  moiety  from  benzoyloxy  
(1,  Ri=OBz,  R 2 =H)  [17]  to  (4-methylbenzoyl)oxy  ( l g )  resulted  in  pronounced  enantiotope  
selectivity  (from 96  %  ee  [17]  to  >98  %  ee)  . providing  the  C3 compound  (2g)  in  almost  
enantiomerically  pure  form.  Although  the  diol  bearing  cyclohexanecarbonyloxy  moiety  at  
position  2  ( l h )  was  transformed  also  with  h igh  enantiotope  selectivity  (2h,  >95  %  e.e.),  
usefulness o f  this  acyl  derivative  is  limited  by  the  slow  but  significant  acyl  migration.  1,3-
Diols  wi th  significantly  smaller  ( l c ,d )  or  sterically  more  demanding  ( la ,b ,e , f )  moieties  at  
position 2 showed moderate, no or even altered  selectivities.  
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FIGURE  1.  Enantiotope  selective  biotransformation  of  prochiral  
1,3-propanediol derivatives (1 and 2) 
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FIGURE  2.  Preparation  of  2-acyloxypropane-l,3-diols  (la-h).  Reaction  conditions:  i.)  cat.  
H2SO4,  RT,  5  h,  35  %;  ii.)  RS02-C1,  KOH,  Et20,  -5°C,  40  min,  RT,  15  min,  43-92  %  ; Hi.) 
Acyl-Cl,  pyridine,  cat.  DMAP,  CH2C12,  RT,  1-12 h,  80-86  %;  iv.)  cc.  HC1,  MeOH,  reflux,  1  
min, 69-76 %; v.) H2,  10% Pd/C, /-PrOH, RT, 67-77 %. 
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FIGURE  3.  Enzymatic  acetylation  of  2-acyloxypropane-l,3-diols  ( la -h)  and  configuration  of  the  
products  (2a-h).  Reagents:  i.)  PPL,  vinyl  acetate,  hexane:THF  1:1,  RT;  ii.)  RS02-C1,  Et3N,  cat.  
DMAP,  CH2CI2,  RT,  43-92  %;  iii.)  Lipase-AK,  vinyl  acetate,  THF,  RT;  iv.)  Acyl-Cl,  Et3N,  cat.  
DMAP,  CH2CI2, RT,  80-86 %; v.) H2,10% Pd/C, /-PrOH, RT, 67-77 %. 
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TABLE  1. Determination  of the enantiomeric  excess  of 3-acetyloxy-2-acyloxypropan-L-ols  (2a-
g) 
Compound  [a]D  (c  1, methanol)  E.e. %  'H-NMR  signals of 2-MTPA esters  
2a  +92  31  1.93 (s);  1.93 (s) 
2b  +6.2  31  4.59-4.62 (dd); 4.57-4.59  (dd)  
2c  0  0  
2d  +1.8  40  4.56 (dd), 4.61  (dd)  
2e  -2.3  16  5.01 (s), 4.95 (s) 
2f  -8.0  67  1.17(d),  1.18(d)  
2g  -27.5  >98  3.49 (d), 3.52 (d) 
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TABLE 2 . Effect of the solvent  on acetylation of 2-(/?-toluenesulfonyl)oxypropane-1,2-dio 1 (la). 
Solvent Time 2a 
Yield  %  E.e.  % [a]D 
(c  1, methanol) 
acetonitrile 7 d 0 
chloroform 7 d 0 
diethyl  ether  Id 0 
ethyl  acetate  10h 64 0 0 
vinyl  acetate  7.5  h  67 5 +1.6 
THF 5 h 77 15 +4.5 
f-butanol 5  h  46 16 +4.7 
hexane:THF  1:1 (5 ml) 7  d  74 31 +9.2 
Reaction  conditions:  0.25g  of substrate  (la),  200  mg  of  porcine  pancreas  lipase  (PPL),  0.6  ml  
of vinyl acetate,  3 ml of solvent, stirring at room  temperature.  
6 
TABLE 3 . PPL-caialyzed  acetylation of 2-acyloxypropane-l,3-diols  (la-h)  
Compound Time Yield  % E.e. % * Configuration [a]D 
(c  1, methanol) 
2a 7 d 74 31 S +9.2 
2b 3  h  71 31 S +6.2 
2c 11 h 67 0 - 0.0 
2d 6  h  79 40 S +1.8 
2e 2 d 80 16 R -2.3 
2f 6  h  82 67 R -8.0 
2g 11 h 77 >98 R -27.5 
2h 5  h  66 > 95  #  R -8 .7 
Reaction  conditions:  0.25 g of substrate (la-h), 200 mg of PPL,  0.8 ml of vinyl acetate, 2.5 ml 
of THF and 2.5  ml of hexane,  stirring  at room temperature;  
* Determined  from the  'H-NMR spectra of the 2a-g MTPA esters.#  Determined  from  optical  
rotation compared  to 2h  prepared  from  12h  of known e.e. 
7 
TABLE 4. Effect of the enzyme on acetylation of 2-(p-toluenesulfonyl)oxypropane-l,2-diol  (la)  
Enzyme  (mg)  Time 2a 
Yield  % E.e.  %  [A]O (C 1, methanol) 
Novozym 435 (50) * 1 d 0 
Papain (200) * 4 d 0 
PfL (20) * 1 d 0 
CcL (100) * 1 d 64 1 -0.2 
Lipase  G (100) * 7 d 51 1 +0.4 
Lipase  A (100) * 7 d 47 2 +0.6 
Lipase AK (50) * 2  h  77 2 +0.7 
Lipase PS (50) * 3  h  72 3 +0.9 
Lipase N (100)  #  7 d 47 4 +1.2 
PPL (200) * 7 d 74 31 +9.2 
Lipase M  (50)#  2 d 75 34 +10.1 
Lipozym IM (50)  #  0.5  h  82 42 +12.5 
Reaction  conditions:  0.25 g of substrate  in the solvent, RT;  * Solvent:  vinyl acetate (2 ml); 
# Solvent: THF (2.5 ml), hexane (2.5 ml), vinyl acetate (0.8 ml) 
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A  series  of  l-acetoxy-3-aryloxypropan-2-ones  l a - m  were  synthesized  and  subjected  to biotransformation  by  
baker's yeast yielding optically active monoacetates 5 or ent-5  and/or diols 4 of moderate to excellent enantiomeric 
purity. The dependence  of  the reduction/hydrolysis  ratio  and stereoselectivity  on  the size  and substitution  pattern  
of  the aromatic moiety  in the substrate is also discussed.  ©  1998 Elsevier Science  Ltd. All rights reserved. 
3-AryIoxypropane-l,2-diols  4 a - m  in  enantiomerically  pure  form  are  versatile  compounds  of  interest  
as  intermediates  in  syntheses  of  pharmaceuticals  such  as  3-receptor  blockers,  or  as  chiral  fragments  in  
optically  active  crown  ethers.  Lipase  catalyzed  acylation  has  proved  to  be  a useful  tool  for  enantiomer  
separation  of  racemic  3-aryloxypropane-l,2-diol  derivatives.1,2  This  kinetic  resolution  using  lipase  
catalyzed  sequential  transesterification  was  found  to  be  highly  enantiomer  selective  for  diols  having  
m-  or  //-substituted  aromatic  moieties,  whereas  the  most  sterically  hindered  ¿/-substituted  derivatives  
showed  decreased  enantiomer  selectivity  or were not  accepted  as substrates.  Without racemization  of  the  
remaining  enantiomer,  however, even highly  enantiomer  selective processes  can  provide  only 50%  of  the  
starting  racemate  in optically  active form. 
Alternatively,  an  enantiotope  selective  method,  such  as  reduction  of  a  prochiral  ketone,  might  yield  
an optically  active product  quantitatively.  Since acetoxymethyl  ketones  with phenyl,3  benzyloxymethyl,4  
or  azidomethyl3  moieties  resulted  in  the  corresponding  monoacetates  of  high  enantiomeric  purity  by  
reduction  with  baker's  yeast,  it seemed  worthwhile  to  investigate  the  analogous  biotransformation  of  3-
aryloxy-l-acetoxypropan-2-ones  l a - m .  Here  we  report  our  results  on  the  preparation  and  baker's  yeast  
mediated  stereoselective  biotransformation  of these  ketones.  
The  3-aryloxy-l-acetoxypropan-2-ones  l a - m  were  prepared  by  alkylation  of  the  corresponding  
phenols  ( 3 a - m )  with  racemic  3-chloropropane-l,2-diol  rac-2,  followed  by  acetylation  of  the  primary  
*  Corresponding  author. E-mail:  poppe.szk@chem.bme.hu 
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Table  1  
Preparation  of  3-aryloxy-l-acetoxypropan-2-oncs  ( l a - m )  
Ar-O' OH 
rac-2 
OH 
rac-4a-m 
Ar-O'^j-^OAc 
OH 
rac- 5a-m 
Ar-O^Jf^OAc 
0 
l a -m 
Ar rac-4a-m rac-5a-m la -m 
Yield  (%)  Yield  (%)  Yield  (%)  
a phenyl 81 79 94 
b 1-naphthyl 82 78 93 
c 2-naphthyl 79 75 90 
d 2-isopropylphenyl 77 83 91 
e 2-chlorophenyl 74 73 88 
f 3-chlorophenyl 55 69 94 
g 4-chlorophenyl 81 62 94 
h 2-mcthylphenyl 79 66 90 
i 3-methylphenyl 66 75 90 
j 4-methylphenyi 71 75 89 
k 3-nitrophenyl 26 68 87 
1 2,6-dimethylphenyl 98 43 79 
m 2,4,6-trichlorophenyl 99 42 71 
Reagents: i.)  NaOH; U.) Ac20.  DMAP, pyridine; Hi.)  oxalyl  chloride,  DMSO, EljN; yields refer to isolated  pure products 
hydroxyl  moiety  of  the  resulting  diols  ( rac -4a-m)  and  Swern-oxidation  of  the  monoacetates  rac-5a-m  
(Table  1).  
Having  the  desired  ketones  in hand,  the  effect  of  the  reaction  conditions  on  enantiotope  selectivity  of  
the  baker's  yeast  reduction  of  1 -acetoxy-3-phenoxypropan-2-one  l a  was  investigated  (Table  2).  Under  
various  conditions,  the  reaction  yielded  the  expected  optically  active  monoacetate  5a  without  noticeable  
hydrolysis,  in  accordance  with  the  results  of  the  analogous  baker's  yeast  reductions.3 - 5  
In  baker's  yeast  mediated  enantiotope  selective  reduction  of  carbonyl  compounds  there  may  be  two  
factors  responsible  for  the  incomplete  stereoselectivity.  Firstly,  it  may  be  due  to  participation  of  more  
than  one  reductase  enzyme  with  different  kinetic  parameters  and  eventually  opposite  selectivity,6-8  or  
secondly,  the  process  may  be  catalyzed  by  a  single  enzyme  but  with  incomplete  selectivity.9  In  the  
majority  of  cases,  it turned  out  that  competing  enzymes  of opposite  selectivity  was  the factor  responsible  
for  poor  selectivity.  Since  the  kinetic  behavior  of  these  competing  enzymes  is  different,  the  selectivity  
may  be  controlled  by  the  reaction  conditions.  The  most  frequently  used  modifications  for  influencing  
the  selectivity  are  e.g.:  modification  of p H ; 1 0 1 1  application  of  lyophilized  yeast  instead  of  the  row  cake  
fo rm; 1 2 1 3  use  of  various  additives  such  as  metal  salts;14  allylic  alcohol  or  a ,3-unsaturated  carbonyl  
compounds;1 2 1" '  ethyl  chloroacetate  and  similar  compounds.1 6  In  Table  2  the  effect  of  these  factors  on  
the enantiotope  selectivity  is shown.  The  reaction  performed  by  wet caked  baker's  yeast  at pH  7 (entry  2)  
provided  the  best  selectivity.  This  selectivity  remained  practically  unaltered  at pH  8,  or  by  adding  some  
salts  or  allylic  alcohol  (entries  3 and  5-7) .  On  the  other  hand,  decreased  selectivity  was  observed  in  the  
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Table 2 
Effect of  the reaction  conditions  on the selectivity  of reduction  of the 
one  la  
-acetoxy-3-phenoxypropan-2-
Û L 
0 
Baker's Cl 
OH yeast i 
la 5a 
Entry Yeast PH Time Additive E.e.  %  
1 Wet Caked n.b.B 3 - 52 
2 Wet Caked 7 1 - 80 
3 Wet Caked 8 1 - 78 
4 Lyophilized 7 1.5 - 64 
5 Wet Caked 7 1 0.1 M K2S04 79 
6 Wet Caked 7 1 0.1 M MgS04 80 
7 Wet Caked 7 2 0.3 M allylic alcohol 79 
8 Wet Caked 7 2 0.15 M ethyl chloroacetate 37 
1  Reaction  conditions:  la,  500  mg;  media  (0.I5M  sodium  phosphate  buffer), 200  ml;  baker's  yeast,  wet  (12  g)  or  lyophilized  
(2.5 g); sucrose. 5 g.6  Non  buffered tap  water.  
non-buffered  reaction  (entry  1),  by  using  lyophilized  yeast  (entry  4)  or  by  adding  ethyl  chloroacetate  
(entry  8).  
Hence,  baker's  yeast  mediated  biotransformations  of  further  l-acetoxy-3-aryloxypropan-2-ones  l a - k  
were  performed  under  the  conditions  which  gave  the  best  selectivity  with  the  unsubstituted  phenoxy  
derivative  la .  The  results  of  these  reactions  are  summarized  in Table  3.  
Surprisingly,  only  the unsubstituted  phenoxy-derivative  l a  was  reduced  without  noticeable  amounts  of  
hydrolysis.  The  2-naphthyloxy-derivative  l b  was  not  reduced  at all,  and  all  the  other  ketones  l c - m  were  
transformed  not  only  into  the  corresponding  monoacetates  5  or  ent-5  but  partially  or  even  fully  into  the  
corresponding  diols  4  indicating  the enzyme  action  of  some  hydrolases  beside  oxidoreductases  in  these  
reactions.  The  differences  between  the  enantiomeric  purities  or  even  the  configuration  of  the  produced  
monoacetates  5  or  ent-5  and  diols  4  imply  that  in  these  reactions  more  than  one  type  of  selectivity  may  
be  decisive.  Analysis  of the  possible  pathways  and  selectivities  is shown  in Fig.  1.  
The  original  enantiomeric  composition  of the monoacetate  fraction  5  versus  ent-5  is determined  by  the  
enantiotope  selectivity  of  the  direct  reduction  (ki,R  versus  ki,<,n,.R).  The  formation  of  the  diol  fraction  
4  and  ent-4  may  proceed  via  two  alternative  routes.  The  first  possible  way  is  the  hydrolysis  of  the  
monoacetate  fraction  (5  and  ent-5)  by  which  the  original  enantiomeric  composition  may  be  altered  by  
the  enantiomer  selectivity  (k2.H  versus  k2,iVIi-H)  of  the  hydrolysis.  The  second  alternative  way  to  diols  
4  and  ent-4  is  the  non-stereoselective  hydrolysis  (ki.n)  of  the  achiral  acetoxy  ketone  1  followed  by  an  
enantiotope  selective  reduction  (k2,R  versus  k2,e,».R)  of  the forming  hydroxy  ketone  6.  
The  reactions  of  the  l-acetoxy-3-aryloxypropan-2-ones  l a - m  (Table  3)  in  buffered (pH  7) media  with  
fermenting  baker's  yeast  resulted,  with  the  exception  of  the  2-isopropyloxyphenoxy  compound  Id,  (5)-
monoacetates  5a,f-j,l ,m  and/or  of  the  (/?)-diols  4b ,d -m  indicating  the  same  geometric  preference  for  
both  products.  In  the  case  of  the  sterically  most  demanding  1-naphthyl  l b  or  phenyl  derivatives  with  
at  least  one  substituent  in  the  o-position  ld ,e ,h,l ,m,  the  formation  of  the  diol  4d,e,h,l,m  of  high  (>90%  
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Table  3  
Baker 's  yeast  mediated  biotransformation  of  l-acetoxy-3-aryloxypropan-2-ones  ( l a - k ) a  
A r - 0 A A 0 A c  B a k e ' s  Ar-O"'  Y ^ O A C A r - 0 " A Y 
sOH 
O yeast OH +  OH  
la-m (en/)-5a-m 4a-m 
Ar Time Monoacetate 5 or ent-S  b Diol 4 
(h) Yield  (%)  %e.e.  (config.)  Yield  (%)  %e.e (config.) 
a phenyl 1 84 83  c  - -
b 1-naphthyl 2 - - 78 >95 d (R) 
c 2-naphthyl 16 no  reaction  no  reaction  
d 2-isopropylphenyl 1 36 28 (Ä) 55 9 3 ' (R)d 
e 2-chlorophenyl 2 - - 82 >95' (.R) 
f 3-chlorophenyl 2 38 93 (5) 48 8 1 ' (R) 
g 4-chlorophenyl 2 65 61 (S) 25 6 3 ' (R) 
h 2-methylphenyl 2 32 65 CS) 47 > 9 5 ' (R) 
i 3-methylphenyl 2 66 77 (S) 26 8 2 ' (.R) 
j 4-methylphenyl 2 36 52 (S) 40 6 8 ' ( £ ) d 
k 3-nitrophenyl 4 - - 80 >95  d  (R) 
1 2,6-dimethylphenyl 1.5 60 >95 (S) 32 >95  d  (R) 
m 2,4,6- 6 58 95 (5) 34 92  d  (R) 
trichlorophenyl 
' Reaction conditions:  la-m,  500  mg;  potassium  phosphate  buffer  (0.15M.  pH  7),  200  ml;  wet  baker's  yeast,  12  g;  sucrose,  
5  g.  b  Configuration  and  enantiomeric  purity  of  the  monoacetates  (5)  were  determined  from  the  specific  rotation  of  the  
corresponding  diols  (4);c  From  'H-NMR  spectra  of  the  MTPA ester  of  Sa; " From optical  rotation  of the diol  [(R)-4)  obtained  by  
alkylating  the corresponding  phenol  (3)  with  (R)-3-chloropropane-1.2-diol  [(R)-2,95  % e.e.]17; '  From  'H-NMR  spectra  of  the di-
MTPA ester  of  the diol. 
A r - 0 " Y Y O A c 
O 
la-m 
Ar-O  y  OAc  
OH 
M.H 
5a-m 
Ar-0  ^ r  OAc  
ÖH 
k->, 
k, .cm-H 
O 
6a-m 
Ar-O  y  OH  
OH 
4a-m 
Ar-O  OH  
6H 
ent-4a-m 
S-2.R 
ertr-5a-m 
Fig.  1. Baker 's  yeast  mediated  reaction  of  l-acetoxy-3-aryloxypropan-2-ones  l a - m  
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e.e.) enantiomeric  purity  is common.  The  reaction  of ketone  with  the  more  bulky  m-nitrophenyl  moiety  
l k  proceeded  also  with  high  selectivity,  while  the compounds  with  smaller /n-substitutents  of the  phenyl  
moiety  l f , i were transformed  with less remarkable  stereoselectivities.  The lowest selectivities  were found 
in the reactions  of the compounds  with /»-substituted  phenyl  rings  l g j .  In three cases,  the diol 4b,e,k  was  
the  sole  product,  while  in  the  other  reactions,  both  the  non-hydrolyzed  monoacetate  ent-Sdf  5f - j , l ,m  
and  the  diol  4d , f - j , l ,m  were  obtained  with  variable  enantiomeric  compositions.  These  results  might  
be  best  interpreted  by  assuming  first  a  fast  enantiotope  selective  reduction  of  the  acetoxy  ketones  1  
with  variable  degree  of  (5)-enantiomer  preference  (ki,R>kiiOT/.R),  followed  by  an  enantiomer  selective  
hydrolysis  (k2,H>k2,«ir-H) with preference towards  the (/?)-diols 4.1 8  By this assumption,  formation of  the  
(/?)-monoacetate  ent-5d  of low enantiomeric excess can also be interpreted  without assuming the  unlikely  
configuration-preference  change  of  the  reduction  within  the  series  of  acetoxy  ketones  1.  Accordingly,  
this  reaction  may  be  the  result  of  the  reduction  of  the  acetoxy  ketone  I d  with  moderate  (5)-enantiotope  
selectivity  followed by  hydrolysis  with  high  enantiomer  selectivity  towards  the  (/?)-diol  4d,  leaving  the  
non-hydrolyzed  (R)-monoacetate  ent-Sd  in excess  in  the  remaining  monoacetate  fraction.  
In conclusion,  baker's  yeast  mediated  reaction  of the  l-acetoxy-3-aryloxypropan-2-ones  l a - m  proved  
to  be  a  useful  method  for the  preparation  of  optically  active  3-aryloxypropan-l,2-diol  derivatives.  This  
transformation showed high selectivities  with the ketones  of sterically hindered  aryl moieties,  while  lower  
selectivities  were found for the  less hindered  ketones  with m- or p-substituted  phenyl  moieties.  Since  the  
opposite  tendency  (i.e.  higher  selectivity  for  the  less  hindered  compounds)  was  found  by  the  lipase-
catalyzed  enantiomer  selective  acylation  processes  of  the  similar  3-aryloxypropan-l,2-diol  derivatives,  
the present baker's  yeast mediated  method  seems to be useful for preparing  such diols bearing  a  sterically  
hindered  aryl  moiety.  
1.  Experimental  
The  ' H  NMR  spectra  were  recorded  on  a  Bruker  AW-250  spectrometer  operating  at  250  MHz.  J H  
N M R  spectra  for  enantiomeric  excess  determinations  were  recorded  at  500  MHz  on  a  Bruker  DRX-
500  spectrometer.  All  spectra  were  taken  in  CDCI3  solution  and  chemical  shift  values  are  expressed  
in  ppm  values  from  TMS  as  internal  standard  on  §  scale.  IR  spectra  of  thin  film  samples  were  
taken  on  a  Specord  2000  spectrometer.  Optical  rotations  were  determined  on  a  Perkin-Elmer  241  
polarimeter.  Thin  layer  chromatography  was  carried  out  using  Merck  Kieselgel  60  F254 alumina  sheets  
applying  hexane:acetone=I0:4  (A) or chloroform:methanol=10:0.5  (B) mixtures  forelution.  Spots  were  
visualized  by treatment  with 5% ethanolic  phosphomolybdic  acid  solution  and heating of the dried  plates.  
Preparative  chromatographic  separations  were  performed  using  vacuum-chromatography19  on  Merck  
Kieselgel  60  (0.063-0.200  mm).  Phenols,  racemic  3-chloropropane-l,2-diol  and  acetic  anhydride  were  
products  of FLUKA or Aldrich.  All  solvents  used  were freshly distilled.  Wet cake or lyophilized  form  of  
baker's  yeast  were from a local  store.  
1.1.  Preparation  of 3-aryloxypropane-l,2-diols  ra.c-4a-m  
To the  solution  of  the phenol  derivative 3 a - m ,  0.1  mol  in ethanol  (60  ml)  a  solution  of NaOH (5.0  g,  
0.125  mol)  in water (20 ml) was  added  and the resulting  mixture  was heated  under  reflux for  10  minutes.  
Then  a  solution  of  racemic  3-chloropropane-l,2-diol  rac-2,  13.3  g,  0.12  mol  in  ethanol  (10  ml)  was  
added  within  5 minutes  and  the  mixture  was  further heated  under  reflux  for between  1 and  2 hours  (the  
progress  of  the  reaction  was  monitored  by TLC;  solvent  A).  After cooling,  the  volume  of  the  resulting  
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mixture  was  reduced  to  about  one  third  by  a  rotary  evaporator  followed  by  addition  of  water  (60  ml)  
and  extraction  with  diethyl  ether (2x75  ml). The combined  organic  layers  were  dried  over Na 2 S0 4  and  
the  solvent  was removed. The  resulting diols 4 a - m  were  usually  purified by  recrystallization  from a  1:1  
mixture  of hexane and diethyl  ether. For yields,  see Table  1.  
1.1.1.  rac-3-Phenoxypropane-l,2-diol  rac-4a  
*H NMR:  3.65-3.85  (m,  2H, CH2-OH),  4.0  (m,  1H, CH), 4.10-4.22  (m,  2H, ArO-CH2) ,  6.84-7.25  
(m, 5H, ArH). IR: 3450 (br), 2910,  1600,1590,1500,1460,1170,1120,1060,1050,  880,750,690  cm" 1 .  
Calcd for C 9 H I 2 0 3 :  C 64.27,  H 7.19. Found:  C 64.46,  H  7.17.  
1.1.2.  ra.c-3-(l -Naphthyloxy)propane-l ,2-diol  rac-46  
NMR:  3.86  (m,  2H,  CH2),  4.02-4.14  (m,  3H,  CH  and ArO-CH2),  6.75-8.24  (m,  7H,  ArH).  IR:  
3290 (br), 2940,1730,  1580,1510,1470,  1390,1270,  1240,1130,1110,  1040, 990, 890, 790,770  cm" 1 .  
Calcd for C13H14O3:  C 71.54,  H 6.47. Found:  C 71.68,  H  6.46.  
1.1.3.  xzc-3-(2-Naphthyloxy)propane-l,2-diol  rac-4c  
"H NMR:  3.77  (m,  2H, CH2-OH),  3.92  (m,  1H, CH),  4.07-4.26  (m,  2H, ArO-CH2) ,  7.09-7.73  (m,  
7H, ArH). IR: 3400 (br), 2940,  1630,  1600,  1510,  1460,  1260,  1220,1180,  1060,  1000, 840,740  cm" 1 .  
Calcd for C13H14O3:  C 71.54,  H 6.47. Found:  C 71.25,  H  6.50.  
1.1.4.  Ta.C'3-(2-Isopropylphenoxy)propane-l,2-diol  rac-4d  
' H  NMR:  1.24  (d,  6H,  2CH3),  3.16,  (m,  1H,  CH-Ar),  3.74  (m,  2H,  CH2-OH),  4.03  (m,  1H,  CH),  
4.07-4.18  (m,  2H, ArO-CH2) ,  6.81-7.25  (m,  4H,  ArH).  IR:  3300  (br),  2960,  2870,  1600,  1500,  1460,  
1380,  1240,  1080,  1050,  930, 760 cm" 1 .  Calcd for C I 2 H I 8 0 3 :  C 68.55,  H 8.63. Found:  C 68.28,  H  8.66.  
1.1.5.  rac-3-(2-Chlorophenoxy)propane-l,2-diol  rac-4e  
' H  NMR:  3.78  (m,  2H,  CH2-OH),  4.07  (m,  1H, CH),  4.10  (m,  2H,  ArO-CH2) ,  6.88-7.31  (m,  4H,  
ArH).  IR:  3300  (br),  2940,  1590,  1490,  1450,  1300,  1250,  1130,  1070,  1030,  740  cm" 1 .  Calcd  for  
C9H11O3CI:  C 53.35,  H 5.47.  Found:  C 53.40,  H  5.46.  
1.1.6.  rac-3-(3-Chlorophenoxy)propane-l,2-diol  rac-4f  
' H  NMR:  3.75  (m,  2H,  CH2-OH),  3.96  (m,  1H,  CH),  4.07  (m,  2H, ArO-CH2) ,  6.69-7.24  (m,  4H,  
ArH).  IR:  3300  (br),  2930,  1600,  1470,  1430,  1280,  1230,  1120,  1060,  890,  860,  770,  680 cm" 1 .  Calcd  
for C9H11O3CI:  C  53.35,  H 5.47. Found:  C 53.37,  H  5.45.  
1.1.7.  ta.c-3-(4-Chlorophenoxy)propane-l,2-diol  rac-4g  
*H NMR:  3.78  (m,  2H,  CH2-OH),  4.01  (m,  1H,  CH),  4.10  (m,  2H,  ArO-CH2) ,  6.79-7.26  (m,  4H,  
ArH).  IR:  3300  (br),  2920,  1600,  1490,  1450,  1280,  1240,  1110,  1050,  880,  820  cm" 1 .  Calcd  for  
C9H11O3CI:  C  53.35,  H 5.47.  Found:  C 53.33,  H  5.49.  
1.1.8.  rac-3-(2-Methylphenoxy)propane-l,2-diol  rac-4h  
' H  NMR:  2.23  (s,  3H,  CH3),  3.76  (m,  2H,  CH2-OH),  4.01  (m,  1H,  CH),  4.12  (m,  2H,  ArO-CH2),  
6.78-7.18  (m,  4H,  ArH).  IR:  3260  (br),  2930,  1610,  1500,  1460,  1310,  1250,  1120,  1050,  990,  750  
cm" 1 .  Calcd  for C10H14O3: C  65.92,  H 7.74. Found:  C 65.69,  H  7.72.  
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1.1.9.  rac-3-(3-Methylphenoxy)propane-l,2-diol  rac-4i  
' H  NMR:  2.27  (s,  3H,  CH3),  3.76  (m,  2H,  CH 2 -OH),  4.00  (m,  1H,  CH),  4.08  (m,  2H,  ArO-CH2),  
6.67-7.18  (m,  4H,  ArH).  IR:  3290  (br),  2930,  1610,  1590,  1490,  1450,  1290,  1260,  1160,  1060,  910,  
860,  770, 690 cm" 1 .  Caled  for C10H14O3: C  65.92,  H  7.74. Found:  C 65.74,  H  7.73.  
1.1.10.  rac-3-(4-Methylphenoxy)propane-l,2-diol  rae-4/  
' H NMR: 2.25 (s, 3H, CH3), 3.72-4.00 (m, 2H, CH 2 -OH),  3.96 (m,  1H, CH), 4.13 (m, 2H, ArO-CH2),  
7.24-7.87  (m, 4H, ArH). IR: 3390 (br),  1580,  1520,  1440,  1360,1320,1250,  1140,  1080,1010,  870,  820  
cm" 1 .  Caled  for C 1 0 Hi 4 O 3 :  C 65.92,  H 7.74. Found:  C 65.99,  H  7.74.  
1  1.1.11.  rac-3-(3-Nitrophenoxy)propane-l,2-diol  rae-4k  
' H  NMR:  3.72-4.00  (m,  2H, CH2),  4.13  (m,  3H,  CH2  and  CH),  7.24-7.87  (m,  4H,  ArH).  IR:  3390  
(br),  1580,  1520,  1440,  1360,1320,  1250,  1140,  1080,  1010,  870,  820, 740 cm" 1 .  Caled for C 9 H n N 0 5 : 
C  50.71,  H 5.20,  N  6.57. Found:  C 50.56,  H  5.22,  N  6.59.  
1.1.12.  Tac-3-(2,6-Dimethylphenoxy)propane-l,2-diol  rae-4/  
' H NMR: 2.21  (s, 6H, CH3),  3.78 (m, 4H, C H 2 - O H  and CH2-OAr), 4.07  (m,  1H, CH), 6.80-7.00  (m,  
3H, ArH). IR: 3384  (br), 2925,  1592,  1477,  1264,  1201,  1026,768 cm" 1 .  Caled  for C n H i 6 0 3 :  C  67.32,  
H  8.22. Found:  C  67.38,  H  8.19.  
1.1.13.  TaC'3-(2,4,6-Trichlorophenoxy)propane-l,2-diol  rac-4m  
' H  NMR:  3.50-4.55  (m,  5H, CH 2 -OH,  CH 2 -OAr  and  CH),  7.25  (s, 2H,  ArH).  IR:  3312  (br),  2943,  
1572,  1553,  1447,  1256,  1053,  858 cm" 1 .  Caled  for C9H9C1303 :  C  39.81,  H  3.34.  Found:  C  39.67,  H  
3.39. 
1.2.  Preparation  of  l-acetoxy-3-aryloxypropan-2-ols  rac-5a-m  
To  a  solution  of  3-aryloxypropane-l,2-diol  rac-4a-m,  50  mmol,  pyridine  (60  mmol)  and  (4-N,N-
dimethylamino)pyridine  (100 mg) in methylene chloride (100 ml) acetic anhydride  (50 mmol) was  added  
dropwise  and  the  resulting  solution  was  stirred  for between  10 and  60  minutes.  Then  the  mixture  was  
washed  with  5%  hydrochloric  acid (2x20  ml),  saturated  NaHC0 3  solution  (20  ml)  and  brine  (15  ml).  
After drying  over N a 2 S 0 4  the solvent  was  removed  by  rotary  evaporation.  The  residue  was purified  by  
preparative  vacuum-chromatography  by eluting  with  hexane:acetone  10:1—10:3.  Yields  of  the  products  
rac-5a-m  are given  in Table  1.  
1.2.1.  rac-l-Acetoxy-3-phenoxypropan-2-ol  rac-5a  
' H  N M R :  2.04  (s,  3H,  C H 3 C O O ) ,  4.05  (m,  2H,  A I O - C H 2 ) ,  4.09  ( M ,  1H, C H ) ,  4.08-4.17  (m,  2H,  
AcO-CH2) ,  6.76-7.22  (m,  5H,  ArH).  IR:  3450  (br),  2940,  1740,  1600,  1500,  1370,  1240,  1050,  760  
c m - 1 . C a l c d f o r C | | H i 4 0 4 :  C 62.85, H6.71.  Found: C62.66,  H6.70.  
1.2.2.  rac-1 -Acetoxy-3-( 1 -naphthyloxy)propan-2-ol  rac-5b  
! H  NMR:  2.14  (s, 3H,  CH3COO),  4.19  (m,  2H,  ArO-CH2) ,  4.28-4.46  (m,  3H, AcO-CH 2  and  CH),  
6.77-8.25 (m, 7H, ArH). IR: 3450 (br),  1710,  1580,1460,1400,1370,  1270,1240,1110,1050,950,790,  
270 cm" 1 .  Calcd for C l 5 H i 6 0 4 :  C 69.22,  H 6.20. Found:  C 69.43,  H  6.19.  
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1.2.3.  rac-7 -Acetoxy-3-(2-naphthyloxy)propan-2-ol  rac-5c 
l H  NMR:  2.12  (s,  3H,  CH3COO),  4.14  (m,  2H,  ArO-CH 2) ,  4.31  (m,  3H,  CH  and  AcO-CH2) ,  
7.13-7.78  (m, 7H,  ArH).  IR:  3450  (br),  2940,  1740,  1630,  1600,  1510,  1460,  1390,  1260,  1220,  1180,  
1050,  840 c m - 1 .  Calcd for C |5H i 60 4 :  C 69.22,  H  6.20. Found:  C 69.35,  H  6.22.  
1.2.4.  TBC-l-Acetoxy-3-(2-isopropylphenoxy)propan-2-ol rac-5d 
' H NMR:  1.10 (d, 6H, 2CH3), 2.10 (s, 3H, CH3COO), 3.17 (m,  1H, CH-Ar), 3.84 (m, 2H,  ArO-CH 2) ,  
4.16 (m, 3H, CH and AcO-CH2) , 6.67-7.11  (m, 4H, ArH). IR: 3460 (br), 2960,2870,  1740,1490,1250,  
1370,  1240,  1090,  1050, 750 cm"1 .  Calcd for Q4H20O4:  C 66.65,  H  7.99. Found:  C 66.45,  H  8.02.  
1.2.5.  mc-l-Acetoxy-3-(2-chlorophenoxy)propan-2-ol  rac-5e  
' H  NMR:  1.94  (s,  3H,  CH3COO),  3.91  (m,  2H,  ArO-CH 2) ,  4.16  (m,  3H,  CH  and  AcO-CH2) ,  
6.74-7.21  (m,  4H,  ArH).  IR:  3440  (br),  2950,  1740,  1590,  1490,  1450,  1370,  1250,  1130,  1060  cm" 1 .  
Calcd for C11H13O4CI:  C 54.00,  H 5.36. Found:  C 54.16,  H  5.34.  
1.2.6.  rac-l-Acetoxy-3-(3-chlorophenoxy)propan-2-ol  rac-5f  
*H  NMR:  1.97  (s,  3H,  CH3COO),  3.81  (m,  2H,  ArO-CH2) ,  4 1 1  (m,  3H,  CH  and  AcO-CH2) ,  
6.62-7.09  (m,  4H,  ArH).  IR:  3440  (br),  2950,  1740,  1600,  1480,  1370,  1230,  1070,  1050,  860  cm" 1 .  
Calcd  for C n H , 3 0 4 C l ;  C 54.00,  H 5.36. Found:  C 53.89,  H  5.38.  
1.2.7.  rac-l-Acetoxy-3-(4-chloropkenoxy)propan-2-ol  rac-Sg  
' H  NMR:  2.06  (s,  3H,  CH3COO),  3.98  (m,  2H,  ArO-CH2) ,  4.07  (m,  1H,  CH),  4.25  (m,  2H,  
AcO-CH2) ,  6.77-7.23  (m, 4H,  ArH).  IR:  3450  (br),  2950,  1740,  1600,  1490,  1370,  1240,  1170,  1090,  
1050,  850 cm" 1 .  Calcd for Ci iHi 3 0 4 Cl :  C 54.00,  H  5.36. Found:  C 54.12,  H  5.35.  
1.2.8.  rac-l-Acetoxy-3-(2-methylphenoxy)propan-2-ol rac-5h 
1 H NMR: 2.02 (s, 3H, CH3COO), 2.22 (s, 3H, CH3), 3.95 (m, 2H, ArO-CH2),  4.08 (m,  1H, CH),  4.25 
(m, 2H, AcO-CH2) ,  6.75-7.12  (m, 4H, ArH). IR: 3450  (br), 2950,  1740,  1600,  1500,  1460,  1380,  1240,  
1190,  1120,  1050, 750 cm" 1 .  Calcd for C i 2 H | 6 0 4 :  C 64.27,  H 7.19. Found:  C 64.40,  H  7.20.  
1.2.9.  Tac-l-Acetoxy-3-(3-methylphenoxy)propan-2-ol  rac-5i  
' H  NMR:  1.96  (s,  3H,  CH3COO),  2.16  (s,  3H,  CH3),  3.79  (m,  2H,  ArO-CH2),  3.90-4.10  (m,  3H,  
CH and AcO-CH2) ,  6.56-7.00  (m, 4H, ArH). IR: 3450  (br), 2926,  1740,  1600,  1590,  1490,  1460,  1370,  
1260,  1160,  1050, 780 cm" 1 .  Calcd for C i 2 H | 6 0 4 :  C  64.27,  H 7.19. Found:  C 64.18,  H  7.18.  
1.2.10.  rac-l-Acetoxy-3-(4-methylphenoxy)propan-2-oI  rac-5/  
' H  NMR:  1.89  (s,  3H,  CH3COO),  2.10  (s,  3H,  CH3),  3.80  (m,  2H,  ArO-CH2),  4.04-4.11  (m,  3H,  
CH  and AcO-CH2) ,  6.62-6.91  (m, 4H, ArH). IR: 3450 (br),  2930,  1740,  1610,  1510,  1460,  1370,  1240,  
1180,  1050, 820 cm" 1 .  Calcd f o r C | 2 H i 6 0 4 :  C 64.27,  H 7.19. Found:  C 64.21,  H  7.18.  
1.2.11.  vac-l-Acetoxy-3-(3-nitrophenoxy)propan-2-ol  rac-5k  
' H  NMR:  2.12  (s,  3H,  CH3COO),  3.72-4.00  (m,  2H,  ArO-CH2) ,  4.14  (m,  1H,  CH),  4.31  (m,  2H,  
AcO-CH2) ,  7.25-7.83  (m,  4H,  ArH).  IR:  3330  (br),  2950,  1740,  1620,. 1530,  1350,  1240,  1050,  1030,  
820,  740 cm" 1 .  Calcd  for C u H i 3 0 6 N :  C 51.77,  H 5.13,  N 5.49. Found:  C  51.56,  H 5.12,  N  5.51.  
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1.2.12.  rae-1 -Acetoxy-3-(2,6-dimethylphenoxy)propan-2-ol rac-5/ 
'HNMR: 2.12 (s, 3H, CH3COO), 2.30 (s, 6H, CH3), 3.80 (m, 2H, ArO-CH2), 3.95 (m,  1H, CH), 4.30 
(m, 2H, AcO-CHi), 6.90-7.10 (m, 3H, ArH). IR: 3456 (br), 2926,  1740,  1592,  1375,1243,  1201,  1092,  
1046, 771 cm"1.  Caled for C I 3 H I 8 0 4 :  C 65.53, H 7.61. Found: C 64.97, H 7.72. 
1.2.13.  rac-l-Acetoxy-3-(2,4,6-trichlorophenoxy)propan-2-ol rac-5wi 
'H  NMR: 2.05 (s,  3H, CH3COO),  4.10 (m,  3H, ArO-CH2  and CH), 4.30  (m, 2H, AcO-CH2),  7.30  
(s, 2H, ArH). IR: 3448 (br), 3076, 2953,  1741,  1553,  1448,  1248,  1047,  1005, 857, 809 cm"1.  Caled for 
CIIHHC1304: C 42.14, H 3.54, CI 33.92. Found: C 42.25, H 3.50. 
1.3.  Preparation of 1-acetoxy-3-aryloxy-propan-2-ones la—m by Swern-oxidation 
To  a  solution  of  oxalyl  chloride  (1.35  ml,  15.0  mmol)  in  methylene  chloride  (25  ml)  dimethyl  
sulfoxide (2.3 ml, 32.0 mol) in methylene chloride (5.0 ml) was added dropwise at -60°C. After stirring 
the  resulting  mixture  for  10 minutes,  racemic  l-acetoxy-3-aryloxypropan-2-ol  rac-5a-m,  10 mmol  in  
methylene  chloride  (10 ml)  was  added  at  -60°C  followed  by  stirring  for 20  minutes  at  -60CC.  Then  
triethylamine  (7.0  ml,  50  mmol)  was  added  and  the  temperature  was  increased  to  room  temperature  
within 30 min. The resulting mixture was washed with water (30 ml) and the aqueous layer was extracted 
with  methylene  chloride  (20 ml).  The combined  organic  solutions  were  washed  with  5%  hydrochloric  
acid  (20  ml),  saturated  NaHC03  solution  (15  ml)  and  brine  (15  ml).  After  drying  over Na2S04  and  
the  solvent  was  removed  in  vacuo.  The  resulting  product  was  usually  pure  enough  for  the  next  step.  
In  several  cases the product  was purified by preparative  vacuum-chromatography  using  hexane:acetone  
10:0.5—10:1 for the elution. For yields  of the resulting ketones la-m,  see Table  1.  
1.3.1.  1 -Acetoxy-3-phenoxypropan-2-one  la  
•H NMR: 2.15 (s, 3H, CH3COO), 4.63 (s, 2H, CH2), 4.98 (s, 2H, CH2), 6.87-7.35  (m, 5H, ArH). IR: 
1740,  1600,  1500,  1430,  1380,  1240,1160,  1070, 760, 690 cm"1.  Calcd for CnH1204:  C 63.45, H 5.81. 
Found: C 63.58, H 5.79. 
1.3.2.  1 -Acetoxy-3-( 1 -naphthyloxy)propan-2-one  lb  
'H NMR: 2.11 (s, 3H, CH3COO), 4.62 (s, 2H, ArO-CH2), 4.96 (s, 2H, AcO-CH2), 6.48-8.17 (m, 7H, 
ArH). IR:  1740,  1630,  1580,  1510,1420,  1400,  1370,  1310,  1240,  1110,  1040,  1020, 980, 860, 790, 770 
cm"1.  Calcd for C I 5 H I 4 0 4 :  C 69.76, H 5.46. Found:  C  69.48, H 5.44. 
1.3.3.  l-Acetoxy-3-(2-naphthyloxy)propan-2-one  lc  
'H NMR: 2.21 (s, 3H, CH3COO), 4.75 (s, 2H, ArO-CH2),  5.02 (s, 2H, AcO-CH2), 7.04-7.81 (m, 7H, 
ArH). IR:  1750,  1730,  1630,  1600,  1510,  1430,  1410,  1370,  1300,  1260,  1250,  1220,  1180,  1110,  1080,  
1030,  1000, 840,  810, 740 cm"1. Calcd for C|5Hi404:  C 69.76, H 5.46. Found: C 69.57, H 5.45. 
1.3.4.  l-Acetoxy-3-(2-isopropylphenoxy)propan-2-one Id 
'H  NMR:  1.15  (d,  6H,  2CH3),  2.03  (d,  6H,  2CH3),  3.25  (m,  1H, CH-Ar),  4.51  (s,  2H,  ArO-CH2),  
4.92  (s,  2H, ACO-CH2),  6.58-7.19  (m,  4H, ArH) .  IR:  2960,  1740,  1600,  1590,  1490,  1450,  1370,  1240,  
1170,  1090,  1070,750 cm"1.  Calcd for CI4HI804:  C  67.18,  H  7.25.  Found:  C  67.42,  H  7.25.  
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1.3.5.  l-Acetoxy-3-(2-chlorophenoxy)propan-2-one  le  
'H  NMR:  2.01  (s,  3H,  CH3COO),  4.57  (s,  2H,  ArO-CH2),  5.0  (s,  2H, AcO-CH2),  6.72-7.31  (m,  
4H,  ArH).  IR:  1740,  1590,  1480,  1420,  1400,  1370,  1300,  1240,  1160,  1070,  750  cm"1.  Caled  for  
C11H11O4CI:  C 54.45, H 4.57. Found: C 54.57, H 4.55. 
1.3.6.  l-Acetoxy-3-(3-chlorophenoxy)propan-2-one  lf  
'H  NMR:  2.05  (s,  3H,  CH3COO),  4.60  (s,  2H, ArO-CH2),  4.88  (s,  2H, AcO-CH2),  6.62-7.22  (m,  
4H, ArH). IR: 2930,  1740,1590,1480,  1430,  1380,  1290,  1230,  1170,  1070,  1020, 860, 770,680 cm"1.  
Caled for Ci 1H11O4CI: C 54.45, H 4.57. Found: C 54.61, H 4.58. 
1.3.7.  l-Acetoxy-3-(4-chlorophenoxy)propan-2-one Ig 
'H  NMR:  2.05  (s,  3H,  CH3COO),  4.56  (s,  2H, AIO-CH2),  4.87  (s,  2H,  AcO-CH2) ,  6.73-7.21  (M,  
4H,  ArH).  IR:  1740,  1600,  1490,  1430,  1370,  1280,  1240,  1160,  1070,  1020,  830 cm"1.  Caled  for  
C11H11O4CI: C  54.45,  H 4.57.  Found:  C  54.39,  H  4.57.  
1.3.8.  1 -Acetoxy-3-(2-methylphenoxy)propan-2-one  lh 
'H NMR: 2.10 (s, 3H, CH3COO),  2.23 (s, 3H, CH3), 4.60 (s,  2H, AIO-CH2),  4.95 (s,  2H,  AcO-CH2),  
6.64-7.09  (m, 4H,  ArH).  IR:  1750,  1600,  1590,  1490,  1430,  1400,  1370,  1240,  1160,  1120,  1060,  850,  
810,750 cm - 1 .  Caled for Ci2HI404 :  C 64.85,  H 6.35.  Found: C 64.59,  H  6.34.  
1.3.9.  l-Acetoxy-3-(3-methylphenoxy)propan-2-one  li  
'H NMR: 2.02 (s, 3H, CH3COO),  2.17 (s, 3H, CH3), 4.51 (s, 2H, ArO-CH2),  4.87 (s, 2H, AcO-CH2), 
6.54-7.07 (m, 4H, ArH). IR: 2920,  1740,  1600,  1590,  1490,  1430,  1370,  1290,  1230,  1150,  1070,  1030,  
880, 780, 690 cm"1.  Caled for Ci2Hi404:  C 64.85, H 6.35. Found: C 64.90, H 6.35. 
1.3.10.  l-Acetoxy-3-(4-methylphenoxy)propan-2-one l j 
'H NMR: 2.11 (s, 3H, CH3COO),  2.21 (s, 3H, CH3), 4.57 (s, 2H, ArO-CH2), 4.95 (s, 2H, AcO-CH2), 
6.61-7.03 (m, 4H, ArH). IR: 2930,  1740,  1610,  1510,  1430,  1410,  1380,  1290,  1240,  1160,  1070,  1020,  
820 cm-1.  Caled for CI2HI404:  C 64.85, H 6.35. Found: C 64.71, H 6.33. 
1.3.11.  l-Acetoxy-3-(3-nitrophenoxy)propan-2-one lk 
'H  NMR:  2.11  (s,  3H,  CH3COO),  4.78  (s,  2H, ArO-CH2),  4.91  (s,  2H, AcO-CH2),  7.19-7.87  (m,  
4H, ArH).  IR:  1750,  1730,  1530,  1480,  1410,  1350,  1240,  1100,  1030,  870,  810,  740 cm"1.  Caled for 
C H H I I 0 6 N :  C 52.18, H 4.38,  N  5.53. Found: C 52.03, H 4.39,  N  5.52.  
1.3.12.  l-Acetoxy-3-(2,6-dimethylphenoxy)propan-2-one 11 
'H NMR: 2.05 (s, 3H, CH3COO),  2.14 (s, 6H, CH3), 4.36 (s, 2H, ArO-CH2), 4.99 (s, 2H, AcO-CH2), 
6.92  (m,  3H,  ArH).  IR:  2937,  1750,  1734,  1475,  1396,  1231,  1168,  1075,  1058,  788 cm"1.  Caled for 
C,3H|604:  C 66.09, H 6.83. Found: C 66.01, H 6.79. 
1.3.13.  l-Acetoxy-3-(2,4,6-trichlorophenoxy)propan-2-one lm 
'H  NMR:  2.18  (s,  3H,  CH3COO),  4.60  (s,  2H,  ArO-CH2),  5.20  (s,  2H,  AcO-CH2),  7.34  (s,  2H,  
ArH). IR: 3066, 2934,  1739,  1728,  1554,  1456,  1422,  1281,  1259,  1070,  1015, 858, 769 cm"1. Caled for 
C11H9CI3CU:  C 42.41, H 2.91. Found: C 42.36, H 2.95. 
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1.4.  Optimization of the reaction conditions for  reduction  of 1-acetoxy-3-phenoxypropan-2-one la 
To 200 ml  of media (as indicated  in Table 2)  l-acetoxy-3-phenoxypropan-2-one  la,  500 mg, sucrose 
(5.0 g),  baker's  yeast  (wet cake  12 g;  or  lyophilized  2.5 g)  and  additive  (as  indicated  in  Table  2) were 
added and the resulting mixture was stirred at room temperature for a period indicated in Table 2. Then the 
reaction  mixture was extracted  with ethyl acetate (2x150 ml), the combined organic layers were washed 
with  brine  (20  ml)  and  dried  over  Na2S04.  After  removing  the  solvent  the  residue  was  subjected  to  
preparative  vacuum-chromatography  (hexane:acetone  10:1—10:5) to yield 75-85% of pure monoacetate 
5a. The enantiomeric composition  of the product 5a (Table 2) was determined by esterification with (/?)-
MTPA-C1 [0.05 mmol scale; triethylamine, cat. DMAP, in CCU, 50°C, 3 h] and 'H NMR analysis  of the 
5a-MTPA-ester  [characteristic  signals:  2.001 (s, C O C H 3 )  for (S)-5a-MTPA ester; 2.065 (s, C O C H 3 )  for 
(/?)-5a-MTPA ester]. 
1.5.  Preparation  of  optically  active  l-acetoxy-3-aryloxypropan-2-ols  5  or  ent-5  and/or  3-
aryloxypropane-l,2-diols  (4 or ent-4) by baker's yeast reaction 
General procedure: To 200 ml of sodium phosphate buffer (0.15 M, pH 7)  l-acetoxy-3-aryloxypropan-
2-one la-k, 0.5 g, sucrose (5.0 g) and baker's yeast (12.0 g wet) were added and the resulting mixture was 
stirred  at room temperature  for a period indicated  in Table 3. Work up and chromatographic  separation  
was carried out similarly as described in the preceding section and yielded monoacetate 5 or ent-5 and/or 
diol 4 or ent-4 fractions.  The IR and 'H NMR spectra of the resulting  l-acetoxy-3-aryloxypropan-2-ols  5  
or ent-5 and/or 3-aryloxypropan-l,2-diols  4 or ent-4  were similar to those of the corresponding  racemic  
compounds. For yield, enantiomeric composition  and configuration of the products, see Table 3. 
Enantiomeric  composition  of  several  diols  4d-j  were  determined  from  'H  NMR  spectra  of  the  
corresponding  di-MTPA  derivatives  [esterification  with  (R)-MTPA-Cl:  triethylamine,  cat.  DMAP,  in  
CCI4,  50°C,  3 h;  characteristic  signals:  di-MTPA ester  of  (/?)-4d:  5.638  (mc, CH-O);  di-MTPA  ester  
of  (S)-4d:  5.699  (mc, CH-O);  di-MTPA ester  of  (/?)-4e:  5.669  (mc, CH-O);  di-MTPA ester  of  (S)-4e:  
5.713 (mc, CH-O);  di-MTPA ester  of  (/?)-4f: 5.620  (mc, CH-O);  di-MTPA ester  of  (S)-4f: 5.665 (mc,  
CH-O); di-MTPA ester of (/?)-4g: 5.627 (mc, CH-O); di-MTPA ester  of (S)-4g: 5.645 (mc, CH-O); di-
MTPA ester of (/?)-4h: 5.641 (mc, CH-O); di-MTPA ester of (S)-4h: 5.705 (mc, CH-O); di-MTPA ester 
of  (/?)-4i:  5.630  (mc, CH-O);  di-MTPA  ester  of  (5)-4i:  5.675  (mc, CH-O);  di-MTPA  ester  of  (/?)-4j:  
5.627 (mc, CH-O); di-MTPA ester of (S)-4j: 5.655 (mc, CH-O)]. 
For determination  of configuration,  several  (/?)-diols 4  were prepared  from  (/?)-3-chloropropane-l,2-
diol  [(/?)-2,  95%  e.e.]  by  coupling  with  the  corresponding  phenol  3  [(/?)-2:  1.2  mmol,  3:  1.5  mmol;  
according to the procedure used for the preparation  of the racemic diols]. 
For direct  comparison  of  the  specific  rotations,  the  monoacetate  fractions 5  were  saponified  [1.2 M 
NaOMe/MeOH, r.t.,  10 min, 80-95% yields] to diols 4 (Table 4). 
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Table 4 
4 Ar Solvent (c= 1) [a]D  (conf.)  
(from 51 fdiol fractionl ifrom  (Ä1-21  
a phenyla ethanol -9.0 (R) -10.5 (R) 
b 1-naphthylb methanol -6.8 (R) -6.5  (R) 
d 2-isopropylphenylc hexane-isopropanol -4.2(5). 13.2 (R) 14.1  (R)  
e 2-chlorophenyld hexane-ethanol 4:1 13.3 (R) 
f 3-chlorophenyle ethanol -9.0 (R) -7.9 (R) 
8 4-chlorophenyl' methanol -8.3 (R) -8.7 (Ä) 
h 2-methylphenyls hexane-isopropanol 12.1  (R)  17.5 (R) 
i 3-methylphenylh ethanol -6.1 (R) -6.5 (R) 
j 4-methylphenyl1 hexane-isopropanol 6.5 (R) 8.6 (R) 12.1  (R)  
k 3-nitrophenyle ethanol -13.7 (R) -12.3 (R) 
1 2,6-dimethylphenylc acetone 2.2 (R) 2.2 (R) 2.1  (R)  
m 2,4,6-trichlorophenylc acetone 2.3  (Ä)  2.2 (R) 2.3  (R) 
* Lit.  ( R M a  (98  %c.e.):  [a]o=  -10.8  ( I .  EtOH).  (S)-4a  (91  %e.e.):  |<x]„=  10.2  (1.  EtOH);  b  Lit.:  (R)-4b:  (a ]„=  -6.76  (1.  
MeOH)20.  -8.1  ( I .  MeOH)21.  -8.5  (4.5,  MeOH)22,  (S)-4b:  [alo= 6.7  ( I .  MeOH)20,  6.9  (1.  MeOH)2 ' ,  7.6  ( I .  MeOH)25,  7.7 ( I , 
MeOH)24.  8.4 (4.5. MeOH) 2 2 ; c  No published  optical  rotation  data  were found; d  Lit.  (R)-4e  (99  Sfce.e.):  [<X]D=  14.0 (I. hexane-
EtOH  4:1).  (5)-4e  (99  %e.e.):  [«]„=  -13.4  (1. hexane-EtOH  4:1);* L i t  ':  (R)-4f  (>99  fce.e.):  [a]o=  -12.7  (1. EtOH).  (5)-4f (98 
*e.e . ) :  [a)D=  13.7 (I.  EtOH); ' L i t . ' : ( R M g  (95 %e.e.):  [a]o=  -11.8 (I.  EtOH).  (S)-4g  (97  %e.e.):  (a]o=  12.3 (I.  EtOH);  * L i t . ' : 
(R)-4h  (>99 %c.c.):  (OJD=  19.8 (0.9, hexane-i-PtOH  4:1). (5)-4h  (>99  %e.e.):  [A]„= -19.3 (0.9,  hexane-i-PrOH  4:1);0 L i t . ' :  <R)-
4i  (>99  %e.e.):  (a]D=  -9.3  (I.  EtOH).  (S)-4i  (97  %e.e.):  (a]o=  9.5  (1. E tOH); '  Lit.  ':  (R)-4j  (97  fce.e.):  [a]o=  -9.2  (I .  EtOH).  
(S)-4j (71  Sfce.e.): [O]D= 7.5 (1.  EtOH).  
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Abstract 
Several monoprotected dihydroxyacetone derivatives 4a-d  and their acetates 5a-d  were prepared and  subjected  
to  biotransformation  with  baker's  yeast.  The  simple  chemical  modification  of  the  substrates  (i.e.  transforming  
the  relatively  small  hydrophilic  hydroxymethyl  group  into  a  larger  hydrophobic  acetoxymethyl  moiety)  inverted  
the  sense of  enantiotope  selectivity  of  these reductions yielding optically  active diols 6a-d,  or their  enantiomeric  
acetates (7a-d) and diols  (ent-6a-d),  respectively.  ©  1999 Elsevier Science Ltd.  AH  rights  reserved.  
1.  Introduction  
Recently,  the synthesis  of optically  active molecules  has attracted  interest due to the different effects 
of  enantiomers.  In  pharmacy,  these  differences  can  be  observed  in  therapeutic  effects1  and  also  in  
adsorption, metabolism and excretion.2 Since biological systems are asymmetric catalysts by their nature, 
biocatalytic  methods are widely applied for the preparation  of optically active compounds.3 
In  the  preparation  of  homochiral  biologically  active  molecules,  such  as  PAF  (platelet-activating  
factor),4  phospholipids,5  phospholipase  A2  inhibitors,6  and  many  others,7  chiral  glycerol  derivatives  
of  high  enantiomeric  purity  might  be  useful C3  building  blocks.  Enantiomer  selective  biocatalytical  
methods,  e.g.  hydrolase-catalyzed  kinetic  resolution  of  racemic  glycerol  derivatives  such  as  glycerol  
acetonide,8,9  or glycerol-2,3-carbonate,10  provided moderate selectivity  and 50% theoretical  limit of the 
desired enantiomer.  
*  Corresponding  author. E-mail: poppe.szk@chem.bme.hu 
09574166/99/$ - see front  matter © 1999  Elsevier Science Ltd. All rights  reserved.  
P1I: S0957-4166(99)00415-2 
4026 J. Bálint  et al. /Tetrahedron:  Asymmetry  10 (1999)  4017-4028  
Enantiotope  selective  reduction  of  prochiral  ketones  theoretically  enables  the  total  conversion  of  
the  substrate  into  a  single  enantiomer  of  the product  chiral  secondary  alcohol.  Such  prochiral  ketone  
precursors  of chiral  C3 building blocks are protected dihydroxyacetone  derivatives. Accordingly,  several  
chiral  C3  derivatives  have  already  been  prepared  by  chiral  ruthenium  complex-catalyzed  asymmetric  
reductions.11-13  The enantiotope  selective baker's  yeast  reduction  might be considered  as a convenient 
biocatalytic  alternative  to  these  methods.  The  3-methoxy-,14  3-benzoyloxy-  and  3-(4-nitrobenzoyl)-
oxy-15  1-hydroxyacetone  derivatives  and  the  3-benzoyloxy-15  and  3-aryloxy-16  1-acetoxyacetone  de-
rivatives were  reduced  by  baker's  yeast  with  various  results.  Although  methods  from  3-O-protected  
dihydroxyacetone  derivatives  leading  to opposite  enantiomeric  forms may increase  the synthetic  value  
of  the  process,  baker's  yeast  reduction  of  the  1-hydroxy- and  1-acetoxy-derivatives  of  3-O-protected  
dihydroxyacetones  with the same protective group has never been performed. 
The known examples for enantiotope selective reduction of hydroxymethyl ketones or their acetates by 
baker's yeast14,17-19  showed that ketones with the relatively small and hydrophilic hydroxymethyl  group  
were reduced  similarly  in a geometrical  sense (as a result  of  the  sequence rules,  however, the products 
may have different configuration labels). On the other hand,  acetoxymethyl  ketones were reduced  with  
the  opposite  sense  of  enantiotopic  preference.  This  inversion  in  the  sense  of  enantiomeric  preference  
was demonstrated  by baker's  yeast reduction  of  phenacyl  alcohols  and their acetates.19-21  It  should be 
mentioned  here  that  reduction  of hydroxymethyl  ketones  and  their  acetates  by  Geotrichum sp.  38  was  
reported to proceed  without inversion  of the sense of the enantiotopic  selectivity.22  
Since  the  monoprotected  dihydroxyacetone  derivatives  are  precursors  of  chiral  C3  building  blocks,  
and  their  acetates  could  presumably  be reduced  by  baker's  yeast  with  opposite  enantiopreference,  we  
thought  it  worthwhile  investigating  the  bioreduction  of  these  compounds.  Here  we report  the  baker's  
yeast  reduction  of  several  synthetically  useful  monoprotected  dihydroxyacetone  derivatives  4a-d  and  
their acetates  5a-d. 
2.  Results and discussion 
The  preparation  of  the  monoprotected  dihydroxyacetone  derivatives  4a-d  and  their  acetates  5a-d  
was  straightforward  starting  from  dihydroxyacetone  1  as  outlined  in  Fig.  1.  Ketones  4a15  and  4b  
were  prepared  by  monoacylation  of  the  dihydroxyacetone  (1,  existing  mostly  in  dimeric  form)  by  
benzoyl  chloride  and  pivaloyl  chloride,  respectively.  The  benzyloxymethyl  ketone  4c  was  obtained11  
from  the  dimethyl  ketal  of  dihydroxyacetone  2  by  subsequent  benzylation  and  acidic  deketalization.  
Monosilylation23  of  dihydroxyacetone  1 provided  the ketone  4d  smoothly. The  acetoxymethyl  ketones  
5a-d  were obtained from their hydroxymethyl  precursors  (4a-d, respectively)  by simple acetylation. 
Since  stereoselectivity  of baker's yeast-catalyzed  reactions  may  depend  considerably  on the reaction 
conditions  (pH, solvent, additives, etc.), it was desirable to find the optimum. Hence, reaction conditions 
of the baker's yeast reduction  of l-benzoyloxy-3-hydroxypropan-2-one  4a were investigated  (Table  1).  
The different reaction  conditions  were chosen  by analogies  with published  modifications of  reaction 
conditions  increasing  the stereoselectivity  of carbonyl-reductions  by baker's yeast. Reductions in apolar 
hydrocarbons with 'non-fermenting'  baker's yeast resulted in increased selectivities.24,25  Such selectivity 
enhancement was obtained by using N2-atmosphere and cosolvent like DMSO.15 Some sulfur-containing 
additives,  such  as  L-cysteine  or  cysteamine,  also  produced  significant  selectivity  enhancement  in  the  
reductions  of  l-acetoxyalkan-2-ones.26  It should be noted, however, that these additives  were also used 
to suppress the hydrolysis  of the ester function in these reactions. Ethanolamine  as a possible  substitute  
for the L-cysteine or cysteamine was also tested as an additive. 
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Figure  1. Preparation  of hydroxymethyl  ketones  4 a - d  and  their  acetates 5a -d .  Reagents  and  solvents:  (i) trimethyl  orthoformate  
in  MeOH;  (ii)  BnBr,  NaH  in THF;  (iii)  3  M  HCI;  (iv)  BzCl,  cat.  DMAP,  pyridine  (for 4a),  PivCl,  cat.  DMAP,  pyridine  (for  4b)  
or TBDMSC1,  imidazole  in T H F  (for 4d);  (v) A c 2 0 ,  cat.  DMAP,  Et3N  in  ethyl  acetate  (for  5a,c,d)  or  AcCl,  cat.  DMAP,  Et3N  
in T H F (for  5b)  
Although  alcohol  dehydrogenases  can  operate  in  ethanol  as  solvent,  no  reduction  was  observed  in  
neat  ethanol  (Entry  1).  Reactions  with  the  traditional  'non-fermenting'  yeast  (Entry  2)  or  with  'non-
fermenting'  yeast  in  the  presence  of  ethanol  as  coupled  substrate  in  cofactor  regeneration  under  N2  
(Entry  3)  proceeded  with  moderate  selectivities.  The  low  isolated  yields  in  hexane  (Entries  4,  5  and  
8)  indicated  low  productivity/conversion  without  significant  increase  in  selectivity.  The  productivities  
and  selectivities  of  systems  containing  glucose  were  better  (Entries  6-9).  The  best  selectivity  yielding  
homochiral  diol  6a  was achieved  by  'fermenting'  baker's  yeast  under  anerobic  conditions  with  ethanol  
as cosolvent  and  L-cysteine as an additive  (Entry  9).  
The reaction  conditions  for the further compounds  were optimized  in a similar  way. The reductions  of  
these  ketones 4b-d  and 5a-d  were conducted  under the conditions  which  gave the highest  enantiotopic  
selectivities,  as listed in Table 2. The results achieved by the baker's  yeast reduction  of the hydroxymethyl 
ketones  4a-d  and  their  acetates  5a-d  confirmed  the  previous  findings19-21  and  our  expectations:  the  
geometrical  sense  of the enantiotopic preference altered  in all the cases when the hydroxymethyl  ketones  
4a-d  versus their  acetates  5a-d  were  reduced.  
In  the  case  of  reduction  of  acetates  5a-d,  however,  substantial  amounts  of  diols  ent-6a-d  were  also  
produced.  Configuration  of  these  diols  ent-6a-d  was  opposite  to  the  diols  6a-d  from  reduction  of  
the  hydroxymethyl  ketones  4a-d.  These  data  confirmed  that  diols  ent-6a-d  were  produced  mostly  by  
reduction  of  the acetoxymethyl  ketones  5a-d  followed by an enzymatic  hydrolysis,  and  were  consistent  
with  our previous  results  on  baker's  yeast  reduction  of  l-acetoxy-3-aryloxypropan-2-ones,16  where  the  
geometrical  sense  of enantiotopic  preference  was the same as for the present  ketones  5a-d  and different 
amounts  of hydrolyzed  products  from enzymatic  hydrolysis  were also obtained.27  
Since  the  hydroxymethyl  ketones 4a-d  were  reduced  substantially  slower  and  with opposite  enantio-
topic  preferences  than  the  acetoxymethyl  ketones  5a-d,  our  results  further  support  the  hypothesis19-21  
assuming  that  these two classes  of ketones  are reduced  mostly  by different enzymes  of  the baker's  yeast  
system. 
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Table  1  
D e p e n d e n c e  of  the  stereoselect ivi ty  on  the  react ion  condi t ions  in  reduct ion  of  ketone  4a  
« X v - 0  = =  « X y O  
E n t r y Y e a s t B u f f e r  (Atm. )  So lven t Add i t i ve ( s ) T i m e Y  b  E . e . c 
(g) (ml ) (ml) (g) (h) (%) (%) 
1 12 •  - E t O H  (100)  - no  reac t ion  
2 12 6 0 - - 2 4 6 0 5 6 
3 8 6 0  (N 2 )  E t O H  (6)  - 2 0 5 6 6 4 
4 15 15 h e x a n e  (150) ,  
E t O H  (1.5),  
D M S O  (1 .5)  
2 4 4 6 77 
5 15 15 h e x a n e  (150) ,  
E t O H  (3)  
- 22 3 6 85 
6 8 6 0  (N 2 ) d  E t O H  (0.6),  
D M S O  (0.6)  
g lucose  (6)  4 5 6 85 
7 8 6 0  (N 2 ) d  E t O H  (1.2)  g lucose  (6) ,  
e t h a n o l a m i n e  (0 .12)  
4 7 6 86 
8 15 15 h e x a n e  (150) ,  
D M S O  (1.5)  
g lucose  (6)  2 4 4 2 89 
9 8 60 (N2)d EtOH (1.2)  glucose (6) 
L-cysteine  (0.3)  
20 80 >97 
* Standard  conditions:  500  mg  of  4a,  0.15  M  pH=  7.0  phosphate  buffer,  baker's  yeast  from  Budafok  factory;  b  Yields  refer  to  
products  purified  by preparative  column  chromatography;  c Absolute  configuration  was taken  from  Ref.  15; enantiomeric  excess  
was  determined  from  the  'H-NMR  spectrum  of  the  (fl)-MTPA  ester  of  7a;  d  Substrate  was  added  30 minutes  after  starting  the  
fermentation. 
3.  Conclusions  
Our results  showed  that the monoprotected  dihydroxyacetone  derivatives 4a-d  and their acetates  5a-d 
are synthetically  useful precursors  of different chiral C3  building  blocks.  In accordance  with the previous 
findings,  these  hydroxymethyl  4a-d  and  acetoxymethyl  5a-d  ketones  were  reduced  by  baker's  yeast  
oppositely  in  a  geometrical  sense,  yielding  optically  active  diols  6a-d,  or  monoacetates  7a-d  and  the  
enantiomeric  diols  ent-6a-d,  respectively.  
4.  Experimental  
The  1H NMR  spectra  were  recorded  on  a  Bruker  AW-250  spectrometer  operating  at  250  MHz.  For  
enantiomeric  excess  determinations,  a Bruker  DRX-500  spectrometer  operating  at 500 MHz  was  used.  
All  spectra  were  taken  in CDC13  solution  and chemical  shifts are expressed  in ppm values from TMS as  
internal  standard  on  5 scale.  IR spectra  of thin film samples  were taken  on a Specord  2000  spectrometer.  
Optical  rotations  were determined  on a Perkin-Elmer  241  polarimeter.  Thin  layer chromatography  was  
carried  out  using  Merck  Kieselgel  60  F254  alumina  sheets  (using  hexane:acetone,  10:4,  if  not  stated  
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Table  2  
Resu l t s  for  bake r ' s  yeast  reduct ion  of  m o n o p r o t e c t e d  d ihyd roxyace tone  derivatives  4 a - d  and  their  
ace ta tes  5 a - d  
«JL® 
4a-d 
1 
0 
Sa-d 
1 
HO 
OH 
X M 
6a-d 
OH 
75a-d 
+ 
OH 
enr-Bft-d 
0 M e t h o d a Yield  C o n f .  % 
E .e . 
% 
M e t h o d  Yie ld  C o n f .  
%  b  
E.e . 
% 
Yie ld  C o n f .  E.e.  
%  %  
A 80 S >97 D  54  Rb  68 22  R  19  
o 
r % 
B 71 S 72 E  56  Rb  >95 9  R  46  
n o A 50 S 55 F  60  S6  85 20  R  33  
V  /  
d  '  
C 21 S 59 F  21  Rh  >97 25  R  77  
"  Common  conditions:  500  mg  of  ketone  (4a-d,  5a-d),  in  0.15  M  pH=7  phosphate  buffer,  baker's  yeast  from  Budafok  factory.  
Methods: A, 20 h  reaction  with  yeast  (8 g)  in  buffer (60 ml)  under  N2 containing  2%  elhanol, glucose  (6 g)  and  L-cysteine  (I  eq.); B, 
24  h reaction  with  yeast  (12 g)  in  buffer (100 ml) under  N2  containing  2%  ethanol  and  glucose  (5  g); C,  48  h reaction  with  yeast  (12  
g)  in  buffer (100  ml)  under  N2 containing  2% ethanol  and glucose  (5  g); D, 3  h reaction  with  yeast  (8  g)  in  buffer (60  ml)  under  N2  
containing  2%  ethanol,  2%  DMSO  and  glucose  (6  g); E, 1.5  h reaction  with  yeast  (12  g)  in  buffer (100  ml)  containing  5%  ethanol  
and  glucose (5  g); F,  4  h reaction  with  yeast  (8 g) in buffer (60 ml)  under  N2  containing  2%  ethanol,  2%  DMSO  and  glucose  (6  g);b  
Due to  a change  in  group preferences,  the absolute  configuration  S  in  the case  of the benzyloxy  product  7c  means  the  same  sense  of  
stereochemistry  as  in the case  of  the other acetates  7a,b,d.  For  determination  of  the configurations, see  Experimental  section.  
otherwise).  Spots  were  visualized  by  treatment  with  5%  ethanolic  phosphomolybdic  acid  solution  and  
heating  of  the  dried  plates.  Preparative  chromatographic  separations  were  performed  using  vacuum-
chromatography28  on  a  Merck  Kieselgel  60  (0.063-0.200  mm).  Chemicals  were  products  of  Fluka  
or  Aldrich.  All  solvents  used  were  freshly  distilled.  Baker's  yeast  manufactured  by  Budafok  factory,  
Budapest,  was obtained  from a local  store.  
4.1.  l-Benzoyloxy-3-hydroxypropan-2-one  4a15  
The reaction15  starting from 1,3-dihydroxyacetone  (1, 20 g, 222 mmol) yielded  the desired  ketone (4a, 
14 g,  32%)  as  a  colorless  crystalline  solid.  Mp:  92-93°C  (lit.:15  95-97°C);  IR  (KBr):  3430  (br),  1718,  
1602,  1452,  1376,  1278,  1180,  1111,  1072,  924,  811,  709  cm"1;  >H NMR:  4.50  (s,  2H, 0-CH2),  5.03  
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(s, 2H, CH2-OBZ),  5.53 (br s,  1H, OH), 7.47 (t, 2H, m-ArH), 7.58 (t,  1H, p-ArH), 8.10 (d, 2H, o-ArH). 
Calcd for CI0HI0O4 :  C, 61.85; H, 5.19. Found: C, 61.66; H, 5.21. 
4.2.  l-Hydroxy-3-pivaloyloxypropan-2-one  4b 
To a  stirred  solution  of  1,3-dihydroxyacetone  (1,  6.75 g,  75 mmol)  and  4-(dimethylamino)pyridine  
(0.1 g) in pyridine  (45 ml) pivaloyl chloride (6.1 ml, 50 mmol) was added dropwise  at 24-25°C. After 
stirring  the  resulting  mixture  at  room  temperature  overnight  pyridine  was  evaporated  in  vacuo.  The  
residue was diluted with ethyl acetate (100 ml) and washed with 5% HC1 (2x20 ml). The aqueous phase 
was re-extracted with ethyl acetate (2x30 ml). The combined organic phases were washed with saturated 
NaHC03  solution  (30 ml) and brine (30 ml). After drying over MgS04  the solvent was evaporated  and  
the  residual  solid  was recrystallized  from hexane  to yield  a crystalline  product  (4b,  3.75  g,  43%). IR 
(KBr): 3408, 2960, 2930,  1735,  1725,  1470,  1360,  1280,  1170,  1070, 880 cm"1;  NMR:  1.25 (s, 9H, 
3 CH3), 4.37 (s, 2H, 0-CH2), 4.73 (s, 2H, CH2-OPiv). Calcd for C8Hi404: C, 55.16; H, 8.10. Found: C, 
55.40; H, 8.07. 
4.3.  l-Benzyloxy-3-hydroxypropan-2-one 4c11 
Preparation  of the monobenzylated  dihydroxyacetone 4a11  started from 1,3-dihydroxyacetone  (1,2.25  
g,  25 mmol)  and via the intermediates  2,2-dimethoxypropane-l,3-diol  [2, 90%, 'H NMR: 3.31  (s, 6H, 
2 OCH3), 3.67 (s, 4H, 2 CH20] and l-benzyloxy-2,2-dimethoxypropan-3-ol  [3, 52%,  *H NMR: 3.27 (s, 
6H, 2 OCH3), 3.53 (s, 2H, CH2-OBn), 3.70 (s, 2H, 0-CH2), 4.58 (s, 2H, OCH2Ph), 7.32 (m, 5H, ArH)] 
resulted  in  a  homogeneous  oily  product  (4c,  1.74  g,  39%  overall).  IR:  3440  (br),  2869,  1731,  1496,  
1434, 1209,1103,1028,  741 cm"1;  NMR: 4.19 (s, 2H, CH2-OBn), 4.47 (s, 2H, 0-CH2), 4.60 (s, 2H, 
OCH2Ph), 7.35 (m, 5H, ArH). Calcd for Ci0Hi0O4:  C, 66.65; H, 6.71. Found: C, 66.33; H, 6.73. 
4.4.  l-(teri-Butyldimethylsilyl)oxy-3-hydroxypropan-2-one 4d23 
Silylation23 from 1,3-dihydroxyacetone (1,2.0 g, 22.2 mmol) provided the desired ketone (4d,  1.39 g, 
60%) as a colorless oil. IR: 3430 (br), 2970, 2940, 2890, 2870,  1740,1490,  1270,  1105, 855, 795 cm"1; 
!H NMR: 0.03 (s, 6H, 2 CH3-Si), 0.91 (s, 9H, 3 CH3), 4.30 (s, 2H, CH2-OTBDMS), 4.49 (s, 2H, 0-CH2). 
Calcd for C9H20O3Si: C, 52.90; H, 9.87. Found: C; 52.73; H, 9.88. 
4.5.  Acetylation of hydroxymethyl ketones 4a-d 
Method  A (for 4a, 4c  and  4d):  To a  stirred  solution  of  hydroxymethyl  ketone  (4a,  7 g,  36  mmol),  
triethylamine  (7  ml,  50  mmol)  and  4-(dimethylamino)pyridine  (0.1  g)  in  ethyl  acetate  (70  ml)  acetic  
anhydride  (4  ml,  42  mmol)  was added  dropwise  at  room  temperature  and  the  resulting  mixture  was  
stirred for 90 min. The reaction mixture was washed with  10% HC1 (2x140 ml),  1  M Na2C03  (140 ml) 
and dried over Na2S04.  Evaporation  of the solvent  resulted  in  an oil. The same procedure was used for 
ketones 4c (1.1 g, 6 mmol) and 4d (1.70 g, 8.32 mmol). 
Method B (for 4b): To a stirred solution of l-hydroxy-3-pivaloyloxypropan-2-one  (4a, 2 g, 11.5 mmol), 
triethylamine (1.75 g, 13.8 mmol) and 4-(dimethylamino)pyridine  (50 mg) in THF (25 ml) acetyl chloride 
(1.08 g,  13.8 mmol) was added dropwise and the mixture was stirred for 90 min. Ethyl acetate (100 ml) 
and  5%  HC1 solution  (15  ml)  were  added  to  the  mixture  and  the  forming layers  were  separated.  The  
aqueous layer was extracted  with ethyl acetate (50 ml). The combined oiganic phases were washed with 
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saturated  NaHCC>3 solution  (25 ml), saturated Na2C03  solution  and dried over Na2S04.  After removal 
of the solvent, preparative vacuum column chromatography  of the residue yielded an oil 5b. 
4.6.  l-Acetoxy-3-benzoyloxypropan-2-one 5a 
Yield:  6.3  g,  75%.  IR:  3069,  2991,  2939,  1737,  1729,  1601,  1451,  1417,  1372,  1277,  1228,  1177,  
1101,  1052,  1025,  977,  834,  715  cm" 1 ;  l H  N M R :  2.20  (s,  3H,  CH3-CO),  4.86  (s,  2H,  CH2-OAc),  5.01  
(s, 2H, CH2-OBZ),  7.46 (t, 2H, m-ArH), 7.58 (t,  1H, p-ArH),  8.09 (d, 2H, o-ArH). Calcd for CI 2 HI 2 0 5 : 
C, 61.01; H, 5.12; Found: C, 61.21; H, 5.10. 
4.7.  l-Acetoxy-3-pivaloyloxypropan-2-one 5b 
Yield:  1.9 g, 77%. IR: 2970,1735,1730,1725,1470,  1360,1470,1360,  1280,  1215,1150,1130,1055  
crn"1; 'H NMR:  1.22 (s, 9H, 3 CH3), 2.12 (s, 3H, CH3-CO), 4.69 (s, 2H, 0-CH2), 4.70 (s, 2H, 0-CH2). 
Calcd for C,0Hi6O5: C, 55.55; H, 7.46; Found: C, 55.45; H, 7.48. 
4.8.  l-Acetoxy-3-benzyloxypropan-2-one 5c 
Yield:  1.23  g,  92%.  IR:  3032,  2937,  2860,  1739,  1732,  1455,  1410,  1374,  1235,  1104,  1071,  1027,  
742,700 CM-1;  NMR:  2.21  (s,  3H, CH3-CO), 4.19  (s, 2H, CH 2 -OBn) ,  4.63  (s,  2H, OCH 2Ph),  4.94  (s,  
2H, CH2-OAC),  7.38 ( M ,  5H, ArH). Calcd for CI 2 HI 4 0 4 :  C,  64.85;  H, 6.35; Found: C ,  65.00; H,  6.33.  
4.9.  l-Acetoxy-3-(\en-butyldimethylsilyl)oxypropan-2-one 5d 
Yield:  1.90  g,  93%.  IR:  2965,  2940,  2895,  2870,  1755,  1740,  1490,  1420,  1390,  1270,  1250,  1110,  
1090, 855,795  CM"1;  LH N M R :  0.03 (s,  6H,  2 CH3-Si) ,  0.87  (s,  9H,  3 CH3),  2.08  (s,  3H, CH3-CO),  4.19  
(s,  2H,  CH2-OTBDMS),  4.87  (s,  2H,  CH2-OAC).  Calcd for CMH2 204Si:  C,  53.63;  H,  9.00;  Found:  C,  
53.81;  H,  9.02.  
4.10.  Baker's yeast-catalyzed stereoselective  reduction  of ketones 4a-d,  5a-d  
4.10.1.  General method 
Yeast was added to the media  as indicated  in Table 2. After stirring  the resulting  cell  suspension for 
30 min, the corresponding  ketone (4a-d, 5a-d;  500 mg) was added. When indicated,  the substrate  was  
previously  dissolved in ethanol (2-4 ml). The reaction  mixture was stirred  (time given in Table 2). The 
resulting  mixture  was extracted  with ethyl  acetate (2x150  ml), the combined  ethyl acetate  layers were 
washed with brine, dried over MgS04, and the solvent was evaporated in vacuo. The residue was purified 
by preparative  vacuum column chromatography  (hexane: acetone,  10:1) to give oily produces)  in yields 
indicated in Table 2. 
4.10.2.  l-Benzoyloxypropane-2,3-diol 6a 
IR:  3400  (br),  2952,  1714,  1602,  1452,  1379,  1316,  1278,  1178,  1117,  1071,  1027,  712 cm"1;  *H  
NMR: 3.50-3.80  (m, 2H, 0-CH2), 4.12 (m,  1H, O-CH), 4.37 (m, 2H, CH2-OBz), 7.43 (t, 2H, m-ArH), 
7.54 (t,  1H, p-ArH), 8.02 (d, 2H, o-ArH). 
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4.10.3.  l-Pivaloyloxypropane-2,3-diol 6b 
IR: 3450,2980,  2960,1730,1480,1460,1370,  1280,1170,1045 cm"1 ;  *HNMR:  1.22 (s, 9H,  3  CH3),  
3.59 and 3.69 (2 dd, 2H, 0-CH 2 ) ,  3.94 (m,  1H, O-CH), 4.16 (m, 2H,  CH2-OPiv).  
4.10.4.  1 -Benzyloxypropane-2,3-diol 6c 
IR:  3385  (br),  2924,  2867,  1646,  1496,  1453,  1364,  1207,  1074,  925,  865,  738,  698  cm"1;  >H NMR: 
3.50-3.78  (m, 4H, 0 -CH 2 ) ,  3.87 (m,  1H, O-CH), 4.55 (s, 2H, OCH2Ph),  7.35 (m, 5H,  ArH).  
4.10.5.  l-(teit-Butyldimethylsilyl)oxypropane-2,3-diol 6d 
IR:  3400,  2970,  2945,  2895,  2865,  1485,  1275,  1250,  1130,  1090,  850,  795 cm"1;  l H  NMR:  0.03  (s,  
3H, CH3-Si), 0.06  (s, 3H, CH3-Si), 0.88 (s, 9H,  3 CH3) , 3.55-3.75  (m, 5H,  2 0 - C H 2  and  O-CH).  
4.10.6.  1 -Acetoxy-3-benzoyloxypropan-2-ol  7a 
IR:  3462 (br),  3065,  2958,  1727,  1721,  1606,1452,1375,  1316,  1276,  1178,  1116,  1071,1047,  1027,  
713 cm"1; ' H NMR: 2.11 (s, 3H, CH3-CO), 4.25 (m, 3H, CH2-OAc and O-CH), 4.42 (m, 2H,  CH2-OBz),  
7.44 (t, 2H, m-ArH), 7.58 (t,  lH,p-ArH),  8.03 (d, 2H,  o-ArH).  
4.10.7.  l-Acetoxyr3-pivaloyloxypropan-2-ol  7b 
IR:  3400 (br),  2980,  2960,  1730,  1725,  1475,  1450,  1370,  1280,  1170,  1045 cm"1;  ' H  NMR:  1.23  (s,  
9H,  3 CH3),  2.09 (s, 3H, CH3-CO), 4.05-4.25  (m, 5H,  2 0 - C H 2  and  O-CH).  
4.10.8.  l-Acetoxy-3-benzyloxypropan-2-ol 7c 
IR:  3445,  3063,  3030,  1738,  1496,  1454,  1369,  1244,  1098,  1045,  740,  699  cm"1 ;  *H NMR:  2.08  
(s,  3H,  CH3-CO),  3.52  (m,  2H,  CH2OBn),  4.05  (m,  1H,  O-CH),  4.16  (m,  2H,  CH2OAc),  4.56  (s,  2H,  
OCH2Ph),  7.33  (m, 5H,  ArH).  
4.10.9.  l-Acetoxy-3-(tett-butyldimethylsilyl)oxypropan-2-ol  7d 
IR:  3460,  2960,  2935,  2895,  2860,  1755,  1735,  1480,  1405,  1380,  1270,  1250,  1120,  1050,  850,  795  
c m ' 1 ;  ' H NMR: 0.02 (s, 3H, CH3-Si),  0.05  (s, 3H, CH3-Si),  0.86 (s, 9H,  3 CH3) ,  2.04 (s, 3H,  CH3-CO),  
3.58 (m, 2H, CH2-OTBDMS),  3.76-4.01  (m,  2H, CH2-OAc),  4.09 (m,  1H, O-CH). 
4.11.  Determination of enantiomeric excess and absolute configuration of the diols (6a-d,  ent-6a-d) and 
monoacetates 7a-d 
4.11.1.  Enantiomeric excess determination 
4.11.1.1.  (A)  MTPA derivatization  of  the  optically  active  monoacetates  7a-d.  A  sample  of  each  
monoacetate (7a-d ,  50 pmol, ca.12 mg) with measured  optical  rotation  was converted into its  (R)-MTPA  
ester [350 pi of 5% (R)-MTPA-Cl solution in carbon tetrachloride, pyridine (25 pl), DMAP (2 mg),  50°C,  
3 h].  A  similar reaction  was carried out with the racemic  monoacetates  rac-lst-d.  The diastereomer  ratio  
referring to the enantiomeric  excess  of the monoacetates 7 a - d  was determined from the ' H NMR  spectra  
of the MTPA ethers  [500 MHz, C/ / 3 CO  signals:  (R,R)-7a-MTPA:  2.07 ppm, (R,S)-7a-MTPA: 2.01  ppm,  
(/?,/?)-7b-MTPA:  2.08  ppm,  (R,5)-7b-MTPA:  2.02  ppm,  (/?,5)-7c-MTPA:  2.03  ppm,  (/?,/?)-7c-MTPA:  
1.97 ppm,  (R.R)-7d-MTPA:  2.05 ppm,  (R,S)-7d-MTPA:  1.98 ppm]. 
4.11.1.2.  (B)  Preparation of  diacetates 8a-d  from  monoacetates  7a-d  and  diols  6a-d  or  ent~6a-d.  
Another  aliquot  of  each  sample 7a -d  used  in  the MTPA ee  determination  was  acetylated  [7a-d:  0.1  g,  
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Et3N (1.4 mmol), DMAP (10 mg), Ac20 (1.1 mmol) in EtOAc (1 ml), at rt, 90 min; purified yields over 
90%] to give the corresponding  oily diacetate 8a-d  with known enantiomeric excess value. 
Diacetates 8a-d or ent-8a-d were also prepared from the optically  active diols [6a-d or ent-6a-d:  0.1  
g, Et3N (2.8 mmol),  DMAP (15 mg), Ac20  (2.2 mmol)  in EtOAc (1 ml),  at rt,  90 min; purified yields 
over 90%] as well. Optical rotations  of these diacetates  8a-d  or e/i;-8a-d  compared to the rotation data 
of the diacetates  8a-d  with  known  enantiomeric  purities  refer to  the enantiomeric  composition  of  the 
corresponding  parent diol 6a-d  or enf-6a-d. 
4.11.2.  l-Benzoyloxy-2,3-diacetoxypropane  8a 
IR: 3065,2962,  1753,1747,1735,1602,1452,1372,1316,1260,1224,1178,1115,1071,1051,1026,  
713 cm"1;  lH NMR: 2.11 (s, 3H, CH3-CO),  2.13 (s, 3H,  CH3-CO), 4.2ÎM.65  (m, 4H, 2 0-CH2),  5.43 
(m,  1H, CH-OAc), 7.45 (t, 2H, m-ArH), 7.58 (t,  1H, p-ArH), 8.04 (d, 2H, o-ArH). 
4.11.3.  2,3-Diacetoxy-l-pivaloyloxypropane  8b 
•  IR: 2970,1745,1735,1725,1470,1360,  1280,1220,1145,  1040 cm"1 ; 'H NMR:  1.20 (s, 9H, 3 CH3), 
2.06 (s, 3H, CH3-CO), 2.08 (s, 3H, CH3-CO), 4.12-4.35 (m, 4H, 2 0-CH2), 5.28 (m, 1H, CH-OAc). 
4.11.4.  l-Benzyloxy-2,3-diacetoxypropane  8c 
IR: 3010,2925,2835,1744,1727,1496,1450,1365,1240,1100,1030,950,735,695  cm"1 ;  *H NMR: 
2.00 (s, 3H, CH3-CO), 2.04 (s, 3H, CH3-CO), 3.56 (m, 2H, CH2-OBn), 4.23 (m, 2H, CH2-OAc), 4.50 (s, 
2H, OCH2Ph), 5.18 (m,  1H, CH-OAc), 7.29 (m, 5H, ArH). 
4.12.  l-(text-Butyldimethylsilyl)oxy-2,3-diacetoxypropane  8d 
IR: 2965,  2940,  2895,  2870,  1755,  1485,  1385,  1270,  1245,  1130,  1060,  850,  795 cm"1;  *H NMR: 
0.03 (s,  3H,  CH3-SO, 0.06 (s, 3H, CH3-Si),  0.88  (s,  9H, 3 CH3),  2.05  (s,  3H,  CH3-CO),  3.69  (m, 2H, 
CH2-OTBDMS), 4.09-4.33 (m, 2H, CH2-OAc), 5.05 (m,  1H, CH-OAc). 
4.13.  Determination of the absolute configuration  of  the monoacetates 7a-d  and diols 6a-d  and ent-
6a-d 
Since  the  absolute  configuration  of  a benzoyloxy  6a,15  and  the  benzyloxy  compounds  6c11'29  and  
7c30,31  are known, the diacetates  8a,c prepared  either from the monoacetates  7a,c  or the diols  6a,c and 
ent-6st,c were suitable for determination  of the absolute configuration of these compounds. 
For  determination  of  the  absolute  configuration  of  pivaloyloxy  compounds  7b,  6b,  and  ent-6b,  an 
optically  active sample of (/?)-3-acetoxypropane-l,2-diol  {[OI]D=—9.9 (c 2, pyridine)  [lit.:32  [<X]D=-9.2,  
(c  1.7, pyridine)]  obtained  by catalytic  hydrogénation  from (/?)-3-acetoxy-1 -benzyloxypropan-2-ol  ma-
nufactured by PfL catalysis30} was converted to (S)-3-acetoxy-1 -pivaloyloxypropane-2-ol ent-To proving 
the absolute  configuration  of  7b.  Configurations  of  the  diols  6b  and  ent-Sb  were determined  via their 
diacetates  8b and ent-%b compared to the diacetate 8b from the monoacetate 7b. 
The  optical  rotation  of  (/?)-1 -(terf-butyldimethylsilyl)oxypropane-2,3-diol  6d  was  reported33  as  
[<X]D=-0.6  (C  1.31,  CHCI3).  Since  the  small  specific  rotation  values  of  the  polar  1,2-diols  are often 
unreliable,34  absolute  configuration  of  the  diols  6d  and  ent-6d  was  determined  by  an  independent  
method.  Silylation  of the above (/?)-3-acetoxypropane-l,2-diol  with TBDMS-C1 (imidazole/THF)  gave  
(£)-1 -acetoxy-3-(fe/t-butyldimethylsilyl)oxypropan-2-ol  {ent-lA,  [a]D=-14.1  (c  1, MeOH)}. The yeast 
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reduction  resulted,  however,  in (/?)-monoacetate  {7d,  [<X]D=+17.6  (C  1 ,  MeOH)}. Acylation  of this (/?)-
monoacetate  7d  resulted  in. (/?)-diacetate  {(/?)-8d,  [a]D=+19.8  (c  1,  MeOH)}.  Since  a  diol  fraction  
{en/-6d,  [CX]D=+0.9  (C  1, CHCI3);  [a]O=+9.2,  (c  1, methanol)} from another reduction  of the  acetoxy-
methyl  ketone  5d  also  resulted  in  (fl)-diacetate  {(/?)-8d,  [a]D=+19.1  (c  1,  MeOH)},  this  diol  ent-6d  
should  have the  (^-configuration.  Therefore,  the  above cited  specific rotation  data for the  (R)-\-(tert-
butyldimethylsilyl)oxypropane-2,3-diol  should be revised. 
The  absolute  configurations,  enantiomeric  excesses  and  optical  rotation  values  of  diols  6a-d  and  
monoacetates  7a-c  prepared  by baker's  yeast  reduction  and  their  diacetate  derivatives  8a-d  are  given  
in Table 3. 
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o 
J O 
j O 
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OH  .  
6b  0  
OH 
7b  O  
OAc 
8b  O  
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^  compared  to  
ear-7b,  see  text  
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H O ^ Â ^ O ^ O 
6c 
7c 
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8c 
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+3.4  (1,  CHCI3)  85  ,  v  M T P A  ester  
+15.2  (1,  ethanol)  85  f rom  7c  
OH 
6d 
OH 
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8d 
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Metacresol  and glycine  can be thought  as  a  dissec-
tion of metatyrosine, which is an excellent substrate of 
phenylalanine ammonia-Iyase  (PAL) (B. Schuster and J. 
Retey, PNAS  92, 8433,  1995). Whereas metacresol was a 
very weak inhibitor and glycine was inert, simultaneous 
addition of both compounds led to synergistic inhibition 
of PAL. [2Hs]Phenylalanine as a substrate showed a ki-
netic deuterium isotope effect of 9% (k^k2H = 1.09 ± 0.01) 
while its Km value was identical to that of the unlabeled 
substrate. The following substrate analogues were syn-
thesized  and  assayed  with  PAL:  cyclooctatetraenyl  
(C OT) -D,L) -alanine  as well  as 2-pyridyl-,  3-pyridyl-,  and  
4-pyridyl-(L)-alanines.  While  COT-(D,L)-alanine  tinned  
out to he a rather reluctant substrate, all three isomers 
of pyridyl-(L)-alanines were converted with a compara-
ble  or even higher Y_„. than L-phenylalanine  into  the  
corresponding  pyridyl  acrylic  acids.  Their  Km  values  
were, however, an order of magnitude higher than that 
of the natural  substrate. These results are discussed in 
terms of the novel mechanism which implies an electro-
philic  attack  of  the  prosthetic  dehydroalanine  at  the  
aromatic  ring.  The  heats  of  formation of  the  putative  
sigma complexes of the electrophilic substitution at the 
pyridine ring have been calculated using semiempirical 
force-field methods. The results show the  feasibility of 
the  proposed  mechanism  also with  the  substrate  ana-
logues.  01998 Academic Plrew 
Key  Words:  phenylalanine  ammonia-lyase;  second-
ary kinetic deuterium isotope effect. 
Phenylalanine  ammonia-lyase  (PAL, EC 4.3.1.5)2  cat-
alyzes  the  reversible  elimination  of  ammonia  to  form  
1 To  whom correspondence should be  addressed. Fax:  (0)721/608-
4823. E-mail: biochem@ochhades.chemie.uni-karIsruhe.de. 
2 Abbreviations  used:  PAL, phenylalanine  ammonia-lyase;  COT,  
cyclooctatetraene;  IPTG,  isopropyl  ß-D-thiogalactoside  
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frans-cinnamic  acid. This  important  plant  enzyme is  at  
the  branching  point  of primary  and  secondary  metabo-
lism, the latter leading to phenylpropanoids  like  lignin,  
flavonoids, and coumarins (1, 2). 
PAL  contains  the  rare  prosthetic  group  dehy-
droalanine,  which is essential  for catalysis.  Working  
with  the  recombinant  enzyme  from  parsley  we  
showed  that  dehydroalanine  is  formed  from  serine  
202  by  an  autocatalytic  posttranslational  modifica-
tion  (3).  When  serine  202  was  changed  to  alanine,  
threonine,  or  glycine  by  site-directed  mutagenesis,  
most  of  the  activity  with  phenylalanine  was  abol-
ished.  The  corresponding  mutants  were,  however,  
still  active  with  4-nitrophenylalanine  as  substrate  
(4).  These  results  parallel  with those  obtained  with  
histidine  ammonia-lyase  (EC  4.3.1.3)  catalyzing  a  
similar  elimination  and  having the  same  prosthetic  
group (5-7).  It has been concluded that  a nitro group 
in  the  appropriate  position  activates  the  ab-
stractable  proton in  the  /3-position  of the  side  chain  
and the  role  of the  dehydroalanine  must  be  similar.  
Consequently,  a mechanism has been proposed  (Fig.  
1)  in  which  the  first  chemical  step  is  the  Friedel-
Crafts  type  electrophilic  attack  of  the  dehydroala-
nine  at the  aromatic  nucleus  (4,  8).  
Support for this  proposal was provided by the find-
ing  that  3-hydroxyphenylalanine  (m-tyrosine)  is  an  
even  better  substrate  for  PAL  than  phenylalanine  
(4).  On  the  other  hand,  tyrosine  (4-hydroxypheny-
lalanine),  whose  OH group is  not  expected  to  facili-
tate  an  electrophilic  attack  in  position  2  of the  phe-
nyl  ring,  is  a  rather  poor  substrate.  To  submit  the  
new  mechanism  to further tests  we  describe  experi-
ments  using  m-cresol  and  glycine  as  inhibitor  and  
cyclooctatetraenyl-(L)-alanine,  2-pyridyl-,  3-pyridyl-,  
and  4-pyridyl-(L)-alanines  as  well  as  [2H6] phenyl-
alanine  as  substrates  for PAL. 
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FIG.  1.  Mechanism  of  the  PAL  reaction.  Electrophilic  a t tack  at  the  phenyl  ring  by  the  dehydroalanine  prosthetic  group  facil i tates  
abstraction  of the  0-HS i  proton  by  an  enzymic  base.  
MATERIALS  AND  M E T H O D S  
(D,L)-ß-Cyclooctatetraenylalanine.  Cyclooctatetraene  (COT)  was  
a  gift  of Professor Gerhard  Schroeder  (Universität  Karlsruhe),  (D.L)-
ß-Cyclooctatetraenylalanine  was  synthesized  as  described  by  meth-
ods  of Huisgen  and  co-workers  (9),  Cope  et  al.  (10,  11), and  P i r rung  
and  Kr i shnamur thy  (12).  
3-Cyclooctatetraenyl-prop-2-en-l-ol.  This  preparat ion  is  as  re-
ported  by Houghton  and  Waight  (13).  
3t-Cyclooctatetraenyl-propenal  2.  A mixture  of 3-cyclooctatetraenyl-
prop-2-en-l-ol  (337  mg,  2.10  mmol) and  active manganese  dioxide  (14)  
(3.8  g)  in  dry  ether  (100  ml) was  stirred  for  4  h  at  room  temperature.  
Filtration  and  removal  of the  solvent  afforded the  aldehyde  (316  mg,  
95%) as  a yellow liquid which was stored a t  -20°C.  'H NMR  (CDC13)  8:  
5.7-6.2  (m,  7H),  5.9 (m,  1H),  7.1 (d,  1H),  9.5  (d,  1H).  
3t-Cyclooctatetraenyl-acrylic  acid  methyl  ester  3.  3-Cyclooctatet-
raenyl-propenal  (213  mg,  1.35  mmol)  was  stirred  a t  room  tempera-
ture wi th  a mixture  of sodium  cyanide  (330 mg, 6.73  mmol),  manga-
nese  dioxide  (2.71  g),  and  acetic  acid  (141  mg,  2.35  mmol)  in  meth-
anol (50 ml) for 90 min. After  filtration  and  removal  of the solvent  the  
crude product  was dissolved  in water  (50 ml). The aqueous  layer  was  
extracted  with e ther  (3  x  50 ml), and the ether extracts  were  washed  
with  aqueous N a H C 0 3  solution  and water  and dried  over  anhydrous  
N a 2 S 0 4 .  Filtration  and  removal  of  e ther  afforded  pure  3  (250  mg,  
99%)  as  a  slightly  yellow  liquid.  'H  NMR  (CDC13)  5: 3.7  (s,  3H),  5.7  
(d,  1H),  5 .7-6 .1  (m,  7H),  7.3  (d,  1H).  
3t-Cyclooctatetraenyl-acrylic  acid  4.  To  a  s t i r red  solut ion  of  
3i -cyclooctate t raenyl-acryl ic  acid  m e t h y l  e s t e r  (250  mg,  1.33  
mmol)  in  methanol  (10  ml)  NaOH  (254  mg)  w a s  added.  A f t e r  
s t i r r i ng  for  2  h  a t  room  t empera tu r e  once  again  N a O H  (100  mg)  
was  added.  S t i r r ing the  mixture  a t  35°C for  4  h and  evapora t ion  of  
t he  solvent  gave  the  crude  product,  which  was  dissolved  in  w a t e r  
and  acidified  with  5%  HC1.  The  r e su l t ing  yellow  prec ip i ta te  was  
ex t rac ted  with  e the r  (3  x  20  ml).  The  combined  organic  l aye r s  
were  washed  with  s a tu ra t ed  N a H C 0 3  solution  and  wa te r .  Dry ing  
over N a 2 S 0 4 ,  filtration,  and  removal  of t he  solvent  gave  pure  4  as  
yellow  crystal l ine  solid  (209  mg,  1.20  mmol,  90%)  of h igh  pur i ty .  
3 H  NMR  (CDC13)  5: 5 .7 -6 .2  (m,  7H),  5.8  (d,  1H),  7.4  (d,  1H);  1 3C  
NMR  (CDC13)  S:  172.37,  148.39,  140.84,  139.47,  133.89,  133.21,  
131.75,  131.33,  130.82,  128.95,  117.10;  HR  MS,  mJz  174.0667  
(calcd  for C u H 1 0 0 2  174.0681).  
L-[2H^Phenylalanine.  L-[2H5)Phenylalanine  was  a  generous  gift  
of the  Hoechst  AG  Frankfur t /M.  
Pyridyl-acrylic  acids.  3i-(3)Pyridyl-acrylic  acid  was  purchased  
from  Fluka.  3f-(2)Pyridyl-acrylic  acid  and  3i-(4)pyridyl-acrylic  acid  
were  synthesized  by the  Knoevenagel  reaction  (15).  
Pyridyl-(L)-alanines.  Reaction  of  the  three  3i-pyridyl-acrylic  ac-
ids  with  ammonia  catalyzed  by  PAL  afforded  the  corresponding  
pyridyl-(L)-alanines  (16).  Alternatively,  the  pyridyl-L-alanines  were  
also  obtained  from  Dr.  Dobler  (Insti tut  fu r  Organische  Kalalysefor-
schung,  Rostock,  Germany).  
PHENYLALANINE  AMMONIA-LYASE  3 
COO coo 
Ki (Gly)  >  20  mM  
Ki (m-cresol)  = 1 7  mM  
Ki (Gly/m-cresol)  =  0.89  mM  
FIG.  2.  m-Cresol  and  glycine  cause  a synergistic  inhibition  of PAL. The formation  of a  covalent  adduct  is speculative.  A noncovalent  tight  
binding  is  also  possible.  
D,L-ß-(2-Pyrimidinyl)alanine.  This  preparation  is  as  reported  by  
Haggerty  et  cd.  (17). 
Bacterial  strains,  plasmids,  and  culture conditions.  Escherichia  coli  
BL21(DE3) cells as host  cells and  pT7.7 as expression vector were  used  
for the expression  of wild-type phenylalanine ammonia-lyase  (3, 4). For 
overexpression  cells  were  grown  in  1 liter  of Luria-Bertani  medium  
(LB) supplemented  with  ampicillin  (85 fig/ml) at  37°C. At  an  OD600  of  
1.0,400  /xM isopropyl ß-D-thiogalactoside (IPTG) was added. Cells were 
harvested  4 h  after induction. The  expression  vector  pT7.7 was  gener-
ously provided  by Dr. Stanley Tabor  (18). The PALI gene from a cDNA 
library from elicitor-treated parsley (Petroselinum crispum  L.) cells and 
antibodies  against  PAL were  generous  gifts  of Prof.  Dr.  K.  Hahlbrock  
(Max-Planck-Institut fur Züchtungsforschung Cologne) and Prof. Dr. N. 
Amrhein  (ETH  Zürich),  respectively.  pT7.7PAL  was  produced  as  de-
scribed  by Schuster  and  Retey  (3).  
Purification.  Transformed E.  coli BL21 cells were grown in  11 LB 
medium containing ampicillin  (85 /xg/ml) to an OD600  of 1.0. Then 0.4  
mM  IPTG  was  added.  Cells  were  harvested  4  h  after  induction  by  
centrifugation at  4500g.  The  cell  pellet  was resuspended  in  10 ml  of  
10  mM potassium  phosphate  buffer, pH  6.6,  containing:  40 units  of  
Benzonase  (Merck,  Darmstadt),  5  mM  benzamidine,  and  0.5  mM  
phenylmethanesulfonyl  fluoride.  Sonication  (Branson  Model  450,  
70% power setting,  10 min ice bath) was followed by centrifugation at 
30,000g  for  30  min.  Purification  was  performed  as  described  by  
Schuster  and  Rbtey  (3,  4).  
SDS/PAGE,  Western  blot,  and  protein  assay.  SDS-PAGE  using  a  
10% Polyacrylamide  gel was performed according to Laemmli  (19) to 
monitor  the  purification  of PAL.  Staining  of the  gel was  carried  out  
with Coomassie brillant  blue  R 250. Western blotting was performed 
using the standard  laboratory protocol adapted  according to Syming-
teon  et al.  (20). Protein  determinations  were  performed  by  measure-
ment  of A26o and A28o  according  to Warburg  and  Christian  (21).  
Enzyme  assay.  PAL  activity  was  determined  spectrophotometri-
cally  using  the  absorption  of  the  reaction  product  cinnamate  (22).  
Standard  conditions for the measurement  of PAL activity were 0.1 M 
Tris-HCl  buffer,  pH  8.8,  0.05-5  mM  L-phenylalanine,  30°C.  The  
extinction  coefficient (e290)  of cinnamic  acid  is  104 liters cm"1  mol"1.  
Determination  ofVmax  and  Km  values.  The kinetic constants  were  
determined  by  measuring  the  UV  absorption  of the  produced  acry-
lates  (3f-(2)pyridyl-acrylic  acid,  e(285j  =  12,520  liters  cm"1  mol"1;  
3t-(3)pyridyl-acrylic  acid.  e,2901  =  8430 liters  cm"1  mol"1;  3i-(4)pyri-
dyl-acrylic  acid,  e(280>  =  8370  liters  cm"1  mol"1;  3i-cyclooctatetrae-
nyl-acrylic acid: e,250)  =  20,700 liters cm"1 mol"1), using 0.05-10  mM 
of  the  corresponding  amino  acid  as  substrate.  Conditions  were  
0.05-10  mM substrate  in  0.1  M Tris-HCl  buffer, pH  8.8, at  30"C.  
Determination  of  the  kinetic  deuterium  isotope  effects.  The  Km  
and  V m „  values  were  determined  spectrophotometricaily.  The  ex-
tinction  coefficient (e29o) of the resulting  [2H5]cinnamate is  104  liters  
cm"1 mol"1 .  To avoid errors, the measurements  of the  corresponding  
undeuterated  phenylalanine  were  carried  out  at  the  same  time.  
Conditions were 0.05-10 mM substrate in 0.1 M Tris-HCl buffer, pH 
8.8, at  30°C.  
Semiempirical  force-field  calculations.  The sigma  complexes  and  
their  corresponding  methyl-substituted  aromatic  counterparts  were  
calculated  by  three  different  semiempirical  force-field  methods:  
MNDO, AMI,  and  PM3.  
Kinetic  investigations  of PAL  with  m-cresol,  glycine,  and  a  mixture  
of m-cresol  and  glycine.  m-Cresol  (5 and  10 mM),  glycine  (15  mM),  
or  an  equimolecular  mixture  of m-cresol  and  glycine  (1  and  7  mM)  
were  added  to the  enzyme  assay.  The Ki values  were determined  by  
using the  standard  linearization  method  of  Lineweaver-Burk.  
RESULTS  AND  DISCUSSION  
Analogous  substrates  and  substrate  mimics.  m-Cresol  
and  glycine  as  mimics  of  3-hydroxyphenylalanine  (m-
tyrosine) were probed as inhibitors of PAL (Fig.  2). While 
glycine  hardly  inhibited  the  enzyme  and  m-cresol was  a  
moderate  inhibitor  (Kt  =  17 mM),  equimolar  amounts  of  
both had  a synergistic effect. It can be concluded that  the  
two  compounds  simultaneously  occupy the  active  site  of  
PAL and  compete  with the  substrate.  
Racemic  COT alanine  was  synthesized  by the  method  
of  Pirrung  and  Krishnamurthy  (12).  The  expected  
product  of  the  PAL  reaction,  cyclooctatetraenyl-
acrylate  was  also  synthesized  and  characterized  (Fig.  
3).  The  known  allylic  alcohol,  3-cyclooctatetraenyl-
prop-2-en-l-ol,  was  prepared  starting  from  cycloocta-
tetraene  according  to  published  procedures  (13).  Mild  
oxidation  in two steps  using the  method  of Corey  et  al.  
(23)  furnished  the  methyl  ester  of  cyclooctatetraenyl-
acrylic acid which was hydrolyzed to the free acid. Each of 
the  three  steps  occurred in  more than  90% yield. 
Determination  of the  extinction  coefficient  (e)  of  the  
cyclooctatetraenyl  acrylate  made  a  kinetic  analysis  of  
the  PAL reaction  with  COT-(D,L)-alanine  possible.  The  
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TABLE  I  
Kinetic  Constants  of  Pyridyl-(L)-alanines  
K m / K m {  L_phe)  V  /V  * max'  maxtL-Phei  
L-Phe 1 1 
2-Pyridyl-L-Ala 22.0 0.8 
3-Pyridyl-L-Ala 41.6 2.4 
4-Pyridyl-L-Ala 12.1 1.8 
COT-D,L-Ala 22.6 0.0058 
COOH 
FIG.  3.  Synthesis  of 3f-cyclooctatetraenyl-acrylic  acid.  
very  low Vm a x  value  (0.6% of that  for  L-phenylalanine)  
and  the  30  times  higher  Km  value  for  this  substrate  
show  that  both  binding  and  turnover  are  impaired.  It  
seems  that  the  binding  pocket  for the  phenyl  group  is  
rather  flat  and  the  puckered  COT  ring  does  not  suit  
into  it  optimally.  Thus  both  the  geometry  and  the  
larger  size  of the  cyclooctatetraene  ring may  place  the  
double  bond  and  the  dehydroalanine  into  an  unfavor-
able  steric  relationship  for the  electrophilic  attack.  
Therefore,  the  synthesis  of the  three  isomeric  pyri-
dyl-(L)-alanines  was  undertaken  (Fig.  4).  Following  a  
Japanese  patent  (16) they  can be synthesized  from  the  
corresponding acrylates using PAL as catalyst.  Accord-
ingly,  the  three  isomeric  pyridylacrylates  were  pre-
pared  by  known  procedures  (15).  In  the  preparative  
conversions  by  PAL  the  equilibrium  of  the  reactions  
was  shifted in the  desired  direction  by  using  high  con-
centrations  of ammonia  (5  M  NH3/NH4).  
In such  a way the pyridyl-(L)-alanines  were  obtained  
in  up  to  80% yield  and  were  spectroscopically  charac-
terized. All three isomers  of pyridyl-(L)-alanines  turned  
out  to  be  excellent  substrates  of  PAL  (Table  I).  Al-
though their Km  values were substantially higher  than  
that  of  L-phenylalanine,  the  3-  and  4-pyridylalanines  
had  higher  Vmax  values.  This  means  that  they  were  
less  tightly  bound  by  the  enzyme,  but  at  saturating  
concentrations  they  reacted  faster  than  the  natural  
substrate.  At the  first  glance  these  results  are  surpris-
„COOH PAL 
5M  NH,  
63% 
COO 
COOH PAL 
5M  NH,  
59% 
COO 
COOH PAL 
5M  NH,  
75% 
COO 
NH, 
FIG.  4.  Synthesis  of pyridyl-alanines.  To  1 mmol  acrylic  acid  in  15 ml  of  5  M N H 4 0 H  solution  (adjusted  by C 0 2  to  pH  10) was  added  1  U  
PAL  (Petroselinum  crispum  L.). Eighteen hours  of agitation  a t  30°C,  filtration  of denatured  protein,  and removal  of t h e  solvent gave the  crude  
product.  Purification:  recrystallization  in  H zO/acetone  or  cation-exchange  chromatography  (Dowex  50W  x  8).  
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ing,  since  electrophilic  substitution  at the  pyridine  nu-
cleus  is  more  difficult than  at  benzene.  The  main  rea-
son  for it  is  that  the  electrophile  (most  often  a  proton)  
adds  first  to  the  pyridine  nitrogen  and  the  positive  
charge  inactivates  the  ring  for  a  further  electrophilic  
attack. 
Since  in  solution  chemistry  it is  not feasible  to  carry  
out  an  electrophilic  attack  at  a  pyridine  ring  without  
first  adding  an  electrophile  (e.g.,  a proton)  to  the  pyri-
dine  nitrogen,  there  is  no  experimental  precedence  for  
the  electrophilic  attack  at  a  neutral  pyridine.  There-
fore, we carried out three different semiempirical  force-
field  calculations  (MNDO,  AMI,  and  PM3)  to have  an  
approximate  measure  for  the  stability  of  the  cr  com-
plexes in the  corresponding  electrophilic  substitutions.  
The differences in the heat  of formation (AHs)  between  
those  of the sigma  complexes  and those  of the  aromatic  
ground  states  for  the  methyl-substituted  phenyl  and  
the  isomeric  pyridine  rings  are  shown  in  Table  II  (see  
also Fig. 6). Since the entropy terms for all species  should  
be  similar,  the  AH  values  can  be taken  as  a measure  for  
the  AG  values.  They  show  relatively  small  differences  
between  the  phenyl  and  pyridinyl  complexes,  but  the  
trend is the expected one; i.e., meta attack in the  pyridine  
ring is  more  favored than  ortho or para  attack.  It  seems,  
however,  that  the  Vm a x  values  are  normally  not  deter-
mined by the rate  of the electrophilic substitution;  rather  
the  rate  of  the  dissociation  of the  enzyme-product  com-
plex  is  at  least  partially  rate-limiting.  This  is  in  agree-
ment with  a  thorough kinetic  investigation  (24)  showing  
no  primary  kinetic  deuterium  isotope  effect  with  [3,3-
2H] phenylalanine  as  substrate.  
The  Km  values  (Table  I) suggest  also the  dissociation  
of  the  enzyme  product  complex  being  rate-limiting.  
Among the  isomers,  3-pyridyl-(L)-alanine  has the  high-
est  Km  and  Vm a x  values.  2-Pyridyl-(L)-alanine  is  a  spe-
cial  case  because  electrophilic  attack  at  the  pyridine  
nitrogen leads  to the  inert  pyridinium  complex.  Conse-
quently  2,6-pyrimidinyl-(L)-alanine  is  not  a  substrate  
for  PAL,  while  3,5-pyrimidinyl-(L)-alanine  is  a  moder-
TABLE Q 
S e m i e m p i r i c a l  Force-Field  Ca lcu la t ions  
( M N D O ,  A M I ,  a n d  PM3)  
Intermediate A  HF  A charge  of  H  
A 180.6 0.048 
B 184.9 0.059 
C 185.4 0.056 
D 194.3 0.072 
E 198.3 0.065 
F 212.0 0.079 
Note.  5Hf,  difference  in  the  heat  of  formation  between  the  cr  
complexes  and  the  aromatic  ground  states.  A charge  of H, difference 
in  charge  of the  methyl  H  atoms  between  the  S complexes  and  the  
aromatic  ground  states.  
1  i  1  1  1  Y  Y  
Y  /c  
-
+  L-Phe  
x  D5-L-Phe  
X  ,  i  1 
-40  -20  0  20  
1/[S] 
F IG .  5.  Lineweaver-Burk  plot  of wild-type  PAL with  L-phenylala-
nine  and  L-[2H5]phenylalanine  as  substrates.  The  reaction  rate  was  
determined  spectrophotometrically  at  A =  290  nm.  
ately  good  substrate  (A.  Gloge  and  J.  Rétey,  unpub-
lished). 
The  AH  value  for  the  cr  complex  of  a  protonated  
pyridine  has  been  also  calculated  as  440  kcal/mol,  i.e.,  
more than  double as high as  the  neutral  pyridine.  This  
is  expected  since  such  a  complex  would  carry two  pos-
itive  charges.  
For  the  reasons  above  we  conclude  that  by  placing  
the  pyridine  ring  into  the  phenyl-binding  hydrophobic  
pocket,  PAL  protects  it  from  protonation,  thus  facili-
tating  the  electrophilic  attack  at  the  ortho  carbon  po-
sition.  On  the  other  hand,  the  higher  polarity  of  the  
pyridine  ring  compared  to  the  phenyl  ring  decreases  
the  binding  affinity,  which  is  reflected  by  higher  Km  
values  (Table  I) and probably higher dissociation  rates  
of the  enzyme-product  complexes.  Accordingly,  the  Kt  
values  of the  pyridylacrylates  are  by  an  order  of  mag-
nitude  higher than that  of cinnamate  (24  ±  3 pM) (24).  
Secondary  kinetic  deuterium  isotope  effect.  To  sub-
mit  the  new  mechanism  involving  a  Friedel-Crafts  
type  acylation  (4,  8)  to  a further test  we  measured  the  
kinetic  deuterium  isotope  effect  of  the  PAL  reaction  
with  L-[2H5] phenylalanine  as substrate. The  Lineweav-
er-Burk  plots  were  derived  from  four  individual  mea-
surements  at  different  substrate  concentrations  (Fig.  
5).  The  labeled  and unlabeled  substrates  were  assayed  
on  the  same  day  and  with  the  same  enzyme  prepara-
tion.  Whereas  the  Km  values  were  identical,  the  Vmax  
values  exhibited  a  kinetic  isotope  effect  of  kH/kD  =  
1.09  ±  0.01.  This  result  strongly  indicates  that  the  
phenyl  ring  is involved in the reaction  mechanism  and  
that  substrate  binding  is  independent  of  isotopic  sub-
stitution.  The  magnitude  of  the  kH/kD  value  is  in  the  
range  of  a  secondary  deuterium  kinetic  isotope  effect.  
The  origin  of  such  an  effect  in  electrophilic  aromatic  
6 GLOGE  ET  AL.  
H  CH,  
CH, 
H  CH,  H  CH,  
CH, 
B 
H  VCH3  
N>v 
H  CH,  
,CH, 
H  CH,  
C H , 
FIG.  6.  Simplified  a  complexes  as  putative  intermediates  in  the  electrophilic  substitution  reactions  at  phenyl  (A), 2-pyridyl  (B),  4-pyridyl  
(C),  3-pyridyl  (D and  E),  as  well  as  3,5-pyrimidinyl  (F)  rings.  
substitutions  has  been  discussed  by  several  authors  
(25,  26)  and  was  thoroughly  reviewed  by  Halevi  (27).  
There  is  agreement  that  two  opposite  effects  play  a  
role,  the  rehybridization  (sp2  —*  sp3)  and  hyperconju-
gation. While the change of hybridization from trigonal 
to tetrahedral  geometry  ordinarily  leads  to  an  inverse  
isotope  effect  (kH/kD  <  1),  this  may  be  overcompen-
sated  by  hyperconjugation  when  the  hydrogen  atom  
moves  out  of  plane  in  the  transition  state.  Since  the  
C-D  bond  contributes  less  than  the  C-H  bond  to  the  
stabilization of the carbenium ion by  hyperconjugation,  
a  normal  isotope  effect ( k H / k D >  1) is  to  be  expected.  
Whatever  the  theoretical  explanation  for  the  ob-
served  effect,  in  nonenzymic  electrophilic  substitution  
of  aromatic  compounds  similar  effects  have  been  ob-
served (28-30)  as in the  present  case. All these  results  
are consistent with the proposed role  of the phenyl  ring  
in the  PAL reaction  and  cannot  be  reconciled  with  the  
previously  accepted mechanism with  no direct  involve-
ment  of the  phenyl  ring.  
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Abstract: 
Several fluoro- and chloro-phenyl alanines are good  substrates of phenylalanine  ammonia-
lyase (PAL / EC 4.3.1.5) from parsley. The enantiomerically pure L-amino acids were obtained 
in good  yields  by reaction  of  the  corresponding  cinnamic  acids  with  5 M  ammonia  solution  
(buffered to pH  10) in the presence of PAL. The kinetic constants for nine different fluoro- and 
chlorophenylalanines  do  not  provide  a  rigorous  proof  for  but  are  consistent  with  the  
previously  proposed  mechanism  comprising  an  electrophilic  attack  of  the  methylidene-
imidazolone cofactor of PAL at the  aromatic nucleus as  a first  chemical step. In the  resulting  
Friedel-Crafrs-Type a-complex the pro-S  ß-proton is activated  for abstraction  by an  enzymic  
base. Results of semiempirical calculations combined with a proposed partial active site model 
showed a correlation between the experimental kinetic constants and the change of polarization 
of  the  pro-S  Cp-H  bond  and  heat  of  formation  of  the  o-complexes,  thus  making  the  
electrophilic  attack  at  the  neutral  aromatic  ring  plausible.  Furthermore,  while  5-pyrimidinyl-
alanine  was  found to  be  a  moderately  good  substrate  of  PAL,  2-pyrimidinyl-alanine  was  an  
inhibitor. 
INTRODUCTION 
Phenylalanine ammonia-lyase (PAL) catalyses the reversible conversion of L-phenylalanine 
to  trans-cmDsamc  acid.  PAL  is  the  key  enzyme  in  the  metabolism  of  phenylpropanoids  in  
plants,  since  cinnamic  acid  is  the  precursor  of  lignins,  flavonoids  and  coumarins.'1,21  Early  
biochemical evidence indicated a catalytically essential electrophilic group at the active sites of 
PAL  and  the  related  enzyme  histidine  ammonia-lyase  (HAL).  Inactivation  by  radiolabelled  
nucleophiles  (KI4CN  and  NaB3H4)  followed  by  total  hydropses  of  the  proteins  afforded  
radioactive  products  which  could  be  derived  from  a  dehydroalanine  residue  being  the  
electrophilic prosthetic group.13,4,5' 
Its precursors have been found by site-directed mutagenesis to be Ser 202[6] and Ser  143[7]  
in PAL and HAL, respectively.  Since both enzymes have been overexpressed  in E.coli  cells in 
active forms, the posttranslational modification takes place autocatalytically.'8,91  
Recently, the  3D structure of HAL has been elucidated  by x-ray analysis which revealed 
that  the  electrophilic  prosthetic  group  is  methylidene-imidazolone  (MIO).[10]  MIO  can  be  
regarded  as a  modified dehydroalanine.  The  ring  structure  and the  geometry  dictated  by the 
protein conformation prevents the  lone pairs of the  imidazole nitrogens to  delocalize  into the 
a/p  unsaturated  carbonyl system thus enhancing the  electrophilicity of the  latter.  The driving 
force  for  the  formation of  MIO from the  tripeptide  Alal42SerGlyl44  is  unknown  but  not  
without  precedence.  The  chromophoric  imidazolone  of  the  green  fluorescent  protein'11,12,131  
must be formed by a similar autocatalytic process. 
The  discovery of the electrophilic prosthetic  group was followed by the proposal that  it  
reacts with the  amino group  of the  substrate  in a  type  of  Michael  addition.'141  This  reaction 
would enhance the leaving ability of the amino group, i.e. facilitate the elimination of ammonia, 
but  leaves the question open how the non-acidic  P-proton could be abstracted  by an enzymic 
base. 
Recently,  experimental  evidence  accumulated  in favour of  an  electrophilic  attack  at  the  
aromatic nucleus as shown in Scheme 1 for the PAL reaction.'15,161 In the Friedel-Crafts-Type 
G-complex the  |3-protons of the  side-chain  are  activated  for abstraction  by an  enzymic  base.  
The proton transfer  is then followed by ammonia elimination concomitant  with restoration of 
the prosthetic group and the aromaticity of the 6-membered ring. 
The question is legitimate,  why the P-proton is abstracted  leading to  an exocyclic  double  
bond  while  abstraction  of  the ring proton  would  straightforwardly  lead  to  re-aromatization.  
Although the latter  would preferentially take place  in solution,  PAL prevents this reaction by 
excluding  any  basic group  in the  binding  site for the phenyl group.  Simultaneously,  a  basic  
group is correctly positioned to abstract the P-proton of the substrate. 
In the present  communication we describe the enantiospecific synthesis of various fluoro-
and  chlorophenylalanines  by  reversal  of  the  PAL reaction.  Kinetic  measurements  with  these  
new  substrates  and  the  results of  theoretical  calculations  and  a  proposed  partial  active  site  
model are discussed in terms of the Friedel-Crafts-type mechanism of the PAL reaction. 
RESULTS AND DISCUSSION 
Enantioselective Synthesis of L-Phenylalanines Halogenated  in the Ring. 
Contrary  to  early  claims  that  the  PAL  reaction  is  irreversible1171  it  can  be  reversed  by  
applying  high  concentrations  of  ammonia.1181  For  preparative  conversions  the  halogenated  
cinnamic acids were  solved in half concentrated  ammonia solution whose pH was  brought  to  
10 by bubbling C02  into it. The reaction was started by addition of recombinant PAL (1-2 iU). 
After  incubation  overnight  at  37°C  the  enzyme  was  removed  by  boiling  and  acidification  
(pH 1.5) followed by filtration. Chromatography on an acidic cation exchange column afforded 
the enantiomerically pure substituted phenylalanines in moderate to  excellent  yields. Their e.e. 
was determined on a chiral column to be more than 99 %. The halogenated cinnamic acids and 
phenylalanines were characterized  by their NMR,  and UV  spectra,  as well as their  Rf values. 
Their structures together with the yields of the isolated phenylalanines are shown in Scheme 2. 
Determination of the Kinetic Constants for the Halogenated  Phenylalanines.  
The  prerequisits  for the  quantitative  measurement  of the  concentrations  of  the  cinnamic  
acid products  was the determination of their  extinction  coefficients (e)  at  the wavelengths  at  
which  a  maximal  difference existed  between those  of the  arylalanines  and  the  corresponding  
cinnamic  acids  (see  experimental  section).  The  values  were  measured  in  0.1 M  Tris-buffer  
pH 8.8.  These were the conditions  also  for the  kinetic  measurements.  In  columns 4  and  5 of 
Table  1 the  Vma*  values relative to that  of phenylalanine  and the  Km values,  respectively,  are  
listed. 
Inspection  of  the  relative  Vmax values reveals that  phenylalanines  halogenated  in the  3'-
position react on PAL significantly fester than the parent compound. This is consistent with an 
electrophilic  attack  of  MIO  at  the  aromatic  nucleus.  A  halogen  substituent  in  3'-position  
facilitates such an attack in ortho or para by stabilisation of the cationoid transition state. Both 
positions  are  available for the  attack  by the  sterically  fixed MIO  due to  free  rotation  of  the 
phenyl ring before substrate binding.  This effect is similar to  that previously found with a  3'-
hydroxyphenylalanine  (/w-tyrosine) as substrate.1151 Halogen substituents in the phenyl ring may 
also  influence the  acidity of the  P-protons of the  side  chain.  While this  effect should  activate  
the  P-protons  in the  neutral  ground  state,  the  opposite  effect is e jec ted  for  the  cationoid  
intermediate.  In  the  latter,  delocalization  of  the  positive  charge  to  the  halogen  atoms  will  
decrease  electron  deficiency  in the  ring  and  hence  diminish  the  acidity  of  the  side  chain  P  
protons.  The acidifying effect of the halogen substituents is however much less than that of  a  
nitrogroup.  Anyway, the P-proton abstraction does not  seem to  be rate determining for good 
substrates  as  shown  by  deuterium  labelling.1191  While  the  attack  by  MIO  is  partially  rate  
determining, another rate-limiting step seems to be product release. The kinetic significance of 
these  two  steps  is  substrate-dependent.  The  Km values  vary  only  moderately,  but  roughly  
increase with increasing numbers of the halogenic substituents.  
Theoretical  Calculations 
To demonstrate the feasibility of the electrophilic attack at the halogenated aromatic rings 
semiempirical  calculations  for  the  heat  of  formation  and  for  the  activating  effect  on  the  
P-protons  by the positive  charge  in the  ring were  carried  out.  To  facilitate the  problem,  the  
calculations (AMI  and PM3)  were applied to  a  simplified model of the putative  a-complexes  
containing the  substrates  in their  zwitterionic form and  a methyl  group which corresponds  to  
the  carbon  of  the  fnethylidene moiety  of  MIO  (Scheme  3).  Conformational  analysis  of  the  
zwitterionic  form  of  L-Phe  indicated  that  the  most  decisive  conformation  factor  for  the  
molecular properties  is the  dihedral angle  (<X>)  between the Ci-Cr  and the pro-S  Cp-H bonds 
(Scheme 3). Results of semiempirical calculations are compiled in columns 2 and 3 of Table 1.  
With respect to the a-complex formation and scissible bond polarization the 2'F, 2'C1 and 
4'C1  substituted  compounds,  particularly  the  B  type  sigma  complexes  are  similar  to  the  
unsubstituted L-Phe. Accordingly, their kinetic behaviour is similar to the natural substrate. 
The  putative  active  site  model  suggests  that  the  aromatic  ring  of  the  substrate  is  
sandwiched between MIO and a phenyl ring of  Phe399. The arrangement as shown in Scheme 
1 allows maximal overlap between the n  system of MIO and the aromatic  C2.position. The 2' H 
of  the  aromatic  moiety  might  be  stabilized  in  a  charge-transfer  or  n  complex  type  manner  
without  the  possibility  of  rearomatization  by  its  removal.  The  conserved  nature  of  the  
analogous phenylalanine  in all PAL and HAL sequences (e.g. the GGNFH segment is present 
in  the  HAL  enzymes  of  microorganisms  such  as  P.  putida  or  B.  subtilis  as  well  as  in  
mammalian HAL enzymes like mice, rat or human) supports the importance of this amino acid. 
In the case of compounds  bearing halogen  at  3'  position,  additional hyperconjugation of 
the  3'-halogen  atoms  with  the  aromatic  it  electrons  of  Phe399  might  also  be possible.  This  
effect  may  lower  the  energy  values  listed  in  Table  1  which  were  calculated  in  vacuo.  In  
addition,  the pro-S  Cp-H  bond  in  the  ground  state  of  the  3',5^2  substituted  compound  is  
significantly more polarized  (ca. 0.040 Mulliken charge  units) then in all the  other models. In 
the case of the pentafiuoro analogue, the effect of hyperconjugation effect with the aromatic it 
electrons  of  Phe399  cannot  overbalance  the  energy  demand  of  the  formation  of  the  sigma  
complex. 
For the  5-pyrimidinyl compound relatively high energy is required for formation of the  a  
complex but  the  polarization of the  scissible pro-S  Cp-H is  relatively  strong.  Accordingly,  a  
high  Km value but  a normal  Vmax  is observed.  The  inhibition observed  with the  2-pyrimidinyl  
compound  is  a  consequence  of  the  stability  of  the  cationic  pyrimidinhim  complex  and  the  
unfavourable proton abstraction from the negatively polarized pro-S  Cp-H bond (Scheme 4). 
All  these  correlations  are  consistent  with  the  intermediacy  of  the  Friedel-Crafts  type  
a-complexes  and the kinetic  significance of their  formation as partially rate-determining  step.  
Further  support for our mechanism was provided by recent publications (20,21). 
Synthesis of and Kinetic Measurements with  Pyrimidinylalanines  
The synthesis of  |3-(2-pyrimidinyl)-D,L-alanine  1 was carried out in six steps following the 
procedure of Haggerty et  al.[22] A chemoenzymatic  strategy was applied to the preparation of 
P-(5-pyrinudinyl)-L-alanine 2. First of P-(5-pyrimidinyl)-aciylic  acid 3 was synthesised  starting  
from  5-bromo-pyrimidine  and  teri-butylaciylate  under  Heck  conditions.  Treatment  of  the  
product  with trifluoro acetic acid afforded the free P-(5-pyrimidinyl)-acrylic  acid 3  which was 
converted  in  57 %  yield  into  the  corresponding  enantiomerically  pure  L-alanine-derivative  2  
using PAL as a catalyst. 
While the 5-pyrimidinyl isomer turned out to be a moderately good  substrate  of PAL,  its 
2-pyrimidinyl counterpart  1 was a  competitive  inhibitor.  The  corresponding  kinetic  constants  
are shown in Table 3. The Kc-value of 2 is comparable to the Ki-value of 1. 
These results support  the postulated ortho-attack  of MIO at the  aromatic nucleus.  When 
both ortho positions are  occupied  by a nitrogen atom such an attack leads to  a  pyrimidinium 
ion which is so  stable that  no further reaction occurs (see Scheme 4).  The competitive nature 
of the inhibition requires however that the binding of 2 is reversible. 
EXPERIMENTAL  SECTION:  
Recombinant  PAL  was  overexpressed  in Ecoli  and purified as  described,  first  according  to  
Schuster and Retey[6J and later using the improved method of Baedeker and Schulz.[23]  
Chloro-  and fluoro-L-phenylalanines:  Chlorocinnamic  acids  and fluorocinnamic acids  were  
purchased from Fluka and from Lancaster.  Reaction of the  chloro-  and  fluorocinnamic acids 
with  ammonia  catalyzed  by  PAL  afforded  the  corresponding  chloro-  and  fluoro-
L-phenylalanines.  To  a  5 M aqueous  NH3-solution,  adjusted to  pH 10  by  C02,  were  added  
100 mg of the  cinnamic  acid  and  1  U wtPAL  (Petroselinum crispum).  The reaction  mixture  
was agitated overnight at 37°C. The solution was acidified with 5 % HC1 to pH 1,5, heated to 
boiling, filtered and applied to a Dowex 50 cation exchange resin column. The elution occurred 
with  diluted  ammonia  solution.  The  crude  product  was  purified with  HPLC  (Nucleosil  100  
CI8,  7pm,  250 x  20mm; flow rate:  5 ml/min; load:  20 mg;  mobile  phase:  0-15 mim  99.9 % 
H20  /  0.1 % TFA,  15-90 min:  linear  increasing  gradient  to  99.9%  CH3CN  /  0.1 %TFA, 
retention  times:  L-phenylalanine:  41.7 min,  2 Vfluoro-L-phenylalanine:  42.4 min,  3'-fluoro-
L-phenylalanine: 44.1 min, 4'-fluoro-L-phenylalanine: 43.9 min, 2',6'-difhioro-L-phenyla]anine: 
42.7 min,  3',5'-difhioro-L-phenylaIanine:  46.5 min,  2',3',4',5',6'-pentafhioro-L-phenylalanine:  
48.4 min, 2'-chloro-L-phenylalanine: 45.3 min, 3'-chloro-L-phenylalanine:  48.0 min, 4'-chloro-
L-phenylalanine: 48.7 min). For the determination of the enantiomeric excess we used a chiral 
column from astec/ict  (Chirobiotic T,  250 x 4.6 mm; mobile phase:  70 % H20  /  30 % EtOH; 
flow  rate:  0,8ml/min;  load:  5 pg;  retention  times:  L-phenylalanine:  7.22min,  2-fluoro-
L-phenylalanine:  6.87 min,  3'-fluoro-L-phenylalanine:  6.98 min,  4Vfluoro-L-phenylalanine:  
7.20 min,  2',6'-difluoro-L-phenylalanine:  6.42 min,  3',5'-difluoro-L-phenylalanine:  6.75 min, 
2',3 ',4',5 ',6'-pentafluoro-L-phenylalanine:  5.89 min,  2'-chloro-L-phenylalanine:  9.06 min, 
3'-chloro-L-phenylalanine:  8.22 min,  4'-chloro-L-phenylalanine:  9.25 min).  In  all  cases  eeis  
over 99 %. 
P-(2-Pyrimidinyl)-D,L-alanine 1. Preparation as  reported  by W.  J. Haggerty,  R.  H.  Springer  
and C. C. Cheng.'201 
f-(5-Pyrimidinyl)-L-alanine  2.  p-(5-Pyrimidinyl)-acrylic  acid  3  obtained  by  Heck  coupling  
between 5-bromopyrimidine and /erf-butyl acrylate, followed by ester-cleavage in TFA.'241 
10 ml of a concentrated, aqueous ammonia-solution were diluted with  10 ml of distilled  water.  
The pH was adjusted to  10.0  by bubbling C02  into the  solution.  To the  solution were  added  
64.3 mg (0.428 mmol)  P-(5-pyrimidinyl)-acrylic  acid  3  and  1  U  PAL.  After 24 h  agitation  at  
37°C the enzyme was denatured by heat  and removed by filtration. The clear  solution applied 
to  a  Dowex  50  cation  exchange  resin  column.  The  ehition  occurred  with  diluted  ammonia  
solution. The crude product was purified with HPLC (Nucleosil  100 CI8,  7pm, 250 x 20mm; 
flow rate:  5ml/min;  load:  20 mg;  mobile  phase:  0-15 min:  99.9%  H20  /  0.1 % TFA,  15-
90 min:  linear increasing gradient to  99.9 %  CH3CN  /  0.1 % TFA, retention times: 23.5 min). 
The solvent was carefully removed  under  reduced  pressure to  give  50 mg (0.246 mmol)  of  a  
white solid. The product was obtained as hydrochloride in 57 % yield. 
Determination  of  Vmax- and Km-values.  The  kinetic  constants  were  determined  by  measuring  
the  UV-absorption  of the  produced  acrylates  (rivms-cinnamic  acid:  8(290) =  10000 liters  cm"1  
mol"1; 2'-fluorocinnamic acid:  S(2so) =  12550 liters  cm"1  mol"1;  3 '-fluorocinnamic acid:  8(280) = 
13850 liters  cm"1  mol"1;  4'-fluorocinnamic  acid:  S(280)  =  15320 liters  cm"1  mol'1;  
2',6'-difluorocinnamic acid:  8(290) =  3960 liters  cm"1  mol"1; 3',5'-difluorocimiamic acid:  8(290) = 
5060 liters  cm"1  mol"1; 2',3',4',5',6'-pentafluorocinnamic  acid:  s(28o) =  7910 liters  cm"1  mol"1;  
2'-chlorocinnamic  acid:  8(285)  =  10770 liters  cm"1  mol"1;  3'-chlorocinnamic  acid:  8(285)  =  
10680 liters  cm'1  mol"1;  4'-chlorocinnamic  acid:  8(290)  =  15790 liters  cm"1  mol"1;  
P-(5-pyrimidinyl)-acrylic  acid:  8(270)  =  11110 liters  cm"1  mol"1)  using  0.05-10 mM  of  the  
corresponding amino acid as substrate. Conditions: 0.05 mM -10 mM substrate in 0.1 M Tris-
HC1 buffer pH 8.8 at 30 °C. •H-NMR (250 MHz; D20,  25°C):  L-phenylalanine: 8 = 7.28-7.43 
(m,  5H),  3.96  (t,  1H),  3.27  (dd,  1H),  3.08  (dd,  1H),  2'-fluoro-L-phenylalanine:  8 = 7.34  (m,  
2H),  7.17  (m,  2H),  4.26  (t,  1H),  3.40  (dd,  1H),  3.20  (dd,  1H),  3'-fluoro-L-phenylalanine:  
8 = 7.38  (m,  1H),  7.08  (m,  3H),  4.19  (t,  1H),  3.32  (dd,  1H),  3.16  (dd,  1H),  4'-fluoro-L-
phenylalanine:  8 = 7.26  (m, 2H),  7.10  (m,  2H),  4.28  (t,  1H),  3.29  (dd,  1H),  3.15  (dd,  1H),  
2',6'-difluoro-L-phenylalanine:  8 = 7.36  (m,  1H),  6.99  (m,  2H),  4.28  (t,  1H),  3.37  (dd,  1H),  
3.26 (dd,  1H),  3',5'-difluoro-L-phenylalanine:  8 = 6.90  (m,  3H),  4.32  (t,  1H),  3.35  (dd,  1H),  
3.17 (dd,  1H), 2',3',4',5',6'-pentafIuoro-L-phenylalanine:  8 = 4.01 (t,  1H), 3.26 (dd,  1H), 3.19 
(dd,  1H),  2'-chloro-L-phenylalanine:  8 = 7.48  (m,  1H),  7.34  (m,  3H),  4.05  (t,  1H),  3.45  (dd,  
1H), 3.16 (dd,  1H),  3'-chloro-L-phenylalanine:  8 = 7.36  (m, 3H),  7.21  (m,  1H), 4.20  (t,  1H),  
3.31 (dd,  1H), 3.16 (dd,  1H), 4'-chloro-L-phenylalanine:  8 = 7.40 (d, 2H),  7.26 (d,  2H),  3.97  
(t,  1H), 3.23 (dd,  1H), 3.10 (dd, 1H).  
Theoretical  calculations.  L-Phenylalanine,  the  halogenated  L-phenylalanine  derivatives,  and  
their  G-complex  models  were  calculated  in  vacuo  using  AMI  and  PM3  methods.  125,261  
Conformational  analysis  showed  two  favoured  states  for  zwitterionic  structures  with  
antiperiplanar pro-S  Hp -NlL  zig-zag  arrangement  (Scheme  3).  All further calculations refer 
to the arrangement with a fixed $  = -90 ° torsion angle. Since the parallel results from the two 
methods were  similar,  values derived from PM3  calculations  are  indicated  only. In the  cases  
where two distinct a-complex models may arise by rotation of the substrate prior to the active 
complex formation, model A represents the structure where the halogen substituent is closer to 
the sp3 centre in the a  complex.  
The putative  active  site  model  was  built  from  a  sequence  segment  of  PAL  (SP:  P24481)  
containing the ASGDL active site motif and the F399 by homology-modelling  1271 using HAL 
structure (PDB:  1B8F  110J) as folding template, followed by Gromos  1271 and Amber  1241 energy 
minimizations.  The ASG  structure  of the model was finally replaced  by MIO taken  from the 
1B8F HAL structure (less than 0.4 Ä deviations in the corresponding atomic positions). 
ACKNOWLEDGEMENTS 
We  thank  M.  Baedeker  and  G.  Schulz  (Universität  Freiburg)  for  the  improved  expression  
system for PAL1231. 
Financial  support  by  the  Deutsche  Forschungsgemeinschaft,  the  Fonds  der  Chemischen  
Industrie and the Hungarian OMFB is gratefully acknowledged. 
REFERENCES 
[1]  K.R. Hanson, E.A.Havir, Recent Adv. Phytochem. 1978,12, 91-137. 
[2]  K. Hahlbrock, D. Schee], Ann. Rev. Plant Phys. Plant Mol. Biol.  1989,  40,347-369.  
[3]  K.R. Hanson, E.A. Havir, Arch. Biochem. Biophys.  1970,141,1-77. 
[4]  K.R. Hanson, E.A Havir, Biochemistry 1973,12,1583-1591. 
[5]  E.A. Havir, P.D. Reid, H.V. March, Plant Physiol. 1971, 48,  130-136.  
[6]  B. Schuster, J. Retey, FEBS Lett. 1994,349, 252-254. 
[7]  M. Langer, G. Reck, J. Reed, J. Retey, Biochemistry 1994,33,6462-6467 
[8]  K.R. Hanson, E.A. Havir,  The Biochemistry of Plants 1981,  7,577-625.  
[9]  W. Schulz, H.G. Eiben, K. Hahlbrock, FEBS Lett. 1989,258, 335-338. 
[10]T.F. Schwede, J. Retey, G.E. Schulz, Biochemistry 1999,38, 5355-5361. 
[11]M. Ormö, A.B. Cubitt, K. Kallio, L.A. Gross, R.Y. Tsien, S.J. Remington, Science 1996, 
273,  1392-1395.  
[12JK.J. Luebke, Chem.  &Biol.  1998,5, 317-322. 
[13] G.J. Palm, A. Zdanov, G.A. Gaitanaris, R. Stauber, G.N. Pavlakis, A. Wlodawer, Nature 
Structural Biology 1997,4, 361-365. 
[14] T.A. Smith, F.H. Cordelle, R.H. Abeles, Arch. Biochem. Biophys. 1967,120, 724-725. 
[15]B. Schuster, J. Retey, Proc. Natl. Acad. Sei.  USA 1995, 92,  8433-8437. 
[16] J. Retey, Naturwissenschaften 1996,83, 439-447. 
[17] A. Peterkofcky, J. Biol.  Chem. 1962,237,  787-795.  
[18]Mitsui Toatsu Chemicals, Jpn. Kokai Tokyo Koho J. P. 06,  113, 870 [94,  113, 870] 
(CLC12P13/06), 26 Apr  1994, Appl. 92/271,476, 09 Oct  1992.  
[19] J.D. Hermes, P.M. Weiss, and W.W. Cleland, Biochemistry  1985,24,2959-2967. 
[20] A. Gloge, B. Langer, L. Poppe, J. Retey, Arch. Biochem. Biophys.  1998,359,1-7.  
[21] A. Lewandowicz, J. Jemielity, M. Kanska, J. Zon, P. Paneth, Arch.Biochem.  Biophys.  
1999,370,216-221. 
[22] W.J. Haggerty, R.H. Springer, C.C. Cheng, J. Heterocycl. Chem. 1964,2,1-6. 
[23] M. Baedeker, G.E. Schulz, FEBS Lett.  1999,457,57-60.  
[24] J.E. Plevyak, J.E. Dickerson, R.F. Heck, J.  Org. Chem. 1979,  44,4078-4080.  
[25] PC Spartan Pro, Wavefunction, Inc.,  18401 Von Karman, Suite 370, Irvine, CA 92612, 
USA. 
[26]HyperChem 5.1: Hypercube, Inc.,  1115 NW4th Street, Gainesville, FL 32601 USA. 
[27] Swiss-PdbViewer, 3.51: N. Guex, M.C. Peitsch, Electrophoresis 1997,18,2714-2723. 
x ^ x 
HSi-abstraction 
V OH „ E N Z Y M E H-B 
COO  ammonia-
elimination 
C O H E N Z Y M E 
x ^ x 
Scheme  1 Postulated mechanism and partial putative active site model for the reaction 
catalyzed by phenylalanine  ammonia-lyase.  
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Scheme 2 Preparative conversion of various halogenated phenylalanines  by reversal of the 
phenylalanine ammonia-lyase  reaction.  
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Scheme 4 The postulated  unproductive pyrimidinium complex  with 2-pyrimidinylalanine  1 and 
the  reaction  with  5-pyrimidinylalanine  2.  (Although  for  the  experiments  the  racemic  
compounds  were  used,  here  only the  L-enantiomers  are  shown  which  are  presumed  to  be  the  
enzymatically active  species).  
Table  1.  Kinetic  constants  for  the  various  phenylalanine  analogues  and  calculated  
properties of their active complex models. 
AAHo.g: the difference for heat of formation calculated for the active complex model for 
L-Phe  and the  ground  state  L-Phe  substrate  was  substracted  from  the  corresponding  
difference for the substituted models and substrates; 
AA Cp-Ho-g:  the  difference in  Mulliken  charges  on  the  Cp-H  atoms  in  the  substrate  
substracted from the corresponding difference in the active complex; 
Vfnax /Vmax-Phe : relative V m a x  values of the analogues compared to V m »  with L-Phe. 
Substrate  AAH^-g  AA Cp-Hj-g  Vmax/Vmax-Phe  K m  
(a complex model) [kcal/mol] [M.c.u] [mM] 
L-Phe 0.0 0.184 1.00 0.033 
2T-L-Phe (A) 15.7 0.135 1.14 0.065 
(B) 7.8 0.129 
3T-L-Phe (A) 3.1 0.109 2.09 0.079 
(B) 1.5 0.116 
4"F-L-Phe 7.6 0.128 0.56 0.010 
2',6T2-L-Phe 21.9 0.160 0.85 0.085 
3',5^-L-Phe 4.8 0.037 2.72 0.159 
2',3',4,,5I,6T5-L-Phe 29.9 0.141 0.16 0.076 
2'Cl-L-Phe (A) 7.4 0.117 1.03 0.050 
CB) 5.2 0.115 
3'Cl-L-Phe (A) -1.7 0.100 2.01 0.094 
(B) -4.2 0.102 
4'Cl-L-Phe 3.2 0.126 0.82 0.045 
p-(5-Pyrimidinyl)-D,L-Ala 
P-(2-Pyrimidinyl)-D,L-Ala 
25.8 
-24.0 
0.229 
-0.314 
0.80 
0.00 
4.2 
(K, = 7 mM) 
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(ll.VJ.93) 
A  convergent  synthesis  of  the  five  novel  analogues  la-e  of  (5'-deoxyadenosin-5'-yl)cobalamin  
( =  'adenosylcobalamin')  is described. The analogues la-e  carry oligomethylene chains (C3-C7)  inserted between 
the central  Co-atom  and  the 5'-0-atom  of  the adenosine  moiety  and  are thought  to  mimick  the  transition-state  
geometry  in coenzyme-B)2-catalyzed  rearrangement.  All five  analogues  were  characterized  by  NMR.  UV.  and  
FAB mass spectrometry. 
Introduction. -  It  is generally  accepted  that  the  first  step  in  coenzyme-B,,-dependent  
enzymic rearrangements  is the homolytic cleavage  of  the  Co—C bond  of  the  coenzyme.  
Recently, a substrate synergysm was shown for methylmalonyl-CoA  mutase,  i.e.  homol-
ysis of the Co—C bond in the enzyme-coenzyme complex occurs only upon binding of the 
substrate  [1]. On the basis of EPR measurements,  it was postulated that  in the  activated 
complex,  the paramagnetic centres,  i.e. Co" and  the 5'-CH2 group of adenosine,  are at a 
distance of 6-12 A [2-4]. Such a drastic change in the coenzyme geometry (and  reactivity)  
must  be  coupled  with  a  conformational  change  of  the  enzyme  protein.  We  devised,  
therefore, coenzyme-BI2 analogues mimicking  the geometry  of the activated complex. In 
these  transition-state  or  intermediate  analogues,  the  distance  between  the  central  Co-
atom  and  the  adenosine  5'-0-atom  is  lengthened  by  the  insertion  of  a  oligomethylene  
chain. Depending on the length  of the chain,  the novel  analogues are expected to act  as  
more or less strong inhibitors of the coenzyme-B,,-dependent  reactions by binding to the 
reactive conformation of enzyme proteins.  
Here  we describe  in  detail  the synthesis  and  properties  of  the  (5'-deoxyadenosin-5'-
yl)cobalamin ( =  'adenosylcobalamin')  analogues la-e  carrying inserts consisting of 3 to 
7 CH, groups between the Co-atom and the 5'-0-atom  of adenosine. 
Results and Discussion. -  Synthesis  of the Target  [a>-(Adenosin-5'-0-yl)alkyl]cobal-
amin  Derivatives  la-e.  On  the  basis  of  mechanistic  and  spectroscopic  studies  on  coen-
zyme-B12-dependent  enzymes  the  transition-state  analogues  la-e  were  devised  in which 
the  central  Co-atom  separated  from  the  5'-0 -position  of  adenosine  by  insertion  of  
shorter  or  longer  CH2  chains  (C3  to  C7,  see  Fig. 1).  Molecular-mechanics  calculations  
showed that the distance between the Co-centre and the 5'-CH, group of adenosine varies 
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from 6.9 to  11.9 A for the zig-zag chain conformers of la-e consisting of 3-7 CH ;  groups,  
respectively  (see  Fig. 2).  Distances  in this range were postulated  in the activated  complex  
on  the  basis  of EPR  measurements  [2—4].  
To  achieve  the  synthesis  of  the  transition-state  analogues  a convergent  strategy  was  
devised  (Scheme).  Starting  from  adenosine  (2)  and  a,a»-diols  5a-e  (n  = 3-7),  interme-
diates  8a-e  (n  —  3-7)  were  prepared  which  carried  an  co-tosyloxy  group  connected  with  
the  5'-0-atom  of  adenosine  through  an  oligomethylene  chain  of  C3  to  C7. Although  all  
reaction  steps  were  conventional,  some  of  them  required  considerable  experimentation  
for finding optimal  conditions.  The 2\3'-0-isopropylideneadenosine  [5] (3) and  7V6-ben-
zoyl-2'.3'-0-isopropylideneadenosine  [6-8] (4) are known compounds; nevertheless,  they  
were  prepared  by  substantially  modified  and  simplified  methods.  The  protected  forms  
6a-e  of the x,co-diols  were prepared  in moderate  yields (39-50%)  as colourless  oils  by an 
improved  method,  in analogy  with  that  described  for  6d  [9] [10], but  involving  extractive  
separation.  They  showed appropriate  'H-NMR  characteristics.  Subsequent  tosylation  of  
6a-e  with  tosyl chloride  in pyridine  was accompanied  with  a high  degree  of  elimination.  
Thus,  tosylation  was  carried  out  using  only  a  slight  excess  of  pyridine  in dry  CH2C12  as  
solvent  providing  the  desired  a-(tetrahydro-2//-pyranyloxy)-co-tosyloxy  derivatives  
7a-e  in  65-81 %  yield  which  were characterized  by  'H- and  "C-NMR  spectroscopy.  The  
key  step  was  the  attachment  of  the  tosylates  7a-e  to  the  doubly  protected  adenosine  4.  
This  is  essentially  a  simple  SN2 substitution,  but  the  conditions  and  the  quality  of  the  
reagents  and  solvents  were  crucial.  The  fully  protected  chain-lengthened  adenosines  
8a-e  were  obtained  in  moderate  to  good  yields (60-87%)  and  characterized  by  'H-  and  
nC-NMR  and,  in one case  (8d),  by high-resolution  mass  spectrometry.  
The  deprotection,  and  further  processing  of  the  intermediates  8a-e,  via  compounds  
9a-e.  lOa-e,  l la-e ,  and  12a-e  is described  in detail  in the  Exper.  Part.  All  intermediates  
were  obtained  in  acceptable  yields  (56-90%),  and  their  'H-  and  nC-NMR  data  were  
consistent  with  their  assumed  structures.  In  the  case  of  compound  lOd.  the  molecular  
weight  was  also  confirmed  by  high-resolution  mass  spectrometry.  The  5'-chain-length-
ened  adenosine  tosylates  12a-e  were  then  coupled  with  vitamin  B,2s.  The  latter  was  
Fig. 2.  Calculated  structures  and  Co—C(  5')  distances:  a)  a  hypothetical  transition  state  for  the  methylmalonyl-CoA  
mutase  andb-P)  transition-state  analogues  l a - e .  Molecu la r -mechan ics  ca lcu la t ions  were pe r fo rmed o n  an  IRIS-70-
G  computer  (Silicon  Graphics)  using  P C M O D E L  4.0  (Serena).  X-Ray  data  of  [3-(adenin-9-yl)propyl]cobalamin  
[17] were applied  for building up  of the starting  structures.  
prepared  in situ  from hydroxocobalamin  ( =  vitamin  B,,b;  13) by reduction  with  NaBH4  
[11] [12]. In this reaction, pretreatment  of the aq. NaBH4 solution with a catalytic amount 
of  a  cobalt(II)  salt  significantly  accelerated  the  rate  of  the  vitamin-B12s  formation  and  
increased  the  yield  of  the  alkylation.  After  preparative  reversed-phase  HPLC,  the  
[a)-(adenosin-5'-<9-yl)alkyl]cobalamins  la-e  were obtained  in 65-80%  yield. They  were  
characterized  by 'H-NMR  spectroscopy and, in the case of lc,  by a COSY spectrum (see  
below). Fast-atom-bombardment  mass spectroscopy  (FAB-MS) confirmed not  only  the  
expected molecular weights but, owing to the corresponding fragmentation patterns,  also  
the structures  of  the analogues  la-e.  Further  characterization  and  purity  determination  
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Scheme.  Synthesis  of  the  Transition-State  Analogues  l a - e  
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a )  Acetone, 70%  HC104  soln., 4-A molecular  sieves.  6)  Pyridine, Me3SiCl;  2. PhCOCl;  3. M e 0 H / H 2 0 ,  NaF,  H + .  
c)  3,4-Dihydro-2//-pyran,  THF,  cat.  TsOH.  d)  TsCl,  pyridine,  CH2C12.  e)  1.  4,  NaH,  D M F ;  2.  7.  f )  Cat.  
NaOMe,  MeOH.  g)  2M  HC1,  MeOH.  h)  TsCl,  pyridine.  CH2C12.  t)  10%  HC1  soln.,  MeOH,  A.  j )  1.  13,  
NaBH 4 ,  cat.  Co(OAc)2,  H 2 0 ,  2.12a-e,  MeOH/H 2Q.  
was achieved  by UV/VIS  spectra  and  anal.  HPLC.  The former varied  only  slightly  and  
were characteristic for alkylated cobalamins  [11] [12], The retention times (rR) in the anal, 
reversed-phase  HPLC  were  in  agreement  with  the  expected  differences in  polarity.  A  
mixture  containing  vitamin  Bl2b  (13),  coenzyme  B12,  and  all  analogues  la-e  could  be  
cleanly separated  into  the components  with  the expected  retention  times. The  analogues  
la-e are red microcrystalline solids, hygroscopic, and light- and heat-sensitive, but stable 
when  stored  in  the dark.  Aqueous  solutions  were also  stable  for days  when  kept  in  the  
dark  at  0°.  
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'H-NMR  Analysis of the fco-(Adenosin-5'-0-yl)alkylJcobalamins  la-«.  The  ID  and  
2D COSY 'H-NMR  spectra  of la-e  (n = 3-7) were obtained  at  500 MHz under  condi-
tions close to those used for the published results on coenzyme B12 ( =  (5'-deoxyadenosin-
5'-yl)cobalamin)  [13] [14]. The  ID  spectra  were measured  and  processed  so as to  allow 
precise integration, and for la,  c, e (n  — 3, 5, 7), the results were accurate enough for the 
determination  of the total number of nonexchangeable protons. During sample prepara-
tion, it was noted that the analogues la  and lc with n = 3 and 5, respectively, were much 
more soluble than the others, and spectroscopic differences between analogues with even 
or odd n were also found (see below). Our results and the literature data are summarized 
in  Tables 1 and  2. The  literature  signal  assignments  provided  a  starting  point  for  our  
Table  1. 500-MHz  'H-NMR  Data for  Coenzyme  Bn  and  the Analogues  Ado-fCH:j  n-Cbl  la-e,  Part  1.a) b) 
Chem. shift rel. to TSP°) 
COB,2 la  (n = 3) lb (n = 4) lc  (n = 5) Id (h = 6) le (« = 7) 
Corrin  Me  
Me(l') br. s  0.47  0.480 0.486 0.504 0.502 0.503 
Me(2') s  1.36  1.364 1.356 1.375 1.376 1.377 
Me(5') s  1.45  1.439 2.482 2.473 2.474 2.487 
Me(7') s  1.70  1.773 1.776 1.767 1.760 1.752 
Me(12') s  0.87  0.841 0.861 0.767 0.813 0.801 
Me'(12') s  1.32  1.364 1.337 1.333 1.338 1.332 
Me(15') s  2.43  2.367 2.305 2.381 2.344 2.388 
Me(17') s  1.36  1.175 1.117 1.204 1.223 1.265 
Corrin  CH  
CH(3) d  4.10  4.064 4.12 4.11 4.10 4.150 
CH(8) dd  3.29  3.399 3.342 3.396 3.39 3.43 
CH(10) s  5.93  5.938 5.893 5.931 5.956 5.953 
CH(13) dd  2.89  3.033 -•2.951 3.012 2.960 2.99 
CH(18) dd  2.65  2.64 2.61 2.63 2.64 2.66 
CH(19) d  4.24  4.044 4.07 4.080 4.078 4.073 
Corrin  side-chain  CH2  (a =  low field,  b =  high  field)  
CH2(2') ¿2.41 2.35,2.31 2.36,2.32 2.39, 2.323 2.40, 2.34 2.41, 2.317 
CH,(3') m  2.06, 1.96 2.08,  1.98  2.09,2.00 2.04, 2.00 2.02, 1.99 2.05,1.97 
CH2(3:) ¿¿¿2.50 2.52, 2.45 2.53,2.45 2.57,2.51 2.54,2.50 2.54, 2.48 
CH2(7') ¿2.19,1.72 2.43,1.910 2.47,1.957 2.425,1.901 2.48, 1.924 2.46, 1.874 
CH,(8') m  1.75,0.81 1.84,0.83 1.83,0.82 1.82,0.82 1.80,0.82 1.79,0.84 
CH2(82) ddd 1.73,0.88 1.77,0.936 1.77,0.92 1.75,  0.95 1.77,0.95 1.70,0.92 
CH2(13') m 2.22,2.00 2.06, 2.01 2.02,1.97 2.10,2.00 2.10,2.01 2.10, 2.00 
CH2(132) ddd 2.54 2.61,2.56 2.53,2.48 2.53, 2.47 2.54,2.46 2.54,2.46 
CH2(17') ddd 2AS,  2.06d) 2.44,2.05 2.40,2.02 2.43,2.05 2.42,2.04 2.48,2.04 
CH2(172) ddd 1.78d) 2.42, 1.74 2.35, 1.68 2.40, 1.74 2.40, 1.75 2.43,1.76 
CH->(18') ¿¿2.65 2.66,2.61 2.61,2.61 2.67,2.62 2.65,2.60 2.68,2.64 
l-Aminopropan-2-ol (Apr; a = low field, b =  high  field)  
CHi(l)(Apr) ¿¿3.54,3.16 3.535,3.189 3.54,3.191 3.538,3.203 3.531,3.205 3.533,3.188 
H—C(2)(Apr) m4.33 4.353 4.358 4.359 4.36 4.353 
Me(3)(Apr) ¿1.21 1.213 1.211 1.210 1.205 1.213 
Total  non- 81 87e) 89 91e) 93 95e) 
exchangeable  H  
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Chem. shift rel to TSP4) 
CoB12 la  (n  = 3) lb (n  =4)  lc  (n  =  5)  Id (n  = 6) le  (« =  7)  
(Dimethylbenzimidazoly  I) ribose (Dbi-Rib) 
H—C(2)(Dbi) s 6.95 6.929 6.929 6.937 6.932 6.939 
H—C(4)(Dbi) s 6.24 6.228 6.229 6.232 6.231 6.230 
H—C(7)(Dbi) s 7.16 7.169 7.157 7.162 7.159 7.159 
Me—C(5), 
Me—C(6)(Dbi) s 2.19 2.219 2.215 2.216 2.218 2.213 
H-C(l')(Rib) d 6.26 6.262 6.246 6.254 6.247 6.257 
H—C(2')(Rib) dd 4.23 4.223 4.219 4.227 4.222 4.228 
H—C(3')(Rib) ddd 4.72 4.735 4.726 4.732 4.730 4.730 
H—C(4')(Rib) di 4.10 4.11 4.10 4.11 4.10 4.110 
2H-C(5')(Rib) dd 3.88, 3.74 3.900,3.744 3.889, 3.736 3.898,3.743 3.89,3.74 3.895, 3.745 
Adenosine  (Ade-Rib)  
H—C(2)(Ade) s 8.19 8.267 8.282 8.256 8.285 8.197 
H—C(8)(Ade) s 8.00 8.274 8.396 8.314 8.395 8.337 
H-C(l')(Rib) d 5.56 6.002 6.061 6.050 6.098 6.070 
H-C(2')(Rib) tidd) 4.54 4.685 4.726 4.696 4.659 4.703 
H—C(3')(Rib) '(dd) 3.74 4.245 4.255 4.361 4.360 4.409 
H—C(4')(Rib) ddd 2.54 4.11 4.167 4.204 4.258 4.275 
2 H—C(5')(Rib) dd 1.55,0.57 3.535,3.376 3.616, 3.54 3.683, 3.559 3.765,3.658 3.745,3.693 
Alkyl-Co  (Abr)  
CH2(1")—Co 1.281,0.49 1.37,0.47 1.35,0.35 1.35,0.50 1.33,0.42 
CH2(2") 0.321,-0.181 0.35, -0.46 0.20, -0.50 0.10, -0.49 0.10, -0.52 
CH2(3*) 3.134,2.936 1.22,1.04 0.93,0.76 0.95,0.79 0.87,0.62 
CH2(4') 3.266,3.17 1.27 0.95 0.92,0.86 
CH2(5") 3.284, 3.22 1.31 0.96,0.88 
CH2(6") 3.42 1.34,1.32 
CH2(7") 3.42,3.38 
a)  Data  for coenzyme BI2 (6.5 mg in 0.35 ml of  10  MM phosphate/D20,  pD 7.0, 20°) are taken from [13]. This 
work: ca. 1-3 mg of analogue la-e in 0.5 ml of 20  MM phosphate/D20, pH 7.4,10°. 
b)  Abbreviations: Apr =  l-aminopropan-2-ol, Dbi =  5,6-dimethylbenzimidazole, Ade =  adenine, Rib =  ribose,  
Alk = oligomethylene  bridge (CH2)n numbered from the Co end. For la-e all assignments were confirmed  by  
observation of the appropriate3 J,4 J, or5 J cross-peaks in the COSY 2D spectra of at least one analogue. 
c)  TSP =  trimethylsilyl  propionate; shift values with 3 decimal places were determined from ID spectra (peak 
picking); values with 2 decimal places (±0.01 ppm) were estimated from the COSY spectrum. 
d)  The specific assignments  for CH2(17')  and CH2(172)  from ( =  CH2(55)  and CH2(56), resp. [13]) (based on 
CH correlations  and long-range coupling of C(18) to CH2(17')  at ca. 2.45 ppm) are probably in  error (see 
text); for the base-off  form of coenzyme B,2  [14], the assignments at pH 2.1  are: CH2(17')  at 2.51  and 1.85 
and CH2(172) at 2.31 and 1.85 ppm. 
e)  Total proton count confirmed by precise integration. 
analysis, and nearly all assignments were independently confirmed through the observa-
tion of long-range coupling effects (V and5 J in the corrin and benzimidazole rings) in the 
COSY spectrum  {Footnote 2 in  Table 2).  Using a 60° mixing pulse, multiplet 'tilt' effects 
could  be  observed  in  many  cases  which  allowed  vicinal  and  geminal  couplings  to  be  
distinguished.  The only literature assignments with which we disagree concern the pro-
tons  CH2(17')  and  CH2(172).  Bax  and  coworkers  [13] assigned  protons  Ha-C(172)  and  
Hb—C(172) as being nearly equivalent at  1.78 ppm. However, by reason of the integration 
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Table  2. J (H,H)  andJ(P,H)  Coupling  Constants  for  Coenzyme  B,2  and  the  Analogues  la-e a )  
Coupling  Vicinal and geminal coupling constants in Hz (±0.1) 
CoB,2 la  (n = 3) lb (h = 4) lc  (n = 5) Id (n  = 6) le  (« = 7) 
CH(3)/Hb—C(3') 10.4 
CH(8)/CH2(8')b) 10.8,4.9 11.5, 5.2 11.4,5.1 
CH( 13)/CH2( 131 )b) 9.2, 2.0 7.6, 3.5 9.6,  1.7 9 
CH(18)/CH(19) 10.5 10.0 10.1 9.9 
Ha—C(21 )/Hb—C(21) -13.3 -12.9 -12.8 
Ha—C(71 )/Hb—C(71) -13.5 -13.7 -13.4 -13.6 -13.4 
Ha—C( 1 )/Hb—C( 1)(Apr) -13.9 -14.4 -14.4 -14.4 -14.6 -14.4 
Ha—C( 1 )/H—C(2)(Apr) <0.9 2.7 2.7 
Hb—C( 1 )/H—C(2)( Apr) 14.4°) 6.7 7.0 6.9 6.9 7.1 
H—C(2)/Me(3)(Apr) 6.3 6.4 6.4 6.4 6.4 
H—C(2)(Apr)/P 7.1 7.0 7.0 
H—C( 1 ')/H-C(2')(Dbi-R/A) 3.0 3.0 3.0 3.0 3.0 3.0 
H—C(2')/H—C(3')(Dbi-Ä/A) 4.3 4.3 3.9 4.3 4.4 4 
H—C(3')/H—C(4')(Dbi-Ä/A) 8.9 8.8 8.7 8.7  '  
H-C(3')(Dbi-ÄiÄ)/P 7.4 7.4 7.2 7.2 
H-C(4')/Ha-C(5')(Dbi-Ri6) 2.7 2.4 2.4 2.4 
H-C(4')/Hb-C(5')(Dbi-Ä») 3.9 3.7 3.6 3.8 
Ha—C(5')/Hb—C(5')(Dbi-Rifc) -13.0 -13.0 -12.9 -13.0 -13.0 
H-C(l')/H-C(2')(Ade-/W) 3.3 4.7 5.1 4.5 4.3 4.3 
H—C(2')/H—C(3')( Ade-R/6) 5.8 5.0 5.3 4.8 4.7 4.8 
H—C(3')/H—C(4')(Ade-Ri6) 6.7 5.2 5.1 5.3 5.2 5.2 
H-C(4')/Ha-C(5')(Ade-R//>) <2.0 2.2 2.3 2.6 2.9 
H-C(4')/Hb-C(5')(Ade-Rih) 9.2 6.3 5.3 4.9 4.9 
Ha—C(5')/Hb—C(5')(Ade-/?/6) -9.2 -11.4 -11.2 -11.4 -11.5 -11.5 
a)  See Footnotes to Table 1; coenzyme B12 data is from [14]; in this work, coupling constants were estimated from 
peak splittings in the  ID spectra wherever possible; the presence of  the following long-range couplings was 
confirmed by COSY cross-peaks for one or more analogues: H-C(4)/H-C(7)(Dbi); H-C(4)/Me-C(5)(Dbi); 
H—C(4)/Me—C(6)(Dbi); H-C(2)/H-C(4)(Dbi); H-C(2)(Dbi)/H-C(l')(Rib);  H-C(8)(Ade)/H-C(l')(Rib);  
Me(2')/Hb-C(2');  Me(7')/Hb-C(7');  CH(13)/Me(15');  CH(13)/Me'(12');  Mei^'j/Me'C^1);  CH(10)/  
Me'(12'); CH(19)/Ha-C(2'). 
b)  Assignments of configuration were not made. 
c)  Probably the sum of two coupling constants. 
we  could  clearly  see  that  only  1 H  appears  near  1.75 ppm,  1 H  near  2.05 ppm,  and  
2  H  near  2.45  ppm.  In  addition,  specific  correlation  peaks  for  vicinal  and  geminal  
couplings  involving  protons  CH2(172)  could  be  distinguished  in  the  COSY  spectrum  
of lb. 
Considering the data in Table 1,  we see that the chemical shifts for the (dimethylbenz-
imidazolyl)ribose moiety change little with chain length n and are very close to the values 
for the natural coenzyme B12. In contrast, the chemical shifts for the adenosine moiety are 
quite  sensitive to the length of the chain due to  the expected  dependence  of  anisotropic  
shielding  effects on  the  distance  between  the  adenosine  group  and  the  corrin  ring.  In  
coenzyme  B12  the  ribose  C(5')  of  adenosine  is  directly  bound  to  Co,  whereas  in  the  
analogues  la-e,  it  is bound  to  the ether  O-atom of  the chain  unit, explaining the  large  
difference in  shifts  of  CH2(5')(Ade-/?/6).  Large  shift  differences are  also  observed  for  
H-C(3')(Ade-/?z'6)  and  H-C(4')(Ade-/?z'6).  When we consider  the changes in  chemical  
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shift for a  given  adenosine proton  as n is increased,  an  interesting 'alternating'  pattern  
emerges.  E.g.,  for  H—C(8)(Ade)  starting  with  n =  3,  chemical-shift  increments  for  in-
creasing n are  +0.12, -0.08,  +0.08, -0.06. A similar pattern  is found for H-C(2)(Ade) 
and  H—C( 1 ')(Ade-J?z'6),  while H-C(3')(Ade-R/6)  shows +0.01,  +0.11,  0.00, +0.05 and 
H—C(4')(Ade-/?i7>) a monotonic behaviour with increments of  0.057,0.037,0.054,0.017.  
The 4 corrin protons CH(3), CH(8), CH(13), and CH(19) which point 'up' in the direction 
of  the  adenosine  group  show  significant  shift  differences for  the  analogues  la-e  os.  
coenzyme B12. The effect is largest for CH(19) which is close to Ht-C(5')(Ade-J?/6)  (NOE 
effect) in coenzyme BI2 [13]. The corrin Me groups Me(12')and  Me(17") also have NOE's 
with Ade-Rib protons in coenzyme B12 [13] and show chain-length-dependent shift effects 
in the analogues.  Interesting shift increment patterns are: for Me(12'),  +0.020,  —0.094,  
+ 0.046,  -0.012;  for  Me(17'),  -0.058,  +0.087,  +0.019,  +0.042;  for  Me(15'),  -0.062,  
+ 0.076,  —0.037,  +0.044.  Again  an  alternating  pattern  can  be  distinguished,  and  this  
suggests that the orientation  of the adenosine group relative to the corrin ring alternates 
with  increasing  methylene  chain  length,  as  would  be  expected,  if  the  chain  adopts  a  
relatively  stable  staggered  conformation.  It  is  noteworthy  that  the  solubility  of  the  
analogues also shows an alternating pattern with increasing chain length. For the corrin 
side chains, significant shift perturbations are found only for protons CH2(7') (shown to 
have NOE's with CH2(5')(Ade-Rib) coenzyme B12 [14]) and Ha-C(13') which neighbours 
the perturbed CH(13).  
The coupling-constant  data  of  Table 2 indicate that  the most  significant differences 
between coenzyme B12 and the analogues la-e occurs in the Ad e-Rib moiety. The confor-
mation of the ribose ring and the orientation  of CH2(5') group are different in coenzyme 
BJ2 due to the steric restrictions on attaching the ribose CH2(5') directly to the Co-atom. 
These steric constraints are not present when the methylene chain is used for attachment. 
Noteworthy are the differences between the chemical shifts of the geminal protons of 
each chain  CH2 group depending on their  distance from the Co-atom.  Thus, in  lc,  the  
diastereotopic protons of CH2(1")—Co exhibit a AS of ca. 1 ppm, and this is also valid for 
all other analogues. The CH2 groups in the second ligand sphere of the Co-atom appear at 
highest  field  (0.2 and  -0.50 ppm,  resp.)  and  show  still  AS  values of  0.6-0.7 ppm.  The  
diastereotopy  of  the  CH2  protons  in  the  third,  fourth,  fifth,  sixth,  and  seventh  ligand  
spheres is still reflected in the 6 values, but is much less pronounced. 
General  Discussion and Conclusions. -  The synthesis and use of artificial coenzyme-
B12  analogues  were  reported  [12]  [15].  (Adeninylalkyl)cobalamins,  first  synthesized  by  
Hogencamp  [15], show the closest resemblance to the analogues la-e described here and 
were found to be competitive inhibitors in respect to coenzyme BI2 in the diol dehydratase 
reaction  [15].  We  expect  from the  novel  analogues  la-e  a  stronger  binding  ability  to  
coenzyme-B12-dependent  enzymes.  In  contrast  to  Hogenkamp 's  analogues,  the  present  
ones contain a ribose moiety that should contribute to binding at the active sites and are 
closer to the structure of the putative transition state. Preliminary kinetic measurements 
with  methylmalonyl-CoA  mutase  confirmed  the  inhibitory  capabilities  of  the  novel  
analogues. 
It  is  noteworthy  that  analogues  of adenosine that  are extended  at  the  5'-site  by an 
alkyl  group  were found in the naturally  occurring hopane  series  [16]. The  role  of  these  
compounds in the metabolism of the corresponding bacteria is unknown. 
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The novel [(adenosin-5'-0-yl)alkyl]cobalamins  may also serve as ligands promoting 
the crystallization of coenzyme-B,2-dependent enzymes. Their detailed biochemical prop-
erties and inhibitory behaviour will be published elsewhere.  
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Industrie.  L. P.  thanks  the  Alexander  oon Humboldt  Foundation  for a postdoctoral  fellowship.  The  authors  are  
grateful to Dr.  U. Zahorszky for the FAB-MS measurements. 
Experimental Part 
1.  General.  Adenosine,  a,co-alkanediols  Sa-e,  3,4-dihydro-2//-pyran,  benzoyl  chloride,  toluene-4-sulfonyl  
chloride, vitamin B)2b, and H20-free DMF were products of Fluka Chemicals, Switzerland. All sovents were freshly 
dried  and distilled  prior to  use.  HPLC Separations: Merck-Hitachi-L-6210  pump,  L-4000 UV detector,  D-2500  
chromato-integrator,  and  Macherey  &  Nagel  250  x  4  mm  Nucleosil-10-C,g  anal,  or  Macherey  &  Nagel  250  
mm x  1" Nucleosil-7-C¡a  prep, columns.  TLC: Macherey & Nagel silica gel234  plastic  plates; solvent  systems:  A,  
hexane/acetone 2 :1; B, hexane/acetone 1:1; C, CHjCl^acetone 2:1 ;D, CH^yMeOH  10:1; detection by UV light 
or  heating  after  3% ethanolic  phosphomolybdic  acid  treatment.  Prep,  column  chromatography  (CC)  of  the  
intermediates:  vacuum  CC  [18]  or  flash  chromatography  (FC)  [19].  M.p.:  Biichi capillary  m.p.  instrument;  
uncorrected.  UV/VIS  Spectra  (/.max(e)  in  nm):  Perkin-Elmer-Lambda-2  spectrometer;  in  0.05M  Tris buffer 
(pH 7.5). NMR Spectra: Bruker-WM-250 or AM-400 spectrometers for 'H and Bruker-WM-250 spectrometer at 
62.90 MHz for l3C and DEPT experiments; CDC13 solns. containing Me4Si as internal standard, unless otherwise 
stated. Detailed 'H-NMR studies of la-e: at 10° and 500 MHz, Bruker-AM-500 spectrometer; sample preparation 
in the dark, adding ca. 3 mg of each substance to 0.4 ml of 20  MM phosphate/D20  buffer and adjusting the pH to 
7.4 ±  0.05: la and lc dissolved completely, lb and Id, e exhibited much lower solubility (max.  1  mg in 0.5 ml).  ID 
Spectra: presaturation (3 s) of the residual H20 resonance, spectral width 7 KHz, 32 K time-domain points, 60° flip 
angle, 5.3 s repetition time, and 512 transients. Resolution enhancement via Lorentz-Gauss lineshape transforma-
tion  (Bruker  software) was performed  before zero-filling to  64 K  and Fourier  transformation.  Precise  baseline  
correction, integration,  and peak picking were performed using the Bruker software routines.  COSY 2D Spectra 
(magnitude-mode)  were obtained for each sample using the following conditions: low-power H20  presaturation  
during the relaxation delay (2.5 s) and the evolution period, spectral width 4900 Hz, 2K time-domain points in t2, 
512 FID's (/1 points) with 24 transients each, mixing pulse flip angle 60°, initial fixed delay of 20 ms in evolution and 
detection periods to further suppress H20 and to provide increased intensity for long-range correlations. The data 
were zero-filled in /[  and, after sine-bell  window multiplication,  were transformed to give  1K x  1K magnitude-
mode spectra. EI-MS (electron impact) and FAB-MS (fast-atom bombardment): Finnigan-MAT-90  high-resolu-
tion instrument; EI at 70 eV; samples for FAB as 5% glycerol solns. 
2. 2' ,3'-Q-Isopropylideneadenosine  (3). A) Adenosine (2;  11.0 g, 41.2 mmol), Ts0H  H20  (23.5 g,  124 mmol) 
and 4 A molecular sieves (25 g) were mixed in 250 ml of dry acetone and stirred at r.t. After stirring for 2 h (clear 
soln.-»solid precipitate),  12 ml (150 mmol) of pyridine were added (-»precipitate nearly dissolved). The mixture 
was poured on a  11-cm column (012.5 cm) filled with neutral A1203 and eluted with  1000 ml of dry MeOH. After 
evaporation of the product-containing  fractions, the solid was recrystallized from acetone: 8.5 g (67%) of pure 3. 
TLC: Rf0.47 (D). M.p. 218-220° ([5]: 217.5-218° (H20)).  'H-NMR: (250 MHz, (D6)DMSO): 1.33 (s, Me);  1.54 (j, 
Me);  3.54 (m, CH2(5')); 4.20 (m, CH(4j); 4.96 (dd, 7(2',3') =  6.1, 7(3',4') = 2.5, CH(3')); 5.23 (/,  OH); 5.34 (dd, 
7(1',2j = 3.3,  7(2',3') =  6.1, CH(2')); 6.11 (d, 7(1',2') =  3.3,  CH(l'));  7.34 (br. j, NH,); 8.14 (s, CH(2));  8.32 (s, 
CH(8)).  'H-NMR (250 MHz, CDC13): 1.39 (s, Me); 1.64 (s, Me); 4.79 (/, I H, CH2(5 j); 4.97 (d, 1  H, CH,(5')); 4.55 
(s, CH(4j); 5.10 (d, CH(3 j); 5.21 (/, CH(2j); 5.85 (d, CH(l')); 5.90 (br. s, NH2); 6.60 (d, OH); 7.84 (s, 1  arom. H); 
8.33 (s, 1  arom. H). 
B) Adenosine (2; 5.2 g,  19.5 mmol),  70% HC104 soln. (1.69 ml,  19.5 mmol), and 4 A molecular sieves (10 g) 
were mixed in  100 ml of dry acetone and stirred for 2 h at r.t. (-»precipitate). A soln. of NaOMe (1.2 g) in MeOH 
(10 ml) was then added in one portion, the resulting mixture heated to boiling and filtrated, the precipitate washed 
with 3 x  50 ml of hot acetone, and the combined filtrate slow by cooled to 0° 4.12 g (69%) of white crystalline 3. 
Anal, data: as described above. 
3. Ns-Benzoyl-2',3'-0-isopropylideneadenosine (4). A) To a soln. of3 (3.98 g,  13 mmol) in dry pyridine (15 ml), 
benzoyl chloride (5.48 g, 4.53 ml, 39 mmol) was added dropwise at r.t. over  15 min. After stirring at r.t. for 4 h, 150 
ml of CH2C12 were added. The resulting soln. was washed with  10% HC1 soln. (40 ml), sat. NaHCQ3 soln. (30 ml), 
2372 HELVETICA  CHIMICA  ACTA -  V o l . 76  (1993)  
and brine (30 ml), dried (MgS04), and evaporated: 7.15 g (95%) of  Ns,N6.5-0-tribenzoyl-2,.3'-0-isopropylidene-
adenosine.  Yellowish solid. This product was used for the next step without further purification. An anal, sample 
was obtained  by vacuum CC (silica gel (63-200 pm), hexane/acetone  3:1).  TLC: Rf0.68 (A).  'H-NMR:  1.40 (s, 
Me);  1.63  (s,  Me);  4.47-4.67  (m,  CH,(5'),  CH(4'));  5.15  (dd,  7(2',3') =  6.7,  7(3',4') = 4.0,  CH(3'));  5.51  (dd,  
7(1',2') = 2.9, CH(2')); 6.13 (d, CH(l')); 7.24-7.57 (m, 3 Hp, 6 HJ;  7.82 (m,4H„ of(Bz)2N); 7.93 (m, 2 H0 of BzO); 
8.13 (s, CH(8)); 8.54 (s, CH(2)). 
To a soln. of 7V6,A'6,5'-0-tribenzoyl-2',3'-0-isopropylideneadenosine  (5.79 g,  10 mmol) in Et0H/H20  10:1  
(60 ml), finely pulverized NaOH (0.6 g,  15 mmol) was added. The mixture was refluxed for 5 min, and after cooling, 
the soln. was concentrated to  1/10 volume, diluted with H20 (30 ml), and extracted with CH2C12 (3 x 40 ml). The 
extract was washed with H20 (20 ml) and brine (20 ml), dried (MgS04),  and evaporated and the residue purified by 
vacuum CC (silica gel, CH2Cl2/acetone 3:1): 2.1 g (52%) of 4. White solid. TLC: Rf  0.40 (C). M.p.  133-134° ([6]: 
132-133° (EtOH); [7]: 151-153°(EtOH)).  'H-NMR:  1.38 (i, Me);  1.63 (s, Me); 3.79 (¿¿,7 = 2.2,11,1  H,CH2(5'));  
3.96 (dd, J  =  2.2,11,  1  H, CH2(5')); 4.52 (br. s, CH(4')); 5.07 (dd, 7(3',4') = 3.3,7(2',3') =  5.8, CH(3')); 5.22 (dd, 
7(1',2') =  5.3, CH(2')); 5.99 (d, CH(l')); 7.38-7.62 (m, Hp, 2 HJ;  8.02 (m, 2 H„); 8.15 (s, CH(8)); 8.74 (s,  CH(2)).  
13C-NMR: 25.23 (1  Me of Me,C); 27.46 (1 Me of Me,C); 62.70 (C(5')); 81.52 (C(3')); 83.46 (C(2')); 86.48 (C(4')); 
93.52 (C(l'));  114.16 (Me2C);  124.07 (C(5));  128.08 (C0);  128.71 (CJ;  132.82 (C„);  133.41 (C,pJ;  142.64 (C(8)); 
150.15 (C(4)); 150.69 (C(6));  152.23 (C(2)); 165.10 (PhCO). 
B) To an ice-cooled soln. of 3 (4.0 g,  13.0 mmol) and 4-(dimethylamino)pyridine (50 mg) in dry pyridine (20 
ml), Me3SiCl (1.76 g,  16.3 mmol, 2.05 ml) was added dropwise over  10 min and the resulting mixture further stirred 
at r.t. for 1  h. Benzoyl chloride (1.83 g,  13.0 mmol, 1.51 ml) was then added and the mixture cooled to 0° within 10 
min. After further stirring at r.t. for 2 h, Me0H/H20 6:4 (30 ml), NaF (1.0 g), and Bu4NCl (100 mg) were added, 
and stirring at r.t. was continued overnight. The mixture was then diluted with 40 ml of H20 and the pH adjusted 
to 2.5 by addition of  5M HQ  (ca.  40 ml).  Extraction with CH2C12 (4 x  50 ml), washing of the combined extracts 
with  2M HC1 (20 ml), sat. NaHC03 soln. (30 ml), and brine (30 ml), drying (MgS04), evaporating, and purifying the 
residue by vacuum CC as described in Method A yielded 3.61 g (68%) of 4. 
4.  a>-[(Tetrahydro-2H-pyran-2-yl)oxyjaIkan-l-ols  6a-e.  General  Procedure.  To  a  soln.  of  a,a>-alkanediol  5  
(0.1 mol) and TsOH (0.1 g) in dry THF (200 ml), 3,4-dihydro-2H-pyran  (0.1 mol) was added dropwise at 0°. The 
mixture was stirred at 0° for 1 h and at r.t. for a further h; then 1  ml of Et3N was added and the solvent evaporated. 
The residue was taken up in H20 (15 ml) and MeOH (75 ml) and the bis(tetrahydro-2H-pyranyloxy) derivative was 
removed by extraction with hexane (4-6 x  30 ml). The MeOH was evaporated  and the residue diluted with Et20 
(80 ml) washed with H20 (2-3  x 20 ml) and brine (20 ml), dried (MgS04),  and evaporated: 6 (39-50%), practically 
homogeneous by TLC. 
3-f(Tetrahydro-2H-pyran-2-yl)oxyJpropan-l-ol (6a). According to the General Procedure, with propane-1,3-
diol (5a;  19 g, 0.25 mol, 20 ml) and 3,4-dihydro-2/f-pyran (8.6 g, 0.10 mol, 9.3 ml): 6.2 g (39%) of 6a. Colourless 
oil.  TLC:  Rf 0.47 (A),  Rf 0.51 (B).  'H-NMR:  1.56 (m, 2 CH2);  1.6-1.95 (m, 2 CH2); 2.94 (/,  OH); 3.45-3.65  (m,  
CH20); 3.7-3.96 (m, 2 CH20); 4.61 ('/', OCHO). 
4-[(Tetrahydro-2H-pyran-2-yl)oxyJbutan-]-ol (6b).  According  to  the  General Procedure,  with  butane-1,4-
diol (5b; 19.7 g, 0.22 mol, 20 ml) and 3,4-dihydro-2#-pyran (8.6 g, 0.10 mol, 9.3 ml): 7.9 g (45%) of 6b. Colourless 
oil. TLC: Rf 0.49 (A),  Rf 0.53 (B).  'H-NMR:  1.34-1.93 (m, 5 CH2); 2.53 (br. s, OH); 3.36-4.0 (m, 3 CH,0); 4.58 
(V,  OCHO).  
5-f (Tetrahydro-2H-pyran-2-yl)oxy]pentan-l-ol (6c). According to the General Procedure,  with pentane-1,5-
diol (5c; 10 g, 96 mmol,  10 ml) and 3,4-dihydro-2//-pyran (8.3 g, 99 mmol, 9.0 ml): 8.34 g (46 %) of 6c. Colourless 
oil. TLC: Rf 0.51 (A),  Rr0.55 (B).  'H-NMR: 1.33-1.91  (m, 6 CH2);  1.98 (br. s, OH); 3.32-3.94 (m, 3 CH,0); 4.56 
(r.OCHO). 
6-[(Tetrahydro-2H-pyran-l-yl)oxy]hexan-l-ol  (6d).  According  to  the General Procedure,  with hexane-1,6-
diol (5d;  15 g, 0.127 mol) and 3,4-dihydro-2//-pyran (10 g, 0.12 mol,  10.9 ml):  12.7 g (50%) of 6d. Colourless oil. 
TLC: Rf 0.53 (A ),Rf 0.57(B).  'H-NMR:  1.35 (m, 2 CH2); 1.4-1.6 (m, 4 CH2); 1.91 (br. i, OH); 3.3-3.5 (m, CH20); 
3.58 (m, CH20); 3.63-3.88 (m, 2 CH20); 4.54 ('i', OCHO). 
7-[(Tetrahydro-2H-pyran-2-yl)oxy]heptan-l-ol (6e). According to the General Procedure,  with heptane-1,7-
diol  (5b; 4.78  g,  36  mmoi,  5.0 ml)  and  3,4-dihydro-2H-pyran  (3.0  g,  36.2  mmol,  3.3  ml):  3.6  g  (43%)  of  6e.  
Colourless oil. TLC: Rf 0.54 (A), Rr0.59 (B). 'H-NMR: 1.2-1.43 (m, 3 CHJ; 1.4-1.9 (m, 5 CH2); 2.49 (br. s, OH); 
3.26-3.90 (m, 3 CH20); 4.55 (m, OCHO). 
5. oi-f  (Tetrahydro-2H-pyran-2-yl)oxy]  alkyl  Toluene-4-sulfonates  7a-e.  General Procedure.  To a soln. of 6 (20 
mmol) and pyridine (40 mmol) in dry CH2C12 (40 ml), TsCl (4.76 g, 25 mmol) was added portionwise at r.t. and the 
resulting mixture stirred for 4 h at r.t. Following dilution with CH2C12 (60 ml), the soln. was washed with 5 %  HCI  
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soln. (20 ml), sat. NaHC03 soln. (30 ml), and brine (20 ml), dried (MgSOJ, and evaporated and the residue purified 
by vacuum CC (silica gel, hexane/acetone 3:1): 7 (65-81 %). 
3-[(Tetrahydro-2H-pyran-2-yl)oxy¡propyl  Toluene-4-sulfonate  (7a).  According  to  the  General  Procedure,  
with 6a (5.5 g, 34 mmol): 8.3 g (78%) of 7a. Slightly yellow oil. TLC: Rf0.51 (A),  Rf 0.75 (B).  'H-NMR:  1.39-1.85  
(m,  3  CHJ;  1.91  (m,  CHJ;  2.43  (s,  AfeC6H4);  3.32-3.50  (m,  CHzO);  3.68-3.80  (m,  CH20);  4.14  (r,  7  =  6.5,  
C//2OTs); 4.52 ('i*, OCHO); 7.33,7.78 (A2B2,4  arom. H).  I3C-NMR:  19.43 (C(4) ofThp); 21.57 (MeC6H4); 25.37 
(C(5) of Thp); 29.24 (C(2)); 30.48 (C(3) of Thp); 62.15 (C(3));  62.76 (C(l));  67.75 (C(6) of  Thp); 98.82 (C(2) of 
Thp);  127.87 (CJ;  129.85 (CJ;  133.04 (CJ;  144.76  (CipJ.  
4-[(Tetrahydro-2K-pyran-2-yl)oxy]butyl  Toluene-4-sulfonate  (7b). According to the  General  Procedure,  with  
6b (7.8 g, 45 mmol): 9.6 g (65%) of 7b. Colourless oil. TLC: Rf0.54 (A),  0.77 (B). 'H-NMR: 1.43-1.92 (m, 5 CHJ; 
2.44  (5, AfeQHJ;  3.25-3.52 (m, CH20);  3.61-3.87  (m, CH20); 4.04 (m, C/f2OTs);  4.53 (m, OCHO); 7.32,  7.77 
(A2B2,  4 arom.  H).  13C-NMR:  19.57  (C(4) of  Thp);  21.61  (MeC6H4);  25.42  (C(5) of  Thp);  25.66 (C(3)); 26.00 
(C(2)); 30.65 (C(3) of Thp); 62.30 (C(4) ofThp); 66.49 (C(6) of Thp); 70.53 (C(l)); 98.81 (C(2) ofThp); 127.86 (CJ; 
129.83 (CJ;  133.14 (CJ;  144.70 (C*J. 
5-f  (Tetrahydro-2H-pyran-2-yl)oxy]pentyl  Toluene-4-sulfonate  (7c). According to the General  Procedure,  with  
6c (8.0 g, 43 mmol):  11.9 g (81 %) of7c. Slightly yellow oil. TLC: Rf0.57 (A),  Rf0.79 (B). 'H-NMR: 1.34-1.90 (m, 
6  CHJ;  2.43  (i,  AfeC6H„);  3.26-3.56  (m,  CH20);  3.64-3.99  (m,  CH20);  4.02  (/,  J  =  6.4,  C//2OTs);  4.53  
(7 \  OCHO); 7.34,  7.78 (A2B2,4  arom. H).  13C-NMR:  19.66 (C(4) ofThp); 21.61 (MeC6H4);  22.23 (C(3)); 25.45 
(C(5) ofThp); 28.65 (C(4)); 29.03 (C(2)); 30.72 (C(3) ofThp); 62.36 (C(5)); 67.08 (C(6) ofThp); 70.53 (C(l)); 98.87 
(C(2) ofThp);  127.84 (CJ;  129.83 (CJ;  133.15 (CJ;  144.69  (Cipso). 
6-[(Tetrahydro-2H-pyran-2-yl)oxyJhexyl  Toluene-4-sulfonate  (7d). According to the General  Procedure,  with  
6d (4.04 g, 20 mmol): 5.62 g (79%) of 7d. Colourless oil. TLC: R{0.60  (A),  R{0.80  (B). 'H-NMR:  1.31 (m, 2 CHJ; 
1.4-2.0 (m, 5 CHJ; 2.44 (J, MeC6HJ; 3.25-3.51 (m, CHzO); 3.62-3.93 (m, CH20); 4.02 (t, J  =  6.4, CH2OTs); 4.54 
('/',  OCHO); 7.34, 7.78 (A2B2, 4 arom. H).  13C-NMR:  19.71 (C(4) ofThp); 21.63 (MeC6HJ;  24.77 (C(4)); 25.09 
(C(3)); 25.21 (C(5) ofThp); 28.76 (C(5)); 29.48 (C(2)); 30.76 (C(3) ofThp); 62.43 (C(6)); 67.35 (C(6) ofThp); 70.60 
(C(l)); 98.92 (C(2) ofThp);  127.87 (CJ;  129.82 (CJ;  133.17 (CJ;  144.68 (Cipso). 
7-[(Tetrahydro-2K-pyran-2-yl)oxy]heptyl  Toluene-4-sulfonate  (7e). According to the General  Procedure,  with  
6e (3.4 g,  15.7 mmol): 4.18 g (72%) of 7e. Slightly yellow oil.  TLC: Rf 0.62 (A),  Rf0.82 (B).  'H-NMR:  1.27 (m, 
3  C H J ;  1 .4-2 .0  (M,  5  C H J ;  2 .44  (s,  AFEC6H4);  3 .25-3 .51  (m,  C H 2 0 ) ;  3 .62-3 .90  (m,  C H 2 0 ) ;  4.01  (I,  J  =  6.4,  
C # 2 O T S ) ; 4 .55  (m, O C H O ) ;  7 .34 ,7 .78  (A2B2,4  arom.  H) .  
6.  N6-Benzoyl-2'  ,3'- O-isopropylidene-5'-  0-[u>-(  tetrahydro-2  H-pyran-2-yl)  alky I]adenosines  8a-e.  General  
Procedure. To a soln. of 4 (1.50 g, 3.65 mmol) in dry DMF(15 ml) under Ar, NaH (120 mg, 5 mmol; 70% content) 
was added. After stirring at 40° for 5 min, 7a (4.38 mmol) in dry DMF (1 ml) was added and the resulting mixture 
further stirred at 50° for 2 h. After evaporation of the main bulk of DMF (4-5 Torr), the residue was purified by FC 
(silica gel, hexane/acetone 2.1): 8 (60-87%). 
~Ns-Benzoyl-2',3'-O-isopropylidene-5'-  0-[3-(tetrahydro-2  H-pyran-2-yl)propyl]adenosine  (8a).  According  to  
the General Procedure, with 4 (0.95 g, 2.3 mmol) and 7a (0.87 g, 2.76 mmol): 0.76 g (60%) of 8a. Foamy solid. TLC: 
Rf 0.46 (B),  RF0.70 (D).  ' H - N M R :  1.38-1.6 (m,  3 C H J ;  1.41 (s, Me); 1.6-1.9 (m, 2 C H J ;  1.66 (i, Me); 3.25-3.9  (m,  
4 CH20); 4.49 (m, H-C(4')); 4.56 (m, OCHO); 4.97 (m, H-C(3')); 5.29 (m, H-C(2')); 6.27 (m, H-C(l'));  7.45-7.6 
0m, 2 Hm, HJ; 8.02 (m, 2 HJ; 8.28 (s, H-C(8)); 8.81 (s, H-C(2)); 9.38 (br. j, NH).  I3C-NMR: 19.61,19.65 (C(4) of 
Thp); 25.34 (1 Me of Me2C); 25.38 (C(5) ofThp); 27.20 (1 Me of Me2C); 29.72 (C(2*)); 30.65 (C(3) ofThp); 62.37, 
62.41  (C(3"j); 64.02, 64.18 (C(l*));  68.81,  68.92 (C(6) ofThp);  71.07 (C(5'));  81.85 (C(3')); 85.18, 85.22 (C(2')); 
86.22 (C(4')); 91.95, 91.99 (C(l')); 98.89,98.95  (C(2) ofThp);  114.15 (Me,C);  123.37 (C(5));  127.93 (CJ;  128.77  
(CJ;  132.70 (CJ;  133.70 (C(>J;  141.69 (C(8));  149.51 (C(4));  151.41 (C(6)j;  152.77 (C(2));  167.76 (C=0). 
Ns-Benzoyl-2',3'-O-isopropylidene-5'-0-[4-(tetrahydro-2H-pyran-2-yl)butyl]adenosine  (8b).  According  to  
the General Procedure, with 4 (0.95 g, 2.3 mmol) and 7b (0.91 g, 2.76 mmol): 0.95 g (73 %) of 8b. Viscous oil. TLC: 
Rf 0.49 (B), Rr0.73 (D).  'H-NMR:  1.4-2.0 (m, 5 CHJ;  1.42 (s, Me);  1.65 (s, Me); 3.25-3.9 (m, 4 CHzO); 4.53 (m, 
H—C(4'),  OCHO); 4.96  (dd, 7(3',4') =  1.8, 7(2',3') =  6.4,  H-C(3'));  5.28  (dd, 7(1',2')=  1.6, H-C(2'));  6.28  (d,  
H-C(l')); 7.4-7.6 (m, 2 Hm, HJ; 8.02 ('d\ 2 HJ; 8.27 (s, H-C(8)); 8.79 (s, H-C(2)); 9.42 (br. J, NH).  13C-NMR: 
19.68 (C(4) ofThp); 25.36 (1 Me of Me2C); 25.36 (C(5) ofThp); 26.24 (C(3*)); 26.24 (C(2')); 27.21 (1 Me of Me2C); 
30.69 (C(3) ofThp); 62.42 (C(4*)); 67.10 (C(6) ofThp); 70.96 (C(l*));  71.51 (C(5')); 81.84 (C(3')); 85.21 (C(2'));  
86.23 (C(4')); 91.94 (C(l'));  98.92 (C(2) ofThp);  114.14 (Me2C);  123.39 (C(5));  127.95 (CJ;  128.75 (CJ;  128.75  
(CJ;  132.68 (CJ;  133.68 (C*J;  141.69 (C(8)); 149.52 (C(4));  151.41 (C(6));  152.74 (C(2));  164.79 (C=0). 
TA6-Ben:oyl-2',3'-O-isopropylidene-5'-  0-[5-(tetrahydro-2H-pyran-2-vl)pentyl¡adenosine  (8c).  According  to  
the General Procedure, with 4 (1.23 g, 3.0 mmol) and 7c (1.23 g, 3.6 mmol): 1.16 g (67%) of 8c. Foamy solid.  TLC:  
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Rf 0.52 (B), Rf 0.75  (Z>). 'H-NMR: 1.2-1.4 (m, CH2);  1.42 (s, Me); 1.4-1.9 (m, 5 CH2);  1.66 (s, Me); 3.26-3.9 (m, 
4 CH,0);  4.55  (m, H-C(4'),  OCHO); 4.96  (dd, 7(3',4') =  1.7, 7(2',3') =  6.6, H-C(3'));  5.29 (dd, 7(1'.2') =  1.8,  
H—C(2')); 6.28 (d, H-C(l')); 7.4-7.6 (m, 2 Hm, H„); 8.03 ('d\  2 H„); 8.29 (s, H-C(8)); 8.82 (s, H-C(2)); 9.4 (br. j, 
NH). 
N6-Ben:oyl-2',3'-  O-isopropylidene-5'-  0-{6-(tetrahydro-2  H-pyran-2-yl)hexyl]adenosine  (8d).  According  to  
the General Procedure, with 4 (1.50,3.65 mmol) and 7d (1.56 g, 4.38 mmol):  1.89 g (87 %) of 8d. Viscous oil. TLC: 
Rf0.56(R),Rf 0.78(D).  'H-NMR: 1.15-1.4(m,2CH2);  1.42(s,Me); 1.4-1.9(m,5CHJ;  1.65(i,Me);3.28-3.9(m,  
4 CH20); 4.54  (m, H-C(4'),  OCHO); 4.96 (dd, 7(3',4') =  1.6, 7(2',3') =  6.7, H-C(3'));  5.28  (dd, 7(1\2') =  2.1,  
H—C(2')); 6.28 (d, H-C(l')); 7.46-7.64 (m, 2 Hm, H„); 8.04 ('</', 2 H0); 8.30 (s, H-C(8)); 8.82 (s, H-C(2)); 9.4 (br. 
s, NH).  13C-NMR:  19.69 (C(4) of Thp); 25.36 (1 Me of Me2C); 25.44 (C(5) of Thp); 25.82 (C(4")); 25.98 (C(3*)); 
27.22 (1 Me of Me2C); 29.27 (C(5*)); 29.61 (C(2*)); 30.73 (C(3) of Thp); 62.37 (C(6')); 67.44 (C(6) of Thp); 70.95 
(C(l')); 71.71 (C(5')); 81.86 (C(3')); 85.27 (C(2')); 86.22 (C(4')); 91.95 (C(l')); 98.86 (C(2) of Thp); 114.13 (Me2C); 
123.42 (C(5));  127.95 (CJ;  128.76 (C„);  132.67 (C,);  133.69 (Cipso);  141.69 (C(8));  149.51  (C(4));  151.45 (C(6)); 
152.73 (C(2)); 167.78 (C=0).  EI-MS: 595 (04, M+),  510 (5), 406 (6), 322 (4), 306 (6), 268 (16), 240 (17), 218 (9), 164 
(45),  136 (12),  105 (19), 85 (25), 84 (80), 83 (42), 69 (13), 56 (26), 55 (100), 54 (23), 41 (17), 39 (15). HR-MS: 595.2986 
(M+,  C3,H4,NJ07, calc. 595.3006). 
Ns-Benzoyl-2',3'-0-isopropylidene-5'-0-[7-(tetrahydro-2H-pyran-2-yl)heptyl]adenosine  (8e).  According  to  
the General Procedure, with 4 (1.23 g, 3.0 mmol) and 7e (1.33 g, 3.6 mmol): 1.41 g (77%) of8d. Viscous oil. TLC: Rf 
0.59 (3),  Rf 0.80 (D).  'H-NMR: 1.15-1.4 (m, 3 CH2);  1.42 (s.  Me); 1.4-1.92 (m, 5 CH2);  1.65 (r, Me); 3.3-3.9 (m, 
4 CH20);  4.54  (m, H-C(4'),  OCHO); 4.96  (dd, 7(3',4') =  1.6, 7(2',3') =  6.6, H-C(3'));  5.28  (dd, 7(1',2') =  2.0,  
H—C(2')); 6.29 (d, H-C(l')); 7.45-7.6 (m, 2 Hm, Hp); 8.03 ('d\  2 H„); 8.29 (s, H-C(8)); 8.81 (s, H-C(2)); 9.3 (br. s, 
NH). 
7.  2",3'- O-Isopropylidene-5'-  0-fa>-(  tetrahydro-2  Yl-pyran-2-yI)  alky I]adenosine  9a-e.  General  Procedure.  A  
soln. of (3.16 mmol) in MeOH (40 ml) containing NaOMe (0.03 g) was stirred overnight. The product was used in 
the next step without isolation. An anal, sample (2 ml) was removed and evaporated. The residue was diluted with 
CH2C12 (10 ml), the soln. washed with H20 (2 ml) and brine (2 ml), dried, and evaporated, and the residue purified 
by  FC (silica  gel,  hexane/acetone  1:1): light  yellow  viscous  oil  (85-90%;  based on  the removed  proportion  of  
reaction mixture). 
2',3'-  O-Isopropylidene-5'-0-[3-(tetrahydro-2  H-pvran-2-yl)propyl¡adenosine  (9a).  According  to  the  General  
Procedure,  with8a (740mg,  1.34 mmol). TLC :Rf 0.18 (R),Rf 0.46(D).  'H-NMR:  1.41 (s,Me); 1.5(m,2CH2);  1.64 
(s. Me);  1.78 (m, 2 CH2); 3.3-3.9 (m, 4 CH20); 4.50 (m, H-C(4'), OCHO); 4.98 (m, H-C(3')); 5.30 (m, H-C(2')); 
6.18 (d, J  =  1.5, H-C(l')); 6.25 (br. 5, NH2); 8.06 (j, H-C(8)); 8.36 (r, H-C(2)).  13C-NMR:  19.66 (C(4) of Thp); 
25.40 (1 Me of Me2C); 25.40 (C(5) of Thp); 27.21 (1 Me of Me2C); 29.78 (C(2*)); 30.67 (C(3) ofThp); 62.38 (C(3')); 
64.15,  64.21  (C(l*)); 68.77,  68.82 (C(6) ofThp); 71.05 (C(5'j);  81.79 (C(3')); 85.00 (C(2')); 86.02 (C(4')); 91.39, 
91.44 (C(l')); 98.93,98.96 (C(2) ofThp); 114.11 (Me2C); 119.94(C(5)); 139.23 (C(8)); 149.47 (C(4)); 153.14(C(2)); 
155.63 (C(6)). 
2',3'- O-Isopropylidene-5'-0-[4-(tetrahydro-2H-pyran-2-yl)butyl¡adenosine  (9b).  According  to  the  General  
Procedure, with 8b (900 mg, 1.59 mmol). TLC: Rf 0.23 (B), Rf 0.49 (D). 'H-NMR: 1.4-1.9 (m, 5 CH2);  1.41 (s. Me); 
1.64 (s,  Me); 3.3-3.9  (m, 4 CH20); 4.52  (m, H-C(4')); 4.55 (m,  OCHO); 4.97 (dd, 7(3',4') =  1.7, 7(2',3') =  6.2,  
H—C(3'));  5.32  (dd, 7(1',2')=  1.4, H-C(2'));  6.29  (d, H-C(l'));  6.39  (br.  s,  NHj);  8.07  (s,  H-C(8));  8.37  (s,  
H—C(2)).  13C-NMR:  19.66 (C(4) ofThp); 25.40 (1 Me of Me2C); 25.43 (C(5) of Thp); 26.29 (C(2")); 26.29 (C(3*)); 
27.21  (1 Me of Me2C); 30.71 (C(3) ofThp); 62.36 (C(4")); 67.14 (C(6) ofThp); 70.95 (C(l")); 71.43 (C(5')); 81.82 
(C(3')); 85.00 (C(2')); 86.04 (C(4')); 91.48 (C(l')); 98.85 (C(2) ofThp); 114.09 (Me2C); 119.96 (C(5)); 139.22 (C(8)); 
149.46 (C(4));  153.14 (C(2));  155.66 (C(6)). 
2' ,3'- O-Isopropylidene-5'-  0-[5-(tetrahydro-2  H-pyran-2-yl)pentyl¡adenosine  (9c).  According  to  the  General  
Procedure, with 8c (1.14 g,  1.96 mmol). TLC: Rf0.29 (B), Rr0.51 (D). 'H-NMR: 1.15-1.35 (m, CHJ;  1.41 (s,  Me); 
1.4-1.9  (m,  5  CH2);  1.64  (s,  Me);  3.3-3.95  (m,  4  CH20);  4.52  (m,  H-C(4'));  4.58  ('r\  OCHO);  4.99  (dd,  
7(3',4') =  1.6,7(2',3') = 6.4, H-C(3')); 5.30 (dd, 7(1',2') =  1.5, H-C(2')); 5.77 (br. r, NH2); 6.20 (d, H-C(l')); 8.05 
(s, H-C(8)); 8.38 (s, H-C(2)).  ,3C-NMR: 19.69 (C(4) ofThp); 22.70 (C(3*)); 25.39 (1 Me of Me2C); 25.47 (C(5) of 
Thp); 27.22 (1 Me of Me2C); 29.21 (C(4*)); 29.45 (C(2*)); 30.75 (C(3) ofThp); 62.40 (C(5*)); 67.36 (C(6) ofThp); 
71.00 (C(l*));  71.61 (C(5')); 81.84 (C(3')): 85.13 (C(2')); 86.13 (C(4'));  91.67 (C(l')); 98.87 (C(2) ofThp);  114.09  
(Me2C);  119.98 (C(5));  139.40 (C(8));  149.39 (C(4));  152.96 (C(2));  155.24 (C(6)). 
2',3'-0-Isopropylidene-5'-0-[6-(tetrahvdro-2H-pyran-2-yl)hexyl]adenosine  (9d).  According  to  the  General  
Procedure with8a (1.80g, 3.03 mmol). TLC: Rr0.35 (B), Rf0.54(D). 'H-NMR: 1.15-1.40 ( m , 2 0 ^ ;  1.41 (s,Me); 
1.4-1.9  (m,  5  CH2);  1.64  (s,  Me);  3.3-3.95  (w,  4  CH20);  4.52  (m,  H-C(4'));  4.57  ('/',  OCHO);  4.98  (dd,  
7(3'.4') =  1.6,7(2',3') = 6.3, H-C(3')); 5.28 (dd, 7(1',2') =  1.3, H-C(2')); 5.8 (br. s, NH2); 6.19 (d, H-C(l')); 8.06 
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(s, H—C(8)); 8.36 (s, H-C(2)).  I3C-NMR:  19.71 (C(4) of Thp); 25.39 (1  Me of Me,C); 25.47 (C(5) ofThp); 25.87 
(C(4')); 26.00 (C(3*)); 27.21 (1 Me of Me,C); 29.33 (C(5")); 29.61 (C(2")); 30.76 (C(3) ofThp); 62.38 (C(6')); 67.50 
(C(6) ofThp); 70.96 (C(l*)); 71.68 (C(5')j; 81.84 (C(3')); 85.11, (C(2')); 86.10 (C(4j); 91.58 (C(l')); 98.85 (C(2) of 
Thp).  114.05 (Me2C);  119.94 (C(5));  139.22 (C(8));  149.46 (C(4));  153.11 (C(2));  155.58 (C(6)).  EI-MS: 491 (1.6, 
M+),  476  (3),  462 (12),  306 (9),  218 (23),  164 (100),  136  (25),  85  (23),  55 (10),  43  (6).  HR-MS:  491.2726  (AT,  
C24H37N506,  calc. 491.2744). 
2,3'-0-Isopropylidene-5'-0-[7-(tetrahydro-2Yi-pyran-2-yl)heptyl]  adenosine  (9e).  According  to  the  General  
Procedure,  with 8a (1.38 g, 2.27 mmol). TLC: Rr0.39 (ft), Rr 0.56 (D).  'H-NMR:  1.15-1.40 (m, 3 CH2);  1.42 (s, 
Me);  1.4-1.9  (m,  5 CHz);  1.63 (s, Me); 3.3-3.95  (m, 4 CH20);  4.51  (m, H-C(4'));  4.56 ('í\  OCHO); 4.96 (dd, 
7(3',4j =  1.7,7(2',3') =  6.4, H-C(3')); 5.29 (dd, 7(1',2') =  1.4, H-C(2')); 5.85 (br. s, NHj); 6.19 (d, H-C(l j); 8.06 
(s, H-C(8));  8.37 (s, H-C(2)).  I3C-NMR:  19.75 (C(4) ofThp); 25.40 (1 Me ofMe2C); 25.49 (C(5) ofThp); 25.94 
(C(4")); 26.13 (C(5*)); 27.22 (1 Me of Me2C); 29.23 (C(3*)); 29.34 (C(6")); 29.66 (C(2")); 30.79 (C(3) ofThp); 62.44 
(C(7*)); 67.62 (C(6) ofThp); 70.98 (C(l')); 71.75 (C(5')); 81.86 (C(3')); 85.13 (C(2')); 86.12 (C(4j); 91.68 (C(l j); 
98.88 (C(2) of Thp);  114.06 (Me2C);  120.01 (C(5));  139.31 (C(8)); 149.32 (C(4));  153.11 (C(2));  155.39 (C(6)). 
8.  5'- O- (co-Hydroxyalkyl)-2',3'-  O-isopropylideneadenosines  lOa-e.  General  Procedure.  To  a MeOH  soln.  of  
crude 9 (from 3.65 mmol of 8, without isolation),  2M  HC1  (4 ml) was added and the mixture stirred at r.t. for 2 h. 
After neutralization (pH 7.5) by sat. NaHC03 soln., the MeOH, was evaporated. The residue was diluted with H20 
to  20  ml,  extracted  with  CH2C12  (3 x  40  ml),  the  combined  CH2C02  soln.  washed  with  brine  (20  ml),  dried  
(MgS04),  and evaporated,  and the remaining oil  purified by FC (silica gel,  CHiCl^MeOH 20:1):  10 (56-71%; 
based on 8) as yellowish semi-solids. 
J'- O- (3-Hydroxypropyl)-2",3'- O-isopropylideneadenosine  (10a).  According to the  General  Procedure:  289 mg 
(56%; based on 8a) of 10a. TLC: Rf0.28 (£>). 'H-NMR:  1.40 (s, Me); 1.64 (s,  Me);  1.75 (m, CHJ; 3.4-3.75 (m, 3 
CH20);  4.49  (m, H-C(4')); 4.97 (dd,  7(2',3') =  6.0, 7(3',4') =  2.1,  H-C(3'));  5.29 (dd, 7(1',2') =  1.7,  H-C(2'));  
6.18~(</, H—C(l')); 6.5 (br. I, NH^; 8.09 (J, H-C(8)); 8.33 (s, H-C(2)).  13C-NMR: 25.37 (1 Me of Me2C); 27.17 (1 
Me of Me2C); 32.19 (C(2*)); 59.68 (C(3*)); 69.19 (C(l*)); 71.04 (C(5 j); 81.58 (C(3')); 84.99 (C(2')); 86.03 (C(4j); 
91.35 (C(l'));  114.23 (Me2C);  119.74 (C(5)); 139.29 (C(8));  149.33 (C(4)); 153.24 (C(2)); 155.70 (C(6)). 
5'-0-(4-Hydroxybutyl)-1.3'-O-isopropylideneadenosine  (10b).  According to  the  General  Procedure:  368  mg  
(61 %;  based on 8b) of  10b. TLC: Rf0.31  (D).  'H-NMR:  1.39 (J, Me); 1.5-1.8 (m, 2 CH2);  1.66 (S, Me); 3.44 (/, 
7  =  6.5, CH2(1*)0); 3.5-3.75 (m, 2 CH20); 4.52 (m, H-C(4')); 4.98 (dd,  7(2',3') =  6.3, 7(3',4') =  2.3, H-C(3 j); 
5.22  (dd, 7(1',2')=  1.9,  H-C(2'));  6.26  (d,  H-C(l'));  6.8  (br.  s,  NH2);  8.20  (s,  H-C(8));  8.35  (J,  H-C(2)).  
I3C-NMR: 25.38 (1 Me ofMe2C); 26.23 (C(3*)); 27.19 (1 Me of Me2C); 29.18 (C(2")); 61.88 (C(4")); 70.93 (C(l')); 
71.68 (C(5')); 81.45 (C(3')); 85.38 (C(2')); 86.29 (C(4')); 91.18 (C(lj);  114.10 (Me2C);  119.51 (C(5));  139.10 (C(8)); 
149.32 (C(4)); 153.27 (C(2));  155.82 (C(6)). 
J'- O- (5-Hydroxypentyl)-2',3'-  O-isopropylideneadenosine  (10c).  According to the  General  Procedure  : 523 mg 
(68%; based on 8c) of 10c. TLC: Rf0.36 (D).  'H-NMR: 1.25-1.65 (m, 3 CH2);  1.40 (s,  Me); 1.65 (r, Me); 3.43 (m, 
CH2(1')0); 3.56 (dd, 7(4',5') = 3.5,7(5'a,5'b) =  10.0, Ha-C(5')); 3.63 (/, 7  =  6.5, CH2(5")); 3.73 (dd, 7(4',5') = 2.4,  
7(5'a,5'b) =  10.0,  Hb-C(5'));  4.53  (m,  H-C(4'));  4.97  (dd, 7(2',3j = 6.4,  7(3',4') =  2.2,  H-C(3'));  5.22  (dd, 
7(1',2') =  1.6, H—C(2')); 5.9 (br. s, NHJ; 6.27 (d, H-C(l')); 8.19 (s, H-C(8)); 8.40 (s, H-C(2)).  I3C-NMR: 21.98 
(C(3*)); 25.38 (1 Me of Me2C); 27.19 (C(4")); 29.22 (1 Me of Me,C); 32.47 (C(2*)); 62.17 (C(5")); 71.01 (C(l"));  
71.88 (C(5')); 81.42 (C(3')); 85.57 (C(2')); 86.65 (C(4')); 91.55 (C(l'));  114.02 (Me2C); 119.49 (C(5));  139.38 (C(8)); 
149.40 (C(4)); 153.29 (C(2));  155.60 (C(6)). 
5'-0-(6-Hydroxyhexyl)-2',3'-O-isopropylideneadenosine  (lOd).  According to the  General  Procedure  : 871  mg  
(71 %;  based on 8d) of lOd. TLC: Rf 0.39(D).  'H-NMR: 1.10-1.85 (m, 4 CH,);  1.39 (J. Me); 1.66 (J, Me); 3.40 (m, 
CH2(1*)0);  3.52  (dd,  7(4',5'a) = 4.2,  7(5'a,5'b) =  10.9,  Ha-C(5'));  3.62  (/,  7 =  6.5,  CH2(6"));  3.70  (dd.  
7(4',5') =  2.4, 7(5'a,5'b) =  10.9, Hb-C(5')); 4.51 (m, H-C(4')); 4.94 (dd,  7(2',3') = 6.6, 7(3',4') =  2.3, H-C(3')); 
5.21 (dd, 7(1',2') =  1.6, H-C(2')); 6.23 (d+  br. s, H-C(l'), NHj); 8.15 (s, H-C(8)); 8.34 (s, H-C(2)).  13C-NMR:  
25.37  (1  Me of  Me2C); 25.39  (C(4*));  25.75  (C(3*)); 27.19  (C(5*));  29.50  (1  Me of  Me2C); 32.48  (C(2*)); 61.84 
(C(6*)); 70.95 (C(l")); 71.61 (C(5')); 81.65 (C(3')); 85.48 (C(2')); 86.41  (C(4')); 91.59 (C(l j);  113.99 (Me2C); 119.48 
(C(5)); 138.99 (C(8)); 149.39(C(4)); 153.30(C(2)); 155.59 (C(6)). EI-MS: 407 (1.6, AT), 306 (9), 218 (23), 164(100), 
136 (25), 85 (23), 55 (10), 43 (6). HR-MS: 407.2151 (M+, C|9H29N505,  calc. 407.2151). 
5'-0-(7-Hydroxyheptyl)-2',3'-O-isopropylideneadenosine  (lOe). According to the  General  Procedure:  611 mg 
(64%; based on 8e) of lOe. TLC: Rf0.42 (D).'1 H-NMR: 1.25-1.35 (m, 3 CH2); 1.35-1.65 (m, 2 CH,);  1.41 (s Me): 
1.66 (s.  Me); 3.43 (m, CH2(1")0); 3.56 (dd, 7(4',5'a) =  3.7,7(5'a,5'b) = 9.8, Ha-C(5')); 3.69 (/, 7 =  6.5, CH,(7")): 
3.73  (dd, 7(4',5'b)=  1.8, 7(5'a,5'b) = 9.8,  H„-C(5'));  4.53 (m, H-C(4'));  4.97  (dd,  7(2',3j = 6.3,  7(3',4') = 2.2.  
H—C(3'));  5.17  (dd, 7(1',2')=  1.6,  H-C(2j);  6.37  (d, H-C(l'));  6.4  (br.  s,  NH,);  8.18  (s,  H-C(8));  8.37  (j.  
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H—C(2)). 13C-NMR: 25.40 (1 Me of Me2C); 25.56 (C(4')); 26.06 (C(5*));  29.16 (C(3*)); 29.29 (C(6*)); 29.41 (1 Me 
of Me2C); 32.51 (C(2')); 62.05 (C(7*)); 70.85 (C(l')); 71.56 (C(5')); 81.46 (C(3')); 85.68 (C(2')); 86.28 (C(4')); 91.47 
(C(l'));  114.02 (Me,C);  119.40 (C(5)); 138.71 (C(8)); 149.39 (C(4));  153.34 (C(2)); 155.57 (C(6)). 
9.  2",3'-0-Isopropylidene-5'-0-{a>[(tol-4-yl)sulfonyloxy]alkyl}adenosines  lla-e.  General Procedure.  To a 
soln. of 10 (2.07 mmol) and  dry pyridine (3 mmol) in dry CH2C12 (5 ml), TsCl (0.47 g, 2.5 mmol) was added and the 
resulting mixture stirred at r.t. for 6 h. After diluting with CH2C12 to a volume of 50 ml, the soln. was washed with 
5%  HC1 soln.  (10 ml),  sat. NaHC03  soln.  (10 ml),  and brine (10 ml),  dried (MgS04),  and evaporated  and the 
residue purified by CC (silica gel, gradient CH2Cl2-*CH2Cl2/acetone-»acetone  (600 ml)); 11 (58-70%) as colour-
less foamy semi-solid. 
2,3'-O-Isopropylidene-5'- O- {3-f (tol-4-yl)sulfonyloxy]propyl]adenosine (11a). According to the General Pro-
cedure with 10a (250 mg, 0.65 mmol): 11a (216 mg, 64%). TLC: Rf 0.46 (D). 'H-NMR: 1.40 (s, Me); 1.63 (s, Me); 
1.77 (m, CHJ; 2.44 (i, AfeC6H4);  3.44 (/, J =  6.6, CH2(1")0); 3.45-3.65 (m,  CH2(5')); 3.99 (T, Ctf2OTs); 4.42 (m, 
H—C(4')); 4.94 (dd, J(2',3') = 6.5,7(3',4') = 2.7, H-C(3')); 5.32 (dd,  7(1',2') = 2.3, H-C(2')); 6.10 (br. s, NHJ; 
6.14 (d, H-C(l')); 7.31,7.73 (A2B2,4 arom. H); 7.96 (s, H-C(8)); 8.34 (s, H-C(2)).  I3C-NMR: 21.67 (MeC6H4); 
25.32 (1  Me of  Me2C); 27.16  (1  Me of  Me2C); 29.99 (C(2*));  66.92 (C(3*)); 67.26 (C(l")); 71.10 (C(5')); 81.68 
(C(3 )); 84.70 (C(2')); 85.93. (C(4')); 91.44 (C(l')); 114.22 (Me2C);  119.93 (C(5)); 127.85 (C0); 129.86 (Cm); 132.89 
(Cp);  139.35 (C(8));  144.84 (C^,);  149.39 (C(4)); 153.13 (C(2));  155.53 (C(6)). 
2,3'-0-Isopropylidene-5'-0-{4-f(tol-4-yl)sulfonyloxy]butyl}adenosine (lib).  According to the General Pro-
cedure, with 10b (330 mg,.0.87 mmol): lib (311 mg, 67%). TLC: Rr0.49 (D). 'H-NMR: 1.42 (i.Me);  1.4-1.8 (m, 
2  CH2);  1.65  (s.  Me);  2.44  (5,  MeC6H4); 3.37  (/,  7 =  6.5,  CH2(1')0);  3.4-3.7  (m, CH,(5'));  3.97  (t,  7 = 6.6,  
Ctf2OTs); 4.47 (m, H-C(4')); 4.96 (dd, 7(2',3') = 6.5,7(3',4') = 2.5, H-C(3')); 5.33 (dd, 7(1',2') = 2.1, H-C(2')); 
6.15 (br. s + d, H-C(l'), NHJ; 7.33,7.77 (A2B2,4 arom. H); 8.00 (s, H-C(8)); 8.34 (s, H-C(2)).  13C-NMR: 21.62 
(MeC6H4); 25.37 (1 Me of Me2C); 25.41 (C(3*)); 25.61 (C(2*)); 27.18 (1 Me of Me2C); 70.19 (C(4")); 70.59 (C(l*)); 
70.97 (C(5')); 81.70 (C(3')); 84.80 (C(2')); 86.01 (C(4')); 91.43 (C(l'));  114.19 (MejC);  119.95 (C(5));  127.86 (C0); 
129.84 (CJ;  132.99 (Cp);  139.31 (C(8)); 144.75 (CipJ;  149.38 (C(4)); 153.09 (C(2));  155.56 (C(6)). 
2,3'- O-Isopropylidene-5'-O- {5-f (tol-4-yl)sulfonyloxy]pentyl}adenosine (11c). According to the General Pro-
cedure,  with  10c (490 mg,  1.25  mmol):  11c  (479 mg,  70%).  TLC: Rf  0.53  (D).  'H-NMR:  1.27 (m, CH2(3")); 
1.35-1.47 (m,CH2(2'));  1.41 (j, Me);  1.60 (m, CH2(4*)); 1.66 (s, Me); 2.44 (i, A/eC6H4); 3.34 (t, J =  6.2, CH2(1')); 
3.56 (dd, 7(4',5') = 4.4,7(5'a,5'b) =  10.1, H,-C(5')); 3.66 (dd, 7(4',5'b) =  2.8,7(5'a,5'b) =  10.1, Hb-C(5')); 3.98  (r, 
7 = 6.6, C/f2OTs); 4.50 (m,  H-C(4')); 4.97 (dd,  7(2',3') = 6.3, 7(3',4') =  2.4, H-C(3'));  5.31 (dd,  7(1',2') =2.1, 
H—C(2')); 6.19 (d, H-C(l')); 6.22 (br. s, NH2); 7.33,7.78 (A2B2,4  arom. H); 8.03 (s, H-C(8)); 8.36 (s, H-C(2)). 
13C-NMR: 21.62 (A/eC6H4);  21.93 (C(3*)); 25.38 (1 Me of  Me2C); 27.19  (1  Me of  Me2C); 28.56 (C(4')); 28.73 
(C(2*)); 70.36 (C(5"));  70.99 (C(l")); 71.19 (C(5')); 81.74 (C(3')); 84.95 (C(2')); 86.10 (C(4')); 91.49 (C(l')); 114.11 
(Me,C);  119.98 (C(5));  127.86 (C0);  129.81 (CJ;  133.06 (Cp);  139.27 (C(8));  144.70 (C,pJ;  149.43 (C(4)); 153.12 
(C(2));  155.62 (C(6)). 
2,3'-O-Isopropylidene-5'-O- {6-[(tol-4-yl)sulfonyloxyJhexyl]adenosine (lid).  According to the General Pro-
cedure  with  lOd (842 mg,  2.07 mmol): lid  (686 mg,  58%).  TLC: Rr 0.56 (D).  'H-NMR:  1.1-1.3  (m,  2 CHj); 
1.3-1.47  (m,  CH2(2*));  1.41  (s,  Me);  1.5-1.7  (m, CH2(5"));  1.66  (s,  Me);  2.44  (s, MeC6H4); 3.37  (/,  7 = 6.4,  
CH2(1"));  3.57  (dd,  7(4',5') = 4.5,  7(5'a,5'b) =  10.6,  H,-C(5'));  3.66  (dd,  7(4',5') = 2.7,  7(5'a,5'b) =  10.6,  
Hb—C(5')); 3.99 (/, 7 = 6.5, CH2OTs); 4.50 (m,  H-C(4')); 4.96 (dd, 7(2',3') = 6.2, 7(3',4') = 2.4, H-C(3')); 5.31 
(dd, 7(1',2') =  2.3, H—C(2')); 5.95 (br. s, NHJ; 6.19 (d, H-C(l')); 7.34,7.78 (A2B2,4 arom. H); 8.04 (s, H-C(8)); 
8.38 (s,  H—C(2)).  13C-NMR: 21.63 (MeC6H4); 25.14 (C(4")); 25.37 (1 Me of Me2C); 25.39 (C(3*)); 27.20 (1 Me of 
Me,C); 28.70 (C(5")); 29.17 (C(2*)); 70.52 (C(6*)); 70.99 (C(l*)); 71.42 (C(5')); 81.80 (C(3')); 85.09 (C(2')); 86.17 
(C(4')); 91.67 (C(l'));  114.09 (Me2C);  120.00 (C(5));  127.88 (C„);  129.82 (CJ;  133.13 (Cp);  139.36 (C(8)); 144.67 
(C1PJ;  149.46 (C(4)); 152.97 (C(2)); 155.35 (C(6)). 
2,3'-O-Isopropylidene-5'-O- {7-[(tol-4-yl)sulfonyloxy]heptyl}adenosine (lie).  According to the General Pro-
cedure,  with  lOe (570  mg,  1.35  mmol): lie  (497  mg, 61%) .  T L C :  R{ 0 .58  (D).  'H-NMR:  1 .1-1 .3  (m,  3  C H 2 ) ;  
1 .35-1.5  (m  CH 2 (2*));  1.42 (s,  Me) ;  1 .5-1.7  (m,  CH 2(6*));  1.67  (s.  M e ) ; 2 .44  (s.  MeC6H4);  3.37  (t,  J  =  6.4,  CH2(1"));  
3.56  (dd,  7(4' ,5 ' )  =  4 .5 ,7(5 'a ,5 'b)  =  10.6, H , - C ( 5 ' ) ) ; 3.67  (dd,  7(4 ' ,5 'b)  =  2 .7 ,7 (5 'a ,5 'b)  =  10.6, H B - C ( 5 ' ) ) ; 3.99  (t,  
J  =  6.5,  CH2OTS);  4.51  (m,  H - C ( 4 ' ) ) ;  4.97  (dd,  7(2' ,3 ' )  =  6.2,  7(3' ,4 ' )  =  2.3,  H - C ( 3 ' ) ) ;  5.31  (dd,  7(1' ,2')  =  2 .2 ,  
H—C(2'));  6 .20  (d, H-C(l')); 6.45  (br. s, NH2); 7.33,  7 .78  (A2B2,4  arom. H); 8.07  (s, H - C ( 8 ) ) ;  8.38  (s, H - C ( 2 ) ) . 
I3C-NMR: 21.61  (MeC6H4); 25.18  (C(4'));  25.38  (1  Me of  Me2C); 25.74  (C(5*));  27.19  (1  Me of  Me2C);  28 .67 
(C(6*)); 28 .67  (C(3"));  29.21  (C(2*));  70.64  (C(7"));  70.95  (C(L*));  71.54  (C(5'));  81.83  (C(3'));  85.07  (C(2'));  86 .08  
(C(4')); 91 .59  (C(l'));  114.01  ( M e 2 C ) ;  119.92  (C(5));  127.86  (C„);  129.78 ( C J ;  133.03  (CP);  139.18  (C(8));  144.65  
(Cipsoy,  149.40 (C(4));  153.08 (C(2));  155.71  (C(6)).  
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10. 5'-0- {a>-[(Tol-4-yl)sulfonyloxy]adenosines  12a-«.  General  Procedure.  Derivative  11  (0.24  mmol)  was  
added  to  a soln. of  10%  HC1 soln.  (0.2 ml) in MeOH  (2 ml) and the mixture heated  under  reflux for 5 min.  The 
mixture  was then cooled  to r.t.  and analyzed  by TLC. This  5 min heating/TLC  analysis procedure  was  repeated  
several  times,  until  the conversion  reached  a desired  degree. The soln.  was then cooled and  neutralized  with  sat.  
NaHC0 3  soln. and evaporated. The residue was diluted to  5 ml with HzO and extracted with C^ClJacetone  5:2  
( 3 x 4  ml), the combined extract washed with brine (2 ml), dried (MgSOJ, and evaporated, and the residue taken 
up  in  CH2C12  (0.5  ml)  and  purified  by  FC  (silica-gel  column  (250 x  10 mm),  gradient  hexane/CH2Cl2/acetone  
1:1:1 -»CH2Cl2/MeOH  10:1): 10-30% of recovered  11 and 25-46% of  12.  
5'- 0-{3-[(  Tol-4-yl)sulfonyloxy]propyl}adenosine  (12a).  According  to  the  General  Procedure,  with  11a  (180  
mg, 0.35 mmol):  76 mg (46%) of  12a. Foamy white solid. TLC:  R{0.32  (£>). 'H-NMR:  1.88 (m, CH,(2*)); 2.38 (s, 
MeC6HJ;  3.4-3.75  (m,  CH2(1"),  CH2(5'));  4.08 (V,  Ctf2OTs); 4.28  (m,  H-C(4'));  4.41  (m,  H-C(3'));  4.64  (m,  
H—C(2')); 6.08 (br. i, H-C(l '));  6.7 (br. r, N H J ;  7.24, 7.70 (A2B2,  4 arom.  H);  8.06 (br. s, H-C(2) or  H-C(8));  
8.08 (j, H—C(8) or H-C(2)).  13C-NMR: 21.58 (MeC6H4); 29.11 (C(2")); 67.14 (C(3*)); 67.64 (C(l*)); 70.53 (C(5')); 
71.16 (C(3')); 75.32 (C(2')); 84.11 (C(4')); 88.86 (C(l'));  119.17(C(5));  127.83 (CJ;  129.91 ( C J ;  132.71 (CJ;  138.95  
(C(8));  144.92 (C i p J ;  148.92 (C(4));  152.54 (C(2));  155.50 (C(6)). 
5'-O-{4-f  (Tol-4-yljsulfonyloxy]butyl}adenosine  (12b).  According  to  the  General Procedure, with  l ib  (275  
mg, 0.52 mmol):  102mg(40%) of  12b. Foamy white solid. TLC: Rf 0.34 (/>). 'H-NMR:  1.65 (m, 2 CH2); 2.41 (j, 
ASeQHJ; 3.4-3.55 (m, CH2(1")); 3.55-3.8 (m, CH2(5')); 4.02 (V, C//2OTs); 4.32 (m, H-C(4')); 4.43 (m, H-C(3')); 
4.61 (m, H—C(2')); 6.08 (d,J  =  3.4, H-C(l '));  6.65 (br. r, NH2); 7.28, 7.73 (A2B2,4  arom. H); 8.12 (br. j,  H-C(2)  
or H—C(8)); 8.17 (s, H-C(8) or H-C(2)).  13C-NMR: 21.60 (MeC6H4);  25.56 (C(3')); 25.74 (C(2'));  70.20 (C(4'));  
70.38 (C(l'));  70.68 (C(5'));  71.04 (C(3'));  75.50 (C(2'));  84.24 (C(4'));  89.27 (C(l'));  119.26 (C(5));  127.83 (CJ; 
129.88 ( C J ;  132.86 (CJ;  138.95 (C(8));  144.86 (Cipm);  148.79 (C(4));  152.44 (C(2));  155.49 (C(6)). 
5'-0-{5-[(Tol-4-yl)sulfonyloxy]pentyl\adenosine  (12c).  According  to  the  General Procedure, with  He  (440  
mg, 0.80 mmol):  145 mg (36%) of  12c. Foamy white solid. TLC: Rf 0.38 (D). 'H-NMR:  1.30(wi,CH2(3"j);  1.51 (m, 
CH2(2*j);  1.69  (m,  CH,(4"));  2.40  (s,  MeC6K4)\  3.4  (m,  CH2(1'));  3.45-3.75  (m,  CH2(5'));  3.99  (t,  J  =  6.4,  
C/72OTs); 4.31 (m, H-C(4')); 4.43 (m, H-C(3'));  4.62 (m, H-C(2'));  6.10 (d, J  =  3.0, H-C(l ')); 6.7 (br. j,  N H J ;  
7.27,  7.72  (A2B2,  4  arom.  H);  8.07 (br. j,  H-C(2)  or  H-C(8));  8.18  (s, H-C(8)  or  H-C(2)).  13C-NMR:  21.60  
(MeCJU);  21.99 (C(3'));  28.52 (C(2"j);  28.83 (C(4*));  70.26 (C(l"));  70.55 (C(5"));  71.21 (C(3'));  71.25  (C(5'));  
75.57  (C(2'));  84.23  (C(4'));  89.02 (C(l'));  119.22 (C(5));  127.82 (CJ;  129.85 ( C J ;  132.91 (CJ;  139.05  (C(8));  
144.78 (C,^J;  148.34 (C(4));  152.45 (C(2));  155.52 (C(6)). 
5'-0-{6-[(Tol-4-yl)sulfonyloxy]hexyl}adenosine  (12d).  According  to  the  General Procedure, with  11a  (643  
mg,  1.14 mmol):  148 mg (25%) of  12d. Foamy white solid. TLC: Rr0.41 (D).  'H-NMR:  1.23 (m, 2 CH2);  1.47 ('r', 
C H J ;  1.55 ('!',  CH2);  2.41  (s,  MeC6H4);  3.42  (/,  7 =  6.1,  CH2(1'));  3.55-3.75  (m,  CH2(5'));  3.96  (t,  J  = 6.7, 
C/f2OTs); 4.34 (m, H-C(4'));  4.44 ('i ', H-C(3'));  4.58 ( T ,  H-C(2')); 6.10 (d, J(Y,2')  = 4.0, H-C(l ' )) ;  6.6 (br. 5, 
NH2);  7.30,  7.75 (A2B2,  4 arom. H);  8.08 (br.  s, H-C(8));  8.18  (J, H-C(2)).  13C-NMR:  21.61  (MeC6H4)\  25.14  
(C(4*j); 25.50 (C(3')); 28.68 (C(5*)); 29.30 (C(2"j); 70.26 (C(6'));  70.65 (C(l'));  71.35 (C(3')); 71.50 (C(5')); 75.78 
(C(2'));  84.47 (C(4'));  89.28 (C(l'));  119.31 (C(5));  127.84 (CJ;  129.83 ( C J ;  132.99 (CJ;  138.40 (C(8));  144.74  
(C i p J ;  148.85 (C(4));  152.41 (C(2));  155.49 (C(6)). 
J'-O- {7-f (Tol-4-yl)sulfonyloxy]heptyl}adenosine  (12e). According to the General Procedure, with l i e  (461 g, 
0.80  mmol):  163 mg (38%)  of  12e. Foamy  white  solid. TLC:  Rf 0.43  (D).  'H-NMR:  1.2 (m,  3 CHJ;  1.55 (m, 2 
C H J ;  2.41 (s, MeC6H4);  3.43 ('/',  CH2(1*)); 3.55-3.8 (m, CH,(5'));  3.98 (/, J  =  6.7, CH2OTs);  4.33 (m, H-C(4')); 
4.46 (m, H-C(3')); 4.64 (m, H-C(2'));  6.13 (d, 7(1',2') =  2.7, H-C(l ' )) ;  6.7 (br. J, NHJ;  7.30,7.75 (A2B2,4  arom.  
H); 8.08 (br. j, H-C(8)); 8.20 (s, H-C(2)).  I3C-NMR: 21.60 (MeC6H4);  25.22 (C(4*)); 25.83 (C(3*)); 28.67 (C(5*)); 
28.76 (C(2')); 29.36 (C(6"));  70.27 (C(7'));  70.73 (C(l'));  71.28 (C(3')); 71.65 (C(5'));  75.71 (C(2'));  84.36  (C(4'));  
89.08 (C(l'));  119.23  (C(5));  127.84 (CJ;  129.83 ( C J ;  133.02 (CJ;  139.02 (C(8));  144.72 ( C ^ J ;  148.85  (C(4));  
152.44 (C(2));  155.55 (C(6)). 
11. fco-( Adenosin-5'-  0-yl)alkylJcobalamins  (la-e).  General  Procedure  [11] [12]. To a soln. of vitamin B12b (13; 
103 mg, 0.075 mmol) and 2 mg of cobalt(II) acetate in 4 ml of deoxygenated H20,  a soln. of NaBH4  (28 mg, 0.75 
mmol) and cobalt(II) acetate (0.5 mg) in  1  ml of deoxygenated H 2 0 was added under AT (cherry coloured-»brown, 
then  greenish  gray)  and  the  resulting  soln.  stirred  at  r.t. for  20 min.  Then  a  soln.  of  12 (0.10 mmol)  in  2  ml  of  
deoxygenated MeOH was added (greenish brown-»deep red) and the mixture stirred at r.t. in the dark for 45 min. 
The soln. was then diluted  with 5 ml of  1 % Ac0H/H20 and  extracted with 50% phenolic CH2C12 ( 3 x 2  ml). The 
combined  phenolic  extracts  were  diluted  with Et20  (50  ml),  and  the  resulting  precipitate  was  filtered  off  and  
washed with dry CH2C12 (2 x  30 ml). Redissolving (with 6 ml of MeOH) and repeating the precipitation with 50 ml 
of Et20  yielded crude  1 (81-88%)  as light  and  heat  sensitive,  hygroscopic,  red  solids. The crude products  were  
purified  by prep. HPLC  (A 280 nm, o =  6 ml/min; eluents:  0.01 % CF3COOH/H2Q  (A) and  MeOH  (B),  using  a  
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linear gradient of 30-70%  Bin  A within 25 min). Typically, a 50-mg portion  of crude 1 in 30 % Me0H/H20  (5 ml) 
was applied onto the column in one run. The product-containing fractions were evaporated  in the dark giving the 
desired pure  1 with 65-80%  recovery (direct chromatographic workup of the reaction mixtures without the above 
described extractive treatment can also be done). 
[3-(Adenosin-5'-0-yl)propyl]cobalamin  (la).  According to  the  General Procedure, with  13  (103 mg,  0.075  
mmol) and  12a (48 mg, 0.10 mmol). Purification by HPLC yielded 98.1 mg(80%) of pure la. Anal. HPLC (v =  0.8  
ml/min, A 280 nm): rR  11.4 min (0-1 min, 30%  Bin  A;  1-25 min, 30-70%  Bin  A;  A,  0.02M NaH2P04;  B, MeOH); 
rR  12.6  min  (0-1  min,  30%  B in  A;  1-25 min,  30-70%  B  in  A\  A,  0.01%  (v/v) CF 3 C00H/H 2 0;  B  MeOH).  
UV/VIS:  262.4  (25300),  288.8  (13600),  316.8  (10800),  342.4  (9900),  518.0  (6700).  FAB-MS:  peak  abundance  
around  [M + H]+  (rel. to the most intensive peak  of this group):  1637 (6),  1638 (100),  1639 (88),  1640 (83),  1641  
(18); fragmentation (the most intensive peaks from the relevant peak groups, normalized to the most intensive peak 
of the spectrum):  1638 (0.08),  1331 (1),  1070 (0.3), 972 (0.7), 277 (8), 225 (21),  185 (91), 93 (100). 
[4-(Adenosm-5'-Q-yl)butyl]cobalamm  (lb).  According  to  the  General Procedure,  with  13  (103  mg,  0.075  
mmol) and  12b (49 mg, 0.10 mmol). Purification by HPLC gave 85.4 mg (69%) of pure lb. Anal. HPLC (v =  0.8  
ml/min, A 280 nm): iR  12.6 min (0-1 min, 30%  BinA\  1-25 min, 30-70%  B in A , A,  0.02M NaH2P04 ;  B, MeOH); 
rR  13.3 min  (0-1  min,  30%  B  in A ; 1-25 min,  30-70%  B  in  A ; A,  0.01%  (v/v) CF 3 C00H/H 2 0;  B,  MeOH).  
UV-VIS:  262.6  (26400),  289.0  (14100),  315.6  (11600),  345.0  (10700),  513.2  (7200).  FAB-MS:  peak  abundance  
around  [Af +  H]+  (rel. to the most  intensive peak  of this group):  1651 (3),  1652 (95),  1653 (100),  1654 (47),  1655  
(19),1656(3); fragmentation (most intensive peaks from the relevant peak groups normalized to the most intensive 
peak of the spectrum):  1653 (0.3),  1331 (2),  1070 (0.5), 972 (0.2),  369 (3), 277 (10),  185 (98), 93 (100). 
[5-(Adenosin-5'-0-yl)pentyl]cobalamin  (lc).  According  to. the  General  Procedure,  with  13  (138  mg,  0.10  
mmol) and  12c (66 mg, 0.13 mmol):  148 mg (88%) of crude lc. Purification of crude lc (120 mg) by HPLC resulted 
in  92.6 mg of pure  lc.  Anal.  HPLC  (v =0.8  ml/min,  A 280 nm): rR  13.3 min (0-1 min,  30%  B  in A ; 1-25 min, 
30-70%  Bin  A;  A,  0.02M NaH2P04; B, MeOH); /R  14.2 min (0-1 min, 30% BinA\  1-25 min, 30-70%  BinA\A,  
0.01%  (oft))  CF 3C00H/H 20;  B, MeOH). UV/VIS:  262.8  (27400),  289.2  (14500),  314.8 (12400),  344.6  (10700),  
511.2 (7500). FAB-MS: peak abundance around [M + H]+ (rel. to the most intensive peak of this group):  1665 (7), 
1666 (100),  1667 (87),  1668 (52),  1669 (19),  1670 (1); fragmentation (most intensive peaks from the relevant  peak 
groups, normalized to the most intensive peak of the spectrum) : 1666 (0.2),  1331 (2),  1070 (0.8), 972 (1.8), 338 (10), 
185(89), 93 (100). 
[6-(Adenosin-5'-0-yl)hexyl]cobalamin  (Id).  According  to  the  General Procedure,  with  13  (103  mg,  0.075  
mmol)  and  12d  (52  mg,  0.10  mmol):  102.4 mg  (81%)  of  crude  Id.  Purification  of  a  51-mg portion  by  HPLC  
resulting 40.9 mg of pure Id. Anal. HPLC (v =0.8 ml/min, A 280 nm):/R  14.6 min (0-1 min, 30%  B in A;  1-25 min, 
30-70%  Bin  A;  A,  0.02M NaH2P04; B, MeOH); /R  15.3 min (0-1 min, 30% Bin  A;  1-25 min, 30-70%  Bin  A;  A,  
0.01%  (o/o) CF 3 C00H/H 2 0;  B,  MeOH).  UV/VIS:  262.8  (26800), 289.2  (14200),  316.4 (12000),  345.4  (10600),  
512.2 (7400).  FAB-MS:  peak  abundance around  [M  +  H]+  (rel. to  the  most  intensive peak  of this group):  1680  
(85),  1681  (100),  1682  (30),  1683  (2);  fragmentation  (most  intensive  peaks  from  the  relevant  peak  groups,  
normalized  to  the most  intensive peak  of the spectrum):  1681 (12),  1331 (100),  1070 (31), 972 (28),  352 (56),  185  
(54),  147(58),  136 (83), 93 (59). 
[7-(Adenosin-5'-0-yl)heptyl]cobalamin  (le).  According  to  the  General  Procedure,  with  13  (138  mg,  0.10  
mmol) and  12e (70 mg, 0.13 mmol):  137.2 mg (81 %) of crude le. Purification of a 35-mg portion by HPLC resulted 
in  22.6 mg  of pure  le.  Anal.  HPLC  (v =  0.8 ml/min,  A  280 nm): fR  15.8 min  (0-1  min,  30%  B  in  A;  1-25 min, 
30-70%  Bin  A,  A,  0.02M NaH2P04;  MeOH);  rR  16.5 min (0-1 min, 30%  BinA\  1-25 min, 30-70%  Bin  A ;  A,  
0.01 %  (u/u) CF 3 C00H/H 2 0;  R, MeOH).  UV/VIS:  262.6  (28900),  289.2  (15400),  314.8 (13300),  344.8  (11300),  
512.0 (8000).  FAB-MS:  peak  abundance around  [M  +  H]+  (rel.  to the most  intensive peak  of this group):  1693  
(26),  1694 (84),  1695 (100),  1696 (8), fragmentation (most  intensive peaks from the relevant  peak groups,  normal-
ized to the most  intensive peak  of the spectrum):  1695 (0.3),  1331 (2.5),  1070 (1), 972 (3.6),  366 (6),  225 (25),  133  
(100), 93 (18). 
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Coenzyme-Bia  analogues  carrying  oligomethylene  
chains  (C3—C7) inserted between the central Co atom and 
the 5'-0 atom of the adenosine moiety mimicking the pu-
tative  posthomolysis  intermediate  in  coenzyme  B12-de-
pendent rearrangements were synthesized and examined 
for their effects on methylmalonyl-CoA mutase from Pro-
pionibacterium  shermanii.  All analogues proved to be in-
hibitors of  methylmalonyl-CoA  mutase  and in all  cases  
competitive inhibition with respect to coenzyme B12 was 
found. Inhibition constants  (K,-) were determined by two 
independent  methods and showed in both cases the pre-
dicted trend: the Kt  values versus chain length had min-
ima  at  the  Cg analogue  in  which  the  distance is  about  
10 Ä between the central Co atom and the 5' carbon of the 
adenosine, assuming a zig-zag chain conformation. This 
is the postulated distance between the Co and 5-methyI-
ene paramagnetic centers generated in the methylmalo-
nyl-CoA—coenzyme B l 2  complex  after  homolytic  cleav-
age of the  Co—C bond,  e 1986 Academic P re» ,  Inc.  
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Coenzyme  BI2  (CoB12)4  is  a  unique  natural  product  
both in respect with its structure and function. By X-ray 
studies Lehnert and Hodgkin  (1)  recognized in  COB]2 a 
covalent cobalt-carbon bond. It is surprisingly stable in 
aqueous  solution  but  undergoes  homolytic  cleavage  in  
CoBi2-dependent  enzymatic  reactions  (2-4).  This  ho-
molysis is an essential step of the catalytic cycle. It was 
suggested  that  binding  to  the  apoprotein  provides  the  
energy  for  homolysis  and  also  for  protection  of  the  
highly reactive  intermediate  from the environment  (5).  
It has also been proposed that the CoB12-dependent en-
zymes promote the cobalt-carbon bond cleavage by ap-
plication of a stretching force by interaction with the ad-
enosyl  moiety  and corrin part  (6).  Babior  and  his  co-
workers  have  suggested  on the  basis  of photolysis  and  
CD  studies  with  (adeninylalkyl)cobalamins  and  etha-
nolamine ammonia lyase  (6, 7) that the distorting force 
may originate from the energy released on binding of co-
balamins to  the  active  site  which  induces  a conforma-
tional change of the enzyme protein and also the adjust-
ment  in the  corrin ring.  In the case of  methylmalonyl-
CoA mutase  (Propionibctcterium shermanii),  however, it 
was demonstrated that the homolysis of the Co-C bond 
in the enzyme-CoB12  complex occurs only upon binding 
of the substrate (8). Whatever is the cause of the distort-
ing  force  responsible  for the  Co-C  bond  cleavage,  the  
apoprotein  has  an  energetically  favored  conformation  
after homolysis in these complexes. On the basis of ESR 
studies  (9-12),  a distance of 6-12 A has been estimated 
in the activated complex between the paramagnetic cen-
tres, i.e.,  Co11 and the 5'-CH2 group of adenosine. 
COBI2 analogues  mimicking the posthomolysis  inter-
mediate  may  give further information on the  structure  
of the activated complex. We have therefore synthesized 
4 Abbreviations  used: CoB12,  coenzyme  BI2;  MDH,  L-raalate:NAD  
oxidoreductase. 
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COB 1 2  analogues  ( 1 3 )  in which the distance  between  the  
corrin  and  the  adenosyl  moieties,  both  being  essential  
for binding to the  enzyme,  were lengthened by  insertion  
of an oligomethylene  chain  ( C 3 - C 7 )  between  the  central  
Co atom  and the  5'-0  atom  of  adenosine  corresponding  
to  the  postulated  C 0 - C 5  distance  of 6-12  A  in  the  acti-
vated complexes.  Depending  on  the  chain  length,  these  
novel analogues  are expected to behave as strong inhibi-
tors  of the  CoB12-dependent  reactions  by binding to  the  
energetically  favored  reactive  conformation  of  the  en-
zyme  proteins.  The  strongest  inhibition  is  expected  by  
those members of the homologous series whose  structure  
is closest  to the  real  transition  state  when bound to  the  
enzyme. 
Diverse  coenzyme  B12  analogues  have  been  probed  
with  CoB12-dependent  enzymes,  such  as  ribonucleotide  
reductase  (14,  15),  diol  dehydratase  (16-26),  and  etha-
nolamine  ammonia  lyase  (6,  7). Although the  inhibition  
kinetics  of  several  coenzyme B i 2  analogues  was  also  in-
vestigated,  it  should  be  mentioned  that  the  majority  of  
previously  studied  analogues  are  models  of  CoB12  in  its  
ground state.  Exceptions  are the  adeninyl(CH2)„cobala-
mins  of longer  alkyl  chain  length  (where  n  is between  4  
and  9; see  Fig.  1)  (7,  15,  17,  18) but they may also not  be  
considered  as  accurate  posthomolysis  intermediate  
mimicks  since the  sugar part  of  adenosyl  moiety,  which  
is  likely  to  contribute  substantially  to  the  binding,  is  
lacking.  Moreover,  according to  our molecular  mechan-
ics  calculations,  the  length  of  the  alkyl  chain  in  these  
adeninylalkylcobalamins  allows  only  smaller  distances  
between  the  corrin  and  the  adeninyl  moieties  than  the  
corresponding  distances  postulated  in biradical  postho-
molysis  intermediates.  Results obtained with these  ana-
logues  may  be  extrapolated  from  one  CoB12-dependent  
enzyme to another only with care. This has been  demon-
strated  by  the  fundamental  differences  observed  be-
tween  coenzyme  B12  activities  of  analogues  containing  
modified «-nucleotide  base  moieties  in growth  of  micro-
organisms  depending  on  either  diol  dehydratase  or  
methylmalonyl-CoA  mutase  (27).  
Here  we  describe  in  detail  the  inhibitory  behavior  of  
the  synthetic  posthomolysis  intermediate  analogues  of  
CoB12-carrying  oligomethylene  chains  ( C 3 - C 7 )  inserted  
between the central  Co atom and the  5'-0  atom of aden-
osine on methylmalonyl-CoA  mutase  (P.  shermanii).  
MATERIALS AND METHODS 
Materials.  Coenzyme  B12,  vitamin  B12,,  adenosine,  and  succinic  
anhydride  were obtained  from Fluka Chemie  AG. L-Malate:NAD  oxi-
doreductase  (EC  1.1.1.37)  (MDH),  0-NADH  Li3  (NADH),  and  coen-
zyme  A (CoA)  were products  of Boehringer  Mannheim  GmbH.  Meth-
ylmalonyl-CoA  mutase  (EC  5.4.99.2),  methylmalonyl-CoA  epimerase  
(EC  5.1.99.1),  methylmalonyl-CoA  carboxyltransferase  (EC  2.1.3.1)  
from  P.  shermanii  were  isolated  and  assayed  according  to  previously  
published  methods  (28-30).  Coenzyme  B12  analogues  ( C 3 - C 7 )  were  
prepared  by  alkylation  of  vitamin  B12,  with  the  corresponding  tosy-
lates (13). For kinetic measurements coenzyme B l2 and analogues  (C3-
C7)  were dissolved  in  bidistilled  water  at 0 -4 'C  in darkness. The  solu-
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FIG.  1.  Structures  of  cobalamin  derivatives  mentioned  in  this  
study. 
tions obtained  were stable  (>95% pure according to HPLC)  for weeks 
when  kept under this conditions  (13). Structures  of cobalamin  deriva-
tives used  in this study are shown  in Fig.  1.  
Molecular  mechanics  calculations.  Molecular  mechanics  calcula-
tions were performed  by using the M M X  modules  of PCMODEL  4.0  
(Serena,  running  on  a  Silicon  Graphics  Irix  70G workstation)  or  Hy-
perChem  2.0  (Autodesk,  running  on  an  IBM-compatible  486  DX50  
PC)  progTam  packages.  
Kinetic  measurements.  Assay  of  methylmalonyl-CoA  mutase  ac-
tivity in  kinetic measurements  was based  on the method  of Zagalak  et  
at  (30) with minor  modifications. In a microcuvette  kept a t  30°C Tr i s -
HC1 buffer  (750  mL  0.05  M, pH  7.5), sodium  pyruvate  (100 pi, 0.05  M),  
NADH  (20 pi,  0.01  M), epimerase  (20 pi,  2.5 U/ml),  transcarboxylase  
(50  pi,  0.4  U/ml),  MDH  (10  pi,  30 U/ml),  mutase  (10  pi,  0.5  U/ml),  
freshly  prepared  succinyl-CoA  (30  pi,  0.01  M),5  coenzyme  B12  (stan-
dard,  5 pi,  1 mM; otherwise,  1 -5 pi, 0.01-1  mM), and  inhibitor  (1-5  pi,  
0.2-2  mM) solutions were mixed and the decrease  of absorbance at  340  
nm  was  recorded  for  several  minutes.  All  operations  with  CoB12  and  
the analogues  C3-C7 were carried out  in the dark. The  rate  of the  suc-
cinyl-CoA-methylmalonyl-CoA  rearrangement  was  calculated  from  
5 CoA  (20 mg)  in N a H C 0 3  solution  (1.8 ml, pH  8) was  reacted  with  
succinic  anhydride  (6 mg) at  0°C under  argon  atmosphere  for 30  min,  
and then the pH value was adjusted to 3.5 with  2 M  HC1. The  resulting  
solution  was  filled  up to  2.0 mi with bidistilled  water and  used as  such.  
HPLC  investigation  showed  that  the  preparation  had  about  90%  of  
succinyl-CoA  content  and  starting  CoA  had  been  completely  con-
sumed. 
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the  change  of  absorption  attributable  to  the  NADH  consumption  in  
coupled enzymatic  reactions  using the  equation  
V  =  1000[(AA  -  AA„)/ti],  
where  V  is the  rate  of  reaction  ( n m o l m i n  '  cm"3),  AA  is the  change  
of the absorption  (min"1),  AA0 is the change of the absorption  without  
enzymatic reaction  (min~'),  t is the absorption  coefficient of NADH  at  
340  nm  (6.22 c m / m o l " 1 ) ,  I is  the  cell  length  (1 cm),  and  1000  is  a  
conversion  factor from micro-  to  nanomoles.  For  kinetic  calculations  
a  mean  rate  value  measured  between  1  and  2  min  was  used  unless  
otherwise  stated.  
RESULTS AND DISCUSSION 
Estimation  of the  Distance  between  Co" and  5'-C Radical  
for  CoB12-Dependent  Enzymes  
The  enzymic  reactions  requiring  COB 1 2  have  several  
common  features.  They  catalyze  molecular  1,2-re-
arrangements  in which a group and a hydrogen atom are 
interchanged.  In  all  reactions  of  this  type  a  key  step  is  
the  homolysis  of the Co-C bond of coenzyme  generating  
Cbl" and  the  5'-adenosyl  radical.  An estimation  can  be  
made  for the  distance between  the  Co11 and the  5'-aden-
osyl  radical  in the transition  complex  after the  homoly-
sis  if we consider the  size  of substrate  together  with  the  
principle  of  "negative  catalysis"  (5); i.e.,  one  important  
role  of  the  apoprotein  is  to  protect  the  highly  reactive  
intermediates  from  the  environment.  Since  substrate  
binding is required to induce homolysis  (8) and as a next 
step  H-transfer from the substrate to the adenosyl  radi-
cal  should occur, we  can assume that  the  corresponding  
portion  of the  substrate  should  fit between  the  Co11  and 
the  5'-adenosyl  radical,  but the  room between these  and  
the  substrate  should  be  less  than  2.0-2.5  A,  which  is  
enough for insertion  of a water  molecule.  
Using  approximate  "space  requirements"  of  sub-
strates  for  several  CoB12-dependent  enzymes  (for  pro-
panediol  and ethanolamine  roughly 3-4  A, while  for the 
methylmalonyl  moiety  of  methylmalonyl-CoA  an  ap-
proximately 6-A "diameter" has been calculated)  a value 
of  about  6-7  A between  the  radicals  formed  by  the  ho-
molysis of COB 1 2  can be predicted  in the case  of enzymes 
acting on  relatively  small  substrates  (e.g.,  diol  dehydra-
tase  or  ethanolamine  ammonia  lyase),  while  a  value  of  
about  9-10  A  is  likely  for  methylmalonyl-CoA  mutase,  
which catalyzes the  rearrangement  of a larger  substrate.  
These considerations  agree well with data obtained from 
ESR  spectroscopy: a value of about 6 A was proposed for 
diol dehydratase  (9,  10), whereas  a value of  about  10-12  
A was postulated  for ribonucleotide  reductase  (11).  
For testing the above hypothesis posthomolysis  inter-
mediate  analogues  of  C O B I 2  carrying an  oligomethylene  
chain  (C3-C7)  between the central  Co atom  and the  5'-0  
atom  of  adenosine  were  synthesized  (13)  and  investi-
gated by examining their inhibitory properties on  meth-
ylmalonyl-CoA  mutase  from P.  shermanii.  
P  E.COB12.P  
S C H E M E  1.  
Inhibition  of Methylmalonyl-CoA  Mutase  Reaction  by  
C3-C 7  Analogues  
According to our preliminary investigations  the C3-C7  
analogues were found to be competitive  inhibitors of the 
methylmalonyl-CoA  mutase  reaction  with  respect  of  
CoB12.  Competitive  inhibition  by CoB12  analogues  may  
be  rationalized  by the  simplified kinetic  model  depicted  
by Scheme  1.  
Considering the small  Km  value of CoB12  (for determi-
nation of  Km  under our experimental  conditions see  Fig.  
2) and the  rate of the S -P  rearrangement it  is concluded 
that once  COBi2 is bound to the apoprotein,  it takes part 
in numerous catalytic  cycles  (i.e.,  k-1  kx,  k2,  k3,  or &4). 
Classical  inhibition equations  are developed for the  true  
substrates;  thus,  they  may  only  be  used  for  determina-
tion  of  kinetic  parameters  for  inhibition  by  COB 1 2  ana-
logues  if  COB 1 2  and  its  competitor  meet  with  the  apo-
protein coincidentally.  Preincubation of the free enzyme 
1/[COB12]  (pM)  
FIG. 2 .  Linweaver-Burk  plot for the dependence of  methylmalonyl-
CoA  mutase-catalyzed  succinyl-CoA-methylmalonyl-CoA  rearrange-
ment on coenzyme  B12 concentration  at  30"C. Vertical bars denote SE of  
the mean for three separate determinations.  (Regression data: R  = 0.997,  
standard  error  = 0.012;  kinetic constants obtained  from linearized  data:  
Km  = 0.238pM;  V™, =  11.3MM-min"1.)  
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[C6]  (pM)  
F IG.  3.  Dixon  linearization  of data obtained  by the  "parallel"  addi-
tion  method  for determination  of  the  if,  value  of  analogue  C6.  Rate  
measurements  were  started  with  synchronous  addition  of  CoB12  and  
analogue  C6 to the  assay mixture  [—, • :  0.5  ixM CoB12  (R  =  0.47);  ,  
O:  1.0  fiM COB12  (R  =  0.89);  • • • , • :  2.5  MM  COB12  (R  =  0.91);  , A: 
5.0  mM C O B 1 2  ( R  = 0.96)]. Individual  K, values were calculated  for each 
line  (K{  =  (slope - [CoB12] • V m a l ) / K m )  by using the  kinetic constants  of  
CoBi2  obtained  under the  same conditions  (cf. Fig.  2). if, of  analogue  
C6  determined  by  this  method  is  the  mean  (if,  =  0.77  ±  0.18  /xM)  of  
these four individual  values.  
with  the  inhibitor  results  in  a  decreased  value  for  the  
apparent  inhibition  constants,  whereas  addition  of  the  
inhibitor after pretreatment  with the coenzyme  leads  to  
their  overestimation.  In  contrast,  the  time  of  substrate  
addition did not influence the rate of reaction,  indicating  
that  our CoB12  analogues  are not competitive  inhibitors  
with  respect  to  the  succinyl-CoA  substrate.  In  our  ki-
netic  investigations  by  the  "parallel"  method  assay  re-
actions  were  started  with  the  simultaneous  addition  of  
COB 1 2 and the inhibitor. Velocity data measured by vary-
ing the coenzyme  and inhibitor concentrations  were an-
alyzed  by  Dixon  linearization.  In  the  case  of  the  ana-
logue  C6,  details  for  determination  of  the  apparent  K,  
value by this method are shown  in Fig.  3.  
Apparent inhibition constants  were obtained  for ana-
logues C 3 - C 5  and C7 by the  same procedure.  The if,  val-
ues  determined  by  the  parallel  method  are  collected  in  
Table  I.  The  results  indicate  that  all  of the  C 3 - C 7  ana-
logues  are strong competitive  inhibitors of the  succinyl-
CoA-methylmalonyl-CoA  rearrangement.  Moreover,  
analogue  C6,  in which  the  distance  in the  zig-zag  chain  
conformation is about  10 A between the central  Co atom 
and the  5' carbon of the adenosine  (13), proved to be the 
strongest inhibitor. This  is in agreement with the postu-
lated  distance  between  the  Co"  and  5'-methylene  radi-
cals in the activated  complex.  
The kinetic model depicted in Scheme  1 suggested an-
other  possibility  for  evaluation  of  the  inhibition  con-
stants  for analogues  C3-C7.  Since  K,- values  for the  ana-
logues are nearly as small as Km  of CoB12, and so  fe,  
releasing  an  inhibitor  when  once  bound  to  the  enzyme  
is  slow  even  if  compared  to  the  time  necessary  for  the  
velocity-assay  reaction.  Accordingly,  if  the  apoprotein  
is preincubated  with  one  of  our inhibitors  and then  the  
reaction  is  started  with  addition  of  CoB12,  in  the  first  
moment  reaction  takes  place  only  with  that  fraction  of  
the enzyme which remained  free. By varying the  inhibi-
tor concentration  and  adding  only  a  minimum  amount  
of COB12)  which provides  rates  corresponding to  Vmttx  in 
uninhibited reactions, the concentration  of the  inhibitor  
that leads to a rate of  Vmai/2  (i.e., if,) can be determined. 
Thus,  analogues  C3-C7  were  also  investigated  by  this  
"direct"  method.  Assay  mixtures  containing  the  meth-
ylmalonyl-CoA  mutase  had been  preincubated  with  the  
inhibitor,  and  the  reaction  was  started  by  addition  of  
CoB12 and succinyl-CoA. Details  of if, determination  by  
the  "direct"  method  in  the  case  of  the  analogue  Cg are 
given in Fig. 4. Inhibition constants  for analogues C3-C5  
and C7 were obtained by the same method. The K,  values  
determined by the direct method are collected in the sec-
ond  column  of  Table  I.  Again,  the  predicted  trend  was  
found: all  of the  analogues were strong inhibitors and if, 
values versus chain length showed  a minimum  at the  C6  
analogue. 
The  fact  that  all  of  our  inhibitors  have  if,  values  of  
the same  order of magnitude  may  be rationalized by  the  
conformational  flexibility  both of the apoprotein and the 
oligomethylene  chain in the posthomolysis  intermediate  
mimics.  A  dramatic  difference  between  the  inhibitory  
properties  of  the  CoB12  analogues  cannot  be  expected  
since  these  analogues  lie  on  the  reaction  path  leading  
from intact CoB12 to the completely  homolysed and sep-
arated  biradical  intermediate.  Nevertheless,  the  maxi-
mum inhibition  was found at the  C6 analogue,  in  which  
the allowed distance between Co and 5'-C of the  adenosyl  
moiety  is closest to the postulated one in the  posthomol-
ysis intermediate,  irrespective  of the method of  determi-
nation. 
T A B L E  I  
Inhibition Constants (if,) of Analogues C3-C7 Obtained 
by "Parallel" and "Direct" Methods" 
Parallel if, Direct if, (N.P.,  R)b  
Analogue (MM) (n M) 
c3 2.48 ± 0.58 0.97 ± 0.15 (9, 0.99) 
C« 1.45 ± 0.29 0.77 ± 0.17 (8, 0.98) 
c5 1.13 + 0.56 0.62 ± 0.10 (8, 0.99) 
c6 0.77 + 0.18 0.48 + 0.12 (8, 0.96) 
c, 2.10 + 0.81 0.65 ± 0.19 (9, 0.93) 
° K, values  of analogues C 3 - C 7  were obtained  in  a manner  similar  to  
that  described  for analogue  C6  (c.f. Fig.  3. and  Fig.  4. for parallel  and  
direct methods  for determination  of if,,  respectively).  
6 In  parentheses:  N.P.,  number  of  experimental  data  points;  R,  re-
gression  coefficient in Dixon  linearization.  
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FIG.  4.  Determination  of  the  K,  value  for analogue  C6 by  the  "di-
rect"  method.  Symbols  (+)  represents  experimental  values  obtained  
by  preincubation  of the  assay  system  with  analogue  C6  for  60  s  and  
starting the  reaction  by addition  of  CoBi2  (2.5 nmol).  Curve  (—)  was  
calculated  by  using  the  parameters  of  line  fitted  (R  -  0.963)  to  the  
experimental  points  by  Dixon  linearization.  The  curve  projected  to  
the  [C6]  axis  at  the  rate  corresponding  to  V r a , /2  (6.2  ml/^M)  gave  a  
value  of the inhibition constant  (K,)  of 0.48 ±  0.12.  
Differences in the  Ki values obtained by the two meth-
ods  may  arise  from  several  factors.  The  real  kinetic  
model  may  be  more  complicated  than  that  depicted  in  
Scheme  1.  The  apoprotein  which  is  built  up  from  two  
nonidentical  subunits  (31,  32)  may  contain  more  than  
one  binding  region  for  CoB12  with  different  binding  
properties toward the individual posthomolysis  interme-
diate  analogues  and  CoB12.  This  assumption  is  sup-
ported by the  results  of titration  of CoB12  bound to  mu-
tase  from  P.  sherrhanii  by  circular  dichroism  measure-
ments  indicating binding  of  more than  1 mol CoB12 to  1  
mol mutase  (33).  
The strong inhibition  of the  mutase  reaction by  all  of  
the  analogues,  however,  indicates  availability  of the  ac-
tive  site  also  for the  larger  posthomolysis  intermediate  
mimicking  analogues.  Thus,  the  active  site  is  probably  
located near to the protein surface and its size should be 
changed  dynamically  during  a catalytic  cycle.  If the  di-
rect method is used, binding of the CoB12 analogue to the 
enzyme protein  is  static  (none  of the  enzyme  molecules  
take  part  in enzymic  reaction)  resulting  in  "frozen" in-
hibitor-protein  complexes.  In  contrast,  by  using  the  
"parallel"  method  binding  to  the  protein  is  a  dynamic  
process;  the  inhibitor  kinetically  competes  with  the  
smaller  CoB12.  
Inhibition  Experiments  with  Hydroxycobalamin,  
Adenosine,  and  CoASH  
Exchange experiments  carried out with the  analogues  
C 3 - C 7  and CoB12 indicated  (parts of the results are  com-
piled in Table  II) that once a transition state analogue  is  
bound to  the  enzyme  protein,  CoBi2  cannot  replace  the  
inhibitor even after several minutes.  Similarly, when the 
enzyme  was  preincubated  with  CoB12,  the  inhibition  
level of the parallel  addition was  reached only after sev-
eral minutes. Data indicate that molecules in which both 
the corrin and adenosyl moieties are present bind tightly 
to the enzyme protein. In addition to the binding regions 
for the  corrin  and adenosyl  moieties,  a third one for the 
CoA substrate  is necessary  for the  enzyme  action  as  in-
dicated  by the  fact that  homolysis  of the  Co-C  bond  in  
the enzyme-CoB12  complex  occurs only upon binding  of  
the substrate  (8).  
We thought it worthwhile to investigate the  inhibitory  
properties  of  molecules  having  binding  ability  to  only  
one  of  the  above  mentioned  three  binding  areas.  Thus,  
inhibition of the mutase reaction was investigated by ad-
dition  of CoASH  (possible  competitor  for the  CoA-sub-
strate-binding  site),  hydroxycobalamin  (competitor  for  
the  corrin-binding  area),  and adenosine  (competitor  for  
the  adenosyl-binding  region)  as  single  inhibitors  and  
also  in  admixtures.  The  results  (Table  II)  indicate  that  
none  of  these  compounds  have  a  dramatic  inhibitory  
effect even at concentrations four times higher than that 
necessary  to  reach  about  50%  inhibition  with  the  ana-
logues  C 3 - C 7 .  Interestingly,  after  a short  inhibition  pe-
riod  HOCbl  seemed to  be  a slight  activator,  even in  ad-
mixture  with  CoASH  and adenosine  at high  concentra-
tion  [it  is  interesting  to  mention  here  that  diol  
dehydratase, in contrast to the mutase, is strongly inhib-
ited  by  methyl-  and  cyano-  (17)  or  hydroxycobalamin  
(18)].  In  the  case  of  methylmalonyl-CoA  mutase  only  
one of the two CoB!2-binding sites  is likely to be catalyt-
TABLE  II  
Effect of Analogues  C3-C7, Hydroxycobalamin, Adenosine, 
and CoASH on the Reaction of Mutase from  P.  shermanii"  
VJ Vm„  {%)"  
Inhibitor  (concentration,  fiM)  2 min  4 min 
C3  (0.5)  48 65 
C4  (0.5)  51 61 
C5  (0.5)  52 67 
C6  (0.5)  51 61 
C7  (0.5)  51 61 
CoASH  (2)  74 100 
Adenosine  (2)  93 100 
HOCbl  (2)  87 105 
HOCbi,  CoASH, adenosine  (1,  each)  84 110 
HOCbl, adenosine  (20,  each)  88 105 
" Rates  of reactions were measured by using the assay described  un-
der  Materials  and  Methods but  at  37°C.  In  each  case  2.0  of  CoB l2  
was  added  to  the  assay  mixture  preincubated  with  the  compounds  
given  below for 60s. 
4 Percentage  rate of the "inhibited"  reaction compared to the rate  of  
the noninhibited  reaction at the same  moment.  
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ically active, but binding a second COB12 molecule to the 
catalytically inactive site may increase the catalytic abil-
ity of the active site. This would allow a slight activation 
by  HOCbl when it  remained bound to the  catalytically  
inactive site but was removed from the active site. 
The above results  indicate that for a tight  and long-
term binding to the mutase protein simultaneous occu-
pation  of  corrin  and  adenosyl  binding  areas  is  not  
enough, but a functional  relation should also exist  be-
tween the two binding parts. 
ACKNOWLEDGMENT 
The authors are grateful to Ms. I. Merkler for the preparation of the 
enzymes from P.  shermanii  
REFERENCES 
1.  Lehnert, P. G., and Hodgkin, D. C. (1962) Nature  192,937-940.  
2.  Zagalak,  B.,  and  Friedrich,  W.  (Eds.)  (1979)  Vitamin  B u ,  de  
Gruyter Verlag, Berlin/New  York.  
3.  Babior, B. M. (1988) BioFactors  1,21-26.  
4.  Retey, J .  (1990)  in  Chemical  Aspects  of Enzyme  Biotechnology  
(Baldwin, T. O., Ed.), pp. 223-234, Plenum, New York. 
5.  Retey, J .  (1990) Angew.  Chem.  102 ,  373-379; Angew.  Chem.  Int.  
Ed.  Engl.  29,355-361.  
6.  Babior, B. M„ and Krouwer, J. S.  (1979) CRC Crit. Rev.  Biochem.  
6,35-102. 
7.  Krouwer, J.  S., Holmquist,  B., Kipnes,  R.  S., and  Babior, B.  M.  
(1980) Biochim.  Biophys.  Acta  612,153-159.  
8.  Zhao,  Y.,  Such, J.,  and  Retey, J.  (1992) Angew.  Chem.  31,  215-
221; Angew.  Chem.  Int.  Ed.  Engl. 31 ,  215-216.  
9.  Babior,  B. M., Moos, T.  H.,  Orme-Johnson,  W.  H., and  Beinert,  
H. (1974) J.  BioL Chem.  249,4537-4544.  
10.  Schepler,  K.  L.,  Dunham,  W.  R„  Sands,  R. H„  Fee,  J.  A.,  and  
Abeles, R. H. (1975) Biochim.  Biophys.  Acta  397,510-518.  
11.  Buettner,  G.  R.,  and  Coffmann, R.  E.  (1977)  Biochim.  Biophys.  
Acta 480 ,  495-505.  
12.  Boas, J .  F., Hicks, P.  R., and  Pilbrow, J. R.  (1978) J.  Chem.  Soc.  
Faraday  Trans.  II74,  417-423.  
13.  Poppe, L., Hull, W. E., and Retey, J .  (1993) Helu.  Chim.  Acta  76 ,  
2367-2383. 
14.  Sando,  G. N., Blakley, L. R., and Hogenkamp, H. P.  C. (1975)  J.  
Biol  Chem.  250,8774-8779.  
15.  Sando, G. N., Grant, M. E., and Hogenkamp, H. P. C. (1976)  Bio-
chim.  Biophys.  Acta  428,228-232.  
16.  Schrauzer,  G. N.,  Katz,  R.  N.,  Grate,  J.  H., and  Vickrey, T.  M.  
(1976) Angew.  Chem.  88 ,  186-187; Angew.  Chem.  Int.  Ed.  Engl  
15,170-171. 
17.  Toraya, T., Kazutoshi,  U., Saburo, F., and Hogenkamp, H. P.  C.  
(1977) J .  BioL Chem.  252,963-970.  
18.  Toraya, T., and Fukui, S. (1982) J.  Nutr.  ScL  VitaminoL  2 8 , 2 2 5 -
236. 
19.  Fukui, S., and Toraya, T. (1984)  in Progress in Bioorganic Chem-
istry  and  Molecular  Biology,  Proceedings  of  the  International  
Symposium on Frontiers of Bioorganic Chemistry and  Molecular  
Biology  (Ovchinikov,  Y. A., Ed.), pp.  487-493,  Elsevier,  Amster-
dam. 
20.  Uahio, K., Fukui, S., and Toraya, T. (1984) Biochim.  Biophys.  Acta  
428 ,  228-232.  
21.  Toraya, T„ Matsumoto, T.,  Ichikawa, M., Itoh, T„  Sugawara,  T.,  
and Mizuno, Y. (1986) J.  BioL  Chem.  261,9289-9293.  
22.  Toraya, T., Watanabe, N., Ichikawa, M„ Matsumoto, T„ and Us-
hio, K. (1987) J.  BioL Chem.  262,8544-8550.  
23.  Toraya, T., and Ishida, A. (1988) Biochemistry  27,7677-7681.  
24.  Ichikawa, M„ and Toraya, T.  (1988) Biochim.  Biophys.  Acta  9 5 2 ,  
191-200. 
25.  Yakusheva, M. I., Gurevich, V. M., and Poznanskaya, A. A. (1982) 
Biokhimiya  47,1471-1475.  
26.  Toraya, T„ and Ishida, A. (1991) J.  BioL  Chem.  266,5430-5437.  
27.  Eberhard,  G.,  Schleyer,  H„  Heinz,  J .  Fridrich,  E.,  Utz,  B-,  and  
Müller, O. (1988) BioL Chem.  Hoppe-Seyler  369,1091-1098.  
28.  Kellermeyer,  R. W.,  Allen,  S. H.  G.,  Stjemholm, R„  and  Wood,  
H. G. (1964) J.  BioL Chem.  239,2562-2569.  
29.  Kellermeyer,  R.  W., and  Wood, H.  G.  (1969)  Methods  EnzymoL  
13,207-215. 
30.  Zagalak, B., Retey, J., and Sund, H.  (1974)  Eur.  J.  Biochem.  44 ,  
529-535. 
31.  Retey, J.  (1982) in B12 (Dolphin, D., Ed.), Vol. 2, pp. 357-379, Wi-
ley, New York. 
32.  Francalanci, F., Davis, N. K., Fuller, J .  R., Mertitt, D., and  Lead-
lay, P. F. (1986) Biochem.  J.  236,489-495.  
33.  Edelmann, L. (1991) Ph.D. Thesis, Universität  Karlsruhe.  
XVI.  meUeklet  
POPPE, L.,  RETEY,  J.:  
Kinetic Investigations using Inhibitors Mimicking the Posthomolysis Intermediate in the 
Coenzyme-Bi2 Dependent Glycerol Dehydratase and Diol Dehydratase Reactions, 
Eur. J. Biochem.,  1997,245, 398. 

Eur. J.  Biochem.  245. 398-401  (1997)  
©  FEBS  1997  
Kinetic investigations with inhibitors that mimic the posthomolysis  intermediate  
in  the  reactions  of  coenzyme-B12-dependent  glycerol  dehydratase  
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Kinetic  investigations  were performed  on  the coenzyme-B ^-dependent  glycerol  dehydratase  and  diol  
dehydratase  reactions  using  1,2-propanediol  as  substrate  and  [a)-(adenosin-5'-0-yl)alkyl]cobalamins  as  
mimics  of  the  posthomolysis  intermediate  state  of  the  coenzyme.  All  the  coenzyme-B,2  analogues  with  
oligomethylene  chains  (C3-C7)  inserted  between  the  central  Co  atom  and  the  5'  O  of  the  adenosine  
moiety  were  competitive  inhibitors  with  respect  to coenzyme  B,2.  The  apparent  inhibition  constants  (K,)  
of  the  shorter-chain  inhibitors,  especially  the  C5  inhibitor,  were  smaller  for  both  enzymes  than  those  of  
the  longer-chain  (C6,  C7)  compounds.  These  results  are  in  agreement  with  the  expected  (0.6—0.9 nm) 
distance  between  the  Co and  5'-methylene  paramagnetic  centers  in  the posthomolysis  intermediate  state  
of  coenzyme Bl2  in  these  reactions.  
Keywords:  [cu-(adenosin-5'-0-yl)alkyl]cobalamin;  analogues of coenzyme B,2: glycerol dehydratase;  pro-
panediol  dehydratase;  kinetic  investigation.  
Coenzyme  B12  (CoB12)  is  an  essential  cofactor  for  several  
enzymes  that catalyze rearrangement reactions  [1—4]. This  mol-
ecule  contains  a  unique  covalent  Co-C  bond,  which  is  stable  
in  aqueous  solution  but  easily  undergoes homolytic  cleavage  in  
CoB,2-dependent  enzymatic  reactions.  This  homolysis  is  the  
essential  initial  step  in  the  catalytic  cycles  of  all  CoB,2-depen-
dent  enzymatic  processes.  Binding  of  CoB,2  to  the  apoprotein  
provides  energy  for  the  Co-C  bond  cleavage  and  protects  the  
highly  reactive  intermediates  from the environment  [5].  CoB,2-
dependent enzymes promote cobalt-carbon bond cleavage by ap-
plication  of  a  stretching  force  by  interaction  with  the  adenosyl  
moiety  and corrin  part  [6]. The energy  required  for this  stretch-
ing  is  provided  by  a  conformational  change  of  the  apoprotein,  
which is probably triggered  by binding the substrate.  In the post-
homolysis  complex,  however,  the protein  should  have  in  a cata-
lytically  active,  relaxed  conformation.  
Therefore, coenzyme-B,2  analogues that mimic the geometry 
of the posthomolysis intermediate, i.e. containing  both the corrin 
part  and  the  adenosyl  moiety  at  a  distance  that  corresponds  to  
the  distance  between  these  moieties  in  the  CoBl2  - apoenzyme 
complex  after the  homolytic  Co-C  bond cleavage,  may  provide  
valuable  information  on  the  structure  of  the  activated  complex.  
For  example,  the  best  fitting  analogue  is  expected  to  be  the  
strongest  inhibitor of a given CoB,.-dependent  reaction.  A series 
of  such posthomolysis-intermediate  analogues  (Fig.  1). in  which  
the  distance  between  the  corrin  part  and  the  adenosyl  moiety  
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tase  (EC 4.2.1.28);  methylmalonyl-CoA  mutase  (EC  5.4.99.2);  alcohol  
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were  varied  by  insertion  of  an  oligomethylene  chain  (C3-C7)  
between  the  5'  O  of  adenosine  and  the  Co  of  corrin.  has  been  
therefore synthesized  [7].  
Based  on  the  principle  of  'negative  catalysis'  [5]  and  the  
space requirement  of the substrate,  we have postulated a distance 
of  approximately  1 nm  between  Coll  and  the  5'  C  radical  in  
the  posthomolysis  intermediate  of  the  (R)-methylmalonyl-CoA  
mutase  from  Propionibacterium  shermanii,  and  we  have  tested  
our hypothesis  by studying  the  inhibitory  properties  of these an-
alogues  [8].  Apparent  inhibition  constants  for  the  C3—C7  ana-
logues  showed  the  predicted  trend:  the strongest  inhibition  was  
found  with  the  C6  analogue,  in  which,  assuming  a  zig-zag  
oligomethylene-chain  conformation,  the  5'C—Co  distance  is  
about  1 nm.  We postulated  a  smaller  (about  600-700  pm)  5'-C  
radical-Coll  distance  for  CoBl2-dependent  enzymes  acting  on  
relatively  small  substrates,  such  as  ethanolamine  or  1,2-pro-
panediol  [8].  Our  postulated  distances  agree  well  with  experi-
mental  data.  A  range  of  0.6—1.2 nm  between  the  Coll  and  5'-
CH2  paramagnetic  centers  has  been  estimated  on  the  basis  of  
EPR  studies  for  several  CoB,2-dependent  enzymes  [9-12]:  a  
value  of  about  0.6 nm  was  proposed  for  diol  dehydratase  [9.  
10],  whereas  a  value  of  about  1.0-1.2  nm  was  calculated  for  
ribonucleotide  reductase  [It].  
To  test  our  hypothesis  on  the  Co-5'-CH2  distance  in  the  
posthomolysis  complex  of  an  enzyme  acting  on  a  small  sub-
strate.  inhibitory  properties  of  the C 3 -C 7  analogues  have  been  
investigated  with glycerol dehydratase  from Citrobacter freimdii 
(overexpressed  in  Escherichia  coli)  and  diol  dehydratase  from  
Salmonella  typhimurium  (overexpressed  in E. coli)  with  racemic  
1,2-propanediol  as  substrate.  
MATERIALS  AND  METHODS  
Materials.  Yeast  alcohol  dehydrogenase  and  /J-NADH  Li3  
were  products  of  Boehringer  Mannheim.  Racemic  1.2-propane-
Poppe  and  Retev  (Eur.  J.  Biochem.  245)  399 
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Fig.  1. Structure  of  corrinoids  used  in  this  study.  
diol was supplied by Aldrich. CoB,2. vitamin B,2 (CN-Cbl) and 
vitamin B,2il (HO-Cbl) were from Fluka. C,— C7 analogues (la-
e) were prepared by alkylation of vitamin B,, with the corre-
sponding tosylates [7], Purities of all cobalamin derivatives were 
checked by HPLC [7] prior to use (all >98% pure). For kinetic 
measurements CoBn and the inhibitors were dissolved in bidis-
tilled water and kept at 0-4°C. All operations with CoB,:. CN-
Cbl and the C,—C7 analogues were carried out in the dark. 
Bacterial strains, cell cultivation and enzyme isolation. 
Glycerol  dehydratase.  Overexpressing E.  coli  cells [13] contain-
ing the genomic DNA of glycerol dehydratase from C.  freundii  
were used. The glycerol dehydratase gene was inserted into a 
pM52 plasmid harboring  Hindlll  and B.srEII fragments in a 
bluescript vector pSK*. 
Overexpressing  media.  6.0 g KH2P04, 14.0 g K,HP04. 3.0 g 
(NH4).S04, 0.2 g MgS04 • 7H.0 and trace element solution 
(1 ml 5.0 g/1 EDTA, 2.0 g/1 FeSO. • 7H.O, 0.1 g/1 ZnS04 • 7H.O, 
25 mg/1 MnS04, 0.3 g/1 H,B04, 0.2 g/1 CoCL • 6H.O. 10mg/l 
CuCl, • 2H.O, 20 mg/1 NiCl2 • 6H,0. 30 mg/1 NaMo04 • 2H.O, 
pH 6.7) were dissolved in 950 ml bidistilled water. The pH was 
adjusted to 7.0, followed by addition of 10.0 g tryptone. 10.0 g 
NaCl and 5.0 g yeast extract to the solution. The solution was 
made up to 1 1 with bidistilled water and sterilized in an auto-
clave. After sterilization, 9.2 g glycerol, 100 mg ampicillin and 
75 mg kanamycin in 20 ml sterile bidistilled water was added and 
the volume was made up to 950 ml with sterile bidistilled water. 
Cell  cultivation  and  harvesting.  Luria-Bertani-agar plates 
containing ampicillin and kanamycin were inoculated with glyc-
erol-dehydratase-overexpressing  E.  coli and incubated at 30°C 
for 20 h. Several (3—5) colonies, taken from different positions 
of the agar plate, were transferred into 50 ml Luria-Bertani me-
dia and incubated at 30°C, with shaking, for 16 h. This culture 
was added to 950 ml overexpressing media and incubated at 
30°C for 12 h, with shaking at 250 rpm (until the AN1(1 reached 
1.0— 1.5). The cell culture was heated to 42°C within 5 min. and 
shaken at this temperature for 0.5 h. Then, the culture was shaken 
at 37 °C for 3 h. The cells were harvested by centrifugation at 
5000 rpm (4400) for 10 min and stored at -80°C until use. 
Enzyme  isolation.  Cells (2.1 g. wet mass) were suspended in 
15 ml 25 m M  potassium phosphate. pH 7.8. 2% (by vol.) race-
mic 1,2-propanediol. and the cells were disrupted by sonication 
at 4—8°C  (Branson sonifier. full power, three times. 1 min 
each). After centrifugation of the resulting slurry at 23000Xg 
and  0°C  for 30 min.  the  supernatant was  centrifuged at 
23000Xg and 4°C for 20 min. 10 ml of the final supernatant 
was filtered through a 0.45-|im filter and applied to a HiLoad 26/ 
60 Superdex 200 (Pharmacia) column. The column was eluted at 
4°C with 25 m M sodium phosphate, pH 7.5. 0.1 M KC1. 2% (by 
vol.) racemic 1.2-propanediol, at 2.5 ml/min. The fractions with 
significant enzyme activity (73 — 78 min) were unified and con-
centrated to 3.8 ml. A specific activity of 120 U/mg on racemic 
1.2-propanediol  substrate was  determined  for  this prepara-
tion. The protein concentration was calculated from 1 45 A,8„-
0.74 A,«,. 
Diol  dehydratase.  Overexpressing  E.  coli  cells containing 
genes of  S.  typhimurium  LT2 diol dehydratase (three ORF, 
pduCDE)  which were cloned in vector p/ac/qPO-bgIII. Expres-
sion of these genes was under the control of a wild-tvpe  lac  
promoter and  lacP.  The genotypes of the strains used were 
TA828  metE205  ara-9  DEL299 pXY18 and TA830  merE205  
ara-9  DEL299 pXY39. 
Overexpressing  media.  6.0 g Na,HP04, 3.0 g KH:P04, 1.0 g 
NH4C1, 0.5 g NaCl in 100 ml bidistilled water (pH 7.4) were 
sterilized in an autoclave. To this solution 2 ml 1 M  MgS04  
(sterilized), 1 ml 0.1 M  CaCl, (sterilized), 10 g sodium succi-
nate, 25 mg histidine, 25 mg methionine, 85 mg ampicillin were 
added, and the solution was made up to 1000 ml with sterilized 
bidistilled water. 
Cell  cultivation.  Cells from  standard Luria-Bertani-agar 
plates containing ampicillin were transferred to 20 ml media and 
incubated at 30°C, with shaking, for 24 h. This culture was 
added to 1000 ml media and incubated with shaking at 250 rpm 
at 30°C for 10 h (until the A«,,, reached about 1.0). 1 m M isopro-
pylthio-/?-D-galactoside was added to. the culture, and shaking 
was continued at 30°C for 5 h (A«,, icreased to 1.4—1.5). 
Enzyme  isolation.  After harvesting by  centrifugation at 
4000 Xg for 10 min, the cells were suspended in 20 ml of 50 m M 
sodium phosphate, pH 8.0, 1%  rac- 1,2-propanediol, and dis-
rupted by sonication at 4-8°C (Branson sonifier, full power, 
three times, 1 min). The  resulting slurry was centrifuged at 
23000Xg at 0°C for 30 min. After decanting the supernatant, 
the pellet was suspended in 20 ml of the above buffer and sub-
jected to a second, similar centrifugation. The pellet from the 
second centrifugation was suspended in 20 ml 50 m M  sodium  
phosphate. pH 8.0, 1% rac-1,2-propanediol, 1% Triton X-100, 
1 % sodium cholate, and stored in an ice bath for 30 min. This 
suspension was centrifuged (23000Xg at 0°C for 20 min). After 
concentration (Centricon cell with 10-kDa membrane), the su-
pernatant was filtered through a 0.45-pm filter and applied to a 
HiLoad 26/60 Superdex 200 (Pharmacia) column [4°C: elution 
with 25 m M sodium phosphate, pH 7.5, 0.1 M KC1 and 2% (by 
vol.) rac-1,2-propanediol; flow rate, 2.5 ml/min]. The fractions 
showing enzyme activity (55—63 min) were unified and concen-
trated to 5 ml. 
Enzyme assay. Alcohol dehydrogenase//?-NADH coupled 
assays of glycerol dehydratase or diol dehydratase activity on 
racemic 1,2-propanediol were based on the method of Bachov-
chin et al. [14] with minor modifications. In a plastic cuvette at 
37°C, 990 pi 40 m M  potassium phosphate, pH 8.0. 0.2 M race-
mic 1,2-propanediol, 0.2 m M /?-NADH, 2.5 pi yeast alcohol de-
hydrogenase (15 U) and 2.5-5 pi glycerol dehydratase or diol 
dehydratase (0.2—0.3 U) were mixed and the resulting solution 
was incubated at 37°C (standard assay, 3 min). A control value 
that was used for correction was determined without addition of 
coenzyme-B,2. The enzymic reaction was started by addition of 
coenzyme Bl2 [standard assay, 2.5 pi 1 m M  (glycerol dehydra-
tase assay), 5 pi, 1 m M  (diol dehydratase assay)], and the 
decrease of absorbance at 340 nm was recorded for several min-
utes at 37 °C. The rate of 1,2-propanediol/propionaldehyde trans-
formation was calculated from  the change of absorption at 
340 nm due to the consumption of NADH  in the coupled en-
zyme assay. The following equation was used: 
V = 1000[(AA-AA„)/e/] 
where V =  rate of reaction (nmol • min"' • cm"5). AA = 
change of the absorption (min"", AA„ = change of the absorp-
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tion  without  enzymatic  reaction  (min-1). e =  absorption coeffi-
cient of/7-NADH at 340 nm (6.22 cm1 • mmol"').  I =  cell  length  
(1 cm),  and  1000 is  a conversion  factor from pmol  to  nmol.  
Kinetic  investigations.  Mean  rate  values  of  the  enzyme  
assays  measured  between  1 - 2  min  (glycerol  dehydratase  assay)  
or 2 - 3  min (dioldehydratase  assay)  were used for calculation  of  
the  kinetic  constants.  
Kinetic  constants  (Km,  Vmax)  for CoB,,  were  determined  by  
means  of  standard  linearization  methods (1 -5  pi 0.001-1  mM  
CoB,,.  9 - 1 2  data  points;  linearization  by  Lineweaver-Burk.  
Hanes  and  Eadie-Hofstee:  average  values  of  kinetic  constants  
were  obtained  by  these  three  methods).  
Apparent inhibition constants  (K,) for C 3 -C ,  analogues. CN-
Cbl  and HO-Cbl  were determined  by  our previously  established  
parallel  method  [8].  CoB,,  ( 1 - 5  pi  0 .1-1  mM)  and  inhibitor  
(1—5 pi 0.01-1  mM)  were  added  simultaneously  to  the  assay  
mixture.  At  three  or  four  CoB,,  concentrations  (0.1-2.5  pM).  
inhibitor  concentrations  were  varied  (8-10  data  points  for  
each).  Inhibition  constants  were  calculated  from  K, = (slope  •  
[CoB,,]  • Vm„)/Km  where  K„ [CoB12]  and  Km  were in  nmol,  and  
y>nu  was  in  nmol/min.  Linear  regression  was  performed  in  a  
Dixon plot, and the final K, taken  as an average  of the  particular  
K-,  values  of  the data  sets  at different [CoB,2]  values.  
R E S U L T S  A N D  D I S C U S S I O N  
The distance between  the paramagnetic  centers (Coll  and  5'-
adenosyl  radical)  in  the  posthomolysis  intermediate  of  coen-
zyme-B,.-dependent  enzymes  can  be  estimated  if  we  consider  
the size of substrate together with the principle  of negative catal-
ysis  [5],  i.e.  one  important  role  of  the  apoprotein  is  to  protect  
the  highly  reactive  intermediates  from the environment.  Conse-
quently,  the substrate  should  fit between  the Con  and  S'-adeno-
syl  radical,  but  the  distance  between  these  and  the  substrate  
should  be  less  than  200—250 pm,  which  is  the  space  require-
ment of a water molecule.  Based on these considerations,  a value 
of  about  0.9—1.0 nm  was  calculated  for  methylmalonyl-CoA  
mutase,  while a value of  about  0.6—0.8 nm between  the radicals 
formed  by  the  homolysis  of  CoB,2  was  predicted  for  enzymes  
acting  on  relatively  small  substrates  (e.g.  diol  dehydratase  or  
glycerol  dehydratase)  [8].  The  inhibition  pattern  of  the  postho-
molysis-intermediate  analogues on (/?)-methylmalonvl-CoA  mu-
tase from P.  shermanii  was  in agreement  with the prediction  that  
the  C6  analogue  (Id;  -1  nm  between  Co  and  5'-C.  assuming  a  
zig-zag  conformation) would  be the  strongest  inhibitor  [8].  
As  examples  of  enzymes  acting  on  a  small  substrate,  we  
chose glycerol  dehydratase  and  diol  dehydratase  for our  kinetic  
studies.  Since  glycerol  dehydratase  is  known  to  accept  glycerol  
and  1,2-propanediol  as substrates  [15],  racemic  1.2-propanediol  
was  applied  as  substrate  throughout  in  our  work,  enabling  us  
to  apply  a  convenient  ultraviolet-based  alcohol  dehydrogenase/  
NADH  coupled  enzyme  assay  [14). The  inhibitory  behavior  of  
the  C5-C7  analogues  of  coenzyme  B,2)  CN-Cbl,  HO-Cbl  and  
adenosine  were  investigated  with  glycerol  dehydratase  and  diol  
dehydratase.  The  C5—C7  analogues  were  tested  as  mimics  of  
the  posthomolysis  intermediate,  having  affinity  for  the  corrin-
binding and the adenosyl-binding  sites  of  the apoprotein.  Inhibi-
tion  by  HO-Cbl  or  CN-Cbl  was  considered  to  be  caused  by  
blocking  the corrin-binding  site,  whereas  adenosine  was  used  as  
a  possible  block  of  the adenosyl-binding  site. The  results  of  our  
kinetic  investigations  are summarized  in  Table  1.  
Inhibition  by  the C , -C 7  analogues  of  glycerol  dehydratase  
and  diol  dehydratase  showed  some  interesting  features.  These  
analogues  are  competitive  inhibitors  with  respect  to  CoB12.  The  
binding  process,  however,  is  not  a  fast  equilibrium  [8],  so  that  
Table  1.  Kinetic  properties  of  CoB,2,  the  C,-C 7  CoB,,  analogues  
( la-e) .  CN-Cbl  and  HO-Cbl  with  glycerol  dehydratase  (from  C.  
freundii  overexpressed  in E.  coli) and  diol dehydratase (from 5.  typh-
imurium  overexpressed  in  E.  coli).  Kinetic  investigations  were  per-
formed as  described  in  Materials  and  Methods.  Km.  apparent  Michaelis-
Menten constant:  K,. apparent  inhibition  constant,  n.d..  no inhibition  de-
tected  up to  5 pM. 
Compound  Type of  Values of  Km and  K, for 
constant 
glycerol  dehydratase  did  dehydratase  
nM 
CoB,, 12.6  ±2.2  750±  110  
la  (CO  K, 10.5 ±  1.5  770±  120  
lb  (CO  K, 9.7 ±  1.2  860 ±  150  
lc  (CO  K, 5.9 ±1 .0 500 ±  80  
Id  (CO  K, 15.1+3.0 830±  120  
le  (CO  K; 11.7 ±1 .6 630±  100  
HO-Cbl K, 8.6 ±1.4 680±  110  
CN-Cbl K. 21.6 ±2.7 1420 ±  200  
Adenosine K, n.d. 7500 ±1400 
several  catalytic  cycles  occur  before  CoBI2  is  replaced  by  the  
inhibitor. Although the kinetic constants for glycerol  dehydratase  
and  diol  dehydratase  differ  by  two  orders  of  magnitude  
(«10  nM for glycerol dehydratase and « 1  pM for diol dehydra-
tase),  which  is  remarkable  considering  the  high  sequence  simi-
larity  of  the two  enzymes,  the relative  inhibition  patterns  of  the  
inhibitors  on  the  two  enzymes  are  quite  similar.  In  agreement  
with  our  expectations,  the  shorter-chain  analogues,  especially  
the C; analogue  (lc),  were  found to  be  slightly  stronger  inhibi-
tors  than  the  C6  or  C7  analogues.  The  K,  values  of  the  C, -C 7  
CoB,, analogues  with glycerol  dehydratase  and diol  dehydratase  
were  of  the  same  order  of  magnitude  as  the  corresponding  Km  
value  of  COB,2. The strongest  inhibitor,  the C5 analogue,  exhib-
ited  significantly  smaller Rvalues  than  the corresponding  Km  of  
CoB,,  with  glycerol  dehydratase  and diol  dehydratase. The  G>—  
C7  analogues  are  therefore considered  to  not  be  transition-state  
analogues,  but  analogues  of  the  posthomolysis  intermediates.  
Homolysis of the Co-C bond of CoB,,  is induced by a conforma-
tional  change  of  the apoprotein  upon  binding  of  the  substrate  to  
the enzyme  • coenzyme complex, pulling  apart  the  5'-deoxyade-
nosyl  moiety  from  the  Co.  A  similar  conformational  change  is  
expected  upon  binding  of  the  posthomolysis-state  analogues  to  
the  apoenzyme.  but  because  of  the  extensibility  of  the  
oligomethylene  chains,  no  homolysis  occurs.  The  relatively  
small  but  significant  differences  in  the  K,  values  can  be  ex-
plained  by  the fact that  all  the distances  between  the  5'-deoxya-
denosyl  moiety  and the Co defined by the oligomethylene  chains  
in  these  analogues  lie  on  the  reaction  pathway  of  the conforma-
tionally  induced  homolysis,  the  optimum  distance  being  the  
length  of  the  pentamethylene  chain.  It  may  seem  that  the flexi-
bility  of  the  longer  chains  (CA  and  C7)  would  also  allow  the  
optimum  distance,  but  this  may  not  be  true  at  the  enzyme's  
active  site,  which  restricts  the  chain's  conformational  freedom  
by  steric  encumbrance.  
The inhibitory potency of the  [cu-(adenosin-5'-0-yl)alkyl]co-
balamins  with  diol  dehydratase  is  of  the  same  order  of  magni-
tude as has been published for that of the  adeninylalkylcobalam-
ins  [16].  Although  the dioldehydratases  assayed  were  from dif-
ferent  sources,  one  can  state  that  the  ribose  position  does  not  
contribute  much  of  the  binding  affinity  of  the  cobalamin  ana-
logues,  while  it  may  be  important  for  the  homolysis  of  the  Co-
C  bond  of  coenzyme  B,,.  
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While  the  K,  values  of  the  strongest  inhibitor,  the  C,  ana-
logue,  are  smaller  than  the  corresponding  Km  of  CoB.-  with  
glycerol  dehydratase  or  diol  dehydratase,  for  (R)-methyl-
malonyl-CoA  mutase.  the  strongest  inhibitor,  the  C„  analogue  
(Id),  had a K, value about  threefold higher than  the  Km of  CoB,-
[8].  This  phenomena  can  be  rationalized  by taking  into  account  
the  'base-on"  or  'base-off  nature (i.e. depending  on whether  the  
lower  ligand  of  the  central  Co  of  CoB,:  in  the  enzyme  • coen-
zyme  complex  is  the  dimethylbenzimidazole  moiety  or  a  histi-
dine  residue  of  the  apoenzyme)  of  the  CoB,-  binding  by  the  
corresponding enzymes. The recently  published crystal  structure  
of  (R)-methylmalonyl-CoA  mutase  from  P. shermanii  showed  
the  'base-off* nature of  the enzyme  [17]. Consequently,  the  loop  
carrying  the  dimethylbenzimidazole  ligand  of  the  C6  inhibitor  
should be removed  and replaced  by the protein  histidine  imidaz-
ole  while  binding  to  the  active  center,  which  results  in  looser  
binding.  In  contrast,  glycerol  dehydratase  and  diol  dehydratase  
seem  to  belong  to  the  'base-on'  family.  No  similarity  with  the  
characteristic  sequence  pattern  [18]  of  known  'base-off  en-
zymes,  considering  the  conserved  residues  that  participate  in  
CoB,-  binding,  was  found  in  the  sequences  of  several  glycerol  
dehydratase  and  diol  dehydratase  enzymes  of  different  origin  
[Daniel,  R.,  personal  communication];  and  investigation  of  the  
EPR  spectra  of a 2-methyl-l,2-propanediol—inactivated  diol de-
hydratase  holoenzyme  obtained  with  [l5N]apoenzyme  and  
[l4N]coenzyme  [19]  also  supports  the  "base-on'  nature  of  diol  
dehydratase.  Accordingly,  fitting the  strongest C,  inhibitor  does  
not  require  a  substantial  change  in  the  Co-ligand  sphere  during  
binding to the post-homolysis  conformation state of  the  glycerol  
dehydratase  or  diol  dehydratase  apoenzymes.  
The  inhibition  patterns  of C,-C 7  analogues  on  glycerol  de-
hydratase  and  diol  dehydratase  alternate  in  a  similar  manner:  
analogues  with  odd  numbers  of  inserted  methylene  units  seem  
to  be  slightly  stronger  inhibitors  than  those  with  even  numbers  
of  methylenes.  Such  alternation  was  found  in the  orientation  of  
adenosyl  moiety  relative  to the  corrin  part  in the calculated  con-
formations  of C 3 -C 7  compounds,  for  'H-NMR  chemical  shifts  
of  several  signals  of these analogues, or for their solubilities  [8].  
Inhibition  kinetic data for HO-Cbl  and CN-Cbl with glycerol 
dehydratase  and  diol  dehydratase  have  interesting  features.  Al-
though  both  of  these  molecules  consist  of  a corrin  part  bearing  
only  a  small  axial  ligand,  there  is  a  remarkable  difference  be-
tween their inhibitory properties. While CN-Cbl. bearing an apo-
lar  ligand,  was  a  moderate  inhibitor,  having  a  AT, value  similar  
to those of Ch and C7 analogues,  HO-Cbl. bearing a polar hydro-
philic  ligand,  was  found  to  be  a  rather  strong  inhibitor,  with  
slightly  smaller  apparent  K,  values  than  the  corresponding  Km  
constants  for  CoB12  in  the  glycerol  dehydratase  and  diol  dehy-
dratase  reactions.  
Adenosine,  however,  showed  different  inhibitory  properties  
toward  glycerol  dehydratase  and  diol  dehydratase.  While  in  the  
diol  dehydratase  reaction,  the  apparent  K,  value  for  adenosine  
was  about  tenfold  higher  than  the  Km  of  CoB,-.  no  significant  
inhibition  of  the  glycerol  dehydratase  reaction  was  found  up  to  
5  pM  ( = 4 0 0  Km  of  COB,2)  adenosine.  
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A series of [íu-(adenosin-5'-0-y/)alkyl]cobalamins  were examined for their inhibitory proper-
ties  of  ribonucleoside  triphosphate  reductase  (RTPR)  from  Lactobacillus  leichmannii  in  the  
presence  of  5'-deoxyadenosylcobalamin  (AdoCbl,  Coenzyme B12).  These AdoCbl  analogs,  in  
which  oligomethylene  chains  (C3-C7)  were  inserted  between  the  conin  Co-atom  and  a  5 ' -0-
atom  of  the  adenosine  moiety,  were  designed  to  probe  the  Co-C  bond  posthomolysis  state  in  
AdoCbl-dependent  enzymes,  a  state  in  which  the  Co  and  5'-C  distance  is  believed  to  be  
significantly  increased.  Experimentally,  all  five  analogs  were  competitive  inhibitors,  with  K¡ 
in the range of 8-56 fiM. Hie  [<u-(adenosin-5'=0-y/)alkyl]cobalamin  analog with C5  methylene 
carbons was  the  strongest  inhibitor. This  same pattern  of  inhibition,  in  which  the C5-analog  is  
the  strongest  inhibitor,  was  previously  observed  in  the  AdoCbl-dependent  eliminase  enzyme  
systems,  diol  dehydratase  and glycerol  dehydratase.  However,  in methylmalonyl  CoA  mutase,  
the  strongest  inhibition  is  by  the  C6-analog.  This  supports  the  hypothesis  that  the  cobalamin  
posthomolysis  intermediate  in the eliminase enzymes differs from that  in the mutase  enzymes.  
These  findings  led, in turn, to an examination  of the visible spectra of enzyme-bound  cob(II)a-
lamin  in these  two subclasses  of AdoCbl-dependent  enzymes. The results reveal  an  additional  
insight  into  the  difference  between  the  two  classes:  in  the  eliminases,  the  y-band  of  bound  
cob(II)alamin is shifted from the 473 nm for free cob(II)alamin to longer wavelengths, 475-480 
nm. However,  in mutases,  the  y-band of bound cob(n)alamin  is shifted to shorter  wavelengths,  
465-470  nm.  Overall,  the results  (a) provide  strong  evidence  that  two  subclasses  of  AdoCbl-
dependent  enzymes exist,  (b) give insights into the probable posthomolysis  state  in  RTPR  and  
other eliminases, and (c) identifies the Cs-analog as the tightest-binding analog for crystallization 
and  other  biophysical  studies.  O  1999 Academic  Press  
An essential process in the catalytic cycle of  5'-deoxyadenosylcobalamin-dependent  
(AdoCbl;  Coenzyme  BI2)  enzymatic  reactions  is  the  reversible  homolytic  cleavage  
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of  the  A d o C b l  C o - C  bond  to  p roduce  cob( I I )a lamin  and  a  5 ' - d e o x y a d e n o s y l  radical  
or  a  cys te inyl  thiyl  radical  (1-3).  T h e  m e c h a n i s m s  by  w h i c h  A d o C b l - d e p e n d e n t  
e n z y m e s  activate,  cleave,  and  r e f o r m  the  C o - C  bond  dur ing  cata lys is  h a v e  been  the  
f o c u s  of  a  wide  variety  of  research  e f for t s  (4-8),  especia l ly  s ince  chemica l  precedent  
s tudies  of  A d o C b l  Co-C  bond  c l eavage  revea led  the  1 0 I 2 ± 1  enzymic  acce lera t ion  of  
this  s tep  th roughout  the  A d o C b l - d e p e n d e n t  e n z y m e s  (9-12).  
In  o rde r  to  bet ter  unders tand  the  s t ructure  of  the  in te rmedia te  spec ies  and  the  
m e c h a n i s m s  involved,  a  series  of  five  novel  adenosy lcoba l amin  analogs ,  [et>-(Adeno-
s in -5 ' -0 -y / ) a lky l ] coba l amins ,  were  des igned  and  prev ious ly  syn thes ized  wi th  the  goal  
of  p rob ing  the  pos thomolys i s  state  g e o m e t r y  in  AdoCb l - ca t a lyzed  reac t ions  (13).  
T h e s e  [a>-(adenos in-5 ' -0-y / )a lkyl ]cobalamins  have  o l igome thy lene  cha ins  ( C 3 - C 7 )  
inser ted  be tween  the  corrin  C o - a t o m  and  the  5 ' - 0 - a t o m  of  adenos ine  (Fig.  1).  De-
p e n d i n g  on  the  length  of  the  o l igome thy lene  chain,  these  novel  ana logs  are  expec ted  
to act as s t ronger or weaker  inhibi tors  of A d o C b l - d e p e n d e n t  reac t ions via their  s t ronger  
or  w e a k e r  b inding  to  the  pos thomolys i s  c o n f o r m a t i o n  of  the  enzyme .  T h e  t ightest  
b ind ing  of  these  A d o C b l  analogs  also  a l lows  an  es t imate  of  the  separa t ion  dis tance  
in  the  e n z y m e  be tween  cob(I I )a lamin  and  5 ' - d e o x y a d e n o s i n e  fo l lowing  C o - C  bond  
homolys i s .  Th i s  series  of  [¿ t»-(adenosin-5 ' -0-y/)a lkyl]cobalamin  ana logs  has  also  been  
R 
NH2 
,0 
HO  OH  
((Adenosine-5'-0-yl)alkyl)cobalamins 
NH2 NH2 
H2N' N-
o —CH 2  ]  
^ - N H 2 
HO  OH  
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-(CH2)5 
Adeninylpentylcobalamin 
—CN 
Cyanocobalamin 
FIG. 1.  Schematic structures of the AdoCbl analogs used in the present studies. 
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examined  in  the AdoCbl-dependent  enzyme  systems  of  methylmalonyl-CoA  mutase  
from Propionibacterium  shermanii  (14), glycerol dehydratase  from  Citrobacterfreun-
dii  (15),  and  diol  dehydratase  from  Salmonella  typhimurium  (15).  
Herein  we  extend  the  analysis  of  the  inhibitory  properties  of  this  series  of  [ÍÜ-
(adenosin-5'-0-y/)alkyl]cobalamins  by examining them with RTPR and in competition 
against  AdoCbl.  The  resulting  competitive  inhibition  pattern  is  compared  to  that  
observed  for  the  three  other,  previously  studied  AdoCbl-dependent  enzymes.  Our  
results,  in combination  with  the literature  (14),  provide the clearest  evidence  to  date  
in support of the hypothesis that the posthomolysis intermediates found in the AdoCbl-
dependent  eliminase  enzymes  are  different than  those  in  the  mutase  enzymes.  The  
results  also yield  an estimate for the Co-C  separation  distance  in  the  posthomolysis  
intermediate  and identify the Cs-analog as the tightest-binding  analog for biophysical 
studies  of  the  AdoCbl(analogs)*RTPR  holoenzyme  complex.  
EXPERIMENTAL  PROCEDURES  
Materials.  The  [o>-(adenosin-5'-0-yZ)alkyl]cobalamins  were synthesized, purified, 
and  characterized  according  to  Poppe  et  al.  (13).  The  L.  leichmannii  ribonucleotide  
triphosphate  reductase  was  isolated  from  overexpressing  Escherichia  coli  cells  (16)  
and purified using our recent shortened protocol (17), one including a dGTP-Sepharose 
affinity column  (18).  AdoCbl,  hydroxycobalamin,  adenosine,  ATP, dithiothreitol,  di-
phenylamine,  and  all  other  materials  were  obtained  from  Sigma  and  used  without  
further purification.  Adeninylpentylcobalamin  (AdePeCbl)  was  synthesized  by  pub-
lished procedures  (19-21),  with  the following modification (full details  are available 
elsewhere  (12)):  since  adeninylpentylchloride  was  initially  too  impure  to  crystallize  
from  aqueous  methanol  as  reported  (21),  adeninylpentylchloride  was  purified  using  
a  Chromatotron  (Harrison  Research  Co.)  with  a 4-mm  silica  gel  disc  (Merck,  7749)  
using  dichloromethane/methanol  (13:1,  v/v)  as  the developing  solvent.  The  resultant  
adeninylpentylcobalamin  was  97%  pure  by  HPLC  (Alltech  Versapack  C]8  column,  
4.1 X  300 mm,  10->um particle  size,  60 A pore size,  eluted  at 0.5 ml/min for 30 min 
with  a linear  gradient  of  10-44%  CH3CN  in  0.085  M H3P04,  adjusted to pH 3  with  
triethylamine). A single 31P resonance was observed at - 0 . 5 ppm vs a H3P04 standard. 
The expected molecular  weight was observed  by mass  spectroscopy  (FAB-MS,  glyc-
erol  matrix:  found, M  +  H  =  1533.6  Da;  calculated,  M  +  H  =  1532.7  Da).  
Methods.  The  analogs  were  tested  as inhibitors  of RTPR's  ability  to  convert  ATP  
to dATP in the presence  of various AdoCbl concentrations. The concentration  of each 
stock  cobalamin  solution  (~2  mM)  was  determined  using  the  literature  extinction  
coefficients for [<w-(adenosin-5'-0-y/)alkyl]cobalamins  (73),  adeninylpentylcobalamin 
(20), or aquocobalamin  (23). The activity of RTPR was assayed using our modification 
of  the diphenylamine  procedure  (17),  an  assay  which  measures  the amount  of  dATP  
produced  from  ATP.  
In  a  typical  kinetic  experiment,  all  procedures  were  done  under  dim  red  light  to  
avoid photolysis of AdoCbl's  sensitive Co-C bond. The pH of the stock assay reaction 
solution  (containing  83.3 mM potassium phosphate  buffer (pH  7.3),  1.67 M  sodium  
acetate,  16.7  mM  ATP, 50 mM  DTT)  was  adjusted to pH  7.3  with  NaOH. The  final  
reaction mixtures contained 50 mM potassium phosphate buffer (pH 7.3),  1  M sodium 
acetate,  10 mM  ATP,  30 mM  DTT,  prechosen  amounts  of  AdoCbl  (1,  2,  3,  8  pM)  
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and  analogs  (1,  5,  10,  15, 20  JJM),  and  0.34  JUM ribonucleotide reductase  (7  FIg)  in  
a  total  volume  of  0.25  ml. All  of  the components,  except  for the  RTPR,  were  mixed  
in  a  13  X  100-mm  glass  test  tube  on  ice.  A  series  of  deoxyribose  standards  were  
prepared  by  adding  dAMP  (150-500  ¡xM)  as  the  deoxyribose  source.  RTPR  was  
added to all of the tubes except those containing the dAMP standard, and the reduction 
of  ATP  by  RTPR  was  initiated  by  incubation  at  37°C  in  a  circulating  water  bath.  
Following  a  10-min  incubation,  the reaction mixtures  were placed  on ice  and 0.2 ml 
of  0.5 M  2-chloroacetamide  in  0.25  M potassium  phosphate  (pH 7.5) was  added  (to  
derivatize free thiols  which  interfere with  the assay's  color development  (24)).  Each  
tube  was  then  vortex  mixed,  capped  with  a  marble,  and  heated  at  100 °C  in  a  heat  
block for 30 min. After cooling briefly on ice,  1 ml of diphenylamine reagent  (25,26)  
was  added. The  diphenylamine  reagent  (made by mixing  0.5 g  diphenylamine,  25 g 
glacial  acetic  acid,  750  jxl  conc.  H2S04,  and  250  /xl  50  mM  cupric  acetate),  which  
contains  0.5  mmol  cupric  acetate  to  accelerate  color  development,  was  freshly  pre-
pared,  since  its  storage  causes  a precipitate  to form in  the  samples.  The  absorbance  
at  594  nm  was  measured  after incubation  at  37  °C for  2  h,  during  which  the  clear  
colorless  solutions  change  to  purple  and  then  blue.  The  amount  of  deoxyribose  
generated  was  calculated  from  the dAMP  standard  point  calibration  curve  (27).  For  
the  determination  of  the  KM  and  Vmax  of  AdoCbl  with  RTPR,  the  above  assay  was  
run using only  AdoCbl  (i.e., no inhibitors)  at various concentrations  (0.1, 0.3, 0.5,  1,  
1.5,  2,  3,  8  /¿M).  
To  generate  cob(II)alamin,  aquocobalamin  was  reduced  by  an  excess  of  thiol  to  
cob(II)alamin  (28-30)  under  the  assay  conditions  (30 mM  DTT,  pH  7.3);  aquocob-
alamin was completely converted to cob(II)alamin by dithiothreitol  within  1 min, and 
the resultant  cob(II)alamin  was  stable for  the duration  of  the assay  period.  Cob(II)a-
lamin inhibition  was evaluated  in the absence  and presence  of  ah  equivalent  amount  
of  adenosine  in  the  assay  solution,  entries  6  and  7 in Table  1, respectively. 
The  KM  and  Vmax  for  AdoCbl  were  estimated  by  the  preferred  direct  linear-plot  
method (31). At each inhibitor concentration, a direct linear plot was used to determine 
Kg?  and  Vpp,  and  the  inhibition  type  (competitive,  pure  noncompetitive,  mixed,  or  
TABLE  1  
Apparent  Inhibition  Constants,  Kfpp, for AdoCbl  Analogs  in  RTPR  Determined  by  the  
Direct  Linear  Method  
Cobalamin  Analog  K,  (FIM)  Inhibition  type  
[3-(Adenosin-5 '-0-y/)propyl]cobalamin  (C3)  55.8 ± 0.4 Competitive 
[4-(Adenosin-5 ' -0-yl)butyl]cobalamin  (C4)  18.9 Hh 0.4 Competitive 
[5-(Adenosin-5 '-0-y/)pentyl]cobalamin  (C5)  7.7 + 0.2 Competitive 
[6-(Adenosin-5'-0-y/)hexyl]cobalamin  (C6)  24.6 0.5 Competitive 
[7-(Adenosin-5'-0-y/)heptyl]cobalamin  (C7)  12.8 0.4 Competitive 
Cob(II)alamin 20.8 + 0.2 Competitive 
Cob(II)alamin  +  Adenosine  14.3 0.2 Competitive 
Cyanocobalamin  (CNCbl)  42.6 0.6 Competitive 
Adeninylpentylcobalamin  (AdePeCbl)  1.3 0.9 - Mixed 
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uncompetitive)  was evaluated  (31,32).  The  inhibition  constants  (K¡) were  then  deter-
mined  in  the  usual  fashion  (31-33)  from  plotting  K$p/Vipp  against  the  inhibitor  
concentration  in  the  competitive  inhibitor  cases  ([ a>-(adenosin-5' -0-y/)alkyl]cobala-
mins, cob(II)alamin, and cyanocobalamin),  and from plotting  1/V®pp against the inhibi-
tor concentration in the pure noncompetitive inhibition case  (adenylpentylcobalamin).  
Supporting  information  available.  The  following additional  control  and other  ex-
periments  are  available  in  the  PhD  Thesis  of  Robert  K.  Suto  (22):  synthesis  and  
characterization  of  adeninylpentylcobalamin;  kinetic  analysis  of  AdoCbl  interaction  
with  RTPR;  all  the  direct  linear  plots  for  each  of  the  nine  AdoCbl  analogs  and  
determination  of  apparent inhibition  constants,  Kfpp, in  RTPR.  
RESULTS 
[a>-(Adenosin-5'-0-yl)alkyl]cobalamin  inhibition  kinetic  studies.  Under the condi-
tions  used,  the  kinetic  values  determined  for  AdoCbl  interacting  with  RTPR  are:  
Km  =  1.5  pM,  and  Vmax = 1 . 8  pM,  as  determined  by  the  direct  linear-plot  method  
(Fig.  2). The  Km  value is consistent  with the range of  values observed  previously  by  
others  (Km  =  1.3  pM  (16),  1.1  pM  (34),  1.59  pM  (34),  and  8.3  pM  (35)).  
The  abilities  of  the  individual  [oKadenosm-5'-O-y0^yl]cobalamin  analogs  to  
inhibit  RTPRs  interaction  with  AdoCbl  were  measured  and  compared  with  several  
other  cobalamins  (Table  1). The  K{ constants  were  calculated  and reported  using  the  
method  of  direct  linear  plots  (31-33)-,  analysis  of  the data using  the classical  Dixon  
linearization  (36,37)  and  Lineweaver-Burk  linearization  (38)  methods  resulted  in  
values  similar  to  the  direct  linear  plot  (available  elsewhere  (22)).  The  direct  linear-
plot data for AdoCbl shown in Fig. 2 is a representative example of the data (22). Figure 
3 shows the plot used to determine  K^  for the C5 analog, again as a representative plot.  
All  of  the  [ct>-(adenosin-5 '-0-yZ)alkyl]cobalamin  analogs  affected the K$p  but  not  
the Vapp; hence, they are competitive inhibitors (31-33).  In RTPR, an odd/even pattern 
in  the oligomethylene  chain number  and in  the observed  Kx is observed  in which  the  
odd-numbered  chain  analogs,  C5  and  C7,  are  stronger  inhibitors  than  the  even-num-
bered  chain  analogs, C4 and C6. The C5 analog is the strongest inhibitor  of the series.  
The  C3-analog  was  a  relatively  poor  inhibitor,  suggesting  that,  in  this  analog,  the  
3-(adenosin-5'-0->'/)propyl  group does not  contribute  significantly  to  binding.  
As expected, none of the [&>-(adenosin-5 '-0->'/)alkyl]cobalamin analogs were active 
coenzymes  of  RTPR  when  examined  in  the  absence  of  AdoCbl.  All  of  the  analogs  
were  stable  in  the presence  of RTPR;  in no  case was Co-C homolysis. observed  (i.e.,  
no  detectable  cob(II)alamin  was  produced).  
Control  experiments  examining  cob(II)alamin,  cyanocobalamin,  and  adenylpentyl-
cobalamin  inhibition  kinetic  studies.  Previously,  Yamada  et  al.  (29)  found  cob(II)-
alamin  to be  a linear competitive  inhibitor, with an  apparent  K^  of  37  ±  2  pM  in  the  
absence  of 5'-deoxyadenosine,  and  an  apparent  K, of  3.0  ±  2 pM  in the presence  of  
50  pM  5'-deoxyadenosine  (and  under  their  exact  conditions).  They  also  found  that  
50  pM  adenosine  significantly increased the binding  of cob(II)alamin,  but  decreased  
the  activity  to  roughly  half.  Since  cob(II)alamin  can  also  mimic  the  posthomolysis  
state,  but  now  without  the  formation  of  the  Co-C  cleavage  hydrogen  abstraction  
product 5'-deoxy adenosine, and thus without generation of the cysteine radical  (39,40),  
we too have examined cob(H)alamin's inhibition properties (and with our more highly 
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FIG. 2.  Direct linear plot of the  Km and Vmax for AdoCbl with RTPR showing the data (solid lines) 
and Km and Fmax (dotted lines). 
pur i f ied ,  d G T P - b a s e d  aff ini ty co lumn  pur i f i ed  R T P R  (77)).  Cob( I I )a lamin  proved  to  
be  a  compet i t ive  inhibitor  in  our  hands  as  wel l ,  wi th  apparent  of  14.3  ±  0.2  /¿M  
(in  the  p resence  of  an  equivalent  a m o u n t  of  adenos ine)  and  20.8  ±  0.2  / ¿M  (in  the  
absence  of  adenos ine) .  Adenos ine  w a s  chosen  for  this  present  work ,  ra ther  than  5 ' -
deoxyadenos ine ,  due  to  the  fac t  that  a  5 '  o x y g e n  is  a l ready  present  in  the  (adenos in-
5 ' -0 -}7)a lky lcoba lamin  series  (see  Fig .  1).  Thus ,  the  p resence  of  a  s to ichiometr ic  
amoun t  of  adenos ine ,  at  least  at  the  concen t ra t ions  of  adenos ine  used  ( 1 - 2 0  /¿M),  
lowered  the  Kx  of  the  cob(II )a lamin  inhibi t ion.  T h e  result  that  cob( I I )a lamin  binds  
tightly  is  fu l ly  consistent  with  the k n o w l e d g e  that  the  corrin  half  of  the  pos thomolys i s  
in termedia te  is  cob(II)a lamin,  and  the  idea  that  t ight  b inding  of  cob( I I )a lamin  and  
5 ' - d e o x y a d e n o s i n e  provides  an  impor tan t  par t  of  the  dr iving  force  fo r  homoly t i c  
c leavage  of  the  C o - C  bond  (12,30,41).  
T h e  use  of  cyanocoba lamin  ( C N C b l ,  Vi tamin  B 1 2 ,  whe re  a  cyano  g roup  is  the  R  
group  in Fig.  1) resulted  in weake r  compe t i t i ve  inhibi t ion.  C N C b l  has  also  been  f o u n d  
to  be  a  modera t e  inhibitor  in  diol  dehydra tase  and  glycerol  dehydra tase  (75) .  
Last,  we  also  examined  aden iny lpen ty lcoba lamin  (AdePeCbl ;  Fig.  1),  an  analog  
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FIG. 3.  Determination of [5-(adenosin-5'-D-vl)pentyl]cobalamin's K, value by plotting A^pp/Vapp 
against inhibitor concentration. Each of the five sets of fC$p and Vapp value were determined by direct 
linear plots for each inhibitor concentration (22). 
that  w a s  f i rs t  synthes ized  in  1976  by  S a n d o  et  al.  (20)  as  par t  of  a  series  of  A d o C b l  
ana logs ,  ( aden iny la lky l )coba lamins .  In  these  ana logs ,  the  r ibose  moie ty  of  the  5 ' -
d e o x y a d e n o s i n e  is  replaced  by  two  to  six  m e t h y l e n e  ca rbons .  This  series  of  ana logs  
have  p rev ious ly  been  shown  to  be  inhibi tors  of  A d o C b l  b ind ing  in  r ibonuc leos ide  
t r iphospha te  reduc tase  (RTPR)  f r o m  Lactobacillus  leichmannii  (20),  diol  dehydra t a se  
from Klebsiella  pneumoniae  (Aerobacter  aerogenes)  (42),  and ethanolamine  ammonia-
lyase  f r o m  Clostridium  sp  (43).  The  A d e P e C b l  ana log  is  of  specif ic  interest  s ince  it  
w a s  (and  still  is,  vide  inf ra)  the  best  ( t ightest  b ind ing)  inhibi tor  known  for  RTPR.  
A d e P e C b l ,  unl ike  all  the  other  analogs  e x a m i n e d ,  w a s  not  a  compet i t ive  inh ib i to r  
(Table  1).  Rather ,  V0pp  and  changed  as  a  f u n c t i o n  of  the  inhibi tor  concen t ra t ion  
and  the re fo re  f i ts  the  criteria  fo r  a  mixed  inhib i tor  (32).  T h e  observed  K{  of  1.3  / ¿M  
( for  pure  noncompe t i t i ve  inhibi t ion)  is  wi th in  expe r imen ta l  error  of  those  p rev ious ly  
obse rved  (20),  a  f ind ing  which  adds  c redence  to  bo th  ou r  data,  and  the  prev ious  data ,  
cons is ten t  wi th  A d e P e C b l  mixed  inhibi t ion.  
We  an t ic ipa ted  that  the  series  of A d o C b l  ana logs ,  [cu- (adenos in-5 ' -0 -y / )a lky l ]coba-
lamins ,  in  wh ich  the  dis tance  be tween  the  corr in  and  the  adenosy l  moiety  w a s  l eng th-
ened  by  inser t ion  of  o l igomethy lene  cha ins  ( C 3 - C 7 ) ,  w o u l d  be  s trong  compe t i t i ve  
inhibi tors  of  R T P R  (14).  The  s t rongest  inhibi tor  of  the  C 3 - C 7  series,  the  C 5 - a n a l o g  
(K,  =  7 .7  ±  0 .2  pM),  b inds  t ighter  than  even  cob ( I I ) a l amin  a lone  (K,  =  20.8  ±  0 . 2  
/¿M),  sugges t ing  that  the  C 5 -ana log  closely  m i m i c s  the  cob( I I )a lamin  pos thomolys i s  
state.  Assuming  that  the  C 5 - ana log  binds  to  R T P R  wi th  its  o l igomethy lene  chain  fu l ly  
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extended,  then  the  distance  between  the  cob(H)alamin  and  the  5'-CH2  group  of  
adenosine  in  the posthomolysis  state can  be estimated  to be  near 9.3 A  (the  distance  
previously  calculated,  see (13)).  Interestingly,  recent  EPR  measurements  with  RTPR  
and  AdoCbl  have  estimated  the  distance  between  cob(II)alamin  and  the  cysteine  
(C408)  thiyl  radical  intermediate,  produced  following Co-C  cleavage  by  abstraction  
of the cys408's  -S-H bond by the 5'-deoxyadenosyl  group  (39,44),  to  be 5 -7 A,  with  
an  upper  limit  of  8 A  (3).  
Comparison  of  [o+(adenosin-5'-0-y/)alkyl]cobalamin  interaction  among  the  
AdoCbl-dependent  enzymes  (Table  2)  shows  that  RTPR,  glycerol  dehydratase,  and  
diol  dehydratase  all  share  a  common  pattern  in  which  the  C5-analog  is  the  best  
inhibitor.  Among these eliminase enzymes, the binding affinity of the AdoCbl analogs 
to RTPR is generally weaker (as is the case for AdoCbl itself  (15)), and the differences 
between the analogs is more pronounced. However, contrasting this, in methylmalonyl-
CoA mutase the Cg-analog is the best inhibitor (14). These results support the suggested 
separation  of AdoCbl-dependent  enzymes into two classifications according to either 
their  catalytic  reactions  (eliminase  vs  mutase)  (2,45),  or  according  to  their  AdoCbl-
binding  motif  (benzimidazole  base-on  vs  histidine  base-on)  (46).  RTPR  and  diol  
dehydratase  are eliminases  that have  been  shown  to belong  to the  structural  class  in  
which the dimethylbenzimidazole base retains its coordination  to cobalt upon binding 
to the enzyme  (47-49).  X-ray crystallography  (50) demonstrates  that  methylmalonyl-
CoA  mutase  displaces  the  dimethylbenzimidazole  base  with  a  histidine  sidechain  
imidazole  base  coordinating  to  the  cobalt.  Other  mutases  are  also predicted  to be  in  
this  structural class due to conservation  of  a structure-based  sequence motif  (46)  and  
independent  EPR  evidence  (51,52).  The difference between  the two  classes  has  also.  
TABLE  2  
Summary  of  Competitive  Inhibition  by  [<w-(Adenosin-5'-0-y/)alkyl]cobalamins  in  
AdoCbl-Dependent  Enzymes"  
Mechanistic  class  Eliminase Mutase 
Structural  class  Benzimidazole  base-on  Histidine  base-on  
Ribonucleotide Glycerol Diol Methylmalonyl-CoA 
No.  of  methylene  reductase dehydratase* dehydratase* mutase" 
groups K t  (/zM)  K ,  ( X  10"3  /iM)  K-A /JM) M) 
3 55.8  ±  0.4  10.5  ±  1.5  0.77  ±  0.12  2.48  ±  0.58  
4 18.9  ±  0.4  9.7  ±  1.2  0.86  ±  0.15  1.45  ±  0.29  
5 7.7  ±  0.2  5.9  ±  1.0  0.50  ±  0.08d  1.13  ±  0.56  
6 24.6  ±  0.5  15.1  ±  3.0  0.83  ±  0.12"  0.77  ± 0 . 1 8  
7 12.8  ±  0.4  11.7  ±  1.6  0.63  ±  0.10  2.10  ±  0.81  
" Obtained  by  the  direct  linear plot  method.  Dixon  and Lineweaver-Burk  analysis  are  available  else-
where  (22).  
b Data  from  Poppe  and  Retey  (75).  
c Data  from  Poppe  and  Retey  (14).  
d  In  answer  to  a  referee's  query, the  difference, and  propagated  error bars  (at  1 or),  between  the  C2  and  
C6  analogs  for dioldehydratase,  are  0.33  ±  0.14;  hence,  the difference is  larger  than  the  ler, but  not  the  
3a ,  error  bars.  
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been demonstrated  by a base-off analog of AdoCbl,  one which  served  as a  coenzyme 
for methylmalonyl-CoA mutase reaction, yet one which is an inhibitor for diol dehydra-
tase  and  glycerol  dehydratase  (55).  
The  series  of  results  with  the  [ o>-(adenosin-5'-0-y/)alkyl] cobalamin  analogs  pro-
vided  herein  (Table  2)  suggests  that  the posthomolysis  cob(II)alamin  and  adenosine  
intermediates  may  be  in  different conformations  in  the  mutases  vs  the  eliminases.  
This hypothesis,  in turn, led us to tabulate the literature spectra of cob(II)alamin  when  
bound  to  AdoCbl-dependent  enzymes  (Table  3).  The  results  reveal  an  additional  
difference in  the posthomolysis  state  between  the two  classes.  In the  eliminases,  the  
y-band  of  bound  cob(II)alamin  is  shifted from the 473 nm for  free cob(II)alamin  in  
neutral H 2 0  to  longer  wavelengths,  475-480  nm.  However,  in  mutases,  the  y-band  
of  bound  cob(II)alamin  is  shifted  to  shorter  wavelengths,  465-470  nm.  (Note  that  
free  cob(II)inamide,  which  does  not  contain  an  axial  base,  has  a 470-nm  maxima,  
and  that  the  X-ray  crystal  structure  of  methylmalonyl-CoA  mutase  contains  bound  
cob(II)alamin  with  a long Co-histidine  bond length  of  ~2.5  A (50).) The  absorption  
spectra  of corrinoids  above 300 nm correspond to  IT-IF*  transitions within the  corrin  
ring.  Unfortunately,  and  although  there  is  a  fair  understanding  of  the  relationship  
between  corrin  structure  and the  corresponding  absorption  spectra  of  Co(III)  corrins  
(e.g.,  the  intensities,  position,  and  number  of  bands  are  generally  sensitive  to  the  
number  and  nature  of  the  axial  hgand  (54,55)),  very  little  is  known  about  how  to  
interpret the absorption spectra of cob(II)alamins. In any event, the local  environment  
of  the  enzyme bound  cob(II)alamin  appears  to be different between  the two  classes  
of AdoCbl-dependent enzymes and compared to that of free cob(II)alamin. One known 
TABLE  3  
Cob(n)alamin  Bound  to  AdoCbl-Dependent  Enzymes  
Enzyme  bound  Reference 
Cob(II)alamin for enzyme  bound  Cob(II)alamin  axial  
Enzyme maxima Cob(II)alamin  Spectra  ligand  (references)  
RTPR 480 (22) Benzimidazole 
475 (29) (47) 
Diol  dehydratase  478 (62) Benzimidazole 
(48,49) 
Glycerol  dehydratase  480 (65) Benzimidazole" 
Ethanolamine 475 (64) Benzimidazole" 
ammonia-lyase 
Methylmalonyl-CoA 467 (65) Histidine 
mutase (50,52) 
Glutamate  mutase  470 (66) Histidine 
m 
2-Methyleneglutarate 465 (67) Histidine" 
mutase 470 m 
/3-Lysine-5,6-aminomutase 468 (69,70) Histidine" 
Free  cob(II)alamin  473 (54) Benzimidazole 
Free  cob(II)inamide  470 (54) — 
" Predicted  cobalt  axial  ligand.  
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difference  is  in  the  nitrogenous  base  coordinated  to  the  cobalt  within  these  two  
subclasses  of  AdoCbl-dependent  enzymes,  an intermolecular  histidine  imidazole  vs.  
an intramolecular 5,6-dimethylbenzimidazole.1  Another conceivable difference is that 
different corrin  ring  conformations  are present  in  the  bound  cob(H)alamin  product.  
The  finding that the [<w-(adenosin-5'-0-y/)alkyl]cobalamins  are competitive  inhibi-
tors, that is, bind at the active site in competition with AdoCbl, whereas the AdePeCbl 
analog  is  apparently  a mixed  inhibitor  (i.e.,  is  clearly  a different type  of  inhibition),  
merits  comment.  Possible  different  types  of,  or  sites  for,  binding  of  the  AdePeCbl  
analog  include  (a)  that  only  the  adenine,  or  only  the  cobalamin,  components  of  
AdePeCbl  bind  at  the  active  site  (i.e.,  but  not  both);  or  (b)  that  only  the  adenine  
moeity  binds  at  either  the  substrate  binding  part  of  the  active  site  or  at  the  separate  
allosteric  site  within  RTPR (56)—that  is, that the adenine  part  of AdePeCbl  may  be  
behaving  as  a partial  mimic  of  ATP. Additional  studies—and  ideally  at  least  one X-
ray  crystallographic  structural  study  of RTPR—will  be  required  to distinguish  these  
possibilities,  however.  
In  conclusion,  the  present  kinetic  studies  of  RTPR  with  the  [ty-(adenosin-5'-0-
y/)alkyl]cobalamins analog series (i) provide the best evidence to date, when combined 
with  some  of  our  earlier  work  (14),  that  the  AdoCbl-dependent  enzymes  break  into  
two subclasses, (ii) demonstrate that the C5-analog is the strongest inhibitor for RTPR 
(father than the longer chain, C6-analog as seen for methylmalonyl-CoA  mutase),  (iii)  
show that the UV-visible spectra of bound cob(II)alamin differ for these two subclasses 
of  AdoCbl-dependent  enzymes  as well,  and  (iv) identify, therefore, the C5  analog  as  
the preferred  one for crystallization  trials  and  certain  biophysical  studies.  
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A  base-off  analogue  of coenzyme-B12  with  a modified nucleotide  loop  
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(Co/?-5'-Deoxyadenosin-5'-yl)-(p-cresolyl)cobamide  (Ado-PCC),  an  analogue  of  the  base-off  form of 
coenzyme-B,2  (CoB,2),  was  prepared  by  alkylation  of  (Coa//?-cyano/aqua)-(p-cresolyl)cobamide  (PCC)  
with  5'-chloro-5'-deoxyadenosine.  The  500 MHz  'H-NMR  spectrum  of  Ado-PCC  in D,0  at  pH 7.4  was  
completely  analyzed  using COSY  and  NOESY  two-dimensional  experiments.  The coenzyme  and  inhibi-
tory activities of Ado-PCC were tested  with three coenzyme-Bl2-dependent  enzymes:  (/?)-methylmalonyl-
CoA  mutase,  glycerol  dehydratase,  and  diol  dehydratase.  Ado-PCC  showed  strong  coenzyme  activity  
with  methylmalonyl-CoA  mutase,  which  is  known  to  bind the  base-off  form of CoB,2.  In  contrast,  Ado-
PCC had  no coenzyme  activity  but acted  instead  as a competitive  inhibitor  with glycerol  dehydratase  and  
diol  dehydratase,  which  are  likely  to  prefer  the  base-on  form of  CoB,2.  These  results  indicate  that  Ado-
PCC,  whose  structure  is  analogous  to  the  base-off  form of  CoB12,  can  be  used  for probing  the  mode  of  
coenzyme  binding  by coenzyme-B,2-dependent  enzymes.  
Keywords:  (Co/7-5'-deoxyadenosin-5'-yl)-(p-cresoiyl)cobamide;  base-off  analog  of  coenzyme-B,2;  (R)-
methylmalonyl-CoA  mutase  (Propionibacterium shermanii)-,  glycerol  dehydratase  (Citrobacter  freundii  
gene  overexpressed  in  Escherichia  coli)', diol  dehydratase  (Salmonella  typhimurium  gene  overexpressed  
in  E.  coli).  
Coenzyme-Bl2,  or adenosylcobalamin  (CoB12) is an essential 
cofactor for several  enzymes catalyzing rearrangement  reactions  
[1-5).  The  homolysis  of  the  unique  covalent  bond  between  
cobalt  and  C5'  of  the  adenosyl  ligand  in  this  fascinating  mole-
cule leads to a 5'-adenosyl  radical  and a pentacoordinated  Co(II)  
atom  and  is  the common  initial  step  in the catalytic  cycle  of  all  
CoB,2-dependent  enzymic  reactions.  It  has  been  assumed  [5]  
that a stretching force between  these moieties  caused  by  binding  
to  the  protein  plays  a  crucial  role  in  homolysis.  The  energy  
required  for  this  homolysis  originates  from  a  conformational  
change  in the protein  induced  by binding of  the substrate.  In  the  
homolysis  of  the  cobalt-carbon  bond,  the nature  of  the  a  ligand  
attached  to the central  cobalt  and  the mode  of binding  of  CoBl2  
to  the protein  may  play  a crucial  role  [6.  7]. CoB,2  may  bind  to  
the  apoenzyme  in  two  different  ways.  In  the  base-off  binding  
mode,  the  5,6-dimethylbenzimidazolyl  moiety  of  the  nucleotide  
Correspondence  to  J.  Retey,  Lehrstuhl  Biochemie  am  Institut  für  
Organische Chemie der Universität  Karlsruhe. Kaiserstraße  12. D-76128 
Karlsruhe.  Germany  
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E-mail:  biochem@ochhades.chemie.uni-karlsruhe.de  
Abbreviations.  CoB,,.  coenzyme B,,:  HO-Cbl. aquacobalamin  (vita-
min B | : J :  CN-Cbl. cyanocobalamin  (vitamin B,,);  PCC,  (CN/aq)-/>cre-
solyl-Cba:  Ado-PCC.  (CN/aq)-p-cresolyl-AdoCba.  
Enzymes.  Glycerol  dehydratase  (EC 4.2.1.30): propanediol  dehydra-
tase  (EC  4.2.1.28):  methylmalonyl-CoA  mutase  (EC  5.4.99.2):  alcohol  
dehydrogenase  (EC  1.1.1.1):  dehydrogenase  (EC  1.1.1.37):  methyl-
malonyl-CoA  epimerase  (EC  5.1.99.1):  methylmalonyl-CoA  carboxyl-
transferase  (EC  2.1.3.1).  
loop  of  COB,2  is  displaced  from  the  cobalt  and  replaced  by  a  
histidine residue of the protein.  In the base-on mode, the original 
- 5,6-dimethylbenzimidazolyl  moiety  of  CoB,2  remains  as  the  a  
ligand  of  cobalt  in the  enzyme-coenzyme  complex.  
The  X-ray  crystal  structure  of  (2/?)-methylmalonyl-CoA  
mutase from Propionibacterium  shermanii.  in a ternary  complex  
with  COBi2  and  desulpho-CoA  (a  truncated  substrate),  proved  
that  the  base-off  binding  mode  operates  for  this  enzyme  [8],  
Sequence  comparison  of  (2/?)-methylmalonyl-CoA  mutase  with  
other  base-off  enzymes  [9]  reveals  some  conserved  residues  in  
the  CoB,2-binding  region.  Moreover,  extensive  structural  simi-
larities  were  found  between  the  cobalamin-binding  domain  of  
this  mutase  and  methionine  synthase  [10.  11],  which  catalyzes  
the transfer of a methyl group from its methylcobalamin cofactor 
to the  substrate  homocysteine  to  form  methionine.  
In contrast, glycerol dehydratase and diol dehydratase appear 
to be base-on  enzymes. This  is supported  by a  preliminary  EPR  
study  of  the complex  between  [14N]coenzvme and diol  dehydra-
tase  [l5N]apoenzyme which  had  been  inactivated  with  2-methyl-
2,2-propanediol  [12].  Furthermore,  sequence  analysis  of  several  
glycerol  dehydratase  and diol dehydratase enzymes from various 
sources  [13]  indicated  that  in  the  CoB,,-binding  domain  there  
are no matches  with the sequence patterns of  the conserved  resi-
dues  of  the  known  base-off  enzymes  [9],  
Although  several  base-off  analogues  of  CoB,;  have  been  
synthesized  for chemical  characterization  and  model  studies  [6.  
7,  14],  to  our  knowledge  none  of  them  has  been  tested  with  
CoB12-dependent  enzymes.  Therefore,  we  took  advantage  of  a  
new base-off analogue  of CoB12.  in which  the nucleotide  loop  is  
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not  coordinated  to  the  cobalt  of  the  corrin  moiety,  and  used  it  
for  kinetic  studies  with  three  CoB.--dependent  enzymes.  The  
coordination  of  the  cobalt  of  CoB,2  by  a  basic  nitrogen  atom  
from the a  side  is required  to allow  homolysis  of  the  Co-carbon  
bond  on  the  /? side  [6.  7],  Therefore,  the  base-off  enzymes  pro-
vide  a histidine  residue  of the  protein  as the essential  a  nitrogen  
ligand.  and  our  base-off  CoB,-  analogue  is  expected  to  act  as  a  
fully  functional  coenzyme  with  these  enzymes.  On  the  other  
hand,  our  base-off analogue  should  not  exhibit  coenzyme  activ-
ity  with  base-on  enzymes  which  do  not  provide  the  essential  
nitrogen  ligand  and  cannot  promote  the  homolysis  of  the  Co-
carbon  bond.  
Here,  we  report  in  detail  the  synthesis,  the  'H-NMR  data,  
and  the enzyme-kinetic  properties  of  (Co/?-5'-deoxyadenosin-5'-
yl)-(/?-cresolyl)cobamide  (Ado-PCC).  a  base-off  analogue  of  
COB,2. 
MATERIALS  AND  METHODS  
Materials.  Adenosine,  coenzyme-BI2.  sodium  tetrahydrobo-
rate,  and  succinic  anhydride  were  obtained  from Fluka  Chemie  
AG.  Racemic  1.2-propanediol  was  supplied  by Aldrich. (Coa/fi-
cyano/aqua)-(p-cresolyl)cobamide  (PCC)  was  isolated  from  
Sporomusa  ovata  cells  in  its  cyano  form  by  extraction  with  
potassium-cyanide-containing  acetic  acid,  pH 5,  followed  by  
centrifugation  at  15000 g  for  15 min,  treatment  of  the  superna-
tant  by neutral  aluminum oxide,  desalting, chromatography  on  a  
XAD-2 column,  and RP18-HPLC  as previously  described  [ 1 5 -
17].  Yeast  alcohol  dehydrogenase,  L-malate:NAD  oxidoreduc-
tase  (malate  dehydrogenase),  /J-NADH  Li?  (NADH),  and  coen-
zyme-A  (CoA)  were  from  Boehringer  Mannheim.  (2/?)-Methyl-
malonyl-CoA  mutase.  methyimalonyl-CoA  epimerase,  and  
methylmalonyl-CoA  carboxyltransferase  from  Propionibacte-
rium  shermanii  were  isolated  and  assayed  according  to  pre-
viously  published  methods  [18-20].  Glycerol  dehydratase  was  
isolated  as  described  previously  [21]  from  overexpressing  
Escherichia  coli  cells  containing  the genomic  DNA  of  glycerol  
dehydratase from Citrobacter freundii  [22. 23]. Diol  dehydratase  
was  isolated  as  previously  published  [21]  from  overexpressing  
E.  coli  cells  containing  genes  of  diol  dehydratase  from  Salmo-
nella  typhimurium  LT2.  
Synthesis and characterization  of  (Co/?-5'-deoxyadenosin-
5'-yI)-(p-cresoIyl)cobamide  (Ado-PCC).  To  a  solution  of  
(Coa//?-cyano/aqua)-(p-cresolyl)cobamide  (7.5 mg,  5.6 pmol)  in  
0.5  ml  deoxygenated  water,  a  solution  of  sodium  tetrahydrobo-
rate (5 mg)  in 0.4  ml deoxygenated  water was added under argon 
atmosphere  at  room  temperature,  and  the  resulting  solution  was  
stirred  for  30 min.  A  solution  of  5'-chloro-5'-deoxyadenosine  
[24]  (10 mg,  28 pmol)  in  0.4 ml  deoxygenated  acetonitrile  was  
subsequently  added, and the mixture  was stirred  at room  temper-
ature  in the dark for  1 h. The reaction mixture  was filtered under 
sterile conditions  through a 30-kDa nitrocellulose membrane  and  
applied  onto  a  preparative  HPLC  column  (Macherey  &  Nagel,  
250 mmX20 mm  Nucleosil-7-C,,,).  The column  was  eluted  with  
a  water/methanol  gradient (20-85%  methanol  over  35 min  at  a  
flow  rate  of  5 ml/min.  diode  array  detection  by  monitoring  at  
240 nm  and  280 nm.  ultraviolet  spectra  between  200 nm  and  
600 nm  from  the  peaks).  The  fractions  containing  the  product  
were  concentrated  in  a  SpeedVac  to  yield  5.7 mg  Ado-PCC  
(yield 64%.  purity  98%).  Analytical  HPLC  indicated  a  retention  
time  /?,.  of  4.5 min  [Macherey  &  Nagel.  125 mmX4  mm,  5  pm 
LiChrospher  100  RP-18 column,  linear gradient: 4 0 - 9 0 %  B  in  
A  over  12 min  (solvent  A:  0.02%  trifluoroacetic  acid  in  water;  
solvent  B:  0.02%  trifluoroacetic  acid  in  methanol),  flow  rate  
1 ml/min.  diode  array  detection].  Peaks  in  the  ultraviolet  region  
were  detected  at  the  following  wavelengths:  268.  305.  381.  
456  nm.  
'H-NMR  spectroscopy.  'H-NMR  spectra  of  Ado-PCC  
(1.1 mg  in  0.4 ml  20 mM  sodium  phosphate/D-0  buffer.  pH  
meter  reading  7.45.  5-mm  sample  tube)  were  recorded  at  10°C  
on  a  Bruker  AM-500  spectrometer  using  conventional  Fourier  
transform  methods  as  in  our previous  studies  [25], The  residual  
HDO  resonance  was  suppressed  by  selective  presaturation.  
Parameters  for  the  one-dimensional  spectrum  were  spectral  
width  4762 Hz.  32 K  time-domain  points,  presaturation  for 4  s,  
50°  flip angle,  acquisition  time  3.44 s,  512  transients.  Data  pro-
cessing  was  performed  with  Lorentz-Gauss  resolution  enhance-
ment  at  a  digital  resolution  of  0.29 Hz.  For  well-resolved  reso-
nances,  chemical  shifts (relative  to internal  trimethylsilyl  propi-
onic  acid)  and  coupling  constants  were  derived  from  the  peak-
picking  output  (cubic  interpolation);  chemical  shifts  given  to  
only  two decimal  places  were estimated  from  cross-peaks  in  the  
two-dimensional  COSY  spectrum.  A  total  of  79  nonexchange-
able protons  was confirmed by  integration  and  the complete  as-
signments  are  given  in Table  1.  
Two-dimensional  magnitude-mode  COSY-/?  and  NOESY  
spectra  were  obtained  using  conventional  pulse  sequences  and  
the  following  parameters.  For  COSY,  spectral  width  4348 Hz, 
2 K  time-domain  points  in  i2,  acquisition  time  0.236 s,  512  f,  
increments  with  48  transients  each,  20 ms  initial  delay  in  each  
time domain  and  /? =  60°  read pulse,  relaxation  delay  with  pre-
saturation  =  3 s,  repetition  time  sine-bell  window  functions,  
zero-filling  to  I K  in  /,,  digital  resolution  4.35 Hz/pt.  For  
NOESY, as for COSY except relaxation delay with  presaturation  
2.5  s,  64  transients  per  increment,  90°  read  pulse,  mixing  time  
600 ms  with  maximum  15%  random  variation.  The  COSY  
spectrum  could  be  analyzed  for  the  complete  assignment  of  all  
coupled  spins;  the  NOESY  spectrum  provided  the  additional  
correlations  needed  to  completely  assign  all  coirin  methyl  
groups. 
Enzyme  kinetics.  Kinetic  studies  were  performed using  the  
NADH-coupled,  ultraviolet-based  assay  systems  developed  for  
methylmalonyl-CoA  mutase  [26], glycerol  dehydratase,  and  diol  
dehydratase  [21].  A  mean  rate  for  the  enzyme  reaction,  mea-
sured  over  the  interval  t  = 2 - 3  min  of  the  assay,  was  used  for  
the  calculation  of  kinetic  parameters.  
Apparent  Michaelis-Menten  constants  (Km,  Vm„)  for  CoB,2  
and  Ado-PCC  were determined  using standard  methods  (1—5 pi 
of 0.001 - 1  mM CoB,2  solutions,  12 data points; linearized  plots  
according  to  Lineweaver-Burk,  Hanes,  and  Eadie-Hofstee).  
Kinetic  constants  were  calculated  as  the  average  of  the  values  
obtained  with  these  three  methods.  
Apparent  inhibition  constants  (Kr)  for Ado-PCC  were  deter-
mined  by  the  so-called  parallel  method  [26].  CoB12  ( 1 - 5  pi  
0 .1 -1  mM  solutions)  and  inhibitor  ( 1 - 5  pi  0 .01-1  mM  solu-
tions)  were  added  simultaneously  to the  assay  mixture.  At  three  
different CoB12 concentrations (0 .1-1  pM), inhibitor  concentra-
tions  were  varied ( 5 - 7  data  points  for each  coenzyme  concen-
tration).  Inhibition  constants  were  calculated  from  the  slope  of  
the  lines  obtained  by  linear  regression  of  these  data  sets  in  a  
Dixon  plot  using  the following  equation:  
K, =  slope  X [CoB,2]  V„JKm  ,  
where  K„  [CoBl2],  Km  concentrations  are  nM  and  Vm„  in  units  
of  nmol/min.  Finally.  K,  was  computed  as  the  average  of  the  
three experimental  K, values obtained at different CoB,2  concen-
trations. 
R E S U L T S 
A  unique  corrinoid,  (Coa//?-cyano/aqua)-(p-cresolyl)cobam-
ide (PCC),  which  differs from vitamin B I2  in the moiety  attached  
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Table  1.500-iVIHz 'H-NMR  data  for CoBu  and  the analogue Ado-PCC in  D-O. Assignment  nomenclature  is analogous  to [25].  Chemical shifts 
for  CoB,-  are  from  [28]  and  [29].  J  coupling  partners  and  assigned  constants  are  given  where  these  could  be  resolved.  Detected  partners  giving  
NOES Y cross-peaks  are given;  bold-face  print  indicates  the strongest  effect, d, doublet:  q. quadruplet:  s.  singlet.  
Assignment Signal 
type 
Chemical shifts 
Ado-PCC  base-ofF  
(pH  7.45.  CoB„  
10 °C)  (pH 2.1,  
20 °C) 
base-on 
CoB,-
(pH  7.0.  
20 °C) 
J  couplings  
-  (Ado-PCC)  
NOEs  (Ado-PCC)  
ppm Hz 
Corrin  methyl  Ml s 0.704 0.81 0.47 M2, M3 
M2 s 1.405 1.48 1.36 Ml,  M5,  H3  
M5 s 2.389 2.43 1.45 M2,  H3,  M7, 7'a,  b  
M7 s 1.819 1.82 1.70 M5 
M120 s 0.845 1.00 0.87 M12a;  M15,  H13  
M12cr s 1.585 1.67 1.32 M12/7 
M15 s 2.336 2.46 2.43 HI 3,  M12,  M17 
M17 s 1.141 1.40 1.36 M15,  H19  
Conin  CH  H3 dd 4.217 4.23 4.10 3'a,  b:2,  9.5  M2,  M5 
H8 dd 3.784 3.73 3.29 8'a,  b:8.7,  4.5  H10 
H10 s 6.994 6.97 5.93 H8, M120.  M12«r  
H13 dd 3.308 3.43 2.89 131a,  b:4.  6  MIS,  M12 /? 
H18 ddd 2.787 2.85 2.65 18' a, b:9,  3  
H19 d 4.653 4.70 4.24 18:10.7 M17,  2' a,  b  
Corrin  CH2  side  chain  2'a,  b  d 2.66,  2.285  2.60,  2.46  2.41 2'a,  b: —13.5 
3'a,  b  m 1.99,1.89 2.11,  1.97  2.06,  1.96  
32a,  b  ddd 2.50, 2.43 2.55 2.50 
V  a,  b  d 2.275,  1.73  2.61,  2.14  2.19,  1.72  7 'a ,  b:  -13.5  M5 
8'a,  b  m 2.25,  1.82  2.21,  1.75  1.75, 0.81 
82a,  b  ddd 2.43,  2.31  2.35,  2.35  1.73, 0.88 
13'a,  b  m 2.18,  1.88  2.21,  1.92  2.22,  2.00  
132a,  b  ddd 2.15,  1.78  2.21,  1.86  2.54 
17* a,  b  ddd 2.42,  1.83  2.51,  1.85  2.45,  2.06 
172a,  b  ddd 2.36,  1.76  2.31,  1.85  2.45,  1.78  
18* a,  b  dd 2.68,  2.49  2.78 2.65 
Aminopropan-2-ol  side  chain  CH2 (Apr-la,  b)  dd 3.470,  3.395  3.38,  3.27  3.54,  3.16  la ,  b: —14.1 
CH  (Apr-2)  dddq 4.42 4.36 4.33 la ,  b:  3.7,  5.0  
CHj (Apr-3) d 1.238 1.23 1.21 2:  6.4  
Loop  ribose  1' d 5.664 6.56 6.26 2':  4.6  2',  Cr2,6  
2' dd 4.331 4.97 4.23 3':  6.3, P:  1.0  3' 
3' dd 4.551 4.83 4.72 4':  2.5,  P:  8.1  5' 
4' dd 4.38 4.79 4.10 5'a,  b:  3.0,  3.5  5' 
5'a,  b  m 3.72,  3.70  3.94,  3.84  3.88,  3.74  5'a, b:  - 1 3  4' 
Cresolyl Cr2,6 d 6.873 ortho:  8.6  1' 
Cr3,5 d 7.026 Cr4-Me 
Cr4-Me s 2.128 Cr3,5 
Adenosyl H2 s 8.233 8.43 8.19 M15  (?)  
H8 s 8.037 8.21 8.00 1', 2',  3'  
1' d 5.615 5.61 5.56 2':  3.8  2',  M12,  M17  
2' dd 4.40 4.34 4.54 3':  6.2  3' 
3' dd 3.754 3.90 3.74 4':  6.2  2' 
4' d 2.002 1.98 2.54 5'a,  b:  1.0, 9.0 
5'a.  b  dd. dd 0.602.  0.312 1.46.  0.38 1.55,  0.57 5'a,  b:  -8 .5  
to  the  ribose CT  of  the  nucleotide  loop,  is  the cofactor used  by  
the  corrinoid-dependent  methyl  transfer enzymes  of  Sporomusa  
ovata  [15-17].  The  a  side  of  the  central  cobalt  in  this cofactor 
cannot  be coordinated  by the p-cresolyl  moiety of the  nucleotide  
loop.  Accordingly.  PCC  is  bound  to  corrinoid-containing  en-
zymes  via  a  histidine  residue  that  serves  as  a  ligand  [27].  The  
reductive  alkylation  of  vitamin  B12a  is an  established  method for 
obtaining  alkylated  corrinoids  [25].  Since  PCC was expected  to  
be  alkylated  analogously,  this corrinoid  was  chosen  as  the  start-
ing compound  for the preparation  of a new  base-off analogue of 
CoB,-  (Fig.  1).  In  accordance  with  our  expectations,  alkylation  
of  PCC  by  5'-chloro-5'-deoxyadenosine  proceeded  exclusively  
from the  /? side,  providing  Ado-PCC  in  good  yield.  
The  500-MHz  'H-NMR  spectrum  of  Ado-PCC  in  D-0  
was  completely  analyzed  with  the  help  of  two-dimensional  
COSY  and  NOESY  experiments.  The  data  for  Ado-PCC  and,  
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Fig.  1.  Synthesis  of  (Co/F5'-deoxyadenosin-5'-yl)-(p-cresolyl)cob-
amide  (Ado-PCC)  from  (Coa/(-cyano/aqua)-(/?-cresolyl)cobamide  
(PCC).  Ligands  X  and  Y  are  on  the  [1 and  a  side  of  the  corrin  ring,  
respectively. 
Table  2.  Kinetic  properties  of  Ado-PCC  with  (2£)-methylmalonyl-
CoA  mutase,  glycerol  dehydratase,  and  diol  dehydratase.  Apparent  
Km  values  were  measured  according  to  the  Enzyme  kinetics  section  in  
Materials  and  Methods.  Apparent  inhibition  constants  were  estimated  
by  the  'parallel'  method  described  in  this  section.  (Fl-Methylmalonyl-
CoA  mutase  was  isolated  from  Propionibacterium  shermanii  (Vm„  =  
23 ±  3 nmol/min  with  CoB,,).  Glycerol  dehydratase  was  isolated  from  
overexpressing  £.  coli  containing  the  gene  from  Citrobacter  freundii  
CK^x  =  48 ± 4  nmol/min  with  CoB,,).  Diol  dehydratase  was  isolated  
from  overexpressing  Escherichia  coli  containing  the  gene  from  Salmo-
nella  typhimurium  (Vmux  =  51 ± 6  nmol/min  with  CoB,.).  n.i..  no  inhibi-
tion.  n.a..  no  coenzyme  activity  was  found  up  to  25 pM  Ado-PCC.  
Enzyme  Km  (CoB,,)  K'm  K,  
(Ado-PCC)  (Ado-PCC)  
nM 
(£)-Methvlmalonyl-CoA  mutase  354±  87  64±21  n.i.  
Glycerol  dehydratase  14±  3  n.a.  160±  37  
Diol  dehydratase  750±120  n.a.  9200±1700  
for comparison, data obtained by Bax and coworkers for the 
base-on [28] and base-off [29] forms of CoB,: are summarized 
in Table 1. 
Three CoB ..-dependent enzymes were  tested  in kinetic 
studies using the resulting base-off analogue. (2/?)-Methylmalo-
nyl-CoA mutase was chosen as a reference enzyme since the 
base-off mode of CoB,, binding had been unambiguously estab-
lished by X-ray crystallography [8]. Glycerol dehydratase and 
diol dehydratase are considered to be base-on enzymes, and 
these were investigated for both coenzyme activity and enzyme 
inhibition. The results of these kinetic investigations are summa-
rized in Table 2. 
D I S C U S S I O N 
Comparison of the 'H-NMR data for Ado-PCC with those 
for CoB,, confirm that the analogue has the base-off structure. 
The corrin methyl groups at positions 1,5. 7. and 12a as well 
as the six methine protons are particularly sensitive to the pres-
ence or absence of 5,6-dimethylbenzimidazolyl as a Iigand  in  
CoB,,. and the chemical shifts for these protons in Ado-PCC 
agree well with the values for base-off CoB,,. The NMR param-
eters for the aminopropanol part of the nucleotide loop in Ado-
PCC are also consistent with the base-off structure: in particular, 
the vicinal coupling constants of 3.7 Hz and 5.0 Hz for Apr-2 
agree well with the values of 3.9 Hz and 5.2 Hz found for base-
off CoB,, [29]. The VPH coupling of phosphorus to the loop 
ribose H3' is the same (8.1Hz) for Ado-PCC and base-off 
CoB,,. but other couplings and shifts for this ribose are signifi-
cantly different due to the influence of the cresolyl moiety. For 
the adenosyl  ß ligand. the greatest sensitivity to base attachment 
is found for the chemical shift of  H4', which is nearly the same 
in Ado-PCC and base-off CoB,,. Interestingly, the chemical 
shifts for adenosyl H5'a. corrin Ml Iß and Ml 7 are, respectively, 
about 0.86, 0.15, and 0.36 ppm upfield of the positions observed 
for base-off CoB,,. This may reflect a different orientation of 
the adenosyl group or specific effects of the cresolyl group in 
Ado-PCC. 
As expected, Ado-PCC proved to be a fully functional co-
enzyme for methylmalonyl-CoA mutase. Surprisingly, the K'm 
value for Ado-PCC is even smaller than that of the natural co-
enzyme. This may be rationalized by considering that the bind-
ing of CoB,, to the enzyme requires first the displacement of 
the 5,6-dimethylbenzimidazolyl moiety bound to cobalt before 
the imidazole side chain of the essential histidine in the protein 
can bind to the cobalt. In contrast, a Co-N bond need not be 
broken before binding of Ado-PCC, whose p-cresolyl moiety 
may in fact fit into the hydrophobic pocket normally occupied 
by the dimethylbenzimidazole of CoB,,. No coenzyme activity 
was found with glycerol dehydratase and diol dehydratase  at  
concentrations two or even three orders of magnitude higher 
than the ATm of CoB,,. providing further evidence for the base-
on mode of cofactor binding for these enzymes. 
The kinetic studies with Ado-PCC, however, revealed signif-
icant competitive inhibition with respect to CoB,, for both glyc-
erol dehydratase and diol dehydratase, with the X, for Ado-PCC 
being about a factor of ten higher than the Km of CoB,,. Cyano-
cobalamin or aquacobalamin with 5,6-dimethylbenzimidazolyl 
as a ligand and CN or OH as  ß ligand are strong inhibitors of 
glycerol dehydratase and diol dehydratase, with K, of 21.6 or 
8.6 and 1420 or 680 nM. respectively [21]. This indicates that a 
base-on analogue can occupy the corrin-binding site and can 
compete with CoB,, binding. The fact that the base-off corrinoid 
PCC with OH  or CN as ß ligand on cobalt proved not to be 
inhibitor for these enzymes indicates that the adenosyl moiety 
as ß ligand is necessary for the binding of Ado-PCC to these 
enzymes and the resulting inhibition. Thus, Ado-PCC is appar-
ently anchored by its adenosyl moiety to the holoenzyme, but 
the (p-cresolyl)cobamide moiety may still fit into the corrinoid 
binding region by adopting a base-on conformation. Conse-
quently, the absence of coenzyme activity for Ado-PCC in glyc-
erol dehydratase and diol dehydratase can be best rationalized 
by the absence of a basic nitrogen as a ligand for the central 
cobalt: such a ligand is required to facilitate the homolysis of 
the Co-C bond in Ado-PCC complexed to enzymes. 
In summary. Ado-PCC has a structure that is completely 
analogous to the base-off form of CoB,,. Ado-PCC proved to be 
a fully functional coenzyme with methylmalonyl-CoA mutase, 
which is known to bind the base-off form of CoB,,. Ado-PCC 
had no coenzyme activity with glycerol dehydratase and diol 
dehydratase, but inhibited these enzymes  in a competitive 
manner, implying that these enzymes require a coenzyme in the 
base-on form. These results indicate that this base-off analogue 
of CoB,, can be used as a general probe for testing the 
coenzyme-binding mode of coenzvme-B „.-dependent enzymes. 
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ABSTRACT 
(Co/?-5 '-Deoxyadenosin-5 '-yl)-(p-cresyl)cobamide  (Ado-PCC)  a  base-off  analogue  of  
coenzyme-Bn  (Ado-Cbl) was used to elucidate the  coenzyme  B12  binding mode of glutamate 
mutase, 2-methyleneglutarate mutase and ethanolamine ammonia-lyase. Ado-PCC functions as 
excellent  coenzyme  for the  carbon  skeleton  rearrangements  with  apparent  Km  values  of  200  
and  10 nM for  glutamate  and  2-methyleneglutarate  mutases,  respectively.  The  corresponding  
values for Ado-Cbl are 60 and 54 nM, respectively. 
In contrast, Ado-PCC showed no coenzyme activity with ethanolamine ammonia-lyase but was 
a  competitive  inhibitor  with  respect  to  Ado-Cbl.  The  Ki  value  for  Ado-PCC  was  26,  the  
apparent Km value for Ado-Cbl was 30 nM. 
These  results  are  in  agreement  with  the  notion  that  in  glutamate  and  2-methyleneglutarate  
mutases  a  conserved  histidine  residue  of  the  protein  is  coordinated  to  the  cobalt  atom  of  
coenzyme  B12, whereas  in ethanolamine  ammonia-lyase  the  dimethylbenzimidazole  residue  of  
the coenzyme itself serves as ligand. 
Keywords: 
(Coyff-5 '-deoxyadenosin-5 '-yl)-(/?-cresyl)cobamide;  base-off  analogue  of  coenzyme-B^;  
ethanolamine  ammonia-lyase  (Salmonella  typhimurium),  glutamate  mutase  (Clostridium  
cochlearium ); 2-methyleneglutarate mutase (Clostridium  barken).  
Abbreviations.  HO-Cbl,  aquacobalamin  (vitamin BI28); Ado-PCC,  (Cofi-S '-deoxyadenosin-5 '-
yl)-(p-cresyl)cobamide. 
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INTRODUCTION 
Coenzyme  Bi2-dependent  enzymes,  as  are  methyltransferases  and  carbon  skeleton  
mutases,  bind  their  cofactor  via  a  conserved  histidine  residue  of  the  protein,  which  is  
coordinated to the cobalt atom of coenzyme B]2, and the dimethylbenzimidazoie residue of the 
coenzyme  is  attached  to  another  site.  On  the  other  hand,  it  has  been  shown  for  
dioldehydratases,  that  upon  binding  of  the  coenzyme  to  the  apoenzyme,  the  
dimethylbenzimidazoie  ligand  remains  coordinated  to  the  cobalt  and  is  not  exchanged  by  
histidine residue from the protein.  This difference in coenzyme binding has been termed "base  
off"  and  "base  on",  respectively.  Since  the  imidazole  part  of  histidine  is  also  a  base,  the  
designation "base exchange" rather than "base off" is more appropriate.  
Until now three methods have been published to distinguish between these binding modes: 
X-ray crystallography  [1,2], EPR spectroscopy  using  1SN-Iabelled  enzymes and/or  coenzymes  
[3-7]  and  using  the  base-off  analogue  of  coenzyme-B«,  Ado-PCC,  which  behaves  either  as  
excellent coenzyme or an inhibitor [8] depending on the binding mode. 
The  first  X-ray  structure  showing  a  cobalamin  coordinated  to  a  histidine  residue of  the  
protein  was  elucidated  by Drennan  et  al  [1]  with  the  methylcobalamin-dependnt  methionine  
synthase.  More  recently,  Mancia  et  aL  [2]  and  Reitzer  et  al.  [9]  identified the  same  kind  of  
binding  in  the  coenzyme-Bi2-dependent  methylmalonyl  CoA-mutase  and  glutamate  mutase,  
respectively. 
The EPR method is based on the superhyperfine splitting of the spectrum of  cob(II)alamin 
by  an  axial  nitrogen  ligand.  Interaction  of  unpaired  electron  with  the  S9Co  nucleus  
P(59CO)=7/2]  [10,  I I ]  leads to  an  octet  (hyperfine  splitting)  while  each  member  thereof  is  
further  split  to  triplets  reflecting  additional  interaction  with  the  axial  nitrogen  ligand.  
Substitution of the latter by the isotope  15N p (15N)=l/2] results in an octet of doublets. On the 
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basis of this phenomenon it has been shown using  15 N-labelled  enzymes that those  rearranging  
carbon  skeletons  replace  the  original  dimethylbenzimidazole  ligand  by  the  imidazole  of  a  
histidine residue of the protein. 
By contrast,  using Ado-Cbl  labelled with  1SN in the  dimethylbenzimidazole  ligand,  it  has  
been  shown  that  diol  dehydratase  [6]  and  ribonucleotide  reductase  [12]  bind  the  cofactor  
without  base  exchange.  The  same  conclusion has  been  drawn  using  an  1 ^-labelled  artificial  
coenzyme  B12 analogue  [7].  
The  third  method  to  differentiate between  the two  binding  modes  is the  use  of base-off 
analogues  of  coenzyme  B12. In  a  previous paper  we  have  shown that  Ado-PCC  served  as  a  
coenzyme in the methylmalonyl-CoA mutase reaction, while it was an inhibitor for propanediol 
dehydratase and glycerol dehydratase [8].  
Here  we  present  further  results  confirming  the  usefulness  of  Ado-PCC  (Fig.  1)  for  
differentiating between the two coenzyme binding modes. 
EXPERIMENTAL 
Materials:  Adenosine,  coenzyme-Bi2  and  sodium tetrahydroborate  were  obtained  from  
Fluka  Chemie  A.G.  Other  other  biochemicals  were  purchased  from  Boehringer  Mannheim.  
(Cofi-5 '-Deoxyadenosin-5 '-yl)-(p-cresyl)cobamide (Ado-PCC) was synthesized and purified as 
previous^ described  [8].  
Enzymes:  Alcohol dehydrogenase from yeast (EC  1.1.1.1) was obtained from Boehringer  
Mannheim.  Glutamate  mutase  (EC  5.4.99.1)  from  Clostridium  cochlearium  [13]  and  2-
methyleneglutarate mutase (EC 5.4.99.4) from Clostridium barkeri  [14] were overproduced in 
E.  coli  and isolated as previously described.  Methylaspartate  ammonia lyase (EC 4.3.1.2)  and  
3-methylitaconate isomerase (EC 5.3.3.6) were isolated from Clostridium barkeri  [15-17]. The 
E. coli  strain CAG626,  which overexpresses the genes coding for ethanolamine ammonia lyase 
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(EC  4.3.1.7)  from  Salmonella  typhimurium  (plasmid  pE  AL31/50)  [18],  was  generously  
provided by Drs. B. Babior [18] and C. B. Grissom [19]. 
Isolation  of ethanolamine ammonia lyase (EAL): 
Cell  cultivation  and  harvesting.  Luria-Bertani-agar  plates  (containing  ampicillm,  60  mg/L)  
were inoculated with the E.  coli  strain and incubated at  37 °C with shaking at  250 rpm for  16 
h. This culture was added to  1  L of the above LB media and incubated at 37 °C with shaking at 
250  rpm  for  3  h  (until  the  Aéoo reached  about  1.0)  and  then  (130  mg  of  isopropyl  {3-D-
thiogalactoside  was added.  The culture was  shaken at  37  °C for further 4 h.  Finally the  cells  
were  harvested  by  centrifugation at  4500  x  g  for  10  min  and  the  pellet  was  washed  with  
potassium phosphate buffer (20 mM, pH 7.5). 
Enzyme  Isolation.  The pellet  (3.5  g  wet  paste)  was  suspended  in  10  mL 20  mM  potassium  
phosphate, pH 7.5, which contained 40 U benzonase (Merck), 5 mM benzamidine and 0.5 mM 
phenylmethylsulfonyl fluoride,  and  the  cells  were  disrupted  by  sonification  (Branson,  Model  
450, 70% power setting) at 4-8 °C for  10 min. The resulting  slurry was centrifuged at  30,000 
x  g  and  0°C  for  30  min.  To  the  supernatant  16.4  %  ammonium  sulfate was  added  and  the  
solution was stirred at 4 °C for 30 min and centrifuged at 30,000 x g and 0 °C for 30 min. The 
pellet  was  dissolved  in  30  mL  10  mM  potassium  phosphate,  pH  7.4,  1  mM  ethanolamine  
hydrochloride,  10 mM potassium chloride, 5 mM dithiotreitol and  10 % (by vol.) glycerol  The  
solution was clarified by dialysis against the same buffer at 4  °C overnight and applied to a 30 
x  16 mm Resource Q column (Pharmacia) equipped with a 25 x  16 mm HiTrap Q (Pharmacia)  
precolumn 20  °C,  6  mL/min.  The  enzyme  was  eluted  with  a  linear  gradient  of  solvent  B  in  
solvent  A;  solvent  A:  potassium  10 mM phosphate,  pH  7.4,  10 mM potassium  chloride,  10  
mM  ethanolamine  hydrochloride  and  5  mM  dithiotreitol;  solvent  B:  10  mM  potassium  
phosphate, pH 7.4,  1.5 M potassium chloride,  10 mM ethanolamine hydrochloride  and 5 mM 
dithiotreitol.  The active fractions of ethanolamine  ammonia lyase were eluted between 20 and 
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30 % of solvent B. The active fractions were combined and applied to  a 600 x 26 mm HiLoad 
26/600  Superdex 200  column (Pharmacia) (4  °C,  1.5 mL/min,  elution with 20 mM potassium 
phosphate, pH 7.5,  0.5 M potassium chloride,  10 mM ethanolamine  hydrochloride  and  5 mM 
dithiotreitol).  The  fractions  showing  enzyme  activity  (100-130  min)  were  combined  to  yield  
34.6  mg of protein with a  specific activity of  36  U/mg.  After the  solution was kept  at  4  °C  
overnight,  glycerol was added to  a final concentration of  50 %  (by vol.)  and the mixture was 
frozen  at  -20  °C.  Under  these  conditions  the  specific  activity  of  28.8  U/mg  remained  
unchanged after storage for six months. 
Enzyme assays: 
Glutamate  mutase:  The assay was based on the  monitoring  of the  absorption  of  mesaconate  
(ham- 240 nm) [15,  16]. The assay mixture (total volume  1 ml) contained:  10 mM glutamate,  
1  mM  mercaptoethanol,  47  mM  Tris/HCl  pH  8.3,  9.4  mM  KC1,  0.94  mM  MgCfe,  3  U  
methylaspartase,  0.25  pM  component  £  and  3.1  pM  component  S  of  glutamate  mutase.  
Component  S was incubated with mercaptoethanol for 3 min at  37°C. The reaction was started 
by addition of the coenzyme or coenzyme analogue [20]. 
2-Mefhyleneglutarate  mutase:  The  assay  was  based  on  the  monitoring  of  the  absorption  of  
dimethylmaleinate at 256 nm [17]. The assay mixture (total volume  1 ml) contained:  10 mM 2-
methyleneglutarate,  100 mM potassium phosphate  buffer (pH  7.4),  0.3  U  3-methylitaconate  
isomerase, and 0.3 pM 2-methyleneglutarate mutase. After incubation of the assay mixture  at  
37 °C for 5 min, the reaction was started by addition of the coenzyme or coenzyme analogue. 
Ethanolamine  ammonia  lyase:  The  assay  was  based  on  established  yeast  alcohol  
dehydrogenase - NADH coupled methods [3,4] with minor modifications. In a cuvette 50 mM 
potassium phosphate  buffer, pH  7.5,  10 mM  ethanolamine  hydrochloride  and  0.2  mM of  P-
NADH, 5 U yeast alcohol dehydrogenase  and 20 pi ethanolamine ammonia lyase solution (1:3 
dilution from the above glycerol stock with 50 mM potassium phosphate, pH 7.5) were mixed 
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and the resulting solution was incubated at  37 °C for 3 min. A blank was determined  without  
addition  of  coenzyme-Bi2.  The  enzymatic  reaction  was  started  by  addition  of  0.001-1  mM  
coenzyme-Bn solution and the decrease of absorbance at 340 nm was recorded for several min 
at 37 °C. The rate of reaction was calculated from the change of absorption at 340 nm. 
Kinetic  investigations:  
The  kinetic  constants  for  coenzyme  B]2  and  Ado-PCC  with  the  three  enzymes  were  
measured using the spectrophotometry  assays described above. The Km  and  Vm«  values were 
determined  with  1 nM  -  1 mM  coenzyme  BI2 or  Ado-PCC  at  9  data  points.  The  standard  
linearisation methods by Lineweaver-Burk, Hanes or Eadie-Hofstee were used. 
The apparent Michaelis constants for coenzyme Bi2  and Ado-PCC are given in Table  1. It 
should be noted  that  the  determined  apparent  Km  values fr>r the  cobamides are  dependent  on  
the concentration of the enzyme in the assay. In the simple Michealis-Menten equation used in 
this  work,  a  basic  assumption  is  a  great  excess  of  substrate  over  enzyme.  Since  here  the  
enzyme  and  coenzyme  concentrations  were  in  the  same  range,  these  constants  should  be  
regarded as apparent relative values. 
The  apparent  inhibition  constant  (Ki)  for  Ado-PCC  was  determined  by  the  so-called  
'parallel'  method  [21].  To  the  assay  mixture  coenzyme  B]2  and  Ado-PCC  were  added  
simultaneously.  The  inhibitor  concentrations  were  varied  (6-8  data  points)  at  three different  
coenzyme  Bi2  concentrations  (0.5  -  2.5  pM).  Inhibition  constants  were  calculated  from  the  
equation: K\ — (slope x [coenzyme BI2] x  Vm^lKm, where K\, Km and [coenzyme BI2] are given 
in nM,  Fmax in nmol/min; the slopes were taken from the linear regressions in Dixon plots  (1/V 
vs.  [Ado-PCC]);  the final was  Kx taken as  an  average  of the  particular  Kx values  at different 
coenzyme BI2 concentrations. 
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RESULTS AND DISCUSSION 
Ado-PCC  a  base-off  analogue  of  coenzyme  B12  [8]  was  probed  as  a  coenzyme  and/or  
inhibitor  of the  coenzyme  B12 dependent  recombinant  enzymes,  ethanolamine  ammonia  lyase,  
2-methyleneglutarate  mutase  and  glutamate  mutase.  The  kinetic  constants  of  Ado-PCC  with  
the three enzymes are listed in Table  1. For ethanolamine ammonia lyase Ado-PCC acts only as 
an  inhibitor  and  the  corresponding  inhibition  constant  (Kj)  is  similar  to  the  relative  Km  for  
coenzyme  B12 (30 nM). 
For  the  two  carbon  skeleton  rearranging  enzymes  2-methyleneglutarate  mutase  and  
glutamate  mutase  Ado-PCC  serves as  coenzyme.  In the  case of  2-methyleneglutarate  mutase  
the  relative  Km  value  for  the  Ado-PCC  was  found  about  five  times  lower  than  that  for  
coenzyme  B12. Moreover,  while  there  was  a  lag  phase  of  1 -  2  min  when  the  reaction  was  
started  with the natural coenzyme, this was not  observed  with Ado-PCC.  On the  other  hand,  
the  Km value for glutamate  mutase was about twice as high with Ado-PCC  as with  coenzyme  
B12. At higher concentrations (>300 nM) Ado-PCC caused some inhibitioa 
Ado-PCC,  a base-off analogue of  coenzyme-BI2,  turned out to  be an  excellent  probe  for  
testing  the  binding  mode  of  Ado-Cbl  dependent  enzymes.  For  those  enzymes  binding  the  
coenzyme  in the  base-exchange  mode,  Ado-PCC  is  an  excellent  coenzyme,  whereas  for  the  
others  it acts as an inhibitor  [8].  Recently, we  suggested that the planar hydrophobic p-cresyl 
group  may  occupy  the  same  hydrophobic  binding  pocket  of  the  base-off  enzymes  as  the  
dimethylbenzimidazolyl  group  of  coenzyme  B12  [8].  This  idea  is  supported  by  the  high  
apparent  affinity, Le. low  Km value, of Ado-PCC  for these  enzymes. In the  case of  Ado-PCC,  
the  removal of the  original base  from the co-ordination  sphere of the cobalt  is not  necessary,  
which  may  facilitate the  binding  process.  Support  for  this  interpretation  comes  from  kinetic  
results  with  2-methyleneglutarate  mutase.  As  mentioned  above,  the  lag phase upon  initiating  
the  reaction  with  coenzyme  B12 is  abolished  when Ado-PCC  is  used  as  coenzyme.  In  other  
9 
words,  the  energy  barrier  to  remove  the  dimethylbenzimidazole  base  from  the  co-ordination  
sphere of the cobalt may cause the lag phase observed with the natural coenzyme. 
CONCLUSIONS 
The  kinetic  results  with  three  further  coenzyme-Bu  dependent  enzymes  confirmed  the  
utility  of  Ado-PCC  to  demonstrate  the  binding  mode  of  the  coenzyme  to  the  protein.  For  
glutamate mutase the base-exchange binding mode has been shown by EPR spectroscopy using 
lsN-labelled enzymes  [4]. Glutamate mutase,  2-methyleneglutarate mutase and  methylmalonyl-
CoA mutase possess in the BI2-hinding region a consensus sequence with a conserved  histidine  
which substitutes for the displaced dimethylbenzimidazole  as axial cobalt  ligand  [2,  13,  14, 22-
25].  Such a consensus sequence is lacking in propanediol and glycerol dehydratases as well as 
in  ethanolamine  ammonia-lyase  [18,  26,  27].  Our  results  with  Ado-PCC  are  consistent  with  
expectations derived from the amino acid sequences of these enzymes.  
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FIGURE  1.  S t ruc ture  o f  (Co/?-5'-deoxyadenosin-5'-yl)-(/?-cresyl)cobarnide  (Ado-PCC)  
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TABLE 1. Kinetic properties  of Ado-PCC  with 2-methyleneglutarate  mutase,  glutamate 
mutase and ethanolamine  ammonia  lyase  
Enzyme Coenzyme  B12 
K m  feai  Km 
Ado-PCC 
feat 
[nM]  [s1]  [nM]  [s1]  
K 
[nM] 
Ethanolamine ammonia lyase  30 ± 6 no activity 25 ± 6 
2-Methyleneglutarate mutase  54 ± 4  2.9 ±0.2  10 ± 1  2.2 ±0.2  no inhibition 
Glutamate mutase 100 ±20  9.0 ± 1  200 ±20  0.9 ±0.1  no inhibition* 
Apparent  ATm  constants  were  measured  as  described  under  Kinetic  investigations'.  Apparent  
inhibition  constant  R  was  estimated  by  the  'parallel'  method  [21].  Enzymes:  ethanolamine  
ammonia-lyase  of Salmonella  typhimurium  overproduced  in E.  coli  (Vmm  =  35 ±  3  nmol/min  
with  coenzyme  B12); 2-methyleneglutarate  mutase  from  Clostridium  barkeri  overproduced  in  
E.  coli  (Fnax =  129  ±  7  nmol/min  with  coenzyme  B12);  glutamate  mutase  from  Clostridium  
cochlearium  overproduced  in E.  coli  (Fmax =  3760 ±  120 nmol/min with coenzyme  B12).  *At  
higher concentrations (>300 nM) Ado-PCC caused some inhibition. 
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A  series  of  (hydroxyalkyl)cobalamins,  i.e.,  la -d ,  (HO—(CH2)„—Cbl,  n = 2 -5 ) ,  two  diaster'eoisomeric  
(2,3-dihydroxypropyl)cobalamins,  i.e., 2a.b ([(/?)-  and (5)-[(HO)2pr]-Cbl)  and their diastereoisomeric  'base-
off  analogues, the (Coy3-2.3-dihydroxypropyl-[l'-C-(p-tolyl)cobamides])  3a,b ([(/?)-  and  (S)-(HO)2pr]-PTC)  
were  prepared  and  characterized  by  their  500-MHz  'H-NMR  spectra.  The  inhibitory  activities  of  these  
compounds  and  of  hydroxocobalamin  (HO—Cbl)  and  (Coa-cyano)(Co/?-hydroxo)[T-0-(p-tolyl)cobamide]  
(HO—PTC)  were  tested  with  two  coenzyme-B12-dependent  enzymes:  glycerol  dehydratase  (GDH)  and  
propane-l,2-diol  dehydratase  (DDH)  (Table4).  The  hydroxyalkyl  and  dihydroxypropyl  derivatives  of  
cobalamin  acted  as strong competitive  inhibitors  of coenzyme B]2  (5'-deoxy-5'-adenosylcobalamin.  Ado-Cbl)  
for both enzymes, with K, values falling within the range defined by HO-Cbl  (best inhibitor) and CN-Cbl (K-,1 
Km  ratio  of  ca. 2).  The  short-chain  HO-(CH2)„-Cbl  (la,b;  n = 2  or  3)  exhibited  K,  equal  to  the  Km  for  
Ado—Cbl. The [(/?)- and (5)-( HO),pr]-Cbl  (2a,b) and the long-chain HO-(CH2)„-Cbl  (lc.d; n = 4,5) were 
less efficient inhibitors, with [(5)-(HO)2pr]-Cbl  (2a) performing slightly better than the  (R)-diastereoisomer  
2b for  both  enzymes.  The  'base-off  analogues, Ado-PTC  and  [(/?)-  and  (5>(HO)2pr]-PTC  (3a.b),  were  
moderate  inhibitors  with  KJKm  ratios of  4.5-28  for GDH  or 7 -13  for DDH. [(5)-(HO)2pr]-PTC  (3a)  was  
the best inhibitor  in this group. The non-alkylated  analogue (HO,CN )-PTC proved to be a very poor inhibitor. 
These  results confirm that  the  'base-on'  binding mode  of coenzyme Bl2  is preferred  for GDH  and DDH. The 
increase  in  K, for PTC-  vs.  Cbl-tvpe  inhibitors may result  from the entropic penalty required  for folding of  the  
PTC nucleotide  chain  into a Cbl-like loop conformation. Hydrophilic  interactions between  the 0-ligand  of  the  
inhibitor  and  ribosyl-  or  substrate-binding  sites  may  make  an  important  contribution  to  the  formation  or  
stabilization  of  the apoenzyme-inhibitor  complex,  especially for the PTC  derivative.  
Introduction.  -  In  several  enzyme-catalyzed  rearrangements,  coenzyme  B12  
(Ado-Cbl;  Ado = 5'-deoxy-5'-adenosyl)  plays  an  essential  role  as  a  cofactor  [1-5].  
The common initial step in these reactions is the homolysis of the bond between the Co-
atom  and  C(5')  of the  adenosyl  ligand on the y3-face of the cofactor, leading to  highly  
reactive radical intermediates  which initiate the rearrangement  of the substrate. It  has 
been assumed that  the energy required for this homolysis originates from a conforma-
tional  change  in the protein  induced  by binding  of the  substrate.  
Coenzyme-B12-dependent  enzymes may bind their cofactor in two different ways. In 
the  'base-on'  mode,  the  original  5,6-dimethylbenzimidazolyl  moiety  of  the  lower  
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nucleotide  loop  of  Ado—Cbl  remains  as the  a-ligand  of  the  Co-atom  in  the  enzyme-
coenzyme  complex.  In  the  'base-off'  binding  mode,  the  5,6-dimethylbenzimidazolvl  
moiety is displaced from the Co-atom and a histidine residue of the protein  coordinates  
to  the  Co-atom  as a-ligand.  
In the homolysis  of the C o - C  bond, the nature  of the a-ligand attached  to the  Co-
center  and  the mode  of binding  of Ado-Cbl  to  the protein  may play  a crucial  role.  It  
was concluded that for homolysis of the C o - C  bond on the /?-side, the central  Co-atom 
of the corrin ring should be coordinated by a basic N-atom from the a-side [6] [7]; i.e., a 
histidine  N-atom  from the protein  for the  'base-off' enzymes  or  a  5,6-dimethylbenzi-
midazole  N-atom  from Ado—Cbl  for  the  'base-on'  enzymes.  On  the  basis  of  X-ray  
crystallography  [8] [9],  EPR  spectroscopy  using  15N-labeled  enzymes  and/or  coen-
zymes  [10-15],  and  enzyme  kinetics  with  Ado—PTC1)  as  a  'base-off  analogue  of  
coenzyme  B12  [16] [17],  the  binding  mode  for  several  coenzyme-B12-dependent  
.enzymes  has  been  determined.  In  the  coenzyme-B12-binding  region  of  the  'base-off  
enzymes, there  is a consensus sequence with  a conserved  histidine  [18-23], but  such a 
sequence  similarity  is lacking  in propanediol  and  glycerol  dehydratases  [24] [25]. 
In  a previous study, we investigated the interaction  of glycerol dehydratase  (GDH)  
and  propanediol  dehydratase  (DDH)  with  a  series  of  [cu-(adenosin-5'-0-yl)alkyl]co-
balamins  (Ado—0(CH2)„,—Cbl;  ra  = 3 - 7 )  as  possible  models  or  mimics  of  the  
posthomolysis  intermediate  state  of  coenzyme  B12  [26].  The  hypothesis  is  that,  
following bond  homolysis,  the  separation  between  the  Co  and  adenosyl  C(5')  atoms  
increases due to a conformational change in the enzyme, possibly triggered by substrate 
binding. Therefore, coenzyme-B,2 analogues with an increased spacing between the Co-
atom  and  the  adenosyl  moiety  may  bind  to  and  stabilize  the  protein  in  the  
posthomolysis  conformation.  The  'optimal'  spacing  may  depend  on  the  size  of  the  
substrate and the geometric relationship between its binding site and the corrin binding 
site.  In  agreement  with  our  expectations  based  on the  small  size  of  the  substrate  for  
GDH and DDH, the short-chain coenzyme-B12 analogues (m = 3 - 5 ) , especially the C5 
analogue  (X; =  5.9 and  500 nM for GDH  and  DDH,  resp.),  were found to  be  slightly  
stronger  inhibitors  than  those  with  longer  chains  (m =  6 and  7; K{ = 11.7 and  15.1 n.vt 
resp.,  for  GDH,  and  630  and  830nM, resp.  for  DDH).  In  our  previous  study,  the  
dehydratase-inhibition  results  obtained  with  hydroxocobalamin  (HO-Cb l )  and  
cyanocobalamin (CN-Cbl)  showed interesting features [26]. Although both  HO-Cb l  
and  CN-Cbl  consist  of  a  cobalamin  bearing  only  a  /J-ligand  of  minimal  size,  their  
inhibition properties differed significantly. While CN-Cbl  with the apolar /i-CN ligand 
proved  to  be  a  moderate  inhibitor,  similar  to  the  long-chain  (m = 6  and  7)  
Ado-0(CH 2 )„ , -Cbl  posthomolysis-state  analogues,  H O - C b l  bearing  the  polar,  
hydrophilic  jS-OH  ligand  was  found  to  be  the  strongest  inhibitor  tested  for  both  
dehydratases. The  ratio  of  Kt  values for H O - C b l  vs. CN-Cbl  was 0.40 for GDH  and  
0.48 for DDH, which translates into a binding free energy difference A AG  of ca. 2.4 kJ/ 
mol in both  cases  (assuming  A G b o u n d = + I n  A^).  
We  rationalized  the  difference in  K, for H O - C b l  vs. CN-Cbl  by proposing  that  
H O - C b l  with  its hydrophilic /J-OH ligand  may  interact  via  a protein-associated  H 2 0  
')  The  abbreviation  PCC  (for  (p-cresolyl)cobamide)  was  used  previously  [10] [16]  to  represent  the  same  
moiety  abbreviated  in  this work  as PTC for  [T-0-(p-tolyl)cobamide].  
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molecule  with the  substrate  binding  site  in  addition  to the  corrin  binding site in each 
dehydratase. The estimated -2 .4 kJ/mol difference in AG  for the binding of  HO-Cbl  
vs. CN-Cbl  is consistent with the formation of one additional H-bond in the  complex.  
Another  possibility  is  that  solvent  H 20  tightly  associated  with  the  OH  ligand  of  
HO-Cbl  is  displaced  upon  binding  of  the  inhibitor  to  the  protein,  leading  to  a  
favorable positive  entropy change not  available for CN—Cbl.  
For  the  dehydratases,  the  binding  of  small,  hydrophilic  substrates  apparently  
provides an important contribution to the energetics of the catalytic process. Only after 
addition  of  substrate  to  the  enzyme-coenzyme-B12  complex,  EPR  signals  can  be  
detected  (Co-C  bond  homolysis);  these  signals  also  indicate  that  a  conformational  
change in the ternary complex results in increased separation between the free radical 
centers  [13] [14].  The  primary  OH  moiety  of  propane-l,2-diol  or  glycerol , is  not  
involved  in  the  enzymic  rearrangement  process;  therefore,  we  assume  that  it  is  
important for the binding of the substrate of the coenzyme-enzyme binary complex via 
hydrophilic  interactions.  
Based  on  these  considerations,  we  decided  to  investigate  several  coenzyme-B12  
analogues with small hydroxyalkyl groups as hydrophilic /J-ligands. Our hypothesis was 
that  such  analogues  may  interact  with  the  protein  at  both  the  corrin  and  substrate  
binding sites and serve as models for a substrate-corrin binding mode, which may mimic 
a posthomolysis  substrate-enzyme-coenzyme  complex. Another  possibility  is that  the  
hydroxyalkyl  group may interact  with  a putative  ribose (adenosyl) binding site, which 
may be important  in binding  of the natural  coenzyme.  
In  this  study,  we report  the  synthesis,  the  'H-NMR  data,  and the  enzyme-kinetic  
behavior of a series of (hydroxyalkyl)cobalamins,  i.e. l a - d  (HO—(CHZ)„—Cbl, n =  2-
5),  two  diastereoisomeric  (2,3-dihydroxypropyl)cobalamins,  i.e.,  2a,b  ([(/?)-  and  
(5 ,)-(HO)2pr]-Cbl)  and  their  diastereoisomeric  'base-off' analogues,  the  (Co/1-2,3-
dihydroxypropyl)[l'-0-(p-tolyl)cobamides]  3a,b  [(/?)-  and  (5)-(HO)2pr]-PTC1)  
(Fig.)  in the  glycerol  dehydratase  and  diol dehydratase  reactions. The preparation  of  
[(R)-  and (5)- (HO) 2 pr] -Cbl  (2a,b) and partial ^ - N M R  data have been  described  
earlier  by  Dixon  et al.  [27],  and  the  X-ray  crystal  structures  [28] are  available  in  the  
Cambridge  Crystallographic Data Files. 
Results. -  The desired  (hydroxyalkyl)cobalamins  were synthesized from HO-Cbl 
or  its  'base-off'  analogue  (Coa-cyano)(Co(5-hydroxo)[l'-0-(/?-tolyl)cobamide]  
(HO—PTC),  which  differs from vitamin  B12a  by  only  the  presence  of  a  (p-tosyl)oxy  
moiety  instead  of  the  5,6-dimethylbenzimidazole  within  the  nucleotide  loop.  The  
established  reductive  alkylation  method  for  obtaining  alkylated  corrinoids  from  
vitamin  B12a  [29] was used in these reactions  as well, and conveniently provided the /J-
alkylated  products  (Fig.)  in good yields.  
One- and two-dimensional  *H-NMR spectra were obtained  in D 2 0  at 500 MHz for 
the two short-chain (hydroxyalkyl)cobalamins la,b (HO(CH2)„-Cbl,  n = 2 and 3), the 
two  diastereoisomeric  'base-on'  dihydroxypropyl  derivatives  2a,b  and  their  diaster-
eoisomeric  'base-off'  analogues  3a,b.  The  geminal,  vicinal,  and  long-range  coupling  
information  provided  by  the  COSY-/?  2D  experiment  and  the  spatial  information  
provided by the 2D-NOESY data were sufficient for the unambiguous assignment  of all 
proton  signals,  with  the  possible  exception  of  methylene  protons  at  positions  C(17')  
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Figure.  Cobalamins  l a - d  and  2a.b ((Co/3-X)-Cbl)  and  I'-O  (p-tolyl)cobamides  3a.b (Co/5-X)-PTC) 
discussed  in  this  work.  Ligands X and Y are on the  0-  and a-side of the corrin ring,  respectively. The 
numbering scheme is that used in the NMR  tables. For X-Cbl, the configurations and conformations of the 
corrin substituents. the nucleotide loop, and the adenosyl group are shown as accurately as possible, according 
to the crvstal structure of coenzyme Bl2 (Ado—Cbl) and in agreement with the NMR data. Bonds drawn close 
to vertical or horizontal directions represent axial or equatorial substituents. respectively. The dimethylbenzi-
midazole (Dbi) group of the nucleotide loop in Cbl derivatives lies essentially in the perpendicular plane 
containing the corrin C(5) and C(15) atoms, with the imidazole proton H-C(2) pointing in the direction of the 
corrin C(15) atom. The ribose conformation of the adenosyl moiety and nucleotide loop of Cbl derivatives is 
predominantly 'CPJ-endo' (H-C(3')/H-C(4')  trans  diaxial), but it is predominantly ,C(2')-e«do' (H-C(2') 
axial) in the 'base-off loop region of the PTC derivatives. As X ligand. the adenosyl moiety is oriented with 
H-C(4') pointing toward H-C(19) and the  trans  H-C(5') pointing toward H-C(IO). The ribose ring is 
roughly perpendicular to the corrin ring with the ring O-atom pointing toward C(14)-C(15). The adenine 
group in 'svn  orientation is roughly parallel to the corrin and lies over H-C(13) and Me^-C(12) with the 
adenine H-C(8) pointing toward the corrin C(7) atom. The dihydroxypropyl moieties used as X ligands are 
shown in conformations most closely matching the adenosyl ribose. which has the (5)-configuration at C(4'). 
The  pro-S  protons at C(l") and C(3") in the dihydroxypropyl ligands are drawn with vertical bonds. 
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and  C(17;).  Table 1 summarizes  the  chemical-shift  data  for four  'base-on'  cobalamin  
compounds  in  comparison  with  the  data  for  Ado-Cbl  [30] [31].  Table 2  compares  
the  chemical-shift  data  for  the  'base-off  analogues  3a.b  with  the  published  data  
for  the  'base-off  form  of  Ado-Cbl  (Ado-'Cbl')  [32]  and  the  'base-off  analogue  
Ado—PTC1)  [16].  
A large number of individual geminal and vicinal coupling constants were evaluated 
in  the  resolution-enhanced  ID  spectra.  For  the  four  Cbl  analogues  la,b  and  2a,b  
examined  in  this  study,  all  resolved  couplings  for  the  corrin-ring  protons  and  side  
chains,  as  well  as  the  couplings  in  the  aminopropyl  and  ribose  segments  of  the  
nucleotide loop, show only minor variations as a function of the /Migand and agree well 
with  the  corresponding  values  for Ado-Cbl  and  the  'base-on'  Ado-0(CH2) ,„-Cbl  
analogues  [29].  As  expected,  for  the  two  (HO)2pr-PTC  'base-off'  derivatives  3a,b  
those couplings which could be determined  deviate  in several cases from the  couplings  
observed for 'base-on' Ado—Cbl, especially  in the nucleotide loop, but agree well with 
the corresponding values measured for Ado—PTC [16]. The coupling constants for the 
hydroxyalkyl  /3-ligands  in  the  new  Cbl  and  PTC  derivatives  are  unique  and  are,  
therefore,  summarized  in  Table 3,  together  with  coupling  constants  for  the  ribose  
moieties. 
The  synthesized  compounds  were  tested  as inhibitors  in  the  glycerol  dehydratase  
and  diol  dehydratase  reactions,  and  the  results  are  summarized  in  Table 4,  with  the  
inhibitors arranged  roughly in the order  of decreasing effectiveness.  Assuming that  the  
relative  Kt values reflect the relative  dissociation  constants  K¿ for the binary  inhibitor-
enzyme complexes, then a relative free energy for inhibitor binding can be calculated as 
shown  in  Table 4. All  of the (hydroxyalkyl)cobalamins,  i.e.. those analogues which can 
be  used  to model  the  substrate-enzyme-coenzyme  complex  that  forms with  the  'base-
on'  form  of  coenzyme  B12  (Ado-Cbl),  proved  to  be  potent  competitive  inhibitors  
(/C¡ = 13-25  nM for GDH. 760-1250  nM for DDH)  with  respect  to Ado-Cbl  (Km  =  
12.6  n.M  for  GDH,  720n.M  for  DDH).  For  both  enzymes,  the  short-chain  
HO(CH :)„-Cbl  analogues  la.b  (n = 2 and 3)  showed  the  strongest  inhibition  with  K,  
equal  within  experimental  error to the  Km  of Ado-Cbl.  Introduction  of  a second  OH  
group to the  G  alkyl  chain  reduced  the  effectiveness of  the  inhibitors  somewhat,  i.e.,  
[(/?)-  and  (5)-(HO)2pr]-Cbl  (2a  and  2b,  resp.)  exhibited  K,  values  of  17.6  and  
14.8 nM. respectively,  for  GDH.  and  1250  and  1080 nM, respectively,  for  DDH.  An  
increase  in  the  chain  length  as  in the  monohydroxyalkyl  analogues  lc.d  (n = 3 and  4)  
also reduced  the effectiveness, resulting  in K{ values  of  17.0 and 25.2 nM,  respectively,  
for GDH,  and  1060 and  950 nM.  respectively,  for DDH. 
On  the  other  hand,  the  dihydroxypropyl  derivatives  of  the  'base-off  corrinato  
complex PTC were significantly less potent as inhibitors and comparable to Ado-PTC 
[16],  Le.,  [(/?)-  and  (S)-(HO)2pr]-PTC  (3a  and  3b,  resp.)  had  K,  values  of  348 and 
57 nM.  respectively, for GDH,  and  6400 and  5100 nM,  respectively, for DDH. 
For  comparison,  the  'base-on'  analogue  HO—Cbl  proved  to  be  the  strongest  
inhibitor with  K, values slightly lower than the Km  for coenzyme B12 (Ado-Cbl),  while  
CN-Cbl  was  about  as  potent  as  the  poorest  hydroxyalkyl-Cbl  (Table  4).  Finally,  
the  parent  'base-off  corrinato  complex  HO-PTC,  bearing  a  /?-hydroxo  ligand,  
showed  only  very  weak  or  no  detectable  inhibition  in  the  GDH  or  DDH  reactions,  
respectively. 
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Table  1.  500-MHz  'H-NMR  Chemical-Shift  Data  ( D : 0 .  pH  7.4,  10')  for  Coenzyme  B,2  (Ado-Cbl)  and  Hydroxyalkyl  Derivatives  
la .b  and  2a.b a) .  Chemical  shifts relative  to TSP (=sodium  3-(trimethylsilyl)  (D4)propanoate) .  
Signal  type  Chemical shifts [ppm] 
Ado-Cblb)  [(/?)-(HO):pr]-Cbl  (2b)  [(5)-(HO)2pr]-Cbl  (2a)  HO(CH:),-Cbl  (lb)  HO(CH,),-Cbl  (la)  
Corrin  Me  
Me-C(l)(a) br.  s  0.47 0.537 0.454 0.540 0.510 
Me-C(2)(e) br.  s  1.36 1.420 1.382 1.411 1.409 
Me-C(5) s 2.45e) 2.514 2.519 2.524 2.537 
Me—C(7)(e) br.  s  1.70 1.798 1.864 1.805 1.823 
Me„-C(12)(e) br.  s  1.32 1.443 1.398 1.468 1.458 
Me„-C(12)(a) br.  s  0.87 1.178 1.260 1.115 1.143 
Me—C(15) br.  s  2.43 2.506 2.523 2.504 2.512 
Me-C(17)(a) s 1.36 1.466 1.441 1.426 1.430 
Corrin  CH  
H-C(3)(e) dd 4.10 4.070 4.066 4.076 4.101 
H-C(8)(e) dd 3.29 3.401 3.278 3.403 3.403 
H-C(IO) s 5.93 6.059 6.045 6.072 6.069 
H-C(13)(e) dd 2.89 3.238 3.248 3.240 3.260 
H—C(18)(a) ddd 2.65 2.67 2.67 2.68 2.672 
H-C(19)(a) d 4.24 4.638 4.183 4.157 4.138 
Corrin  CH,  
CH,(2'U  "  d 2.41 2.582, 2.381 2.422. 2.378 2.43.  2.42 2.452. 2.389 
CH.O 'U m 2.06.  1.96  2.154, 2.025 2.103.  1.970  2.135. 2.030 2.120. 2.015 
CH2(32),.„ ddd 2.50 2.56. 2.486 2.535. 2.460 2.55.  2.48  2.55, 2.48 
CH,(7'),„ d 2.19.  1.72 2.547. 1.976 2.452. 2.232 2.5375. 2.023 2.550. 2.031 
CH,(8')aJ, m 1.75.  0.81  1.815, 0.805 1.895. 0.950 1.84, 0.830 1.860. 0.845 
CH,(82)y.i, ddd 1.73.  0.88  1.815, 0.908 1.83.  0.910  1.80. 0.970 1.82. 0.954 
CH2(13')..„ m 2.22.  2.00  2.16, 2.11 2.22. 2.145 2.115. 2.08 2.10. 2.07 
CH2(132),,i, ddd 2.54 2.64, 2.61 2.65. 2.62 2.65. 2.625 2.65. 2.63 
CH2(17')aJ,  d )  ddd 1.78 2.545,  1.836 2.555.  1.825 2.543. 1.830 2.552. 1.820 
CHjin2)..,,d) ddd 2.45.  2.06  2.477,2.115 2.49, 2.120 2.47.  2.117 2.47. 2.10 
CH2(18'U dd 2.65 2.751, 2.662 2.751. 2.655 2.767. 2.68 2.769. 2.675 
1  -Aminopropan-2-ol  
CH,(1)( Apr), j, dd 3.54.  3.16  3.538, 3.213 3.553. 3.191 3.540. 3.204 3.547. 3.168 
CH(2)(Apr) dddq 4.33 4.354 4.345 4.355 4.345 
Me(3)(Apr) d 1.21 1.207 1.215 1.209 1.214 
Loop  ribose  (C(3')-endo)  
H„—C(l')( Rib) d 6.26 6.285 6.294 6.279 6.287 
H-C(2')(Rib)(e) dd 4.23 4.241 4.236 4.241 4,235 
H-C(3')(Rib)(a) dd 4.72 4.753 4.756 4.748 4.743 
H-C(4')(Rib)(a) dddd 4.10 4.131 4.116 4.132 4.117 
CH2(5')(Rib).h(^) .dd 3.88.  3.74  3.913, 3.755 3.914. 3.754 3.915, 3.755 3.915. 3.751 
Dimethylbenzimidazol 
H-C(2)(Dbi) s 6.95 6.989 6.983 6.989 6.969 
H-C(4)( Dbi) br.  s  6.24 6.252 6.282 6.269 6.289 
H-C(7)(Dbi) br.  s  7.16 7.189 7.197 7.186 7.195 
Me—C(5)(Dbi) s 2.19 2.242 2.242 2.244 2.248 
Me-C(6)(Dbi) s 2.19 2.230 2.234 2.233 2.236 
Alkyl-Co 
1.55. 0.57e) CH2(l"),h dd(d) 1.118, 0.507 1.589, 0.843 1.375. 0.535 1.361. 0.597 
H—C(2") or CH,( 2"),h m 2.54
e) 1.681 1.647 0.50. -0.13 2.54.  1.960 
CH2(3"),„ dd(d) 2.885. 2.778 2.836. 2.730 3.10.  3.07  
a )  Numbering  scheme  according  to  the  Figure:  configuration  codes  in  parentheses:  a =  axial,  e = equatorial,  t = trans,  g =  gauche,  
superscripts  1 or  2 refer to positions  in corrin side chains: subscripts  a and  b refer to  the  high-frequency and  low-frequency  proton  
of  CH2 groups: A p r =  l-aminopropan-2-ol,  Dbi = 5,6-dimethyI-l//-benzimidazoie,  Ade =  adenine. Toi =p-tolyI; Rib and  A d e - R i b  
refer to loop  ribose  (a-side)  and  adenosyl  ribose  (/3-side).  resp. All  assignments  were  confirmed by COSY and NOESY  data,  with  
the  exception  (see  Footnote  d)  of  the  assignments  for  CH : (17 ' )  and  CH,( 172)  which  may  be  reversed  (coupling  or  NOE  with  
Me—C(17)  not  detected).  b )  From  [30], pH  7.0,  20°.  c)  Cited  as  1.45 (typographical  error)  in  [16] and  [29];  in  [29],  the  shift  for  
M e - C ( 5 )  of  compound  l a  should  be  2.439 ppm.  d)  The  original  assignments  for  CH,( 17')  and  CH :(172)  in A d o - C b l  [30]  are  
given  here  as  corrected  (reversed)  by  Pagano  et  al.  [31]; our  assignments  are  made  by  analogy, considering  the  H - C ( 1 7 ' ) b  and  
H - C ( 1 7 2 ) b  shifts: our  previous  assignments  for  AdoO(CH :)„—Cbl  derivatives  [29]  should  also  be  reversed.  c )  For  A d o - C b l ,  
CH2(l")a .„  correspond  to  CH,(5')( Ade-Rib) a .„  and H - C ( 2 " )  to  H - C ( 4 ' ) ( A d e - R i b ) .  
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Table  2.  500-MHz  'H-NMR  Chemical-Shift  Data  ( D : 0 . pH  7.4.10 :)for  Base-off'  Coenzyme  B,,  ( 'base-off  form of  A d o - C b l )  
and  (Cofi-Xl-PTC  Derivatives  3a.b  a ) .  Chemical  shifts relative  to TSP  ( = sodium  3-(trimethylsilyl)  (D 4 )propanoate) .  
Signal  type  Chemical  shifts [ppm] 
Ado-  Cbl'(  base-off) b )  Ado -  PTC c )  [(/?)-(HO)-pr]-PTC  (3b)  [(5)-(HO) :pr]-PTC  (3a)  
Corrin  Me  
Me-C(l)  (a)  br.  s  0.81 0.704 0.788 0.786 
Me-C(2)  (e)  br.  s  1.48 1.405 1.511 1.469 
Me-C(5) s 2.43 2.389 2.374 2.399 
Me-C(7)  (e)  br.  s  1.82 1.819 1.854 1.923 
Me„-C(12)  (e)  br.  s  1.67 1.585 1.648 1.640 
Me„-C(12)  (a)  br.  s  1.00 0.845 1.037 1.094 
Me-C(15) br.  j  2.46 2.336 2.483 2.484 
Me-C(17)  (a)  s 1.40 1.141 1.498 1.469 .  
Corrin  CH  
H-C(3)  (e)  dd 4.23 4.217 4.047 4.128 
H—C(8)  (e)  dd 3.73 3.784 3.797 3.797 
H-C(IO) s 6.97 6.994 7.025 7.036 
H-C(13)(e) dd 3.43 3.308 3.543 3.557 
H-C(18)  (a)  ddd 2.85 2.787 2.870 2.906 
H-C(19)  (a)  d 4.70 4.653 5.106 4.733 
Corrin  CH,  
CH2( 2')Jb  '  d 2.60. 2.46 2.66, 2.285 2.665. 2.495 2.599. 2.480 
CH,(3')ah m 2.11.1.97 1.99. 1.89 2.05,1.925 2.012.  1.91  
CHJO»)^ ddd 2.55 2.507, 2.475 2.532, 2.49 2.520. 2.50 
O W ) * d 2.61, 2.14 2.275,  1.731  2.44Ö, 1.983 2.460, 2.130 
CH,(8'U m 2.21,  1.75  2.250.  1.81 2.295,  1.835  2.32.  1.88  
CH,(83)aJ, ddd 2.35, 2.35 2.41.  2.31 2.445, 2.36 2.43. 2.315 
01,(13')..,, m 2.21.  1.92 2.185.  1.885  2.25,  1.960  2.24.  1.95  
CH,(133U ddd 2.21,  1.86  2.148.1.788 2.185,1.830 2.174.  1.809 
CH,(17'U  d )  ddd 2.51.1.85 2.425,  1.76  2.525.  1.835  2.55.  1.86  
CH,(17=),h  d )  ddd 2.31,1.85 2.365.  1.833  2.39,1.86 2.45.  1.86 
CH,(18'U dd 2.78 2.68.  2.49 2.823 2.85. 2.80 
l-Aminopropan-2-ol  (Apr)  
CH,(l)(Apr),h dd 3.38. 3.27 3.470. 3.395 3.45. 3.42 3.475. 3.426 
CH.(Apr) dddq 4.36 4.42 4.416 4.423 
Me(3)( Apr) d 1.23 1.238 1.248 1.255 
Loop  ribose  (C(2 ')-endo)  
H„-C(l')(Rib)  (e)  d 6.56 5.664 5.660 5.670 
H-C(2')(  Rib)  (a)  dd 4.97 4.331 4.333 4.339 
H-C(3')(Rib)  (e)  dd 4.83 4.551 4.550 4.557 
H-C(4')(Rib)  (a)  dd 4.79 4.38 4.389 4.398 
CH2(5')(RibU(g.g) dd 3.94. 3.84 3.72.  3.70 3.71. 3.70 3.725. 3.710 
Tolyl 
H—C(2)/H-C(6)(Tol) d 6.873 6.878 6.890 
H-C(3)/H-C(5)(Tol) d 7.026 7.033 7.044 
Me-C(4)(Tol) s 2.128 2.120 2.136 
Adenosyl 
H—C(2)( Ade) s 8.43 8.234 
H—C(8)( Ade) s 8.21 8.037 
Hji-C(l ')(Ade-Rib) d 5.61 5.615 
H -  C( 2')( Ade—Rib)  (e)  dd 4.34 4.40 
H -  C( 3')( Ade -  Rib)  (a)  dd 3.90 3.754 
H-C(4')(Ade-Rib)  (a)  ddd 1.98 2.002 
CH:(5')(Ade-Rib)..„(g./) dd 1.46. 0.38 0.602. 0.312 
Dihydroxypropyl 
dd 0.953. -0.134 1.064, 0.372 
H-C(2") m 1.04 1.006 
CH,(3").J,(i.g) dd 2.712. 2.642 2.670. 2.534 
a )  See  Footnote  a  in  Table  1. h) From  [32], pH 2.1 . c ) From  [29], with  minor  revisions for some of the corrin C H :  groups.  d )  Our  
assignments for CH,(17 ' )  and  CH 2 (17 : )  are  not  definitive ( N O E s  with M e - C ( 1 7 )  not  detected)  but  are made  by analogy  with  
those  for  ' b a s e - o f f ' A d o - ' C b f .  
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Table 3.  'H,'H-Coupling  Constants  J  [Hz] for  Ribose  Moieties  or  Hydroxyalkyl  Chains  in  Coji-X  Derivatives  
A Hz]a) 
Ado-Cblb) Ade-Rib  V(5'a.5'b) = -9.2, V(4'.5,a)=  <2. V(4'.5'b)=9.2. V(3'.4j = 6.7, 37(2'.3')=5.8,  V(l'.2')=3.3  
loop Rib  V(5'a.5'b) = -13.0. J/(4',5'a)=2.7. V(4'.5'b)=3.9,3/(3'.4j = 8.9.3/(2'.3')=4.3. -V(l'.2')=3.0 
Ado-PTC Ade-Rib  V(5'a.5'b) = -8.5.3y(4'.5'a) = 1.0,37(4'j'b)=9.0,3y(3'.4j = 6.2. V(2'.3') = 6.2.3y(l'.2')=3.8 
loop Rib  2y(5'a.5'b)=-13.0,3y(4',5'a)=3.0,3y(4'.5'b)=3.5,  -V(3'.4j=2.5.3y(2\3')=6.3,37(l'.2  )=4.6  
[(/?)-(HO)2pr]-Cbl  (2b)  V(la,lb)=  -9.5,3y(la.2)=6.9,3y(lb.2) = 1.8,3y(2.3a) = 7.3, 37( 2.3b) =4.8. :y(3a.3b)= -  11.4  
[(/?)-(HO)2pr]—PTC  (3b)  2y(la.lb)=-7.7, -V(la,2)=7.7.3y(lb,2) = 1.0,3y(2.3a)=6.5,3y(2,3b)=5.6,  V(3a.3b)=  -  11.4  
[(£)-(HO)2pr[-Cbl  (2a)  2y(la.lb) = -8.9,3y(la,2)=5.5,3y(lb.2)=4.2,3y(2,3a)=6.9,  V(2.3b)=4.1,  :y(3a,3b)= -11.4 
[(5)-(HO)2pr]-PTC  (3a)  2y(la.lb) = -7.5.3y(la,2)=4.0.3y(lb.2)=5.3.3y(2.3a)=6.9,3y(2.3b)=4.9,  V(3a.3b) =  -  11.4  
HO(CH2)3-Cbl  (lb)c)  3y(2.3a)= 6.9 and 6.3,3y(2,3b)=6.4  and 4.2,V(3a.3b) =  -  10.7  
HO(CH2)2-Cbl  (la)c)  27(ia. lb) = -7.0.3y(la.2a)  =  6.0. V(la.2b)  =  12.6. 37(lb.2a) =  12.5.3y(lb.2b)  =  4.S. :y(2a.2b) = -10.5 
a)  Alkyl  atoms C(l),  C(2),  and C(3) (" symbol omitted)  are  numbered  starting with  the  Co-bound  atoms and correspond  to  
adenosyl  C-atoms  C(5'),  C(4'),  C(3j.  b)  From  [30].  c)  Tentative  assignments;  complete  determination  of  all  coupling  
constants  was not  possible.  
Table 4.  Kinetic  Properties  of  Hydroxyalkyl  Derivatives  l a - d  and  2a,b  ((Co/3-X)-Cbl)  and  3a.b  ((Co/3-
X ) - P T C )  with  Glycerol  Dehydratase  and  Diol  Dehydratase  
Inhibitor 
K, [nM]a) Relative  AG  [kJ/mol]d)  
GDHb) DDHe) GDHb) DDHC) 
HO-Cbl e) 8.6 ±1.4 680 ±110 -0.98 -0.15 
Ado-Cbl  {Km  data)  12.6 ±2.2 720 ±80 0.0 0.0 
HO(CH2)2—Cbl  (la)  13.4 ±3.2 770 ±70 0.16 0.17 
HO(CH2)3—Cbl  (lb)  13.3 ±3.1 760 ±70 0.14 0.14 
[ ( S M HO ),pr] -  Cbl  (2a)  14.8 ±4.1 1080 ±100 0.41 1.04 
[(Ä)-(HO)2pr]-Cbl  (2b)  17.6 ±4.8 1250 ±110 0.86 1.42 
HO(CH2)4—Cbl  (lc)  17.0 ±4.5 1060 ±90 0.77 0.99 
HO(CH2)5—Cbl  (Id)  25.2 ±7.8 950 ±80 1.78 0.71 
CN—Cble) 21.6 ±2.7 1420 ±200 1.38 1.74 
[(S)-(HO)2pr]-PTC  (3a)  57±7  5100 ± 490  3.87  5.02  
[(R)-(HO)2pr]-PTC  (3b)  348±31  6400 ±580  8.52  5.61  
Ado-PTC  160 ± 37  9200 ±1700  6.52  6.54  
HO—PTC  9960 ±  100  > 25000f)  17.13  >9.1  
a)  Apparent  inhibition  constants  at  37°, estimated  by  the  'parallel'  method  [41];  apparent  Km  constants  for  
Ado-Cbl  were  measured  as  described  previously  [26][41],  b)  Glycerol  dehydratase  from  overexpressing  
Escherichia coli  containing  the  gene  from  Citrobacter freundii  (KmM = 48±4  nmol/min  with Ado-Cbl).  c)  
Diol  dehydratase  from  overexpressing  Escherichia coli  containing  the  gene  from  Salmonella  typhimurium  
(Vm„ = 51 ± 6  nmol/min with Ado-Cbl).  e) From [16].  f) No significant inhibition  was found for up to 25  pM  
HO-PTC.  d)  Estimated free energy  of inhibitor  binding relative  to Ado-Cbl;  calculated  as RTln(KJKm)  at  
37°. 
Discussion.  -  Structural  Properties  of  the  Coenzyme-Bl2  Analogues.  Molecular-
modeling studies for Ado-Cbl  and the [(/?)- and (S)-(HO),pr]-Cbl  (2a,b) gave low-
energy  conformations  which  faithfully  reproduced  the  geometries  of  the  crystal  
structures,  including  the  non-planar  characteristics  of  the  corrin  ring,  the  axial/  
equatorial  orientation  of  side  chains,  the  loop  and  ribose  conformations,  and  the  
orientations  of adenosyl and dimethylbenzimidazole  (Dbi)  groups. These features are 
accurately represented  in the diagrams of the Figure. It should be noted, however, that 
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good  agreement  between  modeled  and  crystal  structures  was  only  obtained  after  
adding appropriate parameters to the HyperChem force field for bonds to the Co- and 
P-atom. 
The dihedral  angles for protons  in the adenosyl ribose (Ade-Rib)  of Ado-Cbl  in  
the  crystal  structure  differed  by  < 20°  from those  in  the  energy-minimized  modeled  
structure.  The  C(3')-endo ribose  conformation  (H-C(3 ' )  axial)  in  the  crystal  must  
predominate  in solution for both Ado-Cbl  and Ado-PTC  since the observed  vicinal  
coupling constants 7( 1\2'), 7(2', 3'), and 7(3',4') were 3.3,5.8, and 6.7 Hz for Ado-Cbl 
[30]  and  3.8,  6.2,  6.2 Hz  for Ado-PTC  [16],  consistent  with  the  modeled  torsional  
angles of ca. 105,38,  and  -  168s obtained for Ado-Cbl.  The modeled  torsional  angles  
for the C(4')-C(5') bond in Ado-Cbl were 69 and -174°, consistent with 7(4',5'a) and 
7(4',5'b)  of  <  2 and  9.2 Hz, respectively,  in Ado-Cbl  and  1.0 and  9.0 Hz,  respectively,  
in  Ado-PTC.  Thus, H b -C(5)  is  trans  to H-C(4 ' )  and  oriented  towards  the  corrin  
C(10) atom while H a-C(5')  points toward the corrin-ring A. These orientations  result  
in  a ca. 1-ppm upfield shift for Hh—C(5') relative to  Ha—C(5')  in both  Ado—Cbl  and  
Ado-PTC.  The ribose ring lies nearly perpendicular to the corrin ring with the  ribose-
ring O-atom  pointing  towards the  corrin  C(14)  atom.  The  adenine  ring  is  in  the  syn  
conformation, nearly parallel  to the  corrin  ring  and positioned  over the corrin-ring  C.  
This results in the characteristic upfield shift of ca. 0.3 ppm for Me^-C(12)  of the Ado 
derivatives  relative  to the  hydroxyalkyl  derivatives.  
In  the  nucleotide  loop  of  the  Cbl  derivatives,  the  a-ribose  conformation  is  also  
C(3')-endo  (dihedral  angles  of  -  26°  for  protons  H - C ( l ' ) ,  H-C(2 ' ) ,  40s  for  
H-C(2 ' ) ,  H—C(3'),  and  -167 s  for  H-C(3 ' ) ,  H-C(4 ' ) ) ,  resulting  in  a  coupling-
constant  pattern  similar  to  that  for  the  Ade-Rib.  The  predominance  of  the  
C(4')-C(5')  rotamer  with  OH  trans  and  both  H-C(5 ' )  gauche  to  H-C(4 ' )  is  
confirmed  by  the  small  values  of  both  coupling  constants.  In  PTC  derivatives,  the  
nucleotide loop is open and flexible. In this case the loop ribose adopts predominantly a 
C(2')-endo  (H-C(2 ' )  axial)  conformation  (dihedral  angles  of  42°  for  H - C ( l ' ) ,  
H—C(2'), - 3 7 s  for H-C(2 ' ) ,  H-C(3 ' ) ,  and -106°  for H-C(3 ' ) ,  H-C(4 ' )  result  in  
vicinal  coupling constants  of  4.6, 6.3, and  2.5 Hz,  resp.).  Modeling  indicates that  the  
C(2')-endo and  C(3')-endo  ribose conformations have  only  a  small  energy difference 
(<4kJ/mol)  for  an  open  nucleotide  loop,  but  that  the  C(3')-endo  conformer  is  
preferred  when  the  loop  is closed  and  Dbi  is attached  to the  Co-atom.  
The  loss  of the Dbi  group  as a-ligand  at  the  Co-atom  perpendicular  to  the  corrin  
plane in the 'base-off  derivatives removes Dbi as a source of upfield aromatic-ring shift 
effects. Therefore, corrin  groups pointing  downwards  and  normally  oriented  over  the  
plane  of  Dbi  (i.e., Me-C( l ) ,  Me-C(2),  Me„-C(12),  CH2(8'),  and  CH:(82))  move  
downfield  in  the  'base-off'  analogues.  In  the  modeling  studies,  it  was  found  that  the  
cobalamin  conformational  energy  is  lowered  by  several  kJ/mol  when  the  side  chain  
located  at  C(8)  and  pointing  axially  downwards  is oriented  to  place  the  CH2  groups  
very  close  to  the  face  of  Dbi  (hydrophobic  stabilization);  this  intramolecular  
interaction  is responsible  for the  unique  and  abnormally  large  shielding  of  these  CH2  
groups  relative  to  other  side  chains.  This  effect  is  lost  in  the  PTC  derivatives.  In  
addition,  all  of the corrin-ring protons are shifted downfield in the PTC analogues  (by  
as much  as  1 ppm for H—C(10); this probably reflects a significant change  in  electron  
density  at  the  Co-atom  (and  the corrin  ring system)  in the  'base-off' form. 
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Some  interesting  conformational  properties  of  the  hydroxyalkyl  ligands  in  the  
coenzyme-B12  analogues  discussed  here  can be  derived  from the  analysis  of  chemical  
shifts and  couplings. The crystal structure  of  [(i?)-(HO)2pr-Cbl  (2b)  [28] shows that  
the  Co-C(l")  bond  has  the  same  angular  orientation  as  the  Co-C(5')  bond  in  
Ado-Cbl  with the pro-S  proton (H a -C(l")  or Ha-C(5'))  pointing towards the corrin-
ring  A  and  the  pro-R  proton  (Hb-C(l")  or  Hb-C(5'))  pointing  toward  C(10).  In  
contrast, C(l")  is rotated  by ca. 90° counterclockwise  in the (S)-(HO)2pr derivative  2a 
so that H5 /-C(l")  points towards H-C(19)  and H ^ - Q l " )  towards Me-C(5).  Here,  
we distinguish CH2 protons by the subscripts a and b to denote low- and high-field shifts 
(high and low frequencies), respectively, and Re and Si to designate the pro-R  andpro-
S  positions.  This  conformational  difference  between  the  two  dihydroxypropyl  
derivatives  (confirmed  as  energy  minima  in  modeling  studies)  is  reflected  in  the  
chemical  shifts  of  the  CH2(1")  protons.  For  [(/?)-(HO)2pr]-Cbl  (2b)  H b -C(l")  has  
nearly  the  same  strongly  shielded  chemical  shift  as  Hb-C(5')  in  Ado-Cbl  (pro-R  
position)  while H a -C(l")  (Ha-C(5))  resonates  downfield by 0.61 (0.98) ppm (pro-S 
position).  For  [(S)-(HO)2pr]-Cbl  (2a),  both  chemical  shifts are  less shielded  by  ca.  
0.4 ppm. consistent with a rotation  away from the central part  of the delocalized  corrin  
double-bond  system.  This  trend  is  also  observed  for  the  (HO)2pr-PTC  analogues,  
although there is a general increase in the local shielding effects when the Co-atom is in 
the  'base-off' form. 
Another  diagnostic  feature  is the  chemical  shift  of  the  corrin  H—C(19)  which  is  
shifted  downfield  by  ca.  0.4 ppm  in  the  (/?)-(HO )2pr  vs.  the  (S)-(HO)2pr  or  Ado  
derivative  for both  the  Cbl  and  PTC  analogues.  The  crystal  structure  shows  that  for  
[(/?)-(HO )2pr] -  Cbl  (2b),  the  O-atom  of  OH-C(2")  is relatively  close  to  H-C(19)  
(2.6 A)  and  is  probably  the  source  of  the  downfield  shift  [27].  This  conformation  
corresponds to the lowest-energy C(l")-C(2")  rotamer in the modeling studies (shown 
in the  Figure); C(3")  is trans to Co and H-C(2")  is approximately  trans to  H5 (-C(l")  
(ca.  145")  and  at  an  angle  of near -100°  to HR e-C(l") ,  consistent  with the  observed  
vicinal  coupling  constants  for  2b  (Table3\  7(l"a,2") =6.9  and  7(l"b,2") =  1.8Hz).  
Similar  coupling constants are observed for [(/?)-(HO )2pr] -  PTC (3b).  On the  other  
hand,  the C(2")-C(3")  bond  is nearly vertical  relative to the  corrin plane,  so that  all  
three  rotamers  for  the  orientation  of  OH—C(3")  are  possible.  Thus,  the  difference  
between  the two J(2",3")  in the (R)-(HO)2pr  derivatives  is smaller. 
In  contrast,  for  [(S)-(HO)2pr]-Cbl  (2a),  H i ( -C(l")  points  towards  H-C(19).  
Modeling  indicates  that  two C(l")-C(2")  rotamers  are  probably  populated.  One  of  
these  has OH-C(2")  trans to the Co-atom,  as in the  crystal  structure,  while the  other  
has C(3") trans, as shown in the Figure. Thus, each H-C( l " )  may spend time in either a 
trans or a gauche position relative to H-C(2"), consistent with the observed 7(1",2") of 
4 - 5  Hz.  In  the  crystal  structure,  OH-C(3")  is  gauche  to  OH-C(2")  and  oriented  
towards  Me—C(17),  corresponding  to  the  rotamer  with  H-C(2")  gauche  to  both  
H-C(3") .  For  the  other  C(l")-C(2")  rotamer  (C(3")  trans  to  Co),  all  three  
C(2")-C(3")  rotamers should be possible, but the conformation with iraw-OH groups 
and  H f t i-C(3")  trans  to  H-C(2")  (Figure)  may  be  favored,  resulting  in  a  larger  
coupling  constant  for  H-C(2")  to  H f ie-C(3")  (tentatively  assigned  as  Ha-C(3")).  
These  observations  and  arguments  apply to [(S)-(HO)2pr]-PTC  (3a)  as well. 
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Another interesting feature of the spectra is the geminal coupling of the CH2 group 
attached  to  the  Co-atom. The  magnitude  of  this  coupling  constant  in  the A d o -  and  
(HO)2pr-Cbl  analogues ranges from 8.9 to 9.5 Hz but is reduced to 7.5 to 8.5 Hz in the 
corresponding PTC derivatives and to 7.0 for HO(CH2)2-Cbl  (la).  A reduction in this 
coupling constant  is consistent  with  an increase  in the  electron-withdrawing  power  of  
the Co-atom in its 'base-off' form or of OH-C(2")  when the C(3") atom is absent. For 
HO(CH2)2-Cbl  (la),  large  trans vicinal  coupling  constants  (12.5 Hz)  were  observed  
(7(l"a,2"b)  and  7(l"b,2"a)).  This  indicates  that  the  hydroxyethyl  group  adopts  
exclusively  a  staggered  conformation  with  Co and  OH  in  a  trans (lantV)  relationship  
and with H a -C( l " )  and Ha-C(2") pointing toward the 'west' side of the corrin ring and 
the  more  strongly  shielded H b -C( l" )  and Hb-C(2")  pointing  toward  the  'east'.  For  
HO(CH2)3-Cbl  (lb),  a detailed  analysis  of the  alkyl coupling constants  could not  be  
made, but  the  CH2(1")  chemical  shifts and  the  shift difference for CH2(2")  were  very  
similar to  the  values  observed  for HO(CH2)2-Cbl  (la),  indicating  similar  conforma-
tional  properties.  
In  summary,  we find  that  the  upper  (/?)  and  lower  (a)  regions  of  the  corrin  ring  
system  in  coenzyme-BI2  analogues  are  largely  independent  in  their  conformational  
properties. The /Migands (Ado, hydroxyalkyl) behave the same in the 'base-on' Cbl and 
'base-off  PTC derivatives. These ligands are restricted  in their conformational freedom 
by the  various  Me  groups  and  side  chains  at  the  corrin  ring.  The  crystal  structures  of  
Ado-Cbl  and the (HO)2pr  derivatives appear to provide good representations for the 
(predominant)  conformation  in  solution.  It  is  interesting  to  note  that  C(4')  of  the  
adenosyl  ligand  has  the  same  (S)-configuration  as  C(2")  of  the  (S)-(HO)2pr  deriva-
tive  (Fig.).  Surprisingly,  the  (5)-(HO)2pr  derivative  has  a  significantly  differ-
ent  conformation  and  orientation  of  the  C3  chain  compared  to  the  Ado  
(C(3')-C(4')-C(5'))  and  (/?)-(HO)2pr  ligands.  which  show  highly  similar  conforma-
tions.  However,  in  the  modeled  structures,  the  orientations  of  the  OH  groups  of  the  
(/?)-(HO)2pr  derivative  poorly  match  those  of  Ado,  while  OH-C(3")  of  the  (S)-
(HO)2pr derivative and OH—C(2')  of Ado both point toward the corrin-ring D and are 
located 4.5-5  A  above the  corrin  C(16)  atom.  Thus, the  (5)-(HO)2pr  derivative  may  
interact more favorably than the (R)-form with  a putative  ribose  binding site or with a 
substrate  binding  site  (see  below),  resulting  in  the  observed  difference between  the  
inhibition  constants K%. 
Inhibitor  Properties  of  the  Coenzyme-B}2  Analogues.  From  the  data  in  Table 4, we 
note  that  the  absolute  values  of  K,  of  inhibitors  and  Km  of  coenzyme  B,2  differ by a  
factor of  20 or more for glycerol dehydratase  and for diol dehydratase. However, there 
are crude similarities in the order or ranking of inhibitor potencies (relative  K^  values) 
for the  two  enzymes.  Such  a  similarity  may be  a  result  of  the  homology found  in  the  
amino-acid  sequences  of  several  representatives  of  these  two  kinds  of  dehydratases  
[24] [25]. Furthermore,  both  dehydratases  accept  either  glycerol  or  racemic  propane-
1,2-diol  as substrate  [29] [33]. 
As expected, all of the 'base-on' hydroxyalkyl analogues were efficient inhibitors of 
both enzymes with  a narrow range of apparent  K .^ The K, values differed by, at most, a 
factor of two from the apparent  Km  for coenzyme B12 (Ado-Cbl).  It  should be  noted  
that  such a range  of  K, corresponds to differences in a binding free energy  AG—AH-
TAS  of  less than  2 kJ/mol,  which  is less than  the  AG  associated  with  a single  H-bond  
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(en.  5 kJ/mol),  and  certainly  within  the  range  of  possible  variations  due  to  entropy  
effects alone [34]. For both enzymes, the two short-chain monohydroxy analogues  la.b. 
i.e. OH(CH2)„-Cbl  (n = 2 and 3),  had  lower  R  relative to the  long-chain  derivatives  
lc,d (n — 4 and 5). One possible interpretation  of this result is that a hydrophilic area of 
interaction  between  the /Migand  and  the  protein  must  lie  relatively  close  to  the  Co-
center.  However,  when  one  compares  ligands  with  different  chain  lengths  and.  
therefore,  different  degrees  of  freedom  for  internal  motions,  the  loss  of  motional  
entropy  upon binding to a protein  must  be taken  into account. At  room  temperature,  
this effect on AG  for binding has been estimated  to be ca.  +1.4 kJ/mol for each single 
bond  whose motion  is 'frozen'  in the complex  [34]. Thus, for alkyl groups with two to 
five C-atoms, interaction of a terminal OH group with a binding pocket in the protein is 
expected  to result  in  an entropy penalty  which  increases  with chain  length  and  which  
may compensate  for or  even  exceed  any  negative  enthalpy  changes  due to  increasing  
hydrophobic  interactions  with  increasing  alkyl chain  length, for example.  
The  kinetic  results  obtained  with  the  'base-on'  dihydroxypropyl  analogues  2a.b  
indicate  that  a  second  OH  group  in  the  /Migand  provides  no  significant  increase  in  
binding  affinity. This is consistent  with the hypothesis that the ligand interacts with  the  
substrate  binding site and that  only the terminal  (primary) OH group  of the  substrate  
(or  ligand)  can be  involved  in  binding  (see  Introduction).  Alternatively,  the  /Migand  
may  interact  with  a  ribose  binding  site  which  is  possibly  utilized  by  the  natural  
coenzyme.  Theoretically,  two  ribose OH  groups  are  available  for H-bonding, but  our  
NMR  and  modeling  studies  indicate  that  in  the  favored  conformations  of  the  
dihydroxypropyl  ligands,  only one  OH  group  can  adopt  an  orientation  similar  to  the  
adenosyl OH-C(2') ,  for example. This 'match'  in orientation  was better for the  [(5)-
(HO)2pr]-Cbl  (2a), and this analogue was indeed a slightly better inhibitor  compared  
to the [(/?)-(HO )2pr]-Cbl  (2b). However, the monohydroxyalkyl  ligands may have a 
small advantage  of greater conformational flexibility for positioning  the terminal  OH  
group  in the  appropriate  orientation for  binding.  
It  is  interesting  and  perhaps  surprising  to  note  that  the  simple  hydroxyethyl  and  
hydroxypropyl groups as /Migands in la,b result in inhibitors with R  equal to the Km for 
coenzyme  B12 (Ado-Cbl).  One  possible  explanation  is that  the  binding  stabilization  
provided  by  the  adenosyl  moiety  is simply  limited  to  the  interaction  of  a  single  OH  
group  with  the  protein,  an  interaction  which  can  be  generated  also  by  the  small  
hydroxyalkyl  group.  Another  and  perhaps  more  likely  explanation  is  that  the  bulky  
adenosyl group introduces positive contributions to AG  (steric repulsions, 'induced fit' 
energy, etc.) which largely compensate the available negative, stabilizing contributions.  
In general, however, it is quite difficult to describe binding interactions and to interpret 
the small differences in Table 4 in an a priori  manner without knowledge of binding-site 
geometry and the residues involved (X-ray structures are not available for the enzymes 
discussed here). A further difficulty arises when binding via H-bonds is concerned. Not 
only  the  number  of  putative  H-bonds  in  the  complex  is  important,  but  also  the  net  
change  in the  total number  of  H-bonds after complexation  and the  net  change  in  the  
number of free solvent H20 molecules. For all of the Cbl derivatives presented here, the 
small range of AG  values represents small differences in the sums over a series of much 
larger  numbers  (enthalpies  and  entropies  with  positive  and  negative  contributions).  
The  differences in  AG  are  smaller  than  the  free  energy  we  can  assign  to  any  single  
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discrete interaction  such as one H-bond. Thus, it is probably reasonable to consider all  
Cbl  derivatives  examined  here  as  essentially  equally  good  inhibitors  for  GDH  and  
DDH. 
In contrast, the 'base-off PTC analogues 3a,b are significantly poorer inhibitors and  '  
exhibit a much wider range of potencies and larger differences in relative K{ values for 
the  two  enzymes.  One  expects  that  the  'unattached'  nucleotide  loop  at  the  PTC  
derivatives  can,  in  principle,  be  folded so  as to  fit  into  the  presumed  binding  pocket  
utilized  by the natural coenzyme and its Cbl analogues [16]. Thus, essentially the same 
enthalpy  of  binding  should  be  achievable  for Ado-PTC  as  for Ado-Cbl,  but  this  
requires  a  significant  entropy  penalty  since  several  degrees  of freedom in the  'open'  
loop will be reduced,  if not frozen, in the final 'closed' or 'base-on' conformation upon 
binding. As many as ten single bonds are involved whose mobilities  will be reduced  in  
the  complex.  For  an  entropic  contribution  of  1.4 kJ/mol  per  bond,  one  predicts  an  
increase in AG  of up to  14 kJ/mol, which covers the range of 4 - 8  kJ/mol calculated for 
Ado—PTC  and  the  dihydroxypropyl  derivatives  3a.b  (Table 4).  The  differences  
between  these three inhibitors are larger than for the  Cbl analogues, but  still no larger 
than  the  free-energy  contribution  for  a  single  H-bond.  As  observed  for  the  Cbl  
derivatives, the [(S)-(HO)2pr]-PTC  (3a)  is a better inhibitor than the (R)-isomer  3b;  
it is, in fact, even better than the Ado analogue. This is consistent with the concept  that  
the  small  (5)-(HO)2pr  ligand  can  enter  into  favorable  interactions  with  either  a  
substrate or ribose site. These interactions may be similar to those pursued  by the Ado 
ligand, but perhaps without unfavorable compensating effects (e.g., protein conforma-
tional  changes)  caused  by the  adenosyl's  bulk, which  may be more  important  when a  
closed  nucleotide  loop is not  already  present.  
It  is surprising that  HO—PTC itself  (with  a /3-hydroxo ligand)  proved to be a very 
poor  inhibitor,  while  the  analogue  HO—Cbl  is  the  best  inhibitor.  This  is  clearly  not  
explainable  with  simple  entropy  effects.  One  possibility  is  that  the  binding  of  
coenzyme-B12  analogues  occurs  in  a stepwise manner  and that  stabilizing  interactions  
between  an  appropriate  /3-ligand  and  the  protein  are  first  necessary  to  give the  PTC  
nucleotide  loop  the  opportunity  to  adequately  fold  to  occupy  the  normal  Dib-loop  
pocket. For HO-PTC.  the  initial  complex  may  not  be  stable  enough to promote  this  
folding process  or  induction  of  the  corresponding  optimal  protein  conformation.  For  
HO-Cbl  the  corrin  moiety  and  the  nucleotide  loop  presumably  already  have  the  
optimal, relatively rigid conformation, so that binding can proceed directly without the 
need for a prestabilizing  complex. As is well-known  in drug design,  if an inhibitor  can  
be produced  with  a rigid conformation matching the  bound  or active conformation  of  
an otherwise flexible substrate, then binding affinity may be enhanced by several orders 
of  magnitude.  
In. conclusion, the inhibition kinetic data presented here confirm that both  glycerol  
dehydratase  and  diol  dehydratase  reactions  utilize  the  'base-on'  binding  mode  of  
coenzyme B12. A series of 'base-on' cobalamin derivatives with hydroxyalkyl ligands on 
the  jS-side,  i.e.,  l a - d  and  2a,b,  proved  to  be  strong  competitive  inhibitors  of  the  
dehydratases  with  a  narrow  range  of  K,;  the  best  inhibitor  had  K,  equal  to  Km  of  
coenzyme  B12. The 'base-off' corrinato  complexes (PTC analogues)  with  adenosyl  or  
hydroxyalkyl ligands on the /?-side, i.e., 3a,b. exhibited significant but poorer potency as 
inhibitors. The parent  compound  HO—PTC,  with  only a /?-hydroxo ligand,  was a  very  
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poor inhibitor while HO -  Cbl was the best for both enzymes. These results indicate that 
for the 'base-off' analogues interactions between the /Migand and a hydrophilic binding 
site near the Co-center (for substrate or possibly for the adenosyl  ribose) are  important  
for stabilizing an initial complex and facilitating the folding of the nucleotide loop into 
a 'base-on' conformation in the final inhibitor-apoenzyme  complex. All  Cbl  analogues  
have  the  'ideal'  'base-on'  conformation  of the  nucleotide  loop, and their potencies  as  
inhibitors,  judged  by  Kit  are  much  less  dependent  upon  the  nature  of  the  /Migand.  
Experimental  Part  
Materials.  Coenzyme  B|2.  vitamin  B ^  <w-haloalkanols.  and  sodium  tetrahydroborate  (NaBH4)  were  
obtained  from  Fluka  Chemie  AG.  The  enantiomeric  (R)-  and  (S)-3-chloropropane-1.2-diols  were obtained  by  
enzymic resolution  [35].  Racemic propane-1.2-dioI was supplied by Aldrich.  (Co«-Cyano)(Co/?-hvdroxo)  [l'-O-
(p-tolyl)cobamide]  (HO-PTC)  was isolated  from Sporomusa  ovata  cells  by  extraction  with  KCN-containing  
AcOH  buffer at  pH 5  followed  by centrifugation. treatment  of  the  supernatant  by  neutral  aluminum  oxide,  
desalting,  chromatography  on  a  XAD-2  column,  and  reversed-phase  HPLC  (RP18)  as  previously  described  
[36-38].  Yeast  alcohol  dehydrogenase  and 0-NADH  Li,  (NADH)  were  products  of  Boehringer  Mannheim  
GmbH.  Glycerol dehydratase (GDH) was isolated as described previously [26] from overexpressing  Escherichia  
coli cells containing  the genomic DNA for glycerol dehydratase  from Citrobacter freundii  [25] [39].  Propanediol  
dehydratase (DDH)  was isolated as reported  previously  [26] from overexpressing  E. coli cells containing genes 
for dioi dehydratase  from Salmonella  typhimurium  LT2.  
[(2-Hydroxyethyi)-,  (3-Hydroxypropyl)-,  (4-HydroxybutyI)-,  and  (5-Hydroxypentyl)  ¡cob)  HI)alamin  
(la.lb.lc.  and  Id.  resp.).  f(S)-2,3-DihydroxypropylJ-  and  f(R)-2,3-DihydroxypropylJcob(III)alamin  (2a  and  
2b.  resp.).  and  {Cof)-f  (S)-2,3-D  ihydroxyp  ropy I)} -  and  fCoPf  (R)-2.3-DihydroxypropylJJ[l'-0-<  p-toiyl)cob-
umidej  (3a and  3b. resp.). To a soln. of HO-Cbl  or H O - P T C  (5 pmol)  in deoxygenated H : 0  (0.5 ml), a soln. 
of NaBH4  (5 mg)  in deoxygenated  H-O (0.4 ml) was added  under  Ar at  r.t.. and  the  resulting soln. was stirred 
for 30 min. Then  a  soln.  of  the  corresponding  cu-haioalkanol  or  -diol  (50-100 pmol)  in  deoxygenated  MeCN  
(0.4 mi) was added, and the mixture was stirred  in the dark at r.t. for 1 h. After sterile filtration through a 30-kD 
nitrocellulose  membrane,  the  mixture  was  submitted  to  prep.  HPLC  (Macherev  &  Nagel.  250mmxl" .  
Nucleosil-7-Cu, column: 20 -  85% Me0H/H20  gradient over 35 min, flow rate  5 ml/min; diode array  detection,  
monitoring  at  240  and  280 nm;  UV  spectra  obtained  between  200  and  600 nm  from the  HPLC  peaks).  The  
fractions containing  the  product  were  concentrated  in  a  SpeedVac  to give  the  desired  (Co/?-X)-Cbl  l a - d  or  
2a.b.  or  (Co/?-X)-PTC  3a.b  in  over  60%  yields.  Purities  of  the  products  were  over  95%  by  anal.  HPLC  
(Macherey  & Nagel.  125 x 4 mm, 5 pm  LiChrospher  100 RP-18  column, linear gradient  of  40 -  70%  B in A  over  
12 min  (A:  0.02%  CF,COOH  in  H 2 0;  B:  0.02%  CF,COOH  in  MeOH),  flow  rate  1 ml/min:  diode-arrav  
detection). 
'H-NMR  Spectroscopy.  Solns.  of  (Co/3-X)-Cbl  la.b  or  2a,b  (2.6-3.1 mg)  or  (Co/3-X)-PTC  3a.b  (0.7-  ,  
0.9 mg)  in  0.4 ml  of  a  20  mM sodium  phosphate/D20  buffer (pH-meter  reading  7.4. 5-mm sample  tube)  were  
measured at  10'  by means  of a Bruker-AM-500  spectrometer  using conventional  Fourier transform methods  as  
in  our  previous  studies  [16] [29].  The  residual  HDO  resonance  was  suppressed  by  selective  presaturation.  
Parameters  for  the  ID  spectra  of  la.b  or  2a.b  were:  spectral  width  4310 Hz.  32 K  time-domain  points,  
presaturation  for 3.1 s. 50:  flip angle, acquisition time 3.8 s, 400 transients. Data  processing was performed with 
zero-filling to  64 K data.  Lorentz-Gauss  resolution  enhancement,  and  a  digital  resolution  of  0.13 Hz.  Similar  
parameters were used for 3a.b. For well-resolved resonances, chemical shifts (given  in three decimal places, rel. 
to  internal  sodium  3-(trimethylsilyl)propanoate  (TSP))  and  coupling  constants  were  derived  from the  peak-
picking  output  (cubic  interpolation):  chemical  shifts, given  in  only  two  decimal  places,  were  estimated  from  
cross-peaks  in  the  2D  COSY experiment.  The  total  number  of  nonexchangeable  protons  was  confirmed  by  
integration,  and  the  complete  assignments are given  in  Tables 1 and  2.  
Two-dimensional  magnitude-mode  COSY-/?  and  NOESY  data  were  obtained  from conventional  pulse  
sequences and the following parameters for la.b or 2a,b. COSY: spectral width 3906 Hz. 2 K time-domain  points  
in f2. acquisition  time 0.261 s. 512 f, increments with 32 transients each, 40 ms initial delay in the f, time  domain  
to enhance  the  effects  of  long-range  couplings, P -  50s  as  read  pulse  to  improve  the  detection  of  cross-peaks  
close to the diagonal  and provide some discrimination  between  vicinal and geminal couplings, relaxation  delay  
with  presaturation  2.25s.  sine-bell  window  functions,  zero-filling  to  I K  in  f,.  digital  resolution  3.8Hz/pt.  
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NOESY: as for COSY, except 48 or 64 transients per t, increment,  90"' read pulse, mixing time 500 ms with  max.  
±  15% random variation. For 3a.b. similar parameters were  used except: presaturation  delay 2.3 or 2.7 s. 30 ms 
initial  t, delay for COSY, 600 ms mixing  time  for NOESY. 
Molecular  Modeling.  As an aid to interpretation  of the NMR data, modeling of Ado-Cbl  and several  of the 
analogues discussed here was performed using the MM +  force field of HyperChem 4.5 (HyperCube. Inc.).  with  
additional  parameters  added  for bond  lengths  and  angles  for C o - C .  Co-N.  Co-O.  and P - 0  bonds.  These  
parameters  were derived  from the X-ray structure  of  Ado—Cbl  [40] (atomic-coordinate  file DADCBL  in  the  
Cambridge  Crystallographic  Data  Files)  and  from parameters  in  the  Alchemy  3  force  field.  In  addition,  the  
atomic coordinate  files CUVClFand  CUVCOL for [(/?)- and (S)-(HO),pr]-Cbl  (2a.b). resp.. [28] were  also  
available. 
Enzyme  Assays.  Assays for glycerol-dehydratase  and  diol-dehydratase  activity  with  racemic  propane-1.2-
diol  as substrate were performed using a yeast alcohol dehydrogenase/NADH-coupled.  UV-based assay system 
at 37:  [26]. A mean rate for the enzyme reaction, measured  over the interval  / =  2 — 3 min of the assay, was used 
for the  calculation  of  kinetic  constants.  
Kinetic  Investigations.  Apparent  inhibition constants  (X;) for l a - d ,  2a.b. and 3a.b were determined  by the 
method  applied  for the  inhibition  kinetics of poslhomolysis analogues of coenzyme B u  (= Ado-Cbl)  [26] [41], 
Ado-Cbl  and  various  amounts  of  inhibitor  were  added  simultaneously  to  the  assay  mixture,  and  the  
experiments  were  repeated  at  several  (usually  three)  concentrations  of  Ado—Cbl.  Inhibition  constants  were  
calculated  from  linearized  data  sets  in  a  Dixon  plot.  K,  was computed  as the  average  of  the  experimental  K,  
values obtained  at different Ado—Cbl  concentrations.  
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Hidrolítikus  enzimek  a szerves  kémiában:  új  lehetőség  
optikailag  aktív  vegyületek  előállítására  
Bevezetés 
A  gyógyszer-  és  finomvegyszergyártás  fejlődé-
sével  egyre  nő  az  igény  a  hatékony,  optikailag  
aktív  vegyületek  előállítására alkalmas  módszerek  
iránt.  Mikrobiológiai,  fermentációs módszereket és 
eljárásokat  már  viszonylag  régóta  alkalmaznak  
ezen  iparágakban  bonyolult  vegyületek  totál-
szintézisére  111.  azok  részbeni  módosítására.  E  
módszerek  többsége  optikailag  aktív  termékeket  
eredményez,  de  problémákat  okozhat  a  folyamat  
szabályozása,  hozama,  a  termékek  elkülönítése  és  
a  speciális  alkalmazhatóság.  
Tisztított  enzimek  alkalmazása  e  problémák  
nagy  részét  megoldja,  és  olyan  vegyületek  elő-
állítására  nyújt  lehetőséget,  melyek  hagyomá-
nyos kémiai módszerekkel nem, vagy csak nehezen 
állíthatóak  elő  hatékonyan.  Napjainkban  már  
ipari  méretekben  is  alkalmaznak  enzimeket,  első-
sorban  oxidációs-redukciós  folyamatok  katalízi-
sére  [1],  ezekkel  enyhe  körülmények  között  nagy  
optikai  tisztaságú  termékek  állíthatók  elő.  Az  
enzimeket néhány tulajdonságuk igen hasznossá és 
értékessé  teheti  a  szerves  kémiában.  Különösen  
fontos lehet  a  szintetikus  alkalmazás  szempontjá-
ból  a  nagy  reakciósebesség  (az  enzim  aktív  cent-
rumában  az  elemi  átalakulások  sűrűsége  akár  
10°—108  s - 1  is  lehet),  a  szelektivitás  (specifikus  
átalakulások  katalízise  igen  nagy  sztereoszelekti-
vitással)  és  az  enyhe  körülmények  (gyakorlatilag  
semleges  pH  és  szobahőmérséklet).  Felhasznál-
hatóságukat  tovább  növeli  a  hosszú  ideig  eltart-
ható,  könnyen  kezelhető, többször  felhasználható,  
rögzített enzimek előállítása  [1,  2,  21,  22, 42,  43].  
Az utóbbi  években a szerves kémikusok is mind 
nagyobb  érdeklődéssel  fordulnak  a  mikrobiológiai  
fll.  enzimatikus  úton  előállítható  optikailag  aktív  
intermedierek  felé  [3—5].  Számos  ilyen  vegyület  
előállítását oldották meg az utóbbi években mikro-
biológiai módszerekkel [6—11], ül. lómájból kivon-
ható  alkohol  dehidrogenáz  (HLADH)  enzim-
rendszerrel  [12—18].  Napjainkban  a  legnagyobb  
fejlődés  azonban  a  hidrolítikus  enzimek  (EC.  3)  
alkalmazásában  mutatkozik  [18—21].  Ennek  oka  
az,  hogy  míg  a  fermentációs  technikák  mikro-
biológiai  ismereteket,  speciális  eszközöket  és  vi-
szonylag híg oldatokat  igényelnek,  vagy  az oxido-
reduktázok  (EC.  1.)  felhasználásának  koenzim-
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igényük  szabhat  határt,  addig  a  hidrolázok  külö-
nösebb  biokémiai  vagy  mikrobiológiai  ismeret  
nélkül,  egyszerű  körülmények  között  használha-
tók.  Yizes  oldatban  az  alábbi,  igen  egyszerű  
reakciót  katalizálják:  
Hidrolízis 
R1 —CO—X—R2-f-H,0—  wR1-CQOH+  
"  + H X - R 2  
X=Q(S,  NH)  
A reakció a szubsztrát szerkezetétől függően vezet-
het  mind  optikailag  aktív  karbonsavakhoz,  mind  
optikailag  aktív  alkoholokhoz  (ill.  X=S,  NH  
esetében  tiolokhoz,  aminokhoz).  Megfelelő  körül-
mények  között  (apoláris  közeg,  sav,  alkohol  vagy  
észter  felesleg)  azonban  a  hidrolázok  katalizál-
hatnak  észteresítési  vagy  átészterezési  reakciókat  
is  [23—26],  melyek  szintén  eredményezhetnek  
optikailag  aktív  vegyületeket.  Ezen  tulajdonsá-
gaik a hidrolítikus enzimeket  különösen  alkalmas-
sá  teszik  optikaüag  aktív  szintézisintermedierek  
előállítására,  elvüeg két úton:  prokirális,  ill.  mező  
vegyületek  átalakításával,  vagy  racém  vegyület-
párok  rezolválásával.  
Szintetikusan alkalmazott  hidrolítikus enzimek 
d-Kimotripszin (CTR)  (EC.  3.4.4.5.)  
Az egyik legrégebben ismert és legtöbbet  tanul-
mányozott  enzim,  az  emlősök  hasnyálmirigyében  
termelődik  és  a  bélcsatornában  aktiválódik.  Az  
emésztés  során a  fehérjék bontását  végzi,  elsősor-
ban  az  aromás  L-amino-karbonsavak  karboxüja  
melletti  peptidkötéseket  hasítja.  
Ezzel  az  enzimmel  végezték  az  első  olyan  vizs-
gálatokat,  melyek  során  prokirális  vegyületeket  
teljes  egészében  optikaüag  aktív  származékká  
alakítottak  enzimatikus  úton  [27—30].  A  külön-
böző  mesterséges  szubsztrátokkal  végzett  össze-
hasonlító kinetikai vizsgálatok  [31,  32] eredménye 
szerint  más hidrolázokhoz  viszonyítva  lassú,  kis  
aktivitású,  de igen nagyfokú szelektivitást  mutató  
enzim.  Aktivitását  az  N-acetü-L-tirozin-etüész-
terrel  mérhető  hidrolízis-sebességgel  definiálták  
[33].  Vízoldható  formában kereskedelmi  forgalom-
ból  beszerezhető  (SIGMA,  REANAL),  rögzített  
formában  [21,  42]  sokáig  tárolható  és  többször  
felhasználható. 
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Disznómáj  karboxil-észteráz  (PLE)  (EC.  3.1.1.1.)  
[34—36] 
A  karboxil-észterázok  az  egész  élővilágban  el-
terjedt,  széles  specificitással  rendelkező  enzimek,  
karbonsav  észterek  hidrolízisét  katalizálják.  Szin-
tetikusan  leginkább  a  disznómájból  kivont  kar-
boxil-észterázt  (PLE)  alkalmazzák.  Ez  az  enzim  
a  legtöbb  mesterséges  szubsztrát  esetében  nagy-
ságrendekkel  aktívabb  az  a-kimotripszinnél  és  
sokszor  szelektivitása  is  megközelíti,  vagy  eléri  
azét.  Tisztasági  fokától  függetlenül  lineáris  reak-
ciólefutást  ad,  szerves  oldószerek  (pl.  benzol)  kis  
koncentrációban  aktiválják  [32,  35].  Mesterséges  
szubsztrát jai elágazó láncú karbonsavak vagy elága-
zó láncú alkoholok  észterei is lehetnek.  Aktivitását  
etil-butiráttal  mérve definiálták  [32,  35].  Tiszta,  
vízoldható  formában  kereskedelmi  forgalomból  
beszerezhető  (SIGMA,  SERVA),  rögzített  formá-
ban  is  ismert  [2,  21].  A  Horgán  és  mtsai  tisztítási  
módszerének  [34]  módosított  első  két  lépésével  
általunk  előállított  nyers  enzimkészítményt  is  
sikerrel  alkalmaztuk  [37,  38],  
Disznó-hasnyálmirigy  lipáz  (PPL)  
(EC.  3.1.1.3.)  [39—41]  
A  lipáz  enzimek  a  zsírok  emésztésében  fontos  
szerepet  játszanak,  a  trigliceridek  észterkötéseinek  
hidrolítikus  hatását  katalizálják.  Több  állati  és  
növényi szövetben megtalálhatóak  [41]. A  hosszabb  
szénláncú  zsírsavak  észtereinek  hasítását  gyorsab-
ban  végzik,  mint  a  rövidekét,  a  di-  és  monoglice-
ridek  hidrolízisét  is  katalizálják  egyre  csökkenő  
mértékben.  Mesterséges  szubsztrátjaik  az  egyenes  
szénláncú  karbonsavak  elágazó  láncú  alkoholokkal  
képzett  észterei  lehetnek.  A  lipázok  aktivitását  
trigliceridek  [39,  41],  újabban  triacetin  hidrolízi-
sének  segítségével  definiálják.  A  szerves  prepara-
tív  kutatásokban  elsősorban  a  kereskedelemből  
(SIGMA)  olcsón  beszerezhető  vízoldható  disznó-
hasnyálmirigy  lipázt  (PPL) használják,  de  emellett  
mikroszervezetek  által  termelt  lipázokat  is  alkal-
maznak  [21—26],  Rögzített  lipáz  is  ismeretes  
[22, 42].  
X = -COOR vagy 
-O-COR 
X X 
ENZIM 
100  %  konverzió  
Y--COOH vagy 
-OH 
X 
KemoszeleUtív reakciók-
/szelektív  redukció1  
-COOR, -COOH; 
véóócsoport  cserék:  
-0-COR, -OH / 
vagy Z;  vagy  Y  
vagy 
származékaik 
W  7.  Z  W  
7.  ábra.  Prokirúlis  vagy  mező  vegyületek  hidrolízise  
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A  hidrolítikus  enzimeket  három  módon  lehet  
hasznosítani  a  preparatív  szerves  kémiában:  pro-
királis  vagy  mező  vegyületek  átalakítására,  racém  
vegyületpárok  rezolválására  illetve  regio-  vagy  
diasztereoszelektív  átalakításokra.  Elvileg  mind-
három  alkalmazási  lehetőség  során  az  enzimkata-
lizált  folyamat  jellege  szerint  az  átalakítás  lehet  
hidrolízis,  észteresítés  ¿11.  átészteresítés.  
Prokirális  vagy  mező vegyületek  átalakítása  
A  hidrolítikus  enzimek  királis  katalízise  e folya-
matban  használható  ki  a  leghatékonyabban  (1.  
ábra).  Ezeknek  a  szimmetriaelemmel  rendelkező  
vegyületeknek  két,  kémiailag  egyenértékű  cso-
portja  eltérő  sebességgel  reagál,  mivel  annak  az  
enantiotóp  csoportnak  az  átalakítása  gyorsabb,  
amelyik  az  enzim  meghatározott  térbeli  szerke-
zetű,  királis  felületű  aktív  centrumába  energeti-
kailag  kedvezőbb  módon  illeszkedik.  
Termék 
(szubsztrát) R1 R s 
Term. % Opt.  t .  %6© 
Enzim Irodalom 
Termek 
a  He  E t =-90 73 PLE [44| 
b  (CH.)jCHj  Me =-90 87 PLE [44] 
/ s z u b s z t r á t / C  ( C H . ) , C H 3  Me =-90 88 PLE [441 
d  Bz  Me > 9 0 100 CTR [451 
R  R  =-90 45 PLE [451 
HOOC ^ - C O C H e 
e  E t  Ph >  90  84 PLE [46] 
f  He  OH 82 45 PLE [19] 
/MeOOC/" g  OCOPh  Me =»90 94 PLE [211 
h  OPh  Me > 9 0 97 PLE [21] 
i  OBz  Me > 9 0 86  '  PLE [21] 
j  Me  Ph > 9 0 81 PLE [21] 
a  Me  H 98 > 9 9 PLE [47,  19, 52—55] 
V 2 
b  Et  H 77 > 9 9 PLE [471 
c  Pr  H 90 > 9 9 PLE [47] 
X d  Pr  H 61 > 9 9 PLE [47] r í e  H>  H 90 > 9 9 PLE [47] 
HOOC  COOMe  f  Ph  H 91 > 9 9 PLE [47] 
/MeOOC/ 
g  Bz  
h  Me  
H 
OH 
90 
62 
> 9 9 
> 9 9 
PLE 
PLE,  CTR  
[47] 
[481 
i  H  OH 88 > 9 9 CTR [30] 
j  H  OH 95 12 PLE [19| 
k  OAc  H 45 87 PLE [49| 
1  NH.  H 93 40 PLE [501 
m H NHCOBz 94 > 9 6 PLE [50] 
HO  OAc  
/AcO/ m 
34 95  PPL  [51] 
2.  ábra.  Prokirális  diészterek  hidrolízise  
Termék 
(szubsztrát) 
HO  OH  
HOOC  COOMe  
/MeOOC/  IV  
HOOC^ÁJ^  COOMe 
/MeOOC/  ¥  
HOOC Á s ^ COOMe 
/MeCOC/  OH  W  
H O - ^ X X  QAc  
/AcO/  7JÍ a 
Term.  Opt.  En-  Iro-
%  t .  %  zim  da-
ee  lom  
92  48  PLE  [19]  
S5  64  PLE  [57]  
48  100  CTR  [19]  
95  98  PLE  [19]  
90  PPL  [58]  
AcO-JLX^OH 
Ü  b  /OAc/  
3.  ábra.  Nyíltláncú  mező  vegyületek  hidrolízise  
36 
15 
80 
95 
PLE PLE [58] [58] 
Az  enzimreakció  után  az  addig  megegyező  X  
csoportok  egyike  megváltozik,  így  a  szimmetrikus  
kiindulási  vegyület  elvileg  teljes  mennyisége  opti-
kailag  aktív  termékké  alakul  át.  Ebben,  a  kémiai-
lag  már  különböző  X  és  Y  csoportokat  megfelelő  
módszerekkel  szelektíven  továbbalakítva,  ugyan-
azon  anyagból  a  származék  tetszés  szerinti  enan-
tiomerjéhez  juthatunk.  
Ez  a  módszer  elvileg  mind  enzimkatalizált  
hidrolízis,  mind  enzimatikus  észteresítési  vagy  
átészteresítési  folyamatok  során  alkalmazható,  a  
mai  napig  azonban  a  két  utóbbi  alkalmazásra  
prokirális  vagy  mező  vegyületek  esetében  még  
nincs  példa.  
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Prokirális  vegyületek  hidrolízise  (2.  ábra).  A  
szubsztrátok  lehetnek  prokirális  dikarbonsavak  
vagy  diolok  észterszármazékai.  Diszubsztituált  
maionészterek  (2.  ábra,  I)  hidrolízise  során  meg-
felelő  szubsztituensek  esetében  jó  szelektivitást  
észleltek  PLE  enzimmel.  Dietil  észterekkel  végzett  
hidrolízisek  során  a  szelektivitás  csökkenése  ta-
pasztalható  [44],  A  CTR  enzim  kizárólag  a  ben-
zillel  szubsztituált  vegyületeket  bidrolizálja,  igen  
jó  optikai  tisztasággal  [44,  45].  
A  /3-szubsztituált  glutársav  észterek  (2.  ábra,  
II)  hidrolízise  PLE  hatására  a poláris  szubszti-
tuensek  esetében  (II:  a—g)  gyorsan  és  jó  optikai  
tisztasággal  (%ee>80)  játszódik  le. Dietil  észterek  
hidrolízisekor  a  szelektivitás  nagymértékben  csök-
ken  [52,  53,  56].  Poláris  szubsztituensek  esetében  
(II:  j,  1)  az  ellentétes  oldal  hidrolízise  gyorsabb,  
alacsony  optikai  tisztaságú  (%ee-= 40)  termékek  
képződnek.  E  vegyületek  hidrolízise  jó  szelektivi-
tással  CTR  enzimmel  valósítható  meg,  illetve  az  
enzimhidrolízis  védett  származékokon  (II:  k,  m)  
PLE  enzimmel  is  jól  elvégezhető.  
Prokirális  diolok  észterszármazékainak  (III)  
átalakítására  eddig  csak  a  PPL  enzimet  alkal-
mazták. 
Nyíltláncú  mczo  vegyületek  hidrolízise  (3.  ábra).  
E  vegyületek  enzimatikus  hidrolízisével  egy  lépés-
ben,  elvileg  teljes  mennyiségben  képezhetőek  
olyan  optikailag  aktív  anyagok,  melyek  egynél  
több  aszimmetriacentrumot  tartalmaznak.  A  VII  
vegyületpár  példáján  azt  figyelhetjük  meg,  hogy  
adott  esetben  másik  enzim  alkalmazásával  ellen-
tétes szelektivitás  érhető  el  [58].  
Gyűrűs mező vegyületek hidrolízise  (4 ja és 4 jb  ábra).  
E  vegyületcsoport  mindbárom  ismertetett  hidro-
litikus  enzim  alkalmazására  lehetőséget  ad,  sok  
Termők R1 R s Term. % 
Opt.  t .  
%  ee  Enzim  Irodalom  
< 
R1 
2 1  COOMe  
R  CH,OAc  
K s COOMe CH.OA0 
COOH 
CH.OH 
COOH 
CH.OH 
90 
74 
42 
- 94  PLE  
93  PPL  
80  PLE  
40  PPL  
[19,59,  60]  
[61. 62] 
[19,  59]  
[62] 
^ R 2 
Y  COOMe  
—  CH.OAc  
COOH  98  90  PLE  [19,59,60]  
CH.OH  78  96  PPL  [61,  62]  
a ? ' 
7 Í  COOH  
—  CH.OAc  
COOMe 
CH.OH 
80 
90 
9  PLE  
89  PPL  
[19,  59,  60]  
161,  62]  
a:; COOH XII  CH.OAc  COOMe CH.OH 7o 67 80  PLE  87  PPL  [19,  59,  60]  [61,  62]  
lR1 
'R2 
Bz 
k  ^R1 
CC a 
< K X 
Bt 
*XC 
COOH 
XIII  CH.OAc  
XV 
COOMe 
CH.OH 
COOH 
COOMe 
CH.OH 
COOH 
CH.OAc 
COOMe 
94 
96 
71 
70 
96 
- 94  PLE  
-99  PPL  
38  PLE  
92  PLE  
[19,  59,  60]  
[62] 
[63] 
[51] 
77  PLE  [64]  
°cC m COOH  COOMe  100 77  PLE  
240 
m k l 
[64] 
4>a ábra.  Gyűrűs  mező  vegyületek  hidrolízise  
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Termék 
R 1 R= 
Term.  Opt.  t .  Enzim  Irodalom  
%  %  ee  
( c p ^  ^  m  COOH  COOMe  86 75  PLE  [65]  
K m COOH  COOMe  S2  98  PLE  [65]  
„-R1 
0  I  Z l X  COOH  COOMe  
"R2 
87  64  PLE  [65]  
OH OAc S3 81  PLE  [2,  58]  
Bz 
m  COOMe  COOH  85 80  PLE  [66] 
R1 S E  C O O H  
^ ^  COOMe  
COOMe 
COOH 
60  PLE  
80  CTR  
[21] 
[21] 
R V C X R1 XXIII 
COOMe COOH 42 PLE [18] 
COOH COOMe 91 PPL [18] 
CH„OAc CH.OH 76 PLE [18] 
CH]OH CH„OAc 22 PPL [18] 
f ^ ^ j  COOMe  COOH  
XXIV COOH  COOMe  
71  PLE  
53  PPL  
[18] 
[18] 
4/b  ábra.  Gyűrűs  mezo  vegyületek  hidrolízise  
esetben  egymást  kiegészítő  módon.  A  legáltaláno-
sabb  a  PLE  enzim  alkalmazása,  ennél  a  termék  
szerkezete és optikai tisztasága  a gyűrű  merevségé-
től,  rögzített  konformációjától  erősen  függ  [19].  
Ha  a  PLE  enzim  dikarbonsav  észterek  esetében  
nem  alkalmazható  megfelelő  szelektivitással  (XI),  
a  megfelelő  diolszármazék  PPL  enzimmel  végzett  
hidrolízise  eredményre  vezethet.  CTR  enzim  alkal-
mazásával  esetenként  jobb optikai tisztaság  érhető  
el,  mint  a  PLE  enzimmel  megvalósítható  (XXII).  
A  prokirális  vagy  mező  vegyületek  enzimhidro-
lízise után  kemoszelektív  átalakításokkal  (5.  ábra)  
a  kívánt  enantiomer  állítható  elő.  
Racém  vegyületpárok  kinetikus  rezolválása  
A  hidrolítikus  enzimek  felhasználhatóak  enan-
tiomer  keverékek  elválasztására  (6. ábra)  [23—26,  
72—83].  A  módszer  azon  alapul,  hogy  az  egyes  
enantiomerek  különböző  sebességgel  alakulnak  át  
az  enzim  királis  felületű aktív  centrumán.  Ha  ez  a  
sebességkülönbség  elegendően nagy,  akkor  a  racém  
vegyületpár  50 % konverzió  után  optikailag  aktív,  
kémiailag  eltérő X  és Y  csoportokat  tartalmazó  
anyagok  elegvévé  alakítható.  E  vegyületek  elvá-
lasztása már egyszerű fizikai módszerekkel  megold-
ható,  elválasztás  és  átalakítások  után  a  két  enan-
tiomer  elvileg  50—50%  termeléssel  nyerhető.  A  
racém  vegyületek  enzimatikus  rezolválását  mind  
hidrolízissel,  mind  észteresítéssel  vagy  átésztere-
sítéssel  meg  lehet  valósítani  [26].  
Racém  vegyületpárok  elválasztása  enzimhidro-
lízissel  (7.  ábra).  Vizes  oldatokban  enzimatikus  
hidrolízis  segítségével  a  racém  karbonsavak  vagy  
alkoholok  észterszármazékai  kinetikusán  rezolvál-
hatóak.  A  konverziót  változtatva  a  kívánt  enan-
tiomer  optikai  tisztasága  növelhető  [72,  75],  
kis  konverzió  esetén  a  reagáló  enantiomer  tiszta-
sága  nő, nagy konverziónál  a  nem  reagálóé.  
Racém vegyületek elválasztása  enzim katalizált  észte-
resítéssel vagy átészteresítéssel ( 8 ¡a és 8 jb ábra).  Meg-
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m k l 
R'  R1  V 
HOOC  COOMe  
/—yáCOOH 
v—\cOOMe 
L1BH4 [68] vagy 
Na,  EtOH,  NH  [69]  
BJH6  [70]  vagy  >-> 
/COCtL, NaBH (71) 
LiBHi vagy 
Na, EtOH, NH3 
B2He vagy 
/COCl/£,  NaBH4  
R1  R2  
a 0-^0 
0 
-  rrS  
5.  ábra.  Az  enzim  hidrolízis  termékeinek  kemoszelektiv  
átalakítása 
felelő  körülmények  között  a  hidrolázok  katalizál-
hatnak  észterképzési  vagy  átészteresítési  reakció-
kat.  Ezek  a  folyamatok  egyensúlyi  okokból  vizes  
oldatokban  nem  valósíthatóak  meg,  ezért  az  ilyen  
típusú  átalakításokat szerves oldószer-víz  emulzió-
ban  [23]  vagy  aprotikus  szerves  oldószerekben  
[25,  26,  74]  végzik.  Az  átalakításokat  ugyanazon  
szubsztráton,  ugyanazon  enzimmel  végezve  meg-
figyelhető,  hogy  a  termékek  optikai  tisztasága  
jelentős  mértékben  megnövekedhet,  ha  vizet  tar-
talmazó  rendszerről,  folyamatról  vízmentesre  (pl.  
hidrolízisről  észteresítésre vagy szerves  oldószer-víz  
emulzióról  vízmentes  oldószerre)  térnek  át  [26,  
74].  A  jelenség  magyarázata  az  lehet  [26],  hogy  a  
kétféle  közegben  az  enzim  szolvatációja  nagymór-
tékben  eltér,  aprotikus,  szerves  oldószerekben  az  
enzim  merevebb,  meghatározottabb  konformációt  
vesz fel. 
Enzimkatalizált  diasztereoszelektív  átalakítások  
A hidrolítikus  enzimek  szelektivitása  kihasznál-
ható  diasztereomer  vegyületek  elválasztására  [75,  
84],  vagy  egy  molekulán  belüli  diasztereotóp  cso-
portok  [85]  közötti  különbségtételre  (9.  ábra)  
olyan  esetekben  is,  mikor  az  kémiailag  nehezen  
megvalósítható,  vagy  fontos,  hogy  a  reakció  
enyhe  körülmények  között  játszódjon  le.  
ENZIM 
50 %  konverzió  
Y 
R - ' 
Királ is 
rész 
Elválasztás; 
funkciós  csoportok  
átalakítása 
és 
X -  -  COOR  v/agy  
-0-cctí 
hidrolízis; 
-COOH  vagy  
-OH 
észteresí tés 
Y«-COOH  vagy  
-OH 
hidro l íz is ; 
-COOR'  vagy  
- 0 - C O R ' 
észteresítés. 
Z= X  vagy Y 
vagy 
származékaik 
6.  ábra.  Racém  ve-
gyületek  kinetikus  
rezolváláaa  hidrolí-
tikus  enzimekkel  
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Hidrolizáló  Termék15  Konv. Term.  Opt.  En-  Iro-
enantiomer-  %  %  t.  zim  dalom  
OH 
COOUe  COOH  
77t7  COOMe  
COOH 
s a  COOMe  
.A^XcoOMe  COOH  
m r  COOMe  
50 04  PLE  [56]  
63 
50  43  46  PLE  [75]  
40  40  
45  80  PLE  [75]  
Átalakuló  Termékb  Konv.Term.  Opt.  En-  Iro-
enantiomer-  %  %  t.  zim  dalom  
% ee 
OH  OCOPr  
MZ  OH  
Á ^ J .  OCOPr  
_  jri  OH  
50 
50 
39 
36 
39 
42 
90  CCL°  [23]  
89 
85  CCLC  [23]  
91 
CY0AC  OH  
OAe 
^s^OCOPr  OH  
Y50X  OCOPr  
50 
60 
< 9 9  PLE  [73]  
< 9 9 
36  < 9 2  
P P L  [72]  
OCOPr 
OH 
OH  OCOPr  
OH 
47  33  95  PPL  [74]  
32  90  
45  34  70  PPL  [74]  
31  57  
^Ht-v  ,-OCOPr  OH  
OCOPr 
rV^OCOPr  OH  
T  .  OCOPr  
60 
60 
60 
95 
81 
95 
PPL  [72]  
PPL  [72]]  
PPL  [72]  
7.  ábra.  Kinetikus  rezolválás  enzimhidrolízissel  
HO-i  ?  OCOPr  
OH 
Br 
X 
Br 
(gj-^COOH 
48  29  87  PPL  [74]  
27  92  
COOH  COOBu  45  40  96  CCL°  [74]  
COOH  78  21  99  
COOBu  20  16  99  CCL"  [74]  
COOH 
1Q)  I  COOBu  45  36  70  CCL=  [74]  
COOH  65  34  65  
Átalakuló  Termékb  Konv. Term.  Opt.  En-  Iro-
enantiomer-  %  %  t.  zim  dalom  
% ee 
Ü™ 
C C 
JtXN 
OC 
\ 
i OH 
OCOPr  50  41  85  CCL°  [23]  
OH  39  88  
OCOPr  45  34  95  P P L  [74]  
OH  31  90  
OCORd  44  
OH 
OH  OCORd  
OH 
52 
OCORd  57(45)  
OH 
98  CCLC  [25]  
80 
80  CCLC  [25]  
69(95)  CCL°  [25,  
88  26]  
OH  OCOEt  50  38  94  PLE  [231  
OH  22  
O L 0H 
ŰH  OCOEt  
OH 
OCOPr 
OH 
50  35  90  PLE  [23]  
29  92  
50  35  93  CCL°  [23]  
35  89  
8/a  ábra.  Kinetikus  rezolválás  enzimatikus  észteresitéssel  
és  átészteresítéssel  
a  az  átalakuló  enantiomernek  megfelelő  konfiguráció;  b  a  második  
sorban  fe l tüntetet t  reagálatlan  vegyület  ellentéles  konfigurációjú;  
c  Cacdida  cyildracea  mikroorganizmusból  kivont  llpáz;  
<fR=. (CH,) u CH, 
8/b  ábra.  Kinetikus  rezolválás  enzimatikus  észteresitéssel  
és  átészteresítéssel  
Alkalmazhatóság,  felhasználás  
Az előzőekben ismertetett  enzimatikus  reakciók-
kal  olyan  királis  építőelemek  széles  köre  állítható  
elő,  melyek  általánosan  alkalmazhatóak  a  szinte-
tikus  kémia  igen  sok  területén.  A  módszer  sok  
esetben összemérhető  mind árban,  mind  hatékony-
ságban  a  „tisztán"  kémiai aszimmetrikus  szintézis-
módszerekkel,  egyes  esetekben  alkalmazása  kife-
jezetten  előnyös.  Egyszerű  laboratóriumi  körül-
mények  között  ezek  a  reakciók  alkalmasak  lehet-
nek  többmólnyi  anyag  előállítására  is  [2].  Az  
utóbbi  években  számos  biológiailag aktív  vegyület  
előállítása  során  alkalmaztak  hidrolítikus  enzi-
meket,  illetve  sok  szintézisintermedier  hatékony  
előállítását  oldották  meg  azok  segítségével:  pl.  
barbiturátok  [20,  21,  46],  /?-laktam  antibiotiku-
mok  [50,  66],  S-a-metil-DOPA  [45],  piretroidok  
[20,  75],  prosztanoidok  [2,  21,  67],  biológiailag  
aktív  makrociklusos  vegyületek  [52—54],  fero-
monok  [84]  és  még  sok  más  biológiailag  aktív  
vegyület  szintézise  valósítható  meg  segítségükkel.  
Kutatócsoportunk  is sikerrel alkalmazta  a  nyers  
PLE  enzimet  a  fáraóhangya  optikailag  aktív  
nyomjelző  feromonjának  szintézise  során  [37,  38]  
többmólnyi  Ha  előállítására,  piretrin  észterek  
kinetikus  rezolválására,  valamint  a  3-acetoxi-
glutársav  dimetilészter  (lik)  hidrolízisére  [49],  
Az  anyag  beérkezett:  198U.  mire .  18.  
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a  rf  ?  .  R'  R
1  
\  /  
COOR 
+  PLE  
y 
A ^ ^ C O O R 
R'  R'  
COOR 
+ 
R!  R1  
COOH 
R ' -  CH})  R 2 -  CHv  R-CHj.  [75]  
R1 -  CHj,  R 1 -  Ct,  R-  CH3:  [75]  
R 1 -  H  ,  R*-  H ;  R-  Et  :  [943  
OH 
COOMe  PLE  COOH 
9.  ábra.  Enzimkatalizált  diasztereoszelektiv  átalakítások  
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(Lezárva  az  1986  januárjáig  összegyűjtött  forrás-
munkák  alapján.)  
SUMMARY 
This  paper  illustrates  the  scope  of  synthetic  - appli-
cabilities  of  hydrolytic  enzymes  in  organic  chemistry.  
The enzymatically produced  optically active compounds 
can  be  used  as  building  blocks  for  a  wide  range  of  
asymetric  synthesis.  
Costs  and  efficiency  of  this  method  are  comparable  
with  tha t  of  ohemical  asymetric  procedures.  Enzymic  
reactions  have  advantages  over  chemical  methods  in  
certain  cases.  
This enzymes are readily available and easily handled 
with  standard  laboratory  equipment  and  are  capable  
catalyzing  transformations  of  prochiral  or  meso as  well  
as racemic substrates into optically  active  compounds.  
PE3IOME 
B  cTaTbe  riOKa3aHO  npuMeHeMHe  rnapojiHTHiecKHx  
3H3HM0B  B npenapaTHBHoii  opraHHiecKOtt  XHMHH.  On-
THiecKH  aKTHBHbie  coeffHHeHHB,  nojiyieHHbie  c  noiwo-
Il)bK>  3H3HM0B,  MOryT  SblTb  UIHpOKO  HCn0Jlb30BaHbJ  B  
KaiecTBe  CTPyKTypHUX  sjieivieHTOB  AJIH aajibHeftinero 
CHHTe3a  aCHMMeTpHBHblX  COeflHHeHHÜ.  3(|>(j)eKTHBH0CTb  
H  CTOHMOCTb  3H3HMHOrO  MeTOfla  CHHTe3a  cpaBHHMa  c  
XHMHieCKHMH  aCHMMeTpHHHUMH  MeTOflaMH  CHHTe3a,  a  
B  onpeflejieHHux  cjiyvanx  a a « e  BBJIBCTCB  npemwy-
iqecTBeHHHM.  Hcnojibsyeiwbie  SHSHMU  jierxo  AOcrynHbi,  
xopooio  o6pa6aTbiBaioTCB  Ha  oöuMHbix  jiafiopaTopHbix  
ycTaHOBKax  H cnocoöHbi  KaTajiH3HpoBaTb  npeBpauieHHH  
npoxHpajibHbix,  MeaocoeAHHeHHü  H  paneMHMecKHx  se-
iqecTB  AO  oimmecKH  AKTHBHMX  coeAHHeHHü.  
x u n .  ÉVFOLYAM,  t.  szám  245 
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